Citrus Sinensis ID: 040808
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.604 | 0.383 | 0.570 | 1e-101 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.612 | 0.384 | 0.560 | 1e-100 | |
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.618 | 0.354 | 0.534 | 1e-98 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.573 | 0.336 | 0.433 | 5e-67 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.612 | 0.381 | 0.420 | 4e-66 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.702 | 0.433 | 0.378 | 7e-66 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.565 | 0.349 | 0.427 | 7e-62 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.573 | 0.283 | 0.417 | 2e-60 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.573 | 0.283 | 0.417 | 6e-60 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.545 | 0.319 | 0.405 | 4e-57 |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 368 bits (945), Expect = e-101, Method: Compositional matrix adjust.
Identities = 181/317 (57%), Positives = 237/317 (74%), Gaps = 8/317 (2%)
Query: 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISR 254
++Y++++++TKSFS +G+GG+ VY G L +GR VAVKV+K+LK + E+FINEVAS+S+
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
TSHVNIV LGFC+E KRA++YEF+ NGSLDQ++ S N T + T+Y IA+GIA
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFM----SRNKSLTQDVTTLYGIALGIA 603
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
RGLEYLH GC RIVH DIKP NI LD + CPK+SDFGLAK EK+ES +S++DTRGT G
Sbjct: 604 RGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIG 663
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKV---SCSSEYFPNAIYKQIE 431
YIAPEVF R +G VSHKSDVYS+GM++ +M+ R V+ + SS YFP+ IYK +E
Sbjct: 664 YIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLE 723
Query: 432 T-EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPK 490
E + +T+EEKE+AKKMI+V LWCIQ P DRPSM +VVEM+EGS++ L+IPPK
Sbjct: 724 DGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPK 783
Query: 491 PSLSLPTGYAKQSSPTS 507
PS+ + T +SS S
Sbjct: 784 PSMHISTEVITESSSLS 800
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 367 bits (942), Expect = e-100, Method: Compositional matrix adjust.
Identities = 180/321 (56%), Positives = 238/321 (74%), Gaps = 8/321 (2%)
Query: 190 LAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEV 249
L K++ Y++++++TKSFS +G+GG+ VY+G L +GR VAVKV+K+LK NG++FINEV
Sbjct: 481 LLLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEV 540
Query: 250 ASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQI 309
S+S+TSHVNIV LGFCYE KRA+I EF+ +GSLDQ+I S N T T+Y I
Sbjct: 541 TSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI----SRNKSLTPNVTTLYGI 596
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT 369
A+GIARGLEYLH GC RIVH DIKP NI LD++FCPK++DFGLAK EK+ES +S++DT
Sbjct: 597 ALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDT 656
Query: 370 RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC--SSEYFPNAIY 427
RGT GYIAPEV R +GG+SHKSDVYSYGM++ +M IG +N +C S+ YFP+ IY
Sbjct: 657 RGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDM-IGARNKVETTTCNGSTAYFPDWIY 715
Query: 428 KQIET-EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486
K +E + + + + EE+ ++ KKMILVSLWCI+ P DRP M KVVEM+EGS++ L+
Sbjct: 716 KDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALE 775
Query: 487 IPPKPSLSLPTGYAKQSSPTS 507
+PPKPS + T +SS S
Sbjct: 776 LPPKPSRHISTELVLESSSLS 796
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 360 bits (924), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 179/335 (53%), Positives = 242/335 (72%), Gaps = 19/335 (5%)
Query: 174 RHDQNAEAAFVRNYGSLAP-KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAV 232
R + ++ ++ +L P K ++Y++V++MTKSF++ +G+GG+ VY GTL D +VAV
Sbjct: 524 RKRKTSDEVRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAV 583
Query: 233 KVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYD 291
KV+K+ K +GE+FINEVAS+S+TSHVNIV LGFC E +RA+IYEF+ NGSLD++I D
Sbjct: 584 KVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISD 643
Query: 292 HESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351
S N L+ +T+Y IA+G+ARGLEYLH GC RIVH DIKP N+ LD++ CPK+SDF
Sbjct: 644 KSSVN----LDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDF 699
Query: 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK-- 409
GLAK EKKES +S+LDTRGT GYIAPE+ R +G VSHKSDVYSYGM++ EM+ RK
Sbjct: 700 GLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKE 759
Query: 410 --NADVKVSCSSEYFPNAIYKQIE---------TEYDFQLDGVVTEEEKEMAKKMILVSL 458
+ + + SS YFP IYK +E TE ++ ++ EE+E+A+KM LV L
Sbjct: 760 RFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGL 819
Query: 459 WCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493
WCIQ+ P DRP M KVVEM+EGS++ L++PP+P L
Sbjct: 820 WCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (652), Expect = 5e-67, Method: Compositional matrix adjust.
Identities = 133/307 (43%), Positives = 187/307 (60%), Gaps = 14/307 (4%)
Query: 191 APKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE-EFINEV 249
+P F+Y D++ T +FS LG GG+ VYKGT+ LVAVK + +GE EFI EV
Sbjct: 516 SPVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEV 575
Query: 250 ASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQI 309
+I H+N+V G+C E R L+YE+M NGSLD++I+ E + L+WRT ++I
Sbjct: 576 NTIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQT--ANLLDWRTRFEI 633
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT 369
AV A+G+ Y H C RI+H DIKP NI LD++FCPK+SDFGLAK ++ S + +
Sbjct: 634 AVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTM-I 692
Query: 370 RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429
RGT GY+APE ++ K+DVYSYGM++ E+V GR+N D+ ++P YK+
Sbjct: 693 RGTRGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKE 750
Query: 430 IET-----EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
+ D +L GV EEE A K V+ WCIQ RPSM +VV++LEG+ +
Sbjct: 751 LTNGTSLKAVDKRLQGVAEEEEVVKALK---VAFWCIQDEVSMRPSMGEVVKLLEGTSDE 807
Query: 485 LQIPPKP 491
+ +PP P
Sbjct: 808 INLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 138/328 (42%), Positives = 199/328 (60%), Gaps = 15/328 (4%)
Query: 172 ETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVA 231
E + + E F+ N + P RF+Y D++ T +FS KLGQGG+ VY+GTLPDG +A
Sbjct: 461 EAPQESSEEDNFLENLSGM-PIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLA 519
Query: 232 VKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYD 291
VK ++ + +EF EV+ I H+++V GFC E R L YEF+ GSL+++I+
Sbjct: 520 VKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFR 579
Query: 292 HESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351
+ +G L+W T + IA+G A+GL YLH C+ RIVH DIKP NI LD++F K+SDF
Sbjct: 580 KK--DGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDF 637
Query: 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411
GLAK +++S + RGT GY+APE + +S KSDVYSYGM++ E++ GRKN
Sbjct: 638 GLAKLMTREQSHV-FTTMRGTRGYLAPEWITNY--AISEKSDVYSYGMVLLELIGGRKNY 694
Query: 412 DVKVSCSSEYFPNAIYKQIETE-----YDFQLDGV-VTEEEKEMAKKMILVSLWCIQTHP 465
D + +FP+ +K++E D ++ V VT+E + A K +LWCIQ
Sbjct: 695 DPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMK---TALWCIQEDM 751
Query: 466 PDRPSMTKVVEMLEGSIENLQIPPKPSL 493
RPSM+KVV+MLEG +Q P ++
Sbjct: 752 QTRPSMSKVVQMLEGVFPVVQPPSSSTM 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 7e-66, Method: Compositional matrix adjust.
Identities = 144/380 (37%), Positives = 212/380 (55%), Gaps = 21/380 (5%)
Query: 132 LLSAAKGSLAGLKEALETGFELKWKLNSSCKNCSSCSYHKETRHDQNAEAAFVRNYGSLA 191
L A +AGL + L W C K R + + Y S A
Sbjct: 422 LWIVAVAVIAGLLGLVAVEIGLWW-----------CCCRKNPRFGTLSSHYTLLEYASGA 470
Query: 192 PKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVAS 251
P +F+Y +++R TKSF +KLG GG+ VY+G L + +VAVK ++ ++ ++F EVA+
Sbjct: 471 PVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVAT 530
Query: 252 ISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
IS T H+N+V +GFC + + R L+YEFM NGSLD +++ +S+ + L W + IA+
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSA---KFLTWEYRFNIAL 587
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
G A+G+ YLH C IVH DIKP NI +D++F K+SDFGLAK K++ +M RG
Sbjct: 588 GTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRG 647
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431
T GY+APE ++ KSDVYSYGM++ E+V G++N DV + + F Y++ E
Sbjct: 648 TRGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFE 705
Query: 432 T-EYDFQLDGVVTEEEK---EMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487
LD ++E++ E +M+ S WCIQ P RP+M KVV+MLEG I ++
Sbjct: 706 KGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG-ITEIKN 764
Query: 488 PPKPSLSLPTGYAKQSSPTS 507
P P ++ S TS
Sbjct: 765 PLCPKTISEVSFSGNSMSTS 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 238 bits (608), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 130/304 (42%), Positives = 184/304 (60%), Gaps = 15/304 (4%)
Query: 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISR 254
FSY +++ TK+FSDKLG GG+ V+KG LPD +AVK ++ + ++F EV +I
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
HVN+V GFC E K+ L+Y++MPNGSLD +++ ++ K L W+ +QIA+G A
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEE-KIVLGWKLRFQIALGTA 601
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
RGL YLH C I+H DIKP NI LD FCPK++DFGLAK + S + + RGT G
Sbjct: 602 RGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV-LTTMRGTRG 660
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK------ 428
Y+APE ++ K+DVYSYGMM+ E+V GR+N + + +FP+
Sbjct: 661 YLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDG 718
Query: 429 QIETEYDFQLDG-VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487
I + D +L+G V EE A K V+ WCIQ RP+M++VV++LEG +E +
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACK---VACWCIQDEESHRPAMSQVVQILEGVLE-VNP 774
Query: 488 PPKP 491
PP P
Sbjct: 775 PPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 127/304 (41%), Positives = 188/304 (61%), Gaps = 11/304 (3%)
Query: 192 PKRFSYSDVRRMTKSF--SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE-EFINE 248
P F+YS+++ T+ F S+KLG+GG+ VYKG L DGR+VAVK++ G+ +F+ E
Sbjct: 679 PYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAE 738
Query: 249 VASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQ 308
+ +IS H N+V G C+E + R L+YE++PNGSLDQ ++ ++ + L+W T Y+
Sbjct: 739 IVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLH----LDWSTRYE 794
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
I +G+ARGL YLH ++RIVH D+K NI LD P+ISDFGLAK + K++ IS
Sbjct: 795 ICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHIST-R 853
Query: 369 TRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428
GT GY+APE R G ++ K+DVY++G++ E+V GR N+D + +Y +
Sbjct: 854 VAGTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWN 911
Query: 429 QIETEYDFQL-DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487
E D +L D +T+ E AK+MI ++L C QT RP M++VV ML G +E +
Sbjct: 912 LHEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDV 971
Query: 488 PPKP 491
KP
Sbjct: 972 TSKP 975
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 6e-60, Method: Compositional matrix adjust.
Identities = 127/304 (41%), Positives = 184/304 (60%), Gaps = 11/304 (3%)
Query: 192 PKRFSYSDVRRMTKSF--SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE-EFINE 248
P F+YS+++ T+ F S+KLG+GG+ VYKG L DGR VAVK++ G+ +F+ E
Sbjct: 678 PYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAE 737
Query: 249 VASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQ 308
+ +IS H N+V G CYE + R L+YE++PNGSLDQ ++ ++ + L+W T Y+
Sbjct: 738 IVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLH----LDWSTRYE 793
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
I +G+ARGL YLH +RIVH D+K NI LD PK+SDFGLAK + K++ IS
Sbjct: 794 ICLGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIST-R 852
Query: 369 TRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428
GT GY+APE R G ++ K+DVY++G++ E+V GR N+D + Y +
Sbjct: 853 VAGTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWN 910
Query: 429 QIETEYDFQL-DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487
E + +L D +TE E K+MI ++L C QT RP M++VV ML G +E +
Sbjct: 911 LHEKGREVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDV 970
Query: 488 PPKP 491
KP
Sbjct: 971 TSKP 974
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 4e-57, Method: Compositional matrix adjust.
Identities = 129/318 (40%), Positives = 187/318 (58%), Gaps = 39/318 (12%)
Query: 192 PKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG-EEFINEVA 250
P++F + ++ + T++F ++G GG+ VYKGTLPD L+AVK + N +G +EF E+A
Sbjct: 502 PQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIA 561
Query: 251 SISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIA 310
I H N+V GFC ++ L+YE+M +GSL++ ++ S NG LEW+ + IA
Sbjct: 562 IIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF---SGNGP-VLEWQERFDIA 617
Query: 311 VGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES--FISMLD 368
+G ARGL YLH GC+ +I+H D+KP NI L + F PKISDFGL+K ++ES F +M
Sbjct: 618 LGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTM-- 675
Query: 369 TRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------- 419
RGT GY+APE +S K+DVYSYGM++ E+V GRKN + +S
Sbjct: 676 -RGTRGYLAPEWITN--AAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNH 732
Query: 420 ----------EYFP-NAIYKQIETEY----DFQLDGVVTEEEKEMAKKMILVSLWCIQTH 464
YFP A+ + Y D +L+G VT +E A+K++ ++L C+
Sbjct: 733 SSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQE---AEKLVRIALCCVHEE 789
Query: 465 PPDRPSMTKVVEMLEGSI 482
P RP+M VV M EGSI
Sbjct: 790 PALRPTMAAVVGMFEGSI 807
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | ||||||
| 224127698 | 580 | predicted protein [Populus trichocarpa] | 0.953 | 0.839 | 0.480 | 1e-138 | |
| 225452094 | 858 | PREDICTED: probable receptor-like protei | 0.661 | 0.393 | 0.671 | 1e-130 | |
| 224108441 | 324 | predicted protein [Populus trichocarpa] | 0.630 | 0.993 | 0.672 | 1e-124 | |
| 224108429 | 365 | predicted protein [Populus trichocarpa] | 0.636 | 0.890 | 0.660 | 1e-124 | |
| 255551426 | 638 | serine/threonine kinase, putative [Ricin | 0.659 | 0.528 | 0.65 | 1e-123 | |
| 356511307 | 669 | PREDICTED: probable receptor-like protei | 0.966 | 0.738 | 0.429 | 1e-123 | |
| 147769927 | 1001 | hypothetical protein VITISV_010117 [Viti | 0.636 | 0.324 | 0.654 | 1e-121 | |
| 449487021 | 598 | PREDICTED: probable receptor-like protei | 0.986 | 0.842 | 0.447 | 1e-120 | |
| 224095678 | 365 | predicted protein [Populus trichocarpa] | 0.659 | 0.923 | 0.634 | 1e-120 | |
| 147795963 | 624 | hypothetical protein VITISV_039936 [Viti | 0.684 | 0.560 | 0.612 | 1e-120 |
| >gi|224127698|ref|XP_002329342.1| predicted protein [Populus trichocarpa] gi|222870796|gb|EEF07927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1283), Expect = e-138, Method: Compositional matrix adjust.
Identities = 274/570 (48%), Positives = 346/570 (60%), Gaps = 83/570 (14%)
Query: 2 LKGTSYPFSGGEREYTCGHPSLNLNCENDTATLVLGEVKYRVLNIDQKEQLLRIAKQVYF 61
++ +YPF G R CG+P +L+C D + + EV Y+VL I ++ I+ + Y
Sbjct: 16 IQNITYPFWGVNRPQYCGYPGFHLDCSGDAPVIKISEVAYQVLEIKSMSRVHLISTE-YT 74
Query: 62 DGFC--PQRNFTIDSTLFTYADGYKMLTLISGCPTMSGNSV----------CYINGLNYA 109
D C P N T DS F+YA K + L GCPT+ + C I+ +
Sbjct: 75 DNICSIPPVNSTFDSDRFSYASNTKNIMLYYGCPTIPSQFLPTLGLSYQFSCNISRTDMV 134
Query: 110 NGFM-------QTGS---------PDCNFSVTIPVAETLLSAAKG--SLAGLKEALETGF 151
++ TGS CN SV IP E+ + + + + A L AL GF
Sbjct: 135 GYYLTRNLSMSATGSFAANISSYLESCNHSVLIPAYESAVRSIESHPTAANLTNALHRGF 194
Query: 152 ELKWKLNSS-CKNC----SSCSYHKET--------------------------------- 173
L+W N S C C C Y+ +T
Sbjct: 195 WLQWTANDSLCNKCKFSGGQCGYNTDTSKFTCYFVTLAMYTMIAVTIIVLCSRRGLSRGR 254
Query: 174 ---------RHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTL 224
+H+ N E + N SL PKR++YS++++MT SF DKLGQGG+ VYKG L
Sbjct: 255 MTSFWRQNAQHNLNIET-IIMNSHSLTPKRYTYSEIKKMTNSFVDKLGQGGFGGVYKGEL 313
Query: 225 PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284
PDGR VAVKV+KN K +GEEF+NEV SISRTSHVNIV LGFC+E+ KRALIYE+MPNGS
Sbjct: 314 PDGRPVAVKVLKNSKGDGEEFVNEVVSISRTSHVNIVTLLGFCFERTKRALIYEYMPNGS 373
Query: 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF 344
LD++IY S +GK L+W +Y+IAVGI RGLEYLHRGCN RIVH DIKPHNI LD DF
Sbjct: 374 LDKFIYRQTSLHGKYNLQWEKLYEIAVGIGRGLEYLHRGCNTRIVHFDIKPHNILLDTDF 433
Query: 345 CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
CPKISDFGLAK +++ES +SM RGTAGYIAPEVFC++FGGVS+KSDVYSYGMM+ EM
Sbjct: 434 CPKISDFGLAKLCKREESMVSMTGARGTAGYIAPEVFCKNFGGVSYKSDVYSYGMMVLEM 493
Query: 405 VIGRKNADVKVSCSSEYF-PNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQT 463
V G++N D+ S SSE F PN +Y E+E L GV+T+E +E KKM+ V LWC+QT
Sbjct: 494 VGGKRNIDIGESQSSEIFLPNCMY---ESEEVSSLHGVITDETEETIKKMVTVGLWCVQT 550
Query: 464 HPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493
+P DRPSMTKVVEMLEGS++ LQ PPKP L
Sbjct: 551 NPLDRPSMTKVVEMLEGSLQFLQTPPKPFL 580
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225452094|ref|XP_002280747.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 472 bits (1214), Expect = e-130, Method: Compositional matrix adjust.
Identities = 229/341 (67%), Positives = 270/341 (79%), Gaps = 3/341 (0%)
Query: 169 YHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGR 228
+ KET +QN EA FVRNYGSLAPKR+ YS V++MT SF+ KLGQGG+ VY+G LPDGR
Sbjct: 520 WKKETGDNQNVEA-FVRNYGSLAPKRYKYSVVKKMTNSFTCKLGQGGFGCVYQGKLPDGR 578
Query: 229 LVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY 288
VAVK++ K NGEEFINEVAS SRTSHVNIV +GFC+E +RALIYEFMPNGSLD+
Sbjct: 579 QVAVKLLSESKGNGEEFINEVASFSRTSHVNIVTLVGFCFEGTRRALIYEFMPNGSLDKL 638
Query: 289 IYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348
IY S N LEW+T+YQIAVGIARGLEYL+RGCN RI+H DIKPHNI LDEDFCPKI
Sbjct: 639 IYQKGSPNANLKLEWKTMYQIAVGIARGLEYLYRGCNTRILHFDIKPHNILLDEDFCPKI 698
Query: 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
SDFGLAK ++KES +SM RGTAGYIAPEVFCR+FGGVSHKSDVYSYGM++ EM+ GR
Sbjct: 699 SDFGLAKLCQRKESMVSMAHARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVFEMIGGR 758
Query: 409 KNADVKVSCSSE-YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPD 467
KN D +VS +S+ YFP IYKQ++ D L + EEE+E A+KM+LVSLWCIQ +P D
Sbjct: 759 KNIDAQVSHTSQIYFPTWIYKQLQPGEDLILHSITNEEEEETARKMVLVSLWCIQLNPSD 818
Query: 468 RPSMTKVVEMLEGSIENLQIPPKPSLSLPTGYAKQSSPTSS 508
RPS+ KVVEMLEGS+++L+IPP P + PT A Q TSS
Sbjct: 819 RPSIDKVVEMLEGSLQSLEIPPNPFM-FPTQNATQDPSTSS 858
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108441|ref|XP_002314847.1| predicted protein [Populus trichocarpa] gi|222863887|gb|EEF01018.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1163), Expect = e-124, Method: Compositional matrix adjust.
Identities = 218/324 (67%), Positives = 261/324 (80%), Gaps = 2/324 (0%)
Query: 171 KETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLV 230
++TR Q+ EA F+RNYG+LAPKR+SYS++++MTK+F +KLGQGGY V+KG L DGRLV
Sbjct: 2 RKTRGSQSMEA-FLRNYGTLAPKRYSYSELKKMTKNFKEKLGQGGYGSVFKGNLLDGRLV 60
Query: 231 AVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY 290
AVKV+K K NGEEF+NEV+SI TSHVNIV LGFC+E KRALIYEFM NGSLD++IY
Sbjct: 61 AVKVLKKSKSNGEEFVNEVSSIGMTSHVNIVTLLGFCFEGPKRALIYEFMSNGSLDKHIY 120
Query: 291 DHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350
+ S + L W T+YQIAVGIARGLEYLHRGCN RI+H DIKPHNI LDE+FCPKISD
Sbjct: 121 EENLSKAQPKLGWETLYQIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDENFCPKISD 180
Query: 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410
FGLAK KES +SML RGTAGYIAPEVFCR+FGGVSHKSDVYSYGM++ EM+ GRKN
Sbjct: 181 FGLAKICPGKESIVSMLGARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVLEMIGGRKN 240
Query: 411 ADVKVSCSSE-YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469
V V +SE YFP+ IYK++E + QL G E E+E A+KMIL SLWCIQT P +RP
Sbjct: 241 FRVGVDNTSEIYFPHWIYKRLEIGEELQLRGAGNEVEEENARKMILASLWCIQTDPSNRP 300
Query: 470 SMTKVVEMLEGSIENLQIPPKPSL 493
M++VV+ML+GS+E+L IPPKP L
Sbjct: 301 PMSRVVDMLQGSLESLPIPPKPYL 324
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108429|ref|XP_002314844.1| predicted protein [Populus trichocarpa] gi|222863884|gb|EEF01015.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 216/327 (66%), Positives = 262/327 (80%), Gaps = 2/327 (0%)
Query: 171 KETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLV 230
++TR Q+ E F+RNYG+LAP+R+SYS++++MTK+F +KLGQGG+ V+KG L DGRLV
Sbjct: 29 RKTRGSQSIEV-FLRNYGTLAPERYSYSELKKMTKNFKEKLGQGGFGSVFKGNLLDGRLV 87
Query: 231 AVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY 290
AVKV+K K NGEEF+NEV+SI RTSHVNIV LGFC+E KRALIYEFM NGSLD++IY
Sbjct: 88 AVKVLKKSKSNGEEFVNEVSSIGRTSHVNIVTLLGFCFEGPKRALIYEFMSNGSLDKHIY 147
Query: 291 DHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350
+ S L W T+YQIAVGIARGLEYLHRGCN RI+H DIKPHNI LDE+FCPKISD
Sbjct: 148 EENLSKAHPKLGWETLYQIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDENFCPKISD 207
Query: 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410
FGLAK KES +SML RGTAGYIAPEVFCR+FGGVSHKSDVYSYGM++ EM+ GRKN
Sbjct: 208 FGLAKICPSKESIVSMLGARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVLEMIGGRKN 267
Query: 411 ADVKVSCSSE-YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469
V V +SE YFP+ IY+++E + QL G E E++ A+KMIL SLWCIQT P +RP
Sbjct: 268 FRVGVDNTSEIYFPHWIYRRLEIGEELQLRGAGNEVEEQNARKMILASLWCIQTDPSNRP 327
Query: 470 SMTKVVEMLEGSIENLQIPPKPSLSLP 496
M++VV+ML+GS+E+L IPPKP LS P
Sbjct: 328 PMSRVVDMLQGSLESLPIPPKPYLSSP 354
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551426|ref|XP_002516759.1| serine/threonine kinase, putative [Ricinus communis] gi|223544132|gb|EEF45657.1| serine/threonine kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1151), Expect = e-123, Method: Compositional matrix adjust.
Identities = 221/340 (65%), Positives = 261/340 (76%), Gaps = 3/340 (0%)
Query: 171 KETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLV 230
K + D+ E F+ NY S PKR+SYSD++RMT SF+ KLGQGG+ VYKG L DGR+V
Sbjct: 294 KNVKKDEKIEN-FILNYQSFMPKRYSYSDIQRMTNSFNHKLGQGGFGGVYKGKLLDGRVV 352
Query: 231 AVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY 290
AVKV+ +GEEFINEVASISRTSH+N+V LGFCYE+ KRALIYE+MPNGSLD++IY
Sbjct: 353 AVKVLSKSTGDGEEFINEVASISRTSHINVVTLLGFCYERSKRALIYEYMPNGSLDKFIY 412
Query: 291 DHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350
D S + L+W+T+Y I VGIARGLEYLHRGCN RIVH DIKPHNI LD+DFCPK+SD
Sbjct: 413 DQGSQGVNKHLDWKTLYDITVGIARGLEYLHRGCNTRIVHFDIKPHNILLDKDFCPKVSD 472
Query: 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410
FGLAK + KES I+ML RGT GYIAPE+F R+FGGVS+KSDVYSYGMMI E+ GR
Sbjct: 473 FGLAKLCKGKESIITMLGARGTIGYIAPEIFIRNFGGVSYKSDVYSYGMMILEICGGRNK 532
Query: 411 ADVKVSCSSE-YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469
+DV VS S E YFP IYK IE+E L +T+EE EM +++ +V LWCIQT+P DRP
Sbjct: 533 SDVGVSHSGEVYFPECIYKYIESEQVSTLHEKITDEEGEMVRRLTIVGLWCIQTNPSDRP 592
Query: 470 SMTKVVEMLEG-SIENLQIPPKPSLSLPTGYAKQSSPTSS 508
SMTKVVEMLEG S+E+LQIPPKPSL PT SS SS
Sbjct: 593 SMTKVVEMLEGSSLESLQIPPKPSLFAPTTPQHYSSTLSS 632
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511307|ref|XP_003524368.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1150), Expect = e-123, Method: Compositional matrix adjust.
Identities = 253/589 (42%), Positives = 345/589 (58%), Gaps = 95/589 (16%)
Query: 2 LKGTSYPFSGGEREYTCGHPSLNLNCENDTATLV-LGEVKYRVLNIDQKEQLLRIAKQVY 60
L+ SYPF GG R CG L C +D T V +G ++ VLNI+Q LR+A+
Sbjct: 64 LRNISYPFWGGNRPQFCGRNGFKLTCMHDQNTSVQVGSQRFNVLNINQTASTLRMARTDL 123
Query: 61 FDGFCPQR--NFTIDSTLFTYADGYKMLTLISGCP----TMSGNSVCYINGLNYANGFMQ 114
C N ++ + F++ + +T+ CP ++ GN+ N N + F
Sbjct: 124 VYDRCSSNFTNTSLSVSPFSFPSTVQNVTIFYECPSGINSVVGNNFTCQNDSNNKHAFYV 183
Query: 115 T---------GSPDCNFSVTIPVAETLLSAAKGSLAGLKEALETGFELKW--KLNSSCKN 163
G C SV + V+E ++ ++G + L++ALE GF++++ +L+S C
Sbjct: 184 VNGTQLKQFPGLQKCGVSVQMQVSEGVVWDSEGGIGALEKALEKGFDVRYDAELSSQCTA 243
Query: 164 C---------------------------SSCSYHKETR---------------------- 174
C S CS HK R
Sbjct: 244 CRDSGGACGTNENDLAQFSCYCSGGTHGSLCSTHKSQRKNRVLKLVLGFVATGFALPLIA 303
Query: 175 -----------------------HDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKL 211
+DQ E AF+ + GSL KR+S+SD++++T SF KL
Sbjct: 304 VIICRNKARIWKFILVQVGKIKKNDQVIE-AFLESQGSLGLKRYSFSDIKKITNSFKIKL 362
Query: 212 GQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK 271
G+GGY VYKG L +G VAVK++ K+NGEEFINEVASIS+TSHVNIV LGFC +
Sbjct: 363 GEGGYGSVYKGKLLNGCSVAVKILNESKENGEEFINEVASISKTSHVNIVSLLGFCLDGS 422
Query: 272 KRALIYEFMPNGSLDQYIYDHESSNGKR--TLEWRTVYQIAVGIARGLEYLHRGCNIRIV 329
++ALIYEFM NGSL++YI++ + +L W ++QIA+GIARGLEYLH+GCN RI+
Sbjct: 423 RKALIYEFMSNGSLEKYIHEKTAETKTTTPSLSWERLHQIAIGIARGLEYLHKGCNTRIL 482
Query: 330 HLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVS 389
H DIKPHNI LDE + PKISDFGLAK + + ES ISM + RGT GY+APEVF + FGGVS
Sbjct: 483 HFDIKPHNILLDEAYRPKISDFGLAKLSTRDESIISMSNARGTVGYVAPEVFSKSFGGVS 542
Query: 390 HKSDVYSYGMMIHEMVIGRKNADVKVSCSSE-YFPN-AIYKQIETEYDFQLDGVVTEEEK 447
HKSDVYSYGMM+ EMV G+KN DV+ S SSE YFP IYK++E D LDG+++ EE
Sbjct: 543 HKSDVYSYGMMLLEMVGGQKNMDVEASRSSEIYFPQLVIYKKLEQGNDLGLDGILSGEEN 602
Query: 448 EMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLP 496
E+AK+M +V LWCIQT P RP++++V++MLEGS+++L++PPKP LS P
Sbjct: 603 EIAKRMTMVGLWCIQTIPSHRPTISRVIDMLEGSVDSLEMPPKPFLSSP 651
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-121, Method: Compositional matrix adjust.
Identities = 214/327 (65%), Positives = 259/327 (79%), Gaps = 2/327 (0%)
Query: 171 KETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLV 230
K+T + N E F+RN+ SLAPKR+ YS+V++MT SF D++G+GGY VYKG L +G LV
Sbjct: 663 KQTGNHLNVET-FLRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLV 721
Query: 231 AVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY 290
AVKV+ K NGEEFINE+ASISRTSHVNIV LGFC++ KRALIYEFMPNGSL+++IY
Sbjct: 722 AVKVLSETKGNGEEFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIY 781
Query: 291 DHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350
D SS L W T+Y IA+GIARGLEYLHRGCN RI+HLDIKPHNI L++DFCPKISD
Sbjct: 782 DKNSSMTYHKLGWETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISD 841
Query: 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410
FGL+K +KES ISM RGTAGYIAPEVFCR+FG VS KSDVYSYGMM+ EMV GRKN
Sbjct: 842 FGLSKLCTRKESIISMSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKN 901
Query: 411 ADVKVSCSSE-YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469
D ++ +SE YFP+ IYK++E + + L G + EEE+ A+KMI+VSLWCIQT+P +RP
Sbjct: 902 TDDGINHTSEIYFPHWIYKRLELDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRP 961
Query: 470 SMTKVVEMLEGSIENLQIPPKPSLSLP 496
M VV+MLEGS+E+LQIPPKP L P
Sbjct: 962 PMNGVVDMLEGSLESLQIPPKPFLYSP 988
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449487021|ref|XP_004157472.1| PREDICTED: probable receptor-like protein kinase At5g39020-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1126), Expect = e-120, Method: Compositional matrix adjust.
Identities = 245/548 (44%), Positives = 331/548 (60%), Gaps = 44/548 (8%)
Query: 2 LKGTSYPFSGGEREYTCGHPSLNLNCEN-DTATLVLGEVKYRVLNIDQKEQLLRIAKQVY 60
L SYPF G +R+ CG L+C+N +T T+ + Y V+NI Q + + IA+
Sbjct: 42 LVNISYPFWGNDRQSFCGRREFGLSCKNNETTTIHINSWPYIVVNISQSDHRMTIARSEL 101
Query: 61 FDGFCPQRNF---TIDSTLFTYADGYKMLTLISGCPTMSGNSVCYI----------NGLN 107
FD +CP + +D + F Y++ L+L CP + ++ N
Sbjct: 102 FDDYCPDKEIGGGALDFSPFKYSNNNLNLSLWYDCPILLEVPKYFVFECVSKGERSGRTN 161
Query: 108 YANGFMQT--GSP---DCNFSVTIPVAETLLSAAKGSLAGLKE-ALETGFELKWK--LNS 159
YA +T SP +C + + + + K + + E ++ GFE++++ ++
Sbjct: 162 YALEESETTKWSPYNRECGIKIDVTITSEIFQEGKTNRTVMMERGMKEGFEVEYEDIYST 221
Query: 160 SCKNCS---------------SCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMT 204
+C+ C+ C K + N E + +R Y L PKR+SYS ++++T
Sbjct: 222 ACEACAFSGTGGLIIFIIIIAICYMRKNKSNKDNIEES-IRRYSILMPKRYSYSKLKKIT 280
Query: 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFL 264
SF +KLGQGG++ +Y+G LPDGR VAVK++ K+NG++FINEV SI+ TSHVNI L
Sbjct: 281 DSFKNKLGQGGFSTIYRGKLPDGRDVAVKLLNESKENGQDFINEVVSITGTSHVNIASLL 340
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
GFCYE+KKRALIYE+MP GSLDQYI L+W T+Y I +G+ARGLEYLHRGC
Sbjct: 341 GFCYERKKRALIYEYMPRGSLDQYISHKGPHRNNIELDWNTLYSIVIGVARGLEYLHRGC 400
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
I+H DIKPHNI LD DFCPKI+DFGLAKQ +ES ++M +GT G+IAPEV R
Sbjct: 401 ITMILHFDIKPHNILLDSDFCPKITDFGLAKQCRARESHVTMTGVKGTVGFIAPEVIFRS 460
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS-EYFPNAIYK---QIETEYDFQLDG 440
FG VSHKSDVYSYGM++ EMV RKN + V SS EYFP+ IY Q E + + L G
Sbjct: 461 FGKVSHKSDVYSYGMLVLEMVGARKNPNDGVGQSSGEYFPDWIYNNLTQSEIDEGYCLRG 520
Query: 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLPTGYA 500
TEEEKEM +KMI+V L CIQT P DRPSMT V+ MLEGS + LQIPPKP+L P +
Sbjct: 521 S-TEEEKEMTRKMIIVGLHCIQTLPDDRPSMTDVIAMLEGSGDGLQIPPKPNLFGPPTF- 578
Query: 501 KQSSPTSS 508
+ P+SS
Sbjct: 579 EHPQPSSS 586
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224095678|ref|XP_002334738.1| predicted protein [Populus trichocarpa] gi|222874466|gb|EEF11597.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1126), Expect = e-120, Method: Compositional matrix adjust.
Identities = 215/339 (63%), Positives = 260/339 (76%), Gaps = 2/339 (0%)
Query: 171 KETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLV 230
K ++H + E F+ +Y SL PKR+SYSD+++MT SF++ LGQGG+ +VY+G LP+GRLV
Sbjct: 6 KNSQHVDSVET-FMMDYHSLTPKRYSYSDIKKMTSSFANILGQGGFGNVYRGKLPEGRLV 64
Query: 231 AVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY 290
AVKV+K KD+GEEF+NEVASISRTSHVN+V LGFCYE+ KRALIYEFMPNGSLD +I
Sbjct: 65 AVKVLKESKDDGEEFMNEVASISRTSHVNVVTLLGFCYERNKRALIYEFMPNGSLDSFIS 124
Query: 291 DHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350
D S + LEW+ +Y+IAV IARGLEYLHRGCN RIVH DIKPHNI LD++FCPKISD
Sbjct: 125 DKGSPHTNCRLEWKKLYEIAVSIARGLEYLHRGCNTRIVHFDIKPHNILLDDEFCPKISD 184
Query: 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410
FGLAK + K S ISM+ RGT GYIAPEVFCR FGGV++KSDVYSYGMM+ EMV K+
Sbjct: 185 FGLAKLCQSKVSKISMIGARGTVGYIAPEVFCRSFGGVTYKSDVYSYGMMVLEMVGQSKD 244
Query: 411 ADV-KVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469
D+ + + YFP+ Y +E L G TEEEKE+ KKMILV LWCIQT P RP
Sbjct: 245 FDMGSLETNEMYFPDWFYMYLEPGKISTLHGGTTEEEKEIVKKMILVGLWCIQTIPSHRP 304
Query: 470 SMTKVVEMLEGSIENLQIPPKPSLSLPTGYAKQSSPTSS 508
SMTKVVEM EGS+++LQIPP+PS S P A++ S T S
Sbjct: 305 SMTKVVEMFEGSLQSLQIPPRPSFSSPRRSAQEQSCTVS 343
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1126), Expect = e-120, Method: Compositional matrix adjust.
Identities = 220/359 (61%), Positives = 268/359 (74%), Gaps = 9/359 (2%)
Query: 139 SLAGLKEALETGFELKWKLNSSCKNCSSCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYS 198
S+ G+ L F K S K K+T + N E F+RN+ SLAPKR+ YS
Sbjct: 261 SITGIGIPLALTFYFSKKFRSIFKE-------KQTGNHLNVET-FLRNHESLAPKRYRYS 312
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV 258
+V++MT SF D++G+GGY VYKG L +G LVAVKV+ K NGEEFINE+ASISRTSHV
Sbjct: 313 EVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGEEFINEIASISRTSHV 372
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
NIV LGFC++ KRALIYEFMPNGSL+++IYD SS L W T+Y IA+GIARGLE
Sbjct: 373 NIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGWETLYNIAIGIARGLE 432
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YLHRGCN RI+HLDIKPHNI L++DFCPKISDFGL+K +KES +SM RGTAGYIAP
Sbjct: 433 YLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESIVSMSGARGTAGYIAP 492
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE-YFPNAIYKQIETEYDFQ 437
EVFCR+FG VS KSDVYSYGMM+ EMV GRKN D ++ +SE YFP+ IYK++E + +
Sbjct: 493 EVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHTSEIYFPHWIYKRLELDEELG 552
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLP 496
L G + EEE+ A+KMI+VSLWCIQT+P +RP M VV+MLEGS+E+LQIPPKP L P
Sbjct: 553 LQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGSLESLQIPPKPFLYSP 611
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | ||||||
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.612 | 0.490 | 0.564 | 9.2e-107 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.622 | 0.477 | 0.557 | 1.9e-104 | |
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.618 | 0.354 | 0.534 | 1.2e-102 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.610 | 0.462 | 0.547 | 8.6e-100 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.614 | 0.368 | 0.571 | 3.7e-99 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.559 | 0.486 | 0.572 | 3.3e-98 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.612 | 0.391 | 0.596 | 1.1e-96 | |
| TAIR|locus:2176707 | 579 | AT5G38250 [Arabidopsis thalian | 0.516 | 0.455 | 0.610 | 1.6e-96 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.606 | 0.466 | 0.594 | 4.2e-95 | |
| TAIR|locus:2177142 | 813 | AT5G39020 [Arabidopsis thalian | 0.606 | 0.381 | 0.562 | 1.3e-94 |
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 940 (336.0 bits), Expect = 9.2e-107, Sum P(2) = 9.2e-107
Identities = 185/328 (56%), Positives = 244/328 (74%)
Query: 188 GSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFIN 247
G + K++SY++VR++TK FS LG+GG+ VY G L DGR VAVK++K+ K NGE+FIN
Sbjct: 304 GLVQLKQYSYAEVRKITKLFSHTLGKGGFGTVYGGNLCDGRKVAVKILKDFKSNGEDFIN 363
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVY 307
EVAS+S+TSHVNIV LGFCYE KRA++YEF+ NGSLDQ++ + +S N L+ T+Y
Sbjct: 364 EVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFLSEKKSLN----LDVSTLY 419
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
+IA+G+ARGL+YLH GC RIVH DIKP NI LD+ FCPK+SDFGLAK EK+ES +S+L
Sbjct: 420 RIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILSLL 479
Query: 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC----SSEYFP 423
D RGT GYIAPEVF +G VSHKSDVYSYGM++ EM IG KN +++ + SS YFP
Sbjct: 480 DARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEM-IGAKNKEIEETAASNSSSAYFP 538
Query: 424 NAIYKQIETEYD-FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482
+ IYK +E D ++ ++ E+KE+AKKM LV LWCIQ P +RP M ++VEM+EGS+
Sbjct: 539 DWIYKNLENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSL 598
Query: 483 ENLQIPPKPSLSLPTGYAKQSSPT-SSF 509
+ L++PPKPS+ Y+ + P SSF
Sbjct: 599 DVLEVPPKPSIH----YSAEPLPQLSSF 622
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 1.9e-104, Sum P(2) = 1.9e-104
Identities = 184/330 (55%), Positives = 245/330 (74%)
Query: 185 RNYGSLAP-KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE 243
+N +L P K +SY+ V +TKSF++ +G+GG+ VY+GTL DGR VAVKV+K + NGE
Sbjct: 327 QNLKALIPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLKESQGNGE 386
Query: 244 EFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEW 303
+FINEVAS+S+TSHVNIV LGFC E KRA+IYEFM NGSLD++I +SS T++W
Sbjct: 387 DFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSKKSS----TMDW 442
Query: 304 RTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363
R +Y IA+G+ARGLEYLH GC RIVH DIKP N+ LD++ PK+SDFGLAK E+KES
Sbjct: 443 RELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESI 502
Query: 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA----DVKVSCSS 419
+S++DTRGT GYIAPEVF R +G VSHKSDVYSYGM++ + +IG +N D S SS
Sbjct: 503 LSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLD-IIGARNKTSTEDTTSSTSS 561
Query: 420 EYFPNAIYKQIETEYDFQ-LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
YFP IY+ +E ++ + ++ ++ EE E+AKKM LV LWCIQ P DRP+M +VVEM+
Sbjct: 562 MYFPEWIYRDLEKAHNGKSIETAISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMM 621
Query: 479 EGSIENLQIPPKPSLS-LPTGYAKQSSPTS 507
EG+++ L++PP+P L +PT ++SS S
Sbjct: 622 EGNLDALEVPPRPVLQQIPTATLQESSTFS 651
|
|
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.2e-102, Sum P(2) = 1.2e-102
Identities = 179/335 (53%), Positives = 242/335 (72%)
Query: 174 RHDQNAEAAFVRNYGSLAP-KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAV 232
R + ++ ++ +L P K ++Y++V++MTKSF++ +G+GG+ VY GTL D +VAV
Sbjct: 524 RKRKTSDEVRLQKLKALIPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAV 583
Query: 233 KVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYD 291
KV+K+ K +GE+FINEVAS+S+TSHVNIV LGFC E +RA+IYEF+ NGSLD++I D
Sbjct: 584 KVLKDSKGTDGEDFINEVASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISD 643
Query: 292 HESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351
S N L+ +T+Y IA+G+ARGLEYLH GC RIVH DIKP N+ LD++ CPK+SDF
Sbjct: 644 KSSVN----LDLKTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDF 699
Query: 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK-- 409
GLAK EKKES +S+LDTRGT GYIAPE+ R +G VSHKSDVYSYGM++ EM+ RK
Sbjct: 700 GLAKLCEKKESILSLLDTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKE 759
Query: 410 --NADVKVSCSSEYFPNAIYKQIE---------TEYDFQLDGVVTEEEKEMAKKMILVSL 458
+ + + SS YFP IYK +E TE ++ ++ EE+E+A+KM LV L
Sbjct: 760 RFDQNSRSDGSSIYFPEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGL 819
Query: 459 WCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493
WCIQ+ P DRP M KVVEM+EGS++ L++PP+P L
Sbjct: 820 WCIQSSPSDRPPMNKVVEMMEGSLDALEVPPRPVL 854
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 886 (316.9 bits), Expect = 8.6e-100, Sum P(2) = 8.6e-100
Identities = 178/325 (54%), Positives = 236/325 (72%)
Query: 189 SLAP-KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLK-DNGEEFI 246
+L P K ++Y+ V+RMTKSF++ +G+GG+ VY+GTL DGR+VAVKV+K K +N E+FI
Sbjct: 329 ALIPLKHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFI 388
Query: 247 NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV 306
NEV+S+S+TSHVNIV LGFC E +RA+IYEF+ NGSLD++I + S L+ +
Sbjct: 389 NEVSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSV----ILDLTAL 444
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366
Y IA+G+ARGLEYLH GC RIVH DIKP N+ LD++ PK+SDFGLAK EKKES +S+
Sbjct: 445 YGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSL 504
Query: 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN---ADVKVSCSSEYFP 423
+DTRGT GYIAPE+ R +G VSHKSDVYSYGM++ EM+ RK + SS YFP
Sbjct: 505 MDTRGTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFP 564
Query: 424 NAIYKQIETEYDFQLDGV---VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480
IYK +E + L+ + ++ EE+E+AKKM LV LWCIQ+ P DRP M KVVEM+EG
Sbjct: 565 EWIYKDLEKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEG 624
Query: 481 SIENLQIPPKPSLS-LPTGYAKQSS 504
S++ L++PP+P L + G +SS
Sbjct: 625 SLDALEVPPRPVLQQIHVGPLLESS 649
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 3.7e-99, Sum P(2) = 3.7e-99
Identities = 191/334 (57%), Positives = 242/334 (72%)
Query: 171 KETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPD--GR 228
K +D+N EA + KR+S+ V++MT SF +G+GG+ VYKG LPD GR
Sbjct: 492 KSELNDENIEAVVML-------KRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGR 544
Query: 229 LVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY 288
+A+K++K K NGEEFINE+ S+SR SHVNIV GFCYE +RA+IYEFMPNGSLD++
Sbjct: 545 DIALKILKESKGNGEEFINELVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKF 604
Query: 289 IYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348
I S N +EW+T+Y IAVG+ARGLEYLH C +IVH DIKP NI +DED CPKI
Sbjct: 605 I----SENMSTKIEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKI 660
Query: 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
SDFGLAK +KKES ISMLD RGT GYIAPE+F +++GGVSHKSDVYSYGM++ EM+
Sbjct: 661 SDFGLAKLCKKKESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGAT 720
Query: 409 KNADVKVSC---SSEYFPNAIYKQIETEYDFQL--DGVVTEEEKE-MAKKMILVSLWCIQ 462
K +V+ S SS YFP+ +Y+ +E + +L D ++ EEE+E + K+M LV LWCIQ
Sbjct: 721 KREEVETSATDKSSMYFPDWVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQ 780
Query: 463 THPPDRPSMTKVVEMLEGS-IENLQIPPKPSLSL 495
T+P DRP M KVVEMLEGS +E LQ+PPKP L+L
Sbjct: 781 TNPSDRPPMRKVVEMLEGSRLEALQVPPKPLLNL 814
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 3.3e-98, Sum P(2) = 3.3e-98
Identities = 173/302 (57%), Positives = 219/302 (72%)
Query: 211 LGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEK 270
+G+GG+ VYKG L DGR VAVK++K+ N E+FINEVASIS+TSHVNIV LGFC+EK
Sbjct: 287 VGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEK 346
Query: 271 KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVH 330
KRA++YEF+ NGSLDQ SSN L+ T+Y IA+G+ARG+EYLH GC RIVH
Sbjct: 347 SKRAIVYEFLENGSLDQ------SSN----LDVSTLYGIALGVARGIEYLHFGCKKRIVH 396
Query: 331 LDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSH 390
DIKP N+ LDE+ PK++DFGLAK EK+ES +S+LDTRGT GYIAPE+F R +G VSH
Sbjct: 397 FDIKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSH 456
Query: 391 KSDVYSYGMMIHEMVIGRKNADVK---VSCSSEYFPNAIYKQIET-EYDFQLDGVVTEEE 446
KSDVYSYGM++ EM R V+ + SS YFP+ I+K +E +Y L +T EE
Sbjct: 457 KSDVYSYGMLVLEMTGARNKERVQNADSNNSSAYFPDWIFKDLENGDYVKLLADGLTREE 516
Query: 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLP--TGYAKQSS 504
+++AKKMILV LWCIQ P DRPSM KVV M+EG++++L PPKP L +P A+ S
Sbjct: 517 EDIAKKMILVGLWCIQFRPSDRPSMNKVVGMMEGNLDSLDPPPKPLLHMPMQNNNAESSQ 576
Query: 505 PT 506
P+
Sbjct: 577 PS 578
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 198/332 (59%), Positives = 242/332 (72%)
Query: 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDG-RLVAVKVMKNLKDNGEEFINEVAS 251
KRFSY V++MTKSF + LG+GG+ VYKG LPDG R VAVK++K ++GE+FINE+AS
Sbjct: 447 KRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIAS 506
Query: 252 ISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
+SRTSH NIV LGFCYE +K+A+IYE MPNGSLD++I S N +EW+T+Y IAV
Sbjct: 507 MSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFI----SKNMSAKMEWKTLYNIAV 562
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
G++ GLEYLH C RIVH DIKP NI +D D CPKISDFGLAK + ES ISML RG
Sbjct: 563 GVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARG 622
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMV----IGR-KNADVKVSCSSEYFPNAI 426
T GYIAPEVF ++FGGVSHKSDVYSYGM++ EM+ IGR +NA S +S YFP+ I
Sbjct: 623 TIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGS--SNTSMYFPDWI 680
Query: 427 YKQIETE--YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
YK +E F D + EE++++ KKM+LV LWCIQT+P DRP M+KVVEMLEGS+E
Sbjct: 681 YKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEA 740
Query: 485 LQIPPKPSLSLPTGYA-----KQSSPTSSFMK 511
LQIPPKP L LP A + TSSF+K
Sbjct: 741 LQIPPKPLLCLPAITAPITVDEDIQETSSFLK 772
|
|
| TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 1.6e-96, Sum P(2) = 1.6e-96
Identities = 171/280 (61%), Positives = 206/280 (73%)
Query: 222 GTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281
G L DGR VAVKV+K+ K N E+FINEVAS+S+TSHVNIV LGFCYE KRA+IYEF+
Sbjct: 290 GRLRDGRKVAVKVLKDSKGNCEDFINEVASMSQTSHVNIVTLLGFCYEGSKRAIIYEFLE 349
Query: 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341
NGSLDQ S N L+ T+Y IA+G+ARGLEYLH GC RIVH DIKP N+ LD
Sbjct: 350 NGSLDQ------SLN----LDVSTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLD 399
Query: 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMI 401
E+ PK++DFGLAK EK+ES +S+LDTRGT GYIAPE+F R +G VSHKSDVYSYGM++
Sbjct: 400 ENLRPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRMYGSVSHKSDVYSYGMLV 459
Query: 402 HEMVIGRKNADVK---VSCSSEYFPNAIYKQIETEYDFQL--DGVVTEEEKEMAKKMILV 456
EM+ R V+ + SS YFP+ IYK +E + +L DG+ EEEK AKKMILV
Sbjct: 460 LEMIGARNKERVQNADPNNSSAYFPDWIYKDLENFDNTRLLGDGLTREEEKN-AKKMILV 518
Query: 457 SLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLP 496
LWCIQ P DRPSM KVVEM+EGS+++L PPKP L +P
Sbjct: 519 GLWCIQFRPSDRPSMNKVVEMMEGSLDSLDPPPKPLLHMP 558
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
Identities = 195/328 (59%), Positives = 241/328 (73%)
Query: 175 HDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVK 233
+DQN EA + KR+SY+ V++MT SF+ LG+GG+ VYKG L D GR VAVK
Sbjct: 308 NDQNVEAVAML-------KRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVK 360
Query: 234 VMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHE 293
++K + NGEEFINEVAS+SRTSHVNIV LGFCYEK KRA+IYEFMPNGSLD+YI
Sbjct: 361 ILKVSEGNGEEFINEVASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYI---- 416
Query: 294 SSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353
S+N +EW +Y +AVGI+RGLEYLH C RIVH DIKP NI +DE+ CPKISDFGL
Sbjct: 417 SANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGL 476
Query: 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD- 412
AK + KES ISML RGT GYIAPE+F ++FG VSHKSDVYSYGM++ EM IG KN +
Sbjct: 477 AKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEM-IGAKNIEK 535
Query: 413 VKVSCS---SEYFPNAIYKQIETEYDFQLDG-VVTEEEKEMAKKMILVSLWCIQTHPPDR 468
V+ S S S YFP +YK E ++ G +T+EE+++AKK++LV+LWCIQ +P DR
Sbjct: 536 VEYSGSNNGSMYFPEWVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDR 595
Query: 469 PSMTKVVEMLEGSIENLQIPPKPSLSLP 496
P M KV+EMLEG++E LQ+PP P L P
Sbjct: 596 PPMIKVIEMLEGNLEALQVPPNPLLFSP 623
|
|
| TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 1.3e-94, Sum P(2) = 1.3e-94
Identities = 179/318 (56%), Positives = 237/318 (74%)
Query: 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASI 252
K++ Y++++++TKSFS +G+GG+ VY+G L +GR VAVKV+K+LK NG++FINEV S+
Sbjct: 484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543
Query: 253 SRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
S+TSHVNIV LGFCYE KRA+I EF+ +GSLDQ+I S N T T+Y IA+G
Sbjct: 544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI----SRNKSLTPNVTTLYGIALG 599
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372
IARGLEYLH GC RIVH DIKP NI LD++FCPK++DFGLAK EK+ES +S++DTRGT
Sbjct: 600 IARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGT 659
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC--SSEYFPNAIYKQI 430
GYIAPEV R +GG+SHKSDVYSYGM++ +M IG +N +C S+ YFP+ IYK +
Sbjct: 660 IGYIAPEVVSRMYGGISHKSDVYSYGMLVLDM-IGARNKVETTTCNGSTAYFPDWIYKDL 718
Query: 431 ET-EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489
E + + + + EE+ ++ KKMILVSLWCI+ P DRP M KVVEM+EGS++ L++PP
Sbjct: 719 ENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPP 778
Query: 490 KPSLSLPTGYAKQSSPTS 507
KPS + T +SS S
Sbjct: 779 KPSRHISTELVLESSSLS 796
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.123.295.1 | hypothetical protein (580 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 511 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| pfam14380 | 94 | pfam14380, WAK_assoc, Wall-associated receptor kin | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 1e-50
Identities = 85/278 (30%), Positives = 127/278 (45%), Gaps = 38/278 (13%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHVNIVPFLG 265
KLG G + VYK G++VAVK++K + ++ E+ + R SH NIV +
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+K L+ E+ G L Y+ L +IA+ I RGLEYLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG------GPLSEDEAKKIALQILRGLEYLHS--- 116
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFCRH 384
I+H D+KP NI LDE+ KI+DFGLAK+ K S L T GT Y+APEV
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS---SSSLTTFVGTPWYMAPEV-LLG 172
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR------KNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
G K DV+S G++++E++ G+ D I + + +F
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ---------LIRRILGPPLEFDE 223
Query: 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ E AK +I C+ P RP+ ++++
Sbjct: 224 PKWSSGS--EEAKDLI---KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-49
Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMK--NLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
LG+GG+ VY G+ VA+K++K + EE + E+ + + +H NIV G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327
++ L+ E+ GSL + ++E L + +I + I GLEYLH +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 328 IVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
I+H D+KP NI LD D K++DFGL+K +S + GT Y+APEV G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL-LGKG 169
Query: 387 GVSHKSDVYSYGMMIHEM 404
S KSD++S G++++E+
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 5e-47
Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 41/285 (14%)
Query: 206 SFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHV 258
+ KLG+G + +VYKG L VAVK +K EEF+ E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
N+V LG C E++ ++ E+M G L Y+ + + L + A+ IARG+E
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-----RPKLSLSDLLSFALQIARGME 116
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YL +H D+ N + E+ KISDFGL++ + + ++AP
Sbjct: 117 YLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAP 172
Query: 379 EVFC-RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPN----AIYKQIETE 433
E F + KSDV+S+G+++ E+ + + +P + + ++
Sbjct: 173 ESLKEGKF---TSKSDVWSFGVLLWEI----------FTLGEQPYPGMSNEEVLEYLKNG 219
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
Y + ++ + L C P DRP+ +++VE+L
Sbjct: 220 Y-------RLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 7e-47
Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 46/288 (15%)
Query: 206 SFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHV 258
+ KLG+G + +VYKGTL VAVK +K EEF+ E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
NIV LG C E++ ++ E+MP G L Y+ + + L + A+ IARG+E
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNR----PKELSLSDLLSFALQIARGME 117
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YL +H D+ N + E+ KISDFGL++ + + + ++AP
Sbjct: 118 YLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAP 173
Query: 379 EVFC-RHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEYFPNAIYKQI 430
E F + KSDV+S+G+++ E+ G NA+V + +
Sbjct: 174 ESLKEGKF---TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV-------------LEYL 217
Query: 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
+ Y + ++ + L C P DRP+ +++VE+L
Sbjct: 218 KKGY-------RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
+KLG+G + VY G+LVA+KV+K K E + E+ + + H NIV
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
++ K L+ E+ G L + G+ + E + I LEYLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLS-EDEARF-YLRQILSALEYLHS--- 115
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
IVH D+KP NI LDED K++DFGLA+Q + E + + GT Y+APEV
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLGK- 171
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI--ETEYDFQLDGVVT 443
G D++S G++++E++ G+ + ++K+I + ++
Sbjct: 172 -GYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPFPPPEWDIS 224
Query: 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
E K++ +K + P R + + ++
Sbjct: 225 PEAKDLIRK-------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 9e-45
Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 48/288 (16%)
Query: 207 FSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVN 259
KLG+G + +VYKGTL VAVK +K EEF+ E + + + SH N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
IV LG C + + ++ E+MP G L ++ H L + + Q+A+ IA+G+EY
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-----GEKLTLKDLLQMALQIAKGMEY 117
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
L VH D+ N + E+ KISDFGL++ + + + + ++APE
Sbjct: 118 LES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEYFPNAIYKQIET 432
G + KSDV+S+G+++ E+ G N +V + +E
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV-------------LELLED 219
Query: 433 EYDFQLDGVVTEEE--KEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
Y +L E E+ + M L C P DRP+ +++VE L
Sbjct: 220 GY--RLP---RPENCPDELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 83/294 (28%), Positives = 129/294 (43%), Gaps = 55/294 (18%)
Query: 209 DKLGQGGYADVYKGTLPDG----RLVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVP 262
KLG+G + +VYKG L VAVK +K E +F+ E + + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYI---YDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
LG C E++ L+ E+M G L Y+ S K TL + + A+ IA+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
L + + VH D+ N + ED KISDFGL++ + + + ++APE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSS-------EYFPNA 425
G + KSDV+S+G+++ E+ G N +V EY P+
Sbjct: 178 SL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDE 235
Query: 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+Y+ + L C Q P DRP+ +++VE LE
Sbjct: 236 LYE---------------------------LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 68/206 (33%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFI----NEVASISRTSHVNIVPFL 264
LG+G + VY D G L+AVK ++ L + EE + E+ +S H NIV +
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 265 GFCYEKKKRAL-IY-EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
G +++K L I+ E++ GSL + GK L + + I GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGK--LPEPVIRKYTRQILEGLAYLHS 119
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
IVH DIK NI +D D K++DFG AK+ E+ RGT ++APEV
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-I 175
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGR 408
R +D++S G + EM G+
Sbjct: 176 RG-EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 67/204 (32%), Positives = 108/204 (52%), Gaps = 19/204 (9%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+K+G+GG+ +VYK G+ VA+KV+K K+ E+ INE+ + + H NIV + G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG- 64
Query: 267 CYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
Y KK ++ EF GSL + + +TL + + + +GLEYLH +
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLL-----KSTNQTLTESQIAYVCKELLKGLEYLH---S 116
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV-FCRH 384
I+H DIK NI L D K+ DFGL+ Q ++ +M+ GT ++APEV +
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKP 173
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
+ K+D++S G+ E+ G+
Sbjct: 174 YDY---KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 78/274 (28%), Positives = 116/274 (42%), Gaps = 23/274 (8%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMK----NLKDNGEEFINEVASISRTSH-VNIVPFL 264
KLG+G + +VY D +LVA+KV+ + E F+ E+ ++ +H NIV
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
F ++ L+ E++ GSL+ + K L I I LEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGR---KGPLSESEALFILAQILSALEYLHS-- 119
Query: 325 NIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKKESFISMLDTR----GTAGYIAPE 379
I+H DIKP NI LD D K+ DFGLAK S S+ GT GY+APE
Sbjct: 120 -KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 380 VF-CRHFGGVSHKSDVYSYGMMIHEMVIGRK-NADVKVSCSSEYFPNAIYKQIETEYDFQ 437
V S SD++S G+ ++E++ G K S ++ I +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471
L E + A ++ + P +R S
Sbjct: 239 LSPSNPELISKAASDLLKK---LLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+G+G + DV G G+ VAVK +K+ + F+ E + ++ H N+V LG
Sbjct: 10 LGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
+ ++ E+M GSL Y+ S G+ + A+ + G+EYL
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLEEK--- 121
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
VH D+ N+ + ED K+SDFGLAK+ + + L + T APE R
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWT----APEAL-RE-K 174
Query: 387 GVSHKSDVYSYGMMIHEM 404
S KSDV+S+G+++ E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 209 DKLGQGGYADVYKGTL-PDGRLVAVKV--MKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
LGQG VYK P G++ A+K + ++ ++ + E+ ++ +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
Y++ + +++ E+M GSL + + + IA I +GL+YLH
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHT--K 118
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIAPEVF 381
I+H DIKP N+ ++ KI+DFG++K E + +F+ GT Y++PE
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSPERI 172
Query: 382 -CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440
+ S+ +D++S G+ + E +G+ + P E
Sbjct: 173 QGESY---SYAADIWSLGLTLLECALGK----------FPFLPPGQPSFFELMQAICDGP 219
Query: 441 VVTEEEKEMAKKMI-LVSLWCIQTHPPDRPSMTKVVEMLE 479
+ +E + + +S C+Q P RPS E+L+
Sbjct: 220 PPSLPAEEFSPEFRDFISA-CLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 207 FSDKLGQGGYADVYKG-TLPDGRLVAVK---VMKNLKDNGEEFINEVASISRTSHVNIVP 262
D +G+G + VYKG L G VA+K + K ++ + + E+ + H NIV
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
++G +I E+ NGSL Q I +L VYQ + +GL YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP--ESLVAVYVYQ----VLQGLAYLHE 117
Query: 323 -GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
G ++H DIK NI +D K++DFG+A + GT ++APEV
Sbjct: 118 QG----VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVI 171
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
G S SD++S G + E++ G
Sbjct: 172 --EMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 211 LGQGGYADVYKGT-LPDGRL----VAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPF 263
LG G + VYKG +P+G VA+KV++ +E ++E ++ H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRT-LEWRTVYQIAVGIARGLEYLHR 322
LG C + LI + MP G L Y+ +H+ + G + L W V IA+G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE- 126
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
R+VH D+ N+ + KI+DFGLAK + E + ++A E
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE--S 182
Query: 383 RHFGGVSHKSDVYSYGMMIHE-MVIGRK 409
+HKSDV+SYG+ + E M G K
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 207 FSDKLGQGGYADVYKGTLP-----DGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVN 259
F +LG+G + V G VAVK + + + +F E+ + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 260 IVPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
IV + G C + R+ LI E++P+GSL Y+ H + L + I +G+
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGM 122
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK-QTEKKESFISMLDTRGTAGYI 376
+YL + R +H D+ NI ++ + KISDFGLAK E K+ + +
Sbjct: 123 DYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEM 404
APE C S SDV+S+G+ ++E+
Sbjct: 180 APE--CLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 71/202 (35%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
+K+G+G +VYK T G+ VA+K M+ K N E INE+ + H NIV +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-S 83
Query: 268 YEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
Y ++ E+M GSL I + R E + Y + + +GLEYLH
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAY-VCREVLQGLEYLHSQ--- 135
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIAPEVFCRHF 385
++H DIK NI L +D K++DFG A Q T++K S++ GT ++APEV R
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAPEVIKRKD 192
Query: 386 GGVSHKSDVYSYGMMIHEMVIG 407
G K D++S G+M EM G
Sbjct: 193 YG--PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 82/276 (29%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 211 LGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNG------EEFINEVASISRTSHVNIVPF 263
LG G + VY+G L DG AVK + D ++ E+A +S+ H NIV +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
LG E+ + E +P GSL + + + S + I GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS------FPEPVIRLYTRQILLGLEYLH-- 119
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
+ VH DIK NI +D + K++DFG+AKQ + F +G+ ++APEV
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE---FSFAKSFKGSPYWMAPEV-IA 174
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
GG +D++S G + EM G K S A++K I + +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATG------KPPWSQLEGVAAVFK-IGRSKELPP---IP 224
Query: 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ + AK IL C+Q P RP+ E+LE
Sbjct: 225 DHLSDEAKDFILK---CLQRDPSLRPTAA---ELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNIVPFLGFCY 268
KLG G + +V++G + VA+K++K + ++F EV ++ R H +++ C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 269 EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRI 328
+ +I E M GSL ++ E + L ++ +A +A G+ YL
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 329 VHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGV 388
+H D+ NI + ED K++DFGLA+ KE D + + APE G
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASH--GTF 181
Query: 389 SHKSDVYSYGMMIHEMV 405
S KSDV+S+G++++EM
Sbjct: 182 STKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 43/277 (15%)
Query: 209 DKLGQGGYADVYK-GTLPDGRLVAVKVMK--NLKDN-GEEFINEVASISRTSHVNIVPFL 264
KLG+G Y VYK L D + A+K + ++ E+ +NE+ ++ +H NI+ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ K ++ E+ P G L + I + ++ + + +++I + + RGL+ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLRGLQALH--- 120
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFCR 383
+I+H D+K NI L + KI D G++K +K +M T+ GT Y+APEV+
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK-----NMAKTQIGTPHYMAPEVWKG 175
Query: 384 HFGGVSHKSDVYSYGMMIHEMVI------GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
S+KSD++S G +++EM R D++ +P I Y
Sbjct: 176 R--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-----PIPPIYSQD 228
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474
L + +Q P RP+ K+
Sbjct: 229 LQNFIR---------------SMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 66/282 (23%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+ ++G G + V+ G + R VA+K ++ + E+FI E + + SH +V G
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C E+ L++EFM +G L Y+ + TL + + + G+ YL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
++H D+ N + E+ K+SDFG+ + + + S T+ + +PEVF F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKFPVKWSSPEVF--SF 175
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445
S KSDV+S+G+++ E ++ + +T Y+ + + V E
Sbjct: 176 SKYSSKSDVWSFGVLMWE----------------------VFSEGKTPYENRSNSEVVET 213
Query: 446 --------EKEMAKKMIL-VSLWCIQTHPPDRPSMTKVVEML 478
+ +A + + + C + P DRPS + ++ L
Sbjct: 214 INAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 36/233 (15%)
Query: 194 RFSYSDVRRMTKSFSDKLGQGGYADVYKGTL--PDGRLVAVKV-MKNLKDNGE-----EF 245
S VR F ++LG+G + VYKG L P+ RL A V +K LK+N E EF
Sbjct: 1 EIPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEF 55
Query: 246 INEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH----------ESS 295
E +S H NIV LG C +++ +++E++ +G L +++ +
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 296 NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
K +L+ IA+ IA G+EYL VH D+ N + E KISDFGL++
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR 172
Query: 356 QTEKKESF----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
+ + S+L R ++ PE +G + +SD++S+G+++ E+
Sbjct: 173 DIYSADYYRVQSKSLLPVR----WMPPEAIL--YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 32/212 (15%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN-----EVASISRTSHVNIVP 262
+KLG+G Y VYK G +VA+K ++ DN EE I E++ + H NIV
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVK 62
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
L + ++K L++E+ L +Y+ L + I + RGL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCDM-DLKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRG--TAGYIAPE 379
RI+H D+KP NI ++ D K++DFGLA+ ++ T T Y APE
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-----THEVVTLWYRAPE 168
Query: 380 VF--CRHFG-GVSHKSDVYSYGMMIHEMVIGR 408
+ +H+ V D++S G + EM+ G+
Sbjct: 169 ILLGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 1e-23
Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPF 263
++G+G + VY DG+L +K + +L E+ +NEV + + +H NI+ +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEI-DLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
EK K ++ E+ G L Q I + + + V + L+YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG--KPFPEEQILDWFVQLCLALKYLHS- 121
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPE 379
+I+H DIKP NI L + K+ DFG++K + ++ + GT Y++PE
Sbjct: 122 --RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV------GTPYYLSPE 173
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGRK 409
+ C++ ++KSD++S G +++E+ +
Sbjct: 174 L-CQN-KPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 2e-23
Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMK--NLKDNGEE--FINEVASISRTSHVNIVP 262
LG+G + V K T G+L A+KV+K + E + E +SR +H IV
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 263 FLGFCYE-KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + ++ ++K L+ E+ P G L ++ R E R + A I LEYLH
Sbjct: 58 -LHYAFQTEEKLYLVLEYAPGGELFSHLSKE-----GRFSEERARFYAA-EIVLALEYLH 110
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEV 380
+ I++ D+KP NI LD D K++DFGLAK+ + S + T GT Y+APEV
Sbjct: 111 S---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN---TFCGTPEYLAPEV 164
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
G D +S G++++EM+ G+
Sbjct: 165 LLG--KGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 28/208 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
+KLG+G Y VYK G++VA+KV+ +D +E I E++ + + IV + G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYIVKYYGSY 67
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARGLEYLHRGC 324
++ ++ E+ GS+ + + +N +TL T +IA +GLEYLH
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM---KITN--KTL---TEEEIAAILYQTLKGLEYLH--- 116
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIAPEV 380
+ + +H DIK NI L+E+ K++DFG++ Q K+ + I GT ++APEV
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI------GTPFWMAPEV 170
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
G ++K+D++S G+ EM G+
Sbjct: 171 IQEI--GYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 29/206 (14%)
Query: 210 KLGQGGYADVYKG-TLPDGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
++G G Y DVYK + G LVA+KV+K D+ E E++ + H NIV + G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR----GLEYLHRG 323
+ K ++ E+ GSL Q IY + T + QIA + R GL YLH
Sbjct: 70 LRRDKLWIVMEYCGGGSL-QDIY-------QVTRGPLSELQIAY-VCRETLKGLAYLH-- 118
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPE 379
+H DIK NI L ED K++DFG++ Q K++SFI GT ++APE
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWMAPE 171
Query: 380 VFC-RHFGGVSHKSDVYSYGMMIHEM 404
V GG K D+++ G+ E+
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 208 SDKLGQGGYADVYKG-TLPDGRLVAVKVMK---NLKDNGEEFINEVASISRTSHVNIVPF 263
+K+G G + VY L G L+AVK ++ N +E +E+ + H N+V +
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G ++K + E+ G+L+ E R L+ + + + GL YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLE------ELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI--SMLDTRGTAGYIAPEVF 381
IVH DIKP NI LD + K+ DFG A + + + + + GT Y+APEV
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 382 CR-----HFGGVSHKSDVYSYGMMIHEMVIGRK 409
H D++S G ++ EM G++
Sbjct: 176 TGGKGKGHGRAA----DIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 9e-23
Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFL 264
K+G+G ++ VYK L DGR+VA+K ++ ++ + E+ + + H N++ +L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
E + ++ E G L + I KR + RT+++ V + LE++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTIWKYFVQLCSALEHMHSK- 125
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
RI+H DIKP N+ + K+ D GL + K + L GT Y++PE H
Sbjct: 126 --RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERI--H 179
Query: 385 FGGVSHKSDVYSYGMMIHEM 404
G + KSD++S G +++EM
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKV--MKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+K+G+G + DVYKG L VAVK D +F+ E + + H NIV +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
C +K+ ++ E +P GSL ++ + N + + Q+++ A G+EYL I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTV---KKLLQMSLDAAAGMEYLESKNCI 115
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
H D+ N + E+ KISDFG++++ E +S + + APE ++G
Sbjct: 116 ---HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL--NYG 170
Query: 387 GVSHKSDVYSYGMMIHE 403
+ +SDV+SYG+++ E
Sbjct: 171 RYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN--EVASISR-TSHVNIVPFLG 265
+LG G + VY G LVA+K MK + EE +N EV S+ + H NIV
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GC 324
E + ++E+M G+L Q + D + + + I I +GL ++H+ G
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKHG- 119
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
H D+KP N+ + KI+DFGLA++ + + + TR Y APE+ R
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR---WYRAPEILLRS 173
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
S D+++ G ++ E+ R
Sbjct: 174 -TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 71/282 (25%), Positives = 125/282 (44%), Gaps = 24/282 (8%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRTSH 257
++ R + KLG G Y +VY+G VAVK +K EEF+ E A + H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
N+V LG C + +I EFM G+L Y+ + ++ + + +A I+ +
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQISSAM 117
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
EYL + +H D+ N + E+ K++DFGL++ +++ + + + A
Sbjct: 118 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTA 173
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
PE + S KSDV+++G+++ E+ S +P Q+ Y+
Sbjct: 174 PESLA--YNKFSIKSDVWAFGVLLWEI--------ATYGMSP--YPGIDLSQV---YELL 218
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
G E + K+ + C Q +P DRPS ++ + E
Sbjct: 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE 269
KLG G + +V+ GT VAVK +K + E F+ E + + H +V C E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 270 KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIV 329
++ ++ E+M GSL ++ E L + +A IA G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK----LRLPQLVDMAAQIAEGMAYLES---RNYI 125
Query: 330 HLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVS 389
H D+ NI + E+ KI+DFGLA+ E E + + + + APE ++G +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA--NYGRFT 182
Query: 390 HKSDVYSYGMMIHEMVI-------GRKNADV 413
KSDV+S+G+++ E+V G N +V
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREV 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 48/284 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVPFLG 265
+LG G V K P G+++AVK ++ + + + E+ + + + IV F G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
Y ++ E+M GSLD+ + R E R + +IAV + +GL YLH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPE-RILGKIAVAVLKGLTYLHE--K 119
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ--TEKKESFISMLDTRGTAGYIAPEVFCR 383
+I+H D+KP NI ++ K+ DFG++ Q ++F+ GT+ Y+APE R
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPE---R 170
Query: 384 HFGGV-SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF---QLD 439
G S KSD++S G+ + E+ GR FP Y D L
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR-------------FP---YPPENDPPDGIFELLQ 214
Query: 440 GVVTEEEKEMAKKMI------LVSLWCIQTHPPDRPSMTKVVEM 477
+V E + V+L C+ P +RPS +++E
Sbjct: 215 YIVNEPPPRLPSGKFSPDFQDFVNL-CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 59/290 (20%)
Query: 211 LGQGGYADVYKGTL--PDGR--LVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVPFL 264
+G G + +V +G L P + VA+K +K + + +F+ E + + + H NI+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G + + +I E+M NGSLD+++ +++ GK + + GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLREND---GK--FTVGQLVGMLRGIASGMKYL---S 123
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE 379
+ VH D+ NI ++ + K+SDFGL+++ E E + T+G G I APE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATYTTKG--GKIPIRWTAPE 178
Query: 380 VFC-RHFGGVSHKSDVYSYGMMIHE-MVIGRK------NADVKVSCSSEYFPNAIYKQIE 431
R F + SDV+S+G+++ E M G + N DV K +E
Sbjct: 179 AIAYRKF---TSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------------IKAVE 222
Query: 432 TEYDFQLDGVVTEEEKEMAKKMIL--VSLWCIQTHPPDRPSMTKVVEMLE 479
Y M L + L C Q +RP+ +++V L+
Sbjct: 223 DGYRLP---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 77/304 (25%), Positives = 138/304 (45%), Gaps = 50/304 (16%)
Query: 200 VRRMTKSFSDKLGQGGYADVYKGTL----PDG--RLVAVKVMKNLKDNG--EEFINEVAS 251
V+R T +LG+G + V+ G P+ LVAVK +K N ++F E
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 252 ISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH----------ESSNGKRTL 301
++ H NIV F G C E +++E+M +G L++++ H +S G+ TL
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 302 EWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361
+ QIAV IA G+ YL + VH D+ N + D KI DFG+++ +
Sbjct: 122 S--QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
Query: 362 SF----ISMLDTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEM-VIGRKNADVKV 415
+ +ML R ++ PE + R F + +SDV+S+G+++ E+ G++
Sbjct: 177 YYRVGGHTMLPIR----WMPPESIMYRKF---TTESDVWSFGVVLWEIFTYGKQ------ 223
Query: 416 SCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475
++ + + IE G + + + ++ + L C + P R ++ +
Sbjct: 224 ----PWYGLSNEEVIE----CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
Query: 476 EMLE 479
E L+
Sbjct: 276 ERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 24/273 (8%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+F +LG G + V+ G VA+K+++ + ++FI E + + SH N+V G
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C +++ ++ E+M NG L Y+ + + GK EW + + + +EYL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERK---GKLGTEW--LLDMCSDVCEAMEYLESNGF 121
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
I H D+ N + ED K+SDFGLA+ + + S T+ + PEVF +
Sbjct: 122 I---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVF--DY 175
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445
S KSDV+S+G+++ E+ S + + E G
Sbjct: 176 SRFSSKSDVWSFGVLMWEV----------FSEGKMPYER--FSNSEVVESVSA-GYRLYR 222
Query: 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
K ++ + C P DRP+ K++ L
Sbjct: 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 75/274 (27%), Positives = 127/274 (46%), Gaps = 30/274 (10%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+ + +G+G + V +G G+ VAVK +K + F+ E A +++ H N+V LG
Sbjct: 9 TLGEIIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
++ E M G+L ++ + G+ + + Q ++ +A G+EYL +
Sbjct: 67 VILHNGLY-IVMELMSKGNLVNFL----RTRGRALVSVIQLLQFSLDVAEGMEYLE---S 118
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
++VH D+ NI + ED K+SDFGLA+ S L + T APE +H
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APEAL-KH- 171
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445
S KSDV+SYG+++ E+ + K+S + + +E Y + E
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECVEKGYRME-----PPE 220
Query: 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+++ S W +T P RPS K+ E LE
Sbjct: 221 GCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 73/284 (25%), Positives = 113/284 (39%), Gaps = 43/284 (15%)
Query: 209 DKLGQGGYADVYKGTL--PDGRL--VAVKVMK--NLKDNGEEFINEVASISRTSHVNIVP 262
KLG G + V +G G++ VAVK +K L D ++F+ E A + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
G ++ E P GSL D + T+ AV IA G+ YL
Sbjct: 61 LYGVVLTHPLM-MVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIAPEVF 381
R +H D+ NI L D KI DFGL + + ++ ++ + + APE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE-- 170
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEYFPNAIYKQIETEY 434
SH SDV+ +G+ + EM G + I K+I+ E
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-------------ILKKIDKEG 217
Query: 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
+ E + + + V L C +P DRP+ + E L
Sbjct: 218 E------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 66/256 (25%), Positives = 114/256 (44%), Gaps = 45/256 (17%)
Query: 207 FSDKLGQGGYADVYKGTL-PDGRLVAVKVMKN---LKDNGEEFIN-EVASISRTS-HVNI 260
F +G+G ++ V + A+K++ +K+ +++ E ++R + H I
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 261 VPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
+ L + ++ ++ + E+ PNG L QYI + S L+ + A I LEY
Sbjct: 65 IK-LYYTFQDEENLYFVLEYAPNGELLQYIRKYGS------LDEKCTRFYAAEILLALEY 117
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK--------------QTEKKESFIS 365
LH + I+H D+KP NI LD+D KI+DFG AK T
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 366 MLDTR----GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY 421
GTA Y++PE+ SD+++ G +I++M+ G+ S+EY
Sbjct: 175 NRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGK----PPFRGSNEY 228
Query: 422 FPNAIYKQI-ETEYDF 436
+++I + EY F
Sbjct: 229 L---TFQKILKLEYSF 241
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 211 LGQGGYADVYKGT--LPDGRL--VAVKVMKN--LKDNGEEFINEVASISRTSHVNIVPFL 264
LG G + V KG + G+ VAVK +K + +EF+ E + +++ H IV +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G C + + L+ E P G L +Y+ E A +A G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE--- 112
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG-----YIAPE 379
+ VH D+ N+ L KISDFG+++ + TAG + APE
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY----RATTAGRWPLKWYAPE 168
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMV 405
C ++G S KSDV+SYG+ + E
Sbjct: 169 --CINYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 68/211 (32%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKV-MKNLKDN-----GEEFINEVASISRTSHVNIVPF 263
LG G + VYKG +P+G V + V +K L + EF++E ++ H ++V
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTL-EWRTVYQIAVGIARGLEYLHR 322
LG C + L+ + MP+G L Y+++H+ + G + L W V IA+G+ YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
R+VH D+ N+ + KI+DFGLA+ E E + + ++A E C
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE--C 182
Query: 383 RHFGGVSHKSDVYSYGMMIHE-MVIGRKNAD 412
H+ +H+SDV+SYG+ I E M G K D
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE---EFINEVASISRTSHVNIVPFLGF 266
+LG+G V K L + ++ N + + + E+ IV + G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 267 CYEKKKR--ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
++ + E+ GSLD IY G R E + + +IA + +GL YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGE-KVLGKIAESVLKGLSYLHSR- 124
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAPEVFCR 383
+I+H DIKP NI L K+ DFG++ E S+ T GT+ Y+APE R
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPE---R 174
Query: 384 HFGG-VSHKSDVYSYGMMIHEMVIGR 408
G S SDV+S G+ + E+ R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 75/294 (25%), Positives = 129/294 (43%), Gaps = 55/294 (18%)
Query: 211 LGQGGYADVYKGTL--PDGRL--VAVKVMK---NLKDNGEEFINEVASISRTSHVNIVPF 263
LG+G + V +G L DG VAVK MK + EEF++E A + H N++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 264 LGFCYEKKKRA------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+G C+E +I FM +G L ++ L +T+ + V IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK----KESFISMLDTRGTA 373
EYL N +H D+ N L ED ++DFGL+K+ ++ I+ + + A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 374 -GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEYFPNA 425
+A V+ + KSDV+++G+ + E+ G +N ++
Sbjct: 184 IESLADRVY-------TSKSDVWAFGVTMWEIATRGQTPYPGVENHEI------------ 224
Query: 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
YD+ G ++ ++ ++ + C + P DRP+ TK+ E+LE
Sbjct: 225 --------YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 211 LGQGGYADVYKG-TLPDGRLVAVK---VMKNLKDNGEEFI--------NEVASISRTSHV 258
+G+G Y VY + G ++AVK + + + +E+ ++ H+
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
NIV +LGF ++ ++ E++P GS+ + + G+ E + V + GL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY----GR--FEEQLVRFFTEQVLEGLA 122
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YLH + I+H D+K N+ +D D KISDFG++K+++ + +G+ ++AP
Sbjct: 123 YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK 409
EV + G S K D++S G ++ EM GR+
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 28/212 (13%)
Query: 211 LGQGGYADVYKGTLPDGRLVAVKVMK---NLKDNGE----EFINEVASISRTSHVNIVPF 263
LG+G Y VY G G+L+AVK ++ + E + EV + HVNIV +
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
LG C + ++ EF+P GS+ + N L + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL------NRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-------TEKKESFISMLDTRGTAGYI 376
C +VH DIK +N+ L + K+ DFG A++ SM GT ++
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM---HGTPYWM 175
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
APEV + G KSD++S G + EM G+
Sbjct: 176 APEVI--NESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCY 268
+G+G Y VYK G+LVA+K+M ++D EE E + + S H NI F G +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-AF 72
Query: 269 EKKKRA-------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
KK L+ E GS+ + + EW + I RGL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW--IAYILRETLRGLAYLH 130
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIA 377
+++H DIK NI L ++ K+ DFG++ Q ++ +FI GT ++A
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMA 181
Query: 378 PEVF-CRHFGGVS--HKSDVYSYGMMIHEM 404
PEV C S +SDV+S G+ E+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV 258
++ R + KLG G + +V+ GT VAVK +K + E F+ E + + H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHD 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
+V E+ ++ E+M GSL ++ D E R L+ + +A +A G+
Sbjct: 62 KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMA 116
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
Y+ R + +H D++ NI + + KI+DFGLA+ E E + + + + AP
Sbjct: 117 YIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMV 405
E +G + KSDV+S+G+++ E+V
Sbjct: 173 EAAL--YGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 79/303 (26%), Positives = 129/303 (42%), Gaps = 70/303 (23%)
Query: 209 DKLGQGGYADVYKGTL-------PDGRLVAVKVMKNLKDNGE--EFINEVASISR--TSH 257
+LGQG + VY+G P+ R VA+K + E EF+NE AS+ + H
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERIEFLNE-ASVMKEFNCH 69
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY----DHESSNGKRTLEWRTVYQIAVGI 313
++V LG + ++ E M G L Y+ + E++ G + Q+A I
Sbjct: 70 -HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK---QTE--KKESFISMLD 368
A G+ YL + VH D+ N + ED KI DFG+ + +T+ +K +L
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLP 184
Query: 369 TRGTAGYIAPE-----VFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVS 416
R ++APE VF + KSDV+S+G+++ EM G N +V
Sbjct: 185 VR----WMAPESLKDGVF-------TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--- 230
Query: 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
F +DG + + K++ + C Q +P RP+ ++V
Sbjct: 231 -----------------LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
Query: 477 MLE 479
L+
Sbjct: 274 SLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 26/282 (9%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV 258
++ R + KLGQG + +V+ GT VA+K +K E F+ E + + H
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
+VP E+ ++ EFM GSL ++ + +GK L+ + +A IA G+
Sbjct: 62 KLVPLYAVVSEEPIY-IVTEFMGKGSLLDFL---KEGDGKY-LKLPQLVDMAAQIADGMA 116
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
Y+ R + +H D++ NI + ++ KI+DFGLA+ E E + + + + AP
Sbjct: 117 YIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAP 172
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
E +G + KSDV+S+G+++ E+V GR V+ + +Q+E Y
Sbjct: 173 EAAL--YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-------REVLEQVERGYRMP 223
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
E E+ K C + P +RP+ + LE
Sbjct: 224 CPQGCPESLHELMKL-------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+F +LG G + V G VA+K++K + +EFI E + + SH +V G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C +++ ++ E+M NG L Y+ +H + + + ++ + G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREH-----GKRFQPSQLLEMCKDVCEGMAYLE---S 118
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
+ +H D+ N +D+ C K+SDFGL++ E + S + ++ + PEV +
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVL--LY 175
Query: 386 GGVSHKSDVYSYGMMIHEM 404
S KSDV+++G+++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 210 KLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLG 265
K+G+G + V+K D R+ A+K + K N EE I+E +++ I+ +
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+K K ++ E+ NG L + + WR QI + GL +LH
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAHLHSK-- 120
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
+I+H DIK N+ LD KI D G+AK +F + + GT Y++PE+ C
Sbjct: 121 -KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VGTPYYLSPEL-CED- 175
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADV 413
+ KSDV++ G++++E G+ D
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 211 LGQGGYADVYKGT-LPDGRL----VAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPF 263
LG G + V+KG +P+G VA+K +++ + +E + + ++ H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESS-NGKRTLEWRTVYQIAVGIARGLEYLHR 322
LG C L+ + P GSL ++ H S + +R L W V IA+G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEE 127
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK--QTEKKESFISMLDTRGTAGYIAPEV 380
+VH ++ NI L D +I+DFG+A + K+ F S T ++A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT--PIKWMALES 182
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMV 405
FG +H+SDV+SYG+ + EM+
Sbjct: 183 I--LFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 71/294 (24%), Positives = 132/294 (44%), Gaps = 49/294 (16%)
Query: 211 LGQGGYADVYKGTL-----PDGRL-VAVKVMKNLKDNGEE-----FINEVASISRT-SHV 258
LG+G + V K P+ VAVK+ LKD+ E ++E+ + H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH------ESSNGKR----TLEWRTVYQ 308
NI+ LG C ++ ++ E+ +G+L ++ S + R TL + +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
A +ARG+E+L + + +H D+ N+ + ED KI+DFGLA+ + + +
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 369 TRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427
R ++APE +F R + +H+SDV+S+G+++ E+ + Y
Sbjct: 194 GRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIFT---------------LGGSPY 235
Query: 428 KQIETE--YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
I E + +G E+ + +++ + C P RP+ ++VE L+
Sbjct: 236 PGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 212 GQGGYADVYKGTLPDGRLV-AVKVMKN----LKDNGEEFINEVASISRTSHVNIVPFL-G 265
G+G + V D + + A+K M K + +NE + +H PFL
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH----PFLVN 64
Query: 266 FCYEKKKRALIY---EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
Y + +Y + + G L +Y H S K + E V I LEYLH
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDL-RY---HLSQKVKFSEE--QVKFWICEIVLALEYLH- 117
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
+ I+H DIKP NI LDE I+DF +A + S GT GY+APEV C
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGTPGYMAPEVLC 172
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRK 409
R G S D +S G+ +E + G++
Sbjct: 173 RQ--GYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 18/222 (8%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV 258
+V R T KLG G + +V+ G VA+K +K + E F+ E + + H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHP 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
+V L ++ +I E+M NGSL ++ ++ G + L + +A IA G+
Sbjct: 62 RLVR-LYAVVTQEPIYIITEYMENGSLVDFL---KTPEGIK-LTINKLIDMAAQIAEGMA 116
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
++ R I H D++ NI + E C KI+DFGLA+ E E + + + + AP
Sbjct: 117 FIERKNYI---HRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAP 172
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADV 413
E ++G + KSDV+S+G+++ E+V G N +V
Sbjct: 173 EAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 8e-18
Identities = 73/288 (25%), Positives = 134/288 (46%), Gaps = 51/288 (17%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFL 264
+ +G G A VY LP+ VA+K + +L+ + +E EV ++S+ +H N+V +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ L+ ++ GSL + +SS + L+ + + + +GLEYLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIM---KSSYPRGGLDEAIIATVLKEVLKGLEYLHS-- 120
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLA--------KQTEKKESFISMLDTRGTAGYI 376
N +I H DIK NI L ED KI+DFG++ + + +++F+ GT ++
Sbjct: 121 NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV------GTPCWM 173
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY--------K 428
APEV + G K+D++S+G+ E+ G + S+Y P +
Sbjct: 174 APEVMEQV-HGYDFKADIWSFGITAIELATGA-------APYSKYPPMKVLMLTLQNDPP 225
Query: 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ET D+ ++ ++M C+Q P RP+ ++++
Sbjct: 226 SLETGADY---KKYSKSFRKMISL-------CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 9e-18
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGE------EFINEVASISRTSHVNIVPF 263
LGQG + VY D GR +AVK + D+ E E+ + H IV +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDH----ESSNGKRTLEWRTVYQIAVGIARGLEY 319
G + + ++ E+MP GS+ + + E+ K T QI G+EY
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYT------RQIL----EGVEY 119
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS-MLDTRGTAGYIAP 378
LH IVH DIK NI D K+ DFG +K+ + S + M GT +++P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMV 405
EV G K+DV+S G + EM+
Sbjct: 177 EVISGE--GYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDN-GEEFIN--EVASISRTSHVNIVPFL 264
K+G+G Y VYK G +VA+K +K ++ G E+ + +H NI+ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
K L++EFM D +Y + +R L + + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFM-----DTDLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
I+H D+KP N+ ++ + K++DFGLA+ T Y APE+
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
G S D++S G + E++ R
Sbjct: 174 -KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 211 LGQGGYADVYKGTLPD------GRL-VAVKVMKNLKDNGE--EFINEVASISRTSHVNIV 261
LG G + +VY+GT D G + VAVK ++ + E EF+ E +S +H NIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYD-HESSNGKRTLEWRTVYQIAVGIARGLEYL 320
LG C + + +I E M G L Y+ D G L + + I + +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 321 HRGCNIRIVHLDIKPHNIRLDED--FCP---KISDFGLAKQTEKKESFISMLDTRGTAGY 375
+ + +H D+ N + E KI DFGLA+ K + + + +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 376 IAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADV 413
+APE G + +SDV+S+G+++ E++ N +V
Sbjct: 180 MAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 63/227 (27%), Positives = 111/227 (48%), Gaps = 37/227 (16%)
Query: 206 SFSDKLGQGGYADVY------------KGTLPDG-----RLVAVKVMK-NLKDNG-EEFI 246
+F +KLG+G + +V+ K + LVAVKV++ + DN E+F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 247 NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHE-----SSNGKRTL 301
EV +SR S NI LG C +I E+M NG L+Q++ H + ++L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 302 EWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361
+ T+ +A IA G+ YL ++ VH D+ N + +++ KI+DFG+++ +
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 362 SFISMLDTRGTA----GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
+ +G A ++A E G + KSDV+++G+ + E+
Sbjct: 185 YY----RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 17/219 (7%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE 269
KLG G + +V+ G + VAVK +K + + F+ E + H +V +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 270 KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIV 329
++ +I E+M GSL ++ +S G + L + + + IA G+ Y+ R +
Sbjct: 73 EEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLI-DFSAQIAEGMAYIERK---NYI 125
Query: 330 HLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVS 389
H D++ N+ + E KI+DFGLA+ E E + + + + APE +FG +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFGSFT 182
Query: 390 HKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY 421
KSDV+S+G++++E+V G N+DV + Y
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 71/252 (28%), Positives = 118/252 (46%), Gaps = 27/252 (10%)
Query: 234 VMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHE 293
V+K + D +E+A + + H NIV +G C +K LI+E++ +L + +
Sbjct: 719 VVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---- 774
Query: 294 SSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK--ISDF 351
R L W +IA+GIA+ L +LH C+ +V ++ P I +D P +S
Sbjct: 775 -----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLP 829
Query: 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411
GL K FIS + Y+APE R ++ KSD+Y +G+++ E++ G+ A
Sbjct: 830 GLLCTDTKC--FIS-------SAYVAPET--RETKDITEKSDIYGFGLILIELLTGKSPA 878
Query: 412 DVKVSCSSEYFPNAIYK----QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPD 467
D + A Y ++ D + G V+ + E+ + M L +L C T P
Sbjct: 879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNL-ALHCTATDPTA 937
Query: 468 RPSMTKVVEMLE 479
RP V++ LE
Sbjct: 938 RPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 25/201 (12%)
Query: 211 LGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEE----FINEVASISRTSHVNIVPFLGF 266
LG+G + +V+KGTL D VAVK K +D +E F++E + + H NIV +G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK--EDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RGCN 325
C +++ ++ E +P G ++ K L+ + + + A+ A G+ YL + C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYLESKNC- 114
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK---KESFISMLDTRGTAGYIAPEVFC 382
+H D+ N + E+ KISDFG+++Q + S + + + T APE
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEAL- 166
Query: 383 RHFGGVSHKSDVYSYGMMIHE 403
++G S +SDV+SYG+++ E
Sbjct: 167 -NYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 32/210 (15%)
Query: 227 GRLVAVKVMKNLKDNGEEFIN----EVASISRTSHVNIVPFLGFCYEKKKRA--LIYEFM 280
G VAVK +K ++G I E+ + H NIV + G C E LI EF+
Sbjct: 33 GEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340
P+GSL +Y+ K + + + AV I +G++YL + + VH D+ N+ +
Sbjct: 91 PSGSLKEYL-----PRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLV 142
Query: 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGY-IAPE--VFCRHFGGVSHKSDVYSY 397
+ + KI DFGL K E + + ++ D + + APE + + + SDV+S+
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY----IASDVWSF 198
Query: 398 GMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427
G+ ++E++ C SE P ++
Sbjct: 199 GVTLYELL---------TYCDSESSPMTLF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 19/196 (9%)
Query: 211 LGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEK 270
+G+G + DV G G VAVK +KN + F+ E + +++ H N+V LG E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 271 KKRALIY-EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIV 329
K I E+M GSL Y+ S G+ L + + ++ + +EYL V
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFV 124
Query: 330 HLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAPEVFCRHFGGV 388
H D+ N+ + ED K+SDFGL K+ S DT + + APE
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKK--F 176
Query: 389 SHKSDVYSYGMMIHEM 404
S KSDV+S+G+++ E+
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK-NLKDNGEEFIN-----EVASISRTSHVNIV 261
KLG+G YA VYK GR+VA+K +K + ++ IN E+ + H NI+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 262 PFLGFCYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
L + K L++EFM L++ I D L + + RGLEYL
Sbjct: 66 GLLD-VFGHKSNINLVFEFME-TDLEKVIKD-----KSIVLTPADIKSYMLMTLRGLEYL 118
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT-EKKESFISMLDTRGTAGYIAPE 379
H I+H D+KP+N+ + D K++DFGLA+ + TR Y APE
Sbjct: 119 HSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR---WYRAPE 172
Query: 380 VF--CRHFG-GVSHKSDVYSYGMMIHEMVIGR 408
+ RH+G GV D++S G + E+++
Sbjct: 173 LLFGARHYGVGV----DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASISRTSHVNIVPFL 264
+ +G+G + V K DG+++ K + +E ++EV + H NIV +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 265 GFCYEKKKRAL--IYEFMPNGSLDQYIYDHESSNGKRT---LEWRTVYQIAVGIARGLEY 319
++ + L + E+ G L Q I K+ +E +++I + L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLI-----QKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 320 LHRGCNI--RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
H + ++H D+KP NI LD + K+ DFGLAK SF GT Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY--VGTPYYMS 178
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEM 404
PE KSD++S G +I+E+
Sbjct: 179 PEQLNHM--SYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLG 265
+K+GQG VY + G+ VA+K M NL+ E INE+ + H NIV +L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ ++ E++ GSL + + G+ R Q LE+LH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ-------ALEFLHSN-- 134
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
+++H DIK NI L D K++DFG Q ++S S + GT ++APEV R
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKA 191
Query: 386 GGVSHKSDVYSYGMMIHEMVIG 407
G K D++S G+M EMV G
Sbjct: 192 YG--PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 65/205 (31%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVM--KNLKDNGEE--FINEVASISRTSHVNIVPFLG 265
LG+GG+ +V + G++ A K + K LK E +NE + + S IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 266 FCYEKK-KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ +E K L+ M G L +IY+ G+ A I GLE+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNV----GEPGFPEARAIFYAAQIICGLEHLH--- 112
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
RIV+ D+KP N+ LD+ +ISD GLA + + + GT GY+APEV
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVL--- 166
Query: 385 FGGV-SHKSDVYSYGMMIHEMVIGR 408
G V D ++ G ++EM+ GR
Sbjct: 167 QGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 53/207 (25%), Positives = 101/207 (48%), Gaps = 10/207 (4%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV 258
++ R + KLG G + +V++G + VAVK +K + ++F+ E + + H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
++ C ++ ++ E M GSL +Y+ R L+ + +A +A G+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG----GAGRALKLPQLIDMAAQVASGMA 117
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YL I H D+ N+ + E+ K++DFGLA+ K++ + + + + AP
Sbjct: 118 YLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAP 173
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMV 405
E + S KSDV+S+G+++ E+V
Sbjct: 174 EAA--LYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEFIN--EVASISR-TSHVNIVPFL 264
K+G+G +++V K + G+ A+K MK + E+ N E+ ++ R + H NI+ +
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 265 GFCYEKK--KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+++K + AL++E M D +Y+ KR L + V + + L+++HR
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYEL-IKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
I H DIKP NI + +D K++DFG + K + + TR Y APE C
Sbjct: 119 ---NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR---WYRAPE--C 169
Query: 383 RHFGGV-SHKSDVYSYGMMIHEMV 405
G K D+++ G + E++
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 35/211 (16%)
Query: 211 LGQGGYADVYKGTLP-DGR---LVAVKVMKN--LKDNGEEFINEVASISRTSHVNIVPFL 264
+G G + +V++G L GR VA+K +K + ++F++E + + + SH NI+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIA---VGIARGLEYLH 321
G + K +I E+M NG+LD+Y+ DH+ + YQ+ GIA G++YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYL- 123
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG------Y 375
++ VH D+ NI ++ + K+SDFGL++ E T T+G +
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE-----GTYTTSGGKIPIRW 176
Query: 376 IAPEVFC-RHFGGVSHKSDVYSYGMMIHEMV 405
APE R F + SDV+S+G+++ E++
Sbjct: 177 TAPEAIAYRKF---TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 207 FSDKLGQGGYADVYK---GTLPD--GRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNI 260
F +LG+G + V L D G +VAVK ++ + ++ +F E+ + H NI
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 261 VPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
V + G CY +R L+ E++P GSL Y+ H + L+ R + A I +G+E
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-----RERLDHRKLLLYASQICKGME 122
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK-QTEKKESFISMLDTRGTAGYIA 377
YL + R VH D+ NI ++ + KI DFGL K + KE + + A
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEM 404
PE S SDV+S+G++++E+
Sbjct: 180 PESLTE--SKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 67/295 (22%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 211 LGQGGYADVYKGT------LPDGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVP 262
LG+G + V K T VAVK++K + E + ++E + + +H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYI------------------YDHESSNGKRTLEWR 304
G C + LI E+ GSL ++ + + +R L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364
+ A I+RG++YL +++VH D+ N+ + E KISDFGL++ +++S++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPN 424
R ++A E H + +SDV+S+G+++ E+V N ++ P
Sbjct: 185 KRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPYPGIA------PE 236
Query: 425 AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
++ ++T Y E + +++M + L C + P RP+ + + LE
Sbjct: 237 RLFNLLKTGYRM-------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 48/290 (16%)
Query: 209 DKLGQGGYADVYK--GTLPDGRLVAVK--VMKNLKD---------NGEEFINEVASISRT 255
+ LG G + VYK L+A+K + N + + ++EV I
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 256 -SHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESS--NGKRTLEWRTVYQIAVG 312
H NIV + E + ++ + + L +H +S K+ ++ I V
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLG----EHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372
+ L YLH+ RIVH D+ P+NI L ED I+DFGLAKQ + + S++ GT
Sbjct: 122 MVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GT 176
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY----K 428
Y PE+ G K+DV+++G ++++M + ++ + K
Sbjct: 177 ILYSCPEIVKNEPYG--EKADVWAFGCILYQM----------CTLQPPFYSTNMLSLATK 224
Query: 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
+E Y+ +G+ +E + V C+ RP + +V M+
Sbjct: 225 IVEAVYEPLPEGMYSE-------DVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+F +LG G + V+ G VA+K + + E+FI E + + SH +V G
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C ++K ++ EFM NG L Y+ + K L + + G+EYL R
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN-- 119
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
+H D+ N + K+SDFG+ + E + S + + PEVF +F
Sbjct: 120 -SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVF--NF 175
Query: 386 GGVSHKSDVYSYGMMIHEM 404
S KSDV+S+G+++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 69/305 (22%), Positives = 140/305 (45%), Gaps = 42/305 (13%)
Query: 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRL---VAVKVMKNL--KDNGEEFINEV 249
++D++ F D +G+G + V K + L A+K MK KD+ +F E+
Sbjct: 4 LEWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 250 ASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHE----------SSNGK 298
+ + H NI+ LG C + L E+ P+G+L ++ +++
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 299 RTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358
TL + + A +ARG++YL + + +H D+ NI + E++ KI+DFGL++
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--- 172
Query: 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS 418
+E ++ R ++A E ++ + SDV+SYG+++ E+V ++C+
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230
Query: 419 SEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
+Y+++ Y + +E ++ ++ C + P +RPS +++ L
Sbjct: 231 E------LYEKLPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVSL 277
Query: 479 EGSIE 483
+E
Sbjct: 278 NRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 211 LGQGGYADVYKGTL-PDGRLVAVKVMK--NLKDNG-EEFI-NEVASISRTSHVNIVPFLG 265
LG GG+ V + R A+K +K ++ + G +E I +E + +H IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+KK ++ E+ G L + D + E+ + IA + EYLH N
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIA-CVVLAFEYLH---N 111
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE---SFISMLDTRGTAGYIAPEVFC 382
I++ D+KP N+ LD + K+ DFG AK+ + + +F GT Y+APE+
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEYVAPEIIL 165
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGR 408
G D +S G++++E++ GR
Sbjct: 166 NK--GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 71/278 (25%), Positives = 137/278 (49%), Gaps = 35/278 (12%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMK--NLKDNG--EEFINEVASISRTSHVNIVPFL 264
K+G+G +++VY+ T L DG VA+K ++ +L D + I E+ + + +H N++ +
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
E + ++ E G L + I + KR + +TV++ V + LE++H
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMH--- 123
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
+ R++H DIKP N+ + K+ D GL + K + L GT Y++PE H
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERI--H 179
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPN-----AIYKQIETEYDFQLD 439
G + KSD++S G +++EM + S ++ + ++ K+IE + D+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM----------AALQSPFYGDKMNLYSLCKKIE-QCDYP-- 226
Query: 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
+ ++ E ++++ + CI P RP +T V ++
Sbjct: 227 PLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDNG--EEFI 246
F S+++ +T LG+G + +V+ LV VK ++ KD EF
Sbjct: 2 FPRSNLQEITT-----LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 247 NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHES---SNGKRTLEW 303
E+ + SH N+V LG C E + +I E+ G L Q++ +S L
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 304 RTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363
+ + IA G+++L R VH D+ N + K+S L+K E +
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 364 I---SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
+++ R ++APE S KSDV+S+G+++ E+
Sbjct: 174 KLRNALIPLR----WLAPE--AVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 211 LGQG--GYADVYKGTLPDGRLVAVKVMKNLKDNGE----EFINEVASISRTSHVNIVPFL 264
LG+G G A +Y+ T D LV K + NL E + +NE+ +S H NI+ +
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 265 GFCYEKKKRALI-YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ LI E+ G+L I + E V I + Y+H+
Sbjct: 66 NH-FMDDNTLLIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSAVSYIHK- 119
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAPEVFC 382
I+H DIK NI L + K+ DFG++K + SM +T GT Y++PE+ C
Sbjct: 120 --AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE---YSMAETVVGTPYYMSPEL-C 173
Query: 383 RHFGGVSH--KSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440
+ GV + KSD+++ G +++E++ ++ D + N + K ++ Y
Sbjct: 174 Q---GVKYNFKSDIWALGCVLYELLTLKRTFD------ATNPLNLVVKIVQGNY------ 218
Query: 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
T + ++I + +Q P RP+ +V++
Sbjct: 219 --TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKV-MKNLKDN-----GEEFINEVASISRTSHVNIVPF 263
LG G + VYKG +PDG V + V +K L++N +E ++E ++ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKR-TLEWRTVYQIAVGIARGLEYLHR 322
LG C + L+ + MP G L Y+ +++ G + L W V IA+G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE- 126
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE-VF 381
+R+VH D+ N+ + KI+DFGLA+ + E+ + ++A E +
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 382 CRHFGGVSHKSDVYSYGMMIHE-MVIGRKNAD 412
R F +H+SDV+SYG+ + E M G K D
Sbjct: 185 HRRF---THQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 56/206 (27%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV 258
++ R + KLGQG + +V+ GT VA+K +K + E F+ E + + H
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
+V E+ ++ E+M GSL ++ + L + +A IA G+
Sbjct: 62 KLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMG----KYLRLPQLVDMAAQIASGMA 116
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
Y+ R + VH D++ NI + E+ K++DFGLA+ E E + + + + AP
Sbjct: 117 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAP 172
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEM 404
E +G + KSDV+S+G+++ E+
Sbjct: 173 EAAL--YGRFTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 23/204 (11%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNL-KDNGEEFINEVASISRTSHVNIVPFLGFC 267
+LG G + VYK + G L A KV++ ++ E+++ E+ ++ +H IV LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327
Y K ++ EF P G++D + + + R L + I + L+YLH +++
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVICRQMLEALQYLH---SMK 130
Query: 328 IVHLDIKPHNIRLDEDFCPKISDFGLA----KQTEKKESFISMLDTRGTAGYIAPE-VFC 382
I+H D+K N+ L D K++DFG++ K ++++SFI GT ++APE V C
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEVVMC 184
Query: 383 RHFGGV--SHKSDVYSYGMMIHEM 404
+K+D++S G+ + EM
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 207 FSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVN 259
F ++LG+ + +YKG L +LVA+K +K++ + + EF E + ++ H N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIY-----------DHESSNGKRTLEWRTVYQ 308
IV LG +++ +++E++ G L +++ E K +L+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
IA+ IA G+EYL + VH D+ NI + E KISD GL+++ + +
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 369 TRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
+ ++ PE +G S SD++S+G+++ E+
Sbjct: 186 SLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 40/231 (17%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVP 262
LG G + V +KG+ G+ A+K++ K E +NE + H +V
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
G + L+ E++P G L + H +G+ Y A + LEYLH
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFY--AAQVVLALEYLH- 118
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
++ IV+ D+KP N+ LD D KI+DFG AK+ + + + GT Y+APE+
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-----GTPEYLAPEIIL 171
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYF---PNAIYKQI 430
G D ++ G++I+EM+ G +F P IY++I
Sbjct: 172 SK--GYGKAVDWWALGILIYEMLAG----------YPPFFDDNPIQIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSH-VNIVPFLGFCY 268
+G G Y VYKG + G+L A+KVM D EE E+ + + SH NI + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 269 EKKKRA------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+K L+ EF GS+ I + + + K EW + I I RGL +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EW--IAYICREILRGLSHLHQ 129
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIAP 378
+++H DIK N+ L E+ K+ DFG++ Q + ++ +FI GT ++AP
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAP 180
Query: 379 EVF-CRHFGGVSH--KSDVYSYGMMIHEMVIG 407
EV C ++ KSD++S G+ EM G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 26/273 (9%)
Query: 209 DKLGQGGYADVYKGTL-PDGRLVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLG 265
+++G+G + +V+ G L D VAVK + D +F+ E + + SH NIV +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C +K+ ++ E + G ++ + G R L+ + + Q+ A G+EYL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL----RTEGPR-LKVKELIQMVENAAAGMEYLESKHC 115
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
I H D+ N + E KISDFG++++ E + + + APE ++
Sbjct: 116 I---HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NY 170
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445
G S +SDV+S+G+++ E S + + N +Q + GV
Sbjct: 171 GRYSSESDVWSFGILLWE----------AFSLGAVPYANLSNQQTR---EAIEQGVRLPC 217
Query: 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
+ + + C + P RPS + V + L
Sbjct: 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
+KLG+G YA VYKG G +VA+K + + G I E++ + H NIV
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ + K L++E+M + L +Y+ ++ + L+ TV + +G+ + H
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-- 119
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG----TAGYIAPEVF 381
R++H D+KP N+ +++ K++DFGLA+ +F ++T T Y AP+V
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYRAPDVL 172
Query: 382 CRHFGGVSHKS--DVYSYGMMIHEMVIGR 408
G ++ + D++S G ++ EM+ GR
Sbjct: 173 ---LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 40/260 (15%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVP 262
+ +G Y V+ K T G + A+KV+K K+ ++ + E +S+ +V
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
KK L+ E++P G L + ++ S L+ I LEYLH
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDL-ASLLENVGS-----LDEDVARIYIAEIVLALEYLH- 110
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT----EKKESFISMLDTR--GTAGYI 376
+ I+H D+KP NI +D + K++DFGL+K + + D R GT YI
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK--NADVKVSCSSEYFPNAIYKQIET-E 433
APEV G S D +S G +++E ++G + + P I++ I +
Sbjct: 169 APEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGET---------PEEIFQNILNGK 217
Query: 434 YDFQLDGVVTEEEKEMAKKM 453
++ D V++E ++ K+
Sbjct: 218 IEWPEDVEVSDEAIDLISKL 237
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 204 TKSFSDKLGQGGYADVYKG----TLPDGRLVAVKVMKNLKDNGE-----EFINEVASISR 254
T F ++LG+ + VYKG T P + AV + K LKD E EF +E SR
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAI-KTLKDKAEGPLREEFKHEAMMRSR 64
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY------DHESSNGKRT----LEWR 304
H NIV LG +++ ++I+ + + L +++ D S++ +T LE
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364
I IA G+E+L + +VH D+ N+ + + KISD GL ++ + +
Sbjct: 125 DFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
M ++ +++PE +G S SD++SYG+++ E+
Sbjct: 182 LMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 211 LGQGGYADVYKG-TLPDGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNIVPFLGFCY 268
LG G + VYK G A K+++ ++ E+F+ E+ +S H NIV +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 269 EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR----GLEYLHRGC 324
+ K ++ EF G+LD + + E R L T QI + R L +LH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELE-----RGL---TEPQIRY-VCRQMLEALNFLHSH- 122
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFG----LAKQTEKKESFISMLDTRGTAGYIAPEV 380
+++H D+K NI L D K++DFG +K+++FI GT ++APEV
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEV 174
Query: 381 F-CRHFGG--VSHKSDVYSYGMMIHEMVIGR 408
C F +K+D++S G+ + E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 50/278 (17%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKV--MKNLKDNGEEFINEVASISRTSHVNIVPF 263
+ + LG G VYK L R++AVKV + + ++ ++E+ + + I+ F
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G + + + ++ EFM GSLD Y R + + +IAV + +GL YL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYL--- 111
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFC 382
+++I+H D+KP N+ ++ K+ DFG++ Q S+ T GT Y+APE
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-----SIAKTYVGTNAYMAPERIS 166
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF----QL 438
G+ SDV+S G+ E+ +GR FP Y QI+ QL
Sbjct: 167 GEQYGI--HSDVWSLGISFMELALGR-------------FP---YPQIQKNQGSLMPLQL 208
Query: 439 DGVVTEEEK------EMAKKMILVSLWCIQTHPPDRPS 470
+ +E+ + ++K + C++ P +RP+
Sbjct: 209 LQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 70/288 (24%), Positives = 122/288 (42%), Gaps = 38/288 (13%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV 258
++ R + KLG G + +V+ T VAVK MK + E F+ E + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
+V L K+ +I EFM GSL ++ +S G + + + IA G+
Sbjct: 62 KLVK-LHAVVTKEPIYIITEFMAKGSLLDFL---KSDEGSK-QPLPKLIDFSAQIAEGMA 116
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
++ + +H D++ NI + KI+DFGLA+ E E + + + + AP
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAP 172
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEYFPNAIYKQIE 431
E +FG + KSDV+S+G+++ E+V G N +V + +E
Sbjct: 173 EAI--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------------IRALE 217
Query: 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
Y EE + + + C + P +RP+ + +L+
Sbjct: 218 RGYRMPRPENCPEE-------LYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 211 LGQGGYADV----YKGTLPD-GRLVAVKVMK--NLKDNGEEFINEVASISRTSHVNIVPF 263
LG+G + V Y G +VAVK +K + N + E+ + H NIV +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 264 LGFCYEK--KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
G C E+ K LI E++P GSL Y+ H+ + + L A I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-------FAQQICEGMAYLH 124
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT-EKKESFISMLDTRGTAGYIAPEV 380
+H D+ N+ LD D KI DFGLAK E E + D + A E
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE- 180
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMV 405
C S+ SDV+S+G+ ++E++
Sbjct: 181 -CLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 29/208 (13%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMK-NLKDNG--EEFINEVA---SISRTSHVNIVPF 263
+G+G Y VYK L GR VA+K ++ L + G + E+A + H NIV
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 264 LGFCY-----EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
L C+ + K L++E + + L Y+ G L T+ + + RG++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPG---LPPETIKDLMRQLLRGVD 121
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
+LH + RIVH D+KP NI + D KI+DFGLA+ + + S++ T Y AP
Sbjct: 122 FLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV---VTLWYRAP 175
Query: 379 EVFCRHFGGVSHKS--DVYSYGMMIHEM 404
EV S+ + D++S G + E+
Sbjct: 176 EVLL----QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 70/299 (23%), Positives = 135/299 (45%), Gaps = 42/299 (14%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTL-------PDGRLVAVKVMKNLKDNGE--EFINEV 249
+V R + +LGQG + VY+G + R VAVK + E EF+NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEA 60
Query: 250 ASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY----DHESSNGKRTLEWRT 305
+ + + ++V LG + + ++ E M +G L Y+ + E++ G+ +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+ Q+A IA G+ YL+ + VH D+ N + DF KI DFG+ + + + +
Sbjct: 121 MIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-- 175
Query: 366 MLDTRGTAG-----YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420
+G G ++APE G + SD++S+G+++ E+ S + +
Sbjct: 176 ---RKGGKGLLPVRWMAPESL--KDGVFTTSSDMWSFGVVLWEI----------TSLAEQ 220
Query: 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ +Q+ F +DG ++ +++ + C Q +P RP+ ++V +L+
Sbjct: 221 PYQGLSNEQV---LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFL 264
K+G+G +++VY+ T L D + VA+K ++ + ++ + E+ + + +H N++ +L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
E + ++ E G L Q I + KR + RTV++ V + +E++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMH--- 123
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
+ R++H DIKP N+ + K+ D GL + K + L GT Y++PE H
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERI--H 179
Query: 385 FGGVSHKSDVYSYGMMIHEMVI 406
G + KSD++S G +++EM
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 58/218 (26%), Positives = 108/218 (49%), Gaps = 35/218 (16%)
Query: 210 KLGQGGYADVY----KGTLP--DGRLVAVKVMKNLKDNG-EEFINEVASISRTSHVNIVP 262
+LG+G + V+ LP D LVAVK +K ++ ++F E ++ H +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDH-----------ESSNGKRTLEWRTVYQIAV 311
F G C E + +++E+M +G L++++ H + + G+ TL + IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG--QMLAIAS 129
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF----ISML 367
IA G+ YL ++ VH D+ N + + KI DFG+++ + + +ML
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 368 DTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEM 404
R ++ PE + R F + +SD++S+G+++ E+
Sbjct: 187 PIR----WMPPESILYRKF---TTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 82/307 (26%)
Query: 211 LGQGGYADVYKGTL--PDGRLVAVKV-MKNLKDNGEE-----FINEVASISRTSHVNIVP 262
LG G + +VY+G DG V ++V +K L ++ E F+ E +S+ +H NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRT-LEWRTVYQIAVGIARGLEYLH 321
+G +E+ R ++ E M G L ++ ++ + + L + + A +A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCP------KISDFGLAKQTEKKESF----ISMLDTRG 371
+H DI N L C KI+DFG+A+ + + +ML +
Sbjct: 134 EN---HFIHRDIAARNCLLT---CKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK- 186
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHE-------------------MVIGRKNAD 412
++ PE F G + K+DV+S+G+++ E V G D
Sbjct: 187 ---WMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241
Query: 413 VKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMT 472
C P +Y +I T+ C Q P DRP+
Sbjct: 242 PPKGC-----PGPVY-RIMTD--------------------------CWQHTPEDRPNFA 269
Query: 473 KVVEMLE 479
++E ++
Sbjct: 270 TILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 21/206 (10%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLG 265
+G+G Y V K G +VA+K K +D+ + + EV + + H NIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
K + L++E++ L+ S G L V + + + Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL---EASPGG---LPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIAPEVFCRH 384
I+H DIKP NI + E K+ DFG A+ + S ++ D T Y APE+
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVATRWYRAPELL--- 173
Query: 385 FGGVSHKS--DVYSYGMMIHEMVIGR 408
G ++ DV++ G ++ E++ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 200 VRRMTKSFSDKLGQGGYADVYKGTL----PDGRLVAVKVMKN--LKDNGEEFINEVASIS 253
++R + +G+G + DVY+G + VAVK KN E+F+ E +
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 254 RTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
+ H +IV +G + ++ E P G L Y+ + K +L+ ++ + +
Sbjct: 63 QFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVN-----KYSLDLASLILYSYQL 116
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
+ L YL + R VH DI N+ + C K+ DFGL++ E ES+ +
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPI 172
Query: 374 GYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADV 413
++APE + R F + SDV+ +G+ + E+++ G KN DV
Sbjct: 173 KWMAPESINFRRF---TSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLG 265
+G+G + +VYK ++VA+KV+ +L +D E+ E+ +S+ I + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 266 FCYEKK-KRALIYEFMPNGS---LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
+ K K +I E+ GS L + E + I + GLEYLH
Sbjct: 67 -SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE----------TYIAFILREVLLGLEYLH 115
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIA 377
+H DIK NI L E+ K++DFG++ Q K+ +F+ GT ++A
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMA 166
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
PEV + G K+D++S G+ E+ G
Sbjct: 167 PEVIKQ--SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 53/154 (34%), Positives = 81/154 (52%), Gaps = 20/154 (12%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEF--INEVASISRTSHVNIVPFLG 265
DKLG+G YA VYKG + G+LVA+K ++ + G F I E + + H NIV
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHES----SNGKRTLEWRTVYQIAVGIARGLEYLH 321
+ KK L++E++ + L QY+ D N + L +Q + RGL Y H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL-----FQ----LLRGLAYCH 120
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
+ R++H D+KP N+ + E K++DFGLA+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 78/274 (28%), Positives = 114/274 (41%), Gaps = 33/274 (12%)
Query: 211 LGQGGYADVYKG-TLPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
LG+G Y VY L +A+K + ++ + + E+A S H NIV +LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327
E + E +P GSL + S G +T+ I GL+YLH + +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQ 128
Query: 328 IVHLDIKPHNIRLDE-DFCPKISDFG----LAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
IVH DIK N+ ++ KISDFG LA E+F GT Y+APEV
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMAPEVID 182
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442
+ G +D++S G I EM G+ + F ++K I E +
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-IHPE--------I 233
Query: 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
E AK IL C + P R S +++
Sbjct: 234 PESLSAEAKNFILR---CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEE-----FINEVASISRTSHVNIVP 262
++G+G Y VYK G LVA+K ++ +N +E I E+ + + H NIV
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 263 FLGFCYEKKKRA--LIYEFMP---NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
K K + +++E+M G LD S K + Q+ GL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM-----KQLL----EGL 113
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG-TAGYI 376
+YLH + I+H DIK NI ++ D K++DFGLA+ K+ S R T Y
Sbjct: 114 QYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD--YTNRVITLWYR 168
Query: 377 APEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
PE+ +G + D++S G ++ E+ +G+
Sbjct: 169 PPELLLGATRYGP---EVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 200 VRRMTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKDNG-EEFINEVASI 252
++R +LG+G + V+ D LVAVK +K+ DN ++F E +
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 253 SRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH-------ESSNGKRTLEWRT 305
+ H +IV F G C E +++E+M +G L++++ H N L
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI- 364
+ IA IA G+ YL + VH D+ N + E+ KI DFG+++ + +
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 365 ---SMLDTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEM 404
+ML R ++ PE + R F + +SDV+S G+++ E+
Sbjct: 179 GGHTMLPIR----WMPPESIMYRKF---TTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 211 LGQGGYADVYKG-TLPDGRLVAVK------VMKNLKDNGEEFIN----EVASISRTSHVN 259
+G G + VY G G L+AVK V + KD ++ E+A + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGS----LDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315
IV +LG + + E++P GS L+ Y E V I +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY----------GAFEETLVRNFVRQILK 117
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-----R 370
GL YLH N I+H DIK NI +D KISDFG++K+ E S + + +
Sbjct: 118 GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN-SLSTKTNGARPSLQ 173
Query: 371 GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
G+ ++APEV + + K+D++S G ++ EM+ G+
Sbjct: 174 GSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 70/243 (28%), Positives = 114/243 (46%), Gaps = 33/243 (13%)
Query: 209 DKLGQGGYADVYKG--TLPDGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVPFL 264
DKLG+G YA VYKG L D LVA+K ++ + G I EV+ + H NIV
Sbjct: 12 DKLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ +K L++E++ + L QY+ D +S + V + RGL Y HR
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS-----INMHNVKLFLFQLLRGLNYCHRR- 123
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
+++H D+KP N+ ++E K++DFGLA+ S + T Y P++
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS--NEVVTLWYRPPDIL--- 176
Query: 385 FGGVSHKS--DVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442
G + + D++ G + +EM GR FP + ++ + + F++ G
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRP-----------LFPGSTVEE-QLHFIFRILGTP 224
Query: 443 TEE 445
TEE
Sbjct: 225 TEE 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 69/242 (28%), Positives = 111/242 (45%), Gaps = 31/242 (12%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVPFLG 265
DKLG+G YA V+KG + LVA+K ++ + G I EV+ + H NIV
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ ++ L++E++ + L QY+ N + V + RGL Y H+
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
+I+H D+KP N+ ++E K++DFGLA+ S + T Y P+V
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVL---L 176
Query: 386 GGVSHKS--DVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
G + + D++ G +++EM GR FP + K+ E F+L G T
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRP-----------MFPGSTVKE-ELHLIFRLLGTPT 224
Query: 444 EE 445
EE
Sbjct: 225 EE 226
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE--FINEVASISRTSH-VNIVPFL 264
++LG+G Y V K +P G ++AVK ++ ++ E+ + ++ R+ V F
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G + + + E M + SLD++ Y G E + +IAV I + LEYLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKF-YKKVYDKGLTIPE-DILGKIAVSIVKALEYLHS-- 121
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF--C 382
+ ++H D+KP N+ ++ + K+ DFG++ +S +D G Y+APE
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDA-GCKPYMAPERINPE 178
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ G KSDV+S G+ + E+ GR
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 30/281 (10%)
Query: 211 LGQGGYADVYKGTL--PDGRL-VAVKVMK---NLKDNGEEFINEVASISRTSHVNIVPFL 264
LG+G + V +G L D L VAVK MK + E+F++E + H N++ +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 265 GFCYEKKKR------ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
G C + + +I FM +G L ++ + + L + + + IA G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YL + +H D+ N L+E+ ++DFGL+K+ + + + +IA
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
E + KSDV+S+G+ + E+ + +P +I YD+
Sbjct: 184 ESLADRV--YTTKSDVWSFGVTMWEIATRGQTP----------YPGVENSEI---YDYLR 228
Query: 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
G ++ + + + C +P DRPS + LE
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 211 LGQGGYADVYKGTL--PDGRLV--AVKVMKNLKDNGE--EFINEVASISRTSHVNIVPFL 264
+G+G + VY GTL DG+ + AVK + + D E +F+ E + SH N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 265 GFCYEKKKRALI-YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG--IARGLEYLH 321
G C + L+ +M +G L +I + + L I G +A+G+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-------IGFGLQVAKGMEYL- 114
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT---AGYIAP 378
+ + VH D+ N LDE F K++DFGLA+ KE + S+ + G ++A
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE-YYSVHNHTGAKLPVKWMAL 171
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMV 405
E + KSDV+S+G+++ E++
Sbjct: 172 ESLQTQ--KFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 211 LGQGGYADVYKGT-LPDGR----LVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVP 262
LG G + VYKG +P+G VA+K ++ K N +E ++E ++ + ++
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPHVCR 73
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKR-TLEWRTVYQIAVGIARGLEYLH 321
LG C + LI + MP G L Y+ +H+ + G + L W V IA+G+ YL
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLE 126
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE-V 380
R+VH D+ N+ + KI+DFGLAK E + ++A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 381 FCRHFGGVSHKSDVYSYGMMIHE-MVIGRKNAD 412
R + +H+SDV+SYG+ + E M G K D
Sbjct: 184 LHRIY---THQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 34/231 (14%)
Query: 211 LGQGGYADVYKGTL-PDGR---LVAVKVMKN--LKDNGEEFINEVASISRTSHVNIVPFL 264
+G G + +V +G L G+ VA+K +K+ + +F++E + + + H NI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIA---VGIARGLEYLH 321
G + + +I EFM NG+LD ++ ++ TV Q+ GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYL- 122
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES---FISMLDTRGTAGYIAP 378
+ VH D+ NI ++ + K+SDFGL++ E S + S L + + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 379 EVFC-RHFGGVSHKSDVYSYGMMIHE-MVIGRK------NADVKVSCSSEY 421
E R F + SDV+SYG+++ E M G + N DV + +Y
Sbjct: 181 EAIAYRKF---TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 227 GRLVAVKVMKNLKDNGEEFI-NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285
GR VAVK M K E + NEV + H NIV + ++ EF+ G+L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 286 DQYIYDHESSNGKRTLEWRTVYQIA---VGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE 342
+ ++ + E QIA + + + L +LH ++H DIK +I L
Sbjct: 104 TDIV-----THTRMNEE-----QIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTS 150
Query: 343 DFCPKISDFG----LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYG 398
D K+SDFG ++K+ +++S + GT ++APEV R G + D++S G
Sbjct: 151 DGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRLPYGT--EVDIWSLG 202
Query: 399 MMIHEMVIG 407
+M+ EMV G
Sbjct: 203 IMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 61/236 (25%), Positives = 115/236 (48%), Gaps = 45/236 (19%)
Query: 207 FSDKLGQGGYADVY------KGTLP---------DGR--LVAVKVMK--NLKDNGEEFIN 247
F +KLG+G + +V+ LP GR LVAVK+++ K+ +F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKR-------- 299
EV +SR NI+ LG C ++ +I E+M NG L+Q++ H + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 300 -----TLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354
+ + ++ +A+ IA G++YL ++ VH D+ N + E+ KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 355 KQTEKKESF----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI 406
+ + + ++L R ++A E C G + SDV+++G+ + E+++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWE--CILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 207 FSDKLGQGGYADVY-------------KGTLPDGR--LVAVKVMKN--LKDNGEEFINEV 249
+KLG+G + +V+ DG+ LVAVK+++ K +F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 250 ASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHE------SSNGKRTLEW 303
+SR + NI+ LG C +I E+M NG L+Q++ E +N ++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 304 RTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363
+ +AV IA G++YL ++ VH D+ N + + KI+DFG+++ + +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 364 ----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI 406
++L R ++A E G + SDV+++G+ + EM
Sbjct: 186 RIQGRAVLPIR----WMAWESIL--LGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 66/271 (24%), Positives = 122/271 (45%), Gaps = 33/271 (12%)
Query: 211 LGQGGYADVY--KGTLPDGRLVAVK---VMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+G+G + V+ + D +LV +K V + KD NE + SH NI+ +
Sbjct: 8 VGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
E K ++ E+ P G+L +YI L+ T+ V I L ++H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKR----CNSLLDEDTILHFFVQILLALHHVH---T 119
Query: 326 IRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
I+H D+K NI LD+ KI DFG++K K +++ GT YI+PE+ C
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPEL-CEG 175
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE 444
+ KSD+++ G +++E+ A +K + + P + K + + D +
Sbjct: 176 -KPYNQKSDIWALGCVLYEL------ASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD 228
Query: 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475
+ +++S+ + P RP +++++
Sbjct: 229 ------LRQLILSM--LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEF--INEVASISRTSHVNIVPFLG 265
+KLG+G YA VYKG + +G+LVA+KV+ + G F I E + + H NIV
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ K+ ++E+M + L QY+ H L V + RGL Y+H
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMIQHPGG-----LHPYNVRLFMFQLLRGLAYIHGQ-- 122
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAK------QTEKKESFISMLDTRGTAGYIAPE 379
I+H D+KP N+ + K++DFGLA+ QT E T Y P+
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--------TLWYRPPD 173
Query: 380 VFCRHFGGVSHKS--DVYSYGMMIHEMVIGR 408
V G + S D++ G + EM+ G+
Sbjct: 174 VL---LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 211 LGQGGYADVYKG--TLPDGRLVAVKVMKNLKDNGEE-----FINEVASISRTSHVNIVPF 263
+G G + +V G LP R + V + K LK E F++E + + + H NI+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAI-KTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIA---VGIARGLEYL 320
G + K ++ E+M NGSLD ++ H+ TV Q+ GIA G++YL
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYL 122
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG---TAGYIA 377
++ VH D+ NI ++ + K+SDFGL++ E + TRG + A
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTA 177
Query: 378 PEVFC-RHFGGVSHKSDVYSYGMMIHEMV 405
PE R F + SDV+SYG+++ E++
Sbjct: 178 PEAIAYRKF---TSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 69/299 (23%), Positives = 134/299 (44%), Gaps = 42/299 (14%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTL-------PDGRLVAVKVMKNLKDNGE--EFINEV 249
+V R + S +LGQG + VY+G P+ R VA+K + E EF+NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEA 60
Query: 250 ASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIY----DHESSNGKRTLEWRT 305
+ + + ++V LG + + +I E M G L Y+ + E++ + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+ Q+A IA G+ YL+ + VH D+ N + EDF KI DFG+ + + + +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-- 175
Query: 366 MLDTRGTAG-----YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420
+G G +++PE G + SDV+S+G+++ E+ + + +
Sbjct: 176 ---RKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEI----------ATLAEQ 220
Query: 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ +Q+ F ++G + ++ + + C Q +P RPS +++ ++
Sbjct: 221 PYQGMSNEQV---LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 30/213 (14%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSH-VNIVPFLGFCY 268
+G G Y VYKG + G+L A+KVM +D EE E+ + + SH NI + G +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG-AF 82
Query: 269 EKKKRA-------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
KK L+ EF GS+ + + + + K +W + I I RGL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE--DW--IAYICREILRGLAHLH 138
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIA 377
+++H DIK N+ L E+ K+ DFG++ Q + ++ +FI GT ++A
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMA 189
Query: 378 PEVF-CRHFGGVS--HKSDVYSYGMMIHEMVIG 407
PEV C + ++SD++S G+ EM G
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 70/210 (33%), Positives = 110/210 (52%), Gaps = 32/210 (15%)
Query: 211 LGQGGYADVY---KGTLPD-GRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVP 262
LGQG + V+ K T PD G+L A+KV+K ++D E ++ +H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 263 FLGFCYEKK-KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + ++ + K LI +F+ G L + S T E Y +A L++LH
Sbjct: 63 -LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALALDHLH 115
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT---EKKE-SFISMLDTRGTAGYIA 377
++ I++ D+KP NI LDE+ K++DFGL+K++ EKK SF GT Y+A
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMA 166
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
PEV R G + +D +S+G+++ EM+ G
Sbjct: 167 PEVVNRR--GHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 47/174 (27%), Positives = 85/174 (48%), Gaps = 27/174 (15%)
Query: 206 SFSDKLGQGGYADVY----KGTLP-------------DGRLVAVKVMKN--LKDNGEEFI 246
+F +KLG+G + +V+ +G LVAVK+++ K+ +F+
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 247 NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNG-----KRTL 301
E+ +SR NI+ L C +I E+M NG L+Q++ HE T+
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 302 EWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
+ T+ +A IA G++YL ++ VH D+ N + +++ KI+DFG+++
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 23/222 (10%)
Query: 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEE--FINEVAS 251
F+ D++ + ++G+G + V K G ++AVK +++ D E+ + ++
Sbjct: 1 FTAEDLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 252 ISRTSH-VNIVPFLGFCYEKKKRALIYEFMPNGSLD---QYIYDHESSNGKRTLEWRTVY 307
+ R+S IV F G + + + E M + SLD +Y+Y+ K + +
Sbjct: 56 VMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVL----KSVIPEEILG 110
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
+IAV + L YL ++I+H D+KP NI LD + K+ DFG++ Q +S
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--DSIAKTR 166
Query: 368 DTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
D G Y+APE + G +SDV+S G+ ++E+ G+
Sbjct: 167 DA-GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 196 SYSDVRRMTKSFSDKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDN--GEEFINEVASI 252
S D ++ F +K+GQG VY + G+ VA+K M NL+ E INE+ +
Sbjct: 13 SVGDPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVM 70
Query: 253 SRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
+ NIV +L + ++ E++ GSL + + G+ R Q
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---- 126
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372
L++LH +++H DIK NI L D K++DFG Q ++S S + GT
Sbjct: 127 ---ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGT 178
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
++APEV R G K D++S G+M EMV G
Sbjct: 179 PYWMAPEVVTRKAYG--PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 211 LGQGGYADVYKGTLP------DGRLVAVKVMKN--LKDNGEEFINEVASISRTSHVNIVP 262
+GQG + V++ P +VAVK++K D +F E A ++ H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYD------HESSNGKRTLEWRTV---------- 306
LG C K L++E+M G L++++ S+ + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK----QTEKKES 362
IA +A G+ YL + VH D+ N + E+ KI+DFGL++ K S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 363 FISMLDTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEM 404
+ R ++ PE +F + + +SDV++YG+++ E+
Sbjct: 190 ENDAIPIR----WMPPESIFYNRY---TTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 74/253 (29%), Positives = 120/253 (47%), Gaps = 34/253 (13%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVM--KNLKDNGEEFIN--EVASISRTSHVNIVP 262
LG+GG+ +V K T G++ A K + K LK E + E + + + IV
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 263 FLGFCYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + +E K L+ M G L +IY+ G+R LE V + I G+ +LH
Sbjct: 58 -LAYAFESKTHLCLVMSLMNGGDLKYHIYN----VGERGLEMERVIHYSAQITCGILHLH 112
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
++ IV+ D+KP N+ LD+ ++SD GLA + + + ++ GT GY+APE+
Sbjct: 113 ---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEIL 166
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR---KNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
S+ D ++ G I+EMV GR K+ KV+ + +E E F+
Sbjct: 167 KEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-----ELKRRTLEDEVKFEH 219
Query: 439 DGVVTEEEKEMAK 451
TEE K++ +
Sbjct: 220 QN-FTEESKDICR 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 71/296 (23%), Positives = 133/296 (44%), Gaps = 46/296 (15%)
Query: 230 VAVKVMKNLKDNG-----EEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPNG 283
VAVK+ LKD+ + ++E+ + H NI+ LG C + ++ E+ G
Sbjct: 47 VAVKM---LKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103
Query: 284 SLDQYI---------YDHESSN-GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI 333
+L +Y+ Y ++ + L ++ + A +ARG+EYL + + +H D+
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDL 160
Query: 334 KPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE-VFCRHFGGVSHKS 392
N+ + ED KI+DFGLA+ + + + R ++APE +F R + +H+S
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQS 217
Query: 393 DVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL--DGVVTEEEKEMA 450
DV+S+G+++ E+ + Y I E F+L +G ++
Sbjct: 218 DVWSFGVLLWEIFT---------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCT 262
Query: 451 KKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLPTGYAKQSSPT 506
++ ++ C P RP+ ++VE L+ + LS+P +Q SP
Sbjct: 263 HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPF---EQYSPG 315
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 64/266 (24%), Positives = 125/266 (46%), Gaps = 37/266 (13%)
Query: 230 VAVKVMKN--LKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286
VAVK++K+ + + + I+E+ + H NI+ LG C + +I E+ G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 287 QYI---------YDHE-SSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPH 336
+Y+ Y + + + L ++ + A +ARG+EYL + + +H D+
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169
Query: 337 NIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE-VFCRHFGGVSHKSDVY 395
N+ + ED KI+DFGLA+ + + + R ++APE +F R + +H+SDV+
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY---THQSDVW 226
Query: 396 SYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL--DGVVTEEEKEMAKKM 453
S+G+++ E+ + Y + E F+L +G ++ ++
Sbjct: 227 SFGVLLWEIFT---------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL 271
Query: 454 ILVSLWCIQTHPPDRPSMTKVVEMLE 479
++ C P RP+ ++VE L+
Sbjct: 272 YMMMRDCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 5e-14
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 34/215 (15%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG-------EEFINEVASISRTSHVNIVP 262
LG G ++ Y+ + G L+AVK + +++ E E+ ++R +H +I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDH----ESSNGKRTLEWRTVYQIAVGIARGLE 318
LG E L E+M GS+ + + E+ T + + RGL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ----------LLRGLS 117
Query: 319 YLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISDFGLAKQTEKKESFISMLDTR--GTA 373
YLH +I+H D+K N+ +D + +I+DFG A + K + + GT
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTI 172
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
++APEV G S DV+S G +I EM +
Sbjct: 173 AFMAPEVLRGEQYGRS--CDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEF--INEVASISRTSHVNIVPFLG 265
+KLG+G YA VYKG + +G+LVA+KV++ ++ G F I E + + H NIV
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ K+ L++E++ + L QY+ H L V + RGL Y+H+
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYMDKHPGG-----LHPENVKLFLFQLLRGLSYIHQR-- 122
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
I+H D+KP N+ + + K++DFGLA+ S + T Y P+V
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS--NEVVTLWYRPPDVL---L 176
Query: 386 GGVSHKS--DVYSYGMMIHEMVIG 407
G + + D++ G + EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 5e-14
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMK-NLKDNG--EEFINEVASISRTSHVNIVPFL 264
+K+G+G Y VYK G +VA+K ++ + + G I E++ + +H NIV L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ + K L++EF+ + L +++ S L ++Q+ G+A + H
Sbjct: 66 DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCHSH- 119
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK------QTEKKESFISMLDTRGTAGYIAP 378
R++H D+KP N+ ++ + K++DFGLA+ +T E T Y AP
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--------TLWYRAP 169
Query: 379 EVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
E+ C+++ S D++S G + EMV R
Sbjct: 170 EILLGCKYY---STAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 7e-14
Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 196 SYSDVRRMTKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDN--GEEFINEVASI 252
S D ++ F +K+GQG VY + G+ VA++ M NL+ E INE+ +
Sbjct: 14 SVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVM 71
Query: 253 SRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
+ NIV +L + ++ E++ GSL + + G+ R Q
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---- 127
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372
LE+LH +++H DIK NI L D K++DFG Q ++S S GT
Sbjct: 128 ---ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGT 179
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
++APEV R G K D++S G+M EM+ G
Sbjct: 180 PYWMAPEVVTRKAYG--PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 211 LGQGGYADVYKGTL-PDGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGF 266
LG+GG+ +V + G++ A K ++ K GE I + V L +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 267 CYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
YE K L+ M G L +IY+ G E A I GLE LHR
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNM----GNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
V+ D+KP NI LD+ +ISD GLA + + ES + GT GY+APEV
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQR 177
Query: 386 GGVSHKSDVYSYGMMIHEMVIGR 408
+S D + G +I+EM+ G+
Sbjct: 178 YTLS--PDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 74/295 (25%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 211 LGQGGYADVYKG-------TLPDGRLVAVKVMKNLKDNGEE-----FINEVASISRTS-H 257
LG+G + V + + PD + V V V K LKDN + I+E+ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPD-QTVTVAV-KMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRT----------LEWRTVY 307
NI+ LG C ++ +I E+ G+L +++ T L ++ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
A +ARG+EYL + R +H D+ N+ + ED KI+DFGLA+ + +
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 368 DTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI 426
+ R ++APE +F R + +H+SDV+S+G+++ E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEIFT---------------LGGSP 236
Query: 427 YKQIETEYDFQL--DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
Y I E F+L +G ++ ++ ++ C P RP+ ++VE L+
Sbjct: 237 YPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 31/212 (14%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
+K+G+G Y VYK G +VA+K ++ L+ E I E++ + +H NIV
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYLHR 322
L + + K L++EF+ + L +Y+ D G L +YQ+ GIA Y H
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIA----YCHS 117
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG----TAGYIAP 378
R++H D+KP N+ +D + K++DFGLA+ +F + T T Y AP
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLAR------AFGVPVRTYTHEVVTLWYRAP 168
Query: 379 EVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
E+ R + S D++S G + EMV R
Sbjct: 169 EILLGSRQY---STPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 52/244 (21%)
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
IV F G Y + ++ E M GSLDQ + R E + +I++ + RGL Y
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPE-NILGKISIAVLRGLTY 114
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ--TEKKESFISMLDTRGTAGYIA 377
L +I+H D+KP NI ++ K+ DFG++ Q SF+ GT Y++
Sbjct: 115 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMS 166
Query: 378 PEVFCRHFGGVSH---KSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434
PE R G +H +SD++S G+ + EM IGR +P I
Sbjct: 167 PE---RLQG--THYTVQSDIWSLGLSLVEMAIGR-------------YP------IPPPD 202
Query: 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLS 494
+L+ + E K + HPPD P + E+L+ + + PPK
Sbjct: 203 AKELEAMFGRPVSEGEAKESHRPV---SGHPPDSPRPMAIFELLDYIVN--EPPPK---- 253
Query: 495 LPTG 498
LP+G
Sbjct: 254 LPSG 257
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 42/192 (21%)
Query: 231 AVKVMKNLKDNGEEFINEVASISRTSHV----NIV-----PFL--GFCYEKKKRAL--IY 277
A+KVM I EV + + HV ++ PF+ F E +R L +
Sbjct: 30 ALKVMA---------IPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80
Query: 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337
E++P G L Y+ + + L + A I LEYLH + IV+ D+KP N
Sbjct: 81 EYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVCALEYLH---SKEIVYRDLKPEN 131
Query: 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR--HFGGVSHKSDVY 395
I LD++ K++DFG AK+ + + GT Y+APEV H V D +
Sbjct: 132 ILLDKEGHIKLTDFGFAKKLRDRTWTLC-----GTPEYLAPEVIQSKGHNKAV----DWW 182
Query: 396 SYGMMIHEMVIG 407
+ G++I+EM++G
Sbjct: 183 ALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 211 LGQGGYADVYKG--TLPDGR--LVAVKVMKNLKDNGEE--FINEVASISRTSHVNIVPFL 264
LG G + ++ +G LP R VA+ ++ + + F+ E ++ + H NIV
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G ++ E+M NG+LD ++ HE L + + G+A G++YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLPGLASGMKYL---S 124
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
+ VH + H + ++ D KIS F Q +K E+ + + + + APE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRL-QEDKSEAIYTTMSGKSPVLWAAPEAI--Q 181
Query: 385 FGGVSHKSDVYSYGMMIHEMV 405
+ S SDV+S+G+++ E++
Sbjct: 182 YHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEE---FINEVASISRTSHVNIVPFLG 265
+G+G Y V K + G++VA+K +D+ + E+ + + H N+V +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
KK+ L++EF+ + LD + NG L+ V + I RG+E+ H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNG---LDESRVRKYLFQILRGIEFCH---S 118
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIAPEVFCRH 384
I+H DIKP NI + + K+ DFG A+ E + + TR Y APE+
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---WYRAPELL--- 172
Query: 385 FGGVSHKS--DVYSYGMMIHEMVIG 407
G + D+++ G ++ EM+ G
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 210 KLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHVNIVPFLG 265
++G G Y DVYK L G L AVK++K + G++F E+ + H NIV + G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
++K + E+ GSL Q IY H + L + + +GL YLH
Sbjct: 74 SYLSREKLWICMEYCGGGSL-QDIY-HVTG----PLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPEVF 381
+ H DIK NI L ++ K++DFG+A + K++SFI GT ++APEV
Sbjct: 128 M---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI------GTPYWMAPEVA 178
Query: 382 C-RHFGGVSHKSDVYSYGMMIHEM 404
GG + D+++ G+ E+
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 26/204 (12%)
Query: 210 KLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHVNIVPFLG 265
++G G Y DVYK + G L A+KV+K + GE+F E+ + H NIV + G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ K + EF GSL Q IY H + L + ++ +GL YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSL-QDIY-HVTG----PLSESQIAYVSRETLQGLYYLH---S 124
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIAPEVF 381
+H DIK NI L ++ K++DFG++ Q K++SFI GT ++APEV
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI------GTPYWMAPEVA 178
Query: 382 C-RHFGGVSHKSDVYSYGMMIHEM 404
GG + D+++ G+ E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE-----EFINEVASISRTSHVNIVPFL 264
++G G + V G + G A V+K L+ + +F+ E H N++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G C E L+ EF P G L Y+ + T + T+ ++A IA GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE-LMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
+H D+ N L D KI D+GL+ K++ +++ +IAPE+
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 385 FGGV-----SHKSDVYSYGMMIHEM 404
G + + +S+V+S G+ I E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 211 LGQGGYADVYKGTL-PDGRLVAVKVMKNL---KDNGEEF-INEVASISRTSHVNIVPFLG 265
LG+GG+ +V + G++ A K ++ K GE +NE + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66
Query: 266 FCYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ YE K L+ M G L +IY H G E R V+ A I GLE LH+
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFE--EGRAVF-YAAEICCGLEDLHQE- 121
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
RIV+ D+KP NI LD+ +ISD GLA + ++ + GT GY+APEV
Sbjct: 122 --RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNE 176
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
+ D ++ G +++EM+ G+
Sbjct: 177 --RYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 210 KLGQGGYADVYKG---TLPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPF 263
+LG G + V KG + VAVK++KN ++ +E + E + + + IV
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+G C E + L+ E G L++++ ++ K E V+Q+++G ++YL
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE--LVHQVSMG----MKYLEET 114
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAPEVFC 382
VH D+ N+ L KISDFGL+K E++ + + APE C
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--C 169
Query: 383 RHFGGVSHKSDVYSYGMMIHE 403
++ S KSDV+S+G+++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 47/217 (21%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNL---KDNGEEFINEVASISRTSHV---NIVPF 263
+G+G Y VY+G +P GR+VA+K++ NL D+ + EVA +S+ NI +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 264 LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTL------EWRTVYQIAVGIARG 316
G Y K R +I E+ GS+ RTL + + I +
Sbjct: 68 YG-SYLKGPRLWIIMEYAEGGSV-------------RTLMKAGPIAEKYISVIIREVLVA 113
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGT 372
L+Y+H+ + ++H DIK NI + K+ DFG+A + K+ +F+ GT
Sbjct: 114 LKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV------GT 164
Query: 373 AGYIAPEVFCRHFGGVSH--KSDVYSYGMMIHEMVIG 407
++APEV G + K+D++S G+ I+EM G
Sbjct: 165 PYWMAPEVI---TEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDN-GEEFINEVASISRTSHVNIVPFLG 265
++G+G + V+K G VA+K + + L+ + + E+ ++ H +V L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
L+ E+MP L + + D E R L V + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMH---A 117
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF--CR 383
I+H D+KP N+ + D KI+DFGLA+ ++E T Y APE+ R
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGAR 176
Query: 384 HFG-GVSHKSDVYSYGMMIHEMVIGR 408
+ GV D+++ G + E++ G
Sbjct: 177 KYDPGV----DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 31/284 (10%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE-----EFINEVASISRTSHVNIVPF 263
D++G G + V G G A V+K L+ + F+ EV +H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYI---YDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
LG C E L+ EF P G L Y+ + ++ + ++A +A GL +L
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMACEVASGLLWL 116
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H+ +H D+ N +L D KI D+GLA + ++ +I+ ++APE+
Sbjct: 117 HQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 381 FCRHFGG------VSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434
G + KS+++S G+ + E+ AD S+ + KQ+ E
Sbjct: 174 V-EIRGQDLLPKDQTKKSNIWSLGVTMWELF---TAADQPYPDLSD---EQVLKQVVREQ 226
Query: 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
D +L + + + + + V +C P RP+ +V E+L
Sbjct: 227 DIKLPK--PQLDLKYSDRWYEVMQFC-WLDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 70/290 (24%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 206 SFSDKLGQGGYADVYKGTL-----PDGRL-VAVKVMKNLKDNGEE--FINEVASISRT-S 256
SF LG G + V + T D + VAVK++K + E ++E+ +S +
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97
Query: 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
H NIV LG C +I E+ G L ++ + L + + +A+G
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR----RKRESFLTLEDLLSFSYQVAKG 153
Query: 317 LEYL-HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGY 375
+ +L + C +H D+ N+ L KI DFGLA+ +++ + R +
Sbjct: 154 MAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 376 IAPEVFCRHFGGV-SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP-----NAIYKQ 429
+APE F V + +SDV+SYG+++ E+ S S +P + YK
Sbjct: 210 MAPESI---FNCVYTFESDVWSYGILLWEI----------FSLGSNPYPGMPVDSKFYKL 256
Query: 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
I+ Y E ++ K C P RP+ ++V+++
Sbjct: 257 IKEGYRMAQPEHAPAEIYDIMKT-------CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 209 DKLGQGGYADVYKG--TLPDGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVPFL 264
+KLG+G YA V+KG L + LVA+K ++ + G I EV+ + H NIV
Sbjct: 12 EKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ K L++E++ + L QY+ D + + V I RGL Y HR
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR- 123
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
+++H D+KP N+ ++E K++DFGLA+ S + T Y P+V
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVLL-- 177
Query: 385 FGGVSHKS---DVYSYGMMIHEMVIGR 408
G S S D++ G + EM GR
Sbjct: 178 --GSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVM--KNLKDNGEEFI--NE--VASISRTSHVNIVPF 263
+G+GG+ +VY D G++ A+K + K +K E + NE + S+ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 264 LGFCYEK-KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+ + + K + I + M G L + H S +G + Y A I GLE++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFY--AAEIILGLEHMH- 114
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
N +V+ D+KP NI LDE +ISD GLA KK+ S+ GT GY+APEV
Sbjct: 115 --NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 168
Query: 383 RHFGGVSHKS--DVYSYGMMIHEMVIG 407
+ GV++ S D +S G M+ +++ G
Sbjct: 169 K---GVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 211 LGQGGYADVYKGTL-PDGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGF 266
LG+GG+ +V + G++ A K ++ K GE I + V L +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 267 CYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
YE K L+ M G L +IY+ + E R ++ A + GLE L R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD---EQRAIF-YAAELCCGLEDLQRE-- 121
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
RIV+ D+KP NI LD+ +ISD GLA Q + E+ + GT GY+APEV
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVINNE- 176
Query: 386 GGVSHKSDVYSYGMMIHEMVIGR 408
+ D + G +I+EM+ G+
Sbjct: 177 -KYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 64/269 (23%), Positives = 123/269 (45%), Gaps = 43/269 (15%)
Query: 230 VAVKVMKNLKDNGEE-----FINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNG 283
VAVK+ LKD+ E ++E+ + H NI+ LG C + +I E+ G
Sbjct: 50 VAVKM---LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106
Query: 284 SLDQYI---------YDHESSN-GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI 333
+L +Y+ Y ++ + + ++ + +ARG+EYL + + +H D+
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDL 163
Query: 334 KPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE-VFCRHFGGVSHKS 392
N+ + E+ KI+DFGLA+ + + + R ++APE +F R + +H+S
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY---THQS 220
Query: 393 DVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL--DGVVTEEEKEMA 450
DV+S+G+++ E+ + Y I E F+L +G ++
Sbjct: 221 DVWSFGVLMWEIFT---------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCT 265
Query: 451 KKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
++ ++ C P RP+ ++VE L+
Sbjct: 266 NELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASI-SRTSHVNIVPFLGF 266
+ +G+G Y VYK T DG L AVK++ + D EE E + S +H N+V F G
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 267 CYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
Y+ K L+ E GS+ + + G+R E Y I G GL++LH
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISY-ILYGALLGLQHLH 145
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
N RI+H D+K +NI L + K+ DFG++ Q + + GT ++APEV
Sbjct: 146 ---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVI 200
Query: 382 -CRHFGGVSH--KSDVYSYGMMIHEMVIG 407
C S+ + DV+S G+ E+ G
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 205 KSFSD--KLGQGGYADVYKGT-LPDGRLVAVKVM----KNLKDNGEEFINEVASISRTSH 257
K F+D ++G G + VY + +VA+K M K + ++ I EV + + H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 258 VNIVPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
N + + G CY ++ A L+ E+ GS + H K+ L+ + I G +G
Sbjct: 75 PNTIEYKG-CYLREHTAWLVMEYCL-GSASDILEVH-----KKPLQEVEIAAICHGALQG 127
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
L YLH I H DIK NI L E K++DFG A SF+ GT ++
Sbjct: 128 LAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWM 178
Query: 377 APEV-FCRHFGGVSHKSDVYSYGMMIHEM 404
APEV G K DV+S G+ E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 69/301 (22%), Positives = 130/301 (43%), Gaps = 45/301 (14%)
Query: 200 VRRMTKSFSDKLGQGGYADVYKGT------LPDGRLVAVKVMKNLKDNG-EEFINEVASI 252
++R +LG+G + V+ D LVAVK +K+ ++F E +
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 61
Query: 253 SRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH----------ESSNGKRTLE 302
+ H +IV F G C + +++E+M +G L++++ H + K L
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 303 WRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362
+ IA IA G+ YL + VH D+ N + + KI DFG+++ +
Sbjct: 122 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 363 FI----SMLDTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC 417
+ +ML R ++ PE + R F + +SDV+S+G+++ E+ K ++S
Sbjct: 179 YRVGGHTMLPIR----WMPPESIMYRKF---TTESDVWSFGVILWEIFTYGKQPWFQLS- 230
Query: 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
+ + I G V E + K++ + L C Q P R ++ ++ ++
Sbjct: 231 -----NTEVIECIT-------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278
Query: 478 L 478
L
Sbjct: 279 L 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 75/268 (27%), Positives = 116/268 (43%), Gaps = 36/268 (13%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVM----KNLKDNGEEFINEVASISRTSHVNIVPFL 264
++G G + VY T +VAVK M K + ++ I EV + + H N + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 265 GFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G CY K+ A L+ E+ GS + H K+ L+ + I G +GL YLH
Sbjct: 88 G-CYLKEHTAWLVMEYCL-GSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV-FC 382
++H DIK NI L E K++DFG A ++ SF+ GT ++APEV
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILA 191
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442
G K DV+S G+ E+ RK ++ S A+Y + +
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMS-----ALYHIAQNDSP------- 238
Query: 443 TEEEKEMAKKMILVSLWCIQTHPPDRPS 470
T + E +C+Q P +RP+
Sbjct: 239 TLQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 17/105 (16%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
VYQI RGL+Y+H + I+H D+KP NI ++ED KI DFGLA+ T+ +
Sbjct: 124 VYQIL----RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----- 171
Query: 366 MLDTRGTAGYIAPEV-FCR-HFGGVSHKSDVYSYGMMIHEMVIGR 408
M T Y APE+ H+ + D++S G ++ E++ G+
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 25/215 (11%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFI-NEVASISRTS 256
D R SF K+G+G V T G+ VAVK M K E + NEV +
Sbjct: 19 DPREYLDSFI-KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
H N+V + ++ EF+ G+L I H N ++ + + + + R
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQ------IATVCLSVLRA 130
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG----LAKQTEKKESFISMLDTRGT 372
L YLH N ++H DIK +I L D K+SDFG ++K+ K++S + GT
Sbjct: 131 LSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GT 181
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
++APEV R G + D++S G+M+ EM+ G
Sbjct: 182 PYWMAPEVISRLPYGT--EVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFI-NEVASISRTSHVNIVPFLGF 266
+K+GQG V+ + G+ VA+K + K +E I NE+ + + NIV FL
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
+ ++ E++ GSL + + + R Q LE+LH
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ-------ALEFLHAN--- 134
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
+++H DIK N+ L D K++DFG Q ++S S + GT ++APEV R
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKAY 192
Query: 387 GVSHKSDVYSYGMMIHEMVIG 407
G K D++S G+M EMV G
Sbjct: 193 G--PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNL-KDNGEEFINEVASISRTSHVNIVPFLGFC 267
+LG G + VYK + G L A KV+ ++ E+++ E+ ++ H NIV L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327
Y + ++ EF G++D + + E R L + + L YLH +
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHEN---K 123
Query: 328 IVHLDIKPHNIRLDEDFCPKISDFGL-AKQT---EKKESFISMLDTRGTAGYIAPE-VFC 382
I+H D+K NI D K++DFG+ AK T ++++SFI GT ++APE V C
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMC 177
Query: 383 RHFGG--VSHKSDVYSYGMMIHEM 404
+K+DV+S G+ + EM
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 47/252 (18%)
Query: 188 GSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG--EE 244
GS S S++ R+ +++G G VYK P GRL A+KV+ ++ +
Sbjct: 64 GSAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ 118
Query: 245 FINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWR 304
E+ + +H N+V + ++ EFM GSL+ G + +
Sbjct: 119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----------GTHIADEQ 168
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG----LAKQTEKK 360
+ +A I G+ YLHR IVH DIKP N+ ++ KI+DFG LA+ +
Sbjct: 169 FLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225
Query: 361 ESFISMLDTRGTAGYIAPEVF---CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC 417
S + GT Y++PE H + D++S G+ I E +GR
Sbjct: 226 NSSV------GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR--------- 270
Query: 418 SSEYFPNAIYKQ 429
FP + +Q
Sbjct: 271 ----FPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 60/289 (20%), Positives = 121/289 (41%), Gaps = 45/289 (15%)
Query: 211 LGQGGYADVYKGTLP----DGRLVAVKVMK---NLKDNGEEFINEVASISRTSHVNIVPF 263
LG+G + V + L + VAVK++K + EEF+ E A + H N++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 264 LGFCYEKKKRA------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+G + + +I FM +G L ++ TL +T+ + + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
EYL + +H D+ N L+E+ ++DFGL+K+ + + ++ ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEYFPNAIYKQI 430
E + SDV+++G+ + E++ G +N+++
Sbjct: 184 LESLADNVYTT--HSDVWAFGVTMWEIMTRGQTPYAGVENSEI----------------- 224
Query: 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
Y++ + G ++ + + + + C P RPS + + LE
Sbjct: 225 ---YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/297 (21%), Positives = 136/297 (45%), Gaps = 43/297 (14%)
Query: 206 SFSDKLGQGGYADVYKGTLP-DGRLV--AVKVMKNL--KDNGEEFINEVASISRTS-HVN 259
F D +G+G + V + + DG + A+K++K +++ +F E+ + + H N
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIY-------------DHESSNGKRTLEWRTV 306
I+ LG C + + E+ P G+L ++ +H +++ TL + +
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS---TLTSQQL 121
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366
Q A +A G++YL + +H D+ N+ + E+ KI+DFGL++ +E ++
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI 426
R ++A E ++ + KSDV+S+G+++ E+V ++C+ +
Sbjct: 176 TMGRLPVRWMAIESL--NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------L 227
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483
Y+++ Y + +E E+ ++ C + P +RP ++ L +E
Sbjct: 228 YEKLPQGYRMEKPRNCDDEVYELMRQ-------CWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 51/233 (21%)
Query: 207 FSDKLGQGGYADVYKG-TLPDGRLVAVK--VMKNLKDNGEEF----INEVASISRTSHVN 259
KLG+G + +VYK + GR+VA+K +M N KD F + E+ + + H N
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPN 68
Query: 260 IVPFLGFCYEK-----KKRALIYEFMPNGSLDQYIYDHESS----NGKRTLEWRTVYQIA 310
+VP + E+ +KR +Y P Y+ DH+ S N L +
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTP------YM-DHDLSGLLENPSVKLTESQIKCYM 121
Query: 311 VGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA------------KQTE 358
+ + G+ YLH N I+H DIK NI +D KI+DFGLA
Sbjct: 122 LQLLEGINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 359 KKESFISMLDTRGTAGYIAPEVF---CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ +++ TR Y PE+ R+ V D++ G + EM R
Sbjct: 179 GTRKYTNLVVTR---WYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 44/219 (20%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEE------FINEVASISRTSHVNIV 261
+K+G+G Y VYKG G++VA MK ++ EE I E++ + H NIV
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVA---MKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV----YQIAVGIARGL 317
++ + LI+EF+ + L +Y+ +S + ++ V YQI GI
Sbjct: 63 CLQDVLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGIL--- 115
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK------QTEKKESFISMLDTRG 371
+ H R++H D+KP N+ +D K++DFGLA+ + E
Sbjct: 116 -FCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-------- 163
Query: 372 TAGYIAPEVFCRHFGGVSHKS--DVYSYGMMIHEMVIGR 408
T Y APEV G + + D++S G + EM +
Sbjct: 164 TLWYRAPEVL---LGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 54/150 (36%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
IV F G + + EFM GSLD+ IY G +E + +IAV + GL Y
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDR-IY---KKGGPIPVE--ILGKIAVAVVEGLTY 118
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAP 378
L+ RI+H DIKP NI ++ K+ DFG++ E S+ DT GT+ Y++P
Sbjct: 119 LYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-----ELINSIADTFVGTSTYMSP 171
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
E G + KSDV+S G+ I E+ +G+
Sbjct: 172 ERI--QGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 209 DKLGQGGYADVYKGTLPDGR-LVAVKV--MKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+++G+G + +VYKG + +VA+K+ ++ +D E+ E+ +S+ I + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ K +I E++ GS + LE + I I +GL+YLH +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL-------KPGPLEETYIATILREILKGLDYLH---S 119
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIAPEVF 381
R +H DIK N+ L E K++DFG+A Q K+ +F+ GT ++APEV
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 173
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIG 407
+ K+D++S G+ E+ G
Sbjct: 174 KQ--SAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 211 LGQGGYADVY---KGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRT--SHVNIVPFL 264
LG G Y V+ K T D G+L A+KV++ + E R HV PFL
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 265 ---GFCYEKK-KRALIYEFMPNGSLDQYIY--DHESSNGKRTLEWRTVYQIAVGIARGLE 318
+ ++ + K LI +++ G + ++Y D+ S + R Y + +A LE
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR------FYSGEIILA--LE 119
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ--TEKKESFISMLDTRGTAGYI 376
+LH+ + IV+ DIK NI LD + ++DFGL+K+ +E+KE S GT Y+
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYM 173
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
APE+ R GG D +S G++I E++ G
Sbjct: 174 APEII-RGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 67/204 (32%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 211 LGQGGYADVYKGTL-PDGRLVAVKVMKNL---KDNGEEF-INEVASISRTSHVNIVPFLG 265
LG+GG+ +V + G++ A K ++ K GE +NE + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 266 FCYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ YE K L+ M G L +IY+ + E R V+ A I GLE LHR
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVF-YAAEITCGLEDLHRE- 121
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
RIV+ D+KP NI LD+ +ISD GLA + + E+ + GT GY+APEV
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV---GTVGYMAPEVVKNE 176
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
S D + G +I+EM+ G+
Sbjct: 177 RYTFS--PDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 210 KLGQGGYADVYKGTLPDGRL---VAVKVMK--NLKDNGEEFINEVASISRTSHVNIVPFL 264
+LG G + V KG + VA+KV+K N K +E + E + + + IV +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G C E + L+ E G L++++ S K + V ++ ++ G++YL G
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL-----SGKKDEITVSNVVELMHQVSMGMKYLE-GK 114
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG-----YIAPE 379
N VH D+ N+ L KISDFGL+K +S+ +AG + APE
Sbjct: 115 NF--VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----KARSAGKWPLKWYAPE 168
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHE 403
C +F S +SDV+SYG+ + E
Sbjct: 169 --CINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 210 KLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFI-NEVASISRTSHVNIVPFLGFC 267
K+G+G V T+ G+LVAVK M K E + NEV + H N+V
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RGCNI 326
+ ++ EF+ G+L I H N ++ + + + + + L LH +G
Sbjct: 87 LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQ------IAAVCLAVLKALSVLHAQG--- 136
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFG----LAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
++H DIK +I L D K+SDFG ++K+ +++S + GT ++APE+
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELIS 189
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIG 407
R G + D++S G+M+ EMV G
Sbjct: 190 RLPYG--PEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 45/230 (19%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKN---LKDNGEEFINEVASISRTSHVNIVPFLGF 266
+G+G + +V+ D G++ A+KV++ +K N + I + + L +
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 267 CYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GC 324
++ ++ L+ E+MP G L + + T + L+ +H+ G
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKLGF 122
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-------------- 370
+H DIKP NI +D D K++DFGL K+ K + L+
Sbjct: 123 ----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 371 -------------GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
GT YIAPEV + D +S G++++EM+ G
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 35/221 (15%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEFI-----NEVASISRTSHVN-IV 261
+K+G+G Y VYK G+LVA+K K + EE I E++ + S IV
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 262 PFLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
L + ++K L++E++ + L +++ + G R L +T+ + +G
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPG-RPLPAKTIKSFMYQLLKG 122
Query: 317 LEYLH-RGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQ-TEKKESFISMLDTRGTA 373
+ + H G ++H D+KP N+ +D+ KI+D GL + + +S+ + T
Sbjct: 123 VAHCHKHG----VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI---VTL 175
Query: 374 GYIAPEVFCRHFGGVSHKS---DVYSYGMMIHEMVIGRKNA 411
Y APEV G +H S D++S G + EM RK
Sbjct: 176 WYRAPEVLL----GSTHYSTPVDIWSVGCIFAEMS--RKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 40/106 (37%), Positives = 56/106 (52%), Gaps = 14/106 (13%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQI RGL+YLH I+H DIKP N+ ++ + KI DFGLA+ E ES
Sbjct: 109 LYQIL----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH- 160
Query: 366 MLDTRGTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGRK 409
M T Y APE+ RH+ D++S G + E+ +GR+
Sbjct: 161 MTQEVVTQYYRAPEILMGSRHYTS---AVDIWSVGCIFAEL-LGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGE--EFINEVASISRTSHVNIVPF 263
D+LG+G Y VYK P G +A+K ++ D + + I E+ + + IV F
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G + + + E+M GSLD+ +Y + E + +I + +GL++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDK-LYA-GGVATEGIPE-DVLRRITYAVVKGLKFLKEE 121
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFC 382
NI +H D+KP N+ ++ + K+ DFG++ S+ T G Y+APE
Sbjct: 122 HNI--IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-----SLAKTNIGCQSYMAPE--- 171
Query: 383 RHFGG-------VSHKSDVYSYGMMIHEMVIGR 408
R G + +SDV+S G+ I EM +GR
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVM--KNLK-DNGEEF-INEVASISRTSHVNIVPFLG 265
+G+GG+ +VY D G++ A+K + K +K GE +NE +S S + PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFI- 59
Query: 266 FC-----YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
C + K I + M G L ++ H + K + A I GLE++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILGLEHM 113
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H N +V+ D+KP NI LDE +ISD GLA KK+ S+ GT GY+APEV
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEV 166
Query: 381 FCRHFGGVSHKS--DVYSYGMMIHEMVIG 407
+ G ++ S D +S G M+ +++ G
Sbjct: 167 LQK---GTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 25/192 (13%)
Query: 290 YDHESSNGKRTLEWRTVYQIAVGIARGLEYL-HRGCNIRIVHLDIKPHNIRLDEDFCPKI 348
E TLE Y V ARG+E+L R C +H D+ NI L E+ KI
Sbjct: 161 EGDELYKEPLTLEDLISYSFQV--ARGMEFLASRKC----IHRDLAARNILLSENNVVKI 214
Query: 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
DFGLA+ K ++ D R ++APE +F + + + +SDV+S+G+++ E+
Sbjct: 215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY---TTQSDVWSFGVLLWEI--- 268
Query: 408 RKNADVKVSCSSEYFPNAIYKQIETEYDFQL-DGVVTEEEKEMAKKMILVSLWCIQTHPP 466
S + +P QI+ E+ +L +G + ++ + L C +P
Sbjct: 269 -------FSLGASPYPGV---QIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318
Query: 467 DRPSMTKVVEML 478
DRP+ +++VE+L
Sbjct: 319 DRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 25/187 (13%)
Query: 227 GRLVAVKVMKNLKDNGEEFI-NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285
GR VAVK+M K E + NEV + H N+V ++ ++ EF+ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RGCNIRIVHLDIKPHNIRLDEDF 344
+ + L + + + + L YLH +G ++H DIK +I L D
Sbjct: 106 TDIV-------SQTRLNEEQIATVCESVLQALCYLHSQG----VIHRDIKSDSILLTLDG 154
Query: 345 CPKISDFG----LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMM 400
K+SDFG ++K K++S + GT ++APEV R G + D++S G+M
Sbjct: 155 RVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTPYGT--EVDIWSLGIM 206
Query: 401 IHEMVIG 407
+ EMV G
Sbjct: 207 VIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 63/294 (21%), Positives = 132/294 (44%), Gaps = 43/294 (14%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEE-----FINEVASISRTSH-VNIVP 262
D +G+G + V K + L +K +K+ + F E+ + + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIY-------------DHESSNGKRTLEWRTVYQI 309
LG C + L E+ P+G+L ++ + +++ TL + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS---TLSSQQLLHF 117
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT 369
A +ARG++YL + + +H D+ NI + E++ KI+DFGL++ +E ++
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 171
Query: 370 RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429
R ++A E ++ + SDV+SYG+++ E+V ++C+ +Y++
Sbjct: 172 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK 223
Query: 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483
+ Y + +E ++ ++ C + P +RPS +++ L +E
Sbjct: 224 LPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 44/222 (19%)
Query: 209 DKLGQGGYADVYKGTLPDGR---LVAVKV--MKNLKDNGEEFINEVASISRTSHVNIVPF 263
+++G+G + +V+KG D R +VA+K+ ++ +D E+ E+ +S+ + +
Sbjct: 10 ERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 264 LGFCYEKKKRALIYEFMPNGS----LDQYIYDHESSNGKRTLEWRTVYQIAV---GIARG 316
G + K +I E++ GS L +D +QIA I +G
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--------------FQIATMLKEILKG 113
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGT 372
L+YLH + + +H DIK N+ L E K++DFG+A Q K+ +F+ GT
Sbjct: 114 LDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GT 164
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR-KNADV 413
++APEV + K+D++S G+ E+ G N+D+
Sbjct: 165 PFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGF 266
+LG G V K L+ + + +L+ + I E+ + + IV F G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
Y + ++ E M GSLDQ + + KR E + ++++ + RGL YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKE-----AKRIPE-EILGKVSIAVLRGLAYLRE--KH 123
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQ--TEKKESFISMLDTRGTAGYIAPEVF-CR 383
+I+H D+KP NI ++ K+ DFG++ Q SF+ GT Y++PE
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT 177
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGR 408
H+ S +SD++S G+ + E+ IGR
Sbjct: 178 HY---SVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 211 LGQGGYADVYKGTL-PDGRLVAVKVM--KNLKD-NGEEFINEVASISRTSHVNIVPFLGF 266
LG+GG+ +V + G+L A K + K LK G E I H + L +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 267 CYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
++ K L+ M G L +IY+ + N E R + A I GLE+LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP-EPRACFYTA-QIISGLEHLHQR-- 116
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GTAGYIAPEVFC 382
RI++ D+KP N+ LD D +ISD GLA + + +S T+ GT G++APE+
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-----KTKGYAGTPGFMAPELLQ 170
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGR 408
S D ++ G+ ++EM+ R
Sbjct: 171 GEEYDFS--VDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 43/277 (15%)
Query: 209 DKLGQGGYADVYKGTLPDGR---LVAVKV--MKNLKDNGEEFINEVASISRTSHVNIVPF 263
+K+G+G + +V+KG D R +VA+K+ ++ +D E+ E+ +S+ + +
Sbjct: 10 EKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G + K +I E++ GS + L+ + I I +GL+YLH
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLE-------PGPLDETQIATILREILKGLDYLH-- 118
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIAPE 379
+ + +H DIK N+ L E K++DFG+A Q K+ +F+ GT ++APE
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPE 171
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439
V + K+D++S G+ E+ G SE P + I L+
Sbjct: 172 VIKQ--SAYDSKADIWSLGITAIELAKGEPP-------HSELHPMKVLFLIPKNNPPTLE 222
Query: 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
G ++ KE + C+ P RP+ ++++
Sbjct: 223 GNYSKPLKEFVEA-------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 200 VRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVK--VMKNLKDNGEE-----FINEVASI 252
+ R + SD L +G + ++ G L D + + +K +KD+ E + E +
Sbjct: 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLL 62
Query: 253 SRTSHVNIVPFLGFCYEKKKRALI-YEFMPNGSLDQYIYD--HESSNGKRTLEWRTVYQI 309
SH NI+P L C E + + Y +M G+L ++ +N + L + + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT 369
A+ IA G+ YLH+ ++H DI N +DE+ KI+D L+ ++ F
Sbjct: 123 AIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALS-----RDLFPMDYHC 174
Query: 370 RGTAGY-----IAPEVFC-RHFGGVSHKSDVYSYGMMIHEMV 405
G +A E + + S SDV+S+G+++ E++
Sbjct: 175 LGDNENRPVKWMALESLVNKEY---SSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 205 KSFSD--KLGQGGYADVYKG-TLPDGRLVAVKVM----KNLKDNGEEFINEVASISRTSH 257
K FSD ++G G + VY + + +VA+K M K + ++ I EV + + H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 258 VNIVPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
N + + G CY ++ A L+ E+ GS + H K+ L+ + + G +G
Sbjct: 75 PNTIQYRG-CYLREHTAWLVMEYCL-GSASDLLEVH-----KKPLQEVEIAAVTHGALQG 127
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
L YLH + ++H D+K NI L E K+ DFG A F+ GT ++
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWM 178
Query: 377 APEV-FCRHFGGVSHKSDVYSYGMMIHEM 404
APEV G K DV+S G+ E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 209 DKLGQGGYADV----YKGTLPDGRLVAVKVMKN---LKDNGEEFINEVASI-SRTSHVNI 260
+ LG G + V +KGT G A+K +K LK + + + SI SH I
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
V + ++ + + EF+ G L + H G+ + Y + +A EYL
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAELVLA--FEYL 134
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H + I++ D+KP N+ LD K++DFG AK+ + + GT Y+APEV
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-----GTPEYLAPEV 186
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIG 407
G D ++ G++++E + G
Sbjct: 187 I--QSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 205 KSFSD--KLGQGGYADVYKGTLPDGR---LVAVKVM----KNLKDNGEEFINEVASISRT 255
K F+D ++G G + VY D R +VA+K M K + ++ I EV + R
Sbjct: 25 KLFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI 82
Query: 256 SHVNIVPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
H N + + G CY ++ A L+ E+ GS + H K+ L+ + I G
Sbjct: 83 KHPNSIEYKG-CYLREHTAWLVMEYCL-GSASDLLEVH-----KKPLQEVEIAAITHGAL 135
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
+GL YLH + ++H DIK NI L E K++DFG A SF+ GT
Sbjct: 136 QGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPY 186
Query: 375 YIAPEV-FCRHFGGVSHKSDVYSYGMMIHEM 404
++APEV G K DV+S G+ E+
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 35/212 (16%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN----LKDNGEEFINEVASISRT-SHVNIV 261
LG+G + V+ KGT + A+K +K + D+ E + E +S H
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH---- 55
Query: 262 PFLG--FCYEKKKRALIY--EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
PFL +C + K L + E++ G L +I S K L T Y A I GL
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFY--AAEIICGL 109
Query: 318 EYLH-RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
++LH +G IV+ D+K NI LD D KI+DFG+ K+ ++ GT YI
Sbjct: 110 QFLHSKG----IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF--CGTPDYI 163
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
APE+ + D +S+G++++EM+IG+
Sbjct: 164 APEILLGQ--KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 43/216 (19%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVMK----NLKDNGEEFINE--VASISRTSHVNI 260
LG+G + V KGT L AVKV+K D+ E + E V +++
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH---- 55
Query: 261 VPFLG---FCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
PFL C++ K R + E++ G L ++ H +G+ Y A I G
Sbjct: 56 -PFLTQLHSCFQTKDRLFFVMEYVNGGDL---MF-HIQRSGRFDEPRARFY--AAEIVLG 108
Query: 317 LEYLH-RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GT 372
L++LH RG I++ D+K N+ LD + KI+DFG+ KE + + T GT
Sbjct: 109 LQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMC-----KEGILGGVTTSTFCGT 159
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
YIAPE+ + D ++ G++++EM+ G+
Sbjct: 160 PDYIAPEIL--SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRT--SHVNIVPFL 264
LG G Y V+ G G+L A+KV+K + E R V PFL
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 265 -----GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
F + K LI +++ G L + H T VY + +A L++
Sbjct: 68 VTLHYAFQTDTKLH-LILDYVNGGEL----FTHLYQREHFTESEVRVYIAEIVLA--LDH 120
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK-----QTEKKESFISMLDTRGTAG 374
LH+ + I++ DIK NI LD + ++DFGL+K + E+ SF GT
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC------GTIE 171
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
Y+APEV GG D +S G++ E++ G
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 9e-11
Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGE--EFIN----EVASISRTSHVNIVPF 263
LGQG + VY D GR +AVK ++ ++ E + +N E+ + H IV +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 264 LGFCYEKKKRAL--IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
G + +R L E MP GS I D S G L + I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYG--ALTENVTRKYTRQILEGVSYLH 123
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK-ESFISMLDTRGTAGYIAPEV 380
IVH DIK NI D K+ DFG +K+ + S M GT +++PEV
Sbjct: 124 SN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
G K+D++S G + EM+ +
Sbjct: 181 ISGE--GYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 32/161 (19%)
Query: 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RGCNIRIVHLDI 333
L+ E++ G I + G +W Q + G+E LH RG I+H DI
Sbjct: 74 LVMEYLNGGDCASLI----KTLGGLPEDW--AKQYIAEVVLGVEDLHQRG----IIHRDI 123
Query: 334 KPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG-GVSHKS 392
KP N+ +D+ K++DFGL++ + + F+ GT Y+APE G G S
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETI---LGVGDDKMS 174
Query: 393 DVYSYGMMIHEMVIGRK--NADVKVSCSSEYFPNAIYKQIE 431
D +S G +I E + G +A+ P+A++ I
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAET---------PDAVFDNIL 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 20/168 (11%)
Query: 244 EFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEW 303
+ I E+ + + IV F G Y + ++ E M GSLDQ + G+ +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGR--IPE 102
Query: 304 RTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ--TEKKE 361
+ + ++++ + +GL YL +I+H D+KP NI ++ K+ DFG++ Q
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160
Query: 362 SFISMLDTRGTAGYIAPEVF-CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
SF+ GT Y++PE H+ S +SD++S G+ + EM IGR
Sbjct: 161 SFV------GTRSYMSPERLQGTHY---SVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 207 FSDKLGQGGYADVYKG---TLPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVN 259
+G+G Y VYK DG+ A+K K K+ E+A + H N
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 260 IVPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+V + E ++ L++++ + L Q I H + ++ V + I G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFH-RQAKRVSIPPSMVKSLLWQILNGV 121
Query: 318 EYLHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAK 355
YLH ++H D+KP NI + E KI D GLA+
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEE-----FINEVASISRTS---HVNI 260
++G G Y VYK P G VA+K ++ E+ + EVA + R H NI
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 261 VPFLGFCYEKK-----KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315
V + C + K L++E +DQ + + L T+ + R
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFE-----HVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGY 375
GL++LH C IVH D+KP NI + K++DFGLA+ + + ++ T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVV---VTLWY 173
Query: 376 IAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
APEV + + D++S G + EM
Sbjct: 174 RAPEVLLQ--STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 262 PFLG--FCYEKKKRALIY--EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
PFL FC + K L + E++ G L +I S+G+ Y A I GL
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI----QSSGRFDEARARFY--AAEIICGL 109
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
++LH+ I++ D+K N+ LD+D KI+DFG+ K+ E S GT YIA
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--CGTPDYIA 164
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
PE+ + D +S+G++++EM+IG+
Sbjct: 165 PEILKGQ--KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 49/169 (28%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 313 IARGLEYL-HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
+ARG+E+L R C +H D+ NI L E+ KI DFGLA+ K ++ R
Sbjct: 183 VARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 372 TAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430
++APE +F + + + +SDV+S+G+++ E+ S + +P QI
Sbjct: 239 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEI----------FSLGASPYPGV---QI 282
Query: 431 ETEYDFQL-DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
E+ +L DG + ++ + L C Q P +RP+ + +VE+L
Sbjct: 283 NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 42/218 (19%)
Query: 210 KLGQGGYADVYKG-TLPDGRLVAVK--VMKNLKDNGEEF----INEVASISRTSHVNIVP 262
K+GQG + +V+K ++VA+K +M+N K E F + E+ + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 75
Query: 263 FLGFCYEKKK-----RA---LIYEFMPNGSLDQYIYDHE----SSNGKRTLEWRTVYQIA 310
+ C K + L++EF +H+ SN + ++
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC----------EHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 311 VGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK--QTEKKESFISMLD 368
+ GL Y+HR +I+H D+K NI + +D K++DFGLA+ K +
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 369 TRGTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEM 404
T Y PE+ R +G D++ G ++ EM
Sbjct: 183 RVVTLWYRPPELLLGERDYG---PPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 66/227 (29%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASI----------S 253
LG+G + V YK T G L A+K +K + I +EV S+ +
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALK------KGDIIARDEVESLMCEKRIFETAN 57
Query: 254 RTSHVNIVPFL---GFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQI 309
H PFL C++ + + E+ G L +I+ E R V+
Sbjct: 58 SERH----PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT------DVFSEPRAVFYA 107
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFIS 365
A + GL+YLH +IV+ D+K N+ LD + KI+DFGL K+ ++ +F
Sbjct: 108 AC-VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC- 162
Query: 366 MLDTRGTAGYIAPEVFCRHFGGVSHKS-----DVYSYGMMIHEMVIG 407
GT ++APEV ++ S D + G++I+EM++G
Sbjct: 163 -----GTPEFLAPEV-------LTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKD------NGEEFIN---EVASISRTSHVNI 260
+LG+G + VY + D + VA + +K LK+ N E + E +S+ H I
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
V F E+ +I E+ LD + E + +TL V + + + G+ Y+
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKL--EELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H+ RI+H D+K NI L + KI DFG+++ + GT Y++PE
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT--GTPYYMSPEA 176
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEM 404
+H G KSD++S G +++EM
Sbjct: 177 L-KH-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 210 KLGQGGYADVY--KGTLPDGRLV--AVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
K+G+G + +Y K V + + K E EV +++ H NIV F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESS--NGKRTLEWRTVYQIAVGIARGLEYLHRG 323
E + ++ E+ G L + I + + L W V I+ GL+++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH-- 118
Query: 324 CNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
+ +I+H DIK NI L ++ K+ DFG+A+Q GT Y++PE+ C
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEI-C 174
Query: 383 RHFGGVSHKSDVYSYGMMIHEM 404
++ ++K+D++S G +++E+
Sbjct: 175 QN-RPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 25/182 (13%)
Query: 300 TLEWRTVYQIAVGIARGLEYL-HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358
TLE Y V A+G+E+L R C +H D+ NI L E+ KI DFGLA+
Sbjct: 177 TLEDLICYSFQV--AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 359 KKESFISMLDTRGTAGYIAPE-VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC 417
K ++ D R ++APE +F R + + +SDV+S+G+++ E+ S
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEI----------FSL 277
Query: 418 SSEYFPNAIYKQIETEYDFQL-DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ +P +I+ E+ +L +G +M L C P RP+ +++VE
Sbjct: 278 GASPYPGV---KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
Query: 477 ML 478
L
Sbjct: 335 HL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 17/105 (16%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
VYQ+ +GL+Y+H I+H D+KP N+ ++ED KI DFGLA+QT+ +
Sbjct: 124 VYQML----KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----- 171
Query: 366 MLDTRGTAGYIAPEVFCR--HFGGVSHKSDVYSYGMMIHEMVIGR 408
M T Y APEV H+ + D++S G ++ EM+ G+
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHY---TQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 211 LGQGGYADVYKGTLP-DGRLVAVKVMKN---LKDNGEEFINEVASISRTSHVNIVPFLG- 265
LG+G + V L G AVK +K L D+ E + + N PFL
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN--PFLTH 60
Query: 266 -FCYEKKKRALIY--EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+C + K L + EF+ G L +I D G+ L T Y A I GL++LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFY--AAEIVCGLQFLHS 114
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
I++ D+K N+ LD D KI+DFG+ K+ ++ S GT YIAPE+
Sbjct: 115 K---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF--CGTPDYIAPEILQ 169
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ D +S+G++++EM+IG+
Sbjct: 170 GL--KYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 40/214 (18%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVP 262
LG+G + V K T G+ A+K++K KD + E + T H P
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH----P 55
Query: 263 FL---GFCYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
FL + ++ R + E+ G L + H S + E R + A I L
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFS-EDRARFYGA-EIVSALG 109
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR----GTAG 374
YLH +V+ D+K N+ LD+D KI+DFGL K+ IS T GT
Sbjct: 110 YLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG------ISDGATMKTFCGTPE 160
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y+APEV + G D + G++++EM+ GR
Sbjct: 161 YLAPEVLEDNDYG--RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG-----EEFINEVASISRTSHVNIVPFL 264
++G G + V + VA V+K LK N EF+ + H NI+ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G C E L++E+ G L Y+ + +R + + ++A IA G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHK-- 117
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA-GYIAPEVFCR 383
+H D+ N L D K+ D+G+ + KE +I D + ++APE+
Sbjct: 118 -HNFLHSDLALRNCFLTSDLTVKVGDYGIGP-SRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 384 HFGGV-----SHKSDVYSYGMMIHEM 404
GG+ + S+V++ G+ + E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 17/108 (15%)
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK-----QTEKKE 361
YQ+ RGL+Y+H ++H D+KP N+ ++ED +I DFG+A+ TE K
Sbjct: 114 YQLL----RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK 409
+ TR Y APE+ + D++S G + EM +GR+
Sbjct: 167 FMTEYVATR---WYRAPELLLS-LPEYTTAIDMWSVGCIFAEM-LGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGE--EFIN----EVASISRTSHVNIVPF 263
LG+G + +VY D GR +AVK + D+ E + +N E+ + H IV +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 264 LGFC---YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
G C E+KK ++ E+MP GS I D + G L + I +G+ YL
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGS----IKDQLKAYG--ALTENVTRRYTRQILQGVSYL 122
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK-KESFISMLDTRGTAGYIAPE 379
H IVH DIK NI D K+ DFG +K+ + S + GT +++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMV 405
V G K+DV+S + EM+
Sbjct: 180 VISGE--GYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 211 LGQGGYADVY---KGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRT--SHVNIVPFL 264
LG G Y V+ K + D G+L A+KV+K + E R H+ PFL
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 265 ---GFCYEKK-KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
+ ++ K LI +++ G L + H S + + +Y + +A LE+L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLA--LEHL 121
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-----TEKKESFISMLDTRGTAGY 375
H+ + I++ DIK NI LD + ++DFGL+K+ E+ SF GT Y
Sbjct: 122 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC------GTIEY 172
Query: 376 IAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
+AP++ GG D +S G++++E++ G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 45/229 (19%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVK-VMKNLKDNG---EEFINEVASISRTSHVNIVPFL 264
+G+GG +VY P R VA+K + ++L +N + F+ E + H IVP
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 265 GFCYEKKKRALIYEFMP--NG----SLDQYIYDHESSNGKRTLEWRT----VYQIAVGIA 314
C + +Y MP G SL + ++ ES + L +T I I
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKIC 123
Query: 315 RGLEYLH-RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR--- 370
+EY+H +G ++H D+KP NI L I D+G A + +E + +D
Sbjct: 124 ATIEYVHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 371 -------------GTAGYIAPEVFCRHFGG-VSHKSDVYSYGMMIHEMV 405
GT Y+APE R G S +D+Y+ G+++++M+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK-NLKDNG--EEFINEVASISRTSHVNIVPFL 264
+K+G+G Y VYK +A+K ++ +D G I E++ + H NIV
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ +K+ L++E+ LD + H S+ R + I RG+ Y H
Sbjct: 68 DVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 325 NIRIVHLDIKPHNIRLDEDFCP-KISDFGLAK------QTEKKESFISMLDTRGTAGYIA 377
+ R++H D+KP N+ +D K++DFGLA+ +T E T Y A
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--------TLWYRA 171
Query: 378 PEVF--CRHFGGVSHKSDVYSYGMMIHEMV 405
PE+ RH+ S D++S G + EMV
Sbjct: 172 PEILLGSRHY---STPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 41/152 (26%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 209 DKLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGE----EFINEVASISRTSHVNIVPF 263
+K+G+G Y V+K +VA+K ++ L D+ E + E+ + H NIV
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ KK L++E+ + L +Y +S NG ++ V + +GL + H
Sbjct: 65 YDVLHSDKKLTLVFEYC-DQDLKKYF---DSCNGD--IDPEIVKSFMFQLLKGLAFCHSH 118
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
++H D+KP N+ ++++ K++DFGLA+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 29/209 (13%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFIN------EVASISRTSHVNIVPF 263
LGQG + VY D GR +A K ++ ++ E E+ + H IV +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 264 LGFCYEKKKRAL--IYEFMPNGS----LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
G ++ ++ L E+MP GS L Y ES K T + I G+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ----------ILEGM 119
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK-ESFISMLDTRGTAGYI 376
YLH IVH DIK NI D K+ DFG +K+ + S + GT ++
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMV 405
+PEV G K+DV+S G + EM+
Sbjct: 177 SPEVISGE--GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 17/105 (16%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQI RGL+Y+H I+H D+KP N+ ++ED KI DFGLA+ T+ +
Sbjct: 126 IYQIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----- 173
Query: 366 MLDTRGTAGYIAPEVFCR--HFGGVSHKSDVYSYGMMIHEMVIGR 408
M T Y APE+ H+ + D++S G ++ E++ GR
Sbjct: 174 MTGYVATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 54/222 (24%)
Query: 211 LGQGGYADVY---KGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISR----TSHV---- 258
LG+GGY V+ K T D G++ A+KV+K A+I R T+H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKK------------ATIVRNQKDTAHTKAER 51
Query: 259 NIV-----PF---LGFCYEKK-KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQI 309
NI+ PF L + ++ K LI E++ G L + H G +E + +
Sbjct: 52 NILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGI-FMEDTACFYL 106
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT----EKKESFIS 365
+ I+ LE+LH+ I++ D+KP NI LD K++DFGL K++ +F
Sbjct: 107 S-EISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC- 161
Query: 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
GT Y+APE+ R G D +S G ++++M+ G
Sbjct: 162 -----GTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 211 LGQGGYADVYKGTLP-DGRLVAVKVMKN---LKDNGEEFI---NEVASISRTSHVNIVPF 263
LG+G + V L GRL AVKV+K L+D+ E + S++R +H PF
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NH----PF 57
Query: 264 LG---FCYEKKKRAL-IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
L C++ R + EF+ G L +I +R E R + A I L +
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARF-YAAEITSALMF 111
Query: 320 LH-RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
LH +G I++ D+K N+ LD + K++DFG+ K E + + GT YIAP
Sbjct: 112 LHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAP 165
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
E+ G S D ++ G++++EM+ G
Sbjct: 166 EILQEMLYGPS--VDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 210 KLGQGGYADVYKG-TLPDG-RLVAVK-VMKNLKDNGEEF--INEVASISRTS---HVNIV 261
++G+G Y V+K L +G R VA+K V + G I EVA + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 262 PFLGFCY-----EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
C + K L++E +DQ + + + + T+ + + RG
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
L++LH + R+VH D+KP NI + K++DFGLA+ + + S++ T Y
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VTLWYR 176
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMV----IGRKNADV 413
APEV + + D++S G + EM + R ++DV
Sbjct: 177 APEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKNLKDNGEE---FINEVASISRTSHVNIVPF 263
+G+G + +V K T G + A+KVMK +E F E I S+ +P
Sbjct: 9 VGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 264 LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
L + ++ K L+ E+ P G L + +E + ++ +A + +H
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--------LAELVLAIHS 117
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
+ VH DIKP N+ +D K++DFG A + + S L GT YIAPEV
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLT 176
Query: 383 --RHFGGVSH--KSDVYSYGMMIHEMVIGR 408
G ++ + D +S G++ +EM+ GR
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 15/113 (13%)
Query: 299 RTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK-QT 357
R LE + + I RGL+Y+H +VH D+KP NI ++E+ KI DFGLA+ Q
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQD 159
Query: 358 EKKESFISMLDTRGTAGYIAPEVFC--RHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ ++S T Y APE+ + + + D++S G + EM+ G+
Sbjct: 160 PQMTGYVS------TRYYRAPEIMLTWQKYD---VEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 47/138 (34%), Positives = 66/138 (47%), Gaps = 25/138 (18%)
Query: 275 LIYEFMPNGSLDQYIY---DHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHL 331
L+ E M + +L Q I DHE + + +YQ+ GI ++LH + I+H
Sbjct: 98 LVMELM-DANLCQVIQMDLDHE------RMSY-LLYQMLCGI----KHLH---SAGIIHR 142
Query: 332 DIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG-GVSH 390
D+KP NI + D KI DFGLA+ SF M T Y APEV G G
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLART--AGTSF-MMTPYVVTRYYRAPEVI---LGMGYKE 196
Query: 391 KSDVYSYGMMIHEMVIGR 408
D++S G ++ EM+ G
Sbjct: 197 NVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 36/110 (32%), Positives = 55/110 (50%), Gaps = 21/110 (19%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQI RGL+YLH N+ +H D+KP NI ++ + KI DFGLA+ + E
Sbjct: 109 LYQIL----RGLKYLHS-ANV--IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 366 MLD----TRGTAGYIAPEVF--CRHFGGVSHKS-DVYSYGMMIHEMVIGR 408
L TR Y APE+ + K+ D++S G + E++ +
Sbjct: 162 FLTEYVVTR---WYRAPELLLSSSRY----TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 25/190 (13%)
Query: 227 GRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVPFL---GFCYEKKKR-ALIYE 278
G+ A+K++K KD + E + T H PFL + ++ K R + E
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH----PFLTSLKYSFQTKDRLCFVME 75
Query: 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNI 338
++ G L ++ + RT + I L+YLH G +IV+ D+K N+
Sbjct: 76 YVNGGELFFHLSRERVFSEDRTRFY------GAEIVSALDYLHSG---KIVYRDLKLENL 126
Query: 339 RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYG 398
LD+D KI+DFGL K E +M GT Y+APEV + G D + G
Sbjct: 127 MLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYG--RAVDWWGLG 182
Query: 399 MMIHEMVIGR 408
++++EM+ GR
Sbjct: 183 VVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 25/205 (12%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVPFL 264
++GQGGY V+ D G +VA+K MK + + E ++ T +V L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTL-EWRTVYQIAVGIARGLEYLHRG 323
+ + L E++P G + N L E + +A ++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLL------NNLGVLSEDHARFYMAEMFE-AVDALHE- 119
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT-EKKESFISMLDTRGTAGYIAPEVFC 382
+ +H D+KP N +D K++DFGL+K S + G+ Y+APEV
Sbjct: 120 --LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV------GSPDYMAPEVL- 170
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIG 407
G D +S G M++E + G
Sbjct: 171 -RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 248 EVASISRTSHVNIVPFL-GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV 306
E +S+ H NIV + + E ++ F G L + + + GK E V
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQK---GKLLPE-NQV 104
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366
+ V IA L+YLH I+H D+K N+ L K+ D G+A+ E + S
Sbjct: 105 VEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST 161
Query: 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI 426
L GT Y++PE+F ++KSDV++ G ++EM A +K + +++ + +
Sbjct: 162 L--IGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEM------ATLKHAFNAKDMNSLV 211
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475
Y+ IE + + + E E+ M + P RPS+ ++
Sbjct: 212 YRIIEGKLP-PMPKDYSPELGELIATM-------LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|222721 pfam14380, WAK_assoc, Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-08
Identities = 24/70 (34%), Positives = 37/70 (52%), Gaps = 5/70 (7%)
Query: 101 CYINGLNYANGFM---QTGSPDCNFSVTIPVAETLLSAAKGSLAGLKEALETGFELKWKL 157
C + +Y++ F+ S C+ SV +PV + L A GS G +E L GFEL+W +
Sbjct: 3 CSGDSGDYSSYFVFPSDDLSGGCSRSVVVPVLGSALGADLGSGDGYEEVLREGFELEWNV 62
Query: 158 NSSCKNCSSC 167
+ +CS C
Sbjct: 63 DPG--DCSEC 70
|
This WAK_assoc domain is cysteine-rich and lies C-terminal to the binding domain, GUB_WAK_bind, pfam13947. Length = 94 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 45/171 (26%), Positives = 68/171 (39%), Gaps = 51/171 (29%)
Query: 275 LIYEFMPNGSLDQYI--YDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLD 332
LI E++P G + + D + R T+ +A+ L Y+HR D
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI--LAIDSIHKLGYIHR---------D 126
Query: 333 IKPHNIRLDEDFCPKISDFGLAK-------------------------------QTEKKE 361
IKP N+ LD K+SDFGL K E
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186
Query: 362 SF-----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
++ T GT YIAPEVF + G + + D +S G++++EM++G
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 35/109 (32%), Positives = 59/109 (54%), Gaps = 17/109 (15%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK---QTEKKES 362
+YQ+ + L+Y+H G ++H D+KP NI L+ D K++DFGLA+ + E+
Sbjct: 113 MYQLL----KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 363 FISMLDTRGTAGYIAPEVF--CRHFG-GVSHKSDVYSYGMMIHEMVIGR 408
+ D T Y APE+ + GV D++S G ++ EM++G+
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 207 FSDKLGQGGYADVY----KGTLPDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHV 258
F LG+G + V KGT L A+K++K D+ E + E ++
Sbjct: 4 FLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 259 NIVPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+ L C++ R + E++ G L +Y H GK Y A I+ GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MY-HIQQVGKFKEPQAVFY--AAEISVGL 114
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GTAG 374
+LHR I++ D+K N+ LD + KI+DFG+ KE + + TR GT
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMVDGVTTRTFCGTPD 166
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412
YIAPE+ G S D ++YG++++EM+ G+ D
Sbjct: 167 YIAPEIIAYQPYGKS--VDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 204 TKSFSDKLGQGGYADVYK-GTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIV 261
T + +G+G Y V+K +G AVK++ + D EE E + S H N+V
Sbjct: 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVV 78
Query: 262 PFLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
F G Y+K + L+ E GS+ + G+R E Y + + G
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF-LKRGERMEEPIIAYILHEALM-G 136
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR------ 370
L++LH + +H D+K +NI L + K+ DFG++ Q + TR
Sbjct: 137 LQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ---------LTSTRLRRNTS 184
Query: 371 -GTAGYIAPEVF-CRHFGGVSH--KSDVYSYGMMIHEM 404
GT ++APEV C ++ + DV+S G+ E+
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 32/210 (15%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVP 262
LG+G + V K T GR A+K+++ KD + E + T H P
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH----P 55
Query: 263 FL---GFCYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
FL + ++ R + E+ G L + H S T E Y I LE
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY--GAEIVSALE 109
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YLH + +V+ DIK N+ LD+D KI+DFGL K+ + +M GT Y+AP
Sbjct: 110 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAP 164
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
EV + G D + G++++EM+ GR
Sbjct: 165 EVLEDNDYG--RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQI RGL+Y+H N+ +H D+KP N+ L+ + KI DFGLA+ + +
Sbjct: 112 LYQIL----RGLKYIH-SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164
Query: 366 ML-DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
L + T Y APE+ + G + D++S G ++ EM+ R
Sbjct: 165 FLTEYVATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 68/250 (27%), Positives = 115/250 (46%), Gaps = 31/250 (12%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVAS----ISRTSHVNIVPFLG 265
+G+G YA V L R+ A+KV+K N +E I+ V + + S+ + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 266 FCYEKKKRAL-IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RG 323
C++ + R + E++ G L H K E Y + +A L YLH RG
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG 116
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
I++ D+K N+ LD + K++D+G+ K+ + S GT YIAPE+
Sbjct: 117 ----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--CGTPNYIAPEILRG 170
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
G S D ++ G+++ EM+ GR D+ S + P+ Q +Y FQ V+
Sbjct: 171 EDYGFS--VDWWALGVLMFEMMAGRSPFDIVGSSDN---PD----QNTEDYLFQ---VIL 218
Query: 444 EEEKEMAKKM 453
E++ + + +
Sbjct: 219 EKQIRIPRSL 228
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 67/282 (23%), Positives = 113/282 (40%), Gaps = 56/282 (19%)
Query: 211 LGQGGYADVYKGTL---PD----GRLVAVKV-MKNLKDNG---EEFINEVASISRTSHVN 259
LGQG + ++YKG L D G V V +K L + F + +S+ SH +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
+V G C + + ++ E++ G LD ++ H N +L W+ +A +A L Y
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFL--HREKNNV-SLHWK--LDVAKQLASALHY 116
Query: 320 LHRGCNIRIVHLDIKPHNI---RLDEDF----CPKISDFGLAKQTEKKESFISMLDTRGT 372
L + ++VH ++ NI R + K+SD G+ +E +
Sbjct: 117 LE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------R 167
Query: 373 AGYIAPEVFCRHFGGVSHKS---DVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429
+IAPE R G + + D +S+G + E+ CS+ P +
Sbjct: 168 IPWIAPE-CIR--NGQASLTIAADKWSFGTTLLEI------------CSNGEEPLSTLSS 212
Query: 430 IETEYDFQLDGVVTE-EEKEMAKKMILVSLWCIQTHPPDRPS 470
E E +Q + + E+A + C P RPS
Sbjct: 213 SEKERFYQDQHRLPMPDCAELANLI----NQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 20/105 (19%)
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK------QTEKKESFISMLDTR 370
LEYLH N IVH D+KP N+ + K++DFGL+K T E I DTR
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK-DTR 169
Query: 371 --------GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
GT YIAPEV R G D ++ G++++E ++G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 53/283 (18%)
Query: 210 KLGQG--GYADVYKGTLPDGRLVAVK---VMKNLKDNGEEFINEVASISRTSHVNIVPFL 264
K+G+G G A + K DG+ +K + K EE EVA +S H NIV +
Sbjct: 7 KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEW--RTVYQIAVGIARGLEYLHR 322
E ++ ++ G L + I N +R + + + V I L+++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKI------NAQRGVLFPEDQILDWFVQICLALKHVH- 118
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAPEVF 381
+ +I+H DIK NI L +D K+ DFG+A+ S + + T GT Y++PE+
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEI- 172
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR--------KNADVKVSCSSEYFPNAIYKQIETE 433
C + ++KSD+++ G +++EM + KN +K+ S Y + +
Sbjct: 173 CEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS-------YPPVSSH 224
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
Y + L + ++ L+ + +P DRPS+ ++E
Sbjct: 225 YSYDL-------------RNLVSQLF--KRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 15/106 (14%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQ+ RGL+Y+H ++H D+KP N+ L+ + KI DFGLA+ T +K F
Sbjct: 114 LYQLL----RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF-- 164
Query: 366 MLDTRGTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGRK 409
M + T Y APE+ C + DV+S G + E+ +GRK
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTA---IDVWSVGCIFAEL-LGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVPF-- 263
+G+G + VY+ D R+ A+KV+ K I E + RT ++ PF
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL-LDESPFIV 59
Query: 264 -LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L F ++ L+ ++M G L + H G+ + E R + IA + LE+LH
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFS-EDRAKFYIA-ELVLALEHLH 113
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
+ IV+ D+KP NI LD + DFGL+K + GT Y+APEV
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYLAPEVL 168
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIG 407
G H D +S G+++ EM G
Sbjct: 169 LDEKGYTKH-VDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 61/241 (25%)
Query: 210 KLGQGGYADVY----KGTLPDGRLVAVKVM-KNLKDNGEEFINEVAS----ISRTSHVNI 260
LG+G V+ KGT G+L A+KV+ K + + V + ++ H
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDH--- 60
Query: 261 VPFLGFCY----EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
PFL Y + L+ ++ P G L + + + GK L A +
Sbjct: 61 -PFLPTLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKC-LSEEVARFYAAEVLLA 115
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS----------- 365
LEYLH + IV+ D+KP NI L E +SDF L+KQ++ + +S
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 366 ----MLDTR------------GTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIG 407
+T GT YIAPEV H V D ++ G++++EM+ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEMLYG 228
Query: 408 R 408
Sbjct: 229 T 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 38/136 (27%), Positives = 67/136 (49%), Gaps = 15/136 (11%)
Query: 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334
++ E+MP G L + +++ +W Y V +A L+ +H ++ +H D+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVK 169
Query: 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFC--RHFGGVSHK 391
P N+ LD+ K++DFG + + DT GT YI+PEV G +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 392 SDVYSYGMMIHEMVIG 407
D +S G+ ++EM++G
Sbjct: 228 CDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 211 LGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV----NIVPFL- 264
+G+G YA V L R+ A+KV+K N +E I+ V + HV + PFL
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQT---EKHVFETASNHPFLV 59
Query: 265 GF--CYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
G C++ + R + EF+ G L H K E Y + +A L +LH
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDL----MFHMQRQRKLPEEHARFYSAEISLA--LNFLH 113
Query: 322 -RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
RG I++ D+K N+ LD + K++D+G+ K+ + S GT YIAPE+
Sbjct: 114 ERG----IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF--CGTPNYIAPEI 167
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413
G S D ++ G+++ EM+ GR D+
Sbjct: 168 LRGEDYGFS--VDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 17/105 (16%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQ+ RGL+Y+H I+H D+KP N+ ++ED +I DFGLA+Q + +
Sbjct: 124 IYQLL----RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----- 171
Query: 366 MLDTRGTAGYIAPEVFCR--HFGGVSHKSDVYSYGMMIHEMVIGR 408
M T Y APE+ H+ + D++S G ++ E++ G+
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 15/103 (14%)
Query: 310 AVGIARGLEYLH-RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
A IA GL +LH +G I++ D+K N+ LD + KI+DFG+ KE+
Sbjct: 107 AAEIAIGLFFLHSKG----IIYRDLKLDNVMLDAEGHIKIADFGMC-----KENIFGGKT 157
Query: 369 TR---GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
TR GT YIAPE+ G S D +++G++++EM+ G+
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 60/236 (25%), Positives = 104/236 (44%), Gaps = 41/236 (17%)
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVY 307
E +++ H NIV F ++ E+ G L Q I GK E T+
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR---GKLFPE-DTIL 103
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
Q V + G++++H R++H DIK NI L ++ K+ DFG A+ ++
Sbjct: 104 QWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160
Query: 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR--------KNADVKVSCSS 419
GT Y+ PE++ ++KSD++S G +++E+ + KN +KV C
Sbjct: 161 --VGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQG 215
Query: 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475
Y P + + Y ++L ++ K+M K+ +P RPS T ++
Sbjct: 216 SYKP------LPSHYSYELRSLI----KQMFKR-----------NPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 38/135 (28%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334
++ E+MP G L + +++ +W Y V +A L+ +H ++ +H D+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVK 169
Query: 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGG--VSHKS 392
P N+ LD+ K++DFG + KE + GT YI+PEV G +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 393 DVYSYGMMIHEMVIG 407
D +S G+ ++EM++G
Sbjct: 229 DWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 44/172 (25%)
Query: 269 EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRI 328
+K+ LI EF+P G + + ++ + + T + +A+ L ++HR
Sbjct: 72 DKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR------ 125
Query: 329 VHLDIKPHNIRLDEDFCPKISDFGLA---KQTEKKE-------------SFISMLDTR-- 370
DIKP N+ LD K+SDFGL K+ + E SF +M R
Sbjct: 126 ---DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 371 ---------------GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
GT YIAPEVF + G + D +S G++++EM+IG
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
EYL ++ IV+ D+KP N+ LD+D K++DFG AK + + + GT YI
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-----GTPEYI 195
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
APE+ G +D ++ G+ I+E+++G
Sbjct: 196 APEILLNV--GHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 46/219 (21%)
Query: 210 KLGQGGYADVYKG-TLPDGRLVAVKV--MKNLKDNGEEF--INEVASISRTSHVNIVP-- 262
++G+G Y VY+ G +VA+K M N +D G + E+ + H NIV
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELK 72
Query: 263 -----------FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
FL Y ++ A + + MP V + +
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMP-----------------TPFSESQVKCLML 115
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
+ RGL+YLH I+H D+K N+ L + C KI+DFGLA+ M
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVV 170
Query: 372 TAGYIAPEVFCRHFGGVSHKS--DVYSYGMMIHEMVIGR 408
T Y APE+ G ++ + D+++ G ++ E++ +
Sbjct: 171 TLWYRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFL-GF- 266
+G+G YA V L + ++ A+KV+K + +E I+ V + + PFL G
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 267 -CYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RG 323
C++ R L+ E++ G L H K E Y + IA L +LH RG
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIA--LNFLHERG 116
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
I++ D+K N+ LD D K++D+G+ K+ S GT YIAPE+
Sbjct: 117 ----IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF--CGTPNYIAPEILRG 170
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413
G S D ++ G+++ EM+ GR D+
Sbjct: 171 EEYGFS--VDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 17/147 (11%)
Query: 266 FC--YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
FC + K ++ E+MP G L + +++ +W Y V +A L+ +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-----KWAKFYTAEVVLA--LDAIH-- 159
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFC 382
++ ++H D+KP N+ LD+ K++DFG + + E+ + DT GT YI+PEV
Sbjct: 160 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD--ETGMVRCDTAVGTPDYISPEVLK 216
Query: 383 RHFGG--VSHKSDVYSYGMMIHEMVIG 407
G + D +S G+ + EM++G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 45/135 (33%), Positives = 64/135 (47%), Gaps = 21/135 (15%)
Query: 277 YEFMPNGSLD-QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKP 335
Y MP D Q I H S K VYQ+ GL+Y+H I+H D+KP
Sbjct: 96 YLVMPYMQTDLQKIMGHPLSEDKVQY---LVYQML----CGLKYIHSA---GIIHRDLKP 145
Query: 336 HNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR--HFGGVSHKSD 393
N+ ++ED KI DFGLA+ + + M T Y APEV H+ + D
Sbjct: 146 GNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHY---NQTVD 197
Query: 394 VYSYGMMIHEMVIGR 408
++S G ++ EM+ G+
Sbjct: 198 IWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL-HRGCNIRIVHLDIKP 335
Y+ + + + D +G L + +ARG+E+L + C VH D+
Sbjct: 214 YKGSNDSEVKNLLSD----DGSEGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAA 265
Query: 336 HNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVY 395
N+ L + KI DFGLA+ +++S T ++APE + + SDV+
Sbjct: 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL--YTTLSDVW 323
Query: 396 SYGMMIHEMVIGRKNADVKVSCSSEYFPNAI-----YKQIETEYDFQLDGVVTEEEKEMA 450
SYG+++ E+ S +P I Y +I++ Y T+E ++
Sbjct: 324 SYGILLWEI----------FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIM 373
Query: 451 KKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
K C + P RPS + +++E
Sbjct: 374 VK-------CWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 211 LGQGGYADVYKGTLPDG-RLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLG 265
+G+G + V + D R+ A+K ++ + + E +++ + IVP L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP-LK 59
Query: 266 FCYE-KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
F ++ +K L+ F+ G L + H G+ L Y + A LE LH+
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCA--LENLHK-- 111
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK----QTEKKESFISMLDTRGTAGYIAPEV 380
+++ D+KP NI LD + DFGL K +K +F GT Y+APE+
Sbjct: 112 -FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC------GTPEYLAPEL 164
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIG 407
H G + D ++ G++++EM+ G
Sbjct: 165 LLGH--GYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 20/161 (12%)
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVY 307
E + +H +++ ++ +P+ S D Y Y + R L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY---LTKRSRPLPIDQAL 160
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
I I GL YLH RI+H D+K NI +++ I D G A+ +F+
Sbjct: 161 IIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--- 214
Query: 368 DTRGTAGYI---APEVFCRHFGGVSHKSDVYSYGMMIHEMV 405
G AG + APEV R + K+D++S G+++ EM+
Sbjct: 215 ---GLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 51/198 (25%), Positives = 82/198 (41%), Gaps = 30/198 (15%)
Query: 227 GRLVAVKVMKNLKDNGEE----FINEVASISRTSHVNIVPFL--GFCYEKKKRALIYEFM 280
G VA+K+++ E F E A +R H NIV L G A ++E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFEYV 61
Query: 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340
P +L + + +++G L ++ + + L H IVH D+KP NI +
Sbjct: 62 PGRTLREVL----AADG--ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 341 ---DEDFCPKISDFGLAKQTEKKESFISMLDTR-----GTAGYIAPEVFCRHFGG--VSH 390
K+ DFG+ TR GT Y APE G V+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE----QLRGEPVTP 168
Query: 391 KSDVYSYGMMIHEMVIGR 408
SD+Y++G++ E + G+
Sbjct: 169 NSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 41/215 (19%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVP 262
LG+G + V K T GR A+K++K KD + E + + H P
Sbjct: 3 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH----P 55
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNG---------KRTLEWRTVYQIAVGI 313
FL AL Y F + D+ + E +NG +R I
Sbjct: 56 FL--------TALKYSFQTH---DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
L+YLH N+ V+ D+K N+ LD+D KI+DFGL K+ K + +M GT
Sbjct: 105 VSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTP 160
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y+APEV + G D + G++++EM+ GR
Sbjct: 161 EYLAPEVLEDNDYG--RAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 19/191 (9%)
Query: 221 KGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280
+G+ P ++VA VM N + +E+ ++ H IV K LI E+
Sbjct: 88 RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147
Query: 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQ-IAVG-----IARGLEYLHRGCNIRIVHLDIK 334
G L++ I K+ L+ +Q VG I L+ +H ++H D+K
Sbjct: 148 SGGDLNKQI--------KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLK 196
Query: 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDV 394
NI L K+ DFG +KQ S GT Y+APE++ R S K+D+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK--RYSKKADM 254
Query: 395 YSYGMMIHEMV 405
+S G++++E++
Sbjct: 255 WSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 44/166 (26%)
Query: 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334
LI EF+P G + + ++ + T + +A+ L ++HR DIK
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR---------DIK 128
Query: 335 PHNIRLDEDFCPKISDFGLA---KQTEKKE-------------SFISM------------ 366
P N+ LD K+SDFGL K+ + E +F +M
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 367 -----LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
T GT YIAPEVF + G + D +S G++++EM+IG
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 44/177 (24%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 313 IARGLEYL-HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
+A+G+ +L + C +H D+ NI L KI DFGLA+ +++ + R
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 372 TAGYIAPEVFCRHFGGV-SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP-----NA 425
++APE F V + +SDV+SYG+++ E+ S S +P +
Sbjct: 279 PVKWMAPESI---FNCVYTFESDVWSYGILLWEI----------FSLGSSPYPGMPVDSK 325
Query: 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482
YK I+ Y E ++ K C P RP+ ++V+++E +
Sbjct: 326 FYKMIKEGYRMLSPECAPSEMYDIMKS-------CWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFIN-----EVASISRTSHVNIVPF 263
K+G+G Y V+K + G++VA+K K ++ + I E+ + + H N+V
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR- 322
+ K+K L++E+ + L +E R + + +I + + + H+
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVL------NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
C +H D+KP NI + + K+ DFG A+ + D T Y APE+
Sbjct: 120 NC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVATRWYRAPELLV 173
Query: 383 RHFGGVSHKS--DVYSYGMMIHEMVIG 407
G + DV++ G + E++ G
Sbjct: 174 ---GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 72/217 (33%)
Query: 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334
LI EF+P G L + +++ + E T + +A + +E +H+ + +H DIK
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFS-----EDVTRFYMAECVL-AIEAVHK---LGFIHRDIK 128
Query: 335 PHNIRLDEDFCPKISDFGLAK--------------------------------------- 355
P NI +D K+SDFGL+
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188
Query: 356 ------QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG-- 407
T KK + T GT YIAPE+F + G + D +S G ++ E +IG
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGAIMFECLIGWP 246
Query: 408 -----------RKNADVKVSCSSEYFPNAIYKQIETE 433
RK + + + YFP+ I+ +E E
Sbjct: 247 PFCSENSHETYRKIINWR---ETLYFPDDIHLSVEAE 280
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 39/135 (28%), Positives = 60/135 (44%), Gaps = 33/135 (24%)
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
++ V I + L YL + +H D+KP NI LD K+ DFG++ + S
Sbjct: 118 KMTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVD-----SKA 170
Query: 368 DTR--GTAGYIAPEVFCR-----HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420
TR G A Y+APE R ++DV+S G+ + E+ G+
Sbjct: 171 KTRSAGCAAYMAPE---RIDPPDPNPKYDIRADVWSLGISLVELATGQ------------ 215
Query: 421 YFPNAIYKQIETEYD 435
FP YK +TE++
Sbjct: 216 -FP---YKNCKTEFE 226
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 7/98 (7%)
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT 369
A IA L YLH ++ IV+ D+KP NI LD ++DFGL K+ + S
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF-- 156
Query: 370 RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
GT Y+APEV H D + G +++EM+ G
Sbjct: 157 CGTPEYLAPEVL--HKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 37/212 (17%)
Query: 211 LGQGGYADVYKGTLP-DGRLVAVKVMK-----NLKDNGEEFINEVASISRTSHVNIVPFL 264
+G+G + V DG+ AVKV++ N K+ + H PFL
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH----PFL 58
Query: 265 -GFCYE---KKKRALIYEFMPNGSLDQYIYDHESSNGKRTL-EWRTVYQIAVGIARGLEY 319
G Y +K + +F+ G L ++ +R+ E R + A IA L Y
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHL------QRERSFPEPRARFYAA-EIASALGY 111
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR----GTAGY 375
LH +I IV+ D+KP NI LD ++DFGL K+ I+ DT GT Y
Sbjct: 112 LH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEG------IAQSDTTTTFCGTPEY 162
Query: 376 IAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
+APEV + + D + G +++EM+ G
Sbjct: 163 LAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK-QTEKKESFISMLDTRGTA 373
R L+Y+H + H D+KP NI + D KI DFGLA+ + I D T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y APE+ F + D++S G + E++ G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 41/208 (19%), Positives = 79/208 (37%), Gaps = 22/208 (10%)
Query: 211 LGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHVNIVPFLGFC 267
+ K P LVAVK + + E+ E+ + + H NI+P++
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNI 326
+ ++ M GS + + H + I + L+Y+H G
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA----IAFILKDVLNALDYIHSKGF-- 122
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDF----GLAKQTEKKESFISMLDTRGTAG---YIAPE 379
+H +K +I L D +S + K +++ + + +++PE
Sbjct: 123 --IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF--PKSSVKNLPWLSPE 178
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
V ++ G + KSD+YS G+ E+ G
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-06
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 12/97 (12%)
Query: 6 SYPFSGGEREYTCGH-PSLNLNCENDTAT--LVLGEVKYRVLNIDQKEQLLRIAKQVYFD 62
YPF G C P L C N T+ L+LG Y VL+I +R+ + +
Sbjct: 14 PYPFGIGPG---CARDPGFELTCNNTTSPPRLLLGNGNYEVLSISLANGTVRVLDPISSN 70
Query: 63 GFCPQRNFTIDSTL-----FTYADGYKMLTLISGCPT 94
+ T + +L F ++ ++ GC T
Sbjct: 71 CYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVV-GCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 44/197 (22%), Positives = 95/197 (48%), Gaps = 33/197 (16%)
Query: 291 DHESSNGKRTLEWRTVYQIAVGIARGLEYL-HRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349
D E + L+ + + + +A+G+++L + C +H D+ N+ L + KI
Sbjct: 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKIC 254
Query: 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPE-VF-CRHFGGVSHKSDVYSYGMMIHEMVIG 407
DFGLA+ +++ + R ++APE +F C + + +SDV+SYG+++ E+
Sbjct: 255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY----TVQSDVWSYGILLWEIFSL 310
Query: 408 RKNADVKVSCSSEYFPNAIYKQIETEY-----DFQLDGVVTEEEKEMAKKMILVSLWCIQ 462
K+ + +S++ YK ++ Y DF E+ I+ W ++
Sbjct: 311 GKSPYPGILVNSKF-----YKMVKRGYQMSRPDFAP--------PEIY--SIMKMCWNLE 355
Query: 463 THPPDRPSMTKVVEMLE 479
P +RP+ +++ ++++
Sbjct: 356 --PTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 211 LGQGGYADVYKGTLP-DGRLVAVKVMKN---LKDNGEEFINEVAS--ISRTSHVNIVPFL 264
+G+G + V DG+ AVKV++ LK ++ I + + H PFL
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH----PFL 58
Query: 265 -GFCYE---KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
G Y K + +++ G L + H + E R + A IA L YL
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGEL----FFHLQRE-RSFPEPRARF-YAAEIASALGYL 112
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H ++ I++ D+KP NI LD ++DFGL K+ + S GT Y+APEV
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF--CGTPEYLAPEV 167
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIG 407
+ D + G +++EM+ G
Sbjct: 168 LRKQ--PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK--QTEKKESF 363
+YQI GL+Y+H ++H D+KP N+ ++ D KI DFGLA+ E+
Sbjct: 111 IYQIL----CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
Query: 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK 409
M + T Y APE+ F + DV+S G ++ E+ +GRK
Sbjct: 164 GFMTEYVATRWYRAPEIML-SFQSYTKAIDVWSVGCILAEL-LGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVP 262
LG+G + V KGT L A+K++K D+ E + E ++ + +
Sbjct: 8 LGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 263 FLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L C++ R + E++ G L I R E V+ A IA GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQI-----QQVGRFKEPHAVF-YAAEIAIGLFFLH 118
Query: 322 -RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GTAGYIA 377
+G I++ D+K N+ LD + KI+DFG+ KE+ + T+ GT YIA
Sbjct: 119 SKG----IIYRDLKLDNVMLDSEGHIKIADFGMC-----KENMWDGVTTKTFCGTPDYIA 169
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
PE+ G S D +++G++++EM+ G+
Sbjct: 170 PEIIAYQPYGKS--VDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 33/171 (19%)
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRA------LIYEFMPNGSLDQYIY---DHESSNGK 298
E+ + +H NI+ L +K L+ E M + +L Q I+ DHE +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMS-- 126
Query: 299 RTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358
+YQ+ GI ++LH I+H D+KP NI + D KI DFGLA+
Sbjct: 127 -----YLLYQMLCGI----KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
Query: 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKS--DVYSYGMMIHEMVIG 407
+ TR Y APEV G+ +K D++S G ++ E+V G
Sbjct: 175 TNFMMTPYVVTR---YYRAPEVIL----GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 49/231 (21%)
Query: 211 LGQGGYADVYKG-TLPDGRLVAVKVMKNLK-------------DNGEEF--INEVASISR 254
LG+G Y V K G++VA+K +K ++ G F + E+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
H NI+ + E L+ + M L + + + K L V I + I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV------DRKIRLTESQVKCILLQIL 129
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA---------------KQTEK 359
GL LH +H D+ P NI ++ KI+DFGLA + ++
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 360 KESFISMLDTRGTAGYIAPEVFCRHFGG--VSHKSDVYSYGMMIHEMVIGR 408
+E S + T Y APE+ G D++S G + E++ G+
Sbjct: 187 REEMTSKV---VTLWYRAPELL---MGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 211 LGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFIN-EVASISRTSHVNIVPFLGF-- 266
+G G + VY+ D VA+K K L+D ++ N E+ + +H+NI+ +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIK--KVLQD--PQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 267 --CYEKKKRAL----IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
C++K ++ + + EF+P ++ +Y+ + +N L V + + R L Y+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNN--HALPLFLVKLYSYQLCRALAYI 186
Query: 321 HRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
H I H D+KP N+ +D + K+ DFG AK + +S + +R Y APE
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF---YRAPE 240
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
+ +H D++S G +I EM++G
Sbjct: 241 LMLGATNYTTH-IDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 35/133 (26%), Positives = 56/133 (42%), Gaps = 46/133 (34%)
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK--------------QTEKKES 362
+E +H + +H DIKP NI +D D K++DFGL +++S
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 363 F-------------ISMLDTR--------------GTAGYIAPEVFCRHFGGVSHKSDVY 395
+ L+ R GT YIAPEV R G + D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWW 228
Query: 396 SYGMMIHEMVIGR 408
S G++++EM++G+
Sbjct: 229 SVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 53/176 (30%), Positives = 78/176 (44%), Gaps = 39/176 (22%)
Query: 209 DKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
++G+G Y VYK D G LVA+K ++ L + E F I E+ + + +H NIV
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 264 LGFC--------YEKKKRA--LIYEFMPN-------GSLDQYIYDHESSNGKRTLEWRTV 306
++K K A L++E+M + L + DH S K+ LE
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE---- 127
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362
GL Y H +H DIK NI L+ K++DFGLA+ +ES
Sbjct: 128 ---------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT 369
A +A + YLH ++ I++ D+KP NI LD ++DFGL K+ + E S
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF-- 156
Query: 370 RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
GT Y+APEV + D + G +++EM+ G
Sbjct: 157 CGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 34/111 (30%), Positives = 51/111 (45%), Gaps = 28/111 (25%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQ+ GI ++LH I+H D+KP NI + D KI DFGLA+
Sbjct: 132 LYQMLCGI----KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---------- 174
Query: 366 MLDTRGTAGYIAPEVFCRHFG--------GVSHKSDVYSYGMMIHEMVIGR 408
T GT+ + P V R++ G D++S G ++ EM+ G
Sbjct: 175 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 32/216 (14%)
Query: 209 DKLGQGGYADVYKGTLPD----GRL----VAVKVMKNLKDNGEEFINEVASI-SRTSHVN 259
+ LGQG + ++KG + G L V +KV+ N E E AS+ S+ SH +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
+V G C + ++ E++ GSLD Y+ +++ + W+ ++A +A L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN---LINISWK--LEVAKQLAWALHF 115
Query: 320 LHRGCNIRIVHLDIKPHNIRL--DEDFCP------KISDFGLAKQTEKKESFISMLDTRG 371
L + + H ++ N+ L +ED K+SD G++ KE +L R
Sbjct: 116 LE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE----ILLER- 167
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
++ PE + +S +D +S+G + E+ G
Sbjct: 168 -IPWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 14/100 (14%)
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLD-EDFCPKISDFGLAKQTEKKES---FISMLDTR 370
RGL+Y+H ++H D+KP N+ ++ ED KI DFGLA+ + S ++S
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE--GL 179
Query: 371 GTAGYIAPEVFC--RHFGGVSHKSDVYSYGMMIHEMVIGR 408
T Y +P + ++ + D+++ G + EM+ G+
Sbjct: 180 VTKWYRSPRLLLSPNNY---TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 71/284 (25%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 211 LGQGGYADV-YKGTLPDGRLVAVKVMKNLKDNGEEFIN----EVASISRTSHVNIVPFLG 265
LG G V + DG AVKV+ +++ E N EV + +IV
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVV-DMEGMSEADKNRAQAEVCCLLNCDFFSIVK--- 95
Query: 266 FCYE----KKKR--------ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
C+E K R AL+ ++ G L Q I +N RT + + +
Sbjct: 96 -CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN--RTFREHEAGLLFIQV 152
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
+ ++H + ++H DIK NI L + K+ DFG +K S GT
Sbjct: 153 LLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433
Y+APE++ R S K+D++S G++++E++ ++ D E ++K +
Sbjct: 210 YYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFD------GENMEEVMHKTLAGR 261
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
YD + EM + I+ +L + + P RPS +K++ M
Sbjct: 262 YDPLPPSI----SPEMQE--IVTAL--LSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 26/226 (11%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEF--INEVASISRTSHVNIVPF--LG 265
K+G+G Y VYK DG+ +K ++ G E+A + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKR---TLEWRTVYQIAVGIARGLEYLHR 322
+ +K L++++ + L I H +S + L V + I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 323 GCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAKQTEKKESFISMLD-TRGTAGYIA 377
++H D+KP NI + E KI+D G A+ ++ LD T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 378 PEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR-----KNADVKVS 416
PE+ RH+ + D+++ G + E++ + D+K S
Sbjct: 184 PELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 62/263 (23%), Positives = 109/263 (41%), Gaps = 34/263 (12%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEF--INEVASISRTSHVNIVPF--LG 265
K+G+G Y VYK DG+ +K ++ G E+A + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKR---TLEWRTVYQIAVGIARGLEYLHR 322
+ +K L++++ + L I H +S + L V + I G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 323 GCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAKQTEKKESFISMLD-TRGTAGYIA 377
++H D+KP NI + E KI+D G A+ ++ LD T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 378 PEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR-----KNADVKVSCSSEYFPNAIYKQI 430
PE+ RH+ + D+++ G + E++ + D+K S Y
Sbjct: 184 PELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP--------YHHD 232
Query: 431 ETEYDFQLDGVVTEEEKEMAKKM 453
+ + F + G +++ E KKM
Sbjct: 233 QLDRIFNVMGFPADKDWEDIKKM 255
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 21/197 (10%)
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
+H + VH DIKP N+ LD + +++DFG + + + S + GT YI+PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173
Query: 380 VFCRHFGGVSH---KSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436
+ G+ + D +S G+ ++EM+ G + +E K + E F
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG------ETPFYAESLVETYGKIMNHEERF 227
Query: 437 QLD---GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE-GSIENLQIPPKPS 492
Q V+EE K++ +++I + + + E ++ +I NL+ P P
Sbjct: 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPD 287
Query: 493 LSLPTGYAKQSSPTSSF 509
+S P S TS+F
Sbjct: 288 VSSP-------SDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT 369
A + L +LHR +++ D+K NI LD + K++DFG+ K+ +
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF-- 156
Query: 370 RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT YIAPE+ G S D ++ G++++EM+ G+
Sbjct: 157 CGTPDYIAPEILQELEYGPS--VDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 211 LGQGGYADVYKGTL--------PDGRLVAVKVMKNLKDNGEE------------------ 244
LGQG ++Y G L + + + +NG E
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 245 FINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWR 304
F + +S+ SH+++ G C + ++ EF+ +G LD + G+ + W+
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL---RKEKGRVPVAWK 119
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR-----LDEDFCP--KISDFGLAKQT 357
+A +A L YL + +VH ++ NI L E P K+SD G++
Sbjct: 120 IT--VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174
Query: 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
+E + + +IAPE +S +D +S+G + E+
Sbjct: 175 LSREERVERIP------WIAPECV-PGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 50/188 (26%), Positives = 77/188 (40%), Gaps = 28/188 (14%)
Query: 244 EFINEVASISRTSHVNIVPFLGFCYEK--KKRALIYEFMPNGSLDQYIYDHESSNGKRTL 301
+ + EV + H NIV ++ K +K ++ EF G L + I GK +
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK--I 115
Query: 302 EWRTVYQIAVGIARGLEYLHR---GCN-IRIVHLDIKPHNIRLDEDF------------- 344
E + I + L Y H G N R++H D+KP NI L
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 345 ----CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMM 400
KI DFGL+K + S + GT Y +PE+ KSD+++ G +
Sbjct: 176 NGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 401 IHEMVIGR 408
I+E+ G+
Sbjct: 233 IYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 50/167 (29%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRA------LIYEFMPNGSLDQYI---YDHESSNGK 298
E+ + +H NI+ L +K L+ E M + +L Q I DHE +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMS-- 122
Query: 299 RTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358
+YQ+ GI ++LH I+H D+KP NI + D KI DFGLA+
Sbjct: 123 -----YLLYQMLCGI----KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170
Query: 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMV 405
+ TR Y APEV G D++S G ++ EMV
Sbjct: 171 TSFMMTPYVVTR---YYRAPEVILGM--GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 211 LGQGGYADVYKGTLPDGR-LVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGF 266
+G+G Y V K + + +VA+K K+ ++N E + E+ + NIV
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRT-VYQIAVGIARGLEYLHRGCN 325
+ K L++E++ L+ E NG + R+ +YQ+ + + + H+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLI----KAIHWCHKN-- 119
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK--KESFISMLDTRGTAGYIAPEVFCR 383
IVH DIKP N+ + + K+ DFG A+ + ++ + TR Y +PE+
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR---WYRSPELL-- 173
Query: 384 HFGGVSHKS-DVYSYGMMIHEMVIGR 408
G K+ D++S G ++ E+ G+
Sbjct: 174 -LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 46/189 (24%), Positives = 78/189 (41%), Gaps = 28/189 (14%)
Query: 226 DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285
+ V VK + K G E I+ + +IS + +N++ + + ++ + MP
Sbjct: 118 QRKKVIVKAVTGGKTPGRE-IDILKTISHRAIINLI------HAYRWKSTVCMVMPKYKC 170
Query: 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RGCNIRIVHLDIKPHNIRLDEDF 344
D + Y + L I + L YLH RG I+H D+K NI LDE
Sbjct: 171 DLFTY----VDRSGPLPLEQAITIQRRLLEALAYLHGRG----IIHRDVKTENIFLDEPE 222
Query: 345 CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV-----FCRHFGGVSHKSDVYSYGM 399
+ DFG A + + GT +PE+ +C K+D++S G+
Sbjct: 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-------KTDIWSAGL 275
Query: 400 MIHEMVIGR 408
++ EM +
Sbjct: 276 VLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 24/175 (13%)
Query: 213 QGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK 271
+G + VY G + +L AVKV+K + +++V + ++ PF+ Y
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 272 KRA----LIYEFMPNGS----LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ A L+ E++ G L Y Y E K E +A L+YLHR
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----------VALALDYLHRH 123
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
I+H D+KP N+ + + K++DFGL+K T +E ++M+D T P
Sbjct: 124 ---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE--LNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 313 IARGLEYL-HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
+A G+E+L + C VH D+ N+ + E KI DFGLA+ + ++IS T
Sbjct: 248 VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
++APE + + SDV+S+G+++ E+
Sbjct: 304 PLKWMAPESIFNNL--YTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 228 RLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD- 286
RL+A K +K + NE+ ++ R +H NI+ E+ R+ +M D
Sbjct: 194 RLIA-KRVKAGSRAAIQLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDF 247
Query: 287 ---QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED 343
++YD R L +T I + +EY+H + +++H DIK NI L+ D
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQT-RAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCD 303
Query: 344 FCPKISDFGLAKQTEK-KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIH 402
+ DFG A EK +E+F GT +PE+ G +D++S G+++
Sbjct: 304 GKIVLGDFGTAMPFEKEREAF--DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILL 359
Query: 403 EMV 405
+M+
Sbjct: 360 DML 362
|
Length = 501 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 19/194 (9%)
Query: 225 PDGRLVAVKVMKNLKDNGEEFI----NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280
P G LV V++ +L++ EE + NEV H NI+ +I FM
Sbjct: 23 PTGTLVTVRIT-DLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIR 339
GS + + + L + I G RGL YLH+ G +H +IK +I
Sbjct: 82 AYGSANSLLKTYFPEGMSEAL----IGNILFGALRGLNYLHQNGY----IHRNIKASHIL 133
Query: 340 LDEDFCPKISD----FGLAKQTEKKESFISMLD-TRGTAGYIAPEVFCRHFGGVSHKSDV 394
+ D +S + L + +K + + +++PE+ + G + KSD+
Sbjct: 134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDI 193
Query: 395 YSYGMMIHEMVIGR 408
YS G+ E+ GR
Sbjct: 194 YSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
+H+ + VH DIKP N+ LD++ +++DFG + + S + GT YI+PE
Sbjct: 118 VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPE 173
Query: 380 VFCRHFGGVSH---KSDVYSYGMMIHEMVIG 407
+ G + D +S G+ ++EM+ G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 209 DKLGQGGYADVYKGTLPD---------GRLVAVKVMKNLKDNGEEFIN----EVASISR- 254
+ LG+G +Y G L +KV+ + D I+ E AS+ R
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
SH +IV G C + ++ EF+ G LD ++ H S+ T W+ +++A +A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM--HRKSD-VLTTPWK--FKVAKQLA 115
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRL-----DEDFCP--KISDFGLAKQTEKKESFISML 367
L YL + +VH ++ NI L D + P K+SD G+ ++ + +
Sbjct: 116 SALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI 172
Query: 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEM 404
+IAPE +S +D +S+G + E+
Sbjct: 173 P------WIAPEC-VEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 47/168 (27%), Positives = 69/168 (41%), Gaps = 23/168 (13%)
Query: 246 INEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRT 305
E + +H +I+ G K LI +P D Y Y KR +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY----LAAKRNIAICD 183
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE--DFCPKISDFGLAKQTEKKESF 363
+ I + R ++YLH RI+H DIK NI ++ D C + DFG A
Sbjct: 184 ILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPVD---- 234
Query: 364 ISMLDTRGTAGYIA---PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
I+ G AG IA PE+ R G + D++S G+++ EM
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPA--VDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 35/138 (25%), Positives = 55/138 (39%), Gaps = 50/138 (36%)
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA---KQTEKKESFISMLDTR-- 370
+E +H+ + +H DIKP NI +D D K++DFGL + T + + S R
Sbjct: 113 AVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169
Query: 371 ----------------------------------------GTAGYIAPEVFCRHFGGVSH 390
GT YIAPEV R G +
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQ 227
Query: 391 KSDVYSYGMMIHEMVIGR 408
D +S G++++EM++G+
Sbjct: 228 LCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 50/198 (25%), Positives = 74/198 (37%), Gaps = 35/198 (17%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVK--VMKNLKDNG--EEFINEVASISRTSHVNIVPFL 264
KLG+G + VYK +L + + V+K + G E ++NE + R + F+
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFV 195
Query: 265 GFCYEK---KKRA---LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG-- 316
E KK L++ + +L + E V + G+ R
Sbjct: 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENK 255
Query: 317 ---------LEYLHRGCNIRIVHLDIKPHNIRLDED---FCPKISDFGLAKQTEKKESFI 364
L L + IVH D+KP NI E F KI D G A ++I
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLGAAADLRVGINYI 313
Query: 365 S---MLDTRGTAGYIAPE 379
+LD R Y APE
Sbjct: 314 PKEFLLDPR----YAAPE 327
|
Length = 566 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 33/201 (16%)
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
IA+ L Y+HR DIKP NI +D + +++DFG + + + S +
Sbjct: 113 IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163
Query: 369 TRGTAGYIAPEVFCRHFGGVSH---KSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNA 425
GT YI+PE+ G + D +S G+ ++EM+ G + +E
Sbjct: 164 V-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG------ETPFYAESLVET 216
Query: 426 IYKQIETEYDFQLDGVVT---EEEKEMAKKMILVSLWCIQTHPPDRPSMT--KVVEMLEG 480
K + + FQ VT E+ K++ +++I C + H + + K G
Sbjct: 217 YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI-----CSREHRLGQNGIEDFKQHPFFTG 271
Query: 481 ----SIENLQIPPKPSLSLPT 497
+I N + P P +S PT
Sbjct: 272 IDWDNIRNCEAPYIPEVSSPT 292
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 45/217 (20%), Positives = 90/217 (41%), Gaps = 45/217 (20%)
Query: 219 VYKGTLPDGRLVAVKVMK----NLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK--- 271
+YKG + + V ++ K K + NE+ ++ R NI+ GF +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 272 -KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVH 330
+ +LI E+ G L + + ++ L ++T +A+ +GL L++ N
Sbjct: 95 PRLSLILEYCTRGYLREVLDK------EKDLSFKTKLDMAIDCCKGLYNLYKYTN----- 143
Query: 331 LDIKPH------NIRLDEDFCPKISDFGLAKQTE----KKESFISMLDTRGTAGYIAPEV 380
KP+ + + E++ KI GL K K +F+ + + ++
Sbjct: 144 ---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYK-----MLNDI 195
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR---KNADVK 414
F + + K D+YS G+++ E+ G+ +N K
Sbjct: 196 FSEY----TIKDDIYSLGVVLWEIFTGKIPFENLTTK 228
|
Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 39/138 (28%), Positives = 58/138 (42%), Gaps = 50/138 (36%)
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA--------KQTEKKESFI--- 364
+E +H+ + +H DIKP NI +D D K++DFGL + +K S I
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 365 SM--------------------LDTR--------------GTAGYIAPEVFCRHFGGVSH 390
SM L+ R GT YIAPEV R G +
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQ 227
Query: 391 KSDVYSYGMMIHEMVIGR 408
D +S G+++ EM++G+
Sbjct: 228 LCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.79 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.19 | |
| PF14380 | 94 | WAK_assoc: Wall-associated receptor kinase C-termi | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.0 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.91 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.36 | |
| PLN02236 | 344 | choline kinase | 97.12 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.03 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.8 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.69 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.58 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.47 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.38 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.27 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.13 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.11 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.09 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.97 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.88 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.85 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.71 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.39 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=451.73 Aligned_cols=285 Identities=41% Similarity=0.710 Sum_probs=242.4
Q ss_pred CCCCCCHHHHHHHHHhhh--cccCCcCceEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHccCCcceeeeeceE
Q 040808 191 APKRFSYSDVRRMTKSFS--DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN-GEEFINEVASISRTSHVNIVPFLGFC 267 (511)
Q Consensus 191 ~~~~~~~~e~~~~~~~~~--~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~ 267 (511)
..+.|++.|++++|++|. ..||+||||+||+|.+.+|+.||||.+...... ..+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 567899999999999998 589999999999999999999999988876554 66799999999999999999999999
Q ss_pred eecC-eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCce
Q 040808 268 YEKK-KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346 (511)
Q Consensus 268 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~ 346 (511)
.+.+ +++||||||++|+|.++|+.... . .++|..+++||.++|+||+|||..|...||||||||+|||||+++.+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~---~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG---E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCC---C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9998 59999999999999999976442 1 88999999999999999999999988899999999999999999999
Q ss_pred EEeeccCccccCC-CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHH
Q 040808 347 KISDFGLAKQTEK-KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNA 425 (511)
Q Consensus 347 kl~DFGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 425 (511)
||+|||+|+..+. ....... . .||.+|+|||++.. +.++.|+|||||||+|+||++|+++.+.........+.+|
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~-~-~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTT-V-MGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred EccCccCcccCCccccceeee-c-CCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999999987765 3322211 1 79999999999965 5899999999999999999999999987654444457888
Q ss_pred HHHHHhhh-hccccCCCCC--hHH-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 426 IYKQIETE-YDFQLDGVVT--EEE-KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 426 ~~~~~~~~-~~~~~~~~~~--~~~-~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+... ....+++.+. ... .+.+.+++.+|++|++.+|++||+|.||+++|+....
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 76666554 2223444432 212 1577889999999999999999999999999976554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=386.31 Aligned_cols=258 Identities=31% Similarity=0.492 Sum_probs=211.4
Q ss_pred hhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecC-eEEEEEEeCCC
Q 040808 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKK-KRALIYEFMPN 282 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~ 282 (511)
+.+.||.|+||+||+|.++....||+|++...... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 44569999999999999976555999999864333 458999999999999999999999999887 79999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEecCCCCCCEEEcCCC-ceEEeeccCccccCCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR-IVHLDIKPHNIRLDEDF-CPKISDFGLAKQTEKK 360 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~ 360 (511)
|+|.++++.. ....+++..++.|+.+||+|++|||++ + ||||||||+||||+.++ ++||+|||+++.....
T Consensus 125 GsL~~~l~~~----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 125 GSLSVLLHKK----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CcHHHHHhhc----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999653 246899999999999999999999998 7 99999999999999998 9999999999876543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. ..+....||+.|||||++.+....++.|+||||||++||||+||+.||.... ....+...........++.
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~------~~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA------PVQVASAVVVGGLRPPIPK 269 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhcCCCCCCCc
Confidence 2 2334467999999999997422379999999999999999999999996432 1222333333333222222
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
.....+..++.+||+.||+.||++.+++.+|+.+.....
T Consensus 270 -------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 270 -------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred -------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 255667788888999999999999999999997766543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=381.73 Aligned_cols=262 Identities=27% Similarity=0.459 Sum_probs=224.1
Q ss_pred HHHHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 198 SDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 198 ~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.++.+....+.++||+|-||.||+|.++....||+|.++......++|.+|+++|++++|+|||+++|+|..++..+|||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 34555556788899999999999999988889999999987777789999999999999999999999999988999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
|||++|+|.+||... ....+...+++.++.|||+|++||+++ ++|||||.+.||||++++.+||+|||||+..
T Consensus 281 E~m~~GsLl~yLr~~----~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR----EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EecccCcHHHHhhhc----CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 999999999999752 246788999999999999999999998 9999999999999999999999999999955
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.++. .....+..-+..|.|||.+.. +.++.|||||||||+||||+| |+.|+... -...+.+.++++.++
T Consensus 354 ~d~~-Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-------sn~ev~~~le~GyRl 423 (468)
T KOG0197|consen 354 GDDE-YTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGM-------SNEEVLELLERGYRL 423 (468)
T ss_pred CCCc-eeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCC-------CHHHHHHHHhccCcC
Confidence 4443 333345556789999999954 589999999999999999998 67666432 245677788888777
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
..+...+ ..+.++|..||+.+|++|||++.+...|+....
T Consensus 424 p~P~~CP-------~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCP-------DEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCC-------HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 6554443 457789999999999999999999999987543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=385.49 Aligned_cols=246 Identities=30% Similarity=0.504 Sum_probs=213.6
Q ss_pred HHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEecc----CCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+|...+.||+|||+.||.++. ..|+.||+|++.+ .....+...+|++|.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4455677899999999999996 7899999999986 3455678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
|+|++++|..+++. .+.+++..++.+..||+.||.|||+. +|+|||||..|+||+++.++||+|||||..+
T Consensus 98 ELC~~~sL~el~Kr------rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR------RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EecCCccHHHHHHh------cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeee
Confidence 99999999999952 36899999999999999999999998 9999999999999999999999999999988
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
.....- ..+.+|||.|+|||++.+. ..+..+||||+|||||.||.|++||+... ....+..+... ++.
T Consensus 169 e~~~Er--k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~-~Y~ 236 (592)
T KOG0575|consen 169 EYDGER--KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLN-EYS 236 (592)
T ss_pred cCcccc--cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhc-Ccc
Confidence 754221 2356799999999999764 78999999999999999999999997542 33455555544 345
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
++..++.++++++++|+ +.||.+|||+++|+.
T Consensus 237 ~P~~ls~~A~dLI~~lL-------~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLL-------RPNPSERPSLDEVLD 268 (592)
T ss_pred cccccCHHHHHHHHHHh-------cCCcccCCCHHHHhc
Confidence 56678888888888887 999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=373.92 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=203.9
Q ss_pred HHHHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCC--------ChHHHHHHHHHHHccCCcceeeeeceEeecCe
Q 040808 202 RMTKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKD--------NGEEFINEVASISRTSHVNIVPFLGFCYEKKK 272 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 272 (511)
+..|-+.+.||+|+||.|-+|. .++|+.||||++++.+. ......+|+++|++++|||||++++++.+.+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3445567899999999999998 45799999999975321 22345799999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC---CceEEe
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED---FCPKIS 349 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~ 349 (511)
.|+||||+.||+|.+++... ..+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred eEEEEEEecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999543 4577777788999999999999998 99999999999999655 889999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCC-CCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGG-VSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
|||+|+...... .+.+.+|||.|.|||++...... ...+.|+||+||+||-+++|.+||... +-+..+.+
T Consensus 322 DFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~------~~~~sl~e 392 (475)
T KOG0615|consen 322 DFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE------YTDPSLKE 392 (475)
T ss_pred ccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc------cCCccHHH
Confidence 999999887443 35567899999999999654223 334889999999999999999999532 22333555
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
++..+... ..+....++..+.+.++-|+|..||++|||++|+++
T Consensus 393 QI~~G~y~----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYA----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCccc----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 55554321 123344555666667777888999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=354.51 Aligned_cols=256 Identities=27% Similarity=0.386 Sum_probs=205.5
Q ss_pred CCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeec
Q 040808 194 RFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEK 270 (511)
Q Consensus 194 ~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 270 (511)
..+.+|+++. +.||+|..|+||++.++ +++.+|+|++... .....++.+|++++++.+||+||.++|.|...
T Consensus 75 ~i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 75 GISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred ccCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 4667777644 56999999999999976 6899999999532 23346889999999999999999999999998
Q ss_pred C-eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 271 K-KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 271 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
. ...++||||.+|+|++++... +.+++..+-.|+.+|++||.|||.. .+||||||||+|||++..|.|||+
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence 8 499999999999999999542 4699999999999999999999963 399999999999999999999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
|||.++.+.... ..+..||..|||||-+.+. .++.++||||||++++|+.+|+.|+..... ...-+..++..
T Consensus 222 DFGVS~~lvnS~----a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--~~~~~~~Ll~~ 293 (364)
T KOG0581|consen 222 DFGVSGILVNSI----ANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNP--PYLDIFELLCA 293 (364)
T ss_pred cccccHHhhhhh----cccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCC--CCCCHHHHHHH
Confidence 999998775541 2456799999999999875 789999999999999999999999865411 01112223333
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+-.+....++.. ....++..++..||+.||.+|||++|+++
T Consensus 294 Iv~~ppP~lP~~------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 294 IVDEPPPRLPEG------EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HhcCCCCCCCcc------cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 333222222222 23445666777899999999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=352.85 Aligned_cols=237 Identities=26% Similarity=0.375 Sum_probs=202.2
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+.+.||+|+||+|+.++.+ +++.+|+|++++.. ...+...+|..+|.+++||.||+++-.|++.+++|||+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 46688999999999999854 59999999998643 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
.||.|..+|.. ...+++..+..++.+|+.||.|||++ +||||||||+|||||++|+++|+|||+++..-..
T Consensus 108 ~GGeLf~hL~~------eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 108 NGGELFYHLQR------EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred CCccHHHHHHh------cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999943 35799999999999999999999998 9999999999999999999999999999965444
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... ....+||+.|||||++.+. .++..+|+||+|+++|||++|.+||.... ...+++.+........+.
T Consensus 179 ~~~--t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~-------~~~~~~~I~~~k~~~~p~ 247 (357)
T KOG0598|consen 179 GDA--TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAED-------VKKMYDKILKGKLPLPPG 247 (357)
T ss_pred CCc--cccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCcc-------HHHHHHHHhcCcCCCCCc
Confidence 332 2346899999999999875 78999999999999999999999997542 233445555544344455
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCC
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRP 469 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP 469 (511)
.++.+.++++++++ +.||++|.
T Consensus 248 ~ls~~ardll~~LL-------~rdp~~RL 269 (357)
T KOG0598|consen 248 YLSEEARDLLKKLL-------KRDPRQRL 269 (357)
T ss_pred cCCHHHHHHHHHHh-------ccCHHHhc
Confidence 57888888888888 99999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=352.32 Aligned_cols=195 Identities=30% Similarity=0.460 Sum_probs=172.7
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.++++||.|+||+||+|+++ ++..||||.+.+.+ ...+-...|+.+|+.++|||||.+++++..++..+||||||.
T Consensus 13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred eehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence 45567999999999999965 58999999987653 334567899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC------CceEEeeccCcc
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED------FCPKISDFGLAK 355 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~DFGla~ 355 (511)
||+|.+||..+ +.+++..+..++.|||.||++||++ +||||||||+||||+.+ -.+||+|||+|+
T Consensus 93 gGDLs~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 93 GGDLSDYIRRR------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999653 4799999999999999999999998 99999999999999764 568999999999
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
.+..... ..+.+|+|-|||||+++. ++++.|+|+||+|+|+|+|++|+.||+..
T Consensus 164 ~L~~~~~---a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGSM---AETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchhH---HHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9976543 235679999999999964 48999999999999999999999999743
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=336.82 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=207.6
Q ss_pred HHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeec-eEee-cCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLG-FCYE-KKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~-~~~~~lv~ 277 (511)
.|.+.++||.|.||+||++. +.+|..+|.|.++-. ....++.+.|+.+|++++|||||+.++ -+.+ ....++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 34577899999999999998 668999999988732 223467889999999999999999998 3433 44489999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN-IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~-~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|++.+|+|...|+... ..++.+++..+++++.|++.||+.+|.+.. .-|+||||||.||+|+.+|.+||+|||+++.
T Consensus 100 E~c~~GDLsqmIk~~K--~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFK--KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HhhcccCHHHHHHHHH--hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999996543 456789999999999999999999999432 1399999999999999999999999999999
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
+.....+. .+.+|||-||+||.+.++ +++.||||||+||++|||..-+.||.... -..+.+.+..+...
T Consensus 178 l~s~~tfA--~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~L~~KI~qgd~~ 246 (375)
T KOG0591|consen 178 LSSKTTFA--HSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLSLCKKIEQGDYP 246 (375)
T ss_pred hcchhHHH--HhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCccccc-------HHHHHHHHHcCCCC
Confidence 98766543 356899999999999775 89999999999999999999999996431 22344455554221
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
+++ ..-...++.+++..|+..||+.||+.-.+++.+...
T Consensus 247 ~~p------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 247 PLP------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred CCc------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 111 123455677788889999999999876666666543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=329.68 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=213.2
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccC
Q 040808 182 AFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTS 256 (511)
Q Consensus 182 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~ 256 (511)
++...+.......+++++.. +.+.||.|+||+|.+++.+ +|..+|+|++++.+ .+.+...+|-.+|+.+.
T Consensus 28 ~~~~~~~~~~~~~~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~ 102 (355)
T KOG0616|consen 28 DFPKKWANTPQNPYSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS 102 (355)
T ss_pred hhhhhhcCCCCCCcchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc
Confidence 45555555555557777764 4567999999999999966 58999999998643 23467789999999999
Q ss_pred CcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 040808 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPH 336 (511)
Q Consensus 257 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~ 336 (511)
||.++++++.|.+.+..+|||||.+||.|..+++. .+.+++..++.+|.||+.||+|||+. +|++|||||+
T Consensus 103 ~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk------~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPE 173 (355)
T KOG0616|consen 103 HPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK------SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPE 173 (355)
T ss_pred CceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh------cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChH
Confidence 99999999999999999999999999999999954 35799999999999999999999998 9999999999
Q ss_pred CEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccC
Q 040808 337 NIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVS 416 (511)
Q Consensus 337 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~ 416 (511)
|||||.+|.+||+|||+|+..... +.+.+|||.|+|||+++.. .+..++|+|||||++|||+.|.+||....
T Consensus 174 NiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~- 245 (355)
T KOG0616|consen 174 NLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDN- 245 (355)
T ss_pred HeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCC-
Confidence 999999999999999999988665 2356899999999999875 78899999999999999999999997542
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCC
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDR 468 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~R 468 (511)
+..+++.|-++ ....+..++.+.++++++++ +.|-.+|
T Consensus 246 ------~~~iY~KI~~~-~v~fP~~fs~~~kdLl~~LL-------~vD~t~R 283 (355)
T KOG0616|consen 246 ------PIQIYEKILEG-KVKFPSYFSSDAKDLLKKLL-------QVDLTKR 283 (355)
T ss_pred ------hHHHHHHHHhC-cccCCcccCHHHHHHHHHHH-------hhhhHhh
Confidence 45667766554 35567788999999999988 5555555
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=353.71 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=204.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.|++.||+|+|++|++|+.+ .++.||||++.+..- ...-...|-.+|.+| .||.|++|+-.|.+...+|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 46778999999999999954 699999999975321 123456788889998 799999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++||+|.++|+.. +.|++...+.++.+|+.||+|||+. |||||||||+|||||+||++||+|||.|+.+..
T Consensus 156 A~nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 156 APNGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cCCCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999643 5789999999999999999999998 999999999999999999999999999998764
Q ss_pred CCce-----------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 360 KESF-----------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 360 ~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
.... ......+||..|.+||++... ..+..+|+|+||||||.|+.|++||.... +-.+++
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~N-------eyliFq 297 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAAN-------EYLIFQ 297 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCcccc-------HHHHHH
Confidence 3221 001346799999999999764 78999999999999999999999996442 223444
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.+.. .++.++..+++...+++++++ ..||++|+|.+++-+-
T Consensus 298 kI~~-l~y~fp~~fp~~a~dLv~KLL-------v~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 KIQA-LDYEFPEGFPEDARDLIKKLL-------VRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHH-hcccCCCCCCHHHHHHHHHHH-------ccCccccccHHHHhhC
Confidence 4433 345666778888888888888 8999999999888654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=352.74 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=203.1
Q ss_pred HHHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeec-Ce
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEK-KK 272 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 272 (511)
..+.+.++||+|+||.||+|.+ .+++.||+|+++.... ..+.+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 4456788999999999999973 2356899999975432 235789999999999 899999999988764 46
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCC--------------------------------------------------------
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSN-------------------------------------------------------- 296 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------- 296 (511)
.++||||+++|+|.+++.......
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 889999999999999996532100
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCcc
Q 040808 297 GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376 (511)
Q Consensus 297 ~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 376 (511)
....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++...............+++.|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 023588899999999999999999998 99999999999999999999999999998764433322223345678999
Q ss_pred chhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHH
Q 040808 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMIL 455 (511)
Q Consensus 377 aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 455 (511)
|||++.+. .++.++||||||+++|||++ |+.||..... .......+........+.. ....+.+
T Consensus 244 aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~-------~~~~l~~ 308 (338)
T cd05102 244 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------NEEFCQRLKDGTRMRAPEN-------ATPEIYR 308 (338)
T ss_pred CcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHhcCCCCCCCCC-------CCHHHHH
Confidence 99998653 67899999999999999997 9988864321 1222223332222222211 2335678
Q ss_pred HHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 456 VSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 456 l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
++.+||+.||++|||+.+|+++|+..+.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=347.78 Aligned_cols=256 Identities=27% Similarity=0.389 Sum_probs=206.7
Q ss_pred HHHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCChHHH--HHHHHHHHccC-CcceeeeeceEeecC-eEEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF--INEVASISRTS-HVNIVPFLGFCYEKK-KRALIY 277 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~ 277 (511)
.+|.+.++||.|.||.||+|+ ...|..||||.+++.-...++. ++|+..|+++. |||||++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 467788999999999999999 5579999999998765556654 57999999999 999999999999888 999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||| ..+|..+++.+ .+.+++..+..|+.||++||+|+|++ |+.|||+||+|||+..+..+||+|||+||.+
T Consensus 90 E~M-d~NLYqLmK~R-----~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDR-----NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred Hhh-hhhHHHHHhhc-----CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999 78999999765 37899999999999999999999999 9999999999999998889999999999998
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH---------
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK--------- 428 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------- 428 (511)
.....+ +.-+.|..|+|||++.+. +.++.+.||||+|||++|+.+-++.|....+ .+.+++
T Consensus 161 ~SkpPY---TeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE------~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 161 RSKPPY---TEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASE------IDQIYKICEVLGTPD 230 (538)
T ss_pred ccCCCc---chhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcH------HHHHHHHHHHhCCCc
Confidence 877664 345689999999999876 6899999999999999999999987753321 111111
Q ss_pred --------HHhhhhccccCCCCChH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 429 --------QIETEYDFQLDGVVTEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 429 --------~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
++.....+.++...... ......+.++++.+|++|||++|||+.|+++.
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 12222222222111111 11234456667778889999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.71 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=196.6
Q ss_pred hhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCCCh---HHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.-..++|+|+||+||+++.++ |+.||||.+..+.++. +-.++|+.+|++++|+|+|.++++|......+||+||+.
T Consensus 5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred hhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc
Confidence 334679999999999999774 9999999998776543 457899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
. ++.+-+... ...++.+.+..++.|++.|+.|+|++ ++|||||||+||||+.+|.+||+|||+|+.+....
T Consensus 85 h-TvL~eLe~~-----p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 85 H-TVLHELERY-----PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred h-HHHHHHHhc-----cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 6 444444332 25689999999999999999999998 99999999999999999999999999999887322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh--------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE-------- 433 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 433 (511)
. .+++.+.|..|+|||.+.+. .+++...||||+||++.||++|.+.|....+ .+.++......
T Consensus 156 d--~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD------iDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 156 D--NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSD------IDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred c--hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcch------HHHHHHHHHHHcccCHHHH
Confidence 1 23566789999999999875 4789999999999999999999988754322 11111111110
Q ss_pred -----------hccccCCCCChHH---HHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 434 -----------YDFQLDGVVTEEE---KEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 434 -----------~~~~~~~~~~~~~---~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
..++......+.. ..+..-+++++..|+++||++|++-++++
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 0111111111111 12333467899999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.01 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=202.4
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccC----CC--ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNL----KD--NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 275 (511)
.|.+.+.||+|+||+|++|.. .+++.||+|++.+. .. ..+...+|+.++++++ ||||+++++++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 456678899999999999984 46899999987753 22 2345667999999999 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-CceEEeeccCc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLA 354 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla 354 (511)
||||+.+|+|.+++.. ...+.+..+..++.|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||++
T Consensus 98 vmEy~~gGdL~~~i~~------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVN------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEecCCccHHHHHHH------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999954 35788899999999999999999998 99999999999999999 99999999999
Q ss_pred cccC-CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 355 KQTE-KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 355 ~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
.... .+. ...+.+||+.|+|||++.+.......++||||+||+||.|++|+.||+... ...++..+..+
T Consensus 169 ~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-------~~~l~~ki~~~ 238 (370)
T KOG0583|consen 169 AISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-------VPNLYRKIRKG 238 (370)
T ss_pred cccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcC
Confidence 9884 222 234678999999999998752244689999999999999999999997531 22333333322
Q ss_pred hccccCCCC-ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 434 YDFQLDGVV-TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 434 ~~~~~~~~~-~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.+.++..+ +.+...++++ |++.||.+|+|+.+++ .-.-
T Consensus 239 -~~~~p~~~~S~~~~~Li~~-------mL~~~P~~R~t~~~i~-~h~w 277 (370)
T KOG0583|consen 239 -EFKIPSYLLSPEARSLIEK-------MLVPDPSTRITLLEIL-EHPW 277 (370)
T ss_pred -CccCCCCcCCHHHHHHHHH-------HcCCCcccCCCHHHHh-hChh
Confidence 34445555 6655555555 5599999999999999 4433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=335.64 Aligned_cols=254 Identities=31% Similarity=0.409 Sum_probs=198.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC-hHHHHHHHHHHHccCCcceeeeeceEeecC--eEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN-GEEFINEVASISRTSHVNIVPFLGFCYEKK--KRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~ 280 (511)
....+.||+|+||+||++... +|+..|||.+...... .+...+|+.+|++++|||||+.+|...... .+++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 345678999999999999965 4999999988754221 456889999999999999999999755444 688999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 359 (511)
++|+|.+++.... . .+++..+..++.||++||+|||++ +++|+||||+||||+. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g----~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 99 PGGSLSDLIKRYG----G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred CCCcHHHHHHHcC----C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999996533 2 699999999999999999999998 9999999999999999 79999999999987764
Q ss_pred -CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 -KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 -~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
..........+||+.|||||++... .....++|||||||++.||+||+.||... .....++...........+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCC
Confidence 1111223356799999999999741 12335999999999999999999998642 1123344444333322334
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
+..++++.++ ++.+|++.+|++|||++++++-.-
T Consensus 245 p~~ls~~a~~-------Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 245 PDSLSDEAKD-------FLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CcccCHHHHH-------HHHHHhhcCcccCcCHHHHhhChh
Confidence 4445554444 445688999999999999987653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=367.24 Aligned_cols=260 Identities=26% Similarity=0.449 Sum_probs=214.0
Q ss_pred HhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
..+.++||+|+||+||+|... +...||||.+++.... ..+|.+|++++..++|||||+|+|+|.+++-.++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 346788999999999999843 3467999999976654 46899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEE
Q 040808 277 YEFMPNGSLDQYIYDHESSNG--------KRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl 348 (511)
+|||..|||.+||..+..... ..+|+..+.+.||.|||.|++||-++ .+|||||-..|+||.++..|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence 999999999999976542211 33489999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHH
Q 040808 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 349 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 427 (511)
+|||+++..-..+-+..-....-...|||||.+.- +.+|.+||||||||+|||+++ |+.|+.... .+.+.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------n~EVI 715 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------NQEVI 715 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccc-------hHHHH
Confidence 99999997755443322112234679999999954 699999999999999999997 888876432 33444
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+.+..+..+ +.....+.++..||+.||+.+|++||+++||-..|+...+
T Consensus 716 e~i~~g~lL-------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQLL-------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCcc-------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 555444322 2234456789999999999999999999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=340.23 Aligned_cols=266 Identities=23% Similarity=0.377 Sum_probs=198.5
Q ss_pred HHHhhhcccCCcCceEEEEEEcCC-----------------CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeee
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPD-----------------GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPF 263 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l 263 (511)
-.+.+.++||+|+||.||++.+++ +..||+|+++.... ...+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 345677899999999999997532 33699999875422 23578999999999999999999
Q ss_pred eceEeecCeEEEEEEeCCCCCHHHHHhcccC-------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEe
Q 040808 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHES-------------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVH 330 (511)
Q Consensus 264 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH 330 (511)
++++.+.+..++||||+++|+|.+++..... ......+++..++.++.||+.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999999865321 11124578899999999999999999998 9999
Q ss_pred cCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhC--C
Q 040808 331 LDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG--R 408 (511)
Q Consensus 331 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg--~ 408 (511)
|||||+|||+++++.+||+|||+++...............++..|+|||++.. +.++.++||||||+++|||+++ .
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999987654433222233456889999999865 3688999999999999999974 4
Q ss_pred CCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 409 KNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 409 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.|+.... .......+......... ......+ ......+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 240 ~p~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELT---DEQVIENAGEFFRDQGR-QVYLFRP---PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCC---HHHHHHHHHHHhhhccc-cccccCC---CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4554221 01011111111111000 0000001 1123457788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.95 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=208.1
Q ss_pred HhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.+.||.|.-++||+|+ ...+..||||++.-.+ .+.+...+|+..++.++||||++.+..|..+...++||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 4566889999999999998 5568999999997443 335788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC-CC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE-KK 360 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~-~~ 360 (511)
+|++.+.++..- ...+++..+..|..++++||.|||++ |.||||||+.||||+++|.|||+|||.+..+. .+
T Consensus 108 ~GS~ldIik~~~----~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 108 GGSLLDIIKTYY----PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred CCcHHHHHHHHc----cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999997654 24599999999999999999999998 99999999999999999999999999765443 22
Q ss_pred Cceeee-cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 361 ESFISM-LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.....- ....||+.|||||++..+..+++.|+||||||++..||.+|..||...-+ ...++..++........
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDPPTLLT 254 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCCCCccc
Confidence 222211 45579999999999777777899999999999999999999999963311 12233333332211111
Q ss_pred CCC-ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVV-TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~-~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... .++.+..-+.+.+++-.||+.||++|||++++++
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111 2334455667788889999999999999999974
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=344.81 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=202.1
Q ss_pred HHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 274 (511)
.+.+.++||+|+||+||+|.. .++..||||+++.... ..+.+.+|+.++..+ +||||++++++|.+.+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 356778999999999999963 2366899999975432 335788999999999 8999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCC-----------------------------------------------------------
Q 040808 275 LIYEFMPNGSLDQYIYDHESS----------------------------------------------------------- 295 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------------- 295 (511)
+||||+++|+|.+++......
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 999999999999999643210
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 296 ----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 296 ----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 0123588999999999999999999998 999999999999999999999999999987654433222
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCCh
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE 444 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (511)
.....++..|+|||++.+. .++.++||||||+++|||++ |..|+.... ......+.+........+..
T Consensus 273 ~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~--- 341 (375)
T cd05104 273 KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMP------VDSKFYKMIKEGYRMLSPEC--- 341 (375)
T ss_pred cCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCC------chHHHHHHHHhCccCCCCCC---
Confidence 2223456789999998653 68899999999999999998 777775321 12222333333222211111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 445 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
...++.+++.+||+.||++|||+.+|+++|+..
T Consensus 342 ----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 ----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 124577888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=345.03 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=204.9
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.+.++||+|.||+||+|.+.+ .||||+++... ...+.|.+||..+++.+|.||+-+.|+|..... ++|.-+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 356899999999999999743 49999998543 345789999999999999999999999998887 999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
-+|..+|+-.+ ..++..+...||.||++|+.|||.+ +|||||||..||+|.+++.|||+|||++..-..-..
T Consensus 472 sSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 472 SSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred chhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999997544 5789999999999999999999999 999999999999999999999999999864322111
Q ss_pred eeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
........|...|||||+++.. .-.++..|||||||+++|||++|..|+.... .+. +.-.+-.+. +...
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dq-----IifmVGrG~---l~pd 613 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQ-----IIFMVGRGY---LMPD 613 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhh-----eEEEecccc---cCcc
Confidence 1112334588899999999532 2368999999999999999999999997321 111 100011110 0122
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
.+.......++|.+|+..||..++++||.+.+|+.+|+.++..
T Consensus 614 ~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 614 LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 2333445667788899999999999999999999999987754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=329.80 Aligned_cols=245 Identities=19% Similarity=0.307 Sum_probs=197.7
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEee----cCeEEEEEEeC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYE----KKKRALIYEFM 280 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 280 (511)
..||+|++|.||+|.. +|+.||||+++..... .+.|.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 3699999999999998 6889999999865433 3567799999999999999999999876 35788999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++.. ...+++.....++.+++.||+|||+. .+++||||||+|||+++++.+||+|||+++.....
T Consensus 105 ~~g~L~~~l~~------~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 105 TRGYLREVLDK------EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCcHHHHHhh------CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 99999999953 24688999999999999999999974 27889999999999999999999999999866433
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH-hhhhccccC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI-ETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 439 (511)
. ....|++.|+|||++.+....++.++|||||||++|||++|+.||.... ...+...+ ........+
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~ 244 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------TKEIYDLIINKNNSLKLP 244 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcCCCCCCC
Confidence 2 2345889999999997644578999999999999999999999996431 22222222 222222222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.. ....+.+++.+||+.||++|||++||++.|+..
T Consensus 245 ~~-------~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 LD-------CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred Cc-------CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11 233466778899999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.97 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=195.1
Q ss_pred hhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 207 FSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+...||+|+||.||+|+-+ +|..+|+|+++++ ..+.+..+.|-.+|....+++||+|+-.|.+.+.+||||||+|
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4578999999999999854 6999999999975 3456788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC-
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK- 360 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~- 360 (511)
||++..+|.. ...|++..+..++.+++.||+-||+. |+|||||||+|+|||..|++||+||||+.-+...
T Consensus 225 GGD~mTLL~~------~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 225 GGDMMTLLMR------KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred CccHHHHHHh------cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999943 46899999999999999999999998 9999999999999999999999999998533210
Q ss_pred --------------------Ccee------e------------------ecCCCCCCCccchhhcccccCCCCccccchh
Q 040808 361 --------------------ESFI------S------------------MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYS 396 (511)
Q Consensus 361 --------------------~~~~------~------------------~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwS 396 (511)
.... . ....+|||.|+|||++.+. .++..+|+||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWS 373 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWS 373 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHH
Confidence 0000 0 1134599999999999886 5889999999
Q ss_pred HHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh---hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC
Q 040808 397 YGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE---YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS 470 (511)
Q Consensus 397 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs 470 (511)
||||+||||.|.+||... -|...++.+... +.++-....++++++++.+++ . ||++|.-
T Consensus 374 LG~ImyEmLvGyPPF~s~-------tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll-------~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSE-------TPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLL-------C-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHh-------c-CHHHhcC
Confidence 999999999999999754 355555554332 333444445566666666655 5 9999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.69 Aligned_cols=259 Identities=23% Similarity=0.321 Sum_probs=198.4
Q ss_pred HHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 277 (511)
.|.-.++||+|.||.||+|+ ..+|+.||+|.++.... ...-.++|+.||+++.||||++|.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 44456789999999999998 56799999999875432 224568999999999999999999998876 6899999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
|||++ +|.-++.. ....+++.++.-++.||+.||+|+|.+ +|+|||||.+|||||.+|.+||+|||||+.+
T Consensus 198 eYMdh-DL~GLl~~-----p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSS-----PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred ecccc-hhhhhhcC-----CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99965 77777743 335799999999999999999999998 9999999999999999999999999999977
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH--------
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ-------- 429 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 429 (511)
...... .++..+-|..|+|||.+.+. ..++.+.|+||.||||.||+.|++.+....+.. .-+.+++.
T Consensus 269 ~~~~~~-~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve---Ql~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 269 TPSGSA-PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVE---QLHKIFKLCGSPTEDY 343 (560)
T ss_pred cCCCCc-ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHH---HHHHHHHHhCCCChhc
Confidence 655432 25566789999999999887 478999999999999999999998886432100 00111110
Q ss_pred -----Hhhhhcc----ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 430 -----IETEYDF----QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 430 -----~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+.....+ .....+.+..+.+....++|+..+|..||.+|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000000 0011111223334445666777777999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.37 Aligned_cols=265 Identities=24% Similarity=0.383 Sum_probs=220.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCCh---HHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||+|+||+||||+-+ +.+.||+|.+.+..... +...+|++|+++++|||||.++++|+...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 445678999999999999965 58899999998766554 45788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
.| +|..+|.. ...++++.+..|+.++..||.|||+. +|+|||+||.||||+.+|++|++|||+|+....+
T Consensus 84 ~g-~L~~il~~------d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 84 VG-DLFTILEQ------DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hh-hHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 66 99999943 35799999999999999999999998 9999999999999999999999999999988765
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc--ccc
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD--FQL 438 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 438 (511)
... .+...|||-|||||.+.+ +.++..+|.||+|||+|||.+|++||. ...+...++.... ...
T Consensus 154 t~v--ltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~----------a~si~~Lv~~I~~d~v~~ 219 (808)
T KOG0597|consen 154 TSV--LTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFY----------ARSITQLVKSILKDPVKP 219 (808)
T ss_pred cee--eeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCch----------HHHHHHHHHHHhcCCCCC
Confidence 443 346789999999999975 488999999999999999999999994 3444443333221 122
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HhhccccCCCCCCCCCCCCCCCCC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE--MLEGSIENLQIPPKPSLSLPTGYA 500 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~--~L~~~~~~l~~p~~p~~~~p~~~~ 500 (511)
+...+.....+++.++ +.||..|.|..+++. ..++.+...+.|..+.+.+|-+..
T Consensus 220 p~~~S~~f~nfl~gLL-------~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~ 276 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLL-------IKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNN 276 (808)
T ss_pred cccccHHHHHHHHHHh-------hcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccC
Confidence 3355666666666666 999999999999984 457777777888888887777653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.33 Aligned_cols=243 Identities=23% Similarity=0.394 Sum_probs=209.5
Q ss_pred hhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 207 FSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+++.||.|+.|.|-+|++ .+|+.+|||++.+.. .....+-+|+.||+.+.||||+++++++++..++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 567799999999999995 479999999997642 233567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|.|.+++.. ++++++..+.+++.||+.|+.|+|.. +|+||||||+|+|||+.+.+||+|||+|.+-..+.
T Consensus 96 gGELFdylv~------kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 96 GGELFDYLVR------KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred CchhHHHHHh------hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999954 45799999999999999999999998 99999999999999999999999999998766554
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
- ..+-+|.|.|.+||++.+. .+.+.++||||.|||||.||+|+.||+.. + -..++..+..+ .+.++..
T Consensus 167 l---LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDd------N-ir~LLlKV~~G-~f~MPs~ 234 (786)
T KOG0588|consen 167 L---LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDD------N-IRVLLLKVQRG-VFEMPSN 234 (786)
T ss_pred c---ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCc------c-HHHHHHHHHcC-cccCCCc
Confidence 3 2355799999999999876 35678999999999999999999999833 2 33444444444 3677788
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
++.+..+++++|+ ..||+.|.|++||++-
T Consensus 235 Is~eaQdLLr~ml-------~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 235 ISSEAQDLLRRML-------DVDPSTRITTEEILKH 263 (786)
T ss_pred CCHHHHHHHHHHh-------ccCccccccHHHHhhC
Confidence 9999999999888 8899999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.21 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=196.8
Q ss_pred HHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+|.-.++||+|.||.||+|+ .++|+.||||.++.... -....++|++.|+.++|+||+.++++|-..+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 34556789999999999999 55799999999975422 235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
|+ -+|+..|+.. ...+....+..++.++++||+|||++ .|+||||||+|+|++.+|.+||+|||+|+.+..
T Consensus 83 m~-tdLe~vIkd~-----~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 83 MP-TDLEVVIKDK-----NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred cc-ccHHHHhccc-----ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 94 5999999543 46789999999999999999999998 999999999999999999999999999998875
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC-------------CCC------
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC-------------SSE------ 420 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~-------------~~~------ 420 (511)
..... +..+.|..|+|||.+.+. ..++...||||.|||+.||+-|.+-+....+. ..+
T Consensus 154 p~~~~--~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 154 PNRIQ--THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CCccc--ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 54322 223678999999999876 57899999999999999999888655422110 000
Q ss_pred CchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.+|+.+ .+...-.......++ ......++++..+|..||.+|+|++|++++
T Consensus 231 ~lpdY~--~~~~~P~~~~~~lf~----aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYV--KIQQFPKPPLNNLFP----AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHH--HHhcCCCCccccccc----cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111111 111000000111111 122334666777779999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.95 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=202.0
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+.++||+|+||.||++..+++..+|+|.+.......+++.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 45678899999999999998888899999988665566789999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++........
T Consensus 86 L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 86 LLNYLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred HHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999985422 3588999999999999999999998 9999999999999999999999999998866433221
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......++..|+|||++... .++.++||||||+++|||++ |+.|+.... .....+.+........+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-------~~~~~~~i~~~~~~~~~~~-- 225 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-------NYEVVEMISRGFRLYRPKL-- 225 (256)
T ss_pred ccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCCCCCCCCCC--
Confidence 12233456789999998653 67889999999999999999 888875331 1222223332221111111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
....+.+++.+||+.+|++||++++++++|.
T Consensus 226 -----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 -----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=321.12 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=207.2
Q ss_pred HHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 201 RRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 201 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+..+++.++||+|++|.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34456778999999999999999877888999999876656678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 84 KYGSLLEYLQGGA----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cCCcHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999995432 24689999999999999999999998 9999999999999999999999999999877532
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. ........+..|+|||++... .++.++||||||+++|||++ |+.|+... ....+...+.........
T Consensus 157 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~-------~~~~~~~~~~~~~~~~~~ 226 (261)
T cd05068 157 IY-EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGM-------TNAEVLQQVDQGYRMPCP 226 (261)
T ss_pred cc-cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCCCCCCC
Confidence 21 111222345689999998653 68899999999999999999 88887532 122333333333222111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
. .....+.+++.+||+.+|++||+++++++.|+.
T Consensus 227 ~-------~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 P-------GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred C-------cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1 223457788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=323.78 Aligned_cols=255 Identities=21% Similarity=0.377 Sum_probs=201.9
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
...+.+.+.||+|+||.||+|+++ .+..||+|+++.... ..+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 344567889999999999999753 356899999986432 23578999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+.
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 84 VTEYMSNGALDSFLRKH-----EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEeCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999999542 24689999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
....... .......++..|+|||.+.+ +.++.++||||||+++|||++ |+.||.... .....+.+....
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~-------~~~~~~~~~~~~ 225 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMS-------GQDVIKAVEDGF 225 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCC-------HHHHHHHHHCCC
Confidence 5432221 11112345678999999865 478899999999999999775 998885331 222333333332
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
....+ ......+.+++..||+.+|++||+++++++.|+..
T Consensus 226 ~~~~~-------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLPAP-------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCC-------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 22221 12344577788999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=320.52 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=205.6
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+.+.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++.+.+.+..+++|||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 34567899999999999999888889999998765555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~L~~~l~~~~----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 87 SLLDFLKSDE----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred cHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999996432 34688899999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......++..|+|||++.. +.++.++||||||+++|+|++ |+.|+.... .......+..........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~-- 227 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-------NSDVMSALQRGYRMPRME-- 227 (261)
T ss_pred -ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCC-------HHHHHHHHHcCCCCCCCC--
Confidence 1223346778999999865 367889999999999999998 888875321 222333333332221111
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.....+.+++.+||+.+|++||++++++++|+.
T Consensus 228 -----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 -----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123457778899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.62 Aligned_cols=261 Identities=23% Similarity=0.435 Sum_probs=201.3
Q ss_pred HHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 274 (511)
.+.+.+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|+++++.+ +|+||++++++|.+....+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 4557789999999999998732 245799999975432 235688999999999 8999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccC------------------------------------------------------------
Q 040808 275 LIYEFMPNGSLDQYIYDHES------------------------------------------------------------ 294 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~------------------------------------------------------------ 294 (511)
+||||+++|+|.+++.....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999999864210
Q ss_pred ----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCC
Q 040808 295 ----SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR 370 (511)
Q Consensus 295 ----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 370 (511)
......+++..+++|+.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...............
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 01123578899999999999999999998 99999999999999999999999999998664433222222234
Q ss_pred CCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHH
Q 040808 371 GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEM 449 (511)
Q Consensus 371 gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (511)
+++.|+|||++.. +.++.++||||||+++|||++ |+.||..... .....+.+........+...
T Consensus 276 ~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~------~~~~~~~~~~~~~~~~~~~~------- 340 (374)
T cd05106 276 LPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILV------NSKFYKMVKRGYQMSRPDFA------- 340 (374)
T ss_pred CccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccc------cHHHHHHHHcccCccCCCCC-------
Confidence 6678999999865 368899999999999999997 9998854321 11122222222222111122
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 450 AKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 450 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
...+.+++.+||+.||++|||+.+|+++|++++
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 245667888999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=360.68 Aligned_cols=268 Identities=27% Similarity=0.455 Sum_probs=213.7
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcC--CCc----EEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecC
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLP--DGR----LVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKK 271 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 271 (511)
+.+..-.+.+.||+|+||.||.|... +|. .||+|.+++..+ ...+|++|..+|+.++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 33444456678999999999999854 343 499999987643 3468999999999999999999999999999
Q ss_pred eEEEEEEeCCCCCHHHHHhcccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 272 KRALIYEFMPNGSLDQYIYDHES-SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
..++++|||++|+|..||.+.+. ......+....++.++.+||+|+.||+++ .+|||||...|+||++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999976532 12246789999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||+|+.+.+.+.......+.-...|||||.+.. +.++.|+|||||||+|||++| |..|+.... ...+...
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~-------n~~v~~~ 916 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRS-------NFEVLLD 916 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcc-------hHHHHHH
Confidence 999996655544333222344568999999976 589999999999999999998 666664332 1223332
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
+.++..+..+ .....++.+||..||+.+|++||++..+++.++.+.....
T Consensus 917 ~~~ggRL~~P-------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 917 VLEGGRLDPP-------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHhCCccCCC-------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 2233233332 2345678899999999999999999999999987766543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=334.59 Aligned_cols=241 Identities=29% Similarity=0.367 Sum_probs=198.8
Q ss_pred hcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCCh-HHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 208 SDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG-EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
-++||+|+-|.||.+. ..+++.||||.+....... +-.++|+.+|+..+|+|||++++.+...+....|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 3689999999999998 5578999999998665544 4578999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+.+.. ..+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.......
T Consensus 358 TDvVt~-------~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR- 426 (550)
T KOG0578|consen 358 TDVVTK-------TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR- 426 (550)
T ss_pred hhhhhc-------ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc-
Confidence 998843 3589999999999999999999998 99999999999999999999999999998876655422
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc--ccCCCCC
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF--QLDGVVT 443 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 443 (511)
.+..|||-|||||++.+. .++.|.||||||+|++||+.|++||-... |-.....+...... ..+..++
T Consensus 427 -~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------PlrAlyLIa~ng~P~lk~~~klS 496 (550)
T KOG0578|consen 427 -STMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------PLRALYLIATNGTPKLKNPEKLS 496 (550)
T ss_pred -ccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCC-------hHHHHHHHhhcCCCCcCCccccC
Confidence 345799999999999775 78999999999999999999999985321 11222223222222 2233334
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. +-++..+||+.|+++|+++.|+|+
T Consensus 497 ~~-------~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 497 PE-------LKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HH-------HHHHHHHHhhcchhcCCCHHHHhc
Confidence 43 445556788999999999999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=342.15 Aligned_cols=264 Identities=28% Similarity=0.452 Sum_probs=208.4
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEcCC--C--cE-EEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEee
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTLPD--G--RL-VAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYE 269 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 269 (511)
++....-.+.++||+|+||.||+|.++. + .. ||+|..+.. .....+|++|+++|+.++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3333334566899999999999998552 3 23 899988842 3345789999999999999999999999999
Q ss_pred cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 270 KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 270 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
....++|||+|+||+|++||.... ..++..+...++.+.|.||+|||++ +++||||-++|+|++.++.+||+
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999996432 3699999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 428 (511)
|||+++....... ......-...|+|||.+.. +.++.++|||||||++||+.+ |..|+... -...+..
T Consensus 305 DFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~-------~~~~v~~ 373 (474)
T KOG0194|consen 305 DFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGM-------KNYEVKA 373 (474)
T ss_pred ccccccCCcceee--ccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCC-------CHHHHHH
Confidence 9999886641111 1112245679999999965 489999999999999999998 77777532 1233444
Q ss_pred HH-hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCC
Q 040808 429 QI-ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIP 488 (511)
Q Consensus 429 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p 488 (511)
.+ ..+.....+. .....+..++..||..+|++||+|.++.+.|+.+.+....+
T Consensus 374 kI~~~~~r~~~~~-------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 374 KIVKNGYRMPIPS-------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred HHHhcCccCCCCC-------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 44 3333333322 23345666777999999999999999999999877765543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=323.96 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=191.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---------------CChHHHHHHHHHHHccCCcceeeeeceE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---------------DNGEEFINEVASISRTSHVNIVPFLGFC 267 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 267 (511)
+|.+.+.||+|.||.|-+|... +++.||||++.+.. ...+...+|++||++++|||||+|+++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 3456778999999999999954 79999999997531 1236788999999999999999999988
Q ss_pred eec--CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc
Q 040808 268 YEK--KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC 345 (511)
Q Consensus 268 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~ 345 (511)
.+. +..|||+|||..|.+... . .....+...+++.++.++..||+|||.+ +||||||||+|+||+++|+
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~---p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWC---P---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred cCcccCceEEEEEeccCCccccC---C---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 764 689999999998887421 1 1222399999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCccccCCC---CceeeecCCCCCCCccchhhcccc--cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC
Q 040808 346 PKISDFGLAKQTEKK---ESFISMLDTRGTAGYIAPEVFCRH--FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420 (511)
Q Consensus 346 ~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~ 420 (511)
+||+|||.+...... ..........|||+|+|||...+. ....+.+.||||+||+||.|+.|+.||...
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~------ 322 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD------ 322 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc------
Confidence 999999999866322 111223346799999999998652 224567899999999999999999999532
Q ss_pred CchHHHHHHHhh-hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 421 YFPNAIYKQIET-EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 421 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
+...+++.|.. ...++..+.+.+..+++ ++++|+.||+.|.+..+|....
T Consensus 323 -~~~~l~~KIvn~pL~fP~~pe~~e~~kDl-------i~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 323 -FELELFDKIVNDPLEFPENPEINEDLKDL-------IKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -hHHHHHHHHhcCcccCCCcccccHHHHHH-------HHHHhhcChhheeehhhheecc
Confidence 22333333322 22222222234444444 4455599999999998886544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=317.84 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=208.8
Q ss_pred HHHHHHHHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCe
Q 040808 198 SDVRRMTKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKK 272 (511)
Q Consensus 198 ~e~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 272 (511)
..-.+.+|.|.+.||+|.||.|-+|. ...|+.||||.+++.+- +.-.+.+|++||+.++||||+.++.+|++.+.
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 33456778888999999999999998 46899999999986542 22367899999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
..+||||..+|.|.+||... +.|++..+..++.||..|+.|+|.+ +|+|||||.+|||||+|+++||+|||
T Consensus 128 IvivMEYaS~GeLYDYiSer------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEEEEecCCccHHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence 99999999999999999543 5799999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
++-++.++.- ..+.+|+|-|.+||++.+. ..-.+..|-||||++||.|+.|..||+..+ ...+.+++..
T Consensus 199 LSNly~~~kf---LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-------hk~lvrQIs~ 267 (668)
T KOG0611|consen 199 LSNLYADKKF---LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-------HKRLVRQISR 267 (668)
T ss_pred hhhhhccccH---HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCch-------HHHHHHHhhc
Confidence 9998877654 3466899999999999775 355788999999999999999999998653 2334455555
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
+..... .-+.... -++.|+|..||++|.|+.+|..-
T Consensus 268 GaYrEP--~~PSdA~-------gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 268 GAYREP--ETPSDAS-------GLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ccccCC--CCCchHH-------HHHHHHHhcCcccchhHHHHhhh
Confidence 543221 1222222 34566779999999999998754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=327.93 Aligned_cols=256 Identities=24% Similarity=0.404 Sum_probs=200.3
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCc----EEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGR----LVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
..++..+.||+|+||+||+|.+. ++. .||+|+++... ...+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 34456678999999999999853 333 48999987533 2346789999999999999999999998764 5779
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 86 v~e~~~~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 999999999999996432 4588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
...............++..|+|||++.+ ..++.++||||||+++|||++ |+.|++... ...+...+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~ 228 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILEKGE 228 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhCCC
Confidence 7765443332233345778999999865 378899999999999999997 898885321 112222222222
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+... ...+..++.+||+.+|++||++.+++..|.....
T Consensus 229 ~~~~~~~~-------~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RLPQPPIC-------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCC-------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 22222221 2346778899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=338.13 Aligned_cols=262 Identities=25% Similarity=0.423 Sum_probs=204.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 274 (511)
.+.+.++||+|+||.||+|... .+..||||+++.... ..+.+.+|+++++++. ||||++++++|.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 4556789999999999999842 134699999975432 2467899999999996 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCC-----------------------------------------------------------
Q 040808 275 LIYEFMPNGSLDQYIYDHESS----------------------------------------------------------- 295 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------------- 295 (511)
+||||+++|+|.++|......
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999998643100
Q ss_pred -------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC
Q 040808 296 -------------------------------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF 344 (511)
Q Consensus 296 -------------------------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~ 344 (511)
.....+++..+..++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCC
Confidence 0123588899999999999999999998 999999999999999999
Q ss_pred ceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCch
Q 040808 345 CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFP 423 (511)
Q Consensus 345 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~ 423 (511)
.+||+|||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.|+.... ..
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~------~~ 346 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMI------VD 346 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccc------hh
Confidence 9999999999876443332222334577899999998653 67899999999999999997 888875321 11
Q ss_pred HHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 424 NAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
......+......... ......+.+++.+||+.+|++||++.+|+++|+.+++
T Consensus 347 ~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STFYNKIKSGYRMAKP-------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHhcCCCCCCC-------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2222333332222111 1234567788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.27 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=204.8
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCC------CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPD------GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
..++.+.+.||+|+||.||+|...+ ++.||+|.++..... .+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456778899999999999998532 478999999765443 36899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc
Q 040808 274 ALIYEFMPNGSLDQYIYDHES--------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC 345 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~ 345 (511)
++||||+++++|.+++..... ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 999999999999999975431 12235688999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchH
Q 040808 346 PKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPN 424 (511)
Q Consensus 346 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 424 (511)
+||+|||+++...............+++.|+|||++.. +.++.++||||||+++|||++ |+.|+.... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-------~~ 231 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-------NE 231 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-------HH
Confidence 99999999976543322111123346789999999865 478899999999999999998 998875321 12
Q ss_pred HHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 425 AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
...+.+.......... .....+.+++.+||+.||++||++.||+++|+.
T Consensus 232 ~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 EVIECITQGRLLQRPR-------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHHcCCcCCCCC-------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 2222222222111111 233456778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=322.66 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=195.8
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|...+.||+|+||+||++.. .+|+.||+|.+.... .....+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 34567899999999999985 478999999986432 2234678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 82 ~~~g~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 82 MNGGDLKFHIYNMG----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred cCCCcHHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999998885432 24689999999999999999999998 999999999999999999999999999987644
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+...+... .....
T Consensus 155 ~~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~-~~~~~ 225 (285)
T cd05631 155 GET---VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKER---VKREEVDRRVKED-QEEYS 225 (285)
T ss_pred CCe---ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHHhhcc-cccCC
Confidence 332 2244699999999999653 7889999999999999999999999743211 1111222222111 11112
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
..++ ..+..++.+||+.||++||+ ++++++
T Consensus 226 ~~~s-------~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 EKFS-------EDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCC-------HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2223 34556777888999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.85 Aligned_cols=250 Identities=25% Similarity=0.438 Sum_probs=201.8
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+.+.||+|+||.||++..+++..+|+|++.......+++.+|++++++++|+||+++++++.+.+..++||||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 45678899999999999998777889999987655566789999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 86 LLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred HHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 999995432 3689999999999999999999998 9999999999999999999999999999866433221
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......++..|+|||.+.+. .++.++||||||+++|||++ |+.|+.... .......+........+..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-- 225 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFS-------NSEVVESVSAGYRLYRPKL-- 225 (256)
T ss_pred ccCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCC-------HHHHHHHHHcCCcCCCCCC--
Confidence 11222345689999998653 67889999999999999998 788875321 1222333333322222222
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
....+.+++.+||+.+|++|||+.+++++|.
T Consensus 226 -----~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 226 -----APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -----CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 2345778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=333.75 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=198.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||.||+|... +++.||+|+++... .....+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999965 58999999997532 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 83 VPGGDFRTLLNN------LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred CCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999953 24688999999999999999999998 999999999999999999999999999986644
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... +......+.........
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~ 219 (333)
T cd05600 154 Y-----ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGST-------PNETWENLKYWKETLQR 219 (333)
T ss_pred c-----cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCC-------HHHHHHHHHhccccccC
Confidence 1 1345699999999999664 78899999999999999999999986432 22222222211111001
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.........+...+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11111011233456677788999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.81 Aligned_cols=257 Identities=25% Similarity=0.467 Sum_probs=203.0
Q ss_pred HhhhcccCCcCceEEEEEEcCC-C-----cEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD-G-----RLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
+.+.+.||+|+||.||+|.... + ..||+|.++.... ...+|.+|+.++.+++||||+++++++.+....+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 3567889999999999998543 2 5799999875432 235789999999999999999999999998999999
Q ss_pred EEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCce
Q 040808 277 YEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~ 346 (511)
|||+++++|.+++...... .....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 9999999999999654211 1125688999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHH
Q 040808 347 KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNA 425 (511)
Q Consensus 347 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 425 (511)
||+|||+++...............+++.|+|||.+.. +.++.++||||||+++|||++ |..|+.... ...
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~-------~~~ 234 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-------NQE 234 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-------HHH
Confidence 9999999986644332222233456889999999865 368899999999999999998 998885331 223
Q ss_pred HHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
+...+........ .......+.+++.+||+.||++||++++|++.|+.
T Consensus 235 ~~~~i~~~~~~~~-------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRSRQLLPC-------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCCC-------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3333332221111 12334567788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=321.71 Aligned_cols=264 Identities=25% Similarity=0.409 Sum_probs=206.3
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
+..+.+.+.||+|+||.||++... ++..+|+|.+..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 344556788999999999999742 345699998875433 2457899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 275 LIYEFMPNGSLDQYIYDHES-------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
+||||+++++|.+++..... ......+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999965421 11224589999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAI 426 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 426 (511)
|+|||+++...............+++.|+|||++... .++.++||||||+++|+|++ |+.|+.... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~-------~~~~ 231 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEV 231 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence 9999999866543322222233467889999998653 68899999999999999998 888875321 2223
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
.+.+........... ....+.+++.+||+.||.+|||+++|++.|+.+.+.
T Consensus 232 ~~~i~~~~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGRVLQRPRT-------CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCCcCCCCCC-------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 333333222222222 223577888999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.78 Aligned_cols=250 Identities=23% Similarity=0.442 Sum_probs=202.0
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+.+.||+|+||+||+|..+++..+|+|.++......+++.+|+.++.+++||||+++++++.+....++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 45678899999999999998777789999988655556789999999999999999999999998889999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++....... .
T Consensus 86 l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 86 LLNYLREHG-----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 999995422 3689999999999999999999998 999999999999999999999999999886644332 1
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......++..|+|||.+.. +.++.++||||||+++|+|++ |+.|+.... ...+...+...........
T Consensus 157 ~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-- 225 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-------NSETVEKVSQGLRLYRPHL-- 225 (256)
T ss_pred ecCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCC-------HHHHHHHHhcCCCCCCCCC--
Confidence 2223346678999999864 367889999999999999998 888875321 1222233322222111111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
....+.+++.+||+.+|++||++.++++.|+
T Consensus 226 -----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 -----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2346778889999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=321.26 Aligned_cols=249 Identities=31% Similarity=0.541 Sum_probs=194.3
Q ss_pred hhcccCCcCceEEEEEEcC-----CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 207 FSDKLGQGGYADVYKGTLP-----DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.||.|.||.||+|.+. .+..|+||+++.... ..++|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999865 256899999965332 247899999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.++|... ....+++..+..|+.||++||+|||+. +++|+||+++||++++++.+||+|||+++....
T Consensus 83 ~~~g~L~~~L~~~----~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 83 CPGGSLDDYLKSK----NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp -TTEBHHHHHHHT----CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999764 135789999999999999999999998 999999999999999999999999999987743
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
...........+...|+|||.+... ..+.++||||||+++|||++ |+.|+... -...+...+........
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~-------~~~~~~~~~~~~~~~~~ 226 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDY-------DNEEIIEKLKQGQRLPI 226 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTS-------CHHHHHHHHHTTEETTS
T ss_pred ccccccccccccccccccccccccc--ccccccccccccccccccccccccccccc-------cccccccccccccccee
Confidence 3333333344577899999998654 58999999999999999999 67776422 22333344444333222
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
+.. ....+..++..||+.+|++|||+++++++|
T Consensus 227 ~~~-------~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDN-------CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTT-------SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc-------hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 222 234577888999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=325.58 Aligned_cols=242 Identities=25% Similarity=0.307 Sum_probs=195.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|..+ +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456788999999999999965 68999999986432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 83 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 83 VPGGELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999532 4688999999999999999999998 999999999999999999999999999987644
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. ....||+.|+|||++.+. ..+.++|||||||++|||++|+.||.... ...+.+.+.... ...+
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~-~~~~ 218 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDN-------PFGIYEKILAGK-LEFP 218 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCC-cCCC
Confidence 32 234599999999998654 67899999999999999999999986431 223333333221 2222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~~ 477 (511)
...+. .+.+++.+||+.||.+||+ ++++++.
T Consensus 219 ~~~~~-------~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDL-------YAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCH-------HHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 33333 3455667788999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=329.28 Aligned_cols=240 Identities=23% Similarity=0.315 Sum_probs=191.8
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.||+|+||.||++..+ +|+.||+|+++... ....++.+|+.++++++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 68999999997532 23356788999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 81 ELFFHLSR------ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence 99999853 24689999999999999999999998 999999999999999999999999999875422211
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+... ...++..++
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~~~~~-~~~~p~~~~ 219 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILME-EIRFPRTLS 219 (323)
T ss_pred -cccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcC-CCCCCCCCC
Confidence 11234699999999999653 67899999999999999999999986331 12222222211 122223333
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
+ .+.+++.+||+.||++|| ++.++++
T Consensus 220 ~-------~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 220 P-------EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred H-------HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3 355667778899999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.51 Aligned_cols=256 Identities=24% Similarity=0.404 Sum_probs=197.7
Q ss_pred hhcccCCcCceEEEEEEcCC-Cc--EEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec------CeEE
Q 040808 207 FSDKLGQGGYADVYKGTLPD-GR--LVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRA 274 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 274 (511)
+.++||+|+||.||+|...+ +. .+|+|.++... ...+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 56789999999999998654 33 68999887542 2346788999999999999999999987532 2568
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
++|||+++|+|.+++...........+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999999885433222345689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
+...............+++.|+|||++.+. .++.++||||||+++|||++ |+.|+... ....+.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~-------~~~~~~~~~~~~ 230 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGV-------ENSEIYDYLRQG 230 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHHcC
Confidence 876543322111223467789999998653 67899999999999999999 77777432 122333333333
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
....... .....+.+++.+||+.+|++|||+.++++.|+..
T Consensus 231 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQPP-------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2222111 1234467888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=315.22 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=202.0
Q ss_pred HhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+.||+|+||+||+|.++. ...||+|+++..... ..+|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 4567889999999999998642 457999998754332 3578999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 86 YMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred cCCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999995432 3689999999999999999999998 99999999999999999999999999998875
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
............+++.|+|||.+... .++.++||||||+++|+|++ |..|+.... ...+.+.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~ 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMS-------NQDVIKAVEDGYRLP 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCC-------HHHHHHHHHcCCCCC
Confidence 33222222233467789999998653 68899999999999999998 888874321 222233333322221
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
... .....+.+++.+||+.+|++||++++|+++|+..
T Consensus 229 ~~~-------~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 PPM-------DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 2234577888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=315.60 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=200.3
Q ss_pred hhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCe------
Q 040808 206 SFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKK------ 272 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 272 (511)
.+.+.||+|+||.||+|.+.. +..||+|+++.... ..+.+.+|+..++.++|+||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999998542 36799999875432 23578999999999999999999998866554
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++++||+++|+|..++...........+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 789999999999999996644333345789999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
+++...............++..|+|||++... .++.++||||||+++|||++ |..|+.... ...+.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-------~~~~~~~~~ 229 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVE-------NHEIYDYLR 229 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH
Confidence 99876544322221223356789999998543 67899999999999999999 777775321 122233332
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
......... .....+.+++.+||+.||++|||+.||++.|+.+
T Consensus 230 ~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNRLKQPE-------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCCCCCc-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222221111 2334577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=313.82 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=206.5
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++++.++||+|+||.||+|..++++.||+|.+.......+++.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 455677888999999999999999888999999999876666788999999999999999999998764 5568999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 82 MENGSLVDFLKTPE----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999985432 34689999999999999999999997 999999999999999999999999999987653
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
... .......++..|+|||++.. +..+.++||||||+++|||++ |+.|+.... .....+.+........
T Consensus 155 ~~~-~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 224 (260)
T cd05067 155 NEY-TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-------NPEVIQNLERGYRMPR 224 (260)
T ss_pred CCc-ccccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHHHHcCCCCCC
Confidence 221 11123346788999999864 367889999999999999998 998885321 2222333333222221
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
... ....+.+++.+||+.+|++||+++++++.|+.
T Consensus 225 ~~~-------~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDN-------CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC-------CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111 23457788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.22 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=203.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.+.++||+|+||.||+|..+ .++.||+|+++......+++.+|++++.+++|+||+++++++......+++|||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 456788999999999999855 5889999999876555678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 88 ~L~~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 88 NLLDYLRECN----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred cHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999995422 34689999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......+++.|+|||.+.+. .++.++||||||+++|||++ |..|+.... .......+...........
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~- 229 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKGYRMERPEG- 229 (263)
T ss_pred -ccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCCCCCCCCCC-
Confidence 11223356789999998653 67889999999999999998 888875321 2223333333222222222
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
....+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 230 ------~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 230 ------CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 234566788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=318.14 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=199.8
Q ss_pred HHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
..+.+.++||+|+||.||+|.++ .+..||+|++..... ...++.+|+.+++.++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 34567789999999999998743 256799999864322 2356889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 275 LIYEFMPNGSLDQYIYDHESSN----GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
+||||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 9999999999999996532111 123568889999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||+++...............+++.|+|||++.+ +.++.++||||||+++|||++ |..|+.... .....+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~~~~~~ 233 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVLRF 233 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHH
Confidence 999986654332221122346788999999865 368899999999999999998 677774321 1222222
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
+.......... .....+.+++.+||+.+|++|||+.|++++|++
T Consensus 234 ~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22221111111 123456778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.41 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=205.8
Q ss_pred HHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
..|.+.++||.|+||.||+|...+++.+|+|++..... ...++.+|+.+++.++|+||+++++++.+....++||||++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34667889999999999999988899999999986544 45688999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 86 ~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 86 KGSLLAFLRSPE----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cCCHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999996432 35689999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. ......++..|+|||.+.. +.++.++||||||+++|+|++ |+.|+.... .......+..........
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-------NHEVYDQITAGYRMPCPA 227 (261)
T ss_pred c--cccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHHhCCcCCCCC
Confidence 1 1223456788999999865 367889999999999999998 788885321 222333333222222111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 228 -------~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 228 -------KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 223456788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=329.46 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=195.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||+|..+ +++.||+|+++... ...+.+.+|+.++++++||||+++++.+.+.+..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 456789999999999999965 58999999997532 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 100 VVGGELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CCCChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999542 4688899999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. ....||+.|+|||++.+. ..+.++|||||||++|||++|+.||.... +...++.+... ...++
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~-~~~~p 235 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDT-------PFRIYEKILAG-RLKFP 235 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcC-CcCCC
Confidence 32 134699999999999654 67899999999999999999999985321 22233333322 12223
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVV 475 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl 475 (511)
...+. .+.+++.+||+.||++||+ +++++
T Consensus 236 ~~~~~-------~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 236 NWFDG-------RARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCH-------HHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 33333 3456777788999999996 57766
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=331.75 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=221.1
Q ss_pred HHHHHHHHHhhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 197 YSDVRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 197 ~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
-.|+++....+.++||.|.||.||.|.++. .-.||||.++......++|+.|+++|+.++|||+|+|+|+|....-+|+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 346666666678899999999999999774 6789999999988889999999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
|.|||.+|+|.+||.+.. +..++.-.++.++.||..|++||..+ ++|||||-..|.|+.++..|||+||||++
T Consensus 341 iTEfM~yGNLLdYLRecn----r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECN----RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEecccCccHHHHHHHhc----hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 999999999999997643 35677788899999999999999998 99999999999999999999999999999
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
++..+. +.....+.-.+.|.|||-+.-+ .++.|+|||+|||+|||+.| |..|+..- --..++..++.+.
T Consensus 414 lMtgDT-YTAHAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGi-------dlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 414 LMTGDT-YTAHAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYGLLEKGY 483 (1157)
T ss_pred hhcCCc-eecccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCc-------cHHHHHHHHhccc
Confidence 986553 3333445567899999998544 89999999999999999997 66665322 1345677777776
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
.+..+. .+..++.+||+.||+|+|.+||++.|+-+.+|.++
T Consensus 484 RM~~Pe-------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 RMDGPE-------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cccCCC-------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 554332 24557899999999999999999999988887554
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.63 Aligned_cols=263 Identities=24% Similarity=0.416 Sum_probs=202.7
Q ss_pred HHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHcc-CCcceeeeeceEee-cCe
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRT-SHVNIVPFLGFCYE-KKK 272 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 272 (511)
..+.+.+.||+|+||.||+|... .++.||+|+++..... .+.+.+|++++.++ +|+||++++++|.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 35677889999999999999632 2478999998754322 34678899999999 79999999998865 457
Q ss_pred EEEEEEeCCCCCHHHHHhcccCC-------------------------------------------------------CC
Q 040808 273 RALIYEFMPNGSLDQYIYDHESS-------------------------------------------------------NG 297 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------~~ 297 (511)
.+++|||+++++|.+++...... ..
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998643210 00
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccc
Q 040808 298 KRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377 (511)
Q Consensus 298 ~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 377 (511)
...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 13689999999999999999999998 999999999999999999999999999987654433222233456788999
Q ss_pred hhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHH
Q 040808 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILV 456 (511)
Q Consensus 378 PE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 456 (511)
||++.+. .++.++|||||||++|||++ |+.|+..... .+.....+........+. .....+.++
T Consensus 244 PE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~-------~~~~~~~~l 308 (337)
T cd05054 244 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------DEEFCRRLKEGTRMRAPE-------YATPEIYSI 308 (337)
T ss_pred cHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCc------cHHHHHHHhccCCCCCCc-------cCCHHHHHH
Confidence 9998653 78899999999999999998 9888753211 112222222222211111 223457788
Q ss_pred HHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 457 SLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 457 ~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+.+||+.+|++||++.||+++|+..++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.37 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=201.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
.+.+.++||+|+||.||+|... .+..||+|+++..... .+.+.+|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4567789999999999999853 2578999999754332 3568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc
Q 040808 276 IYEFMPNGSLDQYIYDHES----------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC 345 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~ 345 (511)
++||+++++|.+++..... ......+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 9999999999999853210 01124588999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchH
Q 040808 346 PKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPN 424 (511)
Q Consensus 346 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 424 (511)
+||+|||+++...............+++.|+|||.+.. +.++.++||||||+++|||++ |..|+... ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-------~~~ 233 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-------SNQ 233 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCC-------CHH
Confidence 99999999887654333222233456789999999854 368899999999999999998 77776432 122
Q ss_pred HHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 425 AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.+...+.......... +....+..++.+||+.+|++||++++|+..|+.
T Consensus 234 ~~~~~i~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 DVIEMIRNRQVLPCPD-------DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHcCCcCCCCC-------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2333333322111111 233446788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.72 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=194.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++||+|+||+||+|... +++.||+|++.... ...+.+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999854 68999999997532 2235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 83 IPGGDMMSLLIRM------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999998542 3588899999999999999999998 999999999999999999999999999764321
Q ss_pred CCc---------------------------------------------eeeecCCCCCCCccchhhcccccCCCCccccc
Q 040808 360 KES---------------------------------------------FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDV 394 (511)
Q Consensus 360 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDv 394 (511)
... ........||+.|+|||++.+. .++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Di 231 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccce
Confidence 000 0001134699999999998653 67899999
Q ss_pred hhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh--ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHH
Q 040808 395 YSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY--DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMT 472 (511)
Q Consensus 395 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~ 472 (511)
|||||++|||++|+.||..... .......+.... .......++++..+++.+|+ |+..++..||+++
T Consensus 232 wSlG~il~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll-----~~~~~~~~R~~~~ 300 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTP------TETQLKVINWENTLHIPPQVKLSPEAVDLITKLC-----CSAEERLGRNGAD 300 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCH------HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHc-----cCcccccCCCCHH
Confidence 9999999999999999964321 111111111111 11112235666666666654 7788888899999
Q ss_pred HHHHH
Q 040808 473 KVVEM 477 (511)
Q Consensus 473 evl~~ 477 (511)
++++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.48 Aligned_cols=237 Identities=22% Similarity=0.376 Sum_probs=197.6
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+|.+.||+|+||+|+++..+ +++.+|||++++. +++.+..+.|..|+.... ||.++.++..|.+.++.++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 46789999999999999976 5889999999974 455677888888887775 99999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+.||++..++ ....+++..+..++.+|+.||+|||++ +|||||||.+|||||.+|++||+|||+++..-.
T Consensus 451 ~~Ggdm~~~~-------~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 451 VAGGDLMHHI-------HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred cCCCcEEEEE-------ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999954333 235799999999999999999999999 999999999999999999999999999986542
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... .+.+.+|||.|||||++.+. .++..+|+|||||+|||||.|+.||...+ .+.+.+.|... +...+
T Consensus 521 ~g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-------Eee~FdsI~~d-~~~yP 588 (694)
T KOG0694|consen 521 QGD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDD-------EEEVFDSIVND-EVRYP 588 (694)
T ss_pred CCC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcC-CCCCC
Confidence 222 23567899999999999774 89999999999999999999999997543 34444444332 23445
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
..++.+...++++|+ ..+|++|.-+
T Consensus 589 ~~ls~ea~~il~~ll-------~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 RFLSKEAIAIMRRLL-------RKNPEKRLGS 613 (694)
T ss_pred CcccHHHHHHHHHHh-------ccCcccccCC
Confidence 667777777777776 9999999966
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=323.91 Aligned_cols=240 Identities=22% Similarity=0.319 Sum_probs=189.5
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
||+|+||+||++... +++.||+|+++.. ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5889999998753 23345788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 149 (312)
T cd05585 81 FHHLQR------EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K 149 (312)
T ss_pred HHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence 999953 24689999999999999999999998 999999999999999999999999999986433222 1
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .....+.+... ...++...+
T Consensus 150 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~-~~~~~~~~~-- 217 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQE-PLRFPDGFD-- 217 (312)
T ss_pred cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcC-CCCCCCcCC--
Confidence 2234699999999999654 68899999999999999999999986321 12222222221 112222233
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
..+.+++.+||+.||++||++..+.+.|
T Consensus 218 -----~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 -----RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred -----HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 3455667788899999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=296.03 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=211.8
Q ss_pred hCCCCCCCCCHHHHHHHHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC----CChHHHHHHHHHHHccCCccee
Q 040808 187 YGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIV 261 (511)
Q Consensus 187 ~~~~~~~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv 261 (511)
+++...+.+++.++ ++++.||+|-||.||.|+. +++-.||+|++.++. ....++.+|++|-+.++||||+
T Consensus 11 ~~~~~~~~~~l~df-----eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnil 85 (281)
T KOG0580|consen 11 FGSRATKTWTLDDF-----EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNIL 85 (281)
T ss_pred cccccccccchhhc-----cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHH
Confidence 34444566777776 4788999999999999994 468899999997642 2346788999999999999999
Q ss_pred eeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 262 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
+++++|.+....||++||.++|+|.+.|.+.. ...+++.....++.|+|.||.|+|.. +||||||||+|+|++
T Consensus 86 rlY~~fhd~~riyLilEya~~gel~k~L~~~~----~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg 158 (281)
T KOG0580|consen 86 RLYGYFHDSKRIYLILEYAPRGELYKDLQEGR----MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLG 158 (281)
T ss_pred hhhhheeccceeEEEEEecCCchHHHHHHhcc----cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccC
Confidence 99999999999999999999999999996543 35688888889999999999999998 999999999999999
Q ss_pred CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCC
Q 040808 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY 421 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~ 421 (511)
..+..|++|||.+-..+.... ...+||..|.+||...+. ..+...|+|++|++.||++.|.+||....
T Consensus 159 ~~~~lkiAdfGwsV~~p~~kR----~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~------ 226 (281)
T KOG0580|consen 159 SAGELKIADFGWSVHAPSNKR----KTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQS------ 226 (281)
T ss_pred CCCCeeccCCCceeecCCCCc----eeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhh------
Confidence 999999999999876653322 345799999999999764 77899999999999999999999997442
Q ss_pred chHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+..++.+.... +..+..++....+ ++.+|+..+|.+|.+..||++
T Consensus 227 -~~etYkrI~k~~-~~~p~~is~~a~d-------lI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 227 -HSETYKRIRKVD-LKFPSTISGGAAD-------LISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -hHHHHHHHHHcc-ccCCcccChhHHH-------HHHHHhccCccccccHHHHhh
Confidence 456677665543 3344556665544 445566999999999999875
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=311.23 Aligned_cols=253 Identities=27% Similarity=0.449 Sum_probs=202.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
..+.+.++||+|+||.||+|..+++..+|+|.++......+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 346678899999999999999888888999999876666678999999999999999999999875 4568899999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 85 GSLLDFLKDGE----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 99999996432 34689999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ......++..|+|||++.. ...+.++||||||+++|||++ |+.|+.... .......+........+.
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~- 226 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMN-------NREVLEQVERGYRMPCPQ- 226 (260)
T ss_pred c-cccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-
Confidence 1 1122346678999999854 368899999999999999999 788875321 122233333222221111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 227 ------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 ------DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223457788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=342.97 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=213.2
Q ss_pred hcccCCcCceEEEEEEcCC----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 208 SDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.||.|.||.|++|.++- ...||||.++.... +..+|+.|+.||.+++||||++|.|+.....-..+|.|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 3679999999999999762 35799999996543 45689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
||+|+.||+.+. ..+.+.++..++.+||.|+.||-+. ++|||||.+.|||++.+...||+|||+++.+.++.
T Consensus 714 NGsLDsFLR~~D-----GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 714 NGSLDSFLRQND-----GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred CCcHHHHHhhcC-----CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999997654 4699999999999999999999987 99999999999999999999999999999886554
Q ss_pred c-eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 362 S-FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 362 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
. ......-.=...|.|||.+. +++++.+|||||||++|||.++ |.+|+..- -.+.+.+.++++..++.+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-------SNQdVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------SNQDVIKAIEQGYRLPPP 856 (996)
T ss_pred CccccccCCccceeecChhHhh--hcccCchhhccccceEEEEecccCCCccccc-------chHHHHHHHHhccCCCCC
Confidence 2 22222222357999999994 4689999999999999999775 88887522 345677778877655433
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
.+.+..+.+||+.|||+|..+||.+.+++.+|.+++.+-
T Consensus 857 -------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 857 -------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred -------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 345567889999999999999999999999999877653
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=317.97 Aligned_cols=259 Identities=25% Similarity=0.444 Sum_probs=203.6
Q ss_pred hhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+.+.||+|+||.||+|... ....+|+|.+..... ..+++.+|+.++++++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999843 235799998875433 2357889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 278 EFMPNGSLDQYIYDHES------------------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
||+++++|.+++..... ......+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 99999999999865321 11224688999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCC
Q 040808 340 LDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCS 418 (511)
Q Consensus 340 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~ 418 (511)
+++++.+||+|||+++...............++..|+|||.+.+. .++.++||||||+++|||++ |+.|+...
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~---- 233 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGI---- 233 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCC----
Confidence 999999999999999866443322222234567889999998653 68899999999999999998 88887532
Q ss_pred CCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 419 SEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.+..+.+.+........+. .....+.+++.+||+.+|++||++.++++.|++++.
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 234 ---APERLFNLLKTGYRMERPE-------NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---CHHHHHHHHhCCCCCCCCC-------CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1333334333332222111 223457788899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.79 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=193.5
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+.++||+|+||+||++... +++.||+|++++.. .....+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 45678999999999999855 58999999997532 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 84 PGGDMMTLLMK------KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred CCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999953 24689999999999999999999998 9999999999999999999999999998765321
Q ss_pred Cce---------------------------------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhC
Q 040808 361 ESF---------------------------------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407 (511)
Q Consensus 361 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg 407 (511)
... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhC
Confidence 100 001234699999999999654 688999999999999999999
Q ss_pred CCCCCCccCCCCCCchHHHHHHHhhh-hccccC--CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 408 RKNADVKVSCSSEYFPNAIYKQIETE-YDFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 408 ~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
+.||.... +...+..+... .....+ ..++++.++++.+|+ |...++..||+++|+++.
T Consensus 233 ~~Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-----~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 233 YPPFCSET-------PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFC-----CEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCC-------HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHc-----CChhhcCCCCCHHHHhCC
Confidence 99996431 22333333221 111122 234555555555442 545566678999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.38 Aligned_cols=267 Identities=23% Similarity=0.373 Sum_probs=197.3
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCC---------------CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeee
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPD---------------GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFL 264 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~ 264 (511)
+-.+.+.++||+|+||.||++...+ ...||+|.++.... ..+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3456677899999999999987532 23589999875322 235789999999999999999999
Q ss_pred ceEeecCeEEEEEEeCCCCCHHHHHhcccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCE
Q 040808 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESS------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNI 338 (511)
Q Consensus 265 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NI 338 (511)
+++......++||||+++++|.+++...... .....+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 9999999999999999999999999643210 1123578999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhC--CCCCCCccC
Q 040808 339 RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG--RKNADVKVS 416 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg--~~p~~~~~~ 416 (511)
++++++.+||+|||++................+++.|+|||++.. +.++.++||||||+++|+|+++ ..|+....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~- 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS- 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC-
Confidence 999999999999999986644332222223345779999999865 3689999999999999999984 44554221
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
...+...+......................+.+++.+||+.+|++|||+++|++.|+.
T Consensus 238 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 ------DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ------hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111000000000000001123468889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.59 Aligned_cols=247 Identities=28% Similarity=0.491 Sum_probs=199.2
Q ss_pred CCCHHHHHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 194 RFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 194 ~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
.+.|.+|.+. +-||.|+.|.||+|+++ ++.||||.++..+. .+++-|++|+|+||+.+.|+|...-.+
T Consensus 120 eiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elkE------TdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELKE------TDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhhh------hhHHHHHhccCcceeeEeeeecCCcee
Confidence 3445555433 46999999999999985 57899998876443 478889999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++|||||+.|.|...|+. .+.+....+.+|..+||.|+.|||.+ .|||||||.-||||+.+-.|||+|||-
T Consensus 188 CIiMEfCa~GqL~~VLka------~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA------GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred EEeeeccccccHHHHHhc------cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence 999999999999999954 35788889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++...+... +....||..|||||++... ..++|+|||||||+|||||||.-|+..-+. ...++..-...
T Consensus 259 S~e~~~~ST---kMSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIwGVGsNs 327 (904)
T KOG4721|consen 259 SKELSDKST---KMSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIWGVGSNS 327 (904)
T ss_pred hHhhhhhhh---hhhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccch------heeEEeccCCc
Confidence 988766532 4567799999999999764 899999999999999999999999853221 01111111111
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
+.+.++.. .++.+..|+..||+..|..||++++++.-|+
T Consensus 328 L~LpvPst-------cP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 328 LHLPVPST-------CPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccccCccc-------CchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 22222222 2334455678899999999999999999887
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=317.10 Aligned_cols=261 Identities=23% Similarity=0.446 Sum_probs=204.0
Q ss_pred HHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 273 (511)
..+.+.+.||+|+||.||++... ....+|+|.+..... ...++.+|++++.++ +|+||+++++++...+..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 34456788999999999999853 236799999875432 235688999999999 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC
Q 040808 274 ALIYEFMPNGSLDQYIYDHES----------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED 343 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~ 343 (511)
+++|||+++|+|.+++..... ......+++..++.++.|++.||+|||+. +|+||||||+|||++++
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 999999999999999965321 02245789999999999999999999998 99999999999999999
Q ss_pred CceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCc
Q 040808 344 FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYF 422 (511)
Q Consensus 344 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~ 422 (511)
+.+||+|||+++...............++..|+|||++.. ..++.++||||||+++|||++ |..|+....
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 239 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 239 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCC-------
Confidence 9999999999987654433222233446778999999855 368899999999999999997 888774321
Q ss_pred hHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 423 PNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
...+.+.+........+. .....+.+++.+||+.+|++|||+.++++.|+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 VEELFKLLKEGYRMEKPQ-------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHcCCcCCCCC-------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 122233333222111111 12345778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.17 Aligned_cols=241 Identities=24% Similarity=0.332 Sum_probs=191.9
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.||+|+||.||++..+ +|+.||+|++.+. .....++.+|+.+++.++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 6899999999753 223457889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 81 ELFFHLSR------ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 99988843 24689999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .....+.+.. ....++..++
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~~~~~-~~~~~p~~~~ 219 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILM-EDIKFPRTLS 219 (328)
T ss_pred -ccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCC-------HHHHHHHhcc-CCccCCCCCC
Confidence 12234699999999998653 67899999999999999999999986331 1122222211 1122223333
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVEM 477 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~~ 477 (511)
. .+.+++.+||+.||++|| ++.++++.
T Consensus 220 ~-------~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 A-------DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred H-------HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3 355666778899999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=323.10 Aligned_cols=240 Identities=24% Similarity=0.335 Sum_probs=191.0
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.||+|+||.||++..+ +|+.||+|+++.. ......+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999854 6899999999753 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 81 ELFFHLSR------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 99988843 24689999999999999999999998 999999999999999999999999999875422221
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .....+.+... ...++..++
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~~~~~-~~~~p~~~~ 219 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILME-EIRFPRTLS 219 (323)
T ss_pred -ccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcC-CCCCCCCCC
Confidence 12234699999999998653 67899999999999999999999986432 12222222111 112223333
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
+ .+.+++.+||+.||++|| ++.++++
T Consensus 220 ~-------~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 220 P-------EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred H-------HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3 345666778899999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=329.74 Aligned_cols=255 Identities=20% Similarity=0.212 Sum_probs=192.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.|.+.++||+|+||.||++.+. +++.||+|... ...+.+|++++++++||||+++++++......++|+|++ +
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-K 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-C
Confidence 4667789999999999999854 68999999754 245789999999999999999999999999999999999 5
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|..++.. ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 167 ~~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 167 TDLYCYLAA------KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 789888843 24688999999999999999999998 999999999999999999999999999975432211
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh---------
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE--------- 433 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 433 (511)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.|+..................+...
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 112345699999999999653 68899999999999999999998764322111110000000000000
Q ss_pred ---------------hcc-ccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 ---------------YDF-QLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ---------------~~~-~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ....... .........+..++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000010 112234556778899999999999999999985
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=339.27 Aligned_cols=251 Identities=21% Similarity=0.239 Sum_probs=197.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-C-CcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-D-GRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.+.||+|+||.||+|... + ++.||+|.+..... ....+.+|+.++++++|||||++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 566789999999999999743 4 67889997754332 23467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 149 gg~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 149 GGDLNKQIKQRL--KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999886532 2235688999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.........||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+........+..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~ 294 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQVLYGKYDPFPCP 294 (478)
T ss_pred ccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCcc
Confidence 22222345699999999998653 68899999999999999999999986321 1222222222211111222
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ...+.+++.+||+.+|++||+++++++
T Consensus 295 ~-------s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 295 V-------SSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C-------CHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2 234667778899999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.82 Aligned_cols=243 Identities=23% Similarity=0.317 Sum_probs=195.9
Q ss_pred HHhhhcccCCcCceEEEEEEcCC--CcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD--GRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+.+.++||+|+||.||+|.+++ +..||+|++... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 35677899999999999998543 468999998643 223467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 111 Ey~~~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 111 EFVIGGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999532 4688999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
.... ....||+.|+|||++.+. ..+.++|||||||++|||++|+.||.... +...++.+.... ..
T Consensus 182 ~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~i~~~~-~~ 246 (340)
T PTZ00426 182 DTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANE-------PLLIYQKILEGI-IY 246 (340)
T ss_pred CCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCC-------HHHHHHHHhcCC-CC
Confidence 4322 234699999999999653 67889999999999999999999996431 233334433322 12
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVEM 477 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~~ 477 (511)
.+...++. +.+++.+||+.||++|+ +++++++.
T Consensus 247 ~p~~~~~~-------~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNN-------CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHH-------HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 23333433 34566677799999995 78888754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=329.45 Aligned_cols=263 Identities=21% Similarity=0.283 Sum_probs=192.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec-----CeEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK-----KKRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 275 (511)
|.+.++||+|+||.||+|... +++.||+|+++... ....++.+|+.++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999954 68999999987432 2335688999999999999999999988543 35799
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+ +++|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 82 v~e~~-~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 82 VFELM-ESDLHQVIKA------NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEecC-CCCHHHHHHh------cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 99999 5789988843 24689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc-eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CCchHHH
Q 040808 356 QTEKKES-FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EYFPNAI 426 (511)
Q Consensus 356 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~ 426 (511)
....... ........||+.|+|||++.+....++.++|||||||++|||++|+.||........ ..-+...
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6533221 111233469999999999865334678899999999999999999999854321000 0000000
Q ss_pred HHHHhh--------hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 427 YKQIET--------EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 427 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...+.. ..........+.........+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 000000000001111123446778899999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=328.01 Aligned_cols=271 Identities=24% Similarity=0.383 Sum_probs=215.8
Q ss_pred CCHHHHHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCe
Q 040808 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKK 272 (511)
Q Consensus 195 ~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 272 (511)
-...|+.+..-.|.++||+|-||.|.++....+..||||+++.... ...+|.+|+++|.+++|||||.|+|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3445666667778999999999999999998889999999986433 23689999999999999999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++|+|||++|+|..|+..++.. .+.-....+|+.||+.|++||.+- ++|||||.+.|+|+|+++++||+|||
T Consensus 610 icmI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcc
Confidence 99999999999999999876532 245556677999999999999997 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh--CCCCCCCccCCCCCCchHHHHHHH
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI--GRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
+++.+-.++.+.....+.-...|||+|.+.- ++++.+||||+||+++||+++ ...|+.... .+.+.+..
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-------~e~vven~ 753 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-------DEQVVENA 753 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhh-------HHHHHHhh
Confidence 9998777766555445556789999999864 589999999999999999775 667764221 11122211
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.+-..-.-...+.....-...++.+++++||+.+.++|||++++...|++.
T Consensus 754 ~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 754 GEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111111112222334566788999999999999999999999988763
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=324.62 Aligned_cols=196 Identities=27% Similarity=0.380 Sum_probs=169.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.|.+.++||+|+||.||++..+ ++..+|+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 3456678999999999999965 688999999875422 2357899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++.. ...+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 86 DGGSLDQVLKE------AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred CCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999953 23588999999999999999999985 26999999999999999999999999998765432
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2 1234699999999999654 688999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.48 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=196.1
Q ss_pred hhhcccCCcCceEEEEEEcC-CCc----EEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGR----LVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.+.+.||+|+||+||+|... +++ .+++|.+..... ...++.+|+.+++++.||||+++++++. ....++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence 45678999999999999853 454 477787754322 2356788888999999999999999875 455789999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++.... ..+++..+..|+.||+.||+|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 89 ~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 89 LSPLGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred eCCCCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999996432 4689999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
............++..|+|||++.. +.++.++||||||+++|||++ |+.|+.... +..+.+.+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-------PHEVPDLLEKGERLA 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCCCcCC
Confidence 4332222233457789999999865 368899999999999999998 988885331 222233333322222
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.... ....+..++.+||+.+|++|||+.|++++|+....
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111 12345677889999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=314.44 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=203.5
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCC------CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPD------GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
+..+.+.+.||+|+||.||+|..++ +..||+|.+..... ...++.+|+.++++++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3445667899999999999998542 36899999875432 234788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSN----GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
++||||+++|+|.+++....... ....+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999996543211 123578999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 428 (511)
|||+++...............++..|+|||.+.. +..+.++||||||+++|||++ |+.|+.... .....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~~~~~~ 232 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-------NEEVLK 232 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCC-------HHHHHH
Confidence 9999986654332222223346889999999865 368899999999999999998 888875321 222333
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.+........+... ...+.+++.+||+.+|++|||+.++++.|+.
T Consensus 233 ~~~~~~~~~~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVIDGGHLDLPENC-------PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHhcCCCCCCCCCC-------CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 33322222222222 3467788899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.82 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=204.0
Q ss_pred HHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
..+.+.++||+|+||+||+|.+.+...||+|+++......+++.+|++++++++|+||+++++.+. ....++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 456788999999999999999777677999999875555678999999999999999999999774 4567899999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 85 GSLLDFLKGEM----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CcHHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 99999996432 24678999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ......++..|+|||+..+ +.++.++||||||+++|||++ |+.|+.... ...+...+........
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-------~~~~~~~~~~~~~~~~--- 224 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPC--- 224 (262)
T ss_pred c-cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------hHHHHHHHhcCCCCCC---
Confidence 1 1123346778999999854 368899999999999999999 777775321 2233333322221111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
..+....+.+++.+||+.+|++||++.++++.|+...
T Consensus 225 ----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 ----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1234456788999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.45 Aligned_cols=197 Identities=28% Similarity=0.423 Sum_probs=167.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||.|+||+||+|..+ +++.||+|+++... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 556788999999999999865 68999999987532 234578899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 87 -~~l~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 87 -SDLKQYLDNC-----GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred -cCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 5999988532 23578899999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
. ......||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred c--cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 11234689999999998653 3578899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=318.46 Aligned_cols=265 Identities=25% Similarity=0.405 Sum_probs=200.2
Q ss_pred HHhhhcccCCcCceEEEEEEcCC-----------------CcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeee
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD-----------------GRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFL 264 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~ 264 (511)
.+.+.++||+|+||.||++...+ +..||+|.+.... ...+++.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 45677899999999999987542 2458999987543 2346788999999999999999999
Q ss_pred ceEeecCeEEEEEEeCCCCCHHHHHhcccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESS-----NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 265 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
+++......+++|||+++++|.+++...... .....+++..++.++.|++.||+|||+. +++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 9999999999999999999999999654311 1123689999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh--CCCCCCCccCC
Q 040808 340 LDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI--GRKNADVKVSC 417 (511)
Q Consensus 340 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt--g~~p~~~~~~~ 417 (511)
++.++.++|+|||+++...............+++.|+|||++.+ +..+.++||||||+++|||++ |..|+....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 99999999999999986654432222234457789999999865 368899999999999999998 555654221
Q ss_pred CCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
...+.+...............+........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 239 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 -----DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -----hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1222222221100000000000011123467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=307.96 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=204.6
Q ss_pred CCCCHHHHHHHHHhhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceE
Q 040808 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFC 267 (511)
Q Consensus 193 ~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~ 267 (511)
....+..++ +.++||.|.-|+||++.+++ +..+|+|++.+.. ....+...|-+||+.++||.+++||+.|
T Consensus 72 ~~l~l~~f~-----llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFR-----LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHH-----HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 445555554 55789999999999999765 6899999998642 2335677899999999999999999999
Q ss_pred eecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 268 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
+.....+|+||||+||+|..+.+.+ ..+.+++..++.++.+++-||+|||-. |||+|||||+||||-++|++.
T Consensus 147 et~~~~cl~meyCpGGdL~~LrqkQ----p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQKQ----PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred eccceeEEEEecCCCccHHHHHhhC----CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEE
Confidence 9999999999999999999887543 357899999999999999999999997 999999999999999999999
Q ss_pred EeeccCccccCCCC---------------------------------c---------------e------eeecCCCCCC
Q 040808 348 ISDFGLAKQTEKKE---------------------------------S---------------F------ISMLDTRGTA 373 (511)
Q Consensus 348 l~DFGla~~~~~~~---------------------------------~---------------~------~~~~~~~gt~ 373 (511)
|+||.|+..+.... . . ......+||.
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 99999885432100 0 0 0112346999
Q ss_pred CccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHH
Q 040808 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKM 453 (511)
Q Consensus 374 ~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (511)
.|+|||++.+. ..+.++|+|+||+++|||+.|..||..... ...+.+.+.+...+.-...++...+++++++
T Consensus 300 EYlAPEvI~G~--GHgsAVDWWtfGIflYEmLyG~TPFKG~~~------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L 371 (459)
T KOG0610|consen 300 EYLAPEVIRGE--GHGSAVDWWTFGIFLYEMLYGTTPFKGSNN------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKL 371 (459)
T ss_pred ccccceeeecC--CCCchhhHHHHHHHHHHHHhCCCCcCCCCc------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence 99999999876 678899999999999999999999975432 2233334444444444445667788888887
Q ss_pred HHHHHhccccCCCCCCC----HHHHH
Q 040808 454 ILVSLWCIQTHPPDRPS----MTKVV 475 (511)
Q Consensus 454 ~~l~~~Cl~~~p~~RPs----~~evl 475 (511)
+ ..||++|.- +.||-
T Consensus 372 L-------vKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 372 L-------VKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred h-------ccChhhhhccccchHHhh
Confidence 7 999999997 55554
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.60 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=193.6
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
++||+|+||.||+|.+. +++.+|+|.+..... ....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999865 689999998864322 235789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 81 LTFLRTE-----GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 9998532 24588999999999999999999998 999999999999999999999999999876543211110
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCCh
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE 444 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (511)
.....++..|+|||.+.+ +..+.++||||||+++|||++ |..|+.... .......+........+.
T Consensus 153 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~---- 219 (252)
T cd05084 153 GGMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLS-------NQQTREAIEQGVRLPCPE---- 219 (252)
T ss_pred CCCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccC-------HHHHHHHHHcCCCCCCcc----
Confidence 011123467999999865 367889999999999999998 777775321 122222222222111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 445 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
.....+.+++.+||+.+|++|||+++|+++|+
T Consensus 220 ---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 ---LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22345777888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=319.30 Aligned_cols=197 Identities=29% Similarity=0.436 Sum_probs=167.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|..+ +++.||+|+++.... ....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~- 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV- 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC-
Confidence 456789999999999999965 689999999875432 2356789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
.++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 86 HTDLCQYMDKH-----PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CcCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 56888887543 24588899999999999999999998 99999999999999999999999999987543322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
. ......||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 12345689999999998653 3578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=307.22 Aligned_cols=245 Identities=25% Similarity=0.415 Sum_probs=194.8
Q ss_pred ccCCcCceEEEEEEc---CCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 210 KLGQGGYADVYKGTL---PDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+||+|+||.||+|.+ .++..+|+|+++..... .+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999964 35788999998754322 357899999999999999999999875 45678999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQK------NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999943 23688999999999999999999998 9999999999999999999999999999876544332
Q ss_pred e-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 364 I-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 364 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ......+++.|+|||.+.. +..+.++||||||+++|||++ |+.||.... ...+.+.+........+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~i~~~~~~~~~~~ 222 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK-------GNEVTQMIESGERMECPQR 222 (257)
T ss_pred eeecCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHCCCCCCCCCC
Confidence 1 1122345679999999854 367889999999999999998 898886321 2233334443332222222
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
. ...+.+++.+||+.||++||++++|+++|++
T Consensus 223 ~-------~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 C-------PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C-------CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2 3446678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=316.30 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=187.9
Q ss_pred HhhhcccCCcCceEEEEEEcC--CCcEEEEEEeccCCC---ChHHHHHHHHHHHcc---CCcceeeeeceEe-----ecC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP--DGRLVAVKVMKNLKD---NGEEFINEVASISRT---SHVNIVPFLGFCY-----EKK 271 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~ 271 (511)
|.+.++||+|+||+||+|... +++.||+|+++.... ....+.+|+.+++++ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 556788999999999999853 478899999874322 234567788777765 6999999999885 345
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 6899999995 69999985432 24589999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|+++....... .....||+.|+|||.+... .++.++||||||+++|||++|+.||..... .+. ...+.
T Consensus 155 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~------~~~-~~~i~ 222 (290)
T cd07862 155 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQ-LGKIL 222 (290)
T ss_pred cceEeccCCcc---cccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCH------HHH-HHHHH
Confidence 99987644321 2234689999999998653 678899999999999999999999864321 111 11111
Q ss_pred hhhccccC---------------CCCCh----HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 TEYDFQLD---------------GVVTE----EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 ~~~~~~~~---------------~~~~~----~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......+ ..... ...+....+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11000000 00000 00112234567889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=317.99 Aligned_cols=264 Identities=23% Similarity=0.377 Sum_probs=196.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-----------------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeee
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-----------------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFL 264 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~ 264 (511)
.+.+.++||+|+||.||++... ++..+|+|+++.... ...++.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3567789999999999998532 234699999875432 235789999999999999999999
Q ss_pred ceEeecCeEEEEEEeCCCCCHHHHHhcccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESS-----NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 265 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
+++.+.+..++||||+++++|.+++...... .....+++..+..++.|++.||+|||+. +++|+||||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEE
Confidence 9999999999999999999999999754321 1123588899999999999999999998 9999999999999
Q ss_pred EcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh--CCCCCCCccCC
Q 040808 340 LDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI--GRKNADVKVSC 417 (511)
Q Consensus 340 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt--g~~p~~~~~~~ 417 (511)
+++++.++|+|||+++...............+++.|+|||.... +.++.++||||||+++|||++ |..|+.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 99999999999999986644332211122335678999998754 468899999999999999998 5566642211
Q ss_pred CCCCchHHHHHHHhhhh-ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 418 SSEYFPNAIYKQIETEY-DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
............... ....+. .......+.+++.+||+.||++||++.+|++.|+.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 --EQVIENTGEFFRDQGRQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHHhhccccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000010111110000 000000 01123457789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.99 Aligned_cols=257 Identities=25% Similarity=0.435 Sum_probs=200.8
Q ss_pred HhhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.+.++||+|+||+||+|.. ..+..+|+|.++..... ..++.+|++++++++||||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 45678999999999999974 24678999998753322 257889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCce
Q 040808 278 EFMPNGSLDQYIYDHES-----------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~ 346 (511)
||+++++|.+++..... ......+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 99999999999854321 01124588999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHH
Q 040808 347 KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNA 425 (511)
Q Consensus 347 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 425 (511)
||+|||+++...............++..|+|||++.+ +.++.++||||||+++|||++ |..|+.... +..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-------~~~ 234 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-------NQE 234 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-------HHH
Confidence 9999999987644332222233346778999999865 368899999999999999998 887874321 223
Q ss_pred HHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
+.+.+........... ...++.+++.+||+.||++||++.+|+++|..
T Consensus 235 ~~~~~~~~~~~~~~~~-------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLPCSED-------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCCCCCC-------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 3333332222222222 23456778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.81 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=203.1
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccC-CcceeeeeceEeecCe
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTS-HVNIVPFLGFCYEKKK 272 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 272 (511)
+..+.+.++||+|+||.||+|++. .++.||+|+++..... .+.+.+|+.++.++. ||||++++++|.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 334456789999999999999853 3468999999854322 357889999999998 9999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCC---------------------------------------------------------
Q 040808 273 RALIYEFMPNGSLDQYIYDHESS--------------------------------------------------------- 295 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 295 (511)
.++||||+++|+|.++++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999999999999653210
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE
Q 040808 296 -----------------------------------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340 (511)
Q Consensus 296 -----------------------------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll 340 (511)
.....+++..+..++.|++.||+|||+. +++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 1123578888999999999999999997 99999999999999
Q ss_pred cCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCC
Q 040808 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSS 419 (511)
Q Consensus 341 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 419 (511)
++++.+||+|||+++...............+++.|+|||.+... .++.++||||||+++|||++ |+.|+....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~---- 346 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELP---- 346 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC----
Confidence 99999999999999865433222222234578899999998653 67889999999999999998 888875321
Q ss_pred CCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
..+...+.+........+.. ....+.+++.+||+.+|++||++++|++.|+..+
T Consensus 347 --~~~~~~~~~~~~~~~~~p~~-------~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 347 --MNEQFYNAIKRGYRMAKPAH-------ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --chHHHHHHHHcCCCCCCCCC-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 12222232333222222212 2345677888999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=314.62 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=204.1
Q ss_pred HhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC-hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN-GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.+.+.||+|+||.||+|... ++..+++|.++..... .+.+.+|++++++++|+||+++++++.+....++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 345678999999999999742 3556999988754332 357889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 278 EFMPNGSLDQYIYDHES----------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
||+++++|.+++..... ......+++..++.++.||+.||+|||++ +++||||||+|||++.++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999965431 11234589999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAI 426 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 426 (511)
|+|||+++...............++..|+|||++... .++.++||||||+++|||++ |+.|+.... ....
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~~~~ 234 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTEV 234 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence 9999999866443322222234567899999998653 67889999999999999998 888875321 1222
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.+.+.......... .....+.+++.+||+.+|++|||+++|+++|+.+.+
T Consensus 235 ~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVLERPR-------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCCCCCc-------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 22232222111111 123457788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.12 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=192.4
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||.||++..+ +++.||+|++++.. ...+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999865 68999999997532 2234578899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQR------QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 999988843 24689999999999999999999998 999999999999999999999999999875322211
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC--CCCchHHHHHHHhhhhccccCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS--SEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||+...... .....+++.+.+... ...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~ 226 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-QIRIPR 226 (329)
T ss_pred --ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC-CCCCCC
Confidence 12234699999999999653 67889999999999999999999996432211 112333444433322 223333
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCC------HHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPS------MTKVV 475 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs------~~evl 475 (511)
.++. .+.+++.+||+.||++||+ +++++
T Consensus 227 ~~~~-------~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 227 SLSV-------KASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCH-------HHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 3333 3455667788999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=314.29 Aligned_cols=260 Identities=18% Similarity=0.244 Sum_probs=194.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||+|+||+||++..+ +++.||+|+++... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456788999999999999975 58899999987542 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 83 EKNMLELLEEM------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 98877655421 24689999999999999999999998 9999999999999999999999999999876433
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CCchHHHHHHHhh
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EYFPNAIYKQIET 432 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 432 (511)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+....+....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccc-cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 221 11234589999999998653 678999999999999999999999864321000 0000000000000
Q ss_pred hhc---cccCC--CCChH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYD---FQLDG--VVTEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~---~~~~~--~~~~~----~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ..... ..... .......+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000 00000 0113345778899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.65 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=205.4
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCC-----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEee-cCeE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPD-----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYE-KKKR 273 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 273 (511)
+..+.+.+.||+|+||.||+|.+.+ +..|++|++..... ..+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4455677899999999999999655 68899999875432 24578899999999999999999998766 5678
Q ss_pred EEEEEeCCCCCHHHHHhcccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 274 ALIYEFMPNGSLDQYIYDHESS--NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
++++||+++++|.+++...... .....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999654211 1125689999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHH
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
|+++...............++..|+|||++... .++.++||||||+++||+++ |+.|+.... +..+...+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~ 232 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEID-------PFEMAAYL 232 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCC-------HHHHHHHH
Confidence 999876443322222233467789999998653 67899999999999999999 998885321 12222333
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.......... .....+.+++.+||+.+|++|||+.+|+++|+...+
T Consensus 233 ~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYRLAQPI-------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCCCCCCC-------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3322211111 123457788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.25 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=201.0
Q ss_pred HHHHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCCC--hHHHHHHHHHHHcc-CCcceeeeeceEeec-C
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKDN--GEEFINEVASISRT-SHVNIVPFLGFCYEK-K 271 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 271 (511)
...+.+.+.||+|+||+||+|.+ .+++.||||+++..... ...+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34567889999999999999973 24788999999754322 35688999999999 689999999988654 5
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCC-------------------------------------------------------
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSN------------------------------------------------------- 296 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------- 296 (511)
..++||||+++|+|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999996432100
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCC
Q 040808 297 ------GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR 370 (511)
Q Consensus 297 ------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 370 (511)
....+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 013478889999999999999999998 99999999999999999999999999998764333222222334
Q ss_pred CCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHH
Q 040808 371 GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEM 449 (511)
Q Consensus 371 gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (511)
+++.|+|||.+.+. .++.++||||||+++|+|++ |..|+.... ........+........+...
T Consensus 243 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~------- 307 (343)
T cd05103 243 LPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFCRRLKEGTRMRAPDYT------- 307 (343)
T ss_pred CCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcc------ccHHHHHHHhccCCCCCCCCC-------
Confidence 67789999998653 67899999999999999997 888875321 111222222222222222111
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 450 AKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 450 ~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+.+++.+||+.+|++|||+.+|++.|+.+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2357788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=322.56 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=190.6
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.||+|+||.||++..+ +|+.||+|+++.. .....++.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 6899999999753 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
+|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 81 ELFFHLSR------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 151 (325)
T ss_pred cHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence 99988843 2468999999999999999999997 5 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .....+.+.. ....++...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~-------~~~~~~~i~~-~~~~~p~~~ 219 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILM-EEIRFPRTL 219 (325)
T ss_pred --ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCC-------HHHHHHHHhc-CCCCCCCCC
Confidence 11234699999999998653 67899999999999999999999985331 1122222211 112223333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
++ .+.+++.+||+.||++|+ ++.++++
T Consensus 220 ~~-------~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 SP-------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CH-------HHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 33 345666778899999997 8998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=306.67 Aligned_cols=250 Identities=24% Similarity=0.478 Sum_probs=201.5
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+++.++||+|+||.||++.+.+++.+|+|.++.......+|.+|++++++++|||++++++++......++||||+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 35678899999999999998778899999988766666789999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++.... ..+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++....... .
T Consensus 86 L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 156 (256)
T cd05112 86 LSDYLRAQR-----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T 156 (256)
T ss_pred HHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence 999985422 4588999999999999999999998 999999999999999999999999999876543321 1
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......++.+|+|||.+.+ +.++.++||||||+++|||++ |+.|+.... .....+.+........+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-------NSEVVETINAGFRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHhCCCCCCCCCC--
Confidence 1122335678999999865 368889999999999999998 888875321 2223333333222211111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
....+.+++.+||+.+|++|||+.+|+++|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1245778899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.92 Aligned_cols=242 Identities=22% Similarity=0.329 Sum_probs=188.4
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||++..+ +++.||+|++++.. ...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 68899999997532 2234577888888776 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~------~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQR------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 999988843 24689999999999999999999998 999999999999999999999999999875432211
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC--CCCchHHHHHHHhhhhccccCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS--SEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ......++.+.+... ...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p~ 226 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIPR 226 (329)
T ss_pred --ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-CCCCCC
Confidence 11234699999999999654 67889999999999999999999996322111 112233344433222 222333
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
..+. .+..++.+||+.||++||+.
T Consensus 227 ~~~~-------~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSV-------KAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCH-------HHHHHHHHHhcCCHHHcCCC
Confidence 3333 35567778889999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=306.35 Aligned_cols=262 Identities=25% Similarity=0.324 Sum_probs=197.5
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcc-eeeeeceEeecC------e
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVN-IVPFLGFCYEKK------K 272 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 272 (511)
.+...++||+|+||+||+|+.+ +|+.||+|.++-... .....++|+.++++++|+| ||++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3445678999999999999954 789999999986544 3356789999999999999 999999998877 8
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++||||+ .-+|.+++....... ..++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 99999999 679999996644211 4577789999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
+|+...-... ..+..++|..|+|||++.+. ..++...||||+|||+.||++++.-|....+. ..-..+.+.+-.
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGt 239 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGT 239 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCC
Confidence 9996653222 23455799999999999876 36899999999999999999998877543210 000001110000
Q ss_pred h-----------hcc--ccC-----CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 433 E-----------YDF--QLD-----GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 433 ~-----------~~~--~~~-----~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
. .+. ... .............-.+++.+||+.+|.+|.|++.++++
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 000 000 00111111111245677788889999999999999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.36 Aligned_cols=253 Identities=24% Similarity=0.272 Sum_probs=197.5
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecC--------
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKK-------- 271 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 271 (511)
.|.+.++||+|+||+||+|+. .+|+.||||++..... ....+.+|+.++..++|+|++++++.+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 456778999999999999985 4789999999875432 2356788999999999999999988765332
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~--~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRA--KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence 3679999999999999996543 2235789999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|+++...............||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+...+.
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~~~~ 258 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMHKTL 258 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHh
Confidence 999876433222222345699999999999653 68899999999999999999999986331 122222222
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
......++... ...+..++.+||+.||++||++.++++.
T Consensus 259 ~~~~~~~~~~~-------~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRYDPLPPSI-------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCCCCCCCCC-------CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22111222222 3456677888999999999999999863
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=322.87 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=188.6
Q ss_pred hhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 207 FSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.++||+|+||+||+|.+. +++.||||++...... .+.+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4578999999999999855 6899999998654322 357889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 158 ~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 158 SLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred cccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 986432 356677889999999999999998 999999999999999999999999999987643221
Q ss_pred eeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
......||..|+|||++... ....+.++|||||||++|||++|+.||..... ..+.. ....+..........
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~---~~~~~-~~~~~~~~~~~~~~~ 298 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ---GDWAS-LMCAICMSQPPEAPA 298 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---ccHHH-HHHHHhccCCCCCCC
Confidence 12234699999999998432 12345689999999999999999999863211 11111 111111111111111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 299 -------~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 299 -------TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223456778888999999999999999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.39 Aligned_cols=240 Identities=25% Similarity=0.336 Sum_probs=190.1
Q ss_pred cccCCcCceEEEEEEc----CCCcEEEEEEeccCC-----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTL----PDGRLVAVKVMKNLK-----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
++||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++.+.+.+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 357899999997531 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.. ...+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLER------EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 999999999853 24578888999999999999999998 999999999999999999999999999875432
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... .....||+.|+|||++.+. ..+.++||||||+++|||++|+.||.... .......+... ...++
T Consensus 153 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~~~~-~~~~~ 220 (323)
T cd05584 153 EGTV--THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKILKG-KLNLP 220 (323)
T ss_pred CCCc--ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcC-CCCCC
Confidence 2211 1234699999999999654 67889999999999999999999986432 11222222221 12222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
...++ .+.+++.+||+.+|++|| +++++++
T Consensus 221 ~~~~~-------~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTP-------EARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCH-------HHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 33333 455677788899999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.93 Aligned_cols=265 Identities=22% Similarity=0.424 Sum_probs=205.8
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcC--------CCcEEEEEEeccCC--CChHHHHHHHHHHHcc-CCcceeeeeceEe
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLP--------DGRLVAVKVMKNLK--DNGEEFINEVASISRT-SHVNIVPFLGFCY 268 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 268 (511)
+....+.+.+.||+|+||.||+|... ++..||+|.++... ...+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44455667889999999999999631 24579999987542 2346788999999999 7999999999999
Q ss_pred ecCeEEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCE
Q 040808 269 EKKKRALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNI 338 (511)
Q Consensus 269 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NI 338 (511)
.....++||||+++|+|.+++...... .....+++..+..++.||+.||+|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999999764321 1124688999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCC
Q 040808 339 RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSC 417 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~ 417 (511)
++++++.+||+|||+++...............+++.|+|||++.+. .++.++||||||+++|+|++ |..|+...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~--- 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGI--- 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccC---
Confidence 9999999999999999877544332222334467889999998653 67899999999999999998 67776422
Q ss_pred CCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
-...+.+.+.......... .....+..++.+||+.+|++|||+.+|++.|++++.
T Consensus 244 ----~~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 ----PVEELFKLLKEGHRMDKPA-------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----CHHHHHHHHHcCCcCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1223333333322211111 223456778889999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=309.21 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=202.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++||+|+||.||+|+.. +++.||+|.++... ....++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456678999999999999854 68999999876422 2234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... .....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 84 ADAGDLSQMIKYFK--KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCcHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999885432 1234688999999999999999999998 999999999999999999999999999887654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... ......|++.|+|||.+.+. ..+.++||||||+++|||++|+.|+..... . ...+...+..... .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~-~~~~~~~~~~~~~---~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKM----N-LFSLCQKIEQCDY---P 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccc----c-HHHHHHHHhcCCC---C
Confidence 322 11234588999999998653 678899999999999999999999853211 1 1112222222111 1
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.. ........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 1123345677888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=309.63 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=190.0
Q ss_pred cccCCcCceEEEEEEcCC---CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLPD---GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.||+|+||.||+|...+ +..+|+|.++..... ...+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998543 457999988754432 247889999999999999999999999989999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++..... ......++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRK-AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999965432 1224567788889999999999999998 9999999999999999999999999999765433322
Q ss_pred eeecCCCCCCCccchhhccccc-----CCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHF-----GGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
.......+++.|+|||++.... ..++.++||||||+++|||++ |+.||..... ..............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-------EQVLTYTVREQQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-------HHHHHHHhhcccCC
Confidence 2222345788999999985421 135789999999999999996 9988853321 11111111111111
Q ss_pred c-CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 438 L-DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 438 ~-~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
. ..... ......+..++..|| .+|++|||+++|+..|+
T Consensus 230 ~~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 11111 011223455677888 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.23 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=197.6
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCc----EEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGR----LVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.+.++||+|+||+||+|.. .+++ .||+|+++.... ..+++.+|+.++..++|+||+++++++... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence 34568899999999999984 3444 489999875322 245788999999999999999999998754 578999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++..
T Consensus 88 ~~~~~g~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 88 QLMPYGCLLDYVREN-----KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EcCCCCCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999998542 24689999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.............+++.|+|||.+.+ +.++.++||||||+++|||++ |..|++... ...+...+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~ 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-------AREIPDLLEKGERL 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCCCcC
Confidence 54433222223346778999999865 368899999999999999998 888875321 22222223322222
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
.... .....+.+++.+||+.||++||++.++++.|+...
T Consensus 231 ~~~~-------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 231 PQPP-------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111 12345677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.39 Aligned_cols=195 Identities=24% Similarity=0.316 Sum_probs=167.8
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCCh---HHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEEeCC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYEFMP 281 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 281 (511)
.++|++|+||.||+|+++ +++.||+|.++..+... -..++|+.+|.+++|||||.+-.+... -+..|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 468999999999999965 68999999998654221 246899999999999999999887753 457999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
. +|...+.... .++....+.-+..|+++|++|||.. .|+||||||+|+|+++.|.+||+|||+|+.+....
T Consensus 161 h-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 161 H-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred h-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 5 8988886543 5788889999999999999999998 99999999999999999999999999999887653
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
..++..+.|..|+|||.+.+. ..++...|+||+|||+.||+++++.|...
T Consensus 232 --k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 232 --KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred --ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 345566789999999999886 47899999999999999999999877543
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=312.85 Aligned_cols=257 Identities=23% Similarity=0.415 Sum_probs=199.4
Q ss_pred HhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
+.+.++||+|+||.||++..+ ++..||+|+++.... ...++.+|+.++++++||||+++++++.++...++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 456678999999999999853 467899999875432 235788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccC----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE
Q 040808 277 YEFMPNGSLDQYIYDHES----------------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~----------------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll 340 (511)
|||+++|+|.+++..... ......+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 999999999999964321 01124588999999999999999999998 99999999999999
Q ss_pred cCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCC
Q 040808 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSS 419 (511)
Q Consensus 341 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 419 (511)
++++.+||+|||+++................+..|+|||.+.+ ..++.++||||||+++|||++ |..|+....
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---- 237 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---- 237 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence 9999999999999876543322111122335678999999865 368899999999999999997 777764221
Q ss_pred CCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
...+...+.......... .....+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 238 ---~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 ---HEEVIYYVRDGNVLSCPD-------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHHHHHhcCCCCCCCC-------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122222232222111111 233567788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=306.00 Aligned_cols=252 Identities=27% Similarity=0.459 Sum_probs=200.7
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+.+.++||+|++|.||++.++++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 45677899999999999999877778999998765555678999999999999999999998875 45688999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++.......
T Consensus 86 ~L~~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 86 SLLDFLKEGD----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 9999996432 24588999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.......++..|+|||...+ +..+.++||||||+++|||++ |+.|+.... .......+.........
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~--- 225 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMV-------NREVLEQVERGYRMPCP--- 225 (260)
T ss_pred cccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCC---
Confidence 11123346788999999854 368899999999999999999 888875321 22222333222111111
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
......+.+++.+||+.+|++||++++|++.|+.
T Consensus 226 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 ----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1234557778889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=320.30 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=205.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCe-EEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKK-RALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e 278 (511)
.|.+.+++|+|+||.+++.+++ ++..+++|.+.-.+ ...+...+|+.++++++|||||...+.|.+++. .++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3556788999999999999865 57899999887433 233467899999999999999999999998887 999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|++||+|.+.|.... ...++++.+..++.|++.|+.|||++ .|+|||||+.||+++.++.|||+|||+|+...
T Consensus 85 Y~eGg~l~~~i~~~k----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred ecCCCCHHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999997654 46799999999999999999999987 99999999999999999999999999999998
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
...... ....||+-|+.||.+.+. .+..|+|||||||++|||.+-+++|.... ....+.+.... .-..+
T Consensus 158 ~~~~~a--~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~-~~~Pl 226 (426)
T KOG0589|consen 158 PEDSLA--STVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRG-LYSPL 226 (426)
T ss_pred Cchhhh--heecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhc-cCCCC
Confidence 776333 245799999999999775 88999999999999999999999997542 23333333332 23344
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
+...+.+.+.+ +..|++.+|+.||++.+++.+
T Consensus 227 p~~ys~el~~l-------v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSL-------VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHH-------HHHHhhcCCccCCCHHHHhhC
Confidence 44445444444 445559999999999999865
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=309.07 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=188.9
Q ss_pred cccCCcCceEEEEEEcCC---CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLPD---GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
++||+|+||.||+|...+ ...+|+|.+...... ...+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997433 356888877643322 346889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++..... ......++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 81 DLKNYLRSNRG-MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred cHHHHHHhccc-cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999976432 1123457888899999999999999998 9999999999999999999999999998765433222
Q ss_pred eeecCCCCCCCccchhhcccc-----cCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 364 ISMLDTRGTAGYIAPEVFCRH-----FGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
.......+++.|+|||++... ....+.++||||||+++|||++ |+.|+.... ...............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~~~~~~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-------DEQVLKQVVREQDIK 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-------HHHHHHHHhhccCcc
Confidence 222334467889999997431 1246789999999999999999 677764321 111222211111111
Q ss_pred c-CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 438 L-DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 438 ~-~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
+ ..... ......+.+++..|| .||++|||+++|++.|.
T Consensus 230 ~~~~~~~---~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLD---LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccc---ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 11111 123344455667787 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.00 Aligned_cols=240 Identities=20% Similarity=0.299 Sum_probs=190.0
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++||+|+||.||+|..+ +++.||+|+++.. ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 5889999999753 22345678899998865 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQR------SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 999998853 24688999999999999999999998 999999999999999999999999999875432222
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.... .....+.+.... ...+...
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~-------~~~~~~~i~~~~-~~~p~~~ 219 (321)
T cd05591 152 T--TTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADN-------EDDLFESILHDD-VLYPVWL 219 (321)
T ss_pred c--ccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCC-CCCCCCC
Confidence 1 2234699999999998653 67899999999999999999999996432 222233332211 1222223
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCC-------CHHHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRP-------SMTKVVE 476 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RP-------s~~evl~ 476 (511)
+. .+.+++.+||+.||++|| +++++++
T Consensus 220 ~~-------~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 SK-------EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CH-------HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 33 355666778899999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=310.32 Aligned_cols=257 Identities=22% Similarity=0.389 Sum_probs=199.2
Q ss_pred HhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.+.++||+|+||.||++... ++..+|+|.+..... ..+.+.+|++++++++|+||+++++++.+....+++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 346789999999999999632 356899998875433 2467999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEE
Q 040808 278 EFMPNGSLDQYIYDHES---------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl 348 (511)
||+++++|.+++..... ......+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 99999999999965431 01124589999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHH
Q 040808 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 349 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 427 (511)
+|||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.|+.... .....
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~ 234 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLS-------NTEAI 234 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCC-------HHHHH
Confidence 999999765433322212223457889999998653 68899999999999999998 888874321 11122
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
..+........... ....+.+++.+||+.||++||++++|++.|+.
T Consensus 235 ~~~~~~~~~~~~~~-------~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELERPRT-------CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCCCCCC-------CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 22222221111111 23446778899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=314.80 Aligned_cols=264 Identities=23% Similarity=0.426 Sum_probs=203.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcC--------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP--------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKK 271 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 271 (511)
..+.+.++||+|+||.||++... ....+|+|.++.... ...++.+|+.+++++ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 34557789999999999999742 245799999875433 235788999999999 5999999999999989
Q ss_pred eEEEEEEeCCCCCHHHHHhcccC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 272 KRALIYEFMPNGSLDQYIYDHES----------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
..+++|||+++|+|.+++..... ......+++..+..++.|++.||+|||+. +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999965431 01224689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCC
Q 040808 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSE 420 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~ 420 (511)
+++.+||+|||+++...............++..|+|||.+.+ +.++.++||||||+++|||++ |+.|+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~------ 240 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGI------ 240 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCC------
Confidence 999999999999987654322211122235568999999865 368899999999999999999 78777432
Q ss_pred CchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
-...+.+.+........... ...++.+++.+||+.+|++|||+.++++.|++....+
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 241 -PVEELFKLLREGHRMDKPSN-------CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -CHHHHHHHHHcCCCCCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 12333333333222211111 2235667888999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=304.41 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=195.5
Q ss_pred cccCCcCceEEEEEEcC--C--CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP--D--GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++||+|+||.||+|... + +..+|+|.+..... ..+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999743 2 26899999986544 4467899999999999999999999875 4568999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++... ..+++..+..++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKR------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999532 3689999999999999999999998 999999999999999999999999999987654432
Q ss_pred ee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 363 FI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 363 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. ......++..|+|||.+.. +.++.++||||||+++|||++ |+.|+.... ...+.+.+..........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 221 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-------GAEVIAMLESGERLPRPE 221 (257)
T ss_pred ccccccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCC-------HHHHHHHHHcCCcCCCCC
Confidence 21 1122234578999999855 368899999999999999998 898885331 122233333322222121
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
. ....+.+++.+||+.+|++||++.+|++.|++.
T Consensus 222 ~-------~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 E-------CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred C-------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 2 234577888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=304.79 Aligned_cols=252 Identities=30% Similarity=0.518 Sum_probs=203.0
Q ss_pred cccCCcCceEEEEEEcCC----CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||.||+|.... +..||+|+++..... .+++.+|++.+.+++|+|++++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 788999999865443 57889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 283 GSLDQYIYDHESS---NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 283 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++|.+++...... .....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999653110 0125789999999999999999999998 999999999999999999999999999988765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
...........+++.|+|||.+... ..+.++||||+|+++|||++ |+.|+... -...+.+.+........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~ 228 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGL-------SNEEVLEYLRKGYRLPK 228 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHHHHcCCCCCC
Confidence 4432223345688999999998654 68899999999999999999 58887643 12233333333222222
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
... ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ~~~-------~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 PEY-------CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred Ccc-------CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 222 2345777888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=316.12 Aligned_cols=263 Identities=24% Similarity=0.424 Sum_probs=203.4
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC--------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeec
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP--------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEK 270 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 270 (511)
...+.+.++||+|+||.||++... +...+|+|.++.... ...++.+|++++.++ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 345677889999999999999742 235799999985432 235788899999999 799999999999999
Q ss_pred CeEEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE
Q 040808 271 KKRALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll 340 (511)
+..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 9999999999999999999754311 1124689999999999999999999998 99999999999999
Q ss_pred cCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCC
Q 040808 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSS 419 (511)
Q Consensus 341 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 419 (511)
++++.+||+|||+++...............+++.|+|||.+.+. .++.++||||||+++|||++ |+.|+....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~---- 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----
Confidence 99999999999998866433221112223356789999998653 67899999999999999998 777774321
Q ss_pred CCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+.+.+.......... .....+.+++.+||+.+|++|||+.+|++.|+.++.
T Consensus 248 ---~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 248 ---VEELFKLLKEGHRMDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred ---HHHHHHHHHcCCCCCCCC-------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 222333333322111111 223456678889999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.48 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=198.5
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccC-----CCCh----HHHHHHHHHHHccC-CcceeeeeceEeecCeEEEE
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL-----KDNG----EEFINEVASISRTS-HVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 276 (511)
++.||.|..++|-++.++ +|...|+|++... ..+. +.-+.|+.||+++. ||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 457999999999998865 6888999998632 2222 34567999999986 99999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+|.|+.|.|.|+|. ..-.+++....+|+.|+.+|++|||.. +|+||||||+|||+|++.++||+|||++..
T Consensus 102 Fdl~prGELFDyLt------s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT------SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhcccchHHHHhh------hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999994 346799999999999999999999998 999999999999999999999999999999
Q ss_pred cCCCCceeeecCCCCCCCccchhhccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCR----HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
++.++.. ...+|||+|+|||.+.. +..+++...|+||+|||||.|+.|-+||... ..-..+..+.+
T Consensus 173 l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlMLR~Ime 242 (411)
T KOG0599|consen 173 LEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLMLRMIME 242 (411)
T ss_pred cCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHHHHHHh
Confidence 9887753 45679999999999843 2236788999999999999999999998411 11122333333
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+. +. -.+++..+.....-+++.+||+.||.+|.|++|++.
T Consensus 243 Gk-yq---F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 243 GK-YQ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cc-cc---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 32 21 123444455555566777888999999999999974
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=305.38 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=206.2
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+..+.+.++||+|+||+||+|.+++++.||+|.+.......+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 34456778999999999999998888899999998766667889999999999999999999999998889999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 85 ~~~L~~~i~~~~----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 85 KGSLLDFLKSGE----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred CCCHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999996432 24689999999999999999999998 99999999999999999999999999998765322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. .......++..|+|||.+.+. ..+.++||||||+++|+|++ |+.|+.... .....+.+........+.
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQVERGYRMPRPP 227 (261)
T ss_pred h-hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC
Confidence 1 111223356789999998653 67889999999999999998 888874321 223333333322221111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
. ....+.+++.+||+.+|++||+++++++.|+.
T Consensus 228 ~-------~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 N-------CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred C-------CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1 13457788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.09 Aligned_cols=250 Identities=23% Similarity=0.296 Sum_probs=193.3
Q ss_pred HhhhcccCCcCceEEEEEEc----CCCcEEEEEEeccCC-----CChHHHHHHHHHHHccC-CcceeeeeceEeecCeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL----PDGRLVAVKVMKNLK-----DNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 274 (511)
|.+.++||+|+||+||+++. .+++.||+|++++.. ...+.+.+|+.++.+++ |+||+++++++.+.+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 45678999999999999874 258899999987431 22356788999999995 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 82 lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999999542 4688999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+........ ......||+.|+|||++.+. ...+.++|||||||++|||++|+.||...... .....+...+.. .
T Consensus 153 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~-~ 226 (332)
T cd05614 153 KEFLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGER---NTQSEVSRRILK-C 226 (332)
T ss_pred ccccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCC---CCHHHHHHHHhc-C
Confidence 865433221 11234699999999998653 24678999999999999999999998643211 112222222221 1
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
...++...+. .+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~~~~~~~-------~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 DPPFPSFIGP-------EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCCH-------HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1122222333 345667788899999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.69 Aligned_cols=198 Identities=25% Similarity=0.347 Sum_probs=166.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||++... +++.||||++.+.. ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 345688999999999999854 68999999986432 2235678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~gg~L~~~l~~------~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 83 LPGGDLMTMLIK------YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred CCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999953 24688999999999999999999998 999999999999999999999999999864321
Q ss_pred CCce------------e---------------------------------eecCCCCCCCccchhhcccccCCCCccccc
Q 040808 360 KESF------------I---------------------------------SMLDTRGTAGYIAPEVFCRHFGGVSHKSDV 394 (511)
Q Consensus 360 ~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDv 394 (511)
.... . ......||+.|+|||++.+. .++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di 231 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceee
Confidence 1000 0 00123599999999999654 68899999
Q ss_pred hhHHHHHHHHHhCCCCCCC
Q 040808 395 YSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 395 wSlG~il~elltg~~p~~~ 413 (511)
|||||++|||++|+.||..
T Consensus 232 wSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred EecchhhhhhhcCCCCCCC
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=309.13 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=197.8
Q ss_pred HhhhcccCCcCceEEEEEEcCC------CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD------GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
+.+.+.||+|+||.||+|.+.+ +..||+|.+...... ...|.+|+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 3456789999999999998643 567999988754322 35689999999999999999999999998899999
Q ss_pred EEeCCCCCHHHHHhcccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC---ceEEeecc
Q 040808 277 YEFMPNGSLDQYIYDHESS-NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF---CPKISDFG 352 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFG 352 (511)
|||+++++|.+++...... .....+++..+..++.||+.||+|||+. +++|+||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence 9999999999999654321 1224689999999999999999999998 999999999999998754 69999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
+++................+..|+|||++.+ +.++.++|||||||++|||++ |+.||.... ...+.+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~-------~~~~~~~~~ 235 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-------NQEVMEFVT 235 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHH
Confidence 9987643322211122234568999999865 368999999999999999997 888875321 112222222
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
.......+.. ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 236 ~~~~~~~~~~-------~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRLDPPKG-------CPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcCCCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2221111111 2345777889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=314.74 Aligned_cols=239 Identities=23% Similarity=0.327 Sum_probs=186.8
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHc-cCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||+|..+ +++.||+|+++... ...+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 58899999997532 233456667777764 4799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQS------SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 999998853 24688999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+... ....+...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~-~~~~~~~~ 219 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGED-------EDELFDSILND-RPHFPRWI 219 (316)
T ss_pred --ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcC-CCCCCCCC
Confidence 12234699999999999654 67899999999999999999999986432 22233333221 11222223
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMT-KVV 475 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~-evl 475 (511)
+. .+.+++.+||+.||++||++. +++
T Consensus 220 ~~-------~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 SK-------EAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CH-------HHHHHHHHHccCCHHHcCCChHHHH
Confidence 33 345667788899999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=317.03 Aligned_cols=268 Identities=23% Similarity=0.429 Sum_probs=206.8
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEcC--------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceE
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTLP--------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFC 267 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~ 267 (511)
++.+.++.+.++||+|+||.||++... .+..||+|+++.... ..+++.+|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 444556778899999999999999732 123699998875432 246789999999999 799999999999
Q ss_pred eecCeEEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 040808 268 YEKKKRALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337 (511)
Q Consensus 268 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~N 337 (511)
.+.+..+++|||+++|+|.+++...... .....+++..+..++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 9999999999999999999999653210 1234688999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccC
Q 040808 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVS 416 (511)
Q Consensus 338 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~ 416 (511)
||+++++.+||+|||+++...............++..|+|||++.+. .++.++||||||+++|||++ |+.|+....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~- 241 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP- 241 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCC-
Confidence 99999999999999999876543322222233456789999998653 67889999999999999998 777774321
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
.....+.+.......... .....+.+++.+||+.+|++||++.++++.|+.+....
T Consensus 242 ------~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 242 ------VEELFKLLKEGHRMDKPA-------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ------HHHHHHHHHcCCCCCCCC-------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 222333332222211111 12345778889999999999999999999999876433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.66 Aligned_cols=261 Identities=24% Similarity=0.394 Sum_probs=199.1
Q ss_pred HHhhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeec--CeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 274 (511)
++.+.++||+|+||.||++.. .++..||+|.++.... ..+++.+|++++++++|+|++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 456678899999999999973 2578899999875432 235789999999999999999999998765 5688
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 85 lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN-----KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEccCCCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 999999999999998432 23589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC--------CCCCchHH
Q 040808 355 KQTEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC--------SSEYFPNA 425 (511)
Q Consensus 355 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~--------~~~~~~~~ 425 (511)
+.......... .....++..|+|||++.+. .++.++||||||+++|||++++.|....... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 87654332211 1234467789999998653 6788999999999999999987654321100 00111111
Q ss_pred HHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
....+.......... .....+.+++.+||+.+|++|||++++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPRPP-------NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 112222221111111 1334678889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=317.39 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=189.7
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||++... +++.||+|++++.. ...+.+.+|+.++.++ +||||+.+++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999854 68899999998542 2234678899999888 599999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQR------QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 999988843 24689999999999999999999998 999999999999999999999999999875322211
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||............+.+.+.+... ....+...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~ 226 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFL 226 (327)
T ss_pred --ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCC
Confidence 11245699999999999653 67899999999999999999999996443222222333444433322 22233333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
+.. +.+++.+||+.||++|+++
T Consensus 227 ~~~-------~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 227 SVK-------ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CHH-------HHHHHHHHhccCHHHcCCC
Confidence 433 4456666779999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.57 Aligned_cols=235 Identities=23% Similarity=0.321 Sum_probs=187.1
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||+|+.+ +++.||+|++++. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 5889999998753 23345678898888876 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~------~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQK------SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 999998853 24688999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+.+.+.... ...+...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~-~~~~~~~ 219 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILNDE-VVYPTWL 219 (320)
T ss_pred --cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhcCC-CCCCCCC
Confidence 12234699999999998653 67889999999999999999999996432 222333332221 1222223
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
+. .+.+++.+||+.||++||++
T Consensus 220 ~~-------~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 SQ-------DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CH-------HHHHHHHHHcccCHHHCCCC
Confidence 33 34566677889999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=324.91 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=196.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|... +++.||+|+++... .....+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456788999999999999965 68999999997532 3346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 83 MPGGDLMNLLIRK------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999542 4689999999999999999999998 999999999999999999999999999986654
Q ss_pred CC---------------------------ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 360 KE---------------------------SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 360 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
.. .........||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCC
Confidence 32 00112234699999999999764 78899999999999999999999986
Q ss_pred CccCCCCCCchHHHHHHHhhh-hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 040808 413 VKVSCSSEYFPNAIYKQIETE-YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-MTKVVEM 477 (511)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-~~evl~~ 477 (511)
... .......+... .....+... .....+.+++.+|++ +|.+||+ ++++++.
T Consensus 232 ~~~-------~~~~~~~i~~~~~~~~~p~~~-----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDT-------LQETYNKIINWKESLRFPPDP-----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCC-------HHHHHHHHhccCCcccCCCCC-----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 432 12222222220 111111111 023345566677887 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=303.38 Aligned_cols=247 Identities=26% Similarity=0.390 Sum_probs=194.0
Q ss_pred ccCCcCceEEEEEEcC---CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 210 KLGQGGYADVYKGTLP---DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
.||+|+||.||+|.+. .+..||+|++..... ..+++.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 356799999875432 2357899999999999999999999875 457899999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.........
T Consensus 81 L~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGK-----KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 99998532 24689999999999999999999998 99999999999999999999999999998665443221
Q ss_pred e-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 365 S-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 365 ~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
. .....+++.|+|||.+.. ..++.++||||||+++|||++ |+.|+.... ...+...+........+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~ 223 (257)
T cd05115 153 KARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-------GPEVMSFIEQGKRLDCPAEC 223 (257)
T ss_pred eccCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-------HHHHHHHHHCCCCCCCCCCC
Confidence 1 122234678999999864 367889999999999999996 998885331 22233333333322222222
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
...+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 224 -------~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 224 -------PPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -------CHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34566788899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=309.19 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=191.2
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
||+|+||+||++..+ +++.||+|.+.... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999855 68999999986432 1235678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 81 RYHIYNVD--EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred HHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 98885432 2235689999999999999999999998 9999999999999999999999999999766543321
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
.....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ....+...+... ....+.
T Consensus 154 ~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-~~~~~~----- 222 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRILND-SVTYPD----- 222 (280)
T ss_pred ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhccc-CCCCcc-----
Confidence 2234689999999999653 67889999999999999999999986432110 011111111111 011111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 --~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 --KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1233456677788899999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=325.96 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=190.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|... +++.||||+++... .....+.+|+.++..++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 345688999999999999965 68999999997532 2335678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 83 LPGGDMMTLLMKK------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCcHHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999542 3589999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcee------------------------------------eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHH
Q 040808 360 KESFI------------------------------------SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHE 403 (511)
Q Consensus 360 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~e 403 (511)
..... ......||+.|+|||++.+. .++.++|||||||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~e 231 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHH
Confidence 21000 01123599999999998653 68899999999999999
Q ss_pred HHhCCCCCCCccCCCCCCchHHHHHHHhh-hhccccC--CCCChHHHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 040808 404 MVIGRKNADVKVSCSSEYFPNAIYKQIET-EYDFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPS---MTKVVE 476 (511)
Q Consensus 404 lltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs---~~evl~ 476 (511)
|++|+.||.... +......+.. ......+ ...++... +++.+|+. +|.+|++ ++++++
T Consensus 232 l~~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~~~-------~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 232 MLVGYPPFCSDN-------PQETYRKIINWKETLQFPDEVPLSPEAK-------DLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hhcCCCCCCCCC-------HHHHHHHHHcCCCccCCCCCCCCCHHHH-------HHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999996432 1122222211 1111111 12333333 34445555 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=312.47 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=196.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|+..++||+|+||+||++... +++.||+|++.... .....+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456678999999999999854 68999999987532 1224578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 82 MNGGDLKFHIYNMG----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred cCCCcHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999885422 24689999999999999999999998 999999999999999999999999999987644
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... .....|++.|+|||++.+ ..++.++||||+|+++|||++|+.||..... ......+...+... .....
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~---~~~~~~~~~~~~~~-~~~~~ 225 (285)
T cd05605 155 GET---IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE---KVKREEVERRVKED-QEEYS 225 (285)
T ss_pred CCc---cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCch---hhHHHHHHHHhhhc-ccccC
Confidence 332 123468999999999865 3678899999999999999999999964321 00111111111111 01111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~~ 477 (511)
......+.+++.+||+.||++|| +++++++.
T Consensus 226 -------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 -------EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 12334566788889999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=308.11 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=190.9
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
||+|+||+||++..+ +|+.||+|.+.... .....+..|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 68999999986421 1223456799999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 150 (277)
T cd05607 81 KYHIYNVG----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--- 150 (277)
T ss_pred HHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence 98885432 34588999999999999999999998 999999999999999999999999999887654332
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
.....|++.|+|||++.+. .++.++||||+||++|||++|+.|+..... ......+........ ... .
T Consensus 151 ~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~-~~~------~ 218 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKE---KVAKEELKRRTLEDE-VKF------E 218 (277)
T ss_pred eeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcc---hhhHHHHHHHhhccc-ccc------c
Confidence 1234689999999998654 588999999999999999999999864321 101111111111110 000 0
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
.......+.+++.+||+.||++||++.|+++.+.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 0112334566777788999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=313.20 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=195.4
Q ss_pred hhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALI 276 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 276 (511)
.+.+.||+|+||+||++.. .+++.||+|+++.... ..+.+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5667899999999988642 3578899999975432 346788999999999999999999988653 468899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+++.
T Consensus 87 ~e~~~~~~l~~~~~~-------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPK-------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 999999999999843 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeee-cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCC--------chHHHH
Q 040808 357 TEKKESFISM-LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY--------FPNAIY 427 (511)
Q Consensus 357 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~--------~~~~~~ 427 (511)
.......... ....++..|+|||.+... ..+.++||||||+++|||++|..|+.......... ....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 6543321111 122356679999998653 67899999999999999999998875432110000 000000
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
+.+........ .......+.+++.+||+.+|++|||+++|+++|+.+
T Consensus 235 ~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPC-------PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCC-------CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111110010 112335677889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=307.81 Aligned_cols=252 Identities=27% Similarity=0.480 Sum_probs=196.8
Q ss_pred ccCCcCceEEEEEEcCC-------CcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 210 KLGQGGYADVYKGTLPD-------GRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.||+|+||.||+|...+ ++.+|+|.+.... ....++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998542 2579999886543 34568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-----ceEEeeccCc
Q 040808 281 PNGSLDQYIYDHESSN-GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-----CPKISDFGLA 354 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~DFGla 354 (511)
++++|.+++....... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999996533211 234588999999999999999999997 999999999999999877 8999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
+...............++..|+|||++.+ +.++.++||||||+++|||++ |+.|+.... .......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-------~~~~~~~~~~~ 229 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHVTAG 229 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccC-------HHHHHHHHhcC
Confidence 86644332221122346788999999865 468999999999999999998 898875321 11222222222
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
....... .....+.+++.+||+.+|++||++++|+++|+.
T Consensus 230 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 GRLQKPE-------NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CccCCcc-------cchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2111111 233456788899999999999999999999873
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=307.13 Aligned_cols=252 Identities=25% Similarity=0.451 Sum_probs=195.0
Q ss_pred cccCCcCceEEEEEEcCC-Cc--EEEEEEeccCC--CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLPD-GR--LVAVKVMKNLK--DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||.||+|.+++ +. .+|+|.++... ...+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 359999999999999653 44 47889887532 2346788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 283 GSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 283 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
|+|.+++...... .....+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999999653211 1123588999999999999999999997 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
++....... .......+..|+|||++.. ..++.++||||||+++|||++ |+.||.... .....+.+.
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~-------~~~~~~~~~ 225 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLP 225 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccC-------HHHHHHHHh
Confidence 986432111 1112234668999999854 367899999999999999997 898885321 122233332
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
......... .....+.+++.+||+.+|.+|||+.+++.+|++++
T Consensus 226 ~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 226 QGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCCCCC-------cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 222211111 12345778889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=316.88 Aligned_cols=198 Identities=27% Similarity=0.377 Sum_probs=170.2
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
...|++.++||+|+||.||++.++ ++..+|+|+++.... ..+++.+|++++++++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 345667889999999999999965 688999998875432 23578999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..+..++.+++.||+|||+. .+++|+||||+|||+++++.+||+|||++....
T Consensus 84 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999532 3588999999999999999999974 279999999999999999999999999987653
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
... .....||..|+|||++.+. .++.++|||||||++|||++|+.|+..
T Consensus 156 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 156 DSM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 321 1234689999999998653 678899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=308.30 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=198.8
Q ss_pred HHhhhcccCCcCceEEEEEEcCC-C---cEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD-G---RLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+++.+.||+|+||.||+|.++. + ..||+|+++.... ...+|.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 34577899999999999998642 3 3699999875422 2458999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 85 EFMENGALDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred ecCCCCcHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999998542 24689999999999999999999998 9999999999999999999999999998766
Q ss_pred CCCCceeeecCC---CCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 358 EKKESFISMLDT---RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 358 ~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
............ ..+..|+|||++.. +.++.++||||||+++|||++ |+.|+.... .....+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-------~~~~~~~i~~~ 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMS-------NQDVINAIEQD 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCC-------HHHHHHHHHcC
Confidence 443221111111 12457999999865 467899999999999999886 998885331 12222333222
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
....... +....+.+++.+||+.+|++||++++|+.+|+..
T Consensus 228 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 YRLPPPM-------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CcCCCcc-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2211111 2234567788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=314.87 Aligned_cols=239 Identities=24% Similarity=0.327 Sum_probs=188.4
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHc-cCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||+|... +++.||+|+++.. ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 5889999999753 2334567778888876 4899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQS------CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 999999853 24688999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+.+.... ...+...
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~-~~~~~~~ 219 (316)
T cd05619 152 K--TCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHD-------EEELFQSIRMDN-PCYPRWL 219 (316)
T ss_pred c--eeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCC-CCCCccC
Confidence 1 1234699999999998653 67899999999999999999999986431 222333332221 1122223
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMT-KVV 475 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~-evl 475 (511)
+ ..+.+++.+||+.||++||++. ++.
T Consensus 220 ~-------~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 T-------REAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C-------HHHHHHHHHHhccCHhhcCCChHHHH
Confidence 3 2345666778899999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=326.76 Aligned_cols=258 Identities=19% Similarity=0.199 Sum_probs=194.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.+.+.++||+|+||.||++.+. .++.||||... ...+.+|++++++++|+|||++++++...+..++|||++ .
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence 4556789999999999999965 58899999533 234678999999999999999999999999999999999 5
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 244 ~~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 244 SDLYTYLGAR-----LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 7998888532 24699999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC-CCCCchHHHHHHHhhhhcc--ccC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC-SSEYFPNAIYKQIETEYDF--QLD 439 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~ 439 (511)
........||+.|+|||++.+. .++.++|||||||++|||++|..++...... ....+...+.+.+...... ...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 1112234699999999999664 6889999999999999999988765432211 1122333333332221100 000
Q ss_pred CC----------------------CChH--HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GV----------------------VTEE--EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~----------------------~~~~--~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.. .... .......+.+++.+||+.||++|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000 00112246678899999999999999999863
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=306.67 Aligned_cols=252 Identities=26% Similarity=0.438 Sum_probs=199.0
Q ss_pred hhhcccCCcCceEEEEEEcC-CC---cEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DG---RLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+..+.||+|+||.||+|.++ ++ ..+|+|.++.... ..+++.+|++++.+++|+|++++.+++.+.+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 45678999999999999865 33 3799999875432 245789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 88 MENGALDKYLRDH-----DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999998542 24689999999999999999999998 999999999999999999999999999876643
Q ss_pred CCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 360 KESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 360 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
...... ......++.|+|||++.. +.++.++||||||+++|||++ |+.|+.... ...+...+.......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-------~~~~~~~i~~~~~~~ 230 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMS-------NHEVMKAINDGFRLP 230 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-------HHHHHHHHhcCCCCC
Confidence 322111 111224567999999865 367899999999999999997 999985321 222333333221111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
. ..+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 A-------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=308.17 Aligned_cols=260 Identities=23% Similarity=0.410 Sum_probs=201.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-----CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEee--cCeEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-----DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYE--KKKRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 275 (511)
+.+.++||+|+||.||++... ++..+|+|+++..... .++|.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 456688999999999999843 3678999999866553 5689999999999999999999999877 567899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 86 v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEecCCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999995432 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC--------CchHHH
Q 040808 356 QTEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE--------YFPNAI 426 (511)
Q Consensus 356 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~--------~~~~~~ 426 (511)
.......... .....++..|+|||.+... .++.++||||||++++||++|+.|+......... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 7763322211 1123456679999998653 6888999999999999999999887543211100 001111
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
...+........ .......+.+++.+||+.+|++||||.+|+++|+.+
T Consensus 236 ~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPR-------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCC-------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111211111111 112235678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=312.20 Aligned_cols=263 Identities=23% Similarity=0.410 Sum_probs=201.7
Q ss_pred HhhhcccCCcCceEEEEEEcCC-C--cEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD-G--RLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+.||+|+||.||+|..++ + ..+++|.++.... ..+.+.+|++++.++ +||||+++++++.+....++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 3567789999999999998653 3 3578888874322 335789999999999 79999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEE
Q 040808 279 FMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl 348 (511)
|+++++|.+++...... .....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 99999999999653211 1123589999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHH
Q 040808 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 349 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 427 (511)
+|||++....... .......+..|+|||++... .++.++||||||+++|||++ |+.||.... ...+.
T Consensus 161 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~-------~~~~~ 228 (297)
T cd05089 161 ADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-------CAELY 228 (297)
T ss_pred CCcCCCcccccee---ccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHH
Confidence 9999986432211 11112235679999998653 67899999999999999997 998885331 22223
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~ 489 (511)
..+........+.. ....+.+++.+||+.+|.+|||+++++++|+..+.......
T Consensus 229 ~~~~~~~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 229 EKLPQGYRMEKPRN-------CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred HHHhcCCCCCCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 33332222222212 23456778889999999999999999999998877654443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=306.68 Aligned_cols=257 Identities=25% Similarity=0.392 Sum_probs=202.6
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.+.||+|+||.||++.. .+++.+|||.+.... ....++.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 45667899999999999995 478999999886432 1235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... .....+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 84 ADAGDLSRMIKHFK--KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCHHHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999986432 2235689999999999999999999998 999999999999999999999999999876654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... .....|+..|+|||.+.+. ..+.++||||||+++|+|++|..|+...... .....+.+.......
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~-- 227 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEQCDYPP-- 227 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccch-----HHHHhhhhhcCCCCC--
Confidence 3321 1234588999999998653 6788999999999999999999998532110 111112222111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.. .......+..++.+||+.+|++||||++|++++++.
T Consensus 228 --~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 --LP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 112344577788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=305.65 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=203.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||.||+|... +|+.||+|.++... ...+++.+|++++++++|+|++++++.+.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456788999999999999966 78999999886421 2246789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... .....+++..+..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 84 ADAGDLSRMIKHFK--KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred CCCCCHHHHHHHhc--ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999986532 2235689999999999999999999998 999999999999999999999999999876544
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.|+..... . ...+.+.+.......
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~-~~~~~~~~~~~~~~~-- 227 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKM----N-LYSLCKKIEKCDYPP-- 227 (267)
T ss_pred CCcc--cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCc----c-HHHHHhhhhcCCCCC--
Confidence 3221 1234588999999998653 678899999999999999999999853211 1 111122222211111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.+ .......+.+++.+||+.+|++|||+.+|+++|+++
T Consensus 228 --~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 --LP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11 113344567888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.59 Aligned_cols=249 Identities=18% Similarity=0.266 Sum_probs=194.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.+.+.++||+|+||+||++..+ +++.||+|++++.. ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 4567789999999999999865 68899999997432 233457889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 124 y~~gg~L~~~l~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 124 YMPGGDLVNLMSN-------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred CCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999843 2478888999999999999999998 99999999999999999999999999998764
Q ss_pred CCCceeeecCCCCCCCccchhhcccc--cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-c
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRH--FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-D 435 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 435 (511)
..... ......||+.|+|||++... .+.++.++|||||||++|||++|+.||.... ....+..+.... .
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~ 265 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMDHKNS 265 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCc
Confidence 33221 12245699999999998543 1247889999999999999999999986432 122233332211 1
Q ss_pred cccC--CCCChHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 040808 436 FQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPD--RPSMTKVVEM 477 (511)
Q Consensus 436 ~~~~--~~~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPs~~evl~~ 477 (511)
...+ ...+.+ +.+++.+||+.+|++ |++++++++.
T Consensus 266 ~~~~~~~~~s~~-------~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPDDIEISKQ-------AKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCCcCCCCHH-------HHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111 123333 344556677888987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=313.88 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=190.6
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||++..+ +++.||+|++++. ....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 5889999999853 22345677899999887 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQR------SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 999998843 23689999999999999999999998 999999999999999999999999999875322221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ...+...+... ....+...
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~-------~~~~~~~i~~~-~~~~~~~~ 219 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSILED-EVRYPRWL 219 (318)
T ss_pred --cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcC-CCCCCCcC
Confidence 11234589999999999654 67899999999999999999999986332 22222222221 11222222
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSM-----TKVVE 476 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~-----~evl~ 476 (511)
+ ..+.+++.+||+.||++||++ .++++
T Consensus 220 ~-------~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 220 S-------KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred C-------HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3 345667788889999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=304.08 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=203.5
Q ss_pred HHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 201 RRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 201 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+..+.+.++||+|+||.||++.+.++..+|+|.+.......+.+.+|++++++++|+||+++++.+.+ ...+++|||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 344567788999999999999997777889999988655556789999999999999999999998877 7789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 83 AKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCCcHHHHHHhCC----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999995432 34688999999999999999999998 9999999999999999999999999999766443
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. .......++..|+|||++.. +.++.++||||||+++|+|++ |+.|+.... ...+...+.........
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 225 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRP 225 (260)
T ss_pred Cc-ccccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHhCCCCCCCc
Confidence 22 11123346678999999865 367889999999999999998 888875321 11222222222221111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
......+.+++.+||+.+|++||++++++++|+.
T Consensus 226 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 -------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1233457788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.64 Aligned_cols=248 Identities=23% Similarity=0.248 Sum_probs=194.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||++..+ +|+.||+|+++.... ..+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456788999999999999855 689999999985422 345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 83 QPGGDLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999996432 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccc----cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH----FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
..... .....||+.|+|||++... ...++.++|||||||++|||++|+.||.... ....+..+.....
T Consensus 155 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~~ 226 (330)
T cd05601 155 NKMVN-SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-------SAKTYNNIMNFQR 226 (330)
T ss_pred CCcee-eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-------HHHHHHHHHcCCC
Confidence 43321 2234699999999998531 2357789999999999999999999986432 1122222222111
Q ss_pred ---cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 ---FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ---~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+......+. .+.+++.+||+ +|++||+++++++
T Consensus 227 ~~~~~~~~~~~~-------~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFPEDPKVSS-------DFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCCCCCCCCH-------HHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111112233 34455566777 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=315.52 Aligned_cols=236 Identities=22% Similarity=0.310 Sum_probs=184.4
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHH-HHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVA-SISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||+|..+ +|+.||+|++.... ....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999965 68999999997532 22345555655 56789999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQR------ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 999999843 24688999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .....+.+... ...+....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~-~~~~~~~~ 219 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEMYDNILNK-PLRLKPNI 219 (323)
T ss_pred --ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcC-CCCCCCCC
Confidence 12234699999999998653 68899999999999999999999986431 12222222221 11222333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMT 472 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~ 472 (511)
+. .+.+++.+||+.||++||++.
T Consensus 220 ~~-------~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 SV-------SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CH-------HHHHHHHHHhhcCHHhCCCCC
Confidence 33 345566677799999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=308.93 Aligned_cols=262 Identities=23% Similarity=0.392 Sum_probs=201.0
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
..++.+.++||+|+||.||+|..+ .+..||+|.++..... ..++.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345667789999999999999743 2457999998754332 34688999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 274 ALIYEFMPNGSLDQYIYDHESS----NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
++||||+++|+|.+++...... ......++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999653211 1124567788899999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 428 (511)
|||+++...............++..|+|||.+.+ +.++.++||||||+++|||++ |+.|+.... ...+.+
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-------~~~~~~ 232 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLK 232 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHH
Confidence 9999986544332211122245778999999865 367899999999999999998 677774321 122222
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
.+.......... .....+.+++.+||+.+|++|||+.++++.|+..+
T Consensus 233 ~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCCCCCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 222221111111 12345778889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.59 Aligned_cols=237 Identities=26% Similarity=0.331 Sum_probs=188.8
Q ss_pred cccCCcCceEEEEEEc----CCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 209 DKLGQGGYADVYKGTL----PDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+.||+|+||.||+++. .+|+.||+|+++... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999874 358899999997532 223467789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSK------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 9999999843 24689999999999999999999998 99999999999999999999999999998654432
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. .....||+.|+|||.+.+. ..+.++||||||+++|||++|+.||.... .......+... ...++..
T Consensus 153 ~~--~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~-------~~~~~~~i~~~-~~~~p~~ 220 (318)
T cd05582 153 KK--AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKD-------RKETMTMILKA-KLGMPQF 220 (318)
T ss_pred Cc--eecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCC-------HHHHHHHHHcC-CCCCCCC
Confidence 21 2244699999999998653 67889999999999999999999986431 22222222221 1122222
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTK 473 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~e 473 (511)
++ ..+.+++.+||+.||++||++.+
T Consensus 221 ~~-------~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LS-------PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC-------HHHHHHHHHHhhcCHhHcCCCCC
Confidence 33 33556777888999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.27 Aligned_cols=246 Identities=27% Similarity=0.442 Sum_probs=196.1
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
+.||+|+||.||+|..++++.+|+|+++..... ...+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888899999998754322 346889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeee
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
+++... ...+++..+..++.+++.||.|||+. +++|+||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 151 (250)
T cd05085 81 SFLRKK-----KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSS 151 (250)
T ss_pred HHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccC
Confidence 998532 23578999999999999999999998 999999999999999999999999999876433221 111
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
....+++.|+|||++.. +.++.++||||||+++|+|++ |..|+.... .......+..........
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~----- 217 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMT-------NQQAREQVEKGYRMSCPQ----- 217 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----
Confidence 12235678999999864 468899999999999999998 888875321 122222332222211111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
.....+.+++.+||+.+|++||++.+++++|.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 --KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12346778889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=314.57 Aligned_cols=239 Identities=24% Similarity=0.335 Sum_probs=188.1
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHc-cCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||.||+|..+ +|+.||+|+++.. ....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 5889999999753 2334566778888875 4899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQD------KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 999999853 24688999999999999999999998 999999999999999999999999999875322211
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+.+.+... ....+...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~-------~~~~~~~~~~~-~~~~~~~~ 219 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDD-------EDELFESIRVD-TPHYPRWI 219 (316)
T ss_pred --ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhC-CCCCCCCC
Confidence 12345699999999999654 68899999999999999999999986331 22233333221 11222223
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMT-KVV 475 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~-evl 475 (511)
+. ++.+++.+||+.||++||++. +++
T Consensus 220 ~~-------~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TK-------ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CH-------HHHHHHHHHccCCHHHcCCChHHHH
Confidence 33 345666778899999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=292.78 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=205.4
Q ss_pred HHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecC-----eEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKK-----KRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 276 (511)
+|++.++||+|||+-||+++ ..+++.+|+|++.-.. .+.+..++|++.-++++|||+++++++...+. ..+++
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll 101 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL 101 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence 45677899999999999998 6789999999887544 56678999999999999999999999886443 48999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
++|...|+|.+.|.... .++..+++.+.+.|+.+|++||++||+. ..+++||||||.|||+.+.+.+++.|||.+..
T Consensus 102 ~Pyy~~Gsl~d~i~~~k--~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 102 LPYYKRGSLLDEIERLK--IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred eehhccccHHHHHHHHh--hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999997654 3456899999999999999999999997 23599999999999999999999999999876
Q ss_pred cCCCCc----ee---eecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 357 TEKKES----FI---SMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 357 ~~~~~~----~~---~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
..-.-. .. ......-|..|+|||.+.-. ....++++|||||||+||+|+.|..||+.-..+... +.-.+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-laLAv-- 255 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-LALAV-- 255 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-EEEee--
Confidence 542111 00 01122478999999999432 236789999999999999999999999743321111 11000
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
......++.... ....|.+++.+|+|.||.+||++.+++..++..+
T Consensus 256 -~n~q~s~P~~~~-------yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 -QNAQISIPNSSR-------YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -eccccccCCCCC-------ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 000111122222 4556778888889999999999999999988754
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=312.66 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=200.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCc--EEEEEEeccCC--CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGR--LVAVKVMKNLK--DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+.||+|+||.||+|.++ ++. .+|+|.++... ....++.+|++++.++ +|+||+++++++.+.+..++|||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 356788999999999999864 454 46777766432 2235788999999999 89999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEE
Q 040808 279 FMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl 348 (511)
|+++++|.+++...... .....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEe
Confidence 99999999999654311 1123689999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHH
Q 040808 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 349 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 427 (511)
+|||+++...... ......++..|+|||++... .++.++||||||+++|||++ |..||.... .....
T Consensus 166 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~ 233 (303)
T cd05088 166 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELY 233 (303)
T ss_pred CccccCcccchhh---hcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCC-------hHHHH
Confidence 9999986432111 11122346789999998553 57889999999999999998 998885321 11222
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCC
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIP 488 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p 488 (511)
+.+.......... .....+.+++.+||+.+|++||++++++++|+.++......
T Consensus 234 ~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 234 EKLPQGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred HHHhcCCcCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 2222221111111 12335678889999999999999999999998876655544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=318.68 Aligned_cols=242 Identities=26% Similarity=0.399 Sum_probs=195.9
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEecc--CCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKN--LKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
.+.||+|.||.||+|.+. .++.||+|++.- .....++..+|+.+|..++++||.+.|+.+..+....++|||+.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 367999999999999954 689999999974 34456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
+.+.+.. ...+.+..+.-|+.+++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+-.........
T Consensus 98 v~~lL~~------~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 98 VLDLLKS------GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hhhhhcc------CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999843 23447777777899999999999998 99999999999999999999999999987765544322
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCCh
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE 444 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (511)
.+.+|||-|||||++.. ..++.|+||||||++++||.+|.+|+..-. |..+.-.+.+.....+.+
T Consensus 169 --~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~h-------PmrvlflIpk~~PP~L~~---- 233 (467)
T KOG0201|consen 169 --KTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLH-------PMRVLFLIPKSAPPRLDG---- 233 (467)
T ss_pred --ccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccC-------cceEEEeccCCCCCcccc----
Confidence 45689999999999975 378999999999999999999999985332 211111111222122222
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 445 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...+.+-+++..||+.||+.||++.++++
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 23334566677799999999999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=313.14 Aligned_cols=201 Identities=24% Similarity=0.331 Sum_probs=162.8
Q ss_pred hcccCCcCceEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEEeCCC
Q 040808 208 SDKLGQGGYADVYKGTLP---DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYEFMPN 282 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 282 (511)
+++||+|+||+||+|..+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. ....+++|||+ +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-E 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-C
Confidence 468999999999999854 46789999987543 23567899999999999999999998854 45688999999 5
Q ss_pred CCHHHHHhcccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE----cCCCceEEeeccCcc
Q 040808 283 GSLDQYIYDHESS---NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAK 355 (511)
Q Consensus 283 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 355 (511)
++|.+++...... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 6888887543211 1224689999999999999999999998 99999999999999 466899999999998
Q ss_pred ccCCCCc-eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 356 QTEKKES-FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 356 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
....... ........||+.|+|||++.+. ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7643321 1122345689999999998653 35788999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=313.92 Aligned_cols=242 Identities=23% Similarity=0.341 Sum_probs=188.3
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHH---HccCCcceeeeeceEeecCeEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASI---SRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
++.+.||+|+||.||+|..+ +++.||||++++.. ...+.+.+|+.++ ++++||||+++++++.+.+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45678999999999999855 68999999997532 2234566666554 5678999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 E~~~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 82 EYAAGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred cCCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999988732 3689999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+...+.... ..
T Consensus 152 ~~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~-~~ 219 (324)
T cd05589 152 MGFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDD-------EEEVFDSIVNDE-VR 219 (324)
T ss_pred CCCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCC-CC
Confidence 32221 11234699999999998653 67889999999999999999999986431 122222222221 12
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
.+..++ ..+.+++.+||+.||++|| ++.++++
T Consensus 220 ~p~~~~-------~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFLS-------REAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCC-------HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 222233 3455677788899999999 4666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=320.57 Aligned_cols=250 Identities=18% Similarity=0.303 Sum_probs=191.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
..|++.++||+|+||.||++..+ +++.+|+|++.+. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34566789999999999999965 5889999998642 122346789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 123 Ey~~gg~L~~~l~~-------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 123 EYMPGGDLVNLMSN-------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred cCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999843 2478889999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhccccc--CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHF--GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY- 434 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 434 (511)
..... .......||+.|+|||++.+.. +.++.++||||+||++|||++|+.||.... ....+..+....
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-------~~~~~~~i~~~~~ 264 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-------LVGTYSKIMDHKN 264 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCc
Confidence 43322 1223456999999999986431 237889999999999999999999996432 112222332211
Q ss_pred cccc--CCCCChHHHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 040808 435 DFQL--DGVVTEEEKEMAKKMILVSLWCIQTHPP--DRPSMTKVVEM 477 (511)
Q Consensus 435 ~~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~~p~--~RPs~~evl~~ 477 (511)
.... ...++...++ ++.+|++.++. .|+++.|+++.
T Consensus 265 ~~~~p~~~~~s~~~~~-------li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNFPEDVEISKHAKN-------LICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCCCcccCCHHHHH-------HHHHHccCchhccCCCCHHHHhcC
Confidence 1111 1122333333 44445564443 48899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=324.91 Aligned_cols=199 Identities=22% Similarity=0.316 Sum_probs=167.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++||+|+||+||+|... +++.||+|++.+.. ...+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 345688999999999999854 68899999987532 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 83 IPGGDMMSLLIRM------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999998532 3588899999999999999999998 999999999999999999999999999753211
Q ss_pred CCc---------------------------------------------eeeecCCCCCCCccchhhcccccCCCCccccc
Q 040808 360 KES---------------------------------------------FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDV 394 (511)
Q Consensus 360 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDv 394 (511)
... ........||+.|+|||++.+. .++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Di 231 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDW 231 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeE
Confidence 000 0001123699999999999654 67899999
Q ss_pred hhHHHHHHHHHhCCCCCCCc
Q 040808 395 YSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 395 wSlG~il~elltg~~p~~~~ 414 (511)
|||||++|||++|+.||...
T Consensus 232 wSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred EechHHHHHHHhCCCCCCCC
Confidence 99999999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.43 Aligned_cols=247 Identities=19% Similarity=0.285 Sum_probs=188.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||++... +++.||+|++.+. ....+.+.+|++++.+++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456789999999999999854 6899999998643 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~g~L~~~i~~------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 83 IPGGDMMSLLIR------LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999953 24588899999999999999999998 999999999999999999999999999753210
Q ss_pred CC-----------------------------------------ceeeecCCCCCCCccchhhcccccCCCCccccchhHH
Q 040808 360 KE-----------------------------------------SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYG 398 (511)
Q Consensus 360 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG 398 (511)
.. .........||+.|+|||++.+. .++.++||||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG 231 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeecc
Confidence 00 00001124699999999999654 678999999999
Q ss_pred HHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh---hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC---CHH
Q 040808 399 MMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET---EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP---SMT 472 (511)
Q Consensus 399 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP---s~~ 472 (511)
|++|||++|+.||.... +......+.. .........++....+++. +|+ .+|++|+ ++.
T Consensus 232 vilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~-------~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 232 VILYEMLVGQPPFLADT-------PAETQLKVINWETTLHIPSQAKLSREASDLIL-------RLC-CGAEDRLGKNGAD 296 (376)
T ss_pred ceeeehhhCCCCCCCCC-------HHHHHHHHhccCccccCCCCCCCCHHHHHHHH-------HHh-cCHhhcCCCCCHH
Confidence 99999999999996432 1111111111 1111111223444433333 333 4999999 888
Q ss_pred HHHHH
Q 040808 473 KVVEM 477 (511)
Q Consensus 473 evl~~ 477 (511)
++++.
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 88754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.98 Aligned_cols=257 Identities=24% Similarity=0.399 Sum_probs=201.0
Q ss_pred HHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 273 (511)
..+.+.+.||+|+||.||++... .+..||+|+++.... ..+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 34567789999999999999731 345799999875432 235788999999999 799999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR----ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999995422 23489999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
++...............++..|+|||.+... ..+.++||||||+++|||++ |+.|+.... ......+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~------~~~~~~~~~~~ 259 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMP------VDSKFYKLIKE 259 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCC------chHHHHHHHHc
Confidence 9866544332222233467889999998653 67889999999999999998 888875321 11222222222
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
......... ....+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 260 ~~~~~~~~~-------~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GYRMAQPEH-------APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcCCCCCC-------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 221111111 224577788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=315.30 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=185.9
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHH-HHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVA-SISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||+|... +|+.||+|++.+.. ....++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999854 68999999997532 22245556655 46779999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~------~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQR------ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 999988843 24689999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+.+... ........
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~~~-~~~~~~~~ 219 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHK-PLVLRPGA 219 (325)
T ss_pred --CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHHcC-CccCCCCC
Confidence 12244699999999999653 67889999999999999999999986432 12222222221 11222233
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
+.. +.+++.+|++.+|++||++.+.++.
T Consensus 220 ~~~-------~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 220 SLT-------AWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CHH-------HHHHHHHHhccCHHhcCCCCCCHHH
Confidence 333 4455666779999999988644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=314.69 Aligned_cols=239 Identities=22% Similarity=0.317 Sum_probs=188.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCc-ceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHV-NIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e 278 (511)
|.+.+.||+|+||.||+|..+ +++.||+|++++. ....+.+..|..++..+.|+ +|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 356788999999999999865 5789999999753 23346788899999999765 58889999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~~~~g~L~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 82 YVNGGDLMYHIQQ------VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred CCCCCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999999853 24588999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+... ....
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~-~~~~ 220 (324)
T cd05587 153 FGGK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGED-------EDELFQSIMEH-NVSY 220 (324)
T ss_pred CCCC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcC-CCCC
Confidence 2211 11234699999999999653 67899999999999999999999986432 22223333221 1122
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
+...+ ..+.+++.+||+.||++|++.
T Consensus 221 ~~~~~-------~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PKSLS-------KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCC-------HHHHHHHHHHhhcCHHHcCCC
Confidence 22233 345567777889999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=306.31 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=192.4
Q ss_pred hhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 206 SFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.+.+.||+|+||.||+|.+ .+++.||+|++..... ...++.+|++++++++||||+++++.+......++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4567899999999999985 4688999999865422 235788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 84 GSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9996542 467888999999999999999998 99999999999999999999999999997654322
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.....||..|+|||++.+. .++.++||||||+++|+|++|+.||...........+....+.+........
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL---- 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCC----
Confidence 1234689999999998654 6789999999999999999999998643221111111111111111111110
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.. ......+.+++.+||+.+|++||+++++++.
T Consensus 221 ~~--~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV--GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC--CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 0122346677888999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=314.19 Aligned_cols=242 Identities=22% Similarity=0.294 Sum_probs=185.7
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHH-HHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVA-SISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||++..+ +++.||+|++.+.. ....++.+|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 57899999997532 12234455544 56788999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQR------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 999999853 24577888899999999999999998 999999999999999999999999999875432221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ....++.+... .......+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~-~~~~~~~~ 219 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNK-PLQLKPNI 219 (325)
T ss_pred --CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCC-------HHHHHHHHHhC-CcCCCCCC
Confidence 12244699999999999653 68899999999999999999999986331 12222222221 12222333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
+.. +.+++.+||+.||.+||++.+.+.++
T Consensus 220 ~~~-------~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 220 TNS-------ARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CHH-------HHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 443 44555667799999999887544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=307.90 Aligned_cols=261 Identities=24% Similarity=0.301 Sum_probs=201.7
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
...+++.++||+|+||+||++... +++.||+|++..... ..+++.+|+++++.++||||+++++.+.+....++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345667789999999999999854 688999998865422 34678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. .+++|+||||+||++++++.++|+|||++....
T Consensus 84 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 84 FMDCGSLDRIYKK------GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred cCCCCCHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999998843 23689999999999999999999973 289999999999999999999999999987543
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC-CchHHHHHHHhhhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE-YFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 437 (511)
.... ....|+..|+|||++.+. .++.++||||||+++|+|++|+.||......... ..+..+...+.......
T Consensus 156 ~~~~----~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 156 NSIA----DTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred hhcc----CccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 2211 234689999999998653 7888999999999999999999999754321111 11111222111111110
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
...... .+....+.+++.+||+.||++|||++||+++.-
T Consensus 230 -~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 -PPRLPS--SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred -CCCCCc--hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 111111 124456778889999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.48 Aligned_cols=247 Identities=29% Similarity=0.431 Sum_probs=196.1
Q ss_pred cccCCcCceEEEEEEcCC--Cc--EEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLPD--GR--LVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++||+|++|.||+|.+.+ ++ .||+|.+..... ..+++.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999998543 33 699999986544 34688999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDA----LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhcc----cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999996532 14689999999999999999999998 999999999999999999999999999987754332
Q ss_pred ee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhh-hccccC
Q 040808 363 FI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETE-YDFQLD 439 (511)
Q Consensus 363 ~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 439 (511)
.. ......++..|+|||++... .++.++||||||+++|||++ |+.|+.... ...+.+.+... ......
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 223 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLS-------GSQILKKIDKEGERLERP 223 (257)
T ss_pred ceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCcCCCC
Confidence 21 11234578899999998653 67889999999999999998 999885321 12222222211 111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
......+.+++.+||+.+|++||++.+|++.|.
T Consensus 224 -------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 -------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123356778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=306.66 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=195.9
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++++++||||+++++.+...+..++||||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 456678999999999999995 468899999987543 334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 90 GGSLQDIYHV------TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999998843 24688999999999999999999998 99999999999999999999999999998664322
Q ss_pred ceeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. ......|++.|+|||.+... .+..+.++||||||+++|||++|+.|+....... .. ..+... .+...
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~------~~-~~~~~~-~~~~~- 229 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------AL-FLMSKS-NFQPP- 229 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh------hh-eeeecC-CCCCC-
Confidence 1 11234588999999998431 2346789999999999999999999885321100 00 000000 00000
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
.. .........+.+++.+||+.+|++|||++++++.|
T Consensus 230 ~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 01112334567788899999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=299.93 Aligned_cols=247 Identities=26% Similarity=0.469 Sum_probs=201.4
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+.+.||.|+||.||+|... |+.||+|.++......+++.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred ccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 456788999999999999874 7889999998765556789999999999999999999999998999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.......
T Consensus 87 L~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 87 LVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred HHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999995432 23689999999999999999999998 999999999999999999999999999987643221
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
...++..|+|||++.. +.++.++||||||+++|||++ |+.|+.... ...+...+........+.
T Consensus 158 ---~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~--- 222 (256)
T cd05039 158 ---SGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPHVEKGYRMEAPE--- 222 (256)
T ss_pred ---cCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHhcCCCCCCcc---
Confidence 2345678999999864 368889999999999999997 888875321 222333333222111111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.....+.+++.+||+.+|++||++++++++|+.
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 ----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 223456778888999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.97 Aligned_cols=250 Identities=25% Similarity=0.419 Sum_probs=190.2
Q ss_pred cccCCcCceEEEEEEcC----CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEe-ecCeEEEEEEeCC
Q 040808 209 DKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCY-EKKKRALIYEFMP 281 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 281 (511)
+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 245799998864322 3467889999999999999999999775 4556889999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.... ..+.+..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999995422 3467788889999999999999998 99999999999999999999999999998654322
Q ss_pred ce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCC-CCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 362 SF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN-ADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 362 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.. .......++..|+|||.+.. ..++.++||||||+++|||++|+.| +... ........+........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 223 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------DSFDITVYLLQGRRLLQ 223 (262)
T ss_pred ceeecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHhcCCCCCC
Confidence 11 11123346778999999865 3688999999999999999996544 4321 11112222222211111
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
+. .....+.+++.+||+.+|++||++.+|+++|+...
T Consensus 224 ~~-------~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 PE-------YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CC-------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11 12345778889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.88 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=194.9
Q ss_pred HhhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 276 (511)
+.+.+.||+|+||+||++.. .+++.||+|.++.... ..+.+.+|++++++++||||+++++++.. ....++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 85 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV 85 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence 45667899999999999974 2578999999875433 24578899999999999999999998754 3468899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~-----~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 86 MEYLPYGSLRDYLQKH-----RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEecCCCCHHHHHHhc-----CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999532 24589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeec-CCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC-----C----CCchHHH
Q 040808 357 TEKKESFISML-DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS-----S----EYFPNAI 426 (511)
Q Consensus 357 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~-----~----~~~~~~~ 426 (511)
........... ...++..|+|||++.+ +..+.++||||||+++|||++|..++....... . ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 65443221111 1123456999999865 367889999999999999999876653221100 0 0000111
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.+.+......... ......+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus 236 ~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAP-------PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111111111 12234577888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.55 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=195.7
Q ss_pred hhhcccCCcCceEEEEEEcC-CCc----EEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGR----LVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
...+.||+|+||.||+|.+. +|+ .||+|.+...... ..++.+|+.++++++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 34568999999999999853 444 5788988754322 24688999999999999999999998754 4679999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++...
T Consensus 89 ~~~~g~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 89 LMPHGCLLDYVHEH-----KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred hcCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 99999999998543 23688999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
............++..|+|||++.+ ..++.++||||||+++|||++ |+.|+.... ...+.+.+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~ 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-------TREIPDLLEKGERLP 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHCCCCCC
Confidence 4433222223446789999999864 368899999999999999997 888875321 122222222222222
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.... ....+..++..||..+|++||++++++++|+....
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 232 QPPI-------CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 12356778899999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=302.76 Aligned_cols=240 Identities=23% Similarity=0.365 Sum_probs=185.5
Q ss_pred cccCCcCceEEEEEEcCC-------------CcEEEEEEeccCCCC-hHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 209 DKLGQGGYADVYKGTLPD-------------GRLVAVKVMKNLKDN-GEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
+.||+|+||.||+|.... ...||+|++...... ...|.+|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 225899988754332 357888999999999999999999999988999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc-------eE
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC-------PK 347 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~-------~k 347 (511)
+||||+++|+|..++... ...+++..++.++.||++||+|||+. +|+||||||+|||++.++. +|
T Consensus 81 lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-----SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 999999999999888532 24689999999999999999999998 9999999999999987664 89
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHH-hCCCCCCCccCCCCCCchHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMV-IGRKNADVKVSCSSEYFPNAI 426 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~ 426 (511)
++|||++....... ...++..|+|||.+... ..++.++||||||+++|||+ +|+.|+.... ... .
T Consensus 153 l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~-~ 218 (262)
T cd05077 153 LSDPGIPITVLSRQ------ECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKT------LAE-K 218 (262)
T ss_pred eCCCCCCccccCcc------cccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcc------hhH-H
Confidence 99999987653322 33578899999988532 46788999999999999998 5777764321 111 1
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
. ...... ... ..+ ....+..++.+||+.||++||++.++++.|+
T Consensus 219 ~-~~~~~~-~~~---~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 219 E-RFYEGQ-CML---VTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred H-HHHhcC-ccC---CCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1 111110 111 111 1234677889999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=313.52 Aligned_cols=239 Identities=22% Similarity=0.304 Sum_probs=188.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+++.+.||+|+||+||+|..+ +++.||+|++++.. ...+.+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 346788999999999999865 57899999997532 2234567788888777 58899999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~~~~g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 82 YVNGGDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred CCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999988532 4588999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+.... ...
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~-~~~ 220 (323)
T cd05616 153 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHN-VAY 220 (323)
T ss_pred CCCC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCC-CCC
Confidence 2221 12244699999999999653 68899999999999999999999996431 223333332221 122
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
+...+ ..+.+++.+|++.+|++|++.
T Consensus 221 p~~~s-------~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMS-------KEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCC-------HHHHHHHHHHcccCHHhcCCC
Confidence 22233 345667778889999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.75 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=198.8
Q ss_pred HHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEee--c
Q 040808 197 YSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYE--K 270 (511)
Q Consensus 197 ~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 270 (511)
..++....|.+.++||+|+||+||++.+. .+..+|+|++..... ....+..|+.++.+++|||||+++++|.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34444455677889999999999999965 578899999875322 23578899999999999999999998854 4
Q ss_pred CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCcEecCCCCCCEEEcC----
Q 040808 271 KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN----IRIVHLDIKPHNIRLDE---- 342 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~----~~iiH~Dlkp~NIll~~---- 342 (511)
...++||||+++|+|.++|.... .....+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~--~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCY--KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 57899999999999999996432 123469999999999999999999998521 25999999999999964
Q ss_pred -------------CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCC
Q 040808 343 -------------DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK 409 (511)
Q Consensus 343 -------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~ 409 (511)
.+.+||+|||+++....... .....||+.|+|||++.+....++.++||||||||||||++|+.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 34589999999987643322 12346999999999986543467899999999999999999999
Q ss_pred CCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 410 NADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 410 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
||.... . ...+...+.....+... . ....+.+++.+||+.+|.+||++.+++.
T Consensus 242 PF~~~~-----~-~~qli~~lk~~p~lpi~-~-------~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKAN-----N-FSQLISELKRGPDLPIK-G-------KSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCC-----c-HHHHHHHHhcCCCCCcC-C-------CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 985321 1 12222222222111111 1 1234667788899999999999999984
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.24 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=201.4
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCc----EEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGR----LVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
.+.+.+.||+|+||+||+|..+ +|+ .+|+|.++.... ..+++.+|+.++++++|+||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 4456789999999999999854 333 589998876543 23678899999999999999999999887 788999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 87 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EecCCCCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999995432 3589999999999999999999997 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
..............++..|+|||.+.. +.++.++||||||+++|||++ |+.|++... ...+...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~ 229 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-------AVEIPDLLEKGER 229 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHhCCCC
Confidence 764433222222334678999999854 367899999999999999998 999986431 2222333333222
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+...+ ..+.+++.+||..+|++||++.++++.|+...+
T Consensus 230 ~~~~~~~~-------~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 LPQPPICT-------IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCC-------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22222222 245677889999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=305.14 Aligned_cols=250 Identities=28% Similarity=0.395 Sum_probs=194.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeec------CeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEK------KKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~lv 276 (511)
|++.++||+|+||.||+|... +++.||+|++........++.+|+.++.++ +|+||+++++++... ...++|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 455678999999999999855 588999999987666667889999999998 699999999998653 468899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 88 MEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEcCCCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 99999999999986422 34689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
...... ......|++.|+|||++... ...++.++|||||||++|||++|+.|+.... +..........
T Consensus 161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-------~~~~~~~~~~~ 231 (272)
T cd06637 161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-------PMRALFLIPRN 231 (272)
T ss_pred cccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-------HHHHHHHHhcC
Confidence 543221 12234689999999998532 2357789999999999999999999985321 11111111111
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ..... ......+.+++.+||+.+|.+|||+.++++
T Consensus 232 ~~---~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PA---PRLKS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC---CCCCC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 00000 112345678889999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=299.37 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=196.3
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEe-ecCeEEEEEEeCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCY-EKKKRALIYEFMPN 282 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~ 282 (511)
.+.+.+.||+|+||.||++... |..||+|.++... ..+.+.+|+.++++++|+|++++++++. +.+..+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 3456788999999999999864 7789999987533 3567999999999999999999999764 55678999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 85 GSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 99999986432 24588999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
....++..|+|||++.. ..++.++||||||+++|||++ |+.|+.... ...+...+..........
T Consensus 157 ----~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~- 222 (256)
T cd05082 157 ----DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPD- 222 (256)
T ss_pred ----CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-
Confidence 12345678999999865 368889999999999999997 888875321 122223333222211111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 ------GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 223456678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.09 Aligned_cols=236 Identities=23% Similarity=0.303 Sum_probs=183.5
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHH-HHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVA-SISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||.||+|+.. +++.||+|++.+.. ....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 68999999987532 22334555654 57889999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQR------ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 999988843 24578888999999999999999998 999999999999999999999999999875422221
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+... ...++...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~-~~~~~~~~ 219 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILHK-PLQLPGGK 219 (321)
T ss_pred --ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhcC-CCCCCCCC
Confidence 12234689999999998653 67889999999999999999999986431 12222222221 11222222
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMT 472 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~ 472 (511)
+ ..+.+++.+||+.+|.+||++.
T Consensus 220 ~-------~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 T-------VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C-------HHHHHHHHHHccCCHhhcCCCC
Confidence 2 3456677888899999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.77 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=192.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+++.. +++.||+|++.+. ....+.+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456788999999999999955 5899999999742 22335688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 83 YVGGDLLTLLSKF-----EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred CCCCcHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999542 24688999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh-hhc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET-EYD 435 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 435 (511)
..... .....||+.|+|||++... .+.++.++|||||||++|||++|+.||.... ..+ .+..+.. ...
T Consensus 155 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~-~~~~i~~~~~~ 226 (331)
T cd05597 155 DGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVE-TYGKIMNHKEH 226 (331)
T ss_pred CCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHH-HHHHHHcCCCc
Confidence 32211 1223599999999998631 2356789999999999999999999985321 111 1222211 111
Q ss_pred cccC---CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 436 FQLD---GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 436 ~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
..++ ...++...+++++|+ |...++..||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll-----~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFPPDVTDVSEEAKDLIRRLI-----CSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCCCccCCCCHHHHHHHHHHc-----cCcccccCCCCHHHHhcC
Confidence 1111 123444445444433 556666668999998865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.67 Aligned_cols=255 Identities=20% Similarity=0.312 Sum_probs=185.0
Q ss_pred ccCCcCceEEEEEEcCCC---cEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 210 KLGQGGYADVYKGTLPDG---RLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+||+|+||+||+|...++ ..+++|.++... ...+.+.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975433 346677665432 234689999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++..... .....++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 82 LKSYLSQEQW--HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred HHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999965431 124567778889999999999999998 99999999999999999999999999986432221111
Q ss_pred eecCCCCCCCccchhhcccc-----cCCCCccccchhHHHHHHHHHhC-CCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 365 SMLDTRGTAGYIAPEVFCRH-----FGGVSHKSDVYSYGMMIHEMVIG-RKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
......++..|+|||++... ....+.++||||||+++|||+++ ..|+.... ..+.....+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~~~~~~~ 230 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS------DREVLNHVIKDQQVKLF 230 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhhcccccC
Confidence 11234588999999997432 12357799999999999999975 55654221 11222222222111111
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
+..... .....+.+++..|| .+|++||++++|+++|.
T Consensus 231 ~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111111 12234555667788 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=323.05 Aligned_cols=261 Identities=21% Similarity=0.219 Sum_probs=195.1
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLP---DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
+.+.+|.+.++||+|+||.||++... .++.||+|.+... ....+|++++++++||||+++++++......++|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 33445778889999999999999743 3678999988653 3456899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
||++ +++|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 165 ~e~~-~~~l~~~l~~------~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 165 MPKY-KCDLFTYVDR------SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred ehhc-CCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 9999 5789888832 35689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH------
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI------ 430 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 430 (511)
..............||+.|+|||++... .++.++|||||||++|||++|+.||..............+.+.+
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 6544332223345699999999999653 67899999999999999999999986443221110000011000
Q ss_pred -------------hhhhccccCC--CCChHH--HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 431 -------------ETEYDFQLDG--VVTEEE--KEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 431 -------------~~~~~~~~~~--~~~~~~--~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.... ..... ..+... ......+..++.+||+.||++|||+.|++..
T Consensus 313 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYA-IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccchhHHHHHHhhc-ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000 000000 0112345567788999999999999999865
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=301.66 Aligned_cols=240 Identities=21% Similarity=0.369 Sum_probs=188.6
Q ss_pred cccCCcCceEEEEEEcCC-C----------cEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 209 DKLGQGGYADVYKGTLPD-G----------RLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.||+|+||.||+|.+.+ + ..+++|++.........|.+|+.++++++|+||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 469999999999999754 3 258888877554446789999999999999999999999988 7789999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-------ceEEee
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-------CPKISD 350 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~D 350 (511)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999996432 2689999999999999999999998 999999999999999888 799999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhC-CCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG-RKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||++....... ...++..|+|||++.......+.++||||||+++|||++| ..|+..... ......
T Consensus 152 fg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-------~~~~~~ 218 (259)
T cd05037 152 PGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-------SEKERF 218 (259)
T ss_pred CCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-------hhHHHH
Confidence 99988654321 2346788999999865433678899999999999999995 555543211 000111
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
......... .. ...+.+++.+||+.+|++|||+.+|++.|+
T Consensus 219 ~~~~~~~~~----~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHRLPM----PD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCCCCC----CC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111111 11 156778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=298.97 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=199.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.+.||+|++|.||+|..+ +++.|++|.+... ....+++.+|++++++++||||+++++++.+....++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45678999999999999865 6899999998643 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.... ...+++..++.++.+++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~L~~~l~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 83 NGDLHKLLKMQR----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999996532 35689999999999999999999998 99999999999999999999999999988765433
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
... ....|++.|+|||++.+. ..+.++||||||+++++|++|+.|+.... .......+........
T Consensus 156 ~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~--- 221 (256)
T cd08529 156 NFA--NTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANN-------QGALILKIIRGVFPPV--- 221 (256)
T ss_pred chh--hccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCC---
Confidence 221 234588999999998653 67889999999999999999999986332 2222222222211111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11344567888899999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=311.34 Aligned_cols=252 Identities=20% Similarity=0.305 Sum_probs=191.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++||+|+||+||++..+ +++.+|+|++.+. ......+.+|+.++..++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 456788999999999999965 5789999998642 22234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~g~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 83 YVGGDLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred cCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999995422 4689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh-hc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE-YD 435 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 435 (511)
.... ......||+.|+|||++... .+.++.++|||||||++|||++|+.||.... ....+..+... ..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~ 226 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKER 226 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-------HHHHHHHHhCCCcc
Confidence 3221 11234699999999998531 2357889999999999999999999986331 11122222211 11
Q ss_pred cccC---CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 436 FQLD---GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 436 ~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...+ ..+++...+++++|+ |...++..|++++++++.
T Consensus 227 ~~~p~~~~~~s~~~~~li~~ll-----~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFPAQVTDVSEDAKDLIRRLI-----CSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCCccccCCHHHHHHHHHHc-----cChhhhcCCCCHHHHhCC
Confidence 1111 123444444444433 445555567899998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=296.52 Aligned_cols=248 Identities=28% Similarity=0.469 Sum_probs=195.9
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
++||+|+||.||++.+.+++.||+|.++.... ..+++.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999976799999999876433 3467899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeee
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
+++... ...+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~l~~~-----~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 81 TFLRKK-----KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 998542 23578999999999999999999998 9999999999999999999999999999866432211111
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
....++..|+|||.+.+ +.++.++||||||+++|||++ |..|+.... +......+........+
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-------~~~~~~~~~~~~~~~~~------ 217 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMS-------NQQTRERIESGYRMPAP------ 217 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCC-------HHHHHHHHhcCCCCCCC------
Confidence 12234677999999865 368899999999999999998 777764321 11222222222111111
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
......+.+++.+||+.+|++|||+.||++.|+.
T Consensus 218 -~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 -QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred -ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1223457778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=304.52 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=185.5
Q ss_pred ccCCcCceEEEEEEcCC-------------------------CcEEEEEEeccCCCC-hHHHHHHHHHHHccCCcceeee
Q 040808 210 KLGQGGYADVYKGTLPD-------------------------GRLVAVKVMKNLKDN-GEEFINEVASISRTSHVNIVPF 263 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l 263 (511)
+||+|+||.||+|.+.. ...||+|++...... ..+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 135899988754332 3578899999999999999999
Q ss_pred eceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC
Q 040808 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED 343 (511)
Q Consensus 264 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~ 343 (511)
++++.+....++||||+++|+|..++... ...+++..+..++.||++||+|||+. +|+||||||+|||++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-----KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99999999999999999999999998532 24688999999999999999999998 99999999999999765
Q ss_pred C-------ceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHH-hCCCCCCCcc
Q 040808 344 F-------CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMV-IGRKNADVKV 415 (511)
Q Consensus 344 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ell-tg~~p~~~~~ 415 (511)
+ .+|++|||++....... ...++..|+|||.+.+. ..++.++||||||+++|||+ +|+.|+....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CcccCccceeeecCCcccccccccc------ccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4 47999999886543221 23478889999998653 46789999999999999995 6888875332
Q ss_pred CCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 416 SCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
. ........... ..+.. ....+.+++.+||+.+|++|||+++|++.|.
T Consensus 227 ~-------~~~~~~~~~~~--~~~~~-------~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 P-------SEKERFYEKKH--RLPEP-------SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred h-------HHHHHHHHhcc--CCCCC-------CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11111111111 11111 1234778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.51 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=196.9
Q ss_pred hhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecC------e
Q 040808 206 SFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKK------K 272 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 272 (511)
.+.+.||+|+||+||+|.+. .++.||+|++..... ..+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999743 368899999875432 2457889999999999999999999886432 3
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++++||+++|+|.+++...........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 478999999999999885433222234689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
+++...............+++.|++||.+... ..+.++||||||+++|||++ |+.|+.... ...+...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~-------~~~~~~~~~ 229 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-------NSEIYNYLI 229 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCC-------HHHHHHHHH
Confidence 99876543322222223456789999998653 67889999999999999999 777764221 122233332
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
......... .....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLKQPP-------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCCCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222111111 1234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.22 Aligned_cols=260 Identities=24% Similarity=0.300 Sum_probs=191.7
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecC-----eEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKK-----KRALI 276 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 276 (511)
.+.++||+|+||+||++... +|+.||+|.+..... ...++.+|+.+++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 34678999999999999954 789999999875322 2357889999999999999999999998766 78999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~e~~~-~~l~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 83 TELMQ-SDLHKIIVS------PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred eeccc-cCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99995 688888743 24689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC---------CCchHHHH
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS---------EYFPNAIY 427 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~---------~~~~~~~~ 427 (511)
....... ......+|+.|+|||++.+. ..++.++|||||||++|||++|+.||........ ......+.
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5433221 12234588999999998653 3578899999999999999999999864321000 00000000
Q ss_pred HHHhhhhcccc-CCCCChHH-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 428 KQIETEYDFQL-DGVVTEEE-------KEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 428 ~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
........... .....+.. ......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 00000000 0113456678889999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.80 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=192.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|..+ +++.||+|.++... .....+.+|++++++++|+||+++++++...+..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 456788999999999999865 68899999987433 233568899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 88 -~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 88 -KDLKQYMDDC-----GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred -CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 5888887542 24578899999999999999999998 99999999999999999999999999997654332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH-----------HHH
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY-----------KQI 430 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~ 430 (511)
.. .....+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||....... ....+. ..+
T Consensus 159 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 159 KT--YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred cc--cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhh
Confidence 21 1234589999999998643 357889999999999999999999986432100 000000 000
Q ss_pred hhh---hccccCCCCC----hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETE---YDFQLDGVVT----EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~---~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... .......... .....+.....+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 0000000000 000112334567788899999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.82 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=187.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeec--------CeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEK--------KKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~ 274 (511)
.|.+.++||+|+||+||+|... +++.||||.+.... ....+|+.++++++||||+++++++... ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 3566789999999999999864 68999999886432 2345799999999999999999876432 2466
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccC
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGL 353 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGl 353 (511)
+||||++ ++|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 144 lvmE~~~-~~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEecCC-ccHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 8999996 57877775432 2235789999999999999999999998 999999999999998664 799999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++........ ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... .+.+.+.+...
T Consensus 218 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~------~~~~~~i~~~~ 287 (440)
T PTZ00036 218 AKNLLAGQRS---VSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSS------VDQLVRIIQVL 287 (440)
T ss_pred chhccCCCCc---ccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHh
Confidence 9876543322 234689999999998653 3578999999999999999999999864321 11111111000
Q ss_pred ---------------hccccCCCCChHHH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 ---------------YDFQLDGVVTEEEK-----EMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ---------------~~~~~~~~~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+........ ....++.+++.+||+.||++|||+.|+++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00001111111111 12245778889999999999999999983
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=300.01 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=199.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-C---CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-D---GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+.||+|+||.||+|.+. + +..+|+|.++.... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 456788999999999999853 2 34799999875432 23578999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||+++...
T Consensus 86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 86 YMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred cCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999995432 4589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 359 KKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 359 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
....... .....++..|+|||++.. +.++.++||||||+++||+++ |+.|+.... .......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-------~~~~~~~~~~~~~~ 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMS-------NQDVIKAIEEGYRL 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCC-------HHHHHHHHhCCCcC
Confidence 4332211 112234568999999965 368899999999999999886 998875321 11222333332222
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.... .....+.+++.+||+.+|++||+|.++++.|+..
T Consensus 229 ~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PAPM-------DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCC-------CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111 1234567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=309.95 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=200.8
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCC----ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKD----NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 275 (511)
+..|.+.++||+|.||.||++..+. |+.+|+|++.+... ..+...+|+++|+++. |||||.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3456677899999999999999664 99999999976533 3368899999999999 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC----CCceEEeec
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE----DFCPKISDF 351 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DF 351 (511)
|||++.||.|.+.|... .+++..+..++.|++.+++|||+. +|+||||||+|+|+.. ++.+|++||
T Consensus 114 vmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999543 299999999999999999999997 9999999999999953 358999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|++........ ....+||+.|+|||++... .++..+||||+|+++|.|++|..||..... ......+.
T Consensus 184 Gla~~~~~~~~---~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-------~~~~~~i~ 251 (382)
T KOG0032|consen 184 GLAKFIKPGER---LHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETE-------FEIFLAIL 251 (382)
T ss_pred CCceEccCCce---EeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCCh-------hHHHHHHH
Confidence 99998877333 3456799999999999653 789999999999999999999999975421 11111222
Q ss_pred hh-hcc--ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 TE-YDF--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 ~~-~~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ..+ .....++...++++++|+ ..||..|+|+.++++
T Consensus 252 ~~~~~f~~~~w~~is~~akd~i~~ll-------~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 252 RGDFDFTSEPWDDISESAKDFIRKLL-------EFDPRKRLTAAQALQ 292 (382)
T ss_pred cCCCCCCCCCccccCHHHHHHHHHhc-------ccCcccCCCHHHHhc
Confidence 21 111 112334556666666655 999999999999988
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=315.44 Aligned_cols=240 Identities=23% Similarity=0.287 Sum_probs=184.3
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHcc---CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRT---SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
||+|+||+||+|+.+ +++.||+|++.+.. .....+..|..++.+. .||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 68999999986432 1223456677777665 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~------~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQK------EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 999998843 24689999999999999999999998 999999999999999999999999999876433222
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
. .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.... ....++.+...........+
T Consensus 152 ~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~ 221 (330)
T cd05586 152 T--TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAED-------TQQMYRNIAFGKVRFPKNVL 221 (330)
T ss_pred C--ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCC-------HHHHHHHHHcCCCCCCCccC
Confidence 1 2244699999999998643 247889999999999999999999986431 22233333222111111122
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPS----MTKVVE 476 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs----~~evl~ 476 (511)
++ .+.+++.+||+.||++||+ +.++++
T Consensus 222 ~~-------~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SD-------EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CH-------HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 33 3445667788999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.76 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=192.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
...+.||+|+||+||+|... +++.||+|.+.... .....+.+|++++++++|+||+.+.+.+.+++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 44578999999999999854 68999999986532 12245788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 83 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 83 NGGDLKFHIYNMG----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred cCccHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999885432 24699999999999999999999998 9999999999999999999999999999765433
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. .....|++.|+|||++.+ ..++.++|+||||+++|+|++|+.||..... ......+...+.... .....
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~---~~~~~~~~~~~~~~~-~~~~~ 226 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE---KVKREEVDRRVLETE-EVYSA 226 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhhhccc-cccCc
Confidence 22 123468999999999865 3688999999999999999999999864311 000111111111111 11111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
.....+.+++.+||+.||++||+ +.++++
T Consensus 227 -------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 -------KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -------cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 12334567788899999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=302.18 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=199.6
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
+.++.+.++||+|+||.||+|.+.+ ...||+|...... ...+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3445677899999999999998543 3469999887543 234679999999999999999999998875 45789
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++|+|.+++... ...+++..++.++.+++.||+|||+. +++|+||||+||+++.++.+||+|||+++
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 84 VMELAPLGELRSYLQVN-----KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEcCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceee
Confidence 99999999999999542 23589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
......... .....+++.|+|||.+... .++.++||||||+++|||++ |+.||.... .......+....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~-------~~~~~~~~~~~~ 225 (270)
T cd05056 156 YLEDESYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVK-------NNDVIGRIENGE 225 (270)
T ss_pred eccccccee-cCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCC
Confidence 765443221 1233456789999998543 67899999999999999996 999885332 111222233322
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....... ....+.+++.+||..+|++|||+.++++.|+...+
T Consensus 226 ~~~~~~~-------~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 RLPMPPN-------CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred cCCCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 2222222 23356678888999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.85 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=187.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHcc---CCcceeeeeceEee-----cCe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRT---SHVNIVPFLGFCYE-----KKK 272 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~ 272 (511)
|.+.++||+|+||+||+|..+ +++.||+|.++.... ....+.+|+++++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456788999999999999865 689999999875321 224566788777765 69999999998864 345
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccC
Confidence 789999996 58988885422 24589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .+ ....+..
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~------~~-~~~~~~~ 221 (288)
T cd07863 154 LARIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSE------AD-QLGKIFD 221 (288)
T ss_pred ccccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCH------HH-HHHHHHH
Confidence 9987654322 1234589999999998653 688999999999999999999998853311 11 1111110
Q ss_pred hhc------c----c-----cCCC----CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYD------F----Q-----LDGV----VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~------~----~-----~~~~----~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... . . .... ......+....+.+++.+||+.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0 0 0000 00001123345667888899999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.72 Aligned_cols=262 Identities=21% Similarity=0.278 Sum_probs=200.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||.||+|.+. +|+.||+|+++.... ..++|.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456789999999999999965 589999999975322 235789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 280 MPNGSLDQYIYDHESS-----NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+++|+|.+++...... .....+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999998642110 1123467788899999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCc----------------eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC
Q 040808 355 KQTEKKES----------------FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS 418 (511)
Q Consensus 355 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~ 418 (511)
+....... ........||+.|+|||++.+. ..+.++|||||||++|||++|+.||.....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~-- 236 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKG-- 236 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcch--
Confidence 86621110 0001123599999999998654 678999999999999999999999864221
Q ss_pred CCCchHHHHH-HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhccccC
Q 040808 419 SEYFPNAIYK-QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-SMTKVVEMLEGSIEN 484 (511)
Q Consensus 419 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~~ 484 (511)
...... .+... .... ...+....+.+++.+||+.||++|| +++++++.|+..++.
T Consensus 237 ----~ki~~~~~i~~P------~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 237 ----RKISYRDVILSP------IEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ----hhhhhhhhccCh------hhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000111 00000 0000 0123344567788899999999996 788888888876553
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=288.64 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=202.4
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.|++.+.||+|.|+.|+++... +|+.+|+|++... ....++..+|+.|.+.++|||||+|.+...+....++|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 3556678999999999999754 6999999988632 33557888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc---CCCceEEeeccCccc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISDFGLAKQ 356 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~ 356 (511)
|.|++|..-|..+ ..+++..+-..+.||+++|.|+|.+ +|||||+||+|+||. ..--+||+|||+|..
T Consensus 92 m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 92 VTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999998777543 3567788888999999999999998 999999999999994 344689999999998
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-c
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-D 435 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 435 (511)
+..+.. .....|||+|||||++.+. .++..+|||+.|||||-|+.|.+||... -...+++++..+. +
T Consensus 163 l~~g~~---~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~-------~~~rlye~I~~g~yd 230 (355)
T KOG0033|consen 163 VNDGEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDE-------DQHRLYEQIKAGAYD 230 (355)
T ss_pred eCCccc---cccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCc-------cHHHHHHHHhccccC
Confidence 874432 3456799999999999764 7899999999999999999999999642 1345666665543 2
Q ss_pred c--ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 436 F--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 436 ~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
+ +....++++.++++++|+ ..||.+|.|+.|.+
T Consensus 231 ~~~~~w~~is~~Ak~LvrrML-------~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 231 YPSPEWDTVTPEAKSLIRRML-------TVNPKKRITADEAL 265 (355)
T ss_pred CCCcccCcCCHHHHHHHHHHh-------ccChhhhccHHHHh
Confidence 2 223567888888888887 89999999998876
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=310.30 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=188.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 278 (511)
+++.+.||+|+||+||+|..+ +|+.||+|++++. ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456788999999999999854 6899999999753 223356788999988886 5678889999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 y~~~g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 82 YVNGGDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999998532 4689999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+.+.+... ....
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~-~~~~ 220 (323)
T cd05615 153 VDGV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGED-------EDELFQSIMEH-NVSY 220 (323)
T ss_pred CCCc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhC-CCCC
Confidence 2221 11234599999999998653 67899999999999999999999986431 22333333221 1122
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
+...+ ..+.+++.+||+.+|++|++.
T Consensus 221 p~~~~-------~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLS-------KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCC-------HHHHHHHHHHcccCHhhCCCC
Confidence 22233 345567778889999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=308.29 Aligned_cols=201 Identities=23% Similarity=0.316 Sum_probs=162.0
Q ss_pred hcccCCcCceEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEEeCCC
Q 040808 208 SDKLGQGGYADVYKGTLP---DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYEFMPN 282 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 282 (511)
+.+||+|+||+||+|..+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. ....++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 357999999999999864 35789999987543 23567899999999999999999998853 567889999985
Q ss_pred CCHHHHHhcccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE----cCCCceEEeeccCcc
Q 040808 283 GSLDQYIYDHES---SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAK 355 (511)
Q Consensus 283 gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 355 (511)
++|.+++..... ......+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 588887753321 11234689999999999999999999998 99999999999999 567899999999998
Q ss_pred ccCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 356 QTEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 356 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
........ .......||+.|+|||++.+. ..++.++||||||+++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76443211 112334689999999998653 35788999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=304.58 Aligned_cols=252 Identities=30% Similarity=0.448 Sum_probs=195.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChH---HHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGE---EFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|++.++||+|+||+||++... +++.+|+|++........ ...+|+.++.+++|+||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 356789999999999999965 577899999987654332 3356999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ...+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp TTEBHHHHHHH------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccc------cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999962 25689999999999999999999998 9999999999999999999999999999764211
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. .......++..|+|||++.. ....+.++||||+|+++|+|++|+.|+..... ........+............
T Consensus 152 ~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T PF00069_consen 152 N--ENFNPFVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKILKRPLPSSSQQ 225 (260)
T ss_dssp T--SEBSSSSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHHHHTHHHHHTTS
T ss_pred c--cccccccccccccccccccc-cccccccccccccccccccccccccccccccc---hhhhhhhhhcccccccccccc
Confidence 1 12334568999999999861 24789999999999999999999999864300 000111111111111000000
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......+.+++.+||+.||++||+++++++
T Consensus 226 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 -----SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001156778889999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.71 Aligned_cols=198 Identities=27% Similarity=0.389 Sum_probs=168.4
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
++.+.||+|+||+||++..+ +++.||+|+++.. ......+.+|+.++.+++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999865 6899999999742 223457788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 84 PGGDMMTLLMK------KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999853 24689999999999999999999998 9999999999999999999999999998754321
Q ss_pred Cce---------------------------------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhC
Q 040808 361 ESF---------------------------------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407 (511)
Q Consensus 361 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg 407 (511)
... .......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccC
Confidence 100 001134699999999998654 678999999999999999999
Q ss_pred CCCCCCc
Q 040808 408 RKNADVK 414 (511)
Q Consensus 408 ~~p~~~~ 414 (511)
+.||...
T Consensus 233 ~~Pf~~~ 239 (360)
T cd05627 233 YPPFCSE 239 (360)
T ss_pred CCCCCCC
Confidence 9998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=302.78 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=193.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+...+.||+|+||+||++... +++.||+|.+..... ....+.+|+.++++++|+|++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345578999999999999855 689999998865321 124577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 82 ~~g~~L~~~l~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 82 MNGGDLKFHIYHMG----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred cCCCcHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999985432 24689999999999999999999998 999999999999999999999999999876644
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... ....|++.|+|||++.+ +.++.++||||||+++|+|++|+.||...... ...... ............
T Consensus 155 ~~~~---~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~~~~~~-~~~~~~~~~~~~ 225 (285)
T cd05630 155 GQTI---KGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK---IKREEV-ERLVKEVQEEYS 225 (285)
T ss_pred Cccc---cCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCcc---chHHHH-HhhhhhhhhhcC
Confidence 3321 23468999999999965 36889999999999999999999999643211 001111 111111111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
...+ ..+.+++.+||+.||++||| ++|+++
T Consensus 226 ~~~~-------~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 EKFS-------PDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ccCC-------HHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2222 33556777888999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=302.23 Aligned_cols=196 Identities=28% Similarity=0.396 Sum_probs=168.6
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEee-----cCeEEEEEE
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYE-----KKKRALIYE 278 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e 278 (511)
.+.||+|+||.|..+.++ +|+.||||.+.+. ....++..+|+.+|+.++|+||+.+.+++.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 357999999999999855 6899999988743 3345788899999999999999999998865 357899999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
+| .-+|...|+.. ..++...+..+++||++||.|+|+. +|+||||||+|+|++.+...||+|||+|+...
T Consensus 107 lM-etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HH-hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecc
Confidence 99 77999988542 3589999999999999999999998 99999999999999999999999999999886
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
.......++.-..|..|+|||++... ..++...||||.|||+.||++|++-|...
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 54222334566789999999999643 68999999999999999999999888644
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.37 Aligned_cols=200 Identities=20% Similarity=0.286 Sum_probs=169.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||+++.+ +++.||+|++.+.. .....+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456788999999999999965 68899999987521 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 83 YVGGDLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred CCCCcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999996422 4688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
..... .....||+.|+|||++.+. .+.++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 155 DGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCcee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 33221 1234699999999998542 13567899999999999999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=313.60 Aligned_cols=250 Identities=18% Similarity=0.273 Sum_probs=191.2
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
..|.+.+.||+|+||.||++..+ +++.+|+|++.+.. ...+.+.+|+.+++.++||||+++++.+.+....++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45566789999999999999965 68899999986421 22345788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++.. ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 123 Ey~~gg~L~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 123 EYMPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred cCCCCCcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999843 2478888999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhccccc--CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHF--GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY- 434 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 434 (511)
...... ......||+.|+|||++.... +.++.++|||||||++|||++|+.||.... ....+..+....
T Consensus 193 ~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~ 264 (371)
T cd05622 193 NKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNHKN 264 (371)
T ss_pred CcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCC
Confidence 543221 123456999999999986431 237889999999999999999999996432 122233332211
Q ss_pred cc--ccCCCCChHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 040808 435 DF--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPD--RPSMTKVVEM 477 (511)
Q Consensus 435 ~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPs~~evl~~ 477 (511)
.. .....++.. +..++.+|++.++.+ |++++++++.
T Consensus 265 ~~~~~~~~~~s~~-------~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 SLTFPDDNDISKE-------AKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cccCCCcCCCCHH-------HHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11 111123333 334455566733332 7789988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=297.05 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=197.6
Q ss_pred HhhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
|.+.++||+|+||.||+|...+ ++.+|+|.++.... .+++.+|++++++++|+||+++++.+.+....++++||++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 4566789999999999999664 88999999876433 678999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.........
T Consensus 84 ~L~~~l~~~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 84 SVSDIMKIT-----NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred cHHHHHHhC-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999998542 25789999999999999999999998 9999999999999999999999999999876543321
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
.....++..|+|||++.+. ..+.++||||||+++|+|++|+.|+..... ......+.... ....
T Consensus 156 --~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~----~~~~- 219 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHP-------MRAIFMIPNKP----PPTL- 219 (256)
T ss_pred --cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcch-------hhhhhhhccCC----CCCC-
Confidence 1233488999999998654 678899999999999999999999864321 00000000000 0001
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.........+.+++.+||+.+|++|||+++|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223345677888999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=296.60 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=197.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||.||++... +++.+|+|.++.. ....+.+.+|+.++++++|+||+++++.+.+....+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 346788999999999999855 6889999988643 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 82 GGDLMQKIKLQR----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999885422 24578999999999999999999998 99999999999999999999999999987664432
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. .....|++.|+|||++.+. ..+.++||||||+++|+|++|+.||.... .......+.......++..
T Consensus 155 ~~--~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 223 (255)
T cd08219 155 AY--ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKVCQGSYKPLPSH 223 (255)
T ss_pred cc--cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHHhcCCCCCCCcc
Confidence 21 1234589999999998653 68899999999999999999999986331 1111222222211111111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
....+.+++.+||+.||++||++.+++..
T Consensus 224 -------~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 -------YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22346677788999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=301.66 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=185.8
Q ss_pred cccCCcCceEEEEEEcCC-C-------cEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLPD-G-------RLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.||+|+||.||+|..+. + ..+|+|.+..... ..+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998542 2 3488888764332 346788999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc--------eEEeec
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC--------PKISDF 351 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~DF 351 (511)
+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999995432 3689999999999999999999998 9999999999999987765 699999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCC-CCCCccCCCCCCchHHHHHHH
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK-NADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~ 430 (511)
|++....... ...+++.|+|||++.+. ..++.++||||||+++|||++|.. |+.... +.......
T Consensus 153 g~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-------~~~~~~~~ 218 (258)
T cd05078 153 GISITVLPKE------ILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALD-------SQKKLQFY 218 (258)
T ss_pred ccccccCCch------hccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhcc-------HHHHHHHH
Confidence 9887554322 23578899999998653 357889999999999999999964 433111 11111111
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
.. ...++... ..++.+++.+||+.+|++|||+++++++|+
T Consensus 219 ~~--~~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 ED--RHQLPAPK-------WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hc--cccCCCCC-------cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 11111111 134678888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=296.50 Aligned_cols=248 Identities=27% Similarity=0.326 Sum_probs=194.2
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
...+.||+|++|.||++... +++.+|+|.+..... ....+.+|++++++++||||+++++++.+....++|+|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 45678999999999999854 689999999864321 22468889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+++...
T Consensus 85 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 85 YMPGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred ECCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999998542 3588899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
....... .....|+..|+|||.+.+. ..+.++||||||+++|||++|+.|+..... .....+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNPQ 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCCCC
Confidence 3221111 1234578899999999764 588999999999999999999999853211 111111111111111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
+... ....+..++.+||+.+|++|||+.++++.
T Consensus 228 ~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSH-------VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCcc-------CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 2222 23345667788999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=300.20 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=194.5
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.+.++||+|+||.||+|... +++.||+|+++.... ....+.+|+.+++.++||||+++++.+.+.+..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 4556788999999999999854 689999999875432 23567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 90 GGSLQDIYHV------TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999853 24689999999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. ......|++.|+|||++.. ..+.++.++|||||||++|+|++|+.|+..... ...+....... ... .
T Consensus 161 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~------~~~~~~~~~~~--~~~-~ 229 (267)
T cd06645 161 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP------MRALFLMTKSN--FQP-P 229 (267)
T ss_pred c--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc------hhhHHhhhccC--CCC-C
Confidence 1 1223468999999999742 123578899999999999999999998753211 01111111111 100 0
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. .........+.+++.+||+.+|++||++++|++
T Consensus 230 ~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 001112234667888899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=308.60 Aligned_cols=200 Identities=21% Similarity=0.247 Sum_probs=164.2
Q ss_pred hhcccCCc--CceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 207 FSDKLGQG--GYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 207 ~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
+.++||+| +|++||++..+ +|+.||+|.++..... .+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 78999999854 6899999999754322 245677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++..+. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+........
T Consensus 82 ~~~~l~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 82 AYGSAKDLICTHF----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred CCCcHHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 9999999995432 23589999999999999999999998 9999999999999999999999999865433211
Q ss_pred Ccee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 361 ESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 361 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
.... ......++..|+|||++.+....++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 1000 0112246788999999965434678999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=303.62 Aligned_cols=256 Identities=23% Similarity=0.325 Sum_probs=193.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|++|.||+|..+ ++..||+|+++... ...+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345678999999999999965 68999999986432 22367889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+ ++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 82 S-MDLKKYLDSLP---KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred C-CCHHHHHhcCC---CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 6 68988885432 235689999999999999999999998 9999999999999999999999999998765432
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh--------
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET-------- 432 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 432 (511)
.. ......+++.|+|||.+.+. ..++.++||||||+++|+|++|+.|+..... .+........
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 155 VR--VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSE------IDQLFRIFRILGTPTEDV 225 (285)
T ss_pred cc--cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHhCCCChhh
Confidence 21 11233578999999998653 3568899999999999999999998864321 0111110000
Q ss_pred ------------hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 ------------EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...................++.+++.+||+.||++|||+++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000011112345567888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=309.35 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=193.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+++.++||+|+||.||++... ++..+|+|.++.... ..+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 345678999999999999855 688899998875322 23568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++... ..+++..+..++.|+++||+|||+. .+++|+||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 83 GGSLDQVLKKA------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999532 4688999999999999999999973 289999999999999999999999999987653322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC-Cch-----------------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE-YFP----------------- 423 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~-~~~----------------- 423 (511)
. ....|++.|+|||.+.+. .++.++||||||+++|+|++|+.|+......... .+.
T Consensus 155 ~----~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 A----NSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred c----ccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence 1 234689999999998653 6788999999999999999999998533210000 000
Q ss_pred --------HHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 424 --------NAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 424 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
..+.+....... ......+. ......+.+++.+||+.+|++|||+.+|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVN-EPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhc-CCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 00000000 0123357788999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=304.78 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=196.0
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+|.+.++||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 445667899999999999985 468899999887543 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~L~~~~~~-------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 101 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999842 3478899999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. .....|++.|+|||.+.+. ..+.++||||||+++|+|++|+.||..... ........... ....
T Consensus 171 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~~~~~~~~~~-~~~~--- 236 (296)
T cd06654 171 SK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNG-TPEL--- 236 (296)
T ss_pred cc--cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCH------HHhHHHHhcCC-CCCC---
Confidence 21 1234588999999998653 678999999999999999999999864321 11111111111 0000
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.........+.+++.+||+.+|++||++.++++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011223445677889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=297.55 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=197.2
Q ss_pred HhhhcccCCcCceEEEEEEcCC--CcEEEEEEeccCC-----------CChHHHHHHHHHHHc-cCCcceeeeeceEeec
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD--GRLVAVKVMKNLK-----------DNGEEFINEVASISR-TSHVNIVPFLGFCYEK 270 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 270 (511)
|.+.+.||+|+||.||+|.++. ++.+|+|.+.... ....++.+|+.++.+ ++|+||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456789999999999999654 7889999875321 122457788888864 7999999999999999
Q ss_pred CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 271 KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
+..++||||+++++|.+++.... .....+++..++.++.|++.||+|||+. .+++|+||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLK--EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999885422 2235689999999999999999999963 2899999999999999999999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
||++....... ......|+..|+|||.+.+ +.++.++||||||+++|||++|+.|+.... ... ....+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~-~~~~~ 225 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLS-LATKI 225 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccC------HHH-HHHHH
Confidence 99998765443 1234568999999999965 367899999999999999999999985321 111 11122
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
......... .......+.+++.+||+.||++||++.||.++|+.
T Consensus 226 ~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 226 VEAVYEPLP------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred hhccCCcCC------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111111100 11123456778889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=295.56 Aligned_cols=248 Identities=30% Similarity=0.543 Sum_probs=198.5
Q ss_pred hhcccCCcCceEEEEEEcCC-----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 207 FSDKLGQGGYADVYKGTLPD-----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.||.|+||.||++...+ +..||+|+++.... ..+.+.+|+..+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56789999999999998653 38899999976544 456899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++....
T Consensus 83 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 83 MEGGDLLDYLRKNR----PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred cCCCCHHHHHHhhh----hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999996432 12289999999999999999999998 999999999999999999999999999987765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
....... ...+++.|+|||.+.. ...+.++||||+|+++++|++ |+.|+... -...+.+.+........
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~ 225 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGM-------SNEEVLEYLKKGYRLPK 225 (258)
T ss_pred ccccccc-cCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHhcCCCCCC
Confidence 4332211 2347889999999844 468899999999999999998 77776532 12222333333222222
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
... ....+.+++.+||+.+|++|||+.+++++|
T Consensus 226 ~~~-------~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PEN-------CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCc-------CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111 344577788899999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=300.36 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=194.7
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-----------ChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-----------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
...+.||+|+||.||+|... +|+.+|+|.++.... ..+.+.+|+.++++++|+|++++++++......
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34578999999999999854 689999998753211 124577899999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred EEEEecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999998532 4688999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++...............|+..|+|||.+.......+.++||||||+++|+|++|+.|+..... .....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhccc
Confidence 986543322222234468999999999865422478899999999999999999999853211 11111111111
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+. ....++...+.+++.+||+.+|++|||+++|++
T Consensus 229 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111 111233456777888899999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=299.11 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=195.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|++.++||+|+||.||+|... ++..+|+|.+.... ...+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456678999999999999965 57889999886533 2346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|..++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 87 GAVDAVMLEL-----ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 9999888532 24689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeecCCCCCCCccchhhccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 363 FISMLDTRGTAGYIAPEVFCR---HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
......+++.|+|||++.. ....++.++|||||||++|||++|+.|+.... +......+.........
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 229 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSEPPTLA 229 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-------HHHHHHHHhhcCCCCCC
Confidence 1223468999999999842 12356789999999999999999999875321 11111111111111100
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
........+.+++.+||+.+|++||++.++++.
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 230 -----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223456778889999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=312.91 Aligned_cols=189 Identities=24% Similarity=0.328 Sum_probs=161.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++.+....++|+|++ .
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-S 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-C
Confidence 4667789999999999999965 5789999975432 3457999999999999999999999999999999999 5
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 141 ~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 141 SDLYTYLTKR-----SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred CcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 7898888542 25689999999999999999999998 999999999999999999999999999975433222
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~ 411 (511)
.....||+.|+|||++.+. .++.++|||||||++|||+++..++
T Consensus 213 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 ---FLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1234599999999999653 6889999999999999999876554
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.36 Aligned_cols=194 Identities=26% Similarity=0.307 Sum_probs=162.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec------CeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 273 (511)
.|.+.+.||+|+||.||++... .++.||||++.... ....++.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 3556788999999999999854 58899999987532 2345788999999999999999999987543 357
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 105 ~lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 105 YIVMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred EEEEeCCC-CCHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 99999995 57777762 2478899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 173 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCCc---ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 986643321 1234689999999999653 6889999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=295.98 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=199.4
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|++.+.||.|+||.||.++. .+++.+++|.+.... ....++.+|++++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45678899999999999984 468899999886432 33457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 82 NGGTLYDKIVRQK----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred CCCcHHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999996432 34689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. ......|++.|+|||.+.+. ..+.++||||||+++|||++|+.|+.... +......+....
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~~~~~------ 217 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATN-------PLNLVVKIVQGN------ 217 (256)
T ss_pred cc--cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCC------
Confidence 32 11234689999999998653 57889999999999999999999986431 122222222211
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
..........++.+++.+||+.+|++||+++++++.+
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 218 -YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111123345577888899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.52 Aligned_cols=259 Identities=27% Similarity=0.479 Sum_probs=209.6
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEcCC---C--cEEEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeecC
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTLPD---G--RLVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEKK 271 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~~~---~--~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 271 (511)
++.+....+.++||+|-||.||+|...+ | -.||||..+.. ..+.+.|+.|.-+|+.++|||||+|+|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3445555667899999999999998432 2 35999999864 34468899999999999999999999999865
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
...+|||.++-|.|..||.. .+..++...+.-++.||+.||+|||+. +.|||||-..|||+...-+|||+||
T Consensus 464 P~WivmEL~~~GELr~yLq~-----nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ-----NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred ceeEEEecccchhHHHHHHh-----ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 47899999999999999954 346789999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHH
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
|+++.+.+..-.... ...-...|||||.+ ++..++.+||||-|||.+||++. |.+||..-.. ..+...+
T Consensus 536 GLSR~~ed~~yYkaS-~~kLPIKWmaPESI--NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-------sDVI~~i 605 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKAS-RGKLPIKWMAPESI--NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-------SDVIGHI 605 (974)
T ss_pred chhhhccccchhhcc-ccccceeecCcccc--chhcccchhhHHHHHHHHHHHHHhcCCccccccc-------cceEEEe
Confidence 999998776544332 33456789999998 56789999999999999999886 8888853211 1122234
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+.+.+++.+.. .+..+..++.+||..+|.+||.+.|+...|..+++
T Consensus 606 EnGeRlP~P~n-------CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 ENGERLPCPPN-------CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cCCCCCCCCCC-------CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 55554444443 34457789999999999999999999988876554
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=311.69 Aligned_cols=194 Identities=27% Similarity=0.313 Sum_probs=162.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec------CeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 273 (511)
.|.+.+.||+|+||.||++... +|+.||+|++.... ....++.+|+.+++.++||||+++++++... ...
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 3556789999999999999864 58999999987532 2345788999999999999999999988644 357
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||++ ++|...+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~lv~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 102 YLVMELMD-ANLCQVIH--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred EEEEeCCC-cCHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 99999995 46666662 2478889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 170 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCcc---CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 976543221 2334689999999999653 6889999999999999999999999643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=301.57 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=186.2
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecC-----eEEEEEEeCC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK-----KRALIYEFMP 281 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~ 281 (511)
.+.+|.|+||.||+|.+. +++.||||..-..+.. --+|+++|+++.|||||+|+-+|.... ...|||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 367999999999999955 5789999987654332 236999999999999999998886432 3348999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-CceEEeeccCccccCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKK 360 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~~~ 360 (511)
. +|..+++... ..+..++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+....+
T Consensus 106 ~-tL~~~~r~~~--~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 106 E-TLYRVIRHYT--RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred H-HHHHHHHHHh--hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 5 9999986532 2235677777888999999999999997 99999999999999976 99999999999999877
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH--------HHhh
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK--------QIET 432 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~ 432 (511)
+...+.. -|.-|+|||.+.+. ..++.+.||||.||++.||+-|++-|....... .+. .+.+ .+..
T Consensus 180 epniSYi---cSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~-eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 180 EPNISYI---CSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLV-EIIKVLGTPTREDIKS 252 (364)
T ss_pred CCceeEE---EeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHH-HHHHHhCCCCHHHHhh
Confidence 7655443 67789999999876 478999999999999999999998875432100 000 0000 0000
Q ss_pred hh----ccccCCCC----Ch-HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EY----DFQLDGVV----TE-EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~----~~~~~~~~----~~-~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ....+... .. .......+.++++.++++.+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 00000000 00 11223445667778888999999999999873
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.89 Aligned_cols=193 Identities=26% Similarity=0.309 Sum_probs=161.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec------CeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK------KKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 273 (511)
.|.+.+.||+|+||.||++... .++.||+|++..... ...++.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 3456788999999999999854 588999999875322 235778899999999999999999988643 357
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 98 ~lv~e~~~-~~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 98 YLVMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred EEEhhhhc-ccHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 99999995 56766662 3478899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 166 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 166 ARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cccCCCccc---cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 986543321 2234689999999998653 678999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=324.99 Aligned_cols=195 Identities=21% Similarity=0.318 Sum_probs=159.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCC------cceeeeeceEeec-CeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSH------VNIVPFLGFCYEK-KKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~l 275 (511)
.|.+.++||+|+||+||+|.+. .++.||||+++.......++..|++++..++| .+++++++++... .+.++
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 4566789999999999999864 58899999997654444566778888777765 4588888888754 57889
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-----------
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF----------- 344 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~----------- 344 (511)
|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEecc-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccccc
Confidence 99988 88999988532 4689999999999999999999973 2899999999999998765
Q ss_pred -----ceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 345 -----CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 345 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||+..
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred CCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999987643322 1245699999999999764 6889999999999999999999999743
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=303.81 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=192.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||.||+|..+ +++.||+|.++... .....+.+|+.++++++|+||+++++++.+....++||||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 456688999999999999865 58899999987432 233567899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|..++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 88 -~~l~~~l~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 88 -KDLKQYLDDC-----GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred -cCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 6998888543 24688999999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC-C-------chHHHHHHHhhh
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE-Y-------FPNAIYKQIETE 433 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~-~-------~~~~~~~~~~~~ 433 (511)
. ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.||......... . .....+..+...
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred C--cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1 11234578999999998653 35788999999999999999999998643210000 0 000000000000
Q ss_pred h---ccccCCCCCh----HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 Y---DFQLDGVVTE----EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ~---~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .........+ ....+...+.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000000000 00112334567888899999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.34 Aligned_cols=246 Identities=27% Similarity=0.334 Sum_probs=190.9
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
..||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999854 678899998875433 3467899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCccccCCCCce
Q 040808 287 QYIYDHESSNGKRTL--EWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~ 363 (511)
+++.... ..+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++.........
T Consensus 94 ~~l~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 94 ALLRSKW-----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHhc-----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 9996432 234 7888899999999999999998 9999999999999976 679999999998766433221
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
.....|++.|+|||++.......+.++||||||+++|+|++|+.|+..... ................++.
T Consensus 166 --~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~--- 235 (268)
T cd06624 166 --TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-----PQAAMFKVGMFKIHPEIPE--- 235 (268)
T ss_pred --cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC-----hhhhHhhhhhhccCCCCCc---
Confidence 123358999999999865433578899999999999999999999853211 0111111100011111111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+..++.+||+.+|++|||+.++++
T Consensus 236 ----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 236 ----SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 22344667788999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=350.25 Aligned_cols=266 Identities=23% Similarity=0.421 Sum_probs=201.4
Q ss_pred CCHHHHHHHHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 195 ~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
+++.++.+. ....+.||+|+||.||+|.. .++..||+|.++...... .+|++++++++|||||+++|+|.+....
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 344444332 22345799999999999996 478999999987544322 3468899999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||+++|+|.+++. .++|..+.+|+.|+++||+|||..+..+|+||||||+||+++.++.+++. ||.
T Consensus 759 ~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred EEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 99999999999999993 38899999999999999999997666799999999999999999988876 666
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
+...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.|++..... ......|........
T Consensus 829 ~~~~~~~------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~ 899 (968)
T PLN00113 829 PGLLCTD------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDC 899 (968)
T ss_pred ccccccC------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCcc
Confidence 5443222 12358899999999865 36899999999999999999999998643221 122333332211110
Q ss_pred -hccccCCCC---ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 434 -YDFQLDGVV---TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 434 -~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.....++.. .....+...++.+++.+||+.+|++||||+||+++|+....
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 001111111 11123445678899999999999999999999999998655
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.00 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=195.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+++.+.||+|+||.||++..+ +++.||+|.++.... ....+.+|+.++++++|+||+++++.+......++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456788999999999999965 689999998875322 23578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|..++.... ....+++..+..++.+++.||+|||+. .+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 83 AGSLDKLYAGGV---ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCHHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999885421 124689999999999999999999964 289999999999999999999999999987653322
Q ss_pred ceeeecCCCCCCCccchhhccccc----CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHF----GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
. ....+++.|+|||.+.+.. ..++.++|||||||++|+|++|+.||.... .......+.......
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~ 226 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-------YANIFAQLSAIVDGD 226 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-------hhhHHHHHHHHhhcC
Confidence 1 2335888999999985421 135789999999999999999999985321 111122222111111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...... +....+.+++.+||+.+|++||+++++++
T Consensus 227 -~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 -PPTLPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -CCCCCc---ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 011111 23445667888899999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=309.23 Aligned_cols=250 Identities=22% Similarity=0.271 Sum_probs=188.7
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec------CeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK------KKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 273 (511)
.|.+.+.||+|+||+||+|.. .+++.||+|++..... ..+++.+|+.++++++|+||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 345667899999999999985 4688999999875322 235678999999999999999999987543 356
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 96 ~~~~~~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 96 YLVTNLM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred EEEeecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 8999988 8899888732 3589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||..... .+.+ ..+...
T Consensus 165 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~-~~~~~~ 231 (343)
T cd07878 165 ARQADDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDY------IDQL-KRIMEV 231 (343)
T ss_pred ceecCCCc-----CCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHH-HHHHHH
Confidence 98764432 234689999999998653 3578899999999999999999999853311 0100 000000
Q ss_pred h-------------------ccccCCCCChHHH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 434 Y-------------------DFQLDGVVTEEEK----EMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 434 ~-------------------~~~~~~~~~~~~~----~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
. ...++........ .....+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000000000 111235678889999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=299.57 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=195.0
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|++.++||.|+||.||+|... +++.+|+|++..... ..+++.+|+.+++.++|+||+++++.+......++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 3566788999999999999965 589999999875432 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|..++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 93 GGAVDAIMLEL-----DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99999887532 24689999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
. ......+++.|+|||++... ...++.++||||||+++|||++|+.|+.... +......+........
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 235 (292)
T cd06644 165 Q--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSEPPTL 235 (292)
T ss_pred c--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-------HHHHHHHHhcCCCccC
Confidence 1 11234588999999998531 1346789999999999999999999885321 1122222211111000
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........++.+++.+||+.+|++||+++++++
T Consensus 236 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001122335667888899999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.65 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=193.2
Q ss_pred HhhhcccCCcCceEEEEEEcCCC-cEEEEEEeccC-CCChHHHHHHHHHHHccC-CcceeeeeceE-ee----c--CeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDG-RLVAVKVMKNL-KDNGEEFINEVASISRTS-HVNIVPFLGFC-YE----K--KKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~----~--~~~~ 274 (511)
..+.+.|.+|||+.||+|.+..+ ..+|+|++-.. ....+...+|+.+|++|+ |+|||.+++.. .. . -...
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 34567899999999999997665 99999987543 333467889999999998 99999999932 21 1 2567
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
|.||||++|.|-+++..+.. ..|++..+++|+.++++|+++||.. ..+|||||||-+||||+.+|..||+|||.+
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eehhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 89999999999999976542 3499999999999999999999985 568999999999999999999999999998
Q ss_pred cccCCCC-ce-----e-eecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHH
Q 040808 355 KQTEKKE-SF-----I-SMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI 426 (511)
Q Consensus 355 ~~~~~~~-~~-----~-~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 426 (511)
...-... .. + .....--|+.|+|||.+.-. .-.+++|+|||||||+||-|.....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 6432111 00 0 00112368999999998321 12689999999999999999999999974411
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
...+.....++.. ......|-.|+..||+.||++||++-+|++.+-.+.
T Consensus 264 laIlng~Y~~P~~-------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 264 LAILNGNYSFPPF-------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred eeEEeccccCCCC-------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 0111111111111 223445566666777999999999999999887654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=296.85 Aligned_cols=246 Identities=26% Similarity=0.368 Sum_probs=195.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.|...+.||+|+||.||+|.+. +++.||+|.++... ...+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3455678999999999999854 58899999987433 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 85 GGGSALDLLKP-------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 99999998832 3588999999999999999999998 9999999999999999999999999999766543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... .....|+..|+|||++.+. .++.++||||||+++|||++|+.|+.... +......+.......+.
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~- 222 (277)
T cd06642 155 QIK--RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLH-------PMRVLFLIPKNSPPTLE- 222 (277)
T ss_pred chh--hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccc-------hhhHHhhhhcCCCCCCC-
Confidence 211 1223588999999998654 67889999999999999999999975321 11111111111111111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
......+.+++.+||+.+|++||++.+|++.
T Consensus 223 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ------GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ------cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1233456788899999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=294.15 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=193.1
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
...+.||+|+||+||+|...+++.+|+|.++.... ....+.+|++++++++|+||+++++++.+....++|||
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 45678999999999999987899999998874322 12457889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 83 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 83 FVPGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred cCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999532 3578999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCc----eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh-
Q 040808 359 KKES----FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE- 433 (511)
Q Consensus 359 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 433 (511)
.... ........|+..|+|||++.+. ..+.++||||||+++|+|++|+.||..... .... . .+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~-~-~~~~~~ 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAM-F-YIGAHR 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHH-H-Hhhhcc
Confidence 2111 0111234589999999998653 678899999999999999999999853211 1111 1 11111
Q ss_pred -hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 -YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 -~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
....++. .....+..++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~-------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLPD-------SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCC-------CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111 12344667788899999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=305.53 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=196.7
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC---ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD---NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.|...++||+||-+.||++...+.+.+|+|.+..... ....|.+|++.|.+++ |.+||+|++|-..++..|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 4566789999999999999988888999987764332 3468999999999997 99999999999999999999998
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
= ..+|...|.... ...+.-.+..+-.|++.++.++|.+ ||||.||||.|+|+-. |.+||+|||+|..+..
T Consensus 442 G-d~DL~kiL~k~~-----~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 442 G-DIDLNKILKKKK-----SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred c-cccHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 6 679999996432 2333227788999999999999998 9999999999999975 6899999999999988
Q ss_pred CCceeeecCCCCCCCccchhhcccccC---------CCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFG---------GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
+...+.....+||+.||+||.+..... .++.+|||||+|||||+|+.|+.||.... .+...+....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl~aI~ 586 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKLHAIT 586 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHHHhhc
Confidence 776666667789999999999843322 37789999999999999999999985221 0111111111
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.-+..+..+. .++. ..++++|..||++||++|||+.|+|+
T Consensus 587 ~P~~~Iefp~-~~~~-----~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 587 DPNHEIEFPD-IPEN-----DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCCccccccC-CCCc-----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1111112221 1221 11778899999999999999999975
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.42 Aligned_cols=254 Identities=24% Similarity=0.402 Sum_probs=196.0
Q ss_pred hhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
...++||+|+||+||+|..+ +.+.+|+|.+...... .+++.+|++++++++|+||+++++++.+.+..++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 44568999999999999854 2467999988764433 467999999999999999999999999989999999
Q ss_pred EeCCCCCHHHHHhcccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 278 EFMPNGSLDQYIYDHESSN---GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999996543111 122689999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
+....... .......+++.|+|||.+.+. ..+.++||||||+++|+|++ |..|+.... ...+.......
T Consensus 165 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-------~~~~~~~~~~~ 234 (275)
T cd05046 165 KDVYNSEY-YKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLS-------DEEVLNRLQAG 234 (275)
T ss_pred cccCcccc-cccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccc-------hHHHHHHHHcC
Confidence 75433221 112233467789999998653 57889999999999999998 677764221 11222222211
Q ss_pred h-ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 434 Y-DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 434 ~-~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
. ...... .....+.+++.+||+.+|++||++.+++.+|.
T Consensus 235 ~~~~~~~~-------~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPVPE-------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCCCC-------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1 111111 12345777889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.84 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=196.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.++||.|+||.||++..+ ++..+|+|+++... ...+.|.+|++++++++|+||+++++.+.+....++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 567788999999999999864 68899999987543 2346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~L~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 87 GALDSIMLELE-----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CcHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999985432 4689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
......|++.|+|||.+... ...++.++||||||+++|+|++|+.|+.... .......+.......+.
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-------PMRVLLKILKSEPPTLD 229 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-------HHHHHHHHhcCCCCCcC
Confidence 11234589999999997421 1346789999999999999999999985321 11112222221111110
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
........+.+++.+||+.+|++||++.+|++.
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 -----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011123346677888999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=291.75 Aligned_cols=245 Identities=28% Similarity=0.468 Sum_probs=195.1
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+.+.||+|+||.||++.. .++.||+|.++.. ...+.+.+|+.++++++|||++++++++... ..++||||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 45678899999999999975 6788999998653 2346889999999999999999999988654 4799999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 L~~~l~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 85 LVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred HHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999996432 24688999999999999999999998 99999999999999999999999999987654321
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
.....+..|+|||.+.. +.++.++||||||+++|||++ |+.|+.... .......+.........
T Consensus 155 --~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~---- 219 (254)
T cd05083 155 --DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-------LKEVKECVEKGYRMEPP---- 219 (254)
T ss_pred --CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCC-------HHHHHHHHhCCCCCCCC----
Confidence 12335678999999864 368889999999999999997 888875331 12222333322211111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
......+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 ---EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1223456678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=301.71 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=202.6
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCCh---HHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|++.+.||+|.|..|-+|++ =.|..||||++.+.+-+. ..+..||..|+.++|||||+||++.......|||.|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 45667899999999999984 479999999998866443 57889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-CCCceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD-EDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~ 359 (511)
.+|+|.+||..++ ..+.+..+.+++.||+.||.|+|+- .||||||||+||.+- .-|-|||.|||++-.+..
T Consensus 100 D~GDl~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred CCchHHHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999998765 5789999999999999999999997 899999999999875 578999999999988877
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
++.. ...+|+.+|-|||++.+. .+-.++.||||||||||-|++|+.||..... .+.+-..+ ...+.++
T Consensus 172 G~kL---~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeAND------SETLTmIm--DCKYtvP 239 (864)
T KOG4717|consen 172 GKKL---TTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEAND------SETLTMIM--DCKYTVP 239 (864)
T ss_pred cchh---hcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccc------hhhhhhhh--cccccCc
Confidence 6653 456799999999999875 3556789999999999999999999963321 11111111 1223444
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
..++.+.++++..|+ +.||++|.+.+|++..
T Consensus 240 shvS~eCrdLI~sML-------vRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 240 SHVSKECRDLIQSML-------VRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhHHHHHHHHHHH-------hcCchhhccHHHHhcc
Confidence 555666666666655 9999999999998753
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=297.64 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=193.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEe-----ecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCY-----EKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~ 277 (511)
+.+.+.||+|+||.||++... +++.+|+|+++......+++.+|+.++.++ +|+||+++++++. ++...++||
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 345678999999999999864 588999999876554456788999999999 6999999999874 345789999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++++|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 100 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 100 ELCNGGSVTDLVKGFL--KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred eecCCCCHHHHHHHhh--ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999886432 2234688999999999999999999998 9999999999999999999999999998866
Q ss_pred CCCCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
..... ......|++.|+|||++... ...++.++||||+||++|||++|+.|+..... ...+. ......
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~------~~~~~-~~~~~~ 245 (286)
T cd06638 175 TSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP------MRALF-KIPRNP 245 (286)
T ss_pred ccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch------hHHHh-hccccC
Confidence 43221 11234689999999998532 13468899999999999999999999853311 01111 111110
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.... ..+ .....++..++.+||+.+|++|||+.||++.
T Consensus 246 ~~~~---~~~--~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTL---HQP--ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcc---cCC--CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 000 0112346778889999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=297.11 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=194.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|++.++||+|+||.||+|.++ +++.||+|++..... ..+.+.+|+.++++++|+|++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 456678999999999999966 589999998865432 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|..++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~l~~~~~~------~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 83 DHTVLNELEKN------PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred CccHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99988877632 23589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh-------
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE------- 433 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 433 (511)
... .....++..|+|||++.+. ..++.++||||||+++|||++|+.||..... .+.... +...
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~ 223 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSD------VDQLYL-IRKTLGDLIPR 223 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCCh------HHHHHH-HHHHhCCCChH
Confidence 321 1233478899999998643 3578899999999999999999999863321 011100 0000
Q ss_pred -------------hccccCCCCC---hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 -------------YDFQLDGVVT---EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 -------------~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......... .........+.+++.+||+.+|++||++.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000 001123456778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=292.21 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=197.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.+.++||.|+||.||+|... +++.+|+|++..... ..+.+.+|++++++++||||+++++.+.+....+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 456788999999999999864 578999999875433 346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 85 ~~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 85 GSLQDIYQVT-----RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CcHHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999998543 24688999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
......++..|+|||.+... .+..+.++||||||+++|||++|+.|+..... ........... + ...
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~------~~~~~~~~~~~--~--~~~ 224 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP------MRALFLISKSN--F--PPP 224 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcc--C--CCc
Confidence 11234588899999998542 12577899999999999999999999853211 11111111110 0 011
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...........+.+++.+||+.+|.+|||+.+|+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11112234456788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=293.58 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=193.0
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC----------hHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN----------GEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
.+...||+|++|.||+|... +++.+|+|.+...... .+.+.+|+.++++++||||+++++++.+....+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 45678999999999999854 5889999988643221 145788999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 83 IFLEYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999532 4588899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcee----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 355 KQTEKKESFI----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 355 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
+......... ......|++.|+|||.+.+. ..+.++||||||+++|+|++|+.||..... ...+. .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~-~~ 224 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIF-KI 224 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHH-HH
Confidence 8765321110 11123588999999998653 678899999999999999999999863211 11111 11
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......++. .....+..++.+||+.+|++||++.+|++
T Consensus 225 ~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GENASPEIPS-------NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hccCCCcCCc-------ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111111 23345667778899999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=293.88 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=196.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|...++||.|+||.||+|.+. +++.||+|++.... .....+.+|+.+++++.|+||+++++++.+....++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 445678999999999999865 58899999987543 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~i~~-------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 86 GGSALDLLRA-------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999842 3578899999999999999999998 99999999999999999999999999997765433
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. .....++..|+|||++.+. ..+.++||||||+++|||++|+.|+.... +......+....
T Consensus 156 ~~--~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~-------~~~~~~~~~~~~------- 217 (277)
T cd06640 156 IK--RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMH-------PMRVLFLIPKNN------- 217 (277)
T ss_pred cc--cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcC-------hHhHhhhhhcCC-------
Confidence 21 1234588899999998653 67899999999999999999999985321 111111111111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111122345567788899999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.70 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=195.7
Q ss_pred HHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
..|.+.++||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 3456678899999999999995 4789999999875432 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++......
T Consensus 99 ~~~~L~~~~~~-------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 99 AGGSLTDVVTE-------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred CCCCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999842 3578899999999999999999998 9999999999999999999999999998765433
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... .+.. +.......
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~------~~~~-~~~~~~~~--- 234 (297)
T cd06656 169 QSK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYL-IATNGTPE--- 234 (297)
T ss_pred ccC--cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch------heee-eccCCCCC---
Confidence 221 1233588999999998653 67899999999999999999999986432110 0000 00000000
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..........+.+++.+||+.+|++||++++|++
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011223344667888999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=300.26 Aligned_cols=258 Identities=19% Similarity=0.261 Sum_probs=191.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||.||+|... +|+.||+|.++.... ....+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456678999999999999965 689999999874322 2356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+ ++|.+++... ...+++..++.++.||++||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~-~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 82 D-QDLKKYFDSC-----NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred C-CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 6 6888887532 24589999999999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH-----------HH
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY-----------KQ 429 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----------~~ 429 (511)
.. ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+...... ......+. ..
T Consensus 153 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 153 VR--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred CC--CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHH
Confidence 21 11234578999999998653 34688999999999999999999886432210 00000000 00
Q ss_pred HhhhhccccCCCCC------hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 430 IETEYDFQLDGVVT------EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 430 ~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+............. .........+.+++.+||+.||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000000 001123345667888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=296.34 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=196.4
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEEeC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYEFM 280 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~ 280 (511)
.+.++||.|++|.||++.+. +++.+|+|.+..... ...++.+|++++++++||||+++++++.+ ....++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 45678999999999999965 588999999875433 34678999999999999999999998864 34789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... .....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 84 EGGSLDSIYKKVK--KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred CCCCHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999875432 1235688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. ....++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... ..+......+.......+..
T Consensus 159 ~~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd06621 159 LA----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP--LGPIELLSYIVNMPNPELKD 230 (287)
T ss_pred cc----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCC--CChHHHHHHHhcCCchhhcc
Confidence 21 123478899999998653 67889999999999999999999987542211 11111222221111111111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. .........+.+++.+||+.+|++|||+.||++
T Consensus 231 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11 101123456788999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.42 Aligned_cols=258 Identities=25% Similarity=0.334 Sum_probs=194.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC------hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN------GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
|.+.+.||+|+||.||+|... +++.||+|.++..... ...+.+|++++++++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 445678999999999999965 6899999999754322 345778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+ +++|.+++.... ..+++..+..++.||++||+|||+. +++|+||||+||+++.++.+||+|||+++..
T Consensus 82 e~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred ccc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 999 999999995321 3689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH-------
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI------- 430 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 430 (511)
...... .....+++.|+|||.+.+. ..++.++||||||+++|||++|..++...... ..+ ..+....
T Consensus 153 ~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~-~~~~~~~~~~~~~~ 226 (298)
T cd07841 153 GSPNRK--MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQL-GKIFEALGTPTEEN 226 (298)
T ss_pred cCCCcc--ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHH-HHHHHHcCCCchhh
Confidence 543221 1233578899999998543 35688999999999999999997766432110 000 0000000
Q ss_pred ----hhhhcc---ccCCCC--ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 431 ----ETEYDF---QLDGVV--TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 431 ----~~~~~~---~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...... ...... ..........+.+++.+||+.+|++|||+.||++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 000000 00112234567789999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.74 Aligned_cols=251 Identities=27% Similarity=0.363 Sum_probs=194.0
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEee------cCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYE------KKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~l 275 (511)
.+.+.++||.|+||.||+|... +++.+|+|++........++..|+.++.++ +|+||+++++++.. ....++
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 3456678999999999999964 688999999876655556788999999998 69999999998853 457899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
+|||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 97 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTK----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEeCCCCcHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 999999999999986432 24578888999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
....... ......|++.|+|||.+... ...++.++||||||+++|||++|+.|+..... ......+..
T Consensus 170 ~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-------~~~~~~~~~ 240 (282)
T cd06636 170 QLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPR 240 (282)
T ss_pred hhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-------HhhhhhHhh
Confidence 6532211 11234589999999998521 23577899999999999999999999853211 111111111
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ...........+.+++.+||+.||.+||++.|+++
T Consensus 241 ~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 NPP------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCC------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 100 01111223456778888999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=288.90 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=194.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEee-cCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYE-KKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 279 (511)
|.+.+.||+|++|.||++..+ +++.||+|.+.... ...+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999855 57899999986532 233568899999999999999999988764 4468899999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... ...+++..+..++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 82 CEGGDLYHKLKEQK----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred cCCCcHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999996422 34689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... .....+++.|+|||++.+. .++.++||||||+++++|++|+.|++... ...... .+.........
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~-~~~~~~~~~~~ 223 (257)
T cd08223 155 QCDM--ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVY-RIIEGKLPPMP 223 (257)
T ss_pred cCCc--cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHH-HHHhcCCCCCc
Confidence 3221 1234588999999998653 67889999999999999999999886321 112222 22221111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
......+.+++.+||+.+|++||++.++++.
T Consensus 224 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 -------KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -------cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1233457788889999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=296.93 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=193.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeec-----CeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEK-----KKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e 278 (511)
.+.+.||+|+||.||++... +++.+|+|++.......+++.+|+.++.++ +|||++++++++... ...++|||
T Consensus 25 ~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 45678999999999999864 688999999976555556788899999998 799999999998753 36899999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++.... .....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++....
T Consensus 105 y~~~~sL~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 105 LCNGGSVTELVKGLL--ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred ECCCCcHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999886432 1235689999999999999999999998 99999999999999999999999999988654
Q ss_pred CCCceeeecCCCCCCCccchhhccccc---CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHF---GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
..... .....|+..|+|||.+.... ...+.++||||||+++|||++|+.|+..... ...+. .+.....
T Consensus 180 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~~~~~-~~~~~~~ 250 (291)
T cd06639 180 STRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------VKTLF-KIPRNPP 250 (291)
T ss_pred ccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------HHHHH-HHhcCCC
Confidence 32211 12345889999999985321 1367899999999999999999999853211 11111 1111111
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+ .. ..+....+.+++.+||+.+|++||++.++++
T Consensus 251 ~~~---~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 PTL---LH--PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCC---Cc--ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 00 1123345778889999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=292.32 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=197.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.+.||.|++|.||+|... +++.||+|++.... .....+.+|+++++.++|+||+++++++.+....++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456678999999999999965 68899999987543 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 83 ~~~L~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 83 GGSCLDLLKP-------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999843 2689999999999999999999998 99999999999999999999999999998775432
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ......+++.|+|||++.+. .++.++||||||+++|+|++|+.|+.... +......+.......+...
T Consensus 153 ~--~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 221 (274)
T cd06609 153 S--KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLH-------PMRVLFLIPKNNPPSLEGN 221 (274)
T ss_pred c--ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCc-------hHHHHHHhhhcCCCCCccc
Confidence 1 11234588899999999654 58899999999999999999999986331 1222222222211111111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+.+++.+||+.+|++|||++++++
T Consensus 222 ------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ------KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ------ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02334667888899999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=293.88 Aligned_cols=249 Identities=26% Similarity=0.420 Sum_probs=196.5
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.+.++||.|+||.||++.++ +++.+|+|.+..... ..+++.+|++++++++||||+++++.+......++++||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 45678999999999999965 689999999876532 335789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+.......
T Consensus 84 ~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 84 GSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999995432 578899999999999999999999 7 99999999999999999999999999987654322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. ...++..|+|||.+.+. ..+.++||||||+++|+|++|+.|+...... +......+....... ...
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~-~~~ 223 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDP-----PDGIFELLQYIVNEP-PPR 223 (265)
T ss_pred hh----cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCccccc-----cccHHHHHHHHhcCC-CCC
Confidence 11 14588999999998664 7889999999999999999999998643211 111111111111111 111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... .....+.+++.+||..+|++|||+.+++.
T Consensus 224 ~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSG--KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChh--hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 13445677888999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.05 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=194.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|++.++||+|+||.||+|..+ +++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 456688999999999999975 589999998865332 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.++... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 83 DHTVLDDLEKY------PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred CccHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999887632 23589999999999999999999998 9999999999999999999999999998876443
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CCchHHHHHHHhh
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EYFPNAIYKQIET 432 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 432 (511)
.. ......++..|+|||++.+. ...+.++||||||+++|||++|+.|+........ ..+..........
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cc--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 32 12234578999999998653 3567899999999999999999988853221000 0000000000000
Q ss_pred h---hccccCCCC-ChH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 E---YDFQLDGVV-TEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~---~~~~~~~~~-~~~----~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ......... ... ...+...+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 000000000 000 1123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=292.71 Aligned_cols=246 Identities=26% Similarity=0.346 Sum_probs=186.0
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC------ChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD------NGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALI 276 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 276 (511)
...+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.++++++||||+++++++.+ ....+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 34678999999999999864 589999998864321 22467889999999999999999998865 3678899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+||+++++|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 85 MEYMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EeCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 9999999999999532 3578899999999999999999997 999999999999999999999999999876
Q ss_pred cCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 357 TEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 357 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
....... .......++..|+|||++.+. .++.++||||||+++|||++|+.||.... ....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~~~~~~~~~~~~- 226 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYE------AMAAIFKIATQPT- 226 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcCCC-
Confidence 5432111 111234588999999998653 67899999999999999999999985321 1111111111111
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...++.. ....+..+ ++||..+|++||+++||++
T Consensus 227 ---~~~~~~~---~~~~~~~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ---NPQLPSH---ISEHARDF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCCCchh---cCHHHHHH-HHHhcCChhhCcCHHHHhc
Confidence 1111111 11222223 3688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=290.11 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=198.2
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 278 (511)
|++.+.||.|+||.||++.. .+++.+|+|+++.... ..+++.+|++++++++|+||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 34567899999999999985 4688999999875332 23568899999999999999999998754 456889999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC--NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|+++++|.+++.... .....+++..++.++.|++.||+|||..+ ..+++|+||||+||++++++.+||+|||++..
T Consensus 82 ~~~~~~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 82 YCEGGDLAQLIQKCK--KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hccCCCHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999996542 22457899999999999999999999322 23999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
........ ....+++.|+|||.+... ..+.++||||||+++++|++|+.|+.... ...+.+.+......
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~ 228 (265)
T cd08217 160 LGHDSSFA--KTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARN-------QLQLASKIKEGKFR 228 (265)
T ss_pred ccCCcccc--cccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcC-------HHHHHHHHhcCCCC
Confidence 76544311 234689999999998653 67889999999999999999999986432 12222222222111
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.++ ......+..++.+||+.+|++||++++|++.
T Consensus 229 ~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RIP-------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCc-------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 1234567788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=297.04 Aligned_cols=258 Identities=20% Similarity=0.274 Sum_probs=196.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999964 68999999987543 22467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+++|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 -~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 82 -PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred -CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999999985432 5689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh---------
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE--------- 431 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 431 (511)
.. .......|+..|+|||.+.+. ...+.++||||+|++++||++|+.++...... .....+...+.
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 153 EP-RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CC-CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhh
Confidence 32 112234689999999998543 35688999999999999999997776432110 00000000000
Q ss_pred --hh---hccccCCCCC----hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 --TE---YDFQLDGVVT----EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 --~~---~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. .......... ....+....+.+++.+||+.+|++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0000000000 001123366788899999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=293.44 Aligned_cols=254 Identities=27% Similarity=0.379 Sum_probs=197.3
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecC------eEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKK------KRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~l 275 (511)
.|.+.+.||+|++|.||+|..+ +++.+++|++.......+++.+|+.+++++ .|+||+++++++.+.. ..++
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 3456788999999999999965 578999999987666667899999999999 6999999999996544 5899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 87 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 87 VMELCGGGSVTDLVKGLR--KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEcCCCCcHHHHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 999999999999985432 1235789999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
....... ......|++.|+|||++... ...++.++||||||+++|+|++|+.|+.... +......+..
T Consensus 162 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~ 232 (275)
T cd06608 162 QLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-------PMRALFKIPR 232 (275)
T ss_pred ecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-------hHHHHHHhhc
Confidence 6543221 11234589999999998532 1346789999999999999999999985321 1111111111
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... .... ........+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~----~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPP----PTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCC----CCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 0111 11224456778889999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=289.20 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=197.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||.||++... +|+.||+|.+.... ...+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456789999999999999854 68999999986432 23457899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 82 EGGDLYKKINAQR----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999985422 23578999999999999999999998 9999999999999999999999999999866443
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... .....|++.|+|||++.+. ..+.++||||||+++++|++|+.|+.... ..+.+.+.+ .......
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~~~-- 221 (256)
T cd08218 155 VEL--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKII-RGSYPPV-- 221 (256)
T ss_pred hhh--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHh-cCCCCCC--
Confidence 221 1123488999999998653 67889999999999999999999985321 122222221 1111111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......+.+++.+||+.+|++||++.+|++
T Consensus 222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 -----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1223445777888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=296.76 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=194.5
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.++||.|++|+||+|.. .+++.||+|.+..... ..+.+.+|+.+++.++|+|++++++++.+....++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 45667899999999999985 4689999998875432 346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.. ..+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 101 ~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 101 GSLTDVVTE-------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CcHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999998842 3589999999999999999999998 999999999999999999999999999876544332
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
. .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||..... . .... .+.......+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~-~~~~-~~~~~~~~~~---- 235 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----L-RALY-LIATNGTPEL---- 235 (296)
T ss_pred c--CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H-HHHH-HHHhcCCccc----
Confidence 1 1234588999999998653 678999999999999999999999864321 1 1111 1111110000
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.........+.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 001122334666788899999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.28 Aligned_cols=253 Identities=20% Similarity=0.252 Sum_probs=195.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||++... .++.||+|.+.... ...+.+.+|+++++.++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999965 57899999987542 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 83 VEGGDCATLLKNI------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred CCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999432 4689999999999999999999998 999999999999999999999999999874211
Q ss_pred CCc-------------eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHH
Q 040808 360 KES-------------FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI 426 (511)
Q Consensus 360 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 426 (511)
... ........|+..|+|||.+.. ...+.++||||||+++|||++|+.|+.... +..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~-------~~~~ 224 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDT-------PEEL 224 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHH
Confidence 100 000112357889999999865 367899999999999999999999985321 2222
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
........... + .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~-~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 FGQVISDDIEW-P----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHhcccCC-C----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22222211000 0 0011233446778888999999999998777777775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=297.79 Aligned_cols=243 Identities=26% Similarity=0.351 Sum_probs=192.1
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
.+||+|+||.||++... +++.||+|.+.... ...+.+.+|+.++..++||||+++++++..++..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999864 68999999986433 33467889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeee
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
.++.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ ..
T Consensus 107 ~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 107 DIVSQ-------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred HHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 87732 3588999999999999999999998 999999999999999999999999999876543321 11
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHH
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (511)
....|++.|+|||++.+. ..+.++||||||+++|||++|+.|+.... +......+........ ...
T Consensus 175 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~-----~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDS-------PVQAMKRLRDSPPPKL-----KNA 240 (297)
T ss_pred cceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhccCCCCc-----ccc
Confidence 234589999999998653 67889999999999999999999986321 1111222221111100 001
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 447 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
......+.+++.+||+.+|++||+++++++.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1122345667788999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=289.95 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=199.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|++.+.||.|+||+||+|... ++..+|+|++.... .....+.+|++++++++|+|++++++.+.+....++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456788999999999999854 68899999987543 244678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 83 GGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999964321 24689999999999999999999998 99999999999999999999999999987665433
Q ss_pred cee--eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 362 SFI--SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 362 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... ......|+..|+|||++... ...+.++||||||+++|+|++|+.|+..... ................
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~ 228 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPP-------MKVLMLTLQNDPPSLE 228 (267)
T ss_pred cccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccCh-------hhhHHHHhcCCCCCcC
Confidence 221 11223588999999998653 3678899999999999999999999863311 1111111111111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ..........+.+++.+||+.||++||+++++++
T Consensus 229 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 T--GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C--ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0111234456778888999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.27 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=206.3
Q ss_pred hhhcccCCcCceEEEEEEcC--CCc--EEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP--DGR--LVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.+.++||+|.||.|++|.+. +|. .||||.++..... ..+|++|+.+|.+|+|+|+++|||+..+ ....+|||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 45688999999999999865 344 5899999865443 5799999999999999999999999887 667899999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++.|+|.+.|+. ..+..|....+..++.|||.|+.||.++ ++|||||-..|+||-..-.|||+||||.+.+..
T Consensus 192 aplGSLldrLrk----a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 192 APLGSLLDRLRK----AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred cccchHHHHHhh----ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999965 2346788899999999999999999998 999999999999999888999999999999887
Q ss_pred CCceeeecCC-CCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 360 KESFISMLDT-RGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 360 ~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
.+....+... .-...|+|||.+.. +.++.+||||+|||++|||++ |..||-.- -...+++.++.+..+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~-------~g~qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGC-------RGIQILKNIDAGERLP 335 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCC-------CHHHHHHhccccccCC
Confidence 7666555443 35679999999954 589999999999999999998 56676432 2445666666444332
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
. .+...+++..++..||..+|++|||+..+.+.+
T Consensus 336 R-------Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 R-------PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred C-------CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2 234566789999999999999999999997443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=289.15 Aligned_cols=245 Identities=29% Similarity=0.417 Sum_probs=193.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC------CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK------DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
...+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|++++++++|+||+++++++.+....++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 45578999999999999966 78999999886532 133578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 83 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 83 LVPGGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred ecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999532 3588999999999999999999998 99999999999999999999999999988764
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... .....|++.|+|||.+... ...+.++|+||||+++|+|++|+.|+.... -................
T Consensus 154 ~~~~---~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~ 223 (258)
T cd06632 154 EFSF---AKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKIGRSKELPPI 223 (258)
T ss_pred cccc---ccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHHHhcccCCCc
Confidence 4331 1234588999999998653 137889999999999999999999986331 01111111110111111
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ....+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~-------~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 PDH-------LSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCC-------cCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111 2344566778899999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=293.27 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=194.9
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccC--CCChHHHHHHHHHHHccC---CcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNL--KDNGEEFINEVASISRTS---HVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e 278 (511)
|.+.++||+|+||.||+|.+ .+++.||+|.++.. ....+++.+|++++++++ |||++++++++.+....++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 34567899999999999995 46899999998753 233467889999999997 9999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++.. ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 83 YAEGGSVRTLMKA-------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred cCCCCcHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 9999999998842 2688999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......|+..|+|||.+.+. ..++.++||||||+++|+|++|+.|+..... .... ..+....
T Consensus 153 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~------~~~~-~~~~~~~---- 218 (277)
T cd06917 153 QNSS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDA------FRAM-MLIPKSK---- 218 (277)
T ss_pred CCcc--ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCCh------hhhh-hccccCC----
Confidence 4432 12234689999999998543 3468899999999999999999999863311 1111 1111110
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
....... .....+.+++.+||+.||++||++.++++
T Consensus 219 ~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDN--GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0111110 13445778889999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=295.58 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=190.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.+.||+|++|+||+|..+ +++.||+|.+..... ....+.+|++++++++|+||+++++++.+....++||||++
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 456678999999999999965 689999999875332 23567889999999999999999999999999999999997
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 87 -~~L~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 87 -TDLKQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred -CCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 59999885432 3688999999999999999999998 99999999999999999999999999987543221
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH-----------HH
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK-----------QI 430 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~ 430 (511)
. ......++..|+|||++.+. ..++.++||||+|+++|+|++|+.||....... + ....+.+ .+
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-D-QLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred c--cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-H-HHHHHHHhcCCCChhhhhhh
Confidence 1 11223478899999998643 357889999999999999999999985332100 0 0000000 00
Q ss_pred hhhh---ccccCCCCChHHH----H--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEY---DFQLDGVVTEEEK----E--MAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~---~~~~~~~~~~~~~----~--~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... ............. . ......+++.+||+.+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0000000000000 0 1145567889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=296.83 Aligned_cols=243 Identities=25% Similarity=0.353 Sum_probs=190.8
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
.+||+|+||.||++... ++..||||.+..... ..+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 56999999999999854 688999999865432 3457889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeee
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
+++.. ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||++........ ..
T Consensus 108 ~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 108 DIVTH-------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 98832 3478999999999999999999998 999999999999999999999999999876533221 11
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHH
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (511)
....|++.|+|||.+.+. ..+.++||||||+++|||++|+.|+.... +......+.......... .
T Consensus 176 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~-----~ 241 (292)
T cd06658 176 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEP-------PLQAMRRIRDNLPPRVKD-----S 241 (292)
T ss_pred ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCcccc-----c
Confidence 234589999999998653 67889999999999999999999986321 111122222211111110 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 447 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
......+..++.+||+.+|++|||++++++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122345566778899999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.51 Aligned_cols=266 Identities=21% Similarity=0.243 Sum_probs=195.4
Q ss_pred HhhhcccCCcCceEEEEEEcC---CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP---DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 275 (511)
|.+.++||+|+||.||+|..+ +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 456788999999999999964 47899999998632 2346788999999999999999999999888 88999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC----CCceEEeec
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE----DFCPKISDF 351 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DF 351 (511)
||||++ ++|.+++..... .....+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 82 v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQ-AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEeCCC-cCHHHHHHhhcc-CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999996 477777754332 1224789999999999999999999998 9999999999999999 999999999
Q ss_pred cCccccCCCCc-eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC--CchHHHHH
Q 040808 352 GLAKQTEKKES-FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE--YFPNAIYK 428 (511)
Q Consensus 352 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~ 428 (511)
|+++....... ........+++.|+|||++.+. ..++.++||||||+++++|++|+.|+......... .+......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 99987643322 1112234578999999988543 35788999999999999999999998654322211 01111111
Q ss_pred HHhhhhc---------------------cccCCCCC-hHHH-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 QIETEYD---------------------FQLDGVVT-EEEK-------EMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 ~~~~~~~---------------------~~~~~~~~-~~~~-------~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+..... .......+ .... ....++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1100000 00000000 0111 22345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.85 Aligned_cols=195 Identities=26% Similarity=0.369 Sum_probs=170.0
Q ss_pred HHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC-C-----cceeeeeceEeecCeEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS-H-----VNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 275 (511)
.+|.+.+.||+|+||.|-+|++ ++++.||||++++.+.-..+...|+.+|..++ | -|+|+++++|...++.+|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 3667788999999999999995 46999999999998877788899999999997 4 389999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC--CCceEEeeccC
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE--DFCPKISDFGL 353 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGl 353 (511)
|+|.+ ..+|.++|+... ...++...++.|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||+
T Consensus 266 VfELL-~~NLYellK~n~----f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK----FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eehhh-hhhHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 99999 779999997643 46799999999999999999999998 9999999999999965 34799999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
|......-- .-.-+.-|+|||++.+. .++.+.||||||||+.||.+|.+.|.
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccC
Confidence 987654321 22356679999999885 89999999999999999999976553
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=309.18 Aligned_cols=242 Identities=27% Similarity=0.394 Sum_probs=197.2
Q ss_pred hhcccCCcCceEEEEEEcC-CCcEEEEEEec-----cCCCChHHHHHHHHHHHccCCcceeeeeceEeecCe--EEEEEE
Q 040808 207 FSDKLGQGGYADVYKGTLP-DGRLVAVKVMK-----NLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKK--RALIYE 278 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 278 (511)
|.++||+|+|-+||+|.+. +|..||.-.++ ++....++|..|+.+|+.|+|+||+++++.+.+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 4567999999999999975 47777743332 233344899999999999999999999999987655 779999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCcccc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQT 357 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~ 357 (511)
.|..|+|..|+..++ .+....+..|+.||++||.|||++ .++|||||||.+||+|+. .|.|||+|.|||...
T Consensus 124 L~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred cccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999997654 577789999999999999999997 569999999999999986 589999999999987
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... ....|||.|||||.+.. .+.+.+||||||+.++||+|+..|+.-- .-+..+|+.+..+....
T Consensus 197 r~s~a----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC------~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 197 RKSHA----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSEC------TNPAQIYKKVTSGIKPA 263 (632)
T ss_pred hcccc----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhh------CCHHHHHHHHHcCCCHH
Confidence 65543 23469999999999975 6889999999999999999999998522 34778898887776542
Q ss_pred cCCCC-ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVV-TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~-~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.-..+ .++ +.+++.+||.. .++|||+.|+|.
T Consensus 264 sl~kV~dPe-------vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVKDPE-------VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccCCHH-------HHHHHHHHhcC-chhccCHHHHhh
Confidence 21122 222 44566778899 999999999984
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.88 Aligned_cols=242 Identities=25% Similarity=0.334 Sum_probs=183.5
Q ss_pred ccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC----hHHHHHHHHHHH---ccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 210 KLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN----GEEFINEVASIS---RTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.||+|+||.||++... +++.+|+|.+.+.... ...+.+|..++. ..+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 6899999998754221 223445554443 3479999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 99999998532 4689999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ....||+.|+|||.+... ..++.++||||+|+++|+|++|+.||....... ...+ ..........++..
T Consensus 152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~-~~~~~~~~~~~~~~ 221 (279)
T cd05633 152 P----HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEI-DRMTLTVNVELPDS 221 (279)
T ss_pred c----cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHH-HHHhhcCCcCCccc
Confidence 1 234589999999998532 357889999999999999999999986432111 1111 11111111122222
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~~ 477 (511)
. ...+.+++.+||+.||++|| |++++++.
T Consensus 222 ~-------~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 222 F-------SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred c-------CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2 23455666778899999999 59998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=306.17 Aligned_cols=240 Identities=26% Similarity=0.360 Sum_probs=192.9
Q ss_pred cccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.||.|+||.||.|.+ ++.+.||||.+.-+... ..+++.||..|.++.|||+|..-|++.......|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 4699999999999994 47889999998754332 257899999999999999999999999888899999999 66
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+-.|.+.-+ ++++.+..+..|..+.+.||+|||+. +.||||||+.||||++.|.|||+|||.|.+....++
T Consensus 111 SAsDlleVh-----kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns- 181 (948)
T KOG0577|consen 111 SASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS- 181 (948)
T ss_pred cHHHHHHHH-----hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchhc-
Confidence 777777543 36788899999999999999999998 999999999999999999999999999988766554
Q ss_pred eeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.+|||-|||||++.. .-|+++.|+||||||++..||...++|..... -...+|... ..... .+
T Consensus 182 -----FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIA-QNesP----tL 245 (948)
T KOG0577|consen 182 -----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIA-QNESP----TL 245 (948)
T ss_pred -----ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHH-hcCCC----CC
Confidence 469999999999843 23689999999999999999999998874321 112233322 22211 11
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ..+....+..++..||+.-|.+|||.++++.
T Consensus 246 q--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 Q--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred C--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1 1233344556777899999999999988763
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=290.85 Aligned_cols=245 Identities=25% Similarity=0.333 Sum_probs=196.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||.|+||.||++... ++..||+|++.+.. ...+.+.+|++++++++||||+++++.+.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456788999999999999965 58999999997532 2346889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~~~~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 82 LLGGDLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999432 4688999999999999999999998 999999999999999999999999999887654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... .....|+..|+|||.+... ..+.++|+||||+++|+|++|+.|+...... ........... .....+
T Consensus 153 ~~~---~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~-~~~~~~ 222 (258)
T cd05578 153 DTL---TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET-ADVLYP 222 (258)
T ss_pred Ccc---ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc-ccccCc
Confidence 432 1234588999999998654 5789999999999999999999998744221 12222222111 111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM--TKVV 475 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~--~evl 475 (511)
. .....+.+++.+||+.||.+||++ +|++
T Consensus 223 ~-------~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 A-------TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c-------cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 223567778888999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.10 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=190.5
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccC-CcceeeeeceEeec--CeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTS-HVNIVPFLGFCYEK--KKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~ 279 (511)
.+.++||+|+||.||+|... +++.||+|.++.... ......+|+.++.++. |+|++++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45678999999999999854 689999999876422 2234567999999886 99999999999887 889999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++ ++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++....
T Consensus 82 ~~-~~l~~~l~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 82 MD-MNLYELIKGR-----KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred CC-ccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 96 6888887432 24689999999999999999999998 9999999999999999 9999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC---------CCCchHHHHHHH
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS---------SEYFPNAIYKQI 430 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~---------~~~~~~~~~~~~ 430 (511)
.... ....++..|+|||++... +..+.++|||||||++|||++|+.|+....... ....+.+ ....
T Consensus 152 ~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (282)
T cd07831 152 KPPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKF 226 (282)
T ss_pred CCCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhh
Confidence 4322 223478999999987543 356889999999999999999999985432100 0000000 0000
Q ss_pred hhh--hccccCCCCC----hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETE--YDFQLDGVVT----EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~--~~~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... .......... .........+.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 0000000000 111234567888999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=294.28 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=191.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+..+.||.|++|.||+|... +++.||||.++... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45678999999999999865 68999999887432 223578899999999999999999999999999999999995
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 83 -~~l~~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 83 -QDLKKFMDASP----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred -cCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 68998885432 35689999999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY------- 434 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 434 (511)
. ......+++.|+|||++.+. ...+.++||||||+++|||++|+.|+..... .+...+......
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSE------IDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred c--ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHhCCCChhhh
Confidence 1 11233478899999988653 3467899999999999999999999853321 111111110000
Q ss_pred ---------ccccCCCCCh----HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 ---------DFQLDGVVTE----EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ---------~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......... ....+...+.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 00112234567889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.68 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=194.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||++... +++.+|+|+++... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456788999999999999865 68999999987532 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+|||+++++.+||+|||+++....
T Consensus 83 ~~~~~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 83 VPGGELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999998542 4688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. ....|++.|+|||.+... ..+.++||||||+++|+|++|+.|+.... .....+.+... ...++
T Consensus 154 ~~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~ 218 (290)
T cd05580 154 RT-----YTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDN-------PIQIYEKILEG-KVRFP 218 (290)
T ss_pred CC-----CCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcC-CccCC
Confidence 42 234589999999998653 67889999999999999999999986332 22223332221 12222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVV 475 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl 475 (511)
...+ ..+.+++.+||+.||++|+ ++++++
T Consensus 219 ~~~~-------~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 SFFS-------PDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred ccCC-------HHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 2222 3455677889999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.32 Aligned_cols=246 Identities=26% Similarity=0.328 Sum_probs=186.0
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC------CChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK------DNGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALI 276 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 276 (511)
.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+. ...+++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 45678999999999999864 58999999885321 1134678899999999999999999988663 568899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++++|.+++... ..+++....+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 85 MEHMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 9999999999998532 3478888999999999999999998 999999999999999999999999999886
Q ss_pred cCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 357 TEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 357 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
....... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.|+.... ....+.+ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~~~~-~~~~-- 224 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFE------AMAAIFK-IATQ-- 224 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccc------hHHHHHH-HhcC--
Confidence 5432111 112234589999999998653 67899999999999999999999985321 0111111 1111
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
......+ ......+..++.+||. +|++||++++|++
T Consensus 225 -~~~~~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 -PTNPVLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCCCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011111 1223344555666764 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=285.30 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=195.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++|+|++++++.+......++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456788999999999999854 68899999987532 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-CceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~~ 359 (511)
++++|.+++.... ...+++..+..++.+++.||+|||++ +++|+||||+||+++++ +.+||+|||++.....
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 82 PGGTLAEYIQKRC----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999996432 34589999999999999999999998 99999999999999854 5689999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... ....|+..|+|||.+.+. ..+.++||||||+++|+|++|+.|+.... .+.... .+.......+.
T Consensus 155 ~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~ 222 (256)
T cd08220 155 KSKA---YTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAAN------LPALVL-KIMSGTFAPIS 222 (256)
T ss_pred Cccc---cccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCc------hHHHHH-HHHhcCCCCCC
Confidence 3321 224588999999998653 67889999999999999999999985332 122221 22111111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ....+.+++.+||+.+|++|||++++++
T Consensus 223 ~~-------~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DR-------YSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CC-------cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 2344667888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.72 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=194.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|++.+.||+|+||+||++... +++.||+|.+..... ..+.+.+|++++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 345678999999999999965 589999999975432 235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~L~~~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 83 CPGGELFRLLQRQP----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred cCCCCHHHHHHhCC----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999985322 35689999999999999999999998 999999999999999999999999999875532
Q ss_pred CCcee---------------------------eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 360 KESFI---------------------------SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 360 ~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
..... ......||..|+|||++.+. ..+.++||||||+++|+|++|+.|+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 21100 01123588999999999654 67889999999999999999999986
Q ss_pred CccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 413 VKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
.... .....+......... . .......+.+++.+||+.+|++|||+...+++|.
T Consensus 234 ~~~~------~~~~~~~~~~~~~~~------~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 234 GSNR------DETFSNILKKEVTFP------G-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred CCch------HHHHHHHhcCCccCC------C-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 3321 111111111111111 1 1114456778888899999999999444444333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=288.13 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=196.4
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+.+.++||.|+||.||+|.. .+++.||+|++..... ....+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 345677899999999999985 4688999999864332 2357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ..+++..+..++.+++.|++|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~l~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 85 GGGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999842 3588999999999999999999998 9999999999999999999999999998766443
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... .....++..|+|||.+.. ...+.++||||||+++|+|++|..|+.... +......+.......+..
T Consensus 155 ~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 223 (277)
T cd06641 155 QIK--RNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELH-------PMKVLFLIPKNNPPTLEG 223 (277)
T ss_pred hhh--hccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccc-------hHHHHHHHhcCCCCCCCc
Confidence 211 123458889999999864 367889999999999999999999985321 222222222221111111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 -------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 -------NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233456678889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=294.89 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=192.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|... +++.||+|.+..... ..+++.+|+++++.++||||+++.+++.+....++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 556678999999999999865 689999999864322 224688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++ |+|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 97 ~~-g~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 97 CL-GSASDILEVH-----KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hC-CCHHHHHHHc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 96 6777776432 24689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.. ...+++.|+|||++.+ ..+.++.++||||||+++|||++|+.|+.... ....+.. +.....
T Consensus 168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------~~~~~~~-~~~~~~--- 231 (307)
T cd06607 168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYH-IAQNDS--- 231 (307)
T ss_pred CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------HHHHHHH-HhcCCC---
Confidence 32 2358889999998742 12467889999999999999999999985321 1111111 111110
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.... .......+.+++.+||+.+|++||++.+|+..
T Consensus 232 -~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -PTLS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111 11234457788889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=297.69 Aligned_cols=240 Identities=27% Similarity=0.378 Sum_probs=195.8
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
-+.||+||||.|+-+..+ +|+.+|.|.+.+. +....-.++|-.||.+++.+.||.+--.|...+.++||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 368999999999999855 6999999988642 23334678999999999999999998889999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.-||+... ...+++..+..++.+|+.||++||+. +||+||+||+|||||+.|+++|+|.|||..+..++.
T Consensus 270 GDLkfHiyn~g----~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 270 GDLKFHIYNHG----NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred CceeEEeeccC----CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 99999997755 36799999999999999999999998 999999999999999999999999999999888776
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.. ...||.||||||++... .++...|+||+||++|||+.|+.||...... .-.+.+.+.+.+ ........+
T Consensus 343 ~~---~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~~-~~~ey~~kF 413 (591)
T KOG0986|consen 343 IR---GRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTLE-DPEEYSDKF 413 (591)
T ss_pred cc---cccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHhc-chhhccccc
Confidence 43 44799999999999764 6899999999999999999999999643211 111122222221 122334556
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCC
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPS 470 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs 470 (511)
+++.+.+.+.++ +.||++|.-
T Consensus 414 S~eakslc~~LL-------~Kdp~~RLG 434 (591)
T KOG0986|consen 414 SEEAKSLCEGLL-------TKDPEKRLG 434 (591)
T ss_pred CHHHHHHHHHHH-------ccCHHHhcc
Confidence 777666666555 999999974
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.65 Aligned_cols=247 Identities=30% Similarity=0.396 Sum_probs=196.2
Q ss_pred ccCCcCceEEEEEEcCC-CcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHHH
Q 040808 210 KLGQGGYADVYKGTLPD-GRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQ 287 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 287 (511)
.||+|.||+||-|++.+ ...+|||-+.... ...+...+|+.+-++++|.|||+.+|.+.+++..-+.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999664 6679999887543 344678899999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCccccCCCCceeee
Q 040808 288 YIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 288 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
++...= +.-.-.+.+.-.+.+||++||.|||.+ .|||||||=+|||++- .|.+||+|||-++.+..-... +
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--T 733 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--T 733 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc--c
Confidence 996422 122226778888999999999999998 9999999999999964 789999999999887655442 2
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHH
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (511)
.+..||..|||||++.....+++.++|||||||++.||.||++||---.. |... +-...-+...+.++++
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs------pqAA---MFkVGmyKvHP~iPee- 803 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS------PQAA---MFKVGMYKVHPPIPEE- 803 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC------hhHh---hhhhcceecCCCCcHH-
Confidence 34569999999999976667899999999999999999999999852211 1111 1111112223344443
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 447 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+..+.-.++++|+.++|.+||+++++++
T Consensus 804 --lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 --LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3344445779999999999999999975
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=294.03 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=189.5
Q ss_pred hhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCC
Q 040808 207 FSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.++||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++. |+||+++++++......+++|||++
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 4567999999999999855 689999999875432 2357889999999997 9999999999998889999999985
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.++..... ......+++..+..++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~l~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 ISLDKFYKYVY-EVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred CCHHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 56655432111 01235689999999999999999999974 2899999999999999999999999999876543321
Q ss_pred eeeecCCCCCCCccchhhccccc-CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHF-GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ....|++.|+|||++.... ..++.++||||||+++|||++|+.||.... .....+...........
T Consensus 164 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~ 231 (288)
T cd06616 164 K---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---------SVFDQLTQVVKGDPPIL 231 (288)
T ss_pred c---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---------hHHHHHhhhcCCCCCcC
Confidence 1 2235889999999986431 257889999999999999999999985321 11111111110000000
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...........+.+++.+||+.+|++|||+++|++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112244567788899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=289.31 Aligned_cols=248 Identities=29% Similarity=0.393 Sum_probs=198.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.+.+.||+|++|.||+|.++ +++.+|+|++.......+.+.+|++++++++|+|++++++.+......++|+||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 345578999999999999976 6889999999865545678899999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 101 ~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 101 SLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 9999996432 3799999999999999999999997 9999999999999999999999999998765433211
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
.....+++.|+|||.+.+. .++.++||||||+++|+|++|+.|+.... +......+....... .
T Consensus 173 --~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~----~- 236 (286)
T cd06614 173 --RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREP-------PLRALFLITTKGIPP----L- 236 (286)
T ss_pred --hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCC----C-
Confidence 1223478899999998653 67899999999999999999999985321 111111111111000 0
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.........+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111223456778889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=293.72 Aligned_cols=256 Identities=19% Similarity=0.255 Sum_probs=190.5
Q ss_pred hhcccCCcCceEEEEEEcCCCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.+.+|.|+++.|+++.. +++.||+|+++.. ....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566666666666655 6899999998754 233467899999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc-
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES- 362 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~- 362 (511)
+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 85 SCEDLLKTHF----PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CHHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999996532 23588999999999999999999998 999999999999999999999999998865532211
Q ss_pred ----eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc-
Q 040808 363 ----FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ- 437 (511)
Q Consensus 363 ----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 437 (511)
........++..|+|||++......++.++||||||+++|||++|+.||..... .....+.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~ 231 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA------TQMLLEKVRGTVPCLL 231 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCcccc
Confidence 011122347789999999865434578899999999999999999999864311 011111111000000
Q ss_pred -----------c-------------CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 -----------L-------------DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 -----------~-------------~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .............++.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 00000111223345778899999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=285.37 Aligned_cols=252 Identities=24% Similarity=0.418 Sum_probs=196.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|...++||+|+||.||+|... +++.||+|+++.... ..+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 455678999999999999854 689999999986544 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 82 SGGTLEELLEH------GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCcHHHHHhh------cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999853 23578899999999999999999998 9999999999999999999999999999876543
Q ss_pred Cceee--ecCCCCCCCccchhhccccc-CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 361 ESFIS--MLDTRGTAGYIAPEVFCRHF-GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 361 ~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... .....+++.|+|||++.... ...+.++||||||+++++|++|+.||..... -....+ .+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-----~~~~~~-~~~~~~~~~ 226 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----EFQIMF-HVGAGHKPP 226 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-----hHHHHH-HHhcCCCCC
Confidence 32111 11345889999999986542 2378899999999999999999999863311 011111 111111111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+. .......+.+++.+||+.+|++|||+.+++.
T Consensus 227 ----~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ----IPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----CCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 1122344567888999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.44 Aligned_cols=197 Identities=29% Similarity=0.405 Sum_probs=163.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.+.||+|+||.||+|... +|+.||+|++..... ....+.+|+.++++++|+||+++++++.+....++||||++
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 345678999999999999854 688999999875432 23467899999999999999999999999999999999995
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++......
T Consensus 87 -~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 87 -TDLAQYMIQH-----PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred -CCHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 7887777432 23578888999999999999999998 99999999999999999999999999987643322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
.. .....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||+.
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 158 QT--YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CC--CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 1233578999999998643 2467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=295.10 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=194.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|++.++||+|+||.||+|.++ +++.||+|+++... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456788999999999999965 58899999987532 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+++.+..++.. ...+++..+..++.+|+.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 83 ERTLLELLEAS------PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 88777665532 24589999999999999999999998 9999999999999999999999999999876554
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh---------
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE--------- 431 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 431 (511)
... ......++..|+|||++.+. ...+.++||||||+++|+|++|+.|+..... .+.+.....
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSD------IDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHH
Confidence 321 11234578899999998653 2678899999999999999999988853211 111111000
Q ss_pred -----hhhcc---ccCCCCChH------HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 -----TEYDF---QLDGVVTEE------EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 -----~~~~~---~~~~~~~~~------~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ......... ......++.+++.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000000 0112466788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=285.47 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=198.3
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 279 (511)
...+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++++++++|+||+++++.+.+. ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999966 68999999987654 3457889999999999999999999999888 899999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 83 VSGGSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred cCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999998532 2789999999999999999999998 999999999999999999999999999987765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
...........++..|+|||.+... ..+.++||||||+++++|++|+.|+.... .....+.+.........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-- 224 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE-- 224 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC--
Confidence 5421112234588999999998654 58899999999999999999999986432 01111111111011111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+ ......+.+++.+|++.+|++||++.++++
T Consensus 225 --~~---~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 --IP---EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --CC---cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11 122456778888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.47 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=192.6
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.++||.|++|.||+|..+ +|..||+|++.... ...+.+.+|++++++++|+|++++++++.+....+++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~- 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL- 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-
Confidence 45678999999999999854 79999999987542 22357889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 DLDLKKYMDSSP----LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred CcCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 579999985432 14689999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh----------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE---------- 431 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 431 (511)
. ......+++.|+|||++.+. ..++.++||||||+++|+|++|+.||..... .....+...
T Consensus 154 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 154 R--TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE------IDQLFRIFRTLGTPDEDVW 224 (283)
T ss_pred c--ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChHHh
Confidence 1 11223468899999988543 3468899999999999999999999853321 000001000
Q ss_pred ----hhhcc--ccC----CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 ----TEYDF--QLD----GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 ----~~~~~--~~~----~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ... .............+.+++.+||+.+|++|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000 0000111122346778899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=284.26 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=199.6
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++.+.||+|++|.||++..+ +++.||+|++..... ..+++.+|+.++.+++|+|++++++++......++||||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 45678999999999999966 599999999876543 356899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++... ..+++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 84 GSLADLLKKV------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999542 468999999999999999999999 8 99999999999999999999999999998765443
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
... ....++..|+|||.+... ..+.++||||||+++|+|++|+.|+..... ..+.+ ..+.+...........
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~-~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQ---PSFFE-LMQAICDGPPPSLPAE 226 (264)
T ss_pred Ccc--cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccc---cCHHH-HHHHHhcCCCCCCCcc
Confidence 321 134588999999998653 778899999999999999999999864421 01111 1222221111111111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.....+.+++.+||+.+|++||++.++++.
T Consensus 227 ------~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 ------EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 034567778888999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=292.68 Aligned_cols=258 Identities=21% Similarity=0.274 Sum_probs=191.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccC-CcceeeeeceEeecCe-----EE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTS-HVNIVPFLGFCYEKKK-----RA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~~ 274 (511)
|.+.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+.++++++ |+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345678999999999999965 689999998875322 2357889999999995 6999999999876655 89
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccC
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGL 353 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGl 353 (511)
+||||+++ +|.+++..... .....+++..++.++.||+.||+|||+. +++||||||+||+++. ++.+||+|||+
T Consensus 83 lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGR-GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEeeccCc-CHHHHHHHhcc-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 99999975 89888865332 1235689999999999999999999998 9999999999999998 89999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++....... ......+++.|+|||++.+. ..++.++||||||+++|+|++|..|+..... .....+.....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~ 228 (295)
T cd07837 158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSE------LQQLLHIFKLL 228 (295)
T ss_pred ceecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHh
Confidence 876533211 11233578899999998543 3578899999999999999999998853211 11111111000
Q ss_pred h---cc------------ccCCCC----ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 Y---DF------------QLDGVV----TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ~---~~------------~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .. ...... ..........+.+++.+||+.||++||++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00 000000 0011123455778889999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=286.18 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=193.2
Q ss_pred hhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
...+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3457899999999999985 5689999999874331 2357889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQ 356 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~ 356 (511)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||++..
T Consensus 83 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 83 EWMAGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred eccCCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999998532 3688999999999999999999998 999999999999998776 599999999876
Q ss_pred cCCCCceee--ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 357 TEKKESFIS--MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 357 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
......... .....|+..|+|||.+.+. ..+.++||||+|+++++|++|+.|+...... .....+.+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~ 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---NHLALIFKIASATT 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCc---chHHHHHHHhccCC
Confidence 643311100 1123578999999998653 6788999999999999999999998533211 11111111111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
....+ ......+.+++.+||+.+|++||++.++++
T Consensus 229 ----~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----APSIP---EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCc---hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111 223455677889999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=294.52 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=190.1
Q ss_pred cccCCc--CceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQG--GYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++||+| +||+||++.+. +|+.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999964 7999999998754322 35678899999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 84 GSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 99999986532 23588999999999999999999998 999999999999999999999999986543221110
Q ss_pred eee-----ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh----
Q 040808 363 FIS-----MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE---- 433 (511)
Q Consensus 363 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 433 (511)
... .....++..|+|||++.+....++.++||||||+++|||++|+.|+..... .......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~ 230 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR------TQMLLQKLKGPPYSP 230 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh------HHHHHHHhcCCCCCC
Confidence 000 001235667999999976544678999999999999999999999864321 00000000000
Q ss_pred ---------------------------h-------ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 ---------------------------Y-------DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ---------------------------~-------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .........+........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 000000011222345567889999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=289.88 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=193.7
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 279 (511)
.+.++||.|+||.||+|... +++.+|+|++.... .....+.+|++++++++|+|++++++++.+. +..++||||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999865 58899999998653 2345788999999999999999999999887 899999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++ ++|.+++... ...+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 82 ~~-~~l~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 82 MD-HDLTGLLDSP-----EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cc-ccHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 96 5898888432 14689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc----
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD---- 435 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 435 (511)
... .......++..|+|||.+.+. ..++.++||||||+++|||++|+.|+..... +..+ ..+.....
T Consensus 153 ~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~------~~~~-~~~~~~~~~~~~ 223 (287)
T cd07840 153 RNS-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTE------LEQL-EKIFELCGSPTD 223 (287)
T ss_pred CCc-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHH-HHHHHHhCCCch
Confidence 432 111233578889999987543 3578899999999999999999999864321 1111 11110000
Q ss_pred --------------cccCCCCC----hHHHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 --------------FQLDGVVT----EEEKE-MAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 --------------~~~~~~~~----~~~~~-~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........ +.... ....+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000 01111 1456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.18 Aligned_cols=202 Identities=22% Similarity=0.287 Sum_probs=157.5
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCC--CcEEEEE------------------EeccCCCChHHHHHHHHHHHccCCccee
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPD--GRLVAVK------------------VMKNLKDNGEEFINEVASISRTSHVNIV 261 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~niv 261 (511)
...|.+.++||+|+||+||++.++. +...+.| .+.........+.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3456778899999999999987542 2222222 1111122235678999999999999999
Q ss_pred eeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 262 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
++++++.+.+..++|+|++ +++|.+++..... ..........+..|+.||+.||+|||++ +|+||||||+|||++
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAF-DWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccc-cccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999998 5688888754321 1112234566778999999999999998 999999999999999
Q ss_pred CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 040808 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~ 411 (511)
.++.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999998765433211 1235699999999999653 6889999999999999999988644
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=288.99 Aligned_cols=243 Identities=26% Similarity=0.355 Sum_probs=192.9
Q ss_pred hcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 208 SDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
.++||+|++|.||++.. .+++.+|+|+++.... ..+.+.+|+.++++++|+||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 35899999999999985 4688999998864332 235688999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.........
T Consensus 104 ~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-- 171 (285)
T cd06648 104 TDIVTH-------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-- 171 (285)
T ss_pred HHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence 999843 3588999999999999999999998 9999999999999999999999999988765433211
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
.....|++.|+|||.+.+. .++.++||||||+++|||++|+.|+.... +......+........ ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~-------~~~~~~~~~~~~~~~~-----~~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEP-------PLQAMKRIRDNLPPKL-----KN 237 (285)
T ss_pred cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHHHhcCCCCC-----cc
Confidence 1234589999999998653 67889999999999999999999985321 1112222222211110 01
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1113345778889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=290.29 Aligned_cols=253 Identities=20% Similarity=0.238 Sum_probs=191.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 278 (511)
|.+.+.||+|+||.||+|..+ +++.+|+|.++.... ....+.+|+.++.+++||||+++++++... ...++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 456678999999999999965 588999999975432 224577899999999999999999998877 89999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|++ ++|.+++.... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 87 ~~~-~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 87 YVE-HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hcC-cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 996 59999885432 3689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh----
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY---- 434 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 434 (511)
.... ......+++.|+|||.+.+. ...+.++||||||+++|||++|+.|+..... .+.. ..+....
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~------~~~~-~~~~~~~~~~~ 227 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSE------IDQL-NKIFKLLGTPT 227 (293)
T ss_pred CCcc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHH-HHHHHHhCCCc
Confidence 4321 11234578899999998653 2468899999999999999999998864321 0000 0000000
Q ss_pred --------cccc-------CC---CCChHHHH--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 --------DFQL-------DG---VVTEEEKE--MAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 --------~~~~-------~~---~~~~~~~~--~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+.. .. ........ +...+.+++.+||+.+|++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 00 00000000 2344667788899999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=286.37 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=193.9
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
||.|+||.||++... +|+.+|+|++.... ...+.+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 48999999987543 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce--
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF-- 363 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-- 363 (511)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENV------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 9999542 3689999999999999999999998 9999999999999999999999999998765433210
Q ss_pred ----eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 364 ----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 364 ----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.......++..|+|||..... ..+.++||||||+++|+|++|+.|+.... +......+.... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~~~~ 221 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGET-------PEEIFQNILNGK-IEWP 221 (265)
T ss_pred ccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCC-cCCC
Confidence 112234588899999998654 57889999999999999999999986432 222222222211 1111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
.. ......+..++.+||+.+|++|||+.++.+.|+
T Consensus 222 ~~-----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 ED-----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cc-----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11 112445677888899999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=281.74 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=197.3
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
...+.||+|++|.||++... +++.+++|++..... ....+.+|++++++++|+|++++++++......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45578999999999999965 688999999976543 4578999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 83 SLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred cHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999985421 4789999999999999999999997 999999999999999999999999999987755432
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
.....++..|+|||.+... ..+.++||||||+++++|++|+.|+.... .......... ..... ..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~----~~ 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELP------PMKALFKIAT-NGPPG----LR 218 (253)
T ss_pred --ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCc------hHHHHHHHHh-cCCCC----cC
Confidence 1234588999999998654 57889999999999999999999986331 1111111111 10000 11
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........+.+++.+||+.||++|||+.++++
T Consensus 219 -~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 -NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11112345777888999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=283.54 Aligned_cols=247 Identities=22% Similarity=0.370 Sum_probs=195.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
+.+.+.||.|+||.||+|..+ +|..+|+|.+... ....+.+.+|++++++++|+||+++++.+.+....++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 346678999999999999965 5889999998653 233457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~ 359 (511)
++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++ .+||+|||.+.....
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 82 DGGDLMKRINRQR----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999995422 23579999999999999999999998 999999999999999875 569999999887654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
..... ....|++.|+|||++... ..+.++||||||++++||++|+.|+.... ....+........ ....
T Consensus 155 ~~~~~--~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~~ 223 (257)
T cd08225 155 SMELA--YTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGYF-APIS 223 (257)
T ss_pred Ccccc--cccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcccC-CCCC
Confidence 33211 223589999999998653 67899999999999999999999985321 1222222221111 1111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .....+.+++.+||+.+|++|||+.+|++
T Consensus 224 ~-------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 P-------NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred C-------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1 12345777788899999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=281.68 Aligned_cols=270 Identities=23% Similarity=0.339 Sum_probs=213.3
Q ss_pred CCCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceE
Q 040808 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFC 267 (511)
Q Consensus 193 ~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 267 (511)
..++..++ +|.+.||+|.||.|.+++-+ .++.+|+|++++. +.....-+.|-.+|+..+||.+..|--.|
T Consensus 163 ~kvTm~dF-----dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDF-----DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchh-----hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 44555554 47889999999999999855 6999999999864 33334556788999999999999998889
Q ss_pred eecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 268 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
...++.++||||..||.|.-+|.. .+.+++...+.+-.+|..||.|||++ +||+||||.+|+|||.+|++|
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsr------er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSR------ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhh------hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceE
Confidence 999999999999999999888833 45788889999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 427 (511)
|+|||+++.--.... .+...+|||.|+|||++..+ .+....|+|.+||++|||++|+.||...+ .+.+.
T Consensus 309 itDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~d-------h~kLF 377 (516)
T KOG0690|consen 309 ITDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKD-------HEKLF 377 (516)
T ss_pred eeecccchhcccccc--eeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccc-------hhHHH
Confidence 999999985432221 24467899999999999776 78899999999999999999999997543 22333
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHh--------hccccCCCCCCCCCCC
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVEML--------EGSIENLQIPPKPSLS 494 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~~L--------~~~~~~l~~p~~p~~~ 494 (511)
+.+ ...++.++..++++.+.++..++ ..||.+|. .+.||.+.= .-..+.+..|=||.-.
T Consensus 378 eLI-l~ed~kFPr~ls~eAktLLsGLL-------~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt 449 (516)
T KOG0690|consen 378 ELI-LMEDLKFPRTLSPEAKTLLSGLL-------KKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT 449 (516)
T ss_pred HHH-HhhhccCCccCCHHHHHHHHHHh-------hcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence 322 22345667888999888888877 89999997 244444221 1123456667677544
Q ss_pred C
Q 040808 495 L 495 (511)
Q Consensus 495 ~ 495 (511)
+
T Consensus 450 S 450 (516)
T KOG0690|consen 450 S 450 (516)
T ss_pred c
Confidence 3
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=285.77 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=198.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||.||++..+ +++.+|+|.+.... ....++.+|++++++++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 346678999999999999854 68899999987532 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... .....+++..++.++.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 82 PFGDLSKAISKRK--KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred CCCCHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999986532 2235789999999999999999999998 9999999999999999999999999999877554
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. ....+++.|+|||.+.+. ..+.++|+||||+++|+|++|+.|+.... .......+....
T Consensus 157 ~~----~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~------ 217 (256)
T cd08530 157 MA----KTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDLRYKVQRGK------ 217 (256)
T ss_pred Cc----ccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCC------
Confidence 21 234588999999998653 67889999999999999999999986332 111112222111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...........+..++.+||+.+|++||++.++++
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 -YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111234556788889999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=287.27 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=190.0
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHH-HHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVAS-ISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.+.||+|+||.||++..+ +|+.||+|.++.... ...++..|+.+ ++..+||||+++++++......+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 45678999999999999965 699999999875432 23456667665 566789999999999999999999999995
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
|+|.+++.... .....+++..++.++.|++.||+|||++ .+++||||||+||+++.++.+||+|||++.......
T Consensus 84 -~~l~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 84 -TSLDKFYKKVY--DKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred -ccHHHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 78988886532 1235789999999999999999999985 289999999999999999999999999988664322
Q ss_pred ceeeecCCCCCCCccchhhcccc--cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRH--FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
. .....|+..|+|||.+.+. ...++.++|+||||+++|+|++|+.|+..... .+ ..+. .........
T Consensus 159 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~-~~~~-~~~~~~~~~-- 227 (283)
T cd06617 159 A---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----PF-QQLK-QVVEEPSPQ-- 227 (283)
T ss_pred c---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----CH-HHHH-HHHhcCCCC--
Confidence 1 1223588999999998542 12467899999999999999999999853211 11 1111 111111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ......+.+++.+||+.+|++||+++++++
T Consensus 228 --~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 --LPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCc--cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 113345777888899999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=287.58 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=194.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||.|++|.||+|... +|+.||+|.++... ...+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345688999999999999965 68899999987543 234677899999999999999999999999999999999997
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 82 -~~l~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 82 -KDLKKYMDTHG---VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred -ccHHHHHHhcC---CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 48988885433 134689999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH-------------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK------------- 428 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------- 428 (511)
. ......+++.|++||.+.+. ..++.++||||||+++|+|++|+.|+..... .+...+
T Consensus 155 ~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 155 N--TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNN------EDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred c--ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCChhhH
Confidence 1 11234578899999998553 3568899999999999999999999864321 111100
Q ss_pred -HHhhhhcc--ccCCCCChH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 -QIETEYDF--QLDGVVTEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 -~~~~~~~~--~~~~~~~~~----~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+...... ......... .......+.+++.+|++.||.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 000000000 0112345668889999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.09 Aligned_cols=268 Identities=22% Similarity=0.284 Sum_probs=194.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeec-----CeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEK-----KKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 276 (511)
|.+.++||+|+||.||+|... +|+.||+|.++... ....++.+|+.++++++|+||+++++++... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 456788999999999999854 68999999986432 2345788999999999999999999987643 357999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~e~~~-~~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 87 QELME-TDLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred ehhcc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99995 588877732 4689999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCcee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC---------CCCchHHH
Q 040808 357 TEKKESFI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS---------SEYFPNAI 426 (511)
Q Consensus 357 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~---------~~~~~~~~ 426 (511)
........ ......||+.|+|||.+.+. ..++.++||||+|+++|+|++|+.||....... ....++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 64332211 11234589999999987543 357889999999999999999999985331100 00000000
Q ss_pred HHHHhhhh------ccccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhccccCC
Q 040808 427 YKQIETEY------DFQLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM--LEGSIENL 485 (511)
Q Consensus 427 ~~~~~~~~------~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~l 485 (511)
..+.... ......... .........+.+++.+||+.+|++|||+.++++. ++......
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~ 302 (336)
T cd07849 235 -NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302 (336)
T ss_pred -HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCC
Confidence 0000000 000000000 0011224557789999999999999999999986 66555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=301.68 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=204.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCCh---HHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|.|+.|.+|++. .+..||||+++++..+. ..+.+|+++|..+.|||||+++.+......+|+||||.
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 345678999999999999954 69999999999875543 45789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
.+|.+.+|+..+. ...+..+..++.|+.+|++|||++ .|+|||||++||||+.+..+||+|||++..+...
T Consensus 138 ~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 138 SGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred cCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999997654 344477888999999999999999 9999999999999999999999999999888654
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. ..+.+|++.|.|||++.+. ...++++|+||+|+++|.|+.|..||+...- ...-.+.+ ...+.++.
T Consensus 209 ~~---lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------k~Lr~rvl--~gk~rIp~ 276 (596)
T KOG0586|consen 209 LM---LQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------KELRPRVL--RGKYRIPF 276 (596)
T ss_pred cc---ccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccc------ccccchhe--eeeecccc
Confidence 33 3467899999999999876 4778999999999999999999999985431 11111111 12345556
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.++.+.++++++|+ -.+|.+|++++++.+
T Consensus 277 ~ms~dce~lLrk~l-------vl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 277 YMSCDCEDLLRKFL-------VLNPSKRGPCDQIMK 305 (596)
T ss_pred eeechhHHHHHHhh-------ccCccccCCHHHhhh
Confidence 67788888888887 789999999999874
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=290.80 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=195.6
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
++.+.+.||+|+||.||++... ++..||+|.+.... ...+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 4556788999999999999854 68899999986432 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.. ..+++..+..++.+++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~L~~~~~~-------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 100 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCcHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999843 3578899999999999999999998 99999999999999999999999999887654332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. .....|++.|+|||.+... .++.++||||||+++|+|++|+.||....... .+.. +..... ..
T Consensus 170 ~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~------~~~~-~~~~~~----~~ 234 (293)
T cd06647 170 SK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYL-IATNGT----PE 234 (293)
T ss_pred cc--cccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhh------heee-hhcCCC----CC
Confidence 21 1233588999999998653 67889999999999999999999986432100 0000 000000 00
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.. ........+.+++.+||+.+|++||++++++..
T Consensus 235 ~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQ-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 111233456678899999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=294.80 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=191.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHcc-CCcceeeeeceEee--cCeEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRT-SHVNIVPFLGFCYE--KKKRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~lv 276 (511)
.|.+.+.||+|+||.||+|.+. +++.+|+|.+... ......+.+|+.+++++ +|+||+++++++.. ....++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4566788999999999999965 5889999988542 22335677899999999 99999999998864 3468999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||++ ++|..++.. ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 88 ~e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 88 FEYME-TDLHAVIRA-------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred ecccc-cCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99996 699988842 2678899999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCce---eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CCchHH
Q 040808 357 TEKKESF---ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EYFPNA 425 (511)
Q Consensus 357 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~ 425 (511)
....... .......||+.|+|||++.+. ...+.++||||||+++|+|++|+.|+........ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6543321 112234589999999988543 3578899999999999999999999853221000 000000
Q ss_pred HHHHHhhh-----hc-c--ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 426 IYKQIETE-----YD-F--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 426 ~~~~~~~~-----~~-~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
....+... .. . ................+.+++.+||+.+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000 00 0 00000011111234567889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=317.45 Aligned_cols=272 Identities=22% Similarity=0.299 Sum_probs=213.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEecc---C-CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKN---L-KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.+.+.+.||+|+||.|.+++.+ .++.||+|++++ . .....-|..|-.+|..-..+-|+.++-.|.+..++|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 4456789999999999999976 589999999986 2 3344578889999998889999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|||||+|-.++... ..+++..+..++.+|..||.-||+. |+|||||||+|||||..|++||+|||.+-.+.
T Consensus 156 Y~pGGDlltLlSk~------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKF------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred cccCchHHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999432 2699999999999999999999997 99999999999999999999999999988777
Q ss_pred CCCceeeecCCCCCCCccchhhcccc--c-CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh---h
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRH--F-GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE---T 432 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~-~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 432 (511)
.+... ....++|||.|++||+++.. . +.++..+|+||+||++|||+.|..||.... +.+. |..|. +
T Consensus 227 ~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveT-Y~KIm~hk~ 298 (1317)
T KOG0612|consen 227 ADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVET-YGKIMNHKE 298 (1317)
T ss_pred CCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHH-HHHHhchhh
Confidence 55543 34567899999999999532 2 568899999999999999999999996321 1221 22222 2
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC---HHHHHHHh--h----ccccCCCCCCCCCCCCCCCCC
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS---MTKVVEML--E----GSIENLQIPPKPSLSLPTGYA 500 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs---~~evl~~L--~----~~~~~l~~p~~p~~~~p~~~~ 500 (511)
...++-...++++.++++.+++ .+|+.|.. ++++-.-- + +.+.+..+|--|-+.+|.-++
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll--------~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTs 367 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALL--------CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTS 367 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHh--------cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccc
Confidence 2334434568889999998877 57788876 76664321 1 223344555556555555443
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.92 Aligned_cols=248 Identities=26% Similarity=0.328 Sum_probs=193.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+...+.||+|+||.||+++.. ++..+|+|.+..... ...++.+|++++++++|+|++++++++.+....++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 445678999999999999954 688999999875322 234688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++ |+|.+.+... ...+++..+..++.+++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 107 CL-GSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CC-CCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 96 5887777432 24689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
. ....|++.|+|||++.. ..+..+.++||||||+++|||++|+.|+.... .......+........
T Consensus 178 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 244 (317)
T cd06635 178 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPTL 244 (317)
T ss_pred c------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccCCCC
Confidence 2 23458899999999742 12467889999999999999999999975321 1111111111111110
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
. .......+.+++.+||+.+|++||++.+|++.+--
T Consensus 245 ---~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 ---Q---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---C---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0 11223346678889999999999999999986654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=285.19 Aligned_cols=243 Identities=26% Similarity=0.340 Sum_probs=188.1
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
||+|+||+||++..+ +|+.||+|++.... .....+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68999999986432 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 150 (277)
T cd05577 81 KYHIYNVG----EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--- 150 (277)
T ss_pred HHHHHHcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence 99996432 24689999999999999999999998 999999999999999999999999999876643222
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ....+...... .........
T Consensus 151 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~--- 221 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---EKEELKRRTLE-MAVEYPDKF--- 221 (277)
T ss_pred cccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccc---cHHHHHhcccc-ccccCCccC---
Confidence 1234578899999998653 57889999999999999999999986432110 11111111111 111111222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 ----SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ----CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23455677788899999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.08 Aligned_cols=264 Identities=21% Similarity=0.274 Sum_probs=193.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeec-----CeEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEK-----KKRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 275 (511)
|.+.+.||+|+||+||+|... +++.||||.++.. .....++.+|+.+++.++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 445678999999999999854 6899999998753 22345678899999999999999999988654 35799
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++
T Consensus 87 v~e~~~-~~L~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 87 VYELMD-TDLHQIIRS------SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEeCCC-CCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 999994 789888843 24689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC---------CCchHHH
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS---------EYFPNAI 426 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~---------~~~~~~~ 426 (511)
........ .....++..|+|||.+... ..++.++||||||+++|+|++|+.||........ ...++..
T Consensus 157 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 157 TTSEKGDF--MTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred ccCCCccc--ccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 76543211 1234578899999998542 3578899999999999999999999853210000 0000000
Q ss_pred -------HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhcc
Q 040808 427 -------YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM--LEGS 481 (511)
Q Consensus 427 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~--L~~~ 481 (511)
..........................+.+++.+||+.+|++|||++++++. ++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000000001111234557788999999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=282.33 Aligned_cols=240 Identities=24% Similarity=0.360 Sum_probs=191.2
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
||.|++|.||++... +++.+|+|++.... ...+.+.+|++++++++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999965 48999999987543 2335789999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--- 148 (262)
T cd05572 81 WTILRDR------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--- 148 (262)
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---
Confidence 9999532 3588999999999999999999998 999999999999999999999999999987754421
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh-hhccccCCCCCh
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET-EYDFQLDGVVTE 444 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 444 (511)
.....|++.|++||.+... .++.++|+||||+++|+|++|+.|+..... -+..+...+.. ......+..
T Consensus 149 ~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--- 218 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFPNY--- 218 (262)
T ss_pred cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCCcc---
Confidence 1234588999999998653 678899999999999999999999864421 01222222221 111111111
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 445 EEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 445 ~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
....+..++.+||+.+|++||+ ++|+++
T Consensus 219 ----~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 ----IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ----cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1345778888999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.40 Aligned_cols=198 Identities=28% Similarity=0.452 Sum_probs=171.7
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeec------CeEEEEEE
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRALIYE 278 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e 278 (511)
.+.||+||||.||+|+.+ .|+.||||.+++. ....+...+|+++|+++.|+|||++.++-.+. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 356999999999999955 6999999999864 34567899999999999999999999986553 36679999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc----CCCceEEeeccCc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD----EDFCPKISDFGLA 354 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~----~~~~~kl~DFGla 354 (511)
||++|+|+..+.+.+ ....|++...+.++..+..||.|||++ +|+||||||.||++- ..-..||+|||.|
T Consensus 98 yC~gGsL~~~L~~PE---N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE---NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCcc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999996654 456799999999999999999999998 999999999999993 3335799999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCcc
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKV 415 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~ 415 (511)
+.++++..+ .+..||..|++||.+.++ +.++..+|.|||||++|+.+||..||....
T Consensus 172 rel~d~s~~---~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNSLF---TSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCCee---eeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 999888754 455699999999999753 478899999999999999999999997553
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=289.28 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=194.0
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC--hHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN--GEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.++||+|++|+||+|... +++.||||.+...... .....+|+..+.+++ |+|++++++++.+.+..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45678999999999999975 5889999998754332 234567999999999 999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~l~~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 EGNLYQLMKDRK----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred CCCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 889999885432 24689999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC---------CCch-HHHHH-HH
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS---------EYFP-NAIYK-QI 430 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~---------~~~~-~~~~~-~~ 430 (511)
.. ....++..|+|||++.+. ...+.++|+||||++++||++|+.|+........ .... .|... .+
T Consensus 154 ~~---~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 PY---TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred Cc---CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 21 223578899999998543 3578999999999999999999988854321000 0000 00000 00
Q ss_pred hhhhccccCCCCChHHH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDGVVTEEEK----EMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
................. .....+..++.+||+.+|++|||++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00001111111111111 11356888999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=289.25 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=191.7
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecC-------
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKK------- 271 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 271 (511)
..+.+.++||+|+||.||+|..+ +|+.||+|+++... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 34566789999999999999965 58899999997432 22356788999999999999999999887654
Q ss_pred ---eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEE
Q 040808 272 ---KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348 (511)
Q Consensus 272 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl 348 (511)
..++|+||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESG-----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777776432 24689999999999999999999998 9999999999999999999999
Q ss_pred eeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 349 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
+|||++........ .......++..|+|||.+.+. ...+.++||||||+++|||++|+.|+..... .. ...
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~------~~-~~~ 228 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQE------LA-QLE 228 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh------HH-HHH
Confidence 99999987654332 111223467889999988543 3568899999999999999999998863211 00 111
Q ss_pred HHhhhhccccC----------------------CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 QIETEYDFQLD----------------------GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+......... .........+...+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110000000 0000011123456788889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=289.29 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=190.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|++|+||+|..+ +|+.||+|.+.... ...+.+.+|++++++++|+||+++++++.+....++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 455678999999999999965 68999999986542 22357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 359 (511)
+ ++|.+++.... ...+++..+..++.||+.||+|||+. +++|+||+|+||++++ ++.+||+|||++.....
T Consensus 84 ~-~~l~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 84 D-LDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred c-ccHHHHHHhCC----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 5 68888874322 23468888999999999999999998 9999999999999985 56799999999976543
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc----
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD---- 435 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 435 (511)
... ......+++.|+|||++.+. ..++.++||||+|+++|+|++|+.|+..... .+.+.+.......
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~------~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE------IDELFKIFRILGTPNEE 226 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChh
Confidence 221 11233578999999998543 3578899999999999999999999864321 1111111100000
Q ss_pred ------------cccCCCCCh----HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 ------------FQLDGVVTE----EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ------------~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
......... ........+.+++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 01112344677888999999999999999986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=283.26 Aligned_cols=241 Identities=25% Similarity=0.308 Sum_probs=182.9
Q ss_pred ccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC----hHHHHHHHH---HHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 210 KLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN----GEEFINEVA---SISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.||+|+||.||++... +++.||+|.+.+.... ...+.+|.. .++...||||+.+++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999854 5889999998753211 123444443 3444579999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQ------HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 9999998843 24689999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ....|+..|+|||.+.+. ..++.++||||+|+++|||++|+.||....... ........ ......++..
T Consensus 152 ~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~ 221 (278)
T cd05606 152 P----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMT-LTMAVELPDS 221 (278)
T ss_pred C----cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccc----hHHHHHHh-hccCCCCCCc
Confidence 1 234589999999998642 257889999999999999999999986432111 11111111 1111222222
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
.+ ..+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~s-------~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 FS-------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC-------HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 33 3455566677799999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=290.35 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=187.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecC--------e
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKK--------K 272 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------~ 272 (511)
|.+.++||+|+||.||+|..+ +++.||+|.+..... ....+.+|++++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 556788999999999999965 689999998864321 2245678999999999999999999887543 4
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++||||+. ++|.+++... ...+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNK-----NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 599999995 5888887432 23689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 353 LAKQTEKKESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 353 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
++......... .......++..|+|||.+.+. ...+.++||||||+++|||++|+.|+..... ......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-------~~~~~~~ 236 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-------QHQLTLI 236 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH
Confidence 99866433211 111233578899999998543 3467899999999999999999988854321 0000011
Q ss_pred hhhh------------------ccccCCCCChHHHH------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEY------------------DFQLDGVVTEEEKE------MAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~------------------~~~~~~~~~~~~~~------~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... .............. ....+.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 00000000000000 1134567899999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=297.37 Aligned_cols=193 Identities=26% Similarity=0.325 Sum_probs=162.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec------CeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 273 (511)
.|...+.||+|+||.||+|... +++.||+|++.+.. ....++.+|+.++++++|+||+++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 3455678999999999999954 68999999986532 2235678899999999999999999988643 357
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 97 YLVMELMD-ANLCQVIQ--------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred EEEEeccC-CCHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 99999994 68888773 2388889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
++....... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||..
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 987644322 2234588999999998653 688999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=275.74 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=203.3
Q ss_pred CHHHHHHHHHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCC-hHHHHHHHHHHHccC-CcceeeeeceEeecCe
Q 040808 196 SYSDVRRMTKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDN-GEEFINEVASISRTS-HVNIVPFLGFCYEKKK 272 (511)
Q Consensus 196 ~~~e~~~~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 272 (511)
++.|+.+.| .+.||+|+|+.|.-++ +.+|..+|||++.+.... ..+..+||+++.+.+ |+||+.|+++|++...
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 355665555 3679999999999998 778999999999877554 357889999999987 9999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC---ceEEe
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF---CPKIS 349 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~ 349 (511)
+|||||-|.||+|..+|..+ +.+++..+.+++.+|+.||.+||.+ ||.||||||+|||-.+.. -+||+
T Consensus 151 FYLVfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred EEEEEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 99999999999999999543 5799999999999999999999998 999999999999996543 47999
Q ss_pred eccCccccCCCCc-----eeeecCCCCCCCccchhhcc---cccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC---
Q 040808 350 DFGLAKQTEKKES-----FISMLDTRGTAGYIAPEVFC---RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS--- 418 (511)
Q Consensus 350 DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~---~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~--- 418 (511)
||.+..-...... .....+.+|+..|||||+.. +....+..+.|.||||||||-||+|.+||...-...
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9988764432221 12234567999999999973 222357789999999999999999999996532211
Q ss_pred --CC---CchHHHHHHHhhhhccccC---CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 419 --SE---YFPNAIYKQIETEYDFQLD---GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 419 --~~---~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+ .-...+++.|+++...-.+ ..++.+.++++..++ -.++.+|.++.++++
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLl-------vrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLL-------VRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHH-------hccHHhhhhhhhccC
Confidence 11 2235567777776532111 223444555555544 789999999988876
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=291.65 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=190.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 278 (511)
|++.++||+|+||.||+|..+ +|+.||+|+++.... ....+.+|+.++++++|+||+++++++.+. +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 456678999999999999965 689999999874322 123567899999999999999999998754 56899999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+. ++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 89 ~~~-~~l~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 89 YCE-QDLASLLDNM-----PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred cCC-CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 995 5898888532 25689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh----
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY---- 434 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 434 (511)
.... ......+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+..... ......+....
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~-------~~~~~~~~~~~~~~~ 229 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSE-------IEQLDLIIQLLGTPN 229 (309)
T ss_pred CccC--CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcCCCC
Confidence 4321 12233468889999998643 3578899999999999999999999863321 11111111100
Q ss_pred --------------ccccCCCC----ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 --------------DFQLDGVV----TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 --------------~~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........ ............+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0001112345567888899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=283.13 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=187.2
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC----hHHHHHHHHH-HHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN----GEEFINEVAS-ISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.||+|+||.||+|... +++.||+|++++.... ...+..|..+ ....+|+|++++++.+.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999864 6899999998754321 2234455544 4455899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 150 (260)
T cd05611 82 GDCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-- 150 (260)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence 9999998532 3688999999999999999999998 9999999999999999999999999998765432
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
....|++.|+|||.+.+. ..+.++||||||+++|+|++|..|+.... ...+...+...... .....
T Consensus 151 ----~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~-~~~~~ 216 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAET-------PDAVFDNILSRRIN-WPEEV 216 (260)
T ss_pred ----ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcccC-CCCcc
Confidence 233588999999998664 47899999999999999999999986331 12222222221110 00011
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
...+...+.+++.+||+.+|++||++.++.+.|.
T Consensus 217 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 ---KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ---cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1123455778888899999999998877766554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=288.97 Aligned_cols=251 Identities=20% Similarity=0.328 Sum_probs=190.6
Q ss_pred HhhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCC--ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKD--NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
+.+.++||+|+||.||+|..++ ++.||||.++.... ...++..|+.++.+.. |+||+++++++.+....+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 3567899999999999999764 89999999975432 2346677887777775 999999999999999999999998
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+++|.+++.... ..+++..+..++.|++.||+|||+. .+++||||+|+||++++++.+||+|||++......
T Consensus 97 -~~~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 97 -STCLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred -CcCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 457877764422 3789999999999999999999973 28999999999999999999999999998766433
Q ss_pred CceeeecCCCCCCCccchhhccccc--CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHF--GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
... ....+++.|+|||.+.+.. +.++.++||||||+++|+|++|+.|+..... .......+.......
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~- 238 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEEPPS- 238 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCCCCC-
Confidence 221 2335788999999986432 3478899999999999999999999853210 011111111111111
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.+. .......+.+++.+||+.||++||+++++++.
T Consensus 239 ---~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ---LPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 01233457778889999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=289.94 Aligned_cols=255 Identities=18% Similarity=0.193 Sum_probs=179.7
Q ss_pred HHHhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCCCh------------HHHHHHHHHHHccCCcceeeeece
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKDNG------------EEFINEVASISRTSHVNIVPFLGF 266 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~------------~~~~~E~~~l~~l~h~niv~l~~~ 266 (511)
..|.+.++||+|+||+||+|...+ +..+|+|+........ .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 345677899999999999998653 4567777644222111 112334455667789999999987
Q ss_pred EeecC----eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC
Q 040808 267 CYEKK----KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE 342 (511)
Q Consensus 267 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~ 342 (511)
+.... ..++++|++ ..++.+.+... ...++..+..|+.|++.||+|||+. +|+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 65443 446778877 44666665321 2357888999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCccccCCCCcee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC
Q 040808 343 DFCPKISDFGLAKQTEKKESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC 417 (511)
Q Consensus 343 ~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~ 417 (511)
++.++|+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 9999999999998664322111 11223599999999998654 6899999999999999999999999643211
Q ss_pred CCCCchH---HHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 418 SSEYFPN---AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 418 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
. ..... ...+.+..... . . ....+.+.+++..||+.+|++||+++++++.|+
T Consensus 240 ~-~~~~~~~~~~~~~~~~~~~-~----~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 G-NLIHAAKCDFIKRLHEGKI-K----I----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred h-HHHHHhHHHHHHHhhhhhh-c----c----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 10000 01122221110 0 0 112355778888899999999999999998763
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.04 Aligned_cols=242 Identities=25% Similarity=0.339 Sum_probs=190.4
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
.+||+|+||.||++..+ +++.||+|.+..... ....+.+|+.++++++|+|++++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999864 689999998864332 3456889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeee
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++......... .
T Consensus 106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~ 173 (292)
T cd06657 106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R 173 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccc--c
Confidence 88732 3578999999999999999999998 9999999999999999999999999998765433211 1
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHH
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (511)
....|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.|+.... .......+......... . .
T Consensus 174 ~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~-~----~ 239 (292)
T cd06657 174 KSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDNLPPKLK-N----L 239 (292)
T ss_pred cccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhhCCcccC-C----c
Confidence 23458899999999854 367889999999999999999999985321 11111112111111100 0 1
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 447 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 112334566778899999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=328.59 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=193.1
Q ss_pred cccCCcCceEEEEEE-cCCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
.+||.|.||.||-|. ..+|...|+|-++-.. .......+|+.++..+.|||+|+.+|+-.+.+..++-||||.+|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 479999999999998 5579999999776432 233567899999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce-
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF- 363 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 363 (511)
|.+.+.. .+..++.....+..|++.|++|||++ |||||||||+||+|+.+|.+|++|||.|..+......
T Consensus 1321 La~ll~~------gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1321 LASLLEH------GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHHHh------cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999842 34566777777889999999999999 9999999999999999999999999999877654211
Q ss_pred -eeecCCCCCCCccchhhccccc-CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHH-HHHHhhhhccccCC
Q 040808 364 -ISMLDTRGTAGYIAPEVFCRHF-GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI-YKQIETEYDFQLDG 440 (511)
Q Consensus 364 -~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 440 (511)
.......||+.|||||++.+.. .+-..+.||||+||+..||+||++||...+ .+|. .=.+..+...+++.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-------ne~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-------NEWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-------chhHHHhHHhccCCCCCch
Confidence 1223457999999999997643 234568999999999999999999996332 2231 11222333334444
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.++.+.++ ++.+||+.||+.|.++.|+++.
T Consensus 1465 ~ls~~g~d-------Fle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1465 RLSSEGRD-------FLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhhHhHHH-------HHHHHHhcCchhhhHHHHHHHh
Confidence 44444443 4456889999999988877653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.50 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=209.7
Q ss_pred hcccCCcCceEEEEEE-cCCC----cEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 208 SDKLGQGGYADVYKGT-LPDG----RLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~-~~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.++||+|+||+||+|. ...| -+||+|++...... ..++++|+.+|.+++|||+++|+|+|.... ..||.+||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 4689999999999997 3433 46999998765443 578999999999999999999999998766 88999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
|.|+|.+|++.++ ..+.....+.|..|||+|+.|||.+ +++||||-..|||+.+-.++||.|||+++....+
T Consensus 780 P~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred ccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999997654 5688899999999999999999998 9999999999999999999999999999998776
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
..........-.+.|||=|.+.. +.++.+||||||||++||++| |..|++... .+.+.+.++.+.++..+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-------~~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-------AEEIPDLLEKGERLSQP 922 (1177)
T ss_pred cccccccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCC-------HHHhhHHHhccccCCCC
Confidence 65555445556788999999854 489999999999999999998 888876432 34455555555544433
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
+. ...++..++++||..|++.||+++++...+.....+.+
T Consensus 923 pi-------CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 923 PI-------CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred CC-------ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 33 23457778899999999999999999988876655443
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=284.46 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=195.5
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.+.||+|++|.||++... +++.+|+|.++.... ....+.+|++++++++|+||+++++++.++...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34578999999999999865 688999999875432 24678899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+ +|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+.......
T Consensus 82 ~-~l~~~l~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 82 T-DLYKLIKDR-----QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred C-CHHHHHHhh-----cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 4 888887542 24789999999999999999999998 99999999999999999999999999998775543
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh---------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET--------- 432 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 432 (511)
. ......++..|+|||.+.+. ...+.++||||||+++|+|++|+.||..... .+.+......
T Consensus 153 ~--~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 153 R--PYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSE------IDQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred c--cccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHcCCCchHhc
Confidence 1 11234578899999998653 3678999999999999999999988854321 0000000000
Q ss_pred --------hhcccc----CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 --------EYDFQL----DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 --------~~~~~~----~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...... .............++.+++.+||+.||.+||++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 00111122334567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=295.38 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=189.3
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCCh---------------HHHHHHHHHHHccCCcceeeeeceEeecC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG---------------EEFINEVASISRTSHVNIVPFLGFCYEKK 271 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 271 (511)
.+.||.|+||+||+|.++ +++.||+|+++...... ..+.+|++++++++|+||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 456999999999999965 68999999986432211 24778999999999999999999999999
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~------~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR------KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 9999999995 699998843 24588999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCC------------ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC
Q 040808 352 GLAKQTEKKE------------SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS 419 (511)
Q Consensus 352 Gla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~ 419 (511)
|+++...... .........+++.|+|||.+.+. ...+.++||||||+++|||++|+.|+......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-- 240 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-- 240 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9997654111 00111233478899999998643 34688999999999999999999998643210
Q ss_pred CCchHHHHHHHhhhhc--------c----ccCCCCCh----HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 420 EYFPNAIYKQIETEYD--------F----QLDGVVTE----EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~--------~----~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+...+..... . ......+. ........+.+++.+||+.+|++|||+++++.
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 -DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred -HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 000011110000000 0 00000001 01112345678889999999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=284.28 Aligned_cols=267 Identities=26% Similarity=0.375 Sum_probs=199.4
Q ss_pred hhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHc--cCCcceeeeeceEeecC----eEEEEEEeC
Q 040808 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISR--TSHVNIVPFLGFCYEKK----KRALIYEFM 280 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~ 280 (511)
+.+.||+|.||.||+|.+.+ +.||||++... +.+.|++|-+|.+. +.|+||+++++.-.... .+.||+||.
T Consensus 214 l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccC-ceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 55679999999999999854 99999999753 34678888888765 57999999998765444 788999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG------CNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
++|+|.+||.. ..++|....+|+..+++||+|||+. ..++|+|||||+.||||..|++.-|+|||+|
T Consensus 291 ~kGsL~dyL~~-------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 291 PKGSLCDYLKA-------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred cCCcHHHHHHh-------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999954 4699999999999999999999963 3568999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCC-----ccccchhHHHHHHHHHhCCCCCCCccCCCCC-CchHHH--
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVS-----HKSDVYSYGMMIHEMVIGRKNADVKVSCSSE-YFPNAI-- 426 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-----~~sDvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~-- 426 (511)
..+............+||..|||||++.+.. .+. .+.||||+|.+||||++.-...+........ .|...+
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhc-ccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9887666555555678999999999996532 222 3689999999999999976544321111111 122111
Q ss_pred ---HHHHhhh-hccccCCCCChHHH--HHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 427 ---YKQIETE-YDFQLDGVVTEEEK--EMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 427 ---~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
.+.++.. ......+.+++.-. .-++-+.+.+.-||..|++-|.|+.-|-+++..+...
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1111110 00111222222211 2344566788999999999999999999998876543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=294.79 Aligned_cols=262 Identities=19% Similarity=0.270 Sum_probs=191.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEee----cCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYE----KKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 276 (511)
|.+.+.||+|+||.||+|..+ +|+.||+|++.... .....+.+|+.++++++||||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 445678999999999999854 68999999987542 234567889999999999999999998753 3578999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 87 ~e~~~-~~l~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 87 MDLME-SDLHHIIHS------DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred Eehhh-hhHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99994 689888843 24589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCcee--eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC---------CCCchHH
Q 040808 357 TEKKESFI--SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS---------SEYFPNA 425 (511)
Q Consensus 357 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~---------~~~~~~~ 425 (511)
........ ......|+..|+|||.+.+. ...+.++||||||+++|||++|+.||....... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 54322111 11234688999999998543 357899999999999999999999985432100 0000000
Q ss_pred H----HHHHhhhh-ccccCCCC--ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 426 I----YKQIETEY-DFQLDGVV--TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 426 ~----~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
. ...+.... ........ ..........+.+++.+||+.+|++||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00000000 00000000 11112234567888999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=282.31 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=190.4
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHcc---CCcceeeeeceEeecCe-----E
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRT---SHVNIVPFLGFCYEKKK-----R 273 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~ 273 (511)
++.++||+|+||.||+|..+ +++.||+|+++..... ...+.+|+.++.++ .|+|++++++++.+.+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999976 4899999999743222 24567788877666 59999999999988776 9
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
+++|||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP----KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence 99999996 58998885422 23689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
+......... ....+++.|+|||++.+. ..+.++||||||+++|||++|+.|+..... .+...+.....
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~ 222 (287)
T cd07838 154 ARIYSFEMAL---TSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSE------ADQLDKIFDVI 222 (287)
T ss_pred ceeccCCccc---ccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCCh------HHHHHHHHHHc
Confidence 9876544321 223478899999998654 678899999999999999999888763221 11111111100
Q ss_pred -----hc-----------c--ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 -----YD-----------F--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 -----~~-----------~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. + ...........+....+.+++.+||+.||++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0 0000011112234456778899999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=284.61 Aligned_cols=254 Identities=23% Similarity=0.275 Sum_probs=195.8
Q ss_pred hhhcccCCcCceEEEEEEc----CCCcEEEEEEeccCC-----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEE
Q 040808 206 SFSDKLGQGGYADVYKGTL----PDGRLVAVKVMKNLK-----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 275 (511)
.+.+.||+|++|.||++.. .+++.||+|++++.. ...+.+.+|++++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 4567899999999999874 257889999987532 2235688999999999 59999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 83 v~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 83 ILDYVNGGELFTHLYQ------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEecCCCCcHHHHHhh------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999843 24588999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
......... .....|+..|+|||.+.+.....+.++||||||+++|||++|+.|+..... ......+.+.+... .
T Consensus 154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~-~ 228 (288)
T cd05583 154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE---QNSQSEISRRILKS-K 228 (288)
T ss_pred ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc---cchHHHHHHHHHcc-C
Confidence 764432211 123458999999999865433478899999999999999999999853211 11111111221111 1
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
...+..+ ...+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 229 ~~~~~~~-------~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 PPFPKTM-------SAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCccc-------CHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111222 2345667788999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=281.05 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=199.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.++.++||+|+||.||++.++ .|+.+|||.+.. ..+.++++.|+.|+++...|++|+.||.+.....+.+|||||-.|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 356789999999999999976 599999998875 445789999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
++.+.+..++ +++.+..+..|+...++||+|||.. .-+|||||..||||+.+|++||+|||.|-.+.+.-.
T Consensus 114 SiSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 114 SISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred cHHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 9999996543 6899999999999999999999997 889999999999999999999999999876543211
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
......|||-|||||++..- .+..++||||||++..||..|++|+..--+....++ +.. ..++.+
T Consensus 185 -KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT----~PPPTF- 249 (502)
T KOG0574|consen 185 -KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPT----KPPPTF- 249 (502)
T ss_pred -hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccC----CCCCCC-
Confidence 12345699999999999764 678899999999999999999999853211100000 000 001111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..........-+++..||-.+|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 122344556777888999999999999988875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.17 Aligned_cols=204 Identities=27% Similarity=0.345 Sum_probs=171.5
Q ss_pred HHhhhcccCCcCceEEEEEEcC---CCc--EEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEee-cCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP---DGR--LVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYE-KKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 274 (511)
.|+...+||+|.||.||+|.-+ +.+ .+|||.++..++. .....+|+.+++.++|+|++.|..++.+ +....
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 3456678999999999999632 223 7999999865332 2578899999999999999999999987 77899
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC----CceEEee
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED----FCPKISD 350 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~D 350 (511)
|++||.+. +|...|+.++.... +.++-..+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.|||+|
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 99999966 88888887776554 6899999999999999999999998 79999999999999877 9999999
Q ss_pred ccCccccCCCCcee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 351 FGLAKQTEKKESFI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 351 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
||+++++...-... +....+.|..|+|||.+.+. ..+|.+.||||.|||+.||++.++.|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999886543322 22344579999999999886 5789999999999999999998877754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=283.22 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=191.7
Q ss_pred hhhcccCCcCceEEEEEEc----CCCcEEEEEEeccCC-----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEE
Q 040808 206 SFSDKLGQGGYADVYKGTL----PDGRLVAVKVMKNLK-----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 275 (511)
.+.+.||.|+||.||++.. .+|+.||+|+++... ...+++.+|++++.++ +|+||+.+++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4567899999999999985 368899999987532 2336788999999999 59999999999999899999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++
T Consensus 83 v~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 83 ILDYINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999532 4588899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
........ ......|+..|+|||.+.......+.++||||||+++|+|++|+.|+..... ......+.+.+... .
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~-~ 228 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILKS-E 228 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhcc-C
Confidence 76443221 1123458999999999865434567899999999999999999999863211 11111111211111 1
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
...+. .....+..++.+||+.+|++|| ++++++.
T Consensus 229 ~~~~~-------~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 PPYPQ-------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCCc-------cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11111 1234466777889999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.24 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=188.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec--------Ce
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK--------KK 272 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~ 272 (511)
|.+.++||+|+||.||+|..+ +++.+|+|++..... ....+.+|++++++++|+||+++++++.+. ..
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 456788999999999999965 689999998864321 234678999999999999999999987543 34
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++|+||+. ++|...+... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 90 ~~lv~~~~~-~~l~~~~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 90 VYMVTPYMD-HDLSGLLENP-----SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred EEEEEecCC-cCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 689999995 4777766432 24699999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCce---------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCch
Q 040808 353 LAKQTEKKESF---------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP 423 (511)
Q Consensus 353 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~ 423 (511)
+++........ .......+++.|+|||.+.+. ..++.++||||||+++|||++|+.|+....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~ 236 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QL 236 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HH
Confidence 99765432211 011233578899999998543 357889999999999999999999886332100 00
Q ss_pred HHHHHH--------------Hhhhhc-c---ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 424 NAIYKQ--------------IETEYD-F---QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 424 ~~~~~~--------------~~~~~~-~---~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+... +..... . ..+.............+.+++.+||+.+|++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 000000 0 0000000011122356788999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=275.62 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=199.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||.|+||.||++... ++..+|+|++.... ....++.+|++++++++|+|++++.+.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345678999999999999965 68899999987543 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.... .....+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 82 DGGDLSQKIKKQK--KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred CCCcHHHHHHHhh--ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999996542 1236799999999999999999999998 9999999999999999999999999999876554
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... .....|++.|+|||.+... ..+.++||||+|+++++|++|+.|++... ...+...........+..
T Consensus 157 ~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 225 (258)
T cd08215 157 VDL--AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKGQYPPIPS 225 (258)
T ss_pred cce--ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcCCCCCCCC
Confidence 311 1234588999999998653 67889999999999999999999986432 122222222221111111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+.+++.+||+.+|++|||+.++++
T Consensus 226 -------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 -------QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22345677888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=275.18 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=196.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||+|++|.||++... +++.||+|.+..... ..+.+.+|++++++++|+|++++++++.+....+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 445678999999999999855 688999999976543 4467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 82 ENGSLRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCcHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999998432 4689999999999999999999998 9999999999999999999999999999877544
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... .....++..|+|||...+. ..+.++||||+|+++|+|++|+.|+.... ................+.
T Consensus 153 ~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 221 (254)
T cd06627 153 SKD--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFRIVQDDHPPLPE 221 (254)
T ss_pred ccc--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhccCCCCCCC
Confidence 321 1234588999999998654 47889999999999999999999885321 111111111111111112
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ....+..++.+||+.+|++|||+.+++.
T Consensus 222 ~-------~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 G-------ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-------CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2 2344567778899999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=284.18 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=191.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
++...+.||+|+||.||+|... +++.+|+|.+.... ....++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3445678999999999999965 58899999886422 223568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+. |+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~-~~l~~~~~~~-----~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 96 YCL-GSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred ccC-CCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 996 6888777432 24588999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCceeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
... ...|++.|+|||.+.+ ..+..+.++||||||+++|+|++|+.|+..... ...... +.......
T Consensus 167 ~~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~ 233 (308)
T cd06634 167 PAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH-IAQNESPA 233 (308)
T ss_pred Ccc------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHH-HhhcCCCC
Confidence 322 3358899999999743 123578899999999999999999998743210 111111 11111111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
. ........+..++.+||+.+|++||++++|++..
T Consensus 234 ~------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 L------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred c------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0 0112334466788899999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=277.80 Aligned_cols=247 Identities=24% Similarity=0.292 Sum_probs=187.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC------CChHHHHHHHHHHHccCCcceeeeeceEeec--CeEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK------DNGEEFINEVASISRTSHVNIVPFLGFCYEK--KKRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 275 (511)
+.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 356778999999999999854 68999999875321 1224788899999999999999999988664 46889
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
++||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 84 v~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 84 FVEYMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEeCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 99999999999998532 3578899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCc-eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKES-FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
....... ........|+..|+|||++.+. ..+.++||||||+++|+|++|+.||.... ....+.+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~ 226 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYE------AMAAIFKIATQPT 226 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccC------HHHHHHHHHcCCC
Confidence 6532111 0111234589999999998653 67889999999999999999999985321 1111222111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...++.. ....+.+++.+||+ +|..||++.++++
T Consensus 227 ~~~~p~~-------~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDG-------VSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcc-------cCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1112222 23445566677878 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=294.08 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=188.2
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec------CeEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRAL 275 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 275 (511)
...+.||+|+||.||+|... +|+.||+|++.... .....+.+|++++++++|+||+++++++... ...++
T Consensus 18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence 34578999999999999854 68999999987532 2235688999999999999999999988654 35689
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
|+||+. .+|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 98 v~e~~~-~~l~~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 98 VMPYMQ-TDLQKIM--------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred Eecccc-cCHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 999995 4777665 13588999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh---
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET--- 432 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 432 (511)
...... ....+++.|+|||.+.+. ..++.++||||||+++|||++|+.||..... ...+...+..
T Consensus 166 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~------~~~~~~~~~~~~~ 233 (342)
T cd07879 166 HADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGV 233 (342)
T ss_pred CCCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCC
Confidence 654322 234578899999998542 3578899999999999999999999864321 1111100000
Q ss_pred -------------------hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hhccc
Q 040808 433 -------------------EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM--LEGSI 482 (511)
Q Consensus 433 -------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~ 482 (511)
....................+.+++.+||+.||++||++.++++. +++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000000000000001123456788899999999999999999844 66543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.37 Aligned_cols=249 Identities=22% Similarity=0.363 Sum_probs=194.3
Q ss_pred hhhcccCCcCceEEEEEEcCC-CcEEEEEEecc-CCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKN-LKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
++...||.|+||.||+|..++ +-..|.|++.. +....++|+-|++||....||+||+|++.|.-.+.+.++.|||+||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 456789999999999999764 55667888864 3445689999999999999999999999998889999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
.++..+-... +.|.+.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+........
T Consensus 115 AVDaimlEL~-----r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q- 185 (1187)
T KOG0579|consen 115 AVDAIMLELG-----RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ- 185 (1187)
T ss_pred hHhHHHHHhc-----cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh-
Confidence 9999886543 6899999999999999999999999 999999999999999999999999998754422111
Q ss_pred eeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.-....|||-|||||+.... ..++..++||||||++|.||..+.+|... .-+.-++-.+..... +.
T Consensus 186 -kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-------lnpMRVllKiaKSeP---PT 254 (1187)
T KOG0579|consen 186 -KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-------LNPMRVLLKIAKSEP---PT 254 (1187)
T ss_pred -hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-------cchHHHHHHHhhcCC---Cc
Confidence 11245699999999998432 24688999999999999999999988532 123333323322211 11
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+.+ ....+.+-++..+||..||..||++.++++
T Consensus 255 LlqP--S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LLQP--SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccCc--chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111 123334555667799999999999998863
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=276.95 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=190.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC------CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK------DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
|.+.++||+|+||.||++... .+..+++|+++... ....++..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 456788999999999999854 35556777765421 22345678999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++|+||||+||++++ +.+||+|||+++..
T Consensus 82 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 82 EYCEGRDLDCKLEELK--HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EeCCCCCHHHHHHHHh--hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999986432 2235789999999999999999999998 9999999999999976 56999999998776
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
...... .....|++.|+|||.+.. ...+.++|+||||+++|+|++|+.|+.... .......+......
T Consensus 156 ~~~~~~--~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~- 223 (260)
T cd08222 156 MGSCDL--ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGPTP- 223 (260)
T ss_pred CCCccc--ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCCCC-
Confidence 443221 123458899999999854 367889999999999999999999985321 11111122111111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. .......+.+++.+||+.+|++||++.++++
T Consensus 224 ---~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SL---PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CC---cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 1233446777888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=275.31 Aligned_cols=234 Identities=19% Similarity=0.227 Sum_probs=177.4
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHc-cCCcceeeeeceEeecCeEEEEEEeCCCCCHHHH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY 288 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 288 (511)
||+|+||.||++..+ +++.+|+|++........ |+..... .+|+||+++++.+...+..++||||+++++|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 599999999999854 688999999875432211 2222221 2699999999999999999999999999999999
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccccCCCCceeeec
Q 040808 289 IYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQTEKKESFISML 367 (511)
Q Consensus 289 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~ 367 (511)
+... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+++......
T Consensus 100 l~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------ 164 (267)
T PHA03390 100 LKKE------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------ 164 (267)
T ss_pred HHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------
Confidence 9532 3789999999999999999999998 999999999999999988 99999999987664332
Q ss_pred CCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHH
Q 040808 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEK 447 (511)
Q Consensus 368 ~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (511)
...|+..|+|||++.+. .++.++||||||+++|||++|+.|+..... ...-...+..... .......
T Consensus 165 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~--~~~~~~~------- 231 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQQ--KKLPFIK------- 231 (267)
T ss_pred cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhhc--ccCCccc-------
Confidence 23589999999999653 678899999999999999999999863321 1110111111111 1111111
Q ss_pred HHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 040808 448 EMAKKMILVSLWCIQTHPPDRPS-MTKVVE 476 (511)
Q Consensus 448 ~~~~~~~~l~~~Cl~~~p~~RPs-~~evl~ 476 (511)
.....+.+++.+||+.+|.+||+ ++++++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 22334556667788999999995 688863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.28 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=194.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecC-----eEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKK-----KRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 275 (511)
|.+.++||.|++|.||+|... +++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.. ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456788999999999999965 58999999987543 23467899999999999999999999988765 7899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||++ ++|.+++.. ...+++..+..++.+++.||+|||+. +|+|+||||+|||++.++.++|+|||++.
T Consensus 82 v~e~~~-~~l~~~l~~------~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 82 VTELME-TDLHKVIKS------PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred Eecchh-hhHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 999996 589888843 23789999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
........ .......+++.|+|||.+.+. ...+.++||||||+++|+|++|+.||..... .. ..+.+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~------~~-~~~~i~~~~ 223 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDY------ID-QLNLIVEVL 223 (330)
T ss_pred eecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCH------HH-HHHHHHHhc
Confidence 76544210 112234578899999998654 2678899999999999999999999854321 00 011110000
Q ss_pred cc---------------------ccCC--CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 435 DF---------------------QLDG--VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 435 ~~---------------------~~~~--~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.. .... ............+.+++.+||+.+|++||+++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 0000 0000011134567788999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=279.48 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=188.0
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.++||+|+||+||+|... +++.||+|++..... ..+++.+|++++++++|||++++++++.+....++||||++
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 467999999999999854 688999999874322 22467899999999999999999999999999999999995
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 105 ~~l~~~l~~~-----~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 105 GSASDLLEVH-----KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 6787777432 24689999999999999999999998 9999999999999999999999999998654322
Q ss_pred eeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
....|+..|+|||++.. ..+.++.++||||||+++|+|++|+.|+..... ...+........ ...
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~----~~~ 240 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNDS----PTL 240 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC----CCC
Confidence 23458899999999843 124678899999999999999999999853211 111111111111 111
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.. ......+.+++.+||+.+|++||++.++++.
T Consensus 241 ~~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 QS---NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred Cc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1122346678889999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=279.25 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=193.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 278 (511)
|.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++ |+||+++++++.+.+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 446678999999999999965 68999999987532 22356889999999999 9999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
++++++|.+++... ..+++..+..|+.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~~~~~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 83 YAPNGELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999542 3699999999999999999999998 99999999999999999999999999988664
Q ss_pred CCCce------------------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC
Q 040808 359 KKESF------------------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420 (511)
Q Consensus 359 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~ 420 (511)
..... .......++..|+|||.+... ..+.++||||||+++++|++|+.|+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~----- 226 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSN----- 226 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCcc-----
Confidence 33210 111223578999999998653 67889999999999999999999986432
Q ss_pred CchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCH----HHHH
Q 040808 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM----TKVV 475 (511)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~----~evl 475 (511)
.....+.+.. ......... ...+.+++.+||+.+|++||++ ++++
T Consensus 227 --~~~~~~~~~~-~~~~~~~~~-------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 227 --EYLTFQKILK-LEYSFPPNF-------PPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred --HHHHHHHHHh-cCCCCCCcc-------CHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1111222211 111112222 3446677888999999999999 6654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=278.85 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=193.5
Q ss_pred hhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 207 FSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.++||+|++|.||+|... +++.+|+|++.... ...+.+.+|+.++++++|+|++++++++.+.+..++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4567999999999999965 58999999998642 234678899999999999999999999999999999999996
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 82 MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 69999995432 4689999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CCchHHHHHHHhhh-
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EYFPNAIYKQIETE- 433 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~- 433 (511)
......++..|+|||.+.+. ...+.++||||||+++|||++|+.|+........ .......+..+...
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred --ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 11223467889999998653 3678899999999999999999988854321000 00000000000000
Q ss_pred -hccccCCC----CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 -YDFQLDGV----VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 -~~~~~~~~----~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........ ...........+.+++.+||+.+|++||++++|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 00111122456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=269.59 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=188.6
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEee----cCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYE----KKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~~~ 282 (511)
++||-|-.|.|-.+..+ +|+.+|+|++..+ ....+||++--+. .|||||.+++++.+ ...+.+|||.|+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG 143 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG 143 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence 57999999999999865 6899999999864 4456788765444 49999999998864 3567789999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCccccCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAKQTEK 359 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~ 359 (511)
|.|...|.++. ...+++.++.+|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+|+....
T Consensus 144 GeLfsriq~~g----~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 144 GELFSRIQDRG----DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred hHHHHHHHHcc----cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 99999997654 46799999999999999999999998 9999999999999954 56799999999998765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-cccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-DFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 438 (511)
.. .+.+.+-||-|.|||++... .++...|+||+||++|-|++|.+||..... ..+......++..+. .++-
T Consensus 217 ~~---~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 217 PG---DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred Cc---cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCccCCC
Confidence 43 34567899999999999654 688889999999999999999999975422 222222233333322 1111
Q ss_pred --CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 439 --DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 439 --~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...+++..++++++|+ ..+|++|.|++++++.
T Consensus 289 pEWs~VSe~aKdlIR~LL-------kt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLL-------KTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHhHHHHHHHHHHHHHh-------cCCchhheeHHHhhcC
Confidence 0123344444454444 9999999999999753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=287.96 Aligned_cols=260 Identities=22% Similarity=0.227 Sum_probs=186.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-C--CcEEEEEEeccCC---CChHHHHHHHHHHHcc-CCcceeeeeceEeec----CeE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-D--GRLVAVKVMKNLK---DNGEEFINEVASISRT-SHVNIVPFLGFCYEK----KKR 273 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~ 273 (511)
+.+.+.||+|+||.||++... . +..||+|.+.... ...+.+.+|+.++.++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456778999999999999954 3 7789999987532 2245788999999999 499999999875432 457
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+
T Consensus 82 ~~~~e~~~-~~L~~~l~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 82 YLYEELME-ADLHQIIRS------GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEeccc-CCHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 88899884 799988843 34689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC---------CCCc
Q 040808 354 AKQTEKKESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS---------SEYF 422 (511)
Q Consensus 354 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~---------~~~~ 422 (511)
++........ .......||+.|+|||++.+. ...+.++||||+|+++|+|++|+.|+....... ....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 9865432211 111234689999999987543 357889999999999999999999886432100 0000
Q ss_pred hHHHHHHHhhhh------cc--ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 423 PNAIYKQIETEY------DF--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 423 ~~~~~~~~~~~~------~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+. ...+.... .. .....+..........+.+++.+||+.||++|||+.+++.
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EET-LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHH-HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000000 00 0000000000011245778889999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=286.93 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=187.8
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecC------eEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKK------KRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 274 (511)
|.+.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 44567899999999999984 4789999999864322 2356889999999999999999999886543 458
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 97 lv~e~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 999999 7899888742 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CCchHHH
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EYFPNAI 426 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~ 426 (511)
....... ....+++.|+|||.+.+. ...+.++||||||+++|+|++|+.||........ ...+...
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 166 RQTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8664332 234578999999998643 3578899999999999999999999863321000 0000000
Q ss_pred HHHHhhh----hccccCCCCChH----HHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 427 YKQIETE----YDFQLDGVVTEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 427 ~~~~~~~----~~~~~~~~~~~~----~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
...+... ....+....... .......+.+++.+|++.||++|||+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000 000000000000 012233466788899999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=269.94 Aligned_cols=235 Identities=29% Similarity=0.365 Sum_probs=189.5
Q ss_pred cCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
||.|+||.||++... +++.+|+|+++.... ..+.+.+|+.++++++|+||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999965 589999999875432 345788999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (250)
T cd05123 81 FSHLSKE------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R 149 (250)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence 9999532 3689999999999999999999997 999999999999999999999999999987654321 1
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
.....++..|+|||.+.+. ..+.++|+||||+++|+|++|+.|+.... .....+.+.. ....++...
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~~~~--- 216 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAED-------RKEIYEKILK-DPLRFPEFL--- 216 (250)
T ss_pred ccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHhc-CCCCCCCCC---
Confidence 2234588999999998654 57889999999999999999999986432 1222222222 112222222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHH
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRPSMTK 473 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~e 473 (511)
...+.+++.+||+.||++||++.+
T Consensus 217 ----~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 ----SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ----CHHHHHHHHHHhcCCHhhCCCccc
Confidence 344566778888999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=286.88 Aligned_cols=261 Identities=20% Similarity=0.224 Sum_probs=186.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeec-----------
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEK----------- 270 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------- 270 (511)
+|.+.+.||.|+||.||+|... +|+.||+|.+..... ..+.+.+|++++++++||||+++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 3456788999999999999854 689999999865433 346788999999999999999999876543
Q ss_pred ---CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-CCCce
Q 040808 271 ---KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD-EDFCP 346 (511)
Q Consensus 271 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~ 346 (511)
...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +++||||||+||+++ +++.+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999996 689888732 3588999999999999999999998 999999999999997 56678
Q ss_pred EEeeccCccccCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC------
Q 040808 347 KISDFGLAKQTEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS------ 419 (511)
Q Consensus 347 kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~------ 419 (511)
||+|||+++.......... .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999976543221111 1123578899999987542 3578899999999999999999999963321000
Q ss_pred ---CCch---HHHHHHHhhhhc-cccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 420 ---EYFP---NAIYKQIETEYD-FQLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 420 ---~~~~---~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...+ ......+..... .......+ .........+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 000000000000 00000000 001123345677889999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=264.43 Aligned_cols=248 Identities=21% Similarity=0.335 Sum_probs=190.9
Q ss_pred hhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCC
Q 040808 207 FSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+...||.|.-|+||++..+ .|...|||.+.+... +..+++..+.++..-+ .|.||+.+|+|..+....+.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 3456999999999999965 589999999986543 3356777887776655 799999999999988889999998 5
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
..+++++... +.++++..+-.+...+..||.||..+ .+|+|||+||+|||+|+.|.+|++|||++-.+-+...
T Consensus 175 ~C~ekLlkri-----k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 175 TCAEKLLKRI-----KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHh-----cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 5566666432 35799999999999999999999987 4999999999999999999999999999876644332
Q ss_pred eeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. +...|-+.|||||-+... ...+..++||||||+.++||.||+.|+..... ...++..+.......
T Consensus 248 h---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t------dFe~ltkvln~ePP~---- 314 (391)
T KOG0983|consen 248 H---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT------DFEVLTKVLNEEPPL---- 314 (391)
T ss_pred c---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc------cHHHHHHHHhcCCCC----
Confidence 2 234589999999999543 45788899999999999999999999964321 122233332222222
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
++... .+.....++...||+.|+.+||...++++
T Consensus 315 L~~~~-gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPGHM-GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCccc-CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22211 14445666777899999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=288.27 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=186.0
Q ss_pred hhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec------CeEEE
Q 040808 206 SFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRAL 275 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 275 (511)
.+.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|+.++.+++|+||+++++++... ...++
T Consensus 20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 3457899999999999985 4689999999875322 235688999999999999999999988643 34678
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
+++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 100 v~~~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 100 VTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred Eehhc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccc
Confidence 88887 8899888732 3589999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CCchHHHH
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EYFPNAIY 427 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~~ 427 (511)
...... ....+++.|+|||.+.+. ...+.++||||||+++|||++|+.|+........ ...+..+.
T Consensus 169 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 169 HTDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred cccccc-----cccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 654322 234588999999998542 3578899999999999999999999853211000 00000000
Q ss_pred HHHhhh--------hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 428 KQIETE--------YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 428 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
..+... ...................+.+++.+|++.||++||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 00000000000000112346788899999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.25 Aligned_cols=254 Identities=25% Similarity=0.368 Sum_probs=180.6
Q ss_pred HHHHhhh--cccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEee-------
Q 040808 202 RMTKSFS--DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYE------- 269 (511)
Q Consensus 202 ~~~~~~~--~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 269 (511)
+...+|. +.||+||||.||+++.+ ||+.||||.+.-.. .......+|+..+++++|||||+.+..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3444554 47999999999999966 89999999997543 334578899999999999999998732210
Q ss_pred -----------------------------------------------------------------------c--------
Q 040808 270 -----------------------------------------------------------------------K-------- 270 (511)
Q Consensus 270 -----------------------------------------------------------------------~-------- 270 (511)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHH
Q 040808 271 ---------------------------------KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317 (511)
Q Consensus 271 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l 317 (511)
...|+-||||+.-+|++++.... ..-.-...++++.+|++||
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-----~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-----FNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-----cchhhHHHHHHHHHHHHHH
Confidence 12457799998888888774321 1113567889999999999
Q ss_pred HHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC----------------CCCceeeecCCCCCCCccchhhc
Q 040808 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----------------KKESFISMLDTRGTAGYIAPEVF 381 (511)
Q Consensus 318 ~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~ 381 (511)
+|+|++ |||||||||.||+||++..|||+|||+|+... ........+...||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999998 99999999999999999999999999998621 00111123456799999999999
Q ss_pred ccccC-CCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhc
Q 040808 382 CRHFG-GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWC 460 (511)
Q Consensus 382 ~~~~~-~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 460 (511)
.+..+ .++.|+|+||||+|++||+.- |...- -...+...+..+. ++.+ ..........=..++.|+
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM------ERa~iL~~LR~g~-iP~~---~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM------ERASILTNLRKGS-IPEP---ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhcc---CCchH------HHHHHHHhcccCC-CCCC---cccccccchHHHHHHHHH
Confidence 76522 689999999999999999843 43210 0112233332211 1111 111122222234567788
Q ss_pred cccCCCCCCCHHHHHH
Q 040808 461 IQTHPPDRPSMTKVVE 476 (511)
Q Consensus 461 l~~~p~~RPs~~evl~ 476 (511)
++.||++|||+.|+|.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 8999999999999963
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=285.21 Aligned_cols=237 Identities=29% Similarity=0.388 Sum_probs=189.8
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.||.|.||+||-|+++ +|+.||||++.+. ....+...+|++||+.++||.||.+.-.|+..++.++|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 57999999999999965 7999999999864 334578899999999999999999999999999999999999 677
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCccccCCCC
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~~~ 361 (511)
..+.|-+.+ +..+++..-..++.||+.||.|||.+ +|+|.||||+||||.. -..+||+|||+|+.+..+.
T Consensus 649 MLEMILSsE----kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSSE----KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHhh----cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 777775433 46799999999999999999999998 9999999999999954 3479999999999987654
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc---cc
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF---QL 438 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 438 (511)
- . ....|||+|+|||+++.. .+...-|+||.|||+|--++|..||... +.+.++++...-+ ..
T Consensus 722 F-R--rsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEd---------EdIndQIQNAaFMyPp~P 787 (888)
T KOG4236|consen 722 F-R--RSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNED---------EDINDQIQNAAFMYPPNP 787 (888)
T ss_pred h-h--hhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCc---------cchhHHhhccccccCCCc
Confidence 2 2 345799999999999765 6888899999999999999999999633 1233344443221 11
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~ev 474 (511)
...+++...+++..++ |..-.+|.|.++-
T Consensus 788 W~eis~~AidlIn~LL-------qVkm~kRysvdk~ 816 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLL-------QVKMRKRYSVDKS 816 (888)
T ss_pred hhhcCHHHHHHHHHHH-------HHHHHHhcchHhh
Confidence 2345566666666666 5556667666554
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=285.11 Aligned_cols=256 Identities=23% Similarity=0.282 Sum_probs=188.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEee-cCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYE-KKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 279 (511)
|.+.+.||.|+||.||++... +++.||+|.+.+. ....+.+.+|++++++++||||+++++++.. ....++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 345678999999999999854 7899999988642 2234678899999999999999999998865 5678999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+ +++|.+++.. ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++.....
T Consensus 92 ~-~~~L~~~~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 92 L-GTDLHRLLTS-------RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred h-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 8 6799888742 3578888899999999999999998 999999999999999999999999999876533
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC--------CchHHHHHHHh
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE--------YFPNAIYKQIE 431 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~ 431 (511)
.. ....+++.|+|||.+.+. ...+.++||||||+++|+|++|+.|+......... ..+..+...+.
T Consensus 161 ~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 161 QM-----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred Cc-----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 21 234578899999987542 35788999999999999999999988543210000 00000000000
Q ss_pred hhh------ccccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 432 TEY------DFQLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 432 ~~~------~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
... ........+ .........+.+++.+||+.+|++|||+++++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000 1111233567788899999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.73 Aligned_cols=266 Identities=24% Similarity=0.420 Sum_probs=209.4
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEcC----C----CcEEEEEEeccCCC--ChHHHHHHHHHHHccC-CcceeeeeceE
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTLP----D----GRLVAVKVMKNLKD--NGEEFINEVASISRTS-HVNIVPFLGFC 267 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~ 267 (511)
|+.+..-.+.+.||+|.||.|++|... . ...||||.++.... +.+.+..|+++|+.+. |+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333333346679999999999999743 1 34699999986544 3568999999999986 99999999999
Q ss_pred eecCeEEEEEEeCCCCCHHHHHhccc---CCCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 040808 268 YEKKKRALIYEFMPNGSLDQYIYDHE---SSNGK-------RTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337 (511)
Q Consensus 268 ~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~-------~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~N 337 (511)
...+..++|.||+..|+|.++++..+ ..... ..+....++.++.|||.|++||++. +++||||-..|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999998765 11111 2489999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccCccccCCCCceeeecCCCC--CCCccchhhcccccCCCCccccchhHHHHHHHHHhC-CCCCCCc
Q 040808 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG--TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG-RKNADVK 414 (511)
Q Consensus 338 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg-~~p~~~~ 414 (511)
||+.++..+||+|||+|+........... ...| ...|||||.+.. ..++.||||||||++||||++. ..|+..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~- 524 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPG- 524 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCC-
Confidence 99999999999999999977665544322 1222 346999999976 3899999999999999999984 455532
Q ss_pred cCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 415 VSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
. .....+++.+..+..+..+.. ...++..+|..||+.+|++||++.++++.++..+.
T Consensus 525 ~-----~~~~~l~~~l~~G~r~~~P~~-------c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 525 I-----PPTEELLEFLKEGNRMEQPEH-------CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred C-----CcHHHHHHHHhcCCCCCCCCC-------CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1 112334555666655443332 24568899999999999999999999999998543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=288.63 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=189.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCe------EE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKK------RA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 274 (511)
|.+.+.||+|++|.||+|... +++.||+|++.... ...+++.+|+.++++++|+|++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345678999999999999965 58899999986532 233567789999999999999999998766554 89
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++
T Consensus 97 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 999998 7799998842 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
....... ....++..|+|||.+.+. ...+.++||||||+++|||++|+.||..... ...+ ..+....
T Consensus 166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~------~~~~-~~i~~~~ 232 (343)
T cd07851 166 RHTDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDH------IDQL-KRIMNLV 232 (343)
T ss_pred ccccccc-----cCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHH-HHHHHhc
Confidence 8664331 234588899999998543 2578899999999999999999999853321 1111 1110000
Q ss_pred c---------------------ccc--CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 D---------------------FQL--DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~---------------------~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ... .............++.+++.+||+.+|++|||+.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 000 00000001112456778999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=276.38 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=191.6
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 275 (511)
....+|...||+|+||.|-+|.-+ ..+.+|||++++. ..+.+--+.|-.+|.... -|.+++++.+|..-+++|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 344578899999999999999865 4778999999864 333444456777777654 5688999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+.||+|.-+|... ..+.+..+..+|.+||-||-+||++ +||+||||.+|||||.+|++||+|||+++
T Consensus 428 VMEyvnGGDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred EEEEecCchhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999998543 4577788889999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
..--... .+.+.+|||.|+|||++. +..++..+|+|||||+||||+.|++||+..+ .+.+...+.+. .
T Consensus 499 Eni~~~~--TTkTFCGTPdYiAPEIi~--YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-------E~elF~aI~eh-n 566 (683)
T KOG0696|consen 499 ENIFDGV--TTKTFCGTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-------EDELFQAIMEH-N 566 (683)
T ss_pred ccccCCc--ceeeecCCCcccccceEE--ecccccchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHHc-c
Confidence 5433322 234568999999999995 3588999999999999999999999998653 34444444433 2
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCC
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP 469 (511)
...+..++.+...+.+.++ ..+|.+|.
T Consensus 567 vsyPKslSkEAv~ickg~l-------tK~P~kRL 593 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLL-------TKHPGKRL 593 (683)
T ss_pred CcCcccccHHHHHHHHHHh-------hcCCcccc
Confidence 3344566766666666655 78888885
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.51 Aligned_cols=142 Identities=24% Similarity=0.355 Sum_probs=126.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|.+. +++.||||+++.... ..+.+.+|+.++..++|+||+++++.+......++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999965 689999999975422 135688899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
+++++|.+++... ..+++..++.|+.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIY------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999532 3588899999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=273.47 Aligned_cols=252 Identities=28% Similarity=0.397 Sum_probs=195.1
Q ss_pred HHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCCh--------HHHHHHHHHHHccCCcceeeeeceEe-ecCeE
Q 040808 204 TKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG--------EEFINEVASISRTSHVNIVPFLGFCY-EKKKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~ 273 (511)
+|-+...||+|||+.||+|. +...+.||+|+-.-.+.+. ....+|..|-+.+.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 34455789999999999998 4568999999876443332 34678999999999999999999995 66789
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc---CCCceEEee
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISD 350 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~D 350 (511)
+-|.|||+|.+|+-||+.+ +.+++..+..|+.||+.||.||... ..+|||-||||.||||- .-|.+||.|
T Consensus 544 CTVLEYceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeeeeecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 9999999999999999654 4688999999999999999999986 56999999999999994 357899999
Q ss_pred ccCccccCCCCce-----eeecCCCCCCCccchhhcccc--cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCch
Q 040808 351 FGLAKQTEKKESF-----ISMLDTRGTAGYIAPEVFCRH--FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP 423 (511)
Q Consensus 351 FGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~ 423 (511)
||+++.+.++... .-+....||..|++||.+.-. ...++.|+||||.|||+|..+.|++||..... .
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs------Q 690 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS------Q 690 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh------H
Confidence 9999988654321 112234699999999998432 34688999999999999999999999974432 1
Q ss_pred HHHHHH--Hh--hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 424 NAIYKQ--IE--TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 424 ~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
..++.. +. ....++..+.++.+.+.+++ +||+...++|....++.
T Consensus 691 QdILqeNTIlkAtEVqFP~KPvVsseAkaFIR-------RCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 QDILQENTILKATEVQFPPKPVVSSEAKAFIR-------RCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHHhhhchhcceeccCCCCCccCHHHHHHHH-------HHHHhhhhhhhhHHHHc
Confidence 112111 11 12234555666766665554 57799999998766654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=239.99 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=166.0
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
-++||+|.||+||+|+.+ .++.||+|.++-... .....++|+-+++.+.|+|||++++....+....+|+||| ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 368999999999999955 589999998874332 2367899999999999999999999999999999999999 67
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+|..+.. ..++.+.+..++.|+++||.++|++ +++|||+||.|+|++.+|..|++|||+++.+.-.-
T Consensus 86 dlkkyfdsln-----g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 86 DLKKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred HHHHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 9999885433 5788999999999999999999998 99999999999999999999999999999875433
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
........|..|++|.++.+. .-++...|+||.|||+.|+.....|..
T Consensus 156 rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCC
Confidence 233445689999999999775 367889999999999999997555543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=283.23 Aligned_cols=243 Identities=25% Similarity=0.361 Sum_probs=203.9
Q ss_pred CCHHHHHHHHHhhhcccCCcCceEEEEEEcCCC-cEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEee
Q 040808 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDG-RLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYE 269 (511)
Q Consensus 195 ~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 269 (511)
..+++++++ ..||-||||.|=+...+.. ..+|+|++++. ..+.+....|-.||...+.|.||++|..|.+
T Consensus 417 v~l~dl~~i-----aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRI-----ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhh-----hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 344555433 3599999999999986553 35899999863 2345678899999999999999999999999
Q ss_pred cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 270 KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 270 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
....|++||-|-||.|...+..+ ..++..+...++..+++|++|||++ +||+|||||+|.+||.+|-+||.
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDR------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEe
Confidence 99999999999999999999543 4688889999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
|||+|+.+..... +.+.+|||.|.|||++... .....+|.||||+++|||++|++||...+ |...+..
T Consensus 563 DFGFAKki~~g~K---TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~d-------pmktYn~ 630 (732)
T KOG0614|consen 563 DFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVD-------PMKTYNL 630 (732)
T ss_pred ehhhHHHhccCCc---eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCc-------hHHHHHH
Confidence 9999999877654 3456799999999999764 67889999999999999999999997543 5566777
Q ss_pred Hhhhhcc-ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC
Q 040808 430 IETEYDF-QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS 470 (511)
Q Consensus 430 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs 470 (511)
+-.+.+. .++..++....++++++. ..+|.+|.-
T Consensus 631 ILkGid~i~~Pr~I~k~a~~Lik~LC-------r~~P~ERLG 665 (732)
T KOG0614|consen 631 ILKGIDKIEFPRRITKTATDLIKKLC-------RDNPTERLG 665 (732)
T ss_pred HHhhhhhhhcccccchhHHHHHHHHH-------hcCcHhhhc
Confidence 6666554 455667777777777777 899999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=285.58 Aligned_cols=237 Identities=24% Similarity=0.342 Sum_probs=188.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+...+|.|+|+.|-.+... +++..++|++.+... +-.+|+.++.+. +|+||+++.+.+.++.+.++|||.+.
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 3456678999999999999855 688899999987633 233567665554 59999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE-cCCCceEEeeccCccccCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL-DEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~DFGla~~~~~~ 360 (511)
++-|.+.+... ......+..|+.+|+.|+.|||++ ||+||||||+|||+ ++.++++|+|||.++.....
T Consensus 400 g~ell~ri~~~-------~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 400 GGELLRRIRSK-------PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccHHHHHHHhc-------chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99888887432 222267778999999999999998 99999999999999 68999999999999887665
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
....+-|..|.|||++.. ..+++++||||||++||+||+|+.|+...... ..++..+... ....
T Consensus 470 -----~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~---~~s~ 533 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMP---KFSE 533 (612)
T ss_pred -----hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCC---cccc
Confidence 234568899999999974 48999999999999999999999999754221 2333333222 1124
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+++..++++..|+ +.||.+||+|.++..
T Consensus 534 ~vS~~AKdLl~~LL-------~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLL-------QVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhc-------cCChhhCcChhhhcc
Confidence 56777777666655 999999999999863
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=265.18 Aligned_cols=221 Identities=20% Similarity=0.206 Sum_probs=172.8
Q ss_pred cCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcc
Q 040808 214 GGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH 292 (511)
Q Consensus 214 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~ 292 (511)
|.+|.||++.+. +++.+|+|.++... .+.+|...+....||||+++++++.+....++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999964 68999999997643 2334555555667999999999999999999999999999999998542
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCC
Q 040808 293 ESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372 (511)
Q Consensus 293 ~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 372 (511)
..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....... ....++
T Consensus 80 ------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~ 145 (237)
T cd05576 80 ------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE 145 (237)
T ss_pred ------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence 3589999999999999999999998 99999999999999999999999999876654321 233467
Q ss_pred CCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHH
Q 040808 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKK 452 (511)
Q Consensus 373 ~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (511)
..|+|||.+.. +..+.++||||+|+++|||++|+.++...... +.......++..++ ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~~~~~~~~~~-------~~ 204 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHTTLNIPEWVS-------EE 204 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccccccCCcccCC-------HH
Confidence 78999999854 36788999999999999999999876432110 00011111222223 34
Q ss_pred HHHHHHhccccCCCCCCCHHH
Q 040808 453 MILVSLWCIQTHPPDRPSMTK 473 (511)
Q Consensus 453 ~~~l~~~Cl~~~p~~RPs~~e 473 (511)
+..++.+||+.||++||++.+
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCc
Confidence 556777788999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=269.35 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=196.0
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHc--cCCcceeeeeceEeec----CeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISR--TSHVNIVPFLGFCYEK----KKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~ 279 (511)
.+.+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.+|.+. ++|+||+.+++.-..+ .++.||.+|
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 45688999999999999994 688999999743 35678888888765 5899999998764322 378899999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-----GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-----~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
-++|||.|||.. ..++.+..++++..+|.||++||. +..+.|.|||||+.|||+..++..-|+|+|||
T Consensus 291 He~GSL~DyL~r-------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 291 HEHGSLYDYLNR-------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred ccCCcHHHHHhh-------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999943 578999999999999999999995 33578999999999999999999999999999
Q ss_pred cccCCCCce--eeecCCCCCCCccchhhcccccC----CCCccccchhHHHHHHHHHhC----------CCCCCCccCCC
Q 040808 355 KQTEKKESF--ISMLDTRGTAGYIAPEVFCRHFG----GVSHKSDVYSYGMMIHEMVIG----------RKNADVKVSCS 418 (511)
Q Consensus 355 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDvwSlG~il~elltg----------~~p~~~~~~~~ 418 (511)
-........ ......+||-.|||||++..... ..-..+||||||.++||+... +.||..-.+ +
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp-~ 442 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP-S 442 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC-C
Confidence 776554322 22344579999999999954211 111368999999999998752 234432221 1
Q ss_pred CCCchHHHHHHHhhhhc-cccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 419 SEYFPNAIYKQIETEYD-FQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 419 ~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+..+.++ .+..- -.+.+.++. ...+.++.|.++|..||..||.-|-|+-.+-+.|.++.+
T Consensus 443 DPs~eeM-----rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEM-----RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHH-----hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1122222 11100 011222222 233577889999999999999999999999999887654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.98 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=195.9
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
..||.|+||+|++-.++ .|+..|||.++.... ...+++.|.+...+- ..||||+++|.+...+...+.||.| .-+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence 36999999999999866 699999999985433 345788888766554 5899999999999888899999999 667
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|+.+-+.-. ...+..+++..+-.|..-+..||.||... ..|||||+||+|||||..|.+||+|||++-.+...-
T Consensus 149 lDklYk~vy-~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--- 222 (361)
T KOG1006|consen 149 LDKLYKRVY-SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--- 222 (361)
T ss_pred HHHHHHHHH-HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---
Confidence 765543211 12245788888889999999999999986 689999999999999999999999999986654321
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC-C
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV-T 443 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 443 (511)
..+.-.|-..|||||-+.....++..+|||||||++|||+.||+.|+.. .+.+++++.....-..+... +
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~---------w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK---------WDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch---------HHHHHHHHHHHHcCCCCeecCc
Confidence 1123348888999999976655688999999999999999999999852 23355555444332222222 2
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.+..+....|...+-.|+..|.++||...++.++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 3335567778889999999999999999998753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=273.83 Aligned_cols=268 Identities=20% Similarity=0.299 Sum_probs=205.7
Q ss_pred CCCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCC--c----ceeeeec
Q 040808 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSH--V----NIVPFLG 265 (511)
Q Consensus 193 ~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~ 265 (511)
..|...|+...+|.+.+.||+|.||.|-.++++ .+..||||+++......+..+-|+++|.++.+ | -+|.+.+
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 455666777777788889999999999999965 47899999999887777888889999999942 2 3788999
Q ss_pred eEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc----
Q 040808 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD---- 341 (511)
Q Consensus 266 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~---- 341 (511)
+|.-.++.++|+|.+ |-++.++|.. ++..+++...+..|+.|+++++++||+. +++|.||||+|||+.
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~----N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKE----NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEY 230 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhcc----CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccce
Confidence 999999999999999 8899999954 3457899999999999999999999998 999999999999993
Q ss_pred ----------------CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHH
Q 040808 342 ----------------EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMV 405 (511)
Q Consensus 342 ----------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ell 405 (511)
++..+||+|||.|.......+ ..+.|..|+|||++.+- +++.++||||+||||.|+.
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELY 303 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheecc--CcCCccCceeeeeEEEEee
Confidence 134689999999988766653 33478899999999885 8999999999999999999
Q ss_pred hCCCCCCCccCCCC--------CCchHHHHHHHhhhhcc---ccC---------------------CCCChHHHHHHHHH
Q 040808 406 IGRKNADVKVSCSS--------EYFPNAIYKQIETEYDF---QLD---------------------GVVTEEEKEMAKKM 453 (511)
Q Consensus 406 tg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~---------------------~~~~~~~~~~~~~~ 453 (511)
+|...|........ ..+|..+.........+ .++ ..... .......+
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~-~d~e~~~L 382 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ-DDLEHVQL 382 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc-CcHHHhHH
Confidence 99988865531110 01111111111000000 000 00000 11233458
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 040808 454 ILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 454 ~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
++|+.++|..||.+|+|+.|++.
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHccCccccccHHHHhc
Confidence 88999999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=269.19 Aligned_cols=152 Identities=26% Similarity=0.386 Sum_probs=134.7
Q ss_pred HHHHhhCCCCCCCCCHHHHHH-HHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC---
Q 040808 182 AFVRNYGSLAPKRFSYSDVRR-MTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS--- 256 (511)
Q Consensus 182 ~~~~~~~~~~~~~~~~~e~~~-~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--- 256 (511)
+-..+|...+++++.++|... .+|-+.+|||.|.|+|||++++ .+.+.||+|+.+......+..+.|+.+|++++
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 455678889999999999988 8898999999999999999995 46889999999977666788899999999985
Q ss_pred --C---cceeeeeceEe----ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 040808 257 --H---VNIVPFLGFCY----EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327 (511)
Q Consensus 257 --h---~niv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~ 327 (511)
| ..||+|++.|. ++.+.++|+|++ |.+|.++|.... .+.++...+.+|+.||+.||.|||+.| +
T Consensus 136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~----YrGlpl~~VK~I~~qvL~GLdYLH~ec--g 208 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN----YRGLPLSCVKEICRQVLTGLDYLHREC--G 208 (590)
T ss_pred CCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC----CCCCcHHHHHHHHHHHHHHHHHHHHhc--C
Confidence 3 36999999996 456999999999 889999996543 467999999999999999999999997 9
Q ss_pred cEecCCCCCCEEE
Q 040808 328 IVHLDIKPHNIRL 340 (511)
Q Consensus 328 iiH~Dlkp~NIll 340 (511)
|||.||||+||||
T Consensus 209 IIHTDlKPENvLl 221 (590)
T KOG1290|consen 209 IIHTDLKPENVLL 221 (590)
T ss_pred ccccCCCcceeee
Confidence 9999999999998
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=276.67 Aligned_cols=230 Identities=21% Similarity=0.346 Sum_probs=185.8
Q ss_pred cccCCcCceEEEEEE-cCCCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.||-|+||+|-++. .+....+|+|.+++.. .+......|-.||.....+-||+|+-.|.+.+.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 469999999999997 5557789999998643 33456778999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC-----
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE----- 358 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~----- 358 (511)
++..+|... ..+++..++.++.+++.|+++.|.. |+|||||||+|||||.+|++||.||||+.-+.
T Consensus 715 DmMSLLIrm------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRM------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999543 4689999999999999999999997 99999999999999999999999999985321
Q ss_pred ----CCCc-----------------------------e--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHH
Q 040808 359 ----KKES-----------------------------F--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHE 403 (511)
Q Consensus 359 ----~~~~-----------------------------~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~e 403 (511)
.++. + ...-..+||+.|+|||++.+. .++..+|+||.||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHH
Confidence 1000 0 000123599999999999775 68889999999999999
Q ss_pred HHhCCCCCCCccCCCCC-CchHHHHHHHhhhhccccCCCCChHHHHHHHHHH
Q 040808 404 MVIGRKNADVKVSCSSE-YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMI 454 (511)
Q Consensus 404 lltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 454 (511)
|+.|+.||-........ .... ++.-+++...+.++.+..+++.+|+
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~n-----w~~~l~~~~~~~ls~e~~~li~kLc 910 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVIN-----WRNFLHIPYQGNLSKEALDLIQKLC 910 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeee-----hhhccccccccccCHHHHHHHHHHh
Confidence 99999999765443332 2222 3344455556778888888888766
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=256.16 Aligned_cols=237 Identities=28% Similarity=0.392 Sum_probs=190.6
Q ss_pred CceEEEEEEcC-CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhc
Q 040808 215 GYADVYKGTLP-DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYD 291 (511)
Q Consensus 215 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 291 (511)
+||.||+|... +|+.+|+|++...... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999976 5899999999764433 57899999999999999999999999999999999999999999999854
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCC
Q 040808 292 HESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371 (511)
Q Consensus 292 ~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 371 (511)
. ..+++..++.++.+++.+++|||+. +++|+||+|+||++++++.++|+|||.+........ .....+
T Consensus 81 ~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~ 148 (244)
T smart00220 81 R------GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVG 148 (244)
T ss_pred c------cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccC
Confidence 2 2388999999999999999999998 999999999999999999999999999987755431 224458
Q ss_pred CCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHH
Q 040808 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAK 451 (511)
Q Consensus 372 t~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (511)
+..|++||.+.. ...+.++||||||+++++|++|..|+.... -...+.+.+...... ..........
T Consensus 149 ~~~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~------~~~~~~~~~~~~~~~-----~~~~~~~~~~ 215 (244)
T smart00220 149 TPEYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDD------QLLELFKKIGKPKPP-----FPPPEWKISP 215 (244)
T ss_pred CcCCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHhccCCC-----CccccccCCH
Confidence 899999999864 367889999999999999999999986421 122222222221111 1111111345
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHH
Q 040808 452 KMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 452 ~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
++.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 6788899999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-33 Score=253.28 Aligned_cols=196 Identities=23% Similarity=0.381 Sum_probs=161.9
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEecc---CCCChHHHHHHHHHHHccCCcceeeeeceEee--------cCeEEE
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKN---LKDNGEEFINEVASISRTSHVNIVPFLGFCYE--------KKKRAL 275 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~~~~l 275 (511)
..+||+|.||.||+|+.+ .|+.||+|++-- ..+-....++|+.+|..+.|+|++.+++.|.. ...++|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 357999999999999965 578899886532 22334678999999999999999999998853 345899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||.+|+. +|.-.+.. ....++...+..++.++..||.|+|+. .|+|||+||.|+||+.+|.+||+|||+++
T Consensus 102 Vf~~ceh-DLaGlLsn-----~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSN-----RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eHHHhhh-hHHHHhcC-----ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 9999965 78777733 335788899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 356 QTEKKESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 356 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
.+...+.. ...+..+.|..|++||.+.+. ..++.+.|||+.|||+.||.+|.+.+..
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccC
Confidence 66433321 223444569999999999875 5789999999999999999999877653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=276.41 Aligned_cols=260 Identities=22% Similarity=0.267 Sum_probs=174.0
Q ss_pred HhhhcccCCcCceEEEEEEc-----------------CCCcEEEEEEeccCCCC-hH--------------HHHHHHHHH
Q 040808 205 KSFSDKLGQGGYADVYKGTL-----------------PDGRLVAVKVMKNLKDN-GE--------------EFINEVASI 252 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~-~~--------------~~~~E~~~l 252 (511)
+.+.++||+|+||+||+|.+ ..++.||||.++..... .+ .+..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 45668999999999999963 23568999998643221 12 334467777
Q ss_pred HccCCcce-----eeeeceEee--------cCeEEEEEEeCCCCCHHHHHhcccCC------------------CCCCCC
Q 040808 253 SRTSHVNI-----VPFLGFCYE--------KKKRALIYEFMPNGSLDQYIYDHESS------------------NGKRTL 301 (511)
Q Consensus 253 ~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l 301 (511)
.+++|.++ ++++++|.. .+..+|||||+++++|.++++..... .....+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77776654 677777753 35689999999999999999643210 012346
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhc
Q 040808 302 EWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381 (511)
Q Consensus 302 ~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 381 (511)
++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||.+
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhh
Confidence 7888999999999999999998 99999999999999999999999999997654332211 1122358999999998
Q ss_pred ccccC--------------------CCCccccchhHHHHHHHHHhCCC-CCCCccCCCCC------CchHHHHHHHhhhh
Q 040808 382 CRHFG--------------------GVSHKSDVYSYGMMIHEMVIGRK-NADVKVSCSSE------YFPNAIYKQIETEY 434 (511)
Q Consensus 382 ~~~~~--------------------~~s~~sDvwSlG~il~elltg~~-p~~~~~~~~~~------~~~~~~~~~~~~~~ 434 (511)
..... ....+.||||+||++++|++|.. |+........+ ....|. .......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-~~~~~~~ 461 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-MYKGQKY 461 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-hhcccCC
Confidence 53210 11235799999999999999885 44321100000 000110 0001111
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCC---CCCCCHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHP---PDRPSMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p---~~RPs~~evl~ 476 (511)
++......++..++++.+|+ ..+| .+|+|++|+++
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL-------~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLI-------TKRDQANRGRLSVGQALS 499 (507)
T ss_pred CcccccccChHHHHHHHHHh-------ccCCCCcccCCCHHHHhC
Confidence 22222334555556666555 6544 78999999974
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=251.99 Aligned_cols=243 Identities=20% Similarity=0.303 Sum_probs=190.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
++...||+|+|..|-.++++ ..+.+|+|++++.- .+.+=...|-.+..+. +||.+|-+..+|.....+++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 35578999999999999965 57899999998632 2222233454444444 599999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++||+|.-++. ..+.++++.+..+..+|..||.|||+. |||+||||.+|+|||..|++||.|+|+++..-.
T Consensus 333 v~ggdlmfhmq------rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 333 VNGGDLMFHMQ------RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ecCcceeeehh------hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999987773 346899999999999999999999998 999999999999999999999999999986543
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC-CCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS-SEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... +.+.+|||.|+|||++.+. .+....|+|++||+++||+.|+.||+.-.... +.+-.+.+++.+.+. .+.+
T Consensus 404 ~gd~--tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek-qiri 478 (593)
T KOG0695|consen 404 PGDT--TSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK-QIRI 478 (593)
T ss_pred CCcc--cccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh-cccc
Confidence 3322 2356899999999999875 78889999999999999999999998544333 335566666655432 2344
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP 469 (511)
+..++-....+++..+ +.||.+|.
T Consensus 479 prslsvkas~vlkgfl-------nkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFL-------NKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhh-------cCCcHHhc
Confidence 4555554444555444 99999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=282.02 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=163.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-C----CcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeece------EeecCeE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-D----GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF------CYEKKKR 273 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~~~~~ 273 (511)
|.+.++||+|+||.||+|.+. + +..||+|.+..... .+.+.+| .+.+..+.+++.++.. ..+....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 456789999999999999965 4 68999998765322 2222222 1222223333322221 2456678
Q ss_pred EEEEEeCCCCCHHHHHhcccCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 274 ALIYEFMPNGSLDQYIYDHESS--------------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
++||||+++++|.+++...... ..........+..|+.||+.||+|||+. +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 9999999999999998643210 0001122344667999999999999998 9999999999999
Q ss_pred EcC-CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccC--------------------CCCccccchhHH
Q 040808 340 LDE-DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG--------------------GVSHKSDVYSYG 398 (511)
Q Consensus 340 l~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~~sDvwSlG 398 (511)
+++ ++.+||+|||+++......... .....+|+.|+|||.+..... .++.++||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 986 6899999999998664332221 123468999999997632211 234567999999
Q ss_pred HHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh------hccccCCCCChHHHHH-------HHHHHHHHHhccccCC
Q 040808 399 MMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE------YDFQLDGVVTEEEKEM-------AKKMILVSLWCIQTHP 465 (511)
Q Consensus 399 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~-------~~~~~~l~~~Cl~~~p 465 (511)
|+||||+++..+.+... ......+... +..........+..+. .....+++.+||+.||
T Consensus 367 viL~el~~~~~~~~~~~--------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNL--------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHhCcCCCchHH--------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999776543210 0000111000 0000001111111110 1123367888999999
Q ss_pred CCCCCHHHHHH
Q 040808 466 PDRPSMTKVVE 476 (511)
Q Consensus 466 ~~RPs~~evl~ 476 (511)
++|||++++++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=276.49 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=201.9
Q ss_pred hhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEe-----ecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCY-----EKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-----~~~~~~lv~e 278 (511)
.|.+.||.|.+|.||+++ .++++.+|+|++....+..++...|.++++... |||++.++|++. .++.+.||||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 456889999999999999 557999999999877777788888999998875 999999999886 3678999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
||.+||.-|+++... ...+.|..+..|+++++.|+.+||.. .++|||||=.||||++++.|||.|||++....
T Consensus 102 fC~gGSVTDLVKn~~----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTK----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred ccCCccHHHHHhhhc----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999997654 46799999999999999999999998 99999999999999999999999999987765
Q ss_pred CCCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
.... ......|||-|||||++... ...++.++|+||||++..||--|.+|+-.. .|...+=.+.
T Consensus 175 sT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm-------HPmraLF~Ip---- 241 (953)
T KOG0587|consen 175 STVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM-------HPMRALFLIP---- 241 (953)
T ss_pred cccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc-------chhhhhccCC----
Confidence 4322 22345699999999999542 235678999999999999999999987422 1221111111
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..++..........+++.+++..||..|-+.||++.++++
T Consensus 242 -RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 -RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111112234456778889999999999999999998874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=229.56 Aligned_cols=198 Identities=29% Similarity=0.404 Sum_probs=163.5
Q ss_pred hcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC--hHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 208 SDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN--GEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+.||+|++|.|-+-++ .+|...|+|.+...-.+ ..+.++|+.+..+. ..|.+|.++|.........+.||.| .-
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 45799999999988874 47999999998754322 35678899887665 5899999999998888999999999 66
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|+.+-.+-. .....+++..+-+||..+.+||.|||++ ..|+|||+||+|||++.+|++|++|||++-.+.+.-.
T Consensus 130 Sldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA- 204 (282)
T KOG0984|consen 130 SLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA- 204 (282)
T ss_pred hHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence 8887764432 3456899999999999999999999998 7999999999999999999999999999977654321
Q ss_pred eeecCCCCCCCccchhhcccc--cCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRH--FGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
.+-..|-..|+|||.+... ...++-||||||||+++.||.+++.|++.
T Consensus 205 --kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 --KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred --HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 1113477889999998542 23688899999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=247.64 Aligned_cols=259 Identities=20% Similarity=0.296 Sum_probs=203.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEe-ecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCY-EKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 274 (511)
+.+.+..+-+|.||.||.|.++ +.+.|-+|.+++.... ...++.|.-.+..++|||+..+.+++. +...++
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 3344567899999999999654 3445778887765444 357889999999999999999999885 456888
Q ss_pred EEEEeCCCCCHHHHHhccc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 275 LIYEFMPNGSLDQYIYDHE--SSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~--~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.+|.++.-|+|..++...+ .....+.+.-.+...++.|++.|++|||++ +|||.||...|.++|+...+||+|=.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccch
Confidence 9999998999999997322 123345678888899999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
+++..-..+-.---...-.+..||+||.+..+ .++..+||||||++||||+| |+.|+..- -|..+..-+.
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeI-------DPfEm~~ylk 512 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEI-------DPFEMEHYLK 512 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCcccc-------CHHHHHHHHh
Confidence 99866443321110112256689999999765 79999999999999999998 67776422 3555666666
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.+.++..+- +.+.++..+|.-||...|++||++++++.-|.+.
T Consensus 513 dGyRlaQP~-------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 513 DGYRLAQPF-------NCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ccceecCCC-------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 666554443 3455688999999999999999999999988753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=261.90 Aligned_cols=192 Identities=24% Similarity=0.277 Sum_probs=165.1
Q ss_pred hhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCCChHH---------HHHHHHHHHccC---CcceeeeeceEeecCeE
Q 040808 207 FSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEE---------FINEVASISRTS---HVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 273 (511)
..+.||+|+||.|++|.++. ...|+||.+.+.+--.+. .-.|++||.++. |+||++++++|++++.+
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 35689999999999999774 567999999875433332 335999999998 99999999999999999
Q ss_pred EEEEEeC-CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 274 ALIYEFM-PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 274 ~lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
||+||.- ++.+|.++|. -+..+++..+.-|+.|++.|+++||++ +|||||||-+||.++.+|.+||+|||
T Consensus 645 yl~te~hg~gIDLFd~IE------~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIE------FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred EEEecCCCCCcchhhhhh------ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 9999985 5678999994 346789999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
.|.....+.- ...+||.+|.|||++.+. ......-|||++|++||.++....|+.
T Consensus 716 saa~~ksgpf----d~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPF----DVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCc----ceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9988765542 345799999999999876 356778899999999999998888764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=229.89 Aligned_cols=211 Identities=34% Similarity=0.566 Sum_probs=181.7
Q ss_pred cCCcCceEEEEEEcCC-CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHHH
Q 040808 211 LGQGGYADVYKGTLPD-GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQ 287 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 287 (511)
||+|++|.||++...+ ++.+++|++...... .+.+.+|++.+++++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999865442 5789999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCccccCCCCceeee
Q 040808 288 YIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 288 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 985421 3688999999999999999999998 9999999999999999 89999999999987654421 12
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHH
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (511)
....+...|++||.+... ...+.++|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 234588899999998542 2667899999999999999
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 447 ~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
..+.+++.+|++.+|++||++.++++.+
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577788889999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=228.52 Aligned_cols=194 Identities=22% Similarity=0.401 Sum_probs=163.4
Q ss_pred HHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEeec--CeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEK--KKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~ 279 (511)
.|.+.+++|+|-|+.||.|. ..+++.++||+++..+ ...+.+|+.||..++ ||||++|+++..+. ..+.||+||
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 35667899999999999998 5678899999998644 357889999999998 99999999998765 467899999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-CceEEeeccCccccC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTE 358 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~ 358 (511)
+.+.+...+- ..++...+..++.+++.||.|+|+. ||.|||+||+|+++|.. -..+|+|+|+|....
T Consensus 117 v~n~Dfk~ly---------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 117 VNNTDFKQLY---------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hccccHHHHh---------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9988876554 4678888999999999999999998 99999999999999864 568999999999887
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCcc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKV 415 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~ 415 (511)
.+..... ...+.-|--||.+.. +..+...-|+|||||++..|+..+.||..+.
T Consensus 185 p~~eYnV---RVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 185 PGKEYNV---RVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCceeee---eeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 7665322 234555678999865 3578889999999999999999999996543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=267.34 Aligned_cols=240 Identities=27% Similarity=0.367 Sum_probs=176.0
Q ss_pred cccCCcCceE-EEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYAD-VYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
+.+|.|+.|+ ||+|.. +||.||||.+-... ..-..+|+..|+.-+ |||||+.++.-.+....|+..|.| ..+|.
T Consensus 515 eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence 5699998875 589998 67899999775422 234578999998775 999999998888889999999999 78999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-----CCceEEeeccCccccCCCC
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-----DFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DFGla~~~~~~~ 361 (511)
+++.... ...........+.+..|+++||++||+- +||||||||.||||+. ...++|+|||+++....+.
T Consensus 591 dlie~~~--~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 591 DLIESSG--LDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHhccc--cchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9997631 1111111144567889999999999996 9999999999999965 3578999999999887655
Q ss_pred c-eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhC-CCCCCCccCCCCCCchHHHHHHHhhh-hcc-c
Q 040808 362 S-FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG-RKNADVKVSCSSEYFPNAIYKQIETE-YDF-Q 437 (511)
Q Consensus 362 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~-~ 437 (511)
. +.......||-||+|||++... .-+.++||||+||++|..++| ..||...... ...|..+ ... .
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---------~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---------QANILTGNYTLVH 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHh---------hhhhhcCccceee
Confidence 4 3334456799999999999764 456689999999999998886 7787643210 0011111 111 1
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
+......++.+++. ++++.+|..||++.+|+
T Consensus 735 L~~~~d~eA~dLI~-------~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 LEPLPDCEAKDLIS-------RMLNPDPQLRPSATDVL 765 (903)
T ss_pred eccCchHHHHHHHH-------HhcCCCcccCCCHHHHh
Confidence 11111123444444 45599999999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-31 Score=242.34 Aligned_cols=193 Identities=28% Similarity=0.428 Sum_probs=162.5
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecC-----eEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKK-----KRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~ 279 (511)
+-||.|+||.||...+. +|+.||+|.+.+...+ ..++.+|+++|..++|.|++..+++..... ..|++.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 45999999999999854 7999999988754332 367889999999999999999998776543 45678999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
| ..+|.+.|.+ ...++...+.-+.+||++||.|||+. +|+||||||.|+|++.|...||+|||+++....
T Consensus 139 m-QSDLHKIIVS------PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 M-QSDLHKIIVS------PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred H-Hhhhhheecc------CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 8 6789988854 34677888888999999999999998 999999999999999999999999999998765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
++.. -++....|.-|+|||++.+. ..++...||||.|||+.||+..+-.|..
T Consensus 209 d~~~-hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 209 RDRL-NMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hhhh-hhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 5542 23445578899999999876 5789999999999999999988876653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=224.14 Aligned_cols=251 Identities=17% Similarity=0.229 Sum_probs=187.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccC-Ccceeeeece-EeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGF-CYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~lv~e~~~ 281 (511)
|++.+.||+|.||.+-++.++ .++.+++|.+........+|.+|..---.|. |.||+.-++. |...+.+.+++||+|
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 567889999999999999977 4788999999988888899999987655554 8999988875 566678889999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc--CCCceEEeeccCccccCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD--EDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~ 359 (511)
.|+|..-+.. ..+.+.....++.|++.||+|+|++ ++||||||.+|||+- +...+||+|||+.+....
T Consensus 106 ~gdL~snv~~-------~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 106 RGDLRSNVEA-------AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cchhhhhcCc-------ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999887732 4577788889999999999999998 999999999999992 344899999999876543
Q ss_pred CCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.-. ....+..|.+||..... .....+.+|||.||++++.+++|..||.... .. .-+-|-+.+++.+...
T Consensus 176 tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~--d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 176 TVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IM--DKPYWEWEQWLKRKNP 247 (378)
T ss_pred eeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-cc--CchHHHHHHHhcccCc
Confidence 221 12246679999987321 1245678999999999999999999997321 11 2234455566665544
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.++.. .+.+..+.+++..+-+..++++|=-+.++-++
T Consensus 248 ~~P~~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPKK----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCchh----hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 33322 22333344445555669999999555555444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=245.26 Aligned_cols=274 Identities=18% Similarity=0.243 Sum_probs=211.5
Q ss_pred CCCCCCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccC------Ccceee
Q 040808 190 LAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTS------HVNIVP 262 (511)
Q Consensus 190 ~~~~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~ 262 (511)
.++.++.++|+...+|.+..-.|+|-|++|-.|.+. .|..||||+|.+.......=+.|++||++|. --+.++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 356788999999999999899999999999999965 4789999999976554455678999999996 347899
Q ss_pred eeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC
Q 040808 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE 342 (511)
Q Consensus 263 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~ 342 (511)
++-.|....+++||||-+ ..+|.+.|+.... ...|....+..++.|+.-||..|..- +|+|.||||+|||+++
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~---nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR---NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCc---ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 999999999999999988 7899999977552 34677888999999999999999985 9999999999999987
Q ss_pred C-CceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC----
Q 040808 343 D-FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC---- 417 (511)
Q Consensus 343 ~-~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~---- 417 (511)
. ..+||+|||.|......+. +....+--|.|||++.+. .++...|+||.||.||||.||+--|......
T Consensus 572 ~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred CcceeeeccCccccccccccc----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 5 5789999999987765542 122245579999999885 7889999999999999999999766432110
Q ss_pred ----CCCCchHHHHHH-------Hhhhh------------------------------ccccCCCCChHHHHHHHHHHHH
Q 040808 418 ----SSEYFPNAIYKQ-------IETEY------------------------------DFQLDGVVTEEEKEMAKKMILV 456 (511)
Q Consensus 418 ----~~~~~~~~~~~~-------~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~l 456 (511)
....||..+... ..... .+.-....+.+....+..+..|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 011122221110 00000 0011223455556677788889
Q ss_pred HHhccccCCCCCCCHHHHHH
Q 040808 457 SLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 457 ~~~Cl~~~p~~RPs~~evl~ 476 (511)
.-.|+..||++|.|..++|.
T Consensus 726 Ldkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHhccChhhcCCHHHHhc
Confidence 99999999999999998864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=224.58 Aligned_cols=198 Identities=33% Similarity=0.485 Sum_probs=168.6
Q ss_pred hhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.+.+.||.|++|.||++...+ ++.+|+|.+..... ..+.+.+|++.+.+++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999999764 88999999986543 357888999999999999999999999988999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 82 GDLFDYLRKKG-----GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999995432 1188999999999999999999998 999999999999999999999999999987755420
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
. ......++..|++||.+. .....+.++|||+||++++||++|+.||+.
T Consensus 154 ~-~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 A-LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c-cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 112335788999999984 224677899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=223.31 Aligned_cols=185 Identities=29% Similarity=0.400 Sum_probs=154.5
Q ss_pred ccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeec------CeEEEEEEe
Q 040808 210 KLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRALIYEF 279 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~ 279 (511)
-+|.|.- .|-.+.+. .++.||+|.+.... ....+..+|...+..+.|+||++++.+|... ...|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4677777 55555543 58899999876432 2346778899999999999999999998643 367899999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
| ..+|...+. ..++...+..|..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|+....
T Consensus 103 m-~~nl~~vi~--------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 103 M-DANLCQVIL--------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred h-hhHHHHHHH--------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCc
Confidence 9 779988884 3477788999999999999999998 999999999999999999999999999987644
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
. ..++....|.-|.|||++.+. ++.+.+||||.||++.||++|+-.|.
T Consensus 171 ~---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 171 D---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred c---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEec
Confidence 3 234566788899999999886 58999999999999999999997765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=228.18 Aligned_cols=195 Identities=25% Similarity=0.397 Sum_probs=161.8
Q ss_pred HhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+...++||+|.|++||++.+. .++.||+|.+.... ...+..+|++.|.++. +.||+++.+++..+++..+|+||
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 345679999999999999854 36789999887543 3467899999999986 89999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCccccC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTE 358 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~ 358 (511)
++..+-.++. ..++...+..+++.++.||+++|.+ |||||||||+|+|.+. .+.-.|.|||+|...+
T Consensus 117 ~~H~~f~~l~---------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 117 FEHDRFRDLY---------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred cCccCHHHHH---------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999888 3577888999999999999999998 9999999999999975 5677899999997211
Q ss_pred CC---------------------------------Cceee---------ecCCCCCCCccchhhcccccCCCCccccchh
Q 040808 359 KK---------------------------------ESFIS---------MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYS 396 (511)
Q Consensus 359 ~~---------------------------------~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwS 396 (511)
.. ..... -....||+||+|||++.+. +..+.++||||
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws 263 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWS 263 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceee
Confidence 00 00000 0122499999999999765 57789999999
Q ss_pred HHHHHHHHHhCCCCCCC
Q 040808 397 YGMMIHEMVIGRKNADV 413 (511)
Q Consensus 397 lG~il~elltg~~p~~~ 413 (511)
.|+|++.+++++.||..
T Consensus 264 ~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccceeehhhcccccccc
Confidence 99999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-27 Score=261.41 Aligned_cols=196 Identities=18% Similarity=0.260 Sum_probs=137.4
Q ss_pred ccCC-cceeeeeceE-------eecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 040808 254 RTSH-VNIVPFLGFC-------YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325 (511)
Q Consensus 254 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~ 325 (511)
+++| .||+++++.| .+...+++++|++ +++|.++|... ...+++..++.++.||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-----DRSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-----cccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 3456 5888888887 2334677889988 77999999532 25699999999999999999999998
Q ss_pred CCcEecCCCCCCEEEcC-------------------CCceEEeeccCccccCCCCc--------------eeeecCCCCC
Q 040808 326 IRIVHLDIKPHNIRLDE-------------------DFCPKISDFGLAKQTEKKES--------------FISMLDTRGT 372 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt 372 (511)
+|+||||||+||||+. ++.+|++|||+++....... ........||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 9999999999999954 44566666666654211000 0001123588
Q ss_pred CCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHH
Q 040808 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKK 452 (511)
Q Consensus 373 ~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (511)
+.|+|||++.+. .++.++|||||||+||||++|..|+... ......+.... .++.......+
T Consensus 179 ~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~---------~~~~~~~~~~~-------~~~~~~~~~~~ 240 (793)
T PLN00181 179 SWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEK---------SRTMSSLRHRV-------LPPQILLNWPK 240 (793)
T ss_pred cceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhH---------HHHHHHHHHhh-------cChhhhhcCHH
Confidence 999999998654 6789999999999999999988775311 11111111110 11111111223
Q ss_pred HHHHHHhccccCCCCCCCHHHHHH
Q 040808 453 MILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 453 ~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...++.+||+.+|.+||+|.||++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 456778999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=203.80 Aligned_cols=167 Identities=18% Similarity=0.187 Sum_probs=124.4
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++... ...+++..++.|+.|++.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVR-----GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence 7899999543 24699999999999999999999997 4 999999999999999 99988764422
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
..||+.|+|||++.+. .++.++|||||||++|||++|+.|+..... ....+ +.+.......... .
T Consensus 64 ------~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~-~~~~~~~~~~~~~-~ 128 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERE-----LSAIL-EILLNGMPADDPR-D 128 (176)
T ss_pred ------CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHH-HHHHHHhccCCcc-c
Confidence 2589999999999654 678999999999999999999999853311 11111 1111111111000 0
Q ss_pred ChHHHHHHH--HHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 443 TEEEKEMAK--KMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 443 ~~~~~~~~~--~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
......... .+.+++.+||+.+|++||++.++++.+...
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111222222 588899999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=237.39 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=189.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+..++|.|.||.||++++. .++..|+|+++-... +..-...|+-+++..+|||||.++|.+...+...+.||||-+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 345678999999999999955 689999999986543 345567899999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+.-+ ...++++.++..+..+.++||+|||+. +-+|||||=.|||+++.|.+|++|||.+-.+...
T Consensus 97 gslQdiy~------~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 97 GSLQDIYH------VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred Ccccceee------ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh--
Confidence 99987653 246799999999999999999999998 8899999999999999999999999988655321
Q ss_pred eeeecCCCCCCCccchhhcc-cccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFC-RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~-~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
...-.+..||+-|||||+.. +..+.+..++|||++|+...|+-.-++|.... .|.-++..+.... +..+ .
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-------hpmr~l~LmTkS~-~qpp-~ 236 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-------HPMRALFLMTKSG-FQPP-T 236 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-------chHHHHHHhhccC-CCCC-c
Confidence 11223556999999999972 33467889999999999999998888775322 2222222221111 1111 1
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
+. +.......+=.++..|+..+|++||+++.++
T Consensus 237 lk-Dk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 LK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cc-CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11 1111112233445557799999999998876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=214.73 Aligned_cols=160 Identities=19% Similarity=0.206 Sum_probs=124.0
Q ss_pred HHhhhcccCCcCceEEEEEEcC--CCcEEEEEEeccC------CCChHHHHHHHHHHHccCCcceee-eeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP--DGRLVAVKVMKNL------KDNGEEFINEVASISRTSHVNIVP-FLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~ 274 (511)
.|.+.+.||+|+||+||+|.++ +++.||||++... ....+.|.+|+++|++++|+|++. +++ .+..+
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~ 94 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDG 94 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcE
Confidence 3566788999999999999854 5778899987532 112356889999999999999985 443 24679
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCCEEEcCCCceEEeeccC
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI-KPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DFGl 353 (511)
+||||+++++|.. +. . .. ...++.+++++|+|||+. +|+|||| ||+|||++.++.+||+|||+
T Consensus 95 LVmE~~~G~~L~~-~~--~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 95 LVRGWTEGVPLHL-AR--P-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred EEEEccCCCCHHH-hC--c-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 9999999999962 21 0 00 135788999999999998 9999999 99999999999999999999
Q ss_pred ccccCCCCceee------ecCCCCCCCccchhhccc
Q 040808 354 AKQTEKKESFIS------MLDTRGTAGYIAPEVFCR 383 (511)
Q Consensus 354 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 383 (511)
|+.......... .....+++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 997754432111 134568889999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=197.09 Aligned_cols=249 Identities=20% Similarity=0.362 Sum_probs=187.4
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++.-||.+...|..|+|+++.+. +++|++... ....++|..|.-.|+.+.||||..++|.|....+..++..|||.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 45667999999999999996544 556666532 22336899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe--eccCccccCCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS--DFGLAKQTEKK 360 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~--DFGla~~~~~~ 360 (511)
|+|...+++.. .-.++..++.+++..+|+|++|||+- ..-|.-.-|.+..+++|++.+++|+ |--++..
T Consensus 272 gslynvlhe~t----~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQT----SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred hHHHHHHhcCc----cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 99999997643 34567788999999999999999996 3345566899999999999998875 2211111
Q ss_pred CceeeecCCCCCCCccchhhcccccCCC-CccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGV-SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.....-.|.|++||.+++..... -..+|+|||++++|||.|...||..-.+ .+--.+...++....++
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp------mecgmkialeglrv~ip 411 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP------MECGMKIALEGLRVHIP 411 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc------hhhhhhhhhccccccCC
Confidence 12334578999999997653222 2468999999999999999999853321 01112222333333333
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
+. +.+.|.+++.-|++.||.+||.++.|+-.||..+
T Consensus 412 pg-------is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PG-------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CC-------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 33 3455777888899999999999999999999754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-22 Score=199.11 Aligned_cols=271 Identities=18% Similarity=0.216 Sum_probs=191.4
Q ss_pred HHhhhcccCCcCceEEEEEEcCC--CcEEEEEEeccCCCC-hHHHHHHHHHHHccCC----cceeeeeceE-eecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD--GRLVAVKVMKNLKDN-GEEFINEVASISRTSH----VNIVPFLGFC-YEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 275 (511)
.+.+.++||+|+||.||++.... ...+|+|+....... ...+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 45677899999999999999654 358999988764322 2367788888888873 5788888877 47778899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-----CceEEee
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-----FCPKISD 350 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~D 350 (511)
||+.+ |.+|.++..... .+.++..+++.|+.|++.+|++||+. |++||||||+|+++... ..+.|.|
T Consensus 99 VM~l~-G~sL~dl~~~~~----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEecc-CccHHHHHHhCC----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99988 999999774432 46799999999999999999999998 99999999999999754 4689999
Q ss_pred ccCcc--ccCCCCce--ee----ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCc
Q 040808 351 FGLAK--QTEKKESF--IS----MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYF 422 (511)
Q Consensus 351 FGla~--~~~~~~~~--~~----~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 422 (511)
||+++ ........ .. ....+||..|+++....+. ..+.+.|+||++.++.|++.|..||........
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--- 245 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--- 245 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccch---
Confidence 99998 32211110 11 1234699999999998664 788999999999999999999999853321100
Q ss_pred hHHHHHHHhhhhccc-cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCCC
Q 040808 423 PNAIYKQIETEYDFQ-LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSL 495 (511)
Q Consensus 423 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~~~ 495 (511)
..-........... .....+.. +.++..-+-..+..++|....+...|++...........++.+
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw 311 (322)
T KOG1164|consen 246 -KSKFEKDPRKLLTDRFGDLKPEE-------FAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDW 311 (322)
T ss_pred -HHHHHHHhhhhccccccCCChHH-------HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcc
Confidence 11111111111111 00111122 2222222335899999999999999887766554444333333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-21 Score=193.64 Aligned_cols=261 Identities=28% Similarity=0.365 Sum_probs=192.0
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC----ChHHHHHHHHHHHccCCc-ceeeeeceEeecCeEEEEEEeC
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD----NGEEFINEVASISRTSHV-NIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+.+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45678999999999999976 7899999875432 356899999999999988 7999999997777789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~ 359 (511)
.++++.+++...... ..+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||+++....
T Consensus 81 ~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 81 DGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 999999777433211 3688899999999999999999998 899999999999999988 799999999986554
Q ss_pred CCcee----eecCCCCCCCccchhhccccc-CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 360 KESFI----SMLDTRGTAGYIAPEVFCRHF-GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 360 ~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
..... ......||..|+|||.+.... ...+...|+||+|++++++++|..|+...... .........+....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcC
Confidence 33221 224557999999999986531 36788999999999999999999996533211 01122222222211
Q ss_pred ccccCCCCChHH-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 435 DFQLDGVVTEEE-KEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 435 ~~~~~~~~~~~~-~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
............ ......+..++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 100000111100 1112345566667778899999998887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=222.34 Aligned_cols=252 Identities=21% Similarity=0.232 Sum_probs=183.1
Q ss_pred hcccCCcCceEEEEEEc-CCCcEEEEEEecc---CCCChH----HHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 208 SDKLGQGGYADVYKGTL-PDGRLVAVKVMKN---LKDNGE----EFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.+.+|.|++|.|+.... ......+.|.... .....+ .+..|+.+-.+++|+|++..+..+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 45799999998877763 3344444443321 111111 255678888889999999888888777666667999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++ +|..++... ..+....+..++.|++.|+.|||.. ||.|||+|++|++++.+|.+||+|||.+.....
T Consensus 403 ~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred ccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 999 999988432 3577788888999999999999998 999999999999999999999999999876654
Q ss_pred CCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 360 KESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 360 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
.... ....+.+|+..|+|||++.+. ..-....||||.|++++.|++|+.||.........+ .. ........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~-~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~-----~~~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGK-EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT-----NNYSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCccccccc-ccCcchhhhhhccceEEEEecCCCccccccccccch-hh-----hccccccc
Confidence 3332 344567899999999999765 234557899999999999999999997554322221 00 00000011
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......-...+......++.++|+.+|.+|.||++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111112234455666777888888999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=184.52 Aligned_cols=138 Identities=20% Similarity=0.213 Sum_probs=107.5
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCC---C-------hHHH-----------------HHHHHHHHccCCcce
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD---N-------GEEF-----------------INEVASISRTSHVNI 260 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-------~~~~-----------------~~E~~~l~~l~h~ni 260 (511)
.+.||+|+||.||+|...+|+.||||+++.... . ..+| .+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999987899999999975421 1 1122 349999999988776
Q ss_pred eeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEecCCCCCCEE
Q 040808 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL-HRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 261 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH~Dlkp~NIl 339 (511)
.....+.. ...++||||++++++...+.. ...++...+..++.|++.+|+|| |+. +|+||||||+|||
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK------DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 44332221 223899999988877644321 24688899999999999999999 677 9999999999999
Q ss_pred EcCCCceEEeeccCcccc
Q 040808 340 LDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 340 l~~~~~~kl~DFGla~~~ 357 (511)
++ ++.++|+|||+|...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-21 Score=181.74 Aligned_cols=200 Identities=22% Similarity=0.287 Sum_probs=163.3
Q ss_pred HHHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeC
Q 040808 203 MTKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
..|.++++||+|+||+++.|+ +-+++.||||.-.. +....+...|....+.|. .++|..++-|-.++.+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 346788999999999999998 55899999997654 334456777888777775 688888887777888889999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-----CceEEeeccCcc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-----FCPKISDFGLAK 355 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~DFGla~ 355 (511)
|-+|+|++.- . .+.++..++.-||.|++.-++|+|++ .+|+|||||+|+||... ..+-++|||+|+
T Consensus 107 -GPSLEDLFD~-C----gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 107 -GPSLEDLFDL-C----GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred -CcCHHHHHHH-h----cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 8899987732 2 36799999999999999999999998 99999999999999543 358899999999
Q ss_pred ccCCCCce-----eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 356 QTEKKESF-----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 356 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
...+..+. ....+..||..||+--...+. ..+.+-|+=|||-+++..|-|..||..-
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 87544321 122244699999998777664 6788999999999999999999999643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=177.96 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=161.8
Q ss_pred HHhhhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCChHHHHHHHHHHHccCC-cceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSH-VNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||.|+||.+|.|. ..+|..||||+-++... ..+..-|..+...+++ ..|..+.-+..+...-.+||+.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 45678899999999999998 67899999998765332 2456778888888875 57777777888899999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCccccC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAKQTE 358 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~ 358 (511)
|-+|++++.-.. +.++..+++-++-|++.-++|+|.+ +.|||||||+|+|..- ...+-++|||+|+...
T Consensus 94 GPsLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 94 GPSLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred CccHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 899999885432 5688899999999999999999998 9999999999999953 3468899999999775
Q ss_pred CCCc-----eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCcc
Q 040808 359 KKES-----FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKV 415 (511)
Q Consensus 359 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~ 415 (511)
+..+ ...-....||..|.+--...+. ..+.+.|+=|+|.+|....-|..||..-.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 4322 1222345699999987766543 45788999999999999999999997543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=177.88 Aligned_cols=140 Identities=21% Similarity=0.193 Sum_probs=109.9
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---------------------------hHHHHHHHHHHHccCCcce
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---------------------------GEEFINEVASISRTSHVNI 260 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni 260 (511)
.+.||+|+||.||+|.+.+|+.||||+++..... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999778999999998754211 1123578999999999987
Q ss_pred eeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCEE
Q 040808 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 261 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NIl 339 (511)
.....+... ..+|||||++++++...... ...++......++.+++.++.+||+ . +|+||||||+|||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence 544433332 24899999988865433211 1356778899999999999999999 7 9999999999999
Q ss_pred EcCCCceEEeeccCccccCC
Q 040808 340 LDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 340 l~~~~~~kl~DFGla~~~~~ 359 (511)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 78999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-22 Score=184.19 Aligned_cols=171 Identities=13% Similarity=0.106 Sum_probs=129.6
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHH----------HHHHHHHHHccCCcceeeeeceEee
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEE----------FINEVASISRTSHVNIVPFLGFCYE 269 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~ 269 (511)
+.+-.|+..+.||.|+||.||+... +++.+|||+++......+. +.+|+..+.++.|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3444566678999999999999766 5678999999754322222 5789999999999999999887654
Q ss_pred c--------CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 270 K--------KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 270 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
. ...+|||||++|.+|.++. .++. ....+++.+|..+|+. +++|||+||+||+++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 3 3578999999999998764 1222 2456899999999998 999999999999999
Q ss_pred CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHH
Q 040808 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMV 405 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ell 405 (511)
.+| ++|+|||..+........ ..++... .+..++|+||||+++.-+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--------------d~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--------------HHHHHHh--HhcccccccceeEeehHHH
Confidence 988 999999988755322210 0022222 3447899999999977654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=174.01 Aligned_cols=184 Identities=15% Similarity=0.057 Sum_probs=139.1
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChH-----HHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCC
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE-----EFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
...|++|+||+||.+.. .++.++.+.+.......+ .|.+|+++|++++ |+++.+++++ ...+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 45799999999997765 678888887776544333 5789999999996 5788888875 34699999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC-CCCCEEEcCCCceEEeeccCccccCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI-KPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
|.+|...+. . ....++.|++.+|+++|+. ||+|||| ||+|||+++++.++|+|||++......
T Consensus 82 G~~L~~~~~----------~---~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 82 GAAMYQRPP----------R---GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred CccHHhhhh----------h---hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999865431 0 1134678999999999998 9999999 799999999999999999999865533
Q ss_pred Cce----e-------eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 361 ESF----I-------SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 361 ~~~----~-------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
... . .......++.|++|+...-....--...++++-|..+|.++|++.+..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 211 0 011223788999998753221112256799999999999999997764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=191.94 Aligned_cols=220 Identities=22% Similarity=0.372 Sum_probs=166.9
Q ss_pred HHccCCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-Ee
Q 040808 252 ISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRI-VH 330 (511)
Q Consensus 252 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i-iH 330 (511)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....++.+|+.||+|||.. .| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-----~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-----DIKLDYFFILSFIRDISKGLAYLHNS---PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-----ccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence 35678999999999999999999999999999999999653 46799999999999999999999997 44 99
Q ss_pred cCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccc--cCC---CCccccchhHHHHHHHHH
Q 040808 331 LDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH--FGG---VSHKSDVYSYGMMIHEMV 405 (511)
Q Consensus 331 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~---~s~~sDvwSlG~il~ell 405 (511)
+.+++.|.++|....+||+|||+.................-..-|.|||.+... ... .+.+.||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999999998776431111111112244579999999653 111 467899999999999999
Q ss_pred hCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 406 IGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 406 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+.+.||+...... -++.+...+.......+.+.+.... +....++.++..||..+|++||++++|-..++....
T Consensus 153 ~r~~~~~~~~~~~---~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 153 FRSGPFDLRNLVE---DPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hccCccccccccC---ChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999997543221 1233333343322222223333222 455578899999999999999999999999887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-21 Score=196.33 Aligned_cols=224 Identities=24% Similarity=0.316 Sum_probs=173.2
Q ss_pred ccCCcCceEEEEEE----cCCCcEEEEEEeccCCC---ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCC
Q 040808 210 KLGQGGYADVYKGT----LPDGRLVAVKVMKNLKD---NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+|+|.||.|+++. .+.|..+|+|++++... .......|..++...+ ||.+|++.-.+......+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999864 23478899999875321 1125566888888887 9999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|.|...+.. ...+.+.....+..+++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-..+
T Consensus 81 gg~lft~l~~------~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSK------EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhcccc------CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 9999888743 34677777888889999999999998 99999999999999999999999999998765543
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. .+||..|||||++. .....+|.||||++++||++|-.||.. .+...|... .+..+..
T Consensus 152 ~------~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~-~~~~p~~ 209 (612)
T KOG0603|consen 152 I------ACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA-ELEMPRE 209 (612)
T ss_pred h------cccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh-ccCCchh
Confidence 2 27999999999986 346789999999999999999999853 222233221 1233344
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
++......++.|. ..+|..|.-.
T Consensus 210 l~~~a~~~~~~l~-------~r~p~nrLg~ 232 (612)
T KOG0603|consen 210 LSAEARSLFRQLF-------KRNPENRLGA 232 (612)
T ss_pred hhHHHHHHHHHHH-------hhCHHHHhcc
Confidence 4444444444444 6777777643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=173.74 Aligned_cols=233 Identities=21% Similarity=0.279 Sum_probs=144.3
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCC----------cc------eeeeec-
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSH----------VN------IVPFLG- 265 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h----------~n------iv~l~~- 265 (511)
++.||.|+++.||.+.+. +|+.+|+|+..... ...+++.+|...+..+.+ -. ++++.+
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 467999999999999976 58999999885332 223567777665555432 11 222211
Q ss_pred --eEeecC--------eEEEEEEeCCCCCHHHHHhcccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 040808 266 --FCYEKK--------KRALIYEFMPNGSLDQYIYDHES-SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334 (511)
Q Consensus 266 --~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlk 334 (511)
++.... ..+++|+-+ .++|.+++..... ......+....++.+..|+++.+++||+. |++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111111 235678777 7788888643111 11123455566677889999999999998 99999999
Q ss_pred CCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccc------cCCCCccccchhHHHHHHHHHhCC
Q 040808 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH------FGGVSHKSDVYSYGMMIHEMVIGR 408 (511)
Q Consensus 335 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDvwSlG~il~elltg~ 408 (511)
|+|++++.+|.++|+||+.......... . ...+..|.+||..... .-.++.+.|.|++|+++|.|.+|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 9999999999999999987765543221 1 3356789999987432 124688899999999999999999
Q ss_pred CCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCC
Q 040808 409 KNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDR 468 (511)
Q Consensus 409 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~R 468 (511)
.|++........ ++ ++.... ++.+.+..++...|+.||.+|
T Consensus 248 lPf~~~~~~~~~---~~---------~f~~C~-------~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADP---EW---------DFSRCR-------DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTS---GG---------GGTTSS----------HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccc---cc---------cchhcC-------CcCHHHHHHHHHHccCCcccC
Confidence 999855332211 11 121112 233344445555669999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9e-19 Score=163.21 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=101.8
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccC-CCChHHHHHHHHHHHcc-----CCcceeeeeceEeecC---e-EEEEEE
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNL-KDNGEEFINEVASISRT-----SHVNIVPFLGFCYEKK---K-RALIYE 278 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv~e 278 (511)
+.||+|+||.||. .-.++.. +||++... ....+.+.+|+.++..+ .||||++++|++.++. . ..+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 4799999999996 2223444 79988753 23446789999999999 5799999999998763 3 337899
Q ss_pred e--CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCcEecCCCCCCEEEcC----CCceEEeec
Q 040808 279 F--MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL-EYLHRGCNIRIVHLDIKPHNIRLDE----DFCPKISDF 351 (511)
Q Consensus 279 ~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~yLH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~DF 351 (511)
| +++|+|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||
T Consensus 86 ~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 86 FDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred CCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 9 6689999999431 24444 35677888777 999998 9999999999999974 348999995
Q ss_pred cCc
Q 040808 352 GLA 354 (511)
Q Consensus 352 Gla 354 (511)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-20 Score=195.58 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=174.8
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC--hHHHH---HHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN--GEEFI---NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+.+.||.+.|=.|.+|+++.|. |+||++-+.... .+.|. .|++ ...++|||.+.+..+.....-.|||-+|.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 34567999999999999998877 999998765432 24444 4444 55568999999888777777778888888
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc--C
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT--E 358 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~--~ 358 (511)
.-+|.|.|.. +..+..-+..-|+.|++.||.-+|.. ||+|||||.+||||+.=.-+.|+||..-+.. +
T Consensus 104 -khnLyDRlST------RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 104 -KHNLYDRLST------RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred -hhhhhhhhcc------chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 4589888832 34566667777999999999999998 9999999999999999889999999876643 2
Q ss_pred CCC--ceeeecC-CCCCCCccchhhcccccC---------CCCccccchhHHHHHHHHHh-CCCCCCCccC----CCCCC
Q 040808 359 KKE--SFISMLD-TRGTAGYIAPEVFCRHFG---------GVSHKSDVYSYGMMIHEMVI-GRKNADVKVS----CSSEY 421 (511)
Q Consensus 359 ~~~--~~~~~~~-~~gt~~y~aPE~~~~~~~---------~~s~~sDvwSlG~il~ellt-g~~p~~~~~~----~~~~~ 421 (511)
.++ .+.-..+ .+.-..|+|||-+....+ .++++-||||+||++.||++ |+++|+...- .....
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD 253 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence 221 1111111 223447999999854211 26678899999999999997 6777753210 00022
Q ss_pred chHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
.++.+++.++. .. +..+++.|++.||+.|.++++.++.-.|.
T Consensus 254 ~~e~~Le~Ied-----------~~-------~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 254 DPEQLLEKIED-----------VS-------LRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred CHHHHHHhCcC-----------cc-------HHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 33333333221 12 33455566699999999999999885553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=191.12 Aligned_cols=190 Identities=24% Similarity=0.302 Sum_probs=148.8
Q ss_pred HHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccC---CcceeeeeceEeecCeEEEEEEe
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS---HVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
..+.+.+.||+|+||+||+|...+|+.||||+-+....+ +|---.+++.||+ -+.|..+.....-.+.-+||+||
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 344556789999999999999888999999987754433 3332334455555 23344444444445566899999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-------CCCceEEeecc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD-------EDFCPKISDFG 352 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~-------~~~~~kl~DFG 352 (511)
.+.|||.+++. ..+..+|.....++.|++.-++.||.. +|||+||||+|.||. +..-++|+|||
T Consensus 776 ~~~Gtlld~~N------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 776 SPYGTLLDLIN------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred cccccHHHhhc------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999994 456799999999999999999999998 999999999999992 34568999999
Q ss_pred Ccccc---CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCC
Q 040808 353 LAKQT---EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408 (511)
Q Consensus 353 la~~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~ 408 (511)
-+-.+ .++.. ....++|-++--+|...+. .+++..|.|.++.+++-||.|+
T Consensus 847 ~siDm~lfp~~~~---F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDGTK---FKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCCcE---EeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHH
Confidence 88533 33333 3345688899999998764 8999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=166.67 Aligned_cols=140 Identities=18% Similarity=0.191 Sum_probs=107.8
Q ss_pred HhhhcccCCcCceEEEEEE--cCCCcEEEEEEeccCCCC-------------------------hHHHHHHHHHHHccCC
Q 040808 205 KSFSDKLGQGGYADVYKGT--LPDGRLVAVKVMKNLKDN-------------------------GEEFINEVASISRTSH 257 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h 257 (511)
+.+.+.||+|+||.||+|. ..+|+.||+|+++..... ...+..|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567889999999999998 568999999998753210 0124679999999976
Q ss_pred cc--eeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-cEecCCC
Q 040808 258 VN--IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR-IVHLDIK 334 (511)
Q Consensus 258 ~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-iiH~Dlk 334 (511)
.+ +.+++++ ...++||||+++++|...... ...+....+..++.|++.+|++||+. + ++|+|||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik 176 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK------DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS 176 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc------cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence 33 3333332 235899999999888655411 12355566788999999999999998 8 9999999
Q ss_pred CCCEEEcCCCceEEeeccCccccC
Q 040808 335 PHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 335 p~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+||+++ ++.++|+|||.+....
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=160.09 Aligned_cols=133 Identities=20% Similarity=0.261 Sum_probs=112.3
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCC---------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD---------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.||+|++|.||+|.. +|..+++|+...... ...++.+|+.++..+.|+++.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 677899998653221 113577899999999999988777777777888999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
++|++|.+++... .+ .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998421 12 7788999999999999998 999999999999999 78899999998865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=158.34 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=108.1
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC-----------------------hHHHHHHHHHHHccCCcc-
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN-----------------------GEEFINEVASISRTSHVN- 259 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~n- 259 (511)
++.+.+.||+|+||.||++..++|+.||||+++..... ...+..|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 35667889999999999999888999999987643210 123567888998888874
Q ss_pred -eeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCE
Q 040808 260 -IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNI 338 (511)
Q Consensus 260 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NI 338 (511)
+...++ ....++||||+++++|.+... ......++.+++.++.++|+. +++|+||||+||
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni 156 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI 156 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc------------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence 333333 245689999999999976541 023457889999999999997 999999999999
Q ss_pred EEcCCCceEEeeccCccccCC
Q 040808 339 RLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~~~~ 359 (511)
++++++.++|+|||++.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9e-18 Score=162.30 Aligned_cols=200 Identities=22% Similarity=0.289 Sum_probs=140.7
Q ss_pred CCcceeeeeceEe---------------------------ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHH
Q 040808 256 SHVNIVPFLGFCY---------------------------EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQ 308 (511)
Q Consensus 256 ~h~niv~l~~~~~---------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 308 (511)
.|||||++.++|. ++...|+||.-. ..+|+.|+.. +..+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-------~~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-------RHRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-------CCCchHHHHH
Confidence 5999999998764 234667888877 5699999954 2355566677
Q ss_pred HHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE--cCCCc--eEEeeccCccccCCCC---ceee-ecCCCCCCCccchhh
Q 040808 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL--DEDFC--PKISDFGLAKQTEKKE---SFIS-MLDTRGTAGYIAPEV 380 (511)
Q Consensus 309 i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll--~~~~~--~kl~DFGla~~~~~~~---~~~~-~~~~~gt~~y~aPE~ 380 (511)
|+.|+++|+.|||++ +|.|||+|++|||+ |+|+. ..|+|||.+-...... .+.+ ..+.-|...-||||+
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 899999999999999 99999999999998 55554 5788999875433211 1111 123347778899999
Q ss_pred cccccCCC----CccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHH
Q 040808 381 FCRHFGGV----SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILV 456 (511)
Q Consensus 381 ~~~~~~~~----s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 456 (511)
.....|.. -.|+|.|+.|.+.||+++...||...... .+.... .++.....++..+++...+++..++
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~r~---Yqe~qLPalp~~vpp~~rqlV~~lL-- 494 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDTRT---YQESQLPALPSRVPPVARQLVFDLL-- 494 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eechhh---hhhhhCCCCcccCChHHHHHHHHHh--
Confidence 85543332 25899999999999999999998642110 111111 2222223445566677777777766
Q ss_pred HHhccccCCCCCCCHHHHHHHhh
Q 040808 457 SLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 457 ~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
+.||++|++.+-....|.
T Consensus 495 -----~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 495 -----KRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -----cCCccccCCccHHHhHHH
Confidence 999999999877776664
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=155.50 Aligned_cols=129 Identities=23% Similarity=0.312 Sum_probs=105.5
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCC--C-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLK--D-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.||+|+||.||+|.. +|..+++|+..... . ..+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999995 56889999865321 1 1245778999999999887665555556666779999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+|++|.+++.... . .++.+++.+|++||+. +++|+|++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998873211 0 7899999999999998 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=176.83 Aligned_cols=132 Identities=19% Similarity=0.272 Sum_probs=107.7
Q ss_pred hhcccCCcCceEEEEEEcCCCcEEEEEE-eccC-CC-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 207 FSDKLGQGGYADVYKGTLPDGRLVAVKV-MKNL-KD-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~-~~~~-~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
..++||+|+||+||+|.+.+.. +++|+ +.+. .. ..+++.+|++++.+++|++++....++.+....++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3578999999999999875443 44443 2221 11 1246889999999999999988877777777889999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++++|.+++. ....++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998883 3467899999999999998 99999999999999 5779999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-18 Score=172.06 Aligned_cols=124 Identities=27% Similarity=0.437 Sum_probs=106.9
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
.+++.|+++...+|.++|.... .....++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~---~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR---TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC---cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence 5789999999999999996544 23567788899999999999999 5 8999999999999999999999999
Q ss_pred cCccccCCCC----ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh
Q 040808 352 GLAKQTEKKE----SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI 406 (511)
Q Consensus 352 Gla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt 406 (511)
|+........ .....+...||..||+||.+.+. .++.|+||||||+||+||+.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHH
Confidence 9987766554 22334566799999999999875 89999999999999999996
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-17 Score=176.71 Aligned_cols=201 Identities=23% Similarity=0.345 Sum_probs=137.2
Q ss_pred hcccCCcCceEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 208 SDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
++.|-.|+||.||..+++. .+.+|+|+-++. . +++- ++.....|.+| |+-.
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~-l----ilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L----ILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc-h----hhhc--cccccCCccee---------------------chhh
Confidence 4678899999999999874 567888543321 1 1110 33333344333 5555
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC-----
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE----- 361 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~----- 361 (511)
+.++. ...++... +.+++|||+. +|+|||+||+|.+|..-|++|+.|||+++..-...
T Consensus 140 tllk~------~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 140 TLLKN------IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhccc------CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 55532 23444332 7789999998 99999999999999999999999999987542110
Q ss_pred -ce-------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 362 -SF-------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 362 -~~-------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
.. ..-...+|||.|+|||++... .+...+|+|++|+|+||.+.|..||+.. -++.++.++...
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGd-------tpeelfg~visd 273 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFGQVISD 273 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCC-------CHHHHHhhhhhh
Confidence 00 011234699999999999764 6889999999999999999999999755 245555554444
Q ss_pred hcccc--CCCCChHHHHHHHHHHHHHHhccccCCCCCC
Q 040808 434 YDFQL--DGVVTEEEKEMAKKMILVSLWCIQTHPPDRP 469 (511)
Q Consensus 434 ~~~~~--~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP 469 (511)
...+. +.....+..+++..|+ +.+|.+|-
T Consensus 274 ~i~wpE~dea~p~Ea~dli~~LL-------~qnp~~Rl 304 (1205)
T KOG0606|consen 274 DIEWPEEDEALPPEAQDLIEQLL-------RQNPLCRL 304 (1205)
T ss_pred hccccccCcCCCHHHHHHHHHHH-------HhChHhhc
Confidence 33332 2333455566666655 88999986
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.6e-17 Score=148.98 Aligned_cols=135 Identities=24% Similarity=0.279 Sum_probs=96.7
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCCCh---HHH----------------------HHHHHHHHccCCcc--e
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---EEF----------------------INEVASISRTSHVN--I 260 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--i 260 (511)
.+.||+|+||+||+|.+.+++.||||+++...... ..+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987532211 111 24555555554432 3
Q ss_pred eeeeceEeecCeEEEEEEeCCCCCHHHH-HhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCE
Q 040808 261 VPFLGFCYEKKKRALIYEFMPNGSLDQY-IYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNI 338 (511)
Q Consensus 261 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NI 338 (511)
.+.++. ...++||||++++++... +... ... ..+..++.+++.++.++|. . +|+|+||||+||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNI 146 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence 333322 246899999998543211 1100 011 5577899999999999999 6 999999999999
Q ss_pred EEcCCCceEEeeccCccccC
Q 040808 339 RLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~~~ 358 (511)
+++ ++.++|+|||.+....
T Consensus 147 li~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE-CCcEEEEECccccccc
Confidence 999 8899999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=7.6e-16 Score=135.78 Aligned_cols=135 Identities=22% Similarity=0.180 Sum_probs=113.5
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCC--cceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSH--VNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
.+.||+|+++.||++...+ ..+++|....... ..++.+|+.++..++| .++.+++++....+..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3579999999999999754 7899999876443 5678899999999987 4888888888777889999999988776
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
..+ +......++.++++++++||.....+++|+|++|+||++++++.++++|||.++..
T Consensus 81 ~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 432 45667778999999999999864457999999999999999899999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=144.15 Aligned_cols=133 Identities=15% Similarity=0.151 Sum_probs=103.4
Q ss_pred cccC-CcCceEEEEEEcCCCcEEEEEEeccCC--------------CChHHHHHHHHHHHccCCcce--eeeeceEeecC
Q 040808 209 DKLG-QGGYADVYKGTLPDGRLVAVKVMKNLK--------------DNGEEFINEVASISRTSHVNI--VPFLGFCYEKK 271 (511)
Q Consensus 209 ~~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 271 (511)
..|| .||.|+||+.... ++.++||...... .....+.+|++++.++.|+++ +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999999874 6789998775311 122467889999999998875 66666543322
Q ss_pred ----eEEEEEEeCCC-CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCce
Q 040808 272 ----KRALIYEFMPN-GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346 (511)
Q Consensus 272 ----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~ 346 (511)
..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+. ||+|+||||+|||++.++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCE
Confidence 23599999997 699988742 234443 356899999999998 99999999999999998999
Q ss_pred EEeeccCccc
Q 040808 347 KISDFGLAKQ 356 (511)
Q Consensus 347 kl~DFGla~~ 356 (511)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999998765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-16 Score=171.07 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=183.6
Q ss_pred HhhhcccCCcCceEEEEEEcC--CCcEEEEEEeccCCC---ChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP--DGRLVAVKVMKNLKD---NGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+-||+|+|+.|-..... ....+|+|.+..... ..+....|..+=..+. |.|++.+++...+.+..+++.+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 445567999999999888753 355677777664432 2233445666666666 9999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQ 356 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~ 356 (511)
|..++++.+-+... .....+...+-.+..|+..++.|+| .. ++.|+||||+|.++++.+ ..+++|||+|..
T Consensus 102 ~s~g~~~f~~i~~~----~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 102 YSDGGSLFSKISHP----DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccccccccccccC----CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999998777311 1124555667778999999999999 65 999999999999999999 999999999988
Q ss_pred cCC-CCceeeecCCCC-CCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 357 TEK-KESFISMLDTRG-TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 357 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
... ..........+| ++.|+|||...+. .......|+||.|+++..+++|..|++........ +..|.... ...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~--~~~ 250 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK--GRF 250 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc--ccc
Confidence 876 444444455678 9999999998763 35677899999999999999999999866443322 12221111 110
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
.......+......+..+ ++..+|+.|.+.+++-
T Consensus 251 ~~~~~~~~~~~~~~~l~k-------~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHK-------ILKENPSNRLSIEELK 284 (601)
T ss_pred ccCccccCChhhhhcccc-------cccCCchhcccccccc
Confidence 112223334444444444 4478999999888764
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.1e-14 Score=119.33 Aligned_cols=86 Identities=26% Similarity=0.595 Sum_probs=66.9
Q ss_pred CCCCCCcCCCCCCCCCC-CCCEEEeeCC--ceEEEEeeeeEEEEEEecCCcEEEEEecccCCCCC-C---C--CCCCcCC
Q 040808 4 GTSYPFSGGEREYTCGH-PSLNLNCEND--TATLVLGEVKYRVLNIDQKEQLLRIAKQVYFDGFC-P---Q--RNFTIDS 74 (511)
Q Consensus 4 ~i~yPF~~~~~~~~CG~-p~~~l~C~~~--~~~l~~~~~~y~v~~I~y~~~~~~~~~~~~~~~~C-~---~--~~~~l~~ 74 (511)
+|+||||++ +.||+ |+|+|+|+++ .+.|.+.+++|+|++|+|.+++|+|.++..+...+ . . .+.+++.
T Consensus 12 ~IpYPFgi~---~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (106)
T PF13947_consen 12 SIPYPFGIG---PGCGRDPGFELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSSSSNSSNSNLSLNG 88 (106)
T ss_pred eecCCCccC---CCCCCCCCcEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCCCCcccccEEeecC
Confidence 599999998 58999 9999999976 67888889999999999999999999987663222 1 1 2223444
Q ss_pred cceEeecCCceEEEEEcCCC
Q 040808 75 TLFTYADGYKMLTLISGCPT 94 (511)
Q Consensus 75 ~~f~~~~~~~~~~~~~~C~~ 94 (511)
||.+++. .|.+++++|..
T Consensus 89 -~~~~s~~-~N~~~~~GC~t 106 (106)
T PF13947_consen 89 -PFFFSSS-SNKFTVVGCNT 106 (106)
T ss_pred -CceEccC-CcEEEEECCCC
Confidence 7777764 55567999963
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=141.96 Aligned_cols=140 Identities=25% Similarity=0.263 Sum_probs=99.4
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCC---------------------------Ch--------------HHHHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD---------------------------NG--------------EEFIN 247 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------------------~~--------------~~~~~ 247 (511)
+.||.|++|.||+|++++|+.||||+.+..-. +. -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 35999999999999999999999999853210 00 02455
Q ss_pred HHHHHHccC----CcceeeeeceEe-ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 040808 248 EVASISRTS----HVNIVPFLGFCY-EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR-GLEYLH 321 (511)
Q Consensus 248 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~-~l~yLH 321 (511)
|+..+.++. |.+-+.+-..+. ..+..+|||||++|++|.++..... ...+ ...++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----cCCC---HHHHHHHHHHHHHHHHH
Confidence 666665553 333333333332 2345799999999999988764321 1122 3446666665 467888
Q ss_pred hCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 322 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
.. |++|+|+||.||++++++.++++|||++.....
T Consensus 275 ~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 87 999999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.1e-13 Score=127.54 Aligned_cols=207 Identities=21% Similarity=0.290 Sum_probs=138.6
Q ss_pred HHHHHHccCCcceeeeeceEeec-----CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 040808 248 EVASISRTSHVNIVPFLGFCYEK-----KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322 (511)
Q Consensus 248 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~ 322 (511)
-..-|-++-|.|||+++.++.+. ....++.|||..|+|..+|+... .....+......+|+.||+.||.|||+
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~--~~~~a~~~~~wkkw~tqIlsal~yLhs 194 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK--KNQKALFQKAWKKWCTQILSALSYLHS 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH--HhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence 34455667799999999988653 45789999999999999997654 234567788888999999999999998
Q ss_pred CCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee--eecCCCCCCCccchhhcccccCCCCccccchhHHHH
Q 040808 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI--SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMM 400 (511)
Q Consensus 323 ~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~i 400 (511)
|...|+|+++..+-|++..+|-+|+.----...-....... ......+-++|.+||+= .....+..+|||+||+-
T Consensus 195 -~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg--~~tn~~~a~dIy~fgmc 271 (458)
T KOG1266|consen 195 -CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG--TTTNTTGASDIYKFGMC 271 (458)
T ss_pred -cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC--cccccccchhhhhhhHH
Confidence 78899999999999999999988875311111000000000 01123478899999984 33366789999999999
Q ss_pred HHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 401 IHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 401 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..||.-+.--.... .+.+.++....... +.+. ..-.. ..+..|++..|..||+|++++.
T Consensus 272 AlemailEiq~tns---eS~~~~ee~ia~~i----~~le---n~lqr-------~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 272 ALEMAILEIQSTNS---ESKVEVEENIANVI----IGLE---NGLQR-------GSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHHHheeccCCC---cceeehhhhhhhhe----eecc---Ccccc-------CcCcccccCCCCCCcchhhhhc
Confidence 99998776332111 11122221111110 1000 11111 2345688999999999998864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-12 Score=118.46 Aligned_cols=130 Identities=22% Similarity=0.168 Sum_probs=96.1
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeCCCCCHHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFMPNGSLDQ 287 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~ 287 (511)
+.|+.|.++.||++... ++.+++|+..........+.+|+.++..+.+.+++ +++.+ .....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 46889999999999864 67899999865443334567899999988765554 34433 2334589999999988753
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 288 YIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC--NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 288 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
.- . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~-----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED-----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 20 0 11235678999999999972 12359999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-12 Score=134.35 Aligned_cols=250 Identities=22% Similarity=0.184 Sum_probs=176.0
Q ss_pred HHHHHHhhhcccCC--cCceEEEEEEc--C-CCcEEEEEEeccCC---CChHHHHHHHHHHHccC-CcceeeeeceEeec
Q 040808 200 VRRMTKSFSDKLGQ--GGYADVYKGTL--P-DGRLVAVKVMKNLK---DNGEEFINEVASISRTS-HVNIVPFLGFCYEK 270 (511)
Q Consensus 200 ~~~~~~~~~~~LG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 270 (511)
+...+..+.+.+|. |.+|.||.+.. + ++..+|+|.-+... ....+-.+|+..-.+++ |+|.++.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 34444556678999 99999999986 3 57889999744321 12233456776666665 99999999999999
Q ss_pred CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCcEecCCCCCCEEEcCC-Cc
Q 040808 271 KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR----GLEYLHRGCNIRIVHLDIKPHNIRLDED-FC 345 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~ 345 (511)
+..++-.|++ +.+|..+..... ..++...++.+..+... ||.++|.. .++|-|+||.||++..+ ..
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred Ccceeeeccc-cchhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 9999999988 688888885543 34666777777778888 99999998 99999999999999999 88
Q ss_pred eEEeeccCccccCCCCcee---eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCc
Q 040808 346 PKISDFGLAKQTEKKESFI---SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYF 422 (511)
Q Consensus 346 ~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 422 (511)
.+++|||+...+....-.. ......|...|++||...+ ..+..+|+|++|.+..+...+....... ++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g------~~ 332 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVG------KN 332 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCC------CC
Confidence 9999999998876554211 1123358889999999854 5788999999999999999887654322 11
Q ss_pred hHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 423 PNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
..|. ++.... .+ .+.......++..+...+++.+|-.|++.+.+.
T Consensus 333 ~~W~--~~r~~~-ip-----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 333 SSWS--QLRQGY-IP-----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred CCcc--cccccc-Cc-----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 2221 111110 00 011111122233355667799999998876654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-12 Score=137.96 Aligned_cols=141 Identities=21% Similarity=0.227 Sum_probs=91.9
Q ss_pred cccCCcCceEEEEEEcCC-CcEEEEEEeccCCC---------------------------C----hH----------HHH
Q 040808 209 DKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKD---------------------------N----GE----------EFI 246 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------------------------~----~~----------~~~ 246 (511)
+-||.|++|.||+|++++ |+.||||+++.... . .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 369999999999999887 99999999964210 0 00 244
Q ss_pred HHHHHHHccC----CcceeeeeceEee-cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 040808 247 NEVASISRTS----HVNIVPFLGFCYE-KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321 (511)
Q Consensus 247 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH 321 (511)
+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.+.+.-.-.........+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4555555543 3344444444433 45678999999999998743211100001122233333333333 3
Q ss_pred hCCCCCcEecCCCCCCEEEcCCC----ceEEeeccCccccCC
Q 040808 322 RGCNIRIVHLDIKPHNIRLDEDF----CPKISDFGLAKQTEK 359 (511)
Q Consensus 322 ~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFGla~~~~~ 359 (511)
.. |++|+|+||.||+++.++ .+++.|||++.....
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 999999999999999888 999999999887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.1e-11 Score=107.96 Aligned_cols=135 Identities=15% Similarity=0.139 Sum_probs=96.6
Q ss_pred cccCCcCceEEEEEEcCC-------CcEEEEEEeccCC----------------------CC-hHHH----HHHHHHHHc
Q 040808 209 DKLGQGGYADVYKGTLPD-------GRLVAVKVMKNLK----------------------DN-GEEF----INEVASISR 254 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~-~~~~----~~E~~~l~~ 254 (511)
..||.|--+.||.|...+ +..+|||+.+.+. .+ ...+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999875210 01 1122 279999998
Q ss_pred cCC--cceeeeeceEeecCeEEEEEEeCCCCCHHH-HHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCcEe
Q 040808 255 TSH--VNIVPFLGFCYEKKKRALIYEFMPNGSLDQ-YIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL-HRGCNIRIVH 330 (511)
Q Consensus 255 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yL-H~~~~~~iiH 330 (511)
+.. .++..++++ ...+|||||+.+..+.. .+. ...++......+..+++.+|..| |+. +++|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-------d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-------DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-------ccccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 864 345555543 45789999996543321 121 12344456677889999999999 776 9999
Q ss_pred cCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 331 LDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 331 ~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
+||++.|||+++ +.+.|+|||.+-...
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999999974 679999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.23 E-value=8e-11 Score=111.14 Aligned_cols=141 Identities=17% Similarity=0.146 Sum_probs=108.4
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCc--ceeeeeceEeec---CeEEEEEEeCC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHV--NIVPFLGFCYEK---KKRALIYEFMP 281 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 281 (511)
+.|+.|..+.||++...+|+.+++|+...... ...++.+|++++..+.+. ++.+++.+..+. +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999977778999999865433 346788999999999764 456677666553 25689999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC------------------------------------- 324 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------- 324 (511)
|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9888665410 24667777788888888888888521
Q ss_pred ----------------CCCcEecCCCCCCEEEcC--CCceEEeeccCccc
Q 040808 325 ----------------NIRIVHLDIKPHNIRLDE--DFCPKISDFGLAKQ 356 (511)
Q Consensus 325 ----------------~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~ 356 (511)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-09 Score=114.17 Aligned_cols=165 Identities=21% Similarity=0.224 Sum_probs=123.8
Q ss_pred cCCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCC
Q 040808 224 LPDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLE 302 (511)
Q Consensus 224 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~ 302 (511)
..++..|.|.+.+.... ..+...+-++-|+.++||||+++++.+...+..|||.|-+. .|..++.. +.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hH
Confidence 34688899998886554 23456778899999999999999999999999999999873 56666633 22
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcc
Q 040808 303 WRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382 (511)
Q Consensus 303 ~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 382 (511)
.....-.+.||+.||-+||..| +++|++|.-.-|++++.|..||++|.++.....-... .....--..|..|+.+.
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcC
Confidence 3445556889999999999775 8999999999999999999999999987554322210 00011122467777653
Q ss_pred cccCCCCccccchhHHHHHHHHHhC
Q 040808 383 RHFGGVSHKSDVYSYGMMIHEMVIG 407 (511)
Q Consensus 383 ~~~~~~s~~sDvwSlG~il~elltg 407 (511)
.+ .-..|.|-||++++|++.|
T Consensus 179 ~s----~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PS----EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc----ccchhhhhHHHHHHHHhCc
Confidence 22 1346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.2e-10 Score=98.45 Aligned_cols=130 Identities=18% Similarity=0.206 Sum_probs=99.7
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEec-cCCC--------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMK-NLKD--------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+++|+-+.+|.+.+.+ ..+.+|.-. +.-. ..++-.+|+.++.++.--.|...+-+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 47899999999997643 446666432 2211 1245678999999988666655555567778889999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
+|-.|.+++... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+...
T Consensus 82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888432 245677788888999998 999999999999998765 999999998743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-11 Score=122.42 Aligned_cols=241 Identities=20% Similarity=0.239 Sum_probs=162.4
Q ss_pred hhcccCCcCceEEEEEEc--CCCcEEEEEEeccCCCC-hH--HHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeC
Q 040808 207 FSDKLGQGGYADVYKGTL--PDGRLVAVKVMKNLKDN-GE--EFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~--~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
+..+||.|.|+.|+.... .++..|++|.+.+.... .+ .-+.|+.+...+ .|.+++.....+......++--||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 446899999999999873 36788999987654222 11 123455555555 3888888877777777888999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-CceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~~ 359 (511)
.++++...+.. ...+.....+++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||.+..+..
T Consensus 349 ~~~s~~l~~~~------~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 349 EGGSSSLRSVT------SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCcchhhhhHH------HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce
Confidence 99998877622 24577778889999999999999987 99999999999999876 7889999999865322
Q ss_pred CCceeeecCCCCCCCcc-chhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYI-APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
... ...+.-++. ..|.+... ...-.+.|++|||.-+.|.+++..-.... ..|. .+..+.....
T Consensus 420 ~~~-----~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~--~i~~~~~p~~ 483 (524)
T KOG0601|consen 420 SSG-----VFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSL--TIRSGDTPNL 483 (524)
T ss_pred ecc-----cccccccccccchhhccc-cccccccccccccccccccccCcccCccc--------ccce--eeecccccCC
Confidence 111 111333344 25555444 36778999999999999999987543221 1111 1111111111
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.+ ...+...+. ...+..++..||.+.++..+.+-
T Consensus 484 ~~-~~~~~q~~~-------kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 PG-LKLQLQVLL-------KVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred Cc-hHHhhhhhh-------hhhcCCccccchhhhhhcccchh
Confidence 11 112222222 23348999999999888766553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.1e-09 Score=94.01 Aligned_cols=141 Identities=21% Similarity=0.271 Sum_probs=103.6
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEec-cC--------CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMK-NL--------KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~-~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.|-+|+-+.|+++.. .|+...||--- +. +-...+-.+|+.+|.++.--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 4577899999999998 56777777432 21 11234677899999988765554444456677778899999
Q ss_pred CCC-CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC---ceEEeeccCcc
Q 040808 280 MPN-GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF---CPKISDFGLAK 355 (511)
Q Consensus 280 ~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~ 355 (511)
+++ .++.+++...-. .....+....++..|-+.|.-||.+ +++|+||..+||+|..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 966 488998865432 2233334467888999999999998 999999999999996544 45899999986
Q ss_pred cc
Q 040808 356 QT 357 (511)
Q Consensus 356 ~~ 357 (511)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-08 Score=103.16 Aligned_cols=172 Identities=16% Similarity=0.284 Sum_probs=131.7
Q ss_pred CceEEEEEEc-CCCcEEEEEEeccCCCC-hHHHHHHHHHHHccCCcceeeeeceEe----ecCeEEEEEEeCCC-CCHHH
Q 040808 215 GYADVYKGTL-PDGRLVAVKVMKNLKDN-GEEFINEVASISRTSHVNIVPFLGFCY----EKKKRALIYEFMPN-GSLDQ 287 (511)
Q Consensus 215 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~ 287 (511)
--.+.|++.. .||..|++|+++-.+.. ......-+++++++.|.|+|++.+++. .+...+|||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3467899984 48999999999432221 123345688899999999999999886 34578899999986 67877
Q ss_pred HHhcccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 288 YIYDHES---------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 288 ~l~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
+-+.... ......+++..+|.++.|++.||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7654321 12345688899999999999999999998 99999999999999999999999998877665
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCC
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p 410 (511)
.+.. |-+.. -.+-|.=.||.++..|.+|...
T Consensus 445 ~d~~----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLES-----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchhH-----HhhhhHHHHHHHHHHHhhcccc
Confidence 4430 11211 1356888999999999999754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-10 Score=122.89 Aligned_cols=238 Identities=16% Similarity=0.215 Sum_probs=157.9
Q ss_pred ccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 210 KLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
-+-.|.++.++.+.-. .|...++|+..... ...+....+-.++-..++|-++...--+......+|+++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 4667888888877633 35445555444321 112333344444444556777766555556678899999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC-----
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK----- 359 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~----- 359 (511)
|...++... ..+.+.....+..+..+++|||.. .+.|+|++|.|+|...+++.+++|||.......
T Consensus 891 ~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 891 LPSKLHNSG------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred chhhhhcCC------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 988885432 344455566677888999999996 699999999999999999999999984322110
Q ss_pred ----------------C--------CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCcc
Q 040808 360 ----------------K--------ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKV 415 (511)
Q Consensus 360 ----------------~--------~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~ 415 (511)
. ..........||+.|.+||...+. .....+|+|+.|+.++|.++|..|+...
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~- 1038 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAE- 1038 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCc-
Confidence 0 000112234699999999999764 5677899999999999999999998744
Q ss_pred CCCCCCchHHHHHHHhhhhccccC--CCCChHHHHHHHHHHHHHHhccccCCCCCCCHH
Q 040808 416 SCSSEYFPNAIYKQIETEYDFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMT 472 (511)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~ 472 (511)
.+..+.+.+......+.. ...+....+.+..+ +..+|.+|-.|.
T Consensus 1039 ------tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~l-------l~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 ------TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRL-------LTEEPTQRLGAK 1084 (1205)
T ss_pred ------chhhhhhccccCCCCCCCCccccChhhhhhhhhh-------hccCchhccCcc
Confidence 344444544444333322 12233333333333 378888888776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.7e-09 Score=94.96 Aligned_cols=125 Identities=25% Similarity=0.310 Sum_probs=80.9
Q ss_pred EEEEEEcCCCcEEEEEEeccCC-----------------------CC----hHHHHHHHHHHHccCCcc--eeeeeceEe
Q 040808 218 DVYKGTLPDGRLVAVKVMKNLK-----------------------DN----GEEFINEVASISRTSHVN--IVPFLGFCY 268 (511)
Q Consensus 218 ~Vy~~~~~~~~~vavK~~~~~~-----------------------~~----~~~~~~E~~~l~~l~h~n--iv~l~~~~~ 268 (511)
.||.|...+|..+|||+.+... .. .....+|++.|.++...+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998899999999875310 00 123567999999998664 4555543
Q ss_pred ecCeEEEEEEeCC--CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCcEecCCCCCCEEEcCCCc
Q 040808 269 EKKKRALIYEFMP--NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY-LHRGCNIRIVHLDIKPHNIRLDEDFC 345 (511)
Q Consensus 269 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~y-LH~~~~~~iiH~Dlkp~NIll~~~~~ 345 (511)
...++||||++ |..+..+... .+.......++.+++..+.. +|+. |++|+||.+.|||++++ .
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~--------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV--------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC--------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred --eCCEEEEEecCCCccchhhHHhc--------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence 23479999998 5445433311 11123445677778886666 4676 99999999999999988 8
Q ss_pred eEEeeccCccccC
Q 040808 346 PKISDFGLAKQTE 358 (511)
Q Consensus 346 ~kl~DFGla~~~~ 358 (511)
+.++|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.6e-08 Score=96.50 Aligned_cols=132 Identities=18% Similarity=0.107 Sum_probs=95.5
Q ss_pred eEEEEEEcCCCcEEEEEEeccCC------------CChHHHHHHHHHHHccCCccee--eeeceEee-----cCeEEEEE
Q 040808 217 ADVYKGTLPDGRLVAVKVMKNLK------------DNGEEFINEVASISRTSHVNIV--PFLGFCYE-----KKKRALIY 277 (511)
Q Consensus 217 g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~niv--~l~~~~~~-----~~~~~lv~ 277 (511)
..|.+... +|+.+.||...... .....+.+|+..+.++...+|. .++++... ...-+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666665 56789999664321 1112478999999888654443 34445433 23567999
Q ss_pred EeCCCC-CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-------CCceEEe
Q 040808 278 EFMPNG-SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-------DFCPKIS 349 (511)
Q Consensus 278 e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-------~~~~kl~ 349 (511)
|++++- +|.+++.... ....+......++.+++..+.-||.. ||+|+|++++|||++. ++.+.++
T Consensus 115 e~l~~~~sL~~~~~~~~----~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 115 EDLAPTISLEDYCADWA----TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred eeCCCCccHHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 999875 8999885322 12345567778999999999999998 9999999999999975 4688999
Q ss_pred eccCccc
Q 040808 350 DFGLAKQ 356 (511)
Q Consensus 350 DFGla~~ 356 (511)
||+.++.
T Consensus 188 Dl~r~~~ 194 (268)
T PRK15123 188 DLHRAQI 194 (268)
T ss_pred ECCcccc
Confidence 9998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.6e-08 Score=93.82 Aligned_cols=134 Identities=24% Similarity=0.247 Sum_probs=96.3
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccC-------------------CC----ChHHHHHHHHHHHccCCc--c
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNL-------------------KD----NGEEFINEVASISRTSHV--N 259 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~-------------------~~----~~~~~~~E~~~l~~l~h~--n 259 (511)
+.++++||-|--|.||.|....|..+|||.=+.. .+ ......+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3567899999999999999999999999975311 00 112456899999998755 5
Q ss_pred eeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 260 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
+.+.++ .+..++|||++.|-.|... .+..+....|+..|++-+.-+-.. |+||+|+.+-||+
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~-----------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRL-----------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNIL 234 (304)
T ss_pred CCCccc----cccceeeeehcccceeecc-----------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEE
Confidence 666654 3567999999988655321 112333334444455544444454 9999999999999
Q ss_pred EcCCCceEEeeccCccc
Q 040808 340 LDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 340 l~~~~~~kl~DFGla~~ 356 (511)
+++||.+.++||-.+..
T Consensus 235 V~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 235 VTEDGDIVVIDWPQAVP 251 (304)
T ss_pred EecCCCEEEEeCccccc
Confidence 99999999999976643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.3e-07 Score=91.83 Aligned_cols=269 Identities=14% Similarity=0.152 Sum_probs=155.9
Q ss_pred hhcccCCcCceEEEEEE-cCCCcEEEEEEeccCCCChHHHHHHHHHHHc-cCCcceeeeeceE------ee-cCeEEEEE
Q 040808 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISR-TSHVNIVPFLGFC------YE-KKKRALIY 277 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~------~~-~~~~~lv~ 277 (511)
.+..||+|+-+.+|-.- ..+ -+-|+........+ ...++.|.. -.||-+-.-+.+= -+ +...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35679999999999543 322 34466654322211 112222322 2355332211111 12 22355778
Q ss_pred EeCCCCC-HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 278 EFMPNGS-LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 278 e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
..+++.. ...+..-......-....|..+++++..++.+.+-||.. |.+-+|+.++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 7776643 333332211223345678999999999999999999998 999999999999999999999998655444
Q ss_pred cCCCCceeeecCCCCCCCccchhhcc-ccc--CCCCccccchhHHHHHHHHHhC-CCCCCCccCCCCC--CchHHH----
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFC-RHF--GGVSHKSDVYSYGMMIHEMVIG-RKNADVKVSCSSE--YFPNAI---- 426 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~~sDvwSlG~il~elltg-~~p~~~~~~~~~~--~~~~~~---- 426 (511)
...+.. .....|.+.|.+||.-. +.+ ..-+..+|-|.||+++++++.| +.|+..--..+.. .....+
T Consensus 167 ~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 433332 23457999999999853 111 1345679999999999999876 7777532111111 111000
Q ss_pred HHHHh-hhhccccCCCCChHHHHHHHHHHHHHHhcccc--CCCCCCCHHHHHHHhhccccCCCC
Q 040808 427 YKQIE-TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQT--HPPDRPSMTKVVEMLEGSIENLQI 487 (511)
Q Consensus 427 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~--~p~~RPs~~evl~~L~~~~~~l~~ 487 (511)
+.... ...... +...+....-+...+-.+..+|+.. ++.-|||++.++..|....+.|.+
T Consensus 244 f~ya~~~~~g~~-p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 244 FAYASDQRRGLK-PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eeechhccCCCC-CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 00000 000010 1111111122333344445566654 367899999999888776666643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.6e-08 Score=105.74 Aligned_cols=151 Identities=22% Similarity=0.357 Sum_probs=99.6
Q ss_pred HHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee--e-----cCCCCCCCccchhhccc
Q 040808 311 VGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS--M-----LDTRGTAGYIAPEVFCR 383 (511)
Q Consensus 311 ~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~--~-----~~~~gt~~y~aPE~~~~ 383 (511)
.+++.|+.|+|+. .++||+.|.|++|.++.++..||+.|+.+........+.. . .-......|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4456999999997 6999999999999999999999999998765544211100 0 01134568999999976
Q ss_pred ccCCCCccccchhHHHHHHHHHhCCCC-CCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccc
Q 040808 384 HFGGVSHKSDVYSYGMMIHEMVIGRKN-ADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQ 462 (511)
Q Consensus 384 ~~~~~s~~sDvwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~ 462 (511)
. ..+.++|+||+|+++|-+..|+++ +..... ...+ .......+.........++.+..+.+.+++ .
T Consensus 184 ~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~---~~~~~~~~~~~~~~s~~~p~el~~~l~k~l-------~ 250 (700)
T KOG2137|consen 184 T--TNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSY---SFSRNLLNAGAFGYSNNLPSELRESLKKLL-------N 250 (700)
T ss_pred c--cccccccceeeeeEEEEEecCCcchhhccCC-cchh---hhhhcccccccccccccCcHHHHHHHHHHh-------c
Confidence 4 678899999999999999944443 332211 1000 000011111112223455666666666666 9
Q ss_pred cCCCCCCCHHHHHH
Q 040808 463 THPPDRPSMTKVVE 476 (511)
Q Consensus 463 ~~p~~RPs~~evl~ 476 (511)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998777653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.4e-08 Score=102.66 Aligned_cols=140 Identities=21% Similarity=0.265 Sum_probs=91.4
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccC-----------------------CC----Ch----H----------HHHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNL-----------------------KD----NG----E----------EFIN 247 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~-----------------------~~----~~----~----------~~~~ 247 (511)
+-|+.++-|.||+|++++|+.||||+.+.. .. .. + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 358899999999999999999999997531 00 00 1 1344
Q ss_pred HHHHHHccC----CcceeeeeceEe-ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 040808 248 EVASISRTS----HVNIVPFLGFCY-EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG-LEYLH 321 (511)
Q Consensus 248 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~-l~yLH 321 (511)
|...+.++. +..-+.+-.++. -.+...|+|||++|-.+.+...-.. ..++... |+..++++ +..+=
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d~k~---ia~~~~~~f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----AGIDRKE---LAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-----cCCCHHH---HHHHHHHHHHHHHH
Confidence 555555543 222233333343 3567899999999988887742211 2333222 23333322 22222
Q ss_pred hCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 322 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
.. |+.|.|.+|.||+++.+|.+.+.|||+......
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 23 899999999999999999999999999876654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.7e-06 Score=79.84 Aligned_cols=137 Identities=15% Similarity=0.103 Sum_probs=100.1
Q ss_pred cCCcCceEEEEEEcCCCcEEEEEEeccC-------CCChHHHHHHHHHHHccCCcc--eeeeeceEee-----cCeEEEE
Q 040808 211 LGQGGYADVYKGTLPDGRLVAVKVMKNL-------KDNGEEFINEVASISRTSHVN--IVPFLGFCYE-----KKKRALI 276 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv 276 (511)
-|+||-+.|+.-...+ ..+=+|.-.+. .-....|.+|+..|.++...+ +.++. ++.. .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 4569999999987644 46778865421 123467999999999987443 33443 3321 1245799
Q ss_pred EEeCCC-CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc--eEEeeccC
Q 040808 277 YEFMPN-GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC--PKISDFGL 353 (511)
Q Consensus 277 ~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGl 353 (511)
+|-+++ .+|.+++.... ....+......+..+++..++-||+. |+.|+|+.+.|||++.++. ++++||.-
T Consensus 104 Te~L~g~~~L~~~l~~~~----~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA----VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCC----cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 997753 68988884422 23456677788999999999999998 9999999999999986666 99999987
Q ss_pred ccc
Q 040808 354 AKQ 356 (511)
Q Consensus 354 a~~ 356 (511)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.1e-07 Score=83.91 Aligned_cols=106 Identities=21% Similarity=0.231 Sum_probs=82.6
Q ss_pred HHHHHHHHHHHccCCcc--eeeeeceEeec----CeEEEEEEeCCC-CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHH
Q 040808 243 EEFINEVASISRTSHVN--IVPFLGFCYEK----KKRALIYEFMPN-GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315 (511)
Q Consensus 243 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~ 315 (511)
..+.+|...+.++...+ +...+++.... ...++|+|++++ .+|.+++.... ..+......++.+++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALAR 129 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHHH
Confidence 46788999888886443 34555555442 245799999987 48999985422 2555667889999999
Q ss_pred HHHHHHhCCCCCcEecCCCCCCEEEcCCC---ceEEeeccCcccc
Q 040808 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDF---CPKISDFGLAKQT 357 (511)
Q Consensus 316 ~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~~~ 357 (511)
.++-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999998 999999999999998887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.1e-07 Score=93.35 Aligned_cols=141 Identities=20% Similarity=0.214 Sum_probs=90.2
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCC-----------------------------------C---ChHHHHHHHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLK-----------------------------------D---NGEEFINEVA 250 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------------------------~---~~~~~~~E~~ 250 (511)
+-||.-+.|.||+|++++|+.||||+-+..- . ..=+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4589999999999999999999999965310 0 0013566665
Q ss_pred HHHcc----CCcc---eeeeeceEee-cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 040808 251 SISRT----SHVN---IVPFLGFCYE-KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322 (511)
Q Consensus 251 ~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~ 322 (511)
-..+. .|-+ -|.+-.++.+ .....|+||||+|..+.|.-.-. ...++...+ +..+.++.. +.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-----~~gi~~~~i---~~~l~~~~~--~q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-----KRGISPHDI---LNKLVEAYL--EQ 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-----HcCCCHHHH---HHHHHHHHH--HH
Confidence 54444 3444 2223333333 45789999999998766553221 133444433 333333211 11
Q ss_pred CCCCCcEecCCCCCCEEEc----CCCceEEeeccCccccCC
Q 040808 323 GCNIRIVHLDIKPHNIRLD----EDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 323 ~~~~~iiH~Dlkp~NIll~----~~~~~kl~DFGla~~~~~ 359 (511)
--..|.+|.|-+|.||+++ .++.+.+.|||+......
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 1112899999999999998 367899999999876643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=3e-06 Score=80.39 Aligned_cols=142 Identities=15% Similarity=0.154 Sum_probs=85.1
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcce--eeeeceEeecCeEEEEEEeCCCCC-H
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI--VPFLGFCYEKKKRALIYEFMPNGS-L 285 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~gs-L 285 (511)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-++ .+.+++..+.+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 36899999999984 24457888876532 34567889999988874443 566777777777889999998863 2
Q ss_pred HHHH--------------hc-----ccCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHhC-CCCCcEecCCC
Q 040808 286 DQYI--------------YD-----HESSNGKRTLEWRTVYQIAV----------GIAR-GLEYLHRG-CNIRIVHLDIK 334 (511)
Q Consensus 286 ~~~l--------------~~-----~~~~~~~~~l~~~~~~~i~~----------~i~~-~l~yLH~~-~~~~iiH~Dlk 334 (511)
...+ .. +........++.. ...+.. .+.. ..++|... ....++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1111 00 0000001111100 000000 0111 12222211 13467899999
Q ss_pred CCCEEEcCCCceEEeeccCccc
Q 040808 335 PHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 335 p~NIll~~~~~~kl~DFGla~~ 356 (511)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=8e-06 Score=76.48 Aligned_cols=135 Identities=24% Similarity=0.298 Sum_probs=92.4
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCC--------------------ChHH-----HHHHHHHHHccC--Ccceee
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKD--------------------NGEE-----FINEVASISRTS--HVNIVP 262 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------~~~~-----~~~E~~~l~~l~--h~niv~ 262 (511)
.|..|--+.||+|...++..+|+|+.+.... +..+ ..+|+.-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5778888999999988899999999864211 1111 135777787775 344445
Q ss_pred eeceEeecCeEEEEEEeCCCCC-HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 263 FLGFCYEKKKRALIYEFMPNGS-LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 263 l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
.+++. .-.|||||+.... -.-.| ....+.......+..++++.+.-|-.. .++||+||+.=|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L-------kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL-------KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc-------ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE
Confidence 55443 3579999995431 11111 112233335666777888888888763 2999999999999999
Q ss_pred CCCceEEeeccCccccC
Q 040808 342 EDFCPKISDFGLAKQTE 358 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~ 358 (511)
++.+.++|||.|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 7799999999886543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-05 Score=74.73 Aligned_cols=128 Identities=15% Similarity=0.131 Sum_probs=79.6
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChH----------HHHHHHHHHHccCCcc---eeeeeceEe-----ec
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE----------EFINEVASISRTSHVN---IVPFLGFCY-----EK 270 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~E~~~l~~l~h~n---iv~l~~~~~-----~~ 270 (511)
+.+-......|.+-.. +|..+.+|..+......+ ...+++..+.++...+ .+.++.+.. -.
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 3444455555555554 567788887764322122 2233444444443222 222222221 22
Q ss_pred CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 271 KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
....|+|||++|..|.+.. .++. .++..+.+++.-||+. |+.|+|.+|.|+++++++ ++++|
T Consensus 116 ~~~~ll~EYIeG~~l~d~~----------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIE----------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eEEEEEEEEecCeecccch----------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEE
Confidence 3556899999998886543 1222 2456677889999998 999999999999999665 99999
Q ss_pred ccCcc
Q 040808 351 FGLAK 355 (511)
Q Consensus 351 FGla~ 355 (511)
|+..+
T Consensus 178 ~~~k~ 182 (229)
T PF06176_consen 178 TQGKR 182 (229)
T ss_pred Ccccc
Confidence 98654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.8e-05 Score=76.00 Aligned_cols=142 Identities=14% Similarity=0.098 Sum_probs=84.4
Q ss_pred cCCcCc-eEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCCCCHHHH
Q 040808 211 LGQGGY-ADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY 288 (511)
Q Consensus 211 LG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 288 (511)
|-.|.. ..||+.... +..+.+|+..... ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444544 889998764 4778889876543 345677888888775 33355667766666678999999999877643
Q ss_pred Hh----------------c-ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhC----CC
Q 040808 289 IY----------------D-HESSNGKRTLEWR--TVYQIAV--------------------GIARGLEYLHRG----CN 325 (511)
Q Consensus 289 l~----------------~-~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~yLH~~----~~ 325 (511)
.. . +........+... ....... .+...++.|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 0 0000001111100 0000000 011112222111 12
Q ss_pred CCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999998888899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF14380 WAK_assoc: Wall-associated receptor kinase C-terminal | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.4e-06 Score=68.92 Aligned_cols=59 Identities=31% Similarity=0.716 Sum_probs=48.0
Q ss_pred CCCCCCCCeeeeccchhhhhhhhcCChhhHHHHHhcceEEEEe-cCCCCCCc----cccccccc
Q 040808 114 QTGSPDCNFSVTIPVAETLLSAAKGSLAGLKEALETGFELKWK-LNSSCKNC----SSCSYHKE 172 (511)
Q Consensus 114 ~~~~~~C~~~v~vPv~~~~~~~~~~s~~~l~~~l~~Gf~l~w~-~~~~c~~~----~~~~~~~~ 172 (511)
..+...|...+.|||+.........+..++.++|++||+|+|. ...+|..| |.|++...
T Consensus 19 ~~~~~~C~~~v~vPV~~~~~~~~~~~~~~~~~~L~~GF~L~w~~~~~~C~~C~~SgG~Cgy~~~ 82 (94)
T PF14380_consen 19 SDLAGSCQKSVVVPVLGSAVDSIDGSSGNYEEVLKKGFELEWNADSGDCRECEASGGRCGYDSN 82 (94)
T ss_pred cccCCcCCEEEEEEECchhhhccccchhHHHHHHhcCcEEEEeCCCCcCcChhcCCCEeCCCCC
Confidence 4577899999999999886644445788999999999999999 45679988 78877654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-05 Score=76.50 Aligned_cols=145 Identities=21% Similarity=0.190 Sum_probs=84.3
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc--eeeeeceEe---ecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN--IVPFLGFCY---EKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~---~~~~~~lv~e~~~~g 283 (511)
+.|+.|..+.||+....+ +.+++|+.... .......+|+.++..+.... +.+++.... .....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468889999999999877 68999987654 33467778888888876433 445555432 234578999999998
Q ss_pred CHHH----------------HHhcc-cCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh--
Q 040808 284 SLDQ----------------YIYDH-ESSNGKRTLEWRT---------VYQI------------AVGIAR-GLEYLHR-- 322 (511)
Q Consensus 284 sL~~----------------~l~~~-~~~~~~~~l~~~~---------~~~i------------~~~i~~-~l~yLH~-- 322 (511)
.+.. .+... ..........+.. .... ...+.. .++.+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 11110 0000111111111 0000 112222 3333332
Q ss_pred --CCCCCcEecCCCCCCEEEc-CCCceEEeeccCcc
Q 040808 323 --GCNIRIVHLDIKPHNIRLD-EDFCPKISDFGLAK 355 (511)
Q Consensus 323 --~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~ 355 (511)
.....++|+|+.|+|||++ +++.+-|+||+.+.
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1235799999999999999 66666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1e-06 Score=91.59 Aligned_cols=181 Identities=19% Similarity=0.124 Sum_probs=130.6
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc-eeeeeceEeecCeEEEEEEeCCCC-CHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN-IVPFLGFCYEKKKRALIYEFMPNG-SLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL~ 286 (511)
+.+++|+++.++|.+....+....+++... ....-++++|.+++||| .+..++-+.......++++++..+ +..
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 457889999999988544444446666543 44556889999999999 666666666677888999998766 221
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeee
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 366 (511)
.-. ......+...+...+...-++++++||+. .=+|+| ||+..+ +..|..||+....+.... ..
T Consensus 324 ~~~-----~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 324 LEM-----TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred ccC-----ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 111 01123344455566677788899999986 558888 888776 578999999987776553 22
Q ss_pred cCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 040808 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411 (511)
Q Consensus 367 ~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~ 411 (511)
....+|+.++|||+...+ .+..+.|+|++|+-..+|--|-.|.
T Consensus 388 ~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCC
Confidence 345699999999998664 7788999999998777777766554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.4e-05 Score=73.35 Aligned_cols=106 Identities=22% Similarity=0.203 Sum_probs=83.3
Q ss_pred HHHHHHHHccCC-cceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 040808 246 INEVASISRTSH-VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324 (511)
Q Consensus 246 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 324 (511)
.+|..+++.+++ +++.+++|.|- ..+|.||.+.+++...- .....-..-+|..+.+||.++++.+++|+...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~---~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY---RPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc---cccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 368888888886 58999999994 47799999877653210 00011235789999999999999999999865
Q ss_pred CCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 325 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
...+.-.|++++|+-++++|.+|++|...+....
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 5568889999999999999999999998765543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=9e-05 Score=73.37 Aligned_cols=75 Identities=13% Similarity=0.109 Sum_probs=55.9
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCC---cceeeeeceEee---cCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSH---VNIVPFLGFCYE---KKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~~~ 282 (511)
+.||.|..+.||.....+++ +.+|..+. ......+.+|.+.|+.+.. ..+.++++++.. .+..++|||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 46999999999999876664 66777443 2234678899999988863 356778877654 3668999999988
Q ss_pred CCH
Q 040808 283 GSL 285 (511)
Q Consensus 283 gsL 285 (511)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.7e-05 Score=84.25 Aligned_cols=149 Identities=15% Similarity=0.234 Sum_probs=91.1
Q ss_pred cccCCcCceEEEEEEcCCC---cEEEEEEeccCC--CChHHHHHHHHHHHccC-Ccce--eeeeceEeec---CeEEEEE
Q 040808 209 DKLGQGGYADVYKGTLPDG---RLVAVKVMKNLK--DNGEEFINEVASISRTS-HVNI--VPFLGFCYEK---KKRALIY 277 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv~ 277 (511)
+.|+.|.++.+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+++.+|.+. +..++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 5689999999999876553 367777664322 22356889999999986 6654 6777777664 4678999
Q ss_pred EeCCCCCHHH--------------------H---HhcccCCC-C----CCCCCH--HHHHHHH---------------HH
Q 040808 278 EFMPNGSLDQ--------------------Y---IYDHESSN-G----KRTLEW--RTVYQIA---------------VG 312 (511)
Q Consensus 278 e~~~~gsL~~--------------------~---l~~~~~~~-~----~~~l~~--~~~~~i~---------------~~ 312 (511)
||++|..+.+ . |+...... + ..+..+ ..+..+. ..
T Consensus 124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~ 203 (822)
T PLN02876 124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK 203 (822)
T ss_pred EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence 9998764321 1 11100000 0 001111 1111111 12
Q ss_pred HHHHHHHHHhCCC--------CCcEecCCCCCCEEEcC-CCc-eEEeeccCcccc
Q 040808 313 IARGLEYLHRGCN--------IRIVHLDIKPHNIRLDE-DFC-PKISDFGLAKQT 357 (511)
Q Consensus 313 i~~~l~yLH~~~~--------~~iiH~Dlkp~NIll~~-~~~-~kl~DFGla~~~ 357 (511)
+...+++|..+.. ..++|+|+++.|||++. ++. +-|.||+++..-
T Consensus 204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 3345677754322 35999999999999985 333 579999987654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.0001 Score=70.32 Aligned_cols=73 Identities=21% Similarity=0.207 Sum_probs=48.1
Q ss_pred cccCCcCceEEEEEEcCC--CcEEEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeCCCCCH
Q 040808 209 DKLGQGGYADVYKGTLPD--GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
+.|..|-...+|+....+ +..|++|+........-+..+|+.++..+...+++ ++++.+. ..++|||++|.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 457778888999998664 67899997764322222334788888888644443 3433322 2489999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00024 Score=65.62 Aligned_cols=130 Identities=26% Similarity=0.364 Sum_probs=90.2
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCC-----------------CChHHHHHHHHHHHccC------Ccceeeeec
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLK-----------------DNGEEFINEVASISRTS------HVNIVPFLG 265 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~~ 265 (511)
..||+|+.-.||. +.+.....||+..... ....+..+|+.-..++. +..|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3599999999995 4455668888887544 22355666776555555 778999999
Q ss_pred eEeecCeEEEEEEeCCC------CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 266 FCYEKKKRALIYEFMPN------GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 266 ~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
+..++....+|+|.+.+ -||.+++.. ..++. ...+ .+-+-.+||-+. .|+.+|++|+||+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-------~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE-------GGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc-------CCccH-HHHH---HHHHHHHHHHHc---CCeecCCCcccEE
Confidence 99999889999998743 368888843 23444 3333 334445677776 8999999999999
Q ss_pred EcCC--C--ceEEee-ccCc
Q 040808 340 LDED--F--CPKISD-FGLA 354 (511)
Q Consensus 340 l~~~--~--~~kl~D-FGla 354 (511)
+..+ + .+.|+| ||..
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEecCCCceEEEEEeCCCCc
Confidence 9532 2 466776 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.91 E-value=8.4e-05 Score=70.96 Aligned_cols=73 Identities=12% Similarity=0.153 Sum_probs=44.6
Q ss_pred cccCCcCce-EEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCc---ceeeeeceEeec---CeEEEEEEeCC
Q 040808 209 DKLGQGGYA-DVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV---NIVPFLGFCYEK---KKRALIYEFMP 281 (511)
Q Consensus 209 ~~LG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~ 281 (511)
+.|+.||.. .||+. +..+++|+.+. .....++.+|++.+..+... -+.++++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 346766665 58875 23577787554 22345788899999877632 233333332221 24578999998
Q ss_pred CCCHH
Q 040808 282 NGSLD 286 (511)
Q Consensus 282 ~gsL~ 286 (511)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00013 Score=64.89 Aligned_cols=127 Identities=18% Similarity=0.179 Sum_probs=84.6
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeCCCCCHH
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
.+.||+|++|.||+|.+.+ ..+|+|+-+.. .....+..|+++|..+.-.++. +++.+- .-.+.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~-~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRG-GEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeeccC-ceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchh
Confidence 4579999999999999854 58999987643 3356788899999988766553 233221 223459999888887
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC-CCCEEEcCCCceEEeeccCccc
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK-PHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlk-p~NIll~~~~~~kl~DFGla~~ 356 (511)
+.-.. .+-.. +..+++.---|-. +||-|..|. |...+|-.++.+.|+||..|+.
T Consensus 101 ~~~~~---------~~rk~----l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIG---------GDRKH----LLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhc---------ccHHH----HHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 66521 12222 2334555333344 399999997 4444444445899999998863
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00014 Score=66.72 Aligned_cols=123 Identities=28% Similarity=0.460 Sum_probs=88.7
Q ss_pred HHhhhcccCCcCc-eEEEEEEcCCCcEEEEEEecc------------CC----------CChHHHHHHHHHHHccCC---
Q 040808 204 TKSFSDKLGQGGY-ADVYKGTLPDGRLVAVKVMKN------------LK----------DNGEEFINEVASISRTSH--- 257 (511)
Q Consensus 204 ~~~~~~~LG~G~~-g~Vy~~~~~~~~~vavK~~~~------------~~----------~~~~~~~~E~~~l~~l~h--- 257 (511)
...|.+.||.|.- |.||++.. +|+.+|+|+.+. .. ...+.|.+|.....++++
T Consensus 38 ~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 38 DIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred cEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 3457789999999 99999998 567999999431 00 112458889988888863
Q ss_pred cce--eeeeceEeec------------------CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHH
Q 040808 258 VNI--VPFLGFCYEK------------------KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317 (511)
Q Consensus 258 ~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l 317 (511)
.++ |+.+||..-. ..+.+|.||.+... .+.. +-+.+|.+-+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~----~~~~~~~~dl 177 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQI----RDIPQMLRDL 177 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccch----hHHHHHHHHH
Confidence 345 8888887311 13467888875532 1122 2355677888
Q ss_pred HHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 318 ~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
..+|+. ||+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 999998 9999999999997 4589999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.85 E-value=5.6e-05 Score=84.05 Aligned_cols=195 Identities=18% Similarity=0.266 Sum_probs=134.6
Q ss_pred HHHHHHccCCcceeeeeceEeecCeEE----EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 040808 248 EVASISRTSHVNIVPFLGFCYEKKKRA----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323 (511)
Q Consensus 248 E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~ 323 (511)
|.+.+..+.|+|++.++.+-.+..... +..|++...++...+.. ...++....+.+..++.+||+|+|+.
T Consensus 232 e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~------v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 232 ELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS------VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh------ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 566778889999999988776543332 45677888888877743 35788899999999999999999997
Q ss_pred CCCCcEecCCCCC---CEEEcCCCceEEe--eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHH
Q 040808 324 CNIRIVHLDIKPH---NIRLDEDFCPKIS--DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYG 398 (511)
Q Consensus 324 ~~~~iiH~Dlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG 398 (511)
.+.|.-+..+ +-..+..+.+..+ ||+.++......... ...-+..+.++|....+....+...|+|.+|
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 5555555444 4455667777777 999888776544321 1224556788888866555555667999999
Q ss_pred HHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 399 MMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 399 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
..+..+..|..+...... +..+ + ..... ..+......|+..++++|+++.+++...
T Consensus 380 ll~~~~~~~~~i~~~~~~------~~~~-----------l-~~~~~------~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV------PVSL-----------L-DVLST------SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHhhhhhcCcccccccc------hhhh-----------h-ccccc------hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999999988755432110 0000 0 00111 1345566789999999999999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00028 Score=68.23 Aligned_cols=140 Identities=11% Similarity=0.088 Sum_probs=78.9
Q ss_pred cCCcCceEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeCCCCCHHHH
Q 040808 211 LGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG-EEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFMPNGSLDQY 288 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~~ 288 (511)
+..|-.+.+|+... +++.+++|+........ -+..+|.++++.+...+++ +++... . ..+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 56688889998874 56778889765432221 2456788888888654442 333322 2 3689999988665321
Q ss_pred --------------Hhc-ccCCCCCCCCCHH-HHHHHHH---------HHHHHHHHHHhC-----CCCCcEecCCCCCCE
Q 040808 289 --------------IYD-HESSNGKRTLEWR-TVYQIAV---------GIARGLEYLHRG-----CNIRIVHLDIKPHNI 338 (511)
Q Consensus 289 --------------l~~-~~~~~~~~~l~~~-~~~~i~~---------~i~~~l~yLH~~-----~~~~iiH~Dlkp~NI 338 (511)
+.. +........++.. .+..+.. .+...++.+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111 1111111122221 1111111 111112222111 123689999999999
Q ss_pred EEcCCCceEEeeccCccc
Q 040808 339 RLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~ 356 (511)
++++++ +.|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999887 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00065 Score=69.47 Aligned_cols=74 Identities=12% Similarity=0.144 Sum_probs=53.4
Q ss_pred cccCCcCceEEEEEEcCCC-cEEEEEEeccC--------CCChHHHHHHHHHHHccC---CcceeeeeceEeecCeEEEE
Q 040808 209 DKLGQGGYADVYKGTLPDG-RLVAVKVMKNL--------KDNGEEFINEVASISRTS---HVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~-~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 276 (511)
+.||.|.+..||++...+| +.+.||.-... ....+++..|.+.|..+. -..+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4699999999999998776 58999975311 123467788888888763 2346666654 45667899
Q ss_pred EEeCCCCC
Q 040808 277 YEFMPNGS 284 (511)
Q Consensus 277 ~e~~~~gs 284 (511)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00036 Score=69.24 Aligned_cols=144 Identities=25% Similarity=0.273 Sum_probs=84.6
Q ss_pred cccCCcCceEEEEEEcCC-------CcEEEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeC
Q 040808 209 DKLGQGGYADVYKGTLPD-------GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~ 280 (511)
+.|..|-...||+....+ ++.+++|+.........+..+|++++..+...++. ++++++. + .+|+||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 345667777999988654 57899999776443334567788888887644433 4444443 2 3589999
Q ss_pred CCCCHHHHH--------------hc-ccCCCC--C-----CCCCHHHHHH--------------------------HHHH
Q 040808 281 PNGSLDQYI--------------YD-HESSNG--K-----RTLEWRTVYQ--------------------------IAVG 312 (511)
Q Consensus 281 ~~gsL~~~l--------------~~-~~~~~~--~-----~~l~~~~~~~--------------------------i~~~ 312 (511)
+|.++.... .. +..... . ...-|..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 887654311 00 110000 0 0011111111 1122
Q ss_pred HHHHHHHHHh------CCCCCcEecCCCCCCEEEcCC----CceEEeeccCccc
Q 040808 313 IARGLEYLHR------GCNIRIVHLDIKPHNIRLDED----FCPKISDFGLAKQ 356 (511)
Q Consensus 313 i~~~l~yLH~------~~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~ 356 (511)
+...+++|-. .....++|+|+.+.|||++++ +.+.++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2233344432 245689999999999999985 7899999988753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0013 Score=65.11 Aligned_cols=144 Identities=17% Similarity=0.131 Sum_probs=85.2
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc--eeeeece------EeecCeEEEEEEeC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN--IVPFLGF------CYEKKKRALIYEFM 280 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~ 280 (511)
+.|..|....+|+....+ ..+++|+... ...++...|++++..+.+.+ +.+++.. ....+..++|++++
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 357778778999987644 4688898765 33456667888887775433 3344331 12345668999999
Q ss_pred CCCCHHH-----------HH---hccc-CCC----CCCCCCHHHHH----------HHHHHHHHHHHHHHh----CCCCC
Q 040808 281 PNGSLDQ-----------YI---YDHE-SSN----GKRTLEWRTVY----------QIAVGIARGLEYLHR----GCNIR 327 (511)
Q Consensus 281 ~~gsL~~-----------~l---~~~~-~~~----~~~~l~~~~~~----------~i~~~i~~~l~yLH~----~~~~~ 327 (511)
+|..+.. .+ +... ... ......|.... .....+..++.++.+ ....+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 8866422 00 1000 000 01112222211 111223344555543 12347
Q ss_pred cEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 328 IVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 328 iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
++|+|+.|.||++++++.+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999998778899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0034 Score=62.81 Aligned_cols=143 Identities=16% Similarity=0.194 Sum_probs=76.7
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc--eeeeec------eEeecCeEEEEEEeCC
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN--IVPFLG------FCYEKKKRALIYEFMP 281 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~e~~~ 281 (511)
.|+.|...++|+....+| .+++|+... ...+....|+.++..+...+ +.+.+. +....+..++++||++
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 466777789999886655 688898762 22334444555555553222 222221 1123556789999998
Q ss_pred CCCHH-----------HHHhc-ccCCC-------CCCCCCH-HHHHH------------HH-HHHHHHHHHHHhC----C
Q 040808 282 NGSLD-----------QYIYD-HESSN-------GKRTLEW-RTVYQ------------IA-VGIARGLEYLHRG----C 324 (511)
Q Consensus 282 ~gsL~-----------~~l~~-~~~~~-------~~~~l~~-~~~~~------------i~-~~i~~~l~yLH~~----~ 324 (511)
|..+. +.+.. +.... ....+.| ..... .. ..+...++.+.+. -
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 86431 11110 00000 0111212 11111 11 1111222333211 2
Q ss_pred CCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 325 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
..+++|+|++|.||+++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999977666899999764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0032 Score=62.62 Aligned_cols=144 Identities=19% Similarity=0.221 Sum_probs=81.6
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc--eeeeeceE------eecCeEEEEEEeCC
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN--IVPFLGFC------YEKKKRALIYEFMP 281 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~e~~~ 281 (511)
.++.|....+|+....+| .+++|+.+... ..++...|++++..+...+ +.+++... ...+..++++||++
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~ 106 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQ 106 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCC
Confidence 467777789999876555 57788775432 2345566777777764322 33333311 22456789999998
Q ss_pred CCCHH-----------HHH---hcccC-C--CCC---CCCCHHHHH------------HHHHHHHHHHHHHHh----CCC
Q 040808 282 NGSLD-----------QYI---YDHES-S--NGK---RTLEWRTVY------------QIAVGIARGLEYLHR----GCN 325 (511)
Q Consensus 282 ~gsL~-----------~~l---~~~~~-~--~~~---~~l~~~~~~------------~i~~~i~~~l~yLH~----~~~ 325 (511)
|..+. ..+ +.... . ... ..-.|.... .....+...++++.. ...
T Consensus 107 G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~ 186 (307)
T TIGR00938 107 GLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLP 186 (307)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 75431 111 11000 0 000 011121111 011223345555542 224
Q ss_pred CCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
.+++|+|+++.||++++++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0052 Score=62.15 Aligned_cols=144 Identities=19% Similarity=0.205 Sum_probs=83.2
Q ss_pred ccCCcCceEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeCCCC
Q 040808 210 KLGQGGYADVYKGTLPD-----GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.|-.|-...+|+....+ ++.|++|+........-+..+|..++..+...++. ++++.+..+ .|.||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 45557888999987432 36799998865432222336788888888755553 445554332 589999776
Q ss_pred CHHHH-----------------HhcccCCCCCCCCCHHHHHHHHHH-----------------HHHHHHHHH----h-CC
Q 040808 284 SLDQY-----------------IYDHESSNGKRTLEWRTVYQIAVG-----------------IARGLEYLH----R-GC 324 (511)
Q Consensus 284 sL~~~-----------------l~~~~~~~~~~~l~~~~~~~i~~~-----------------i~~~l~yLH----~-~~ 324 (511)
+|... ++............|..+..+..+ +...+..|. . ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65421 111110111112223333333221 111222222 1 22
Q ss_pred CCCcEecCCCCCCEEEcC-CCceEEeeccCcccc
Q 040808 325 NIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQT 357 (511)
Q Consensus 325 ~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~ 357 (511)
...++|+|+++.|||+++ ++.+.++||..+...
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 347899999999999986 478999999887543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00072 Score=65.79 Aligned_cols=132 Identities=17% Similarity=0.171 Sum_probs=89.7
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccC-------------------CCCh----HHHHHHHHHHHccCCc--c
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNL-------------------KDNG----EEFINEVASISRTSHV--N 259 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~-------------------~~~~----~~~~~E~~~l~~l~h~--n 259 (511)
+.++++||-|--+-||.+...+|++.++|+-+-. ..+. -...+|++-|+.+... -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999999999999999964210 0110 1245688888877632 2
Q ss_pred eeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 260 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
+.+.++ .+..++|||++.+-.|...- ...+..++.. .+..-|--|-.+ |+||+|..-=||+
T Consensus 174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~---------~v~d~~~ly~---~lm~~Iv~la~~---GlIHgDFNEFNim 234 (465)
T KOG2268|consen 174 VPKPID----HNRHCVVMELVDGYPLRQVR---------HVEDPPTLYD---DLMGLIVRLANH---GLIHGDFNEFNIM 234 (465)
T ss_pred CCCccc----ccceeeHHHhhcccceeeee---------ecCChHHHHH---HHHHHHHHHHHc---CceecccchheeE
Confidence 334443 45678999999887764321 1223333333 333334445555 9999999999999
Q ss_pred EcCCCceEEeeccCcc
Q 040808 340 LDEDFCPKISDFGLAK 355 (511)
Q Consensus 340 l~~~~~~kl~DFGla~ 355 (511)
+++++.++++||-..-
T Consensus 235 v~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMV 250 (465)
T ss_pred EecCCCEEEeechHhh
Confidence 9999999999997543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.011 Score=59.10 Aligned_cols=142 Identities=22% Similarity=0.314 Sum_probs=84.4
Q ss_pred cCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcce------eeeec----eEeecCeEEEEEEeC
Q 040808 211 LGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI------VPFLG----FCYEKKKRALIYEFM 280 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni------v~l~~----~~~~~~~~~lv~e~~ 280 (511)
|.+ .-..||+....+|+. ++|+.... ....+...|.+.+..+.-.+| ..+=| ....+.+.+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 454 566889998877776 99988876 555666677777776643222 11111 111123788899999
Q ss_pred CCCCHHH-----HH----------h----ccc--CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC---
Q 040808 281 PNGSLDQ-----YI----------Y----DHE--SSNGKRTLEWRT-------------VYQIAVGIARGLEYLHRG--- 323 (511)
Q Consensus 281 ~~gsL~~-----~l----------~----~~~--~~~~~~~l~~~~-------------~~~i~~~i~~~l~yLH~~--- 323 (511)
+|..+.. .+ + ... .........|.. ......++...++.+.+.
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9887762 11 0 000 111122334430 011233444444444432
Q ss_pred -CCCC---cEecCCCCCCEEEcCCCc-eEEeeccCcc
Q 040808 324 -CNIR---IVHLDIKPHNIRLDEDFC-PKISDFGLAK 355 (511)
Q Consensus 324 -~~~~---iiH~Dlkp~NIll~~~~~-~kl~DFGla~ 355 (511)
-... +||+|+.|.||+++++.. +.++|||-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1223 999999999999999874 8899999764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.011 Score=57.95 Aligned_cols=32 Identities=34% Similarity=0.430 Sum_probs=25.9
Q ss_pred CCcEecCCCCCCEEEcCCCc-eEEeeccCcccc
Q 040808 326 IRIVHLDIKPHNIRLDEDFC-PKISDFGLAKQT 357 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~~~ 357 (511)
..++|+|++|.|||+++++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 469999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.013 Score=58.35 Aligned_cols=137 Identities=22% Similarity=0.255 Sum_probs=94.6
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccC----------------------CCChHH-----HHHHHHHHHccCCccee
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNL----------------------KDNGEE-----FINEVASISRTSHVNIV 261 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~----------------------~~~~~~-----~~~E~~~l~~l~h~niv 261 (511)
..|..|--+.||.+.-.+|..+|||+.+.+ +.+.+. .-.|+.-|.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 457788899999999889999999998632 111111 12477888888766543
Q ss_pred eeeceEeecCeEEEEEEeCCCCC-HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE
Q 040808 262 PFLGFCYEKKKRALIYEFMPNGS-LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340 (511)
Q Consensus 262 ~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll 340 (511)
-.--+.. ....|||+|+-... ..-. -....++...+..+-.+++.-+.-|-+.| ++||.||.-=|+|+
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPk-------LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPK-------LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCcc-------cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 2211111 23579999984211 1111 12245666678888888888899998887 89999999999998
Q ss_pred cCCCceEEeeccCcccc
Q 040808 341 DEDFCPKISDFGLAKQT 357 (511)
Q Consensus 341 ~~~~~~kl~DFGla~~~ 357 (511)
-+ |.+.++|-+.+-..
T Consensus 299 hd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVEH 314 (520)
T ss_pred EC-CEEEEEEccccccC
Confidence 64 68999998877543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.023 Score=56.47 Aligned_cols=29 Identities=28% Similarity=0.289 Sum_probs=25.4
Q ss_pred CCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 58999999999999987 568899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.033 Score=55.98 Aligned_cols=78 Identities=13% Similarity=0.128 Sum_probs=51.5
Q ss_pred ccCCcCceEEEEEEcCCC-cEEEEEEecc----C----CCChHHHHHHHHHHHccC--Cc-ceeeeeceEeecCeEEEEE
Q 040808 210 KLGQGGYADVYKGTLPDG-RLVAVKVMKN----L----KDNGEEFINEVASISRTS--HV-NIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~-~~vavK~~~~----~----~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 277 (511)
.||.|.-..||++...+| +.|+||.-.. . ....++..-|.+.|.... -| .+.+++ ..+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 589999999999997654 5899996431 1 223456667778876654 23 344444 45667778999
Q ss_pred EeCCCC-CHHHHH
Q 040808 278 EFMPNG-SLDQYI 289 (511)
Q Consensus 278 e~~~~g-sL~~~l 289 (511)
|+++.. .|++.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999643 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.01 Score=58.30 Aligned_cols=72 Identities=18% Similarity=0.318 Sum_probs=46.6
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccC---CcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS---HVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.++.|....+|+.. .+++.+.||+-.. .....|..|.+-|+.|. --.+.+++++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 458889999999988 5678899998773 23456788888888884 335667888777667779999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.069 Score=53.60 Aligned_cols=71 Identities=18% Similarity=0.139 Sum_probs=45.8
Q ss_pred cCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCc--ceeeee---c--eEeecCeEEEEEEeCCCCC
Q 040808 214 GGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV--NIVPFL---G--FCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 214 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~gs 284 (511)
+.-..||+....++..+++|+.+.......+...|++.+..+... .++... | ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445689999887888999998864444456667788777666422 122211 2 1223456788999998754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.036 Score=54.93 Aligned_cols=141 Identities=16% Similarity=0.237 Sum_probs=79.1
Q ss_pred EEEEEEcCCCcEEEEEEecc---CCCChHHHHHHHHHHHccCC--cceeeeeceEeecC--eEEEEEEeCCCCCHHH---
Q 040808 218 DVYKGTLPDGRLVAVKVMKN---LKDNGEEFINEVASISRTSH--VNIVPFLGFCYEKK--KRALIYEFMPNGSLDQ--- 287 (511)
Q Consensus 218 ~Vy~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~gsL~~--- 287 (511)
.+|..... ++.+++. ... .........+|+.+|+.+.- .-+...++.|.++. ..+.||+|.+|..+.+
T Consensus 40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 33444433 6778887 331 12233556678888887653 23445667777665 7799999998732221
Q ss_pred ---------------HHhccc-CC-------------CCCCCCCHHHHHHH--------HHHHHHHHHHHHhCC-----C
Q 040808 288 ---------------YIYDHE-SS-------------NGKRTLEWRTVYQI--------AVGIARGLEYLHRGC-----N 325 (511)
Q Consensus 288 ---------------~l~~~~-~~-------------~~~~~l~~~~~~~i--------~~~i~~~l~yLH~~~-----~ 325 (511)
.|.... .. ...+--.|...++. +-....-..||+... .
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 111100 00 00000111111110 112223345555432 3
Q ss_pred CCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
..++|+|+++.||+++.+.-+=|.||+++..-..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 56999999999999999888999999998765443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.076 Score=61.47 Aligned_cols=146 Identities=18% Similarity=0.221 Sum_probs=80.5
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccC-------Ccceeeee-ce----Eee-cC--eEE
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-------HVNIVPFL-GF----CYE-KK--KRA 274 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~~----~~~-~~--~~~ 274 (511)
.|+ |..-.+|+....+|+.+++|+.+... .......|.+.|..+. -|.+++.. |- ... .+ +.+
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~v 109 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLL 109 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEE
Confidence 464 45688899988788899999998643 2233334445554332 23333322 11 111 12 466
Q ss_pred EEEEeCCCCCHHHHH-----------------h----cccCCCCCCCCCHHH-----------------HHHHHHHHHHH
Q 040808 275 LIYEFMPNGSLDQYI-----------------Y----DHESSNGKRTLEWRT-----------------VYQIAVGIARG 316 (511)
Q Consensus 275 lv~e~~~~gsL~~~l-----------------~----~~~~~~~~~~l~~~~-----------------~~~i~~~i~~~ 316 (511)
-+++|++|..|.+.. + ........+.+.|.. ...++.++...
T Consensus 110 rLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~~ 189 (1013)
T PRK06148 110 RLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLAR 189 (1013)
T ss_pred EEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHHH
Confidence 789999998776511 0 011111112333321 11222233332
Q ss_pred HHH----HHhCCCCCcEecCCCCCCEEEcCCC--ceE-EeeccCcccc
Q 040808 317 LEY----LHRGCNIRIVHLDIKPHNIRLDEDF--CPK-ISDFGLAKQT 357 (511)
Q Consensus 317 l~y----LH~~~~~~iiH~Dlkp~NIll~~~~--~~k-l~DFGla~~~ 357 (511)
.+- .-..-..++||+|+.+.|||++.++ .+. |+|||.+...
T Consensus 190 ~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 190 FERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 221 1112345899999999999999875 555 9999987543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.064 Score=54.96 Aligned_cols=78 Identities=12% Similarity=0.053 Sum_probs=51.3
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEec-----cCC---CChHHHHHHHHHHHccC---CcceeeeeceEeecCeEEEEE
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMK-----NLK---DNGEEFINEVASISRTS---HVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~-----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.||.|.-..||+.... ++.++||.-. ... ...++...|++.|..+. ...+.+++.++. +..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 46899999999998864 4568899764 111 13344455677776554 246777887666 4468899
Q ss_pred EeCCC--CCHHHHH
Q 040808 278 EFMPN--GSLDQYI 289 (511)
Q Consensus 278 e~~~~--gsL~~~l 289 (511)
|++++ ..+.+.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 3344444
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.0087 Score=55.99 Aligned_cols=126 Identities=20% Similarity=0.224 Sum_probs=63.4
Q ss_pred CcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-eeeeceEeecCeEEEEEEeCCCCCHHHH-------H---------
Q 040808 227 GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-VPFLGFCYEKKKRALIYEFMPNGSLDQY-------I--------- 289 (511)
Q Consensus 227 ~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~~-------l--------- 289 (511)
++.|+||+........-...+|..+++.+...++ .++++.+.++ .|+||+++.+|..- +
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678899888765555667788888888875555 3445544332 57799866554321 0
Q ss_pred -hcccC-CCCCCCCCHHHHHHH----------------------HHHHHHHHHHHHh-----CCCCCcEecCCCCCCEEE
Q 040808 290 -YDHES-SNGKRTLEWRTVYQI----------------------AVGIARGLEYLHR-----GCNIRIVHLDIKPHNIRL 340 (511)
Q Consensus 290 -~~~~~-~~~~~~l~~~~~~~i----------------------~~~i~~~l~yLH~-----~~~~~iiH~Dlkp~NIll 340 (511)
+.... ......-.|..+..+ ...+..-+..+.+ ..+..+.|+|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 00000 011111122222222 1112222222221 112468999999999999
Q ss_pred -cCCCceEEeeccCccc
Q 040808 341 -DEDFCPKISDFGLAKQ 356 (511)
Q Consensus 341 -~~~~~~kl~DFGla~~ 356 (511)
+.++.++++||..|..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8889999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.035 Score=55.30 Aligned_cols=32 Identities=19% Similarity=0.119 Sum_probs=28.6
Q ss_pred CCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 325 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
..+++|+|+.++|+|+++++.+-++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999988754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.073 Score=53.55 Aligned_cols=145 Identities=17% Similarity=0.195 Sum_probs=81.5
Q ss_pred cccCCcCceEEEEEEcCC----CcEEEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeCCCC
Q 040808 209 DKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.|..|=...+|+....+ +..|.+|+........-+..+|..+++.+...++. ++++++. .+ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 345557778899887543 24789998765433222345788888888765553 4555542 22 589998776
Q ss_pred CHHH--------------HH---hcccCCCCCCCCCHHHHHHHHHHH----------------------HHHHHHHHh--
Q 040808 284 SLDQ--------------YI---YDHESSNGKRTLEWRTVYQIAVGI----------------------ARGLEYLHR-- 322 (511)
Q Consensus 284 sL~~--------------~l---~~~~~~~~~~~l~~~~~~~i~~~i----------------------~~~l~yLH~-- 322 (511)
+|.. .+ +..........-.|..+..+..++ ..-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5421 11 111100111111233332222221 111222221
Q ss_pred ---CCCCCcEecCCCCCCEEEcC-CCceEEeeccCcccc
Q 040808 323 ---GCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQT 357 (511)
Q Consensus 323 ---~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~ 357 (511)
..+.-.+|.|+.+.|||+++ ++.++++||..|...
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11235799999999999975 578999999987644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.00084 Score=76.80 Aligned_cols=160 Identities=13% Similarity=-0.019 Sum_probs=108.7
Q ss_pred HHHHHHHHccCCcceeeeeceEe--ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 040808 246 INEVASISRTSHVNIVPFLGFCY--EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323 (511)
Q Consensus 246 ~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~ 323 (511)
+.|...++...|+++.....-.. +....+.+++|+.+|.+.+.|.... .+...+...-+...-.+...+..-.|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~--ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL--EESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc--ccCCcchhchHHHHHHHHHhccchhhhc
Confidence 34444555667988876654433 2345678899999999999986532 2233343333333333335555555543
Q ss_pred C--CCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHH
Q 040808 324 C--NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMI 401 (511)
Q Consensus 324 ~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il 401 (511)
. +.-.+|+++|+-|.+|..+..+|++++|+.+.......+. ....+++-|+.|+....- ..+.++|+|..|+-+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~--Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFF--GLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSL 1430 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhh--hhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHH
Confidence 3 2347899999999999999999999999999433332221 223577888999987553 677789999999999
Q ss_pred HHHHhCCCCC
Q 040808 402 HEMVIGRKNA 411 (511)
Q Consensus 402 ~elltg~~p~ 411 (511)
|+.--|..++
T Consensus 1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred HHHhcccHHH
Confidence 9998887665
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.041 Score=56.09 Aligned_cols=79 Identities=13% Similarity=0.100 Sum_probs=52.6
Q ss_pred cccCCcCceEEEEEEcCC-CcEEEEEEecc----C---CCChHHHHHHHHHHHccC--Cc-ceeeeeceEeecCeEEEEE
Q 040808 209 DKLGQGGYADVYKGTLPD-GRLVAVKVMKN----L---KDNGEEFINEVASISRTS--HV-NIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 277 (511)
+.||.|.-..||++.+.+ ++.|+||.-.. . .-..++..-|.+.|+... -| .+.+++ +.+.+...+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHHH
Confidence 468999999999999753 56799985431 1 223466777888887654 23 344455 45666778999
Q ss_pred EeCCCC-CHHHHH
Q 040808 278 EFMPNG-SLDQYI 289 (511)
Q Consensus 278 e~~~~g-sL~~~l 289 (511)
|+++.. .|++.|
T Consensus 113 EdL~~~~ilR~~L 125 (409)
T PRK12396 113 EDLSDHTILRTAL 125 (409)
T ss_pred HhCcccHHHHHHH
Confidence 998642 244444
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.049 Score=50.55 Aligned_cols=152 Identities=16% Similarity=0.138 Sum_probs=95.7
Q ss_pred cCceEEEEEEcCCCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhc
Q 040808 214 GGYADVYKGTLPDGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYD 291 (511)
Q Consensus 214 G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 291 (511)
||.++.-.++.+-| ...+|.++..... ..-|.++..++++++ .|+++.. .+.-..-++.|+|-.-
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc--------
Confidence 56667666665443 3556666554433 346788999998875 5677762 2444567899988221
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCC
Q 040808 292 HESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371 (511)
Q Consensus 292 ~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 371 (511)
+.... .++.-=+.+|.-.|+. +.+.+|+|-.|+||+-|..|.+||.|-+.-.. .
T Consensus 140 -------~i~~~----N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------ 193 (308)
T PF07387_consen 140 -------KINFS----NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------ 193 (308)
T ss_pred -------ccchh----HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--h------------
Confidence 11111 1122224678888965 35899999999999999999999999875321 1
Q ss_pred CCCccchhhcccccCCCCccccchhHHHHHHHHHhCCC
Q 040808 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK 409 (511)
Q Consensus 372 t~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~ 409 (511)
+-.|.--|+ ...+.++.+=+|=.-+++++...+
T Consensus 194 ~V~~vN~~Y-----~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 194 QVNMVNIEY-----ESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eeeEEeeec-----cccChHHHHHHHHHHHHHHHHHHh
Confidence 111333222 246777888777777777776554
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.12 Score=51.54 Aligned_cols=112 Identities=16% Similarity=0.192 Sum_probs=76.2
Q ss_pred cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 270 KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 270 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
....|++|++- |+++. .+ ....|++.+.++.+.+.-++-+..+ ...-|||+.-.||||+ +|.+.|+
T Consensus 298 ~~y~yl~~kdh-gt~is-~i---------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLI 363 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-II---------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLI 363 (488)
T ss_pred ceEEEEEEecC-Cceee-ee---------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEE
Confidence 34556777764 44442 22 3467889999999998888888876 5899999999999999 8999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCC
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~ 408 (511)
||-++++-..+. .+... ..-.|-.+.+ .-+..-|||-+ |--|+.|.
T Consensus 364 DfklsRl~~~q~-~isy~------rldhp~lF~G---~dd~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 364 DFKLSRLSYSQG-IISYN------RLDHPDLFNG---VDDYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred EeeeeecccCCc-eeecc------ccCchhhhcC---ccceeeeHHHH---HHHHhcCc
Confidence 999999543332 22211 2234555543 33566778774 44455555
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.092 Score=53.80 Aligned_cols=74 Identities=19% Similarity=0.178 Sum_probs=45.3
Q ss_pred cccCCcCceEEEEEEcCCC--cE-----EEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEeC
Q 040808 209 DKLGQGGYADVYKGTLPDG--RL-----VAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~ 280 (511)
+.|..|-...+|++...++ .. |.+++........-+-.+|+++++.+...++. ++++.+.. .+++||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 3465688899999875432 22 44443322221122345789999998876664 45555532 5999999
Q ss_pred CCCCHH
Q 040808 281 PNGSLD 286 (511)
Q Consensus 281 ~~gsL~ 286 (511)
+|.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 887654
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.12 Score=49.67 Aligned_cols=77 Identities=21% Similarity=0.202 Sum_probs=56.0
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC-CCCCHHHH
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM-PNGSLDQY 288 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~-~~gsL~~~ 288 (511)
.+..|..+.|+.+...+|...++|+........++..-+ ..|....-...|++++. +.+...|++|.+ ++-+|.+.
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~L~~~ 85 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAA--DPERGALLLERLDPGRSLASL 85 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeecc--ccccchhhhhhccCCCchhhc
Confidence 466789999999999999999999987654433333222 44777777888999874 344668899998 55577655
Q ss_pred H
Q 040808 289 I 289 (511)
Q Consensus 289 l 289 (511)
.
T Consensus 86 ~ 86 (253)
T PF04655_consen 86 P 86 (253)
T ss_pred c
Confidence 4
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 511 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-34 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-30 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 321 bits (826), Expect = e-107
Identities = 113/302 (37%), Positives = 169/302 (55%), Gaps = 23/302 (7%)
Query: 192 PKRFSYSDVRRMTKSFSD--KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE--EFIN 247
KRFS +++ + +FS+ LG+GG+ VYKG L DG LVAVK +K + G +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVY 307
EV IS H N++ GFC +R L+Y +M NGS+ + E + L+W
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQ 134
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
+IA+G ARGL YLH C+ +I+H D+K NI LDE+F + DFGLAK + K++ ++
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-- 192
Query: 368 DTR--GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY---- 421
T GT G+IAPE G S K+DV+ YG+M+ E++ G++ D+ + +
Sbjct: 193 -TAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 422 ---FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
K++E D L G +EE +++I V+L C Q+ P +RP M++VV ML
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEE---VEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 479 EG 480
EG
Sbjct: 307 EG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 3e-92
Identities = 101/302 (33%), Positives = 154/302 (50%), Gaps = 24/302 (7%)
Query: 193 KRFSYSDVRRMTKSFSDK--LGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE-EFINEV 249
R D+ T +F K +G G + VYKG L DG VA+K G EF E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 250 ASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQI 309
++S H ++V +GFC E+ + LIY++M NG+L +++Y S ++ W +I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG--SDLPTMSMSWEQRLEI 144
Query: 310 AVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLD 368
+G ARGL YLH I+H D+K NI LDE+F PKI+DFG++K+ TE ++ +S
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS--- 198
Query: 369 TR--GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY----- 421
T GT GYI PE F + G ++ KSDVYS+G+++ E++ R +
Sbjct: 199 TVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481
+ Q+E D L + E +K ++ C+ DRPSM V+ LE +
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPES---LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
Query: 482 IE 483
+
Sbjct: 314 LR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 280 bits (720), Expect = 1e-91
Identities = 91/314 (28%), Positives = 149/314 (47%), Gaps = 41/314 (13%)
Query: 189 SLAPKRFSYSDVRRMTKSFSD--------KLGQGGYADVYKGTLPDGRLVAVKVMKNLKD 240
FS+ +++ +T +F + K+G+GG+ VYKG + + VAVK + + D
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67
Query: 241 NG-----EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESS 295
++F E+ +++ H N+V LGF + L+Y +MPNGSL +
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC---L 124
Query: 296 NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
+G L W +IA G A G+ +LH +I H DIK NI LDE F KISDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLAR 181
Query: 356 Q-TEKKESFISMLDTR--GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412
+ ++ ++ +R GT Y+APE + KSD+YS+G+++ E++ G D
Sbjct: 182 ASEKFAQTVMT---SRIVGTTAYMAPEALRGEI---TPKSDIYSFGVVLLEIITGLPAVD 235
Query: 413 VK------VSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPP 466
+ E K IE D +++ + + M V+ C+
Sbjct: 236 EHREPQLLLDIKEEIEDEE--KTIEDYIDKKMNDADSTS----VEAMYSVASQCLHEKKN 289
Query: 467 DRPSMTKVVEMLEG 480
RP + KV ++L+
Sbjct: 290 KRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-68
Identities = 71/299 (23%), Positives = 105/299 (35%), Gaps = 36/299 (12%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+ +G + V+K VAVK+ + EV S+ H NI+ F+G
Sbjct: 27 QLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 266 FCYE----KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
LI F GSL ++ + + W + IA +ARGL YLH
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLH 138
Query: 322 -------RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
G I H DIK N+ L + I+DFGLA + E +S GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 375 YIAPEVFCRHFGG---VSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431
Y+APEV + D+Y+ G+++ E+ AD V F I +
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 432 TEYDFQLDGVVTEE-----------EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
E + VV + + + C R S V E +
Sbjct: 259 LE---DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-67
Identities = 76/294 (25%), Positives = 139/294 (47%), Gaps = 35/294 (11%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPF 263
+K+G G + V++ G VAVK++ + EF+ EVA + R H NIV F
Sbjct: 41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+G + +++ E++ GSL + ++ + + L+ R +A +A+G+ YLH
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
N IVH ++K N+ +D+ + K+ DFGL++ K +F+S GT ++APEV R
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVL-R 212
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
+ KSDVYS+G+++ E+ + + N Q+ + V
Sbjct: 213 D-EPSNEKSDVYSFGVILWELA-----------TLQQPWGNLNPAQV-------VAAVGF 253
Query: 444 EEE-----KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPS 492
+ + + + ++ + C P RPS ++++L I++ PP S
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRS 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-63
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 37/291 (12%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+ +G+G + V K + VA+K +++ + + FI E+ +SR +H NIV G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
C L+ E+ GSL ++ E + ++G+ YLH
Sbjct: 70 C--LNPVCLVMEYAEGGSLYNVLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 327 RIVHLDIKPHNIRLDEDF-CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
++H D+KP N+ L KI DFG A + M + +G+A ++APEVF
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS- 178
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445
S K DV+S+G+++ E++ RK P + +I F++ V
Sbjct: 179 -NYSEKCDVFSWGIILWEVITRRK-------------P---FDEIGG-PAFRIMWAVHNG 220
Query: 446 E-----KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKP 491
K + K + + C P RPSM ++V+++ + +P
Sbjct: 221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-61
Identities = 73/314 (23%), Positives = 132/314 (42%), Gaps = 51/314 (16%)
Query: 188 GSLAPKRFSYSDVRRMTKS---FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG- 242
G++ F S + + + + ++G+GG+ V+KG + D +VA+K + G
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 243 -------EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESS 295
+EF EV +S +H NIV G ++ EF+P G L + D
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK--- 115
Query: 296 NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-----DFCPKISD 350
++W ++ + IA G+EY+ N IVH D++ NI L C K++D
Sbjct: 116 --AHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410
FGL++Q+ S+ G ++APE + K+D YS+ M+++ ++ G
Sbjct: 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE-- 225
Query: 411 ADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE-----KEMAKKMILVSLWCIQTHP 465
F Y +I+ ++ + E ++ ++ V C P
Sbjct: 226 ---------GPFDEYSYGKIKF-----INMIREEGLRPTIPEDCPPRLRNVIELCWSGDP 271
Query: 466 PDRPSMTKVVEMLE 479
RP + +V+ L
Sbjct: 272 KKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 6e-59
Identities = 58/289 (20%), Positives = 106/289 (36%), Gaps = 50/289 (17%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVP 262
+F KL + +++KG G + VKV+K + +F E + SH N++P
Sbjct: 13 NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 263 FLGFCYE--KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
LG C LI +MP GSL +++ ++ + A+ +ARG+ +L
Sbjct: 72 VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFL 127
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H I + ++ +DED +IS + ++APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEA 179
Query: 381 FC-RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439
+ +D++S+ +++ E+V F + +I
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTRE-----------VPFADLSNMEI-------GM 221
Query: 440 GVVTEEE---------KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
V E ++K M + C+ P RP +V +LE
Sbjct: 222 KVALEGLRPTIPPGISPHVSKLMKI----CMNEDPAKRPKFDMIVPILE 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-58
Identities = 74/322 (22%), Positives = 116/322 (36%), Gaps = 45/322 (13%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINE--VASISRTSHVNIVPF 263
+ +G+G Y VYKG+L D R VAVKV N + FINE + + H NI F
Sbjct: 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFS--FANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 264 LGFCYE-----KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
+ + + L+ E+ PNGSL +Y+ H T +W + ++A + RGL
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLA 125
Query: 319 YLH------RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK------QTEKKESFISM 366
YLH I H D+ N+ + D ISDFGL+ E +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 367 LDTRGTAGYIAPEVF-----CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY 421
+ GT Y+APEV R + D+Y+ G++ E+ + + S
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 422 FPNAIYKQIETEYDFQLDGVVTE-----------EEKEMAKKMILVSLWCIQTHPPDRPS 470
++ V E E + + C R +
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
Query: 471 MTKVVEMLEGSIENLQIPPKPS 492
E + + + S
Sbjct: 306 AQXAEERMAELMMIWERNKSVS 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-56
Identities = 75/317 (23%), Positives = 128/317 (40%), Gaps = 56/317 (17%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPF 263
+ +G+G + VY G G VA++++ +DN + F EV + +T H N+V F
Sbjct: 37 IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+G C A+I +L + D K L+ QIA I +G+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLH-- 147
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK---QTEKKESFISMLDTRGTAGYIAPEV 380
I+H D+K N+ D I+DFGL + + G ++APE+
Sbjct: 148 -AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 381 FCRHFGGV-------SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433
+ S SDV++ G + +E+ +P +K E
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE-------------WP---FKTQPAE 249
Query: 434 YDFQLDGVVTEEEK------EMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487
+ + K M K++ + L+C +RP+ TK+++MLE ++
Sbjct: 250 ---AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE------KL 300
Query: 488 PPKP-SLSLPTGYAKQS 503
P + LS P + K +
Sbjct: 301 PKRNRRLSHPGHFWKSA 317
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-56
Identities = 75/283 (26%), Positives = 131/283 (46%), Gaps = 36/283 (12%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE---EFINEVASISRTSHVNIVPF 263
++G G + VYKG G VAVK++ + F NEV + +T HVNI+ F
Sbjct: 28 VGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+G+ + A++ ++ SL +++ E E + + IA ARG++YLH
Sbjct: 86 MGYST-APQLAIVTQWCEGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA- 138
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
+I +H D+K +NI L ED KI DFGLA + + G+ ++APEV
Sbjct: 139 KSI--IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 384 HFGG-VSHKSDVYSYGMMIHEMVIGR------KNADVKVSCSSEYFPNAIYKQIETEYDF 436
S +SDVY++G++++E++ G+ N D I + +
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------------QIIEMVGRGS-- 242
Query: 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
L +++ K+M + C++ +RPS +++ +E
Sbjct: 243 -LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-56
Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 58/295 (19%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG-----EEFINEVASISRTSHVNIV 261
+ +G GG+ VY+ G VAVK ++ D E E + H NI+
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
G C ++ L+ EF G L++ + + + + AV IARG+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLS-------GKRIPPDILVNWAVQIARGMNYLH 122
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCP--------KISDFGLAKQTEKKESFISMLDTRGTA 373
+ I+H D+K NI + + KI+DFGLA++ + + G
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAY 178
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433
++APEV R S SDV+SYG+++ E++ G F +
Sbjct: 179 AWMAPEVI-RA-SMFSKGSDVWSYGVLLWELLTGE-----------VPFRGIDGLAV--- 222
Query: 434 YDFQLDGVVTEEE---------KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
GV + + AK M C P RPS T +++ L
Sbjct: 223 ----AYGVAMNKLALPIPSTCPEPFAKLM----EDCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 8e-56
Identities = 81/343 (23%), Positives = 139/343 (40%), Gaps = 56/343 (16%)
Query: 189 SLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNL-KDNGEEFI 246
S+ + F SD+ + LG+G + K T G ++ +K + ++ F+
Sbjct: 1 SMPHRIFRPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55
Query: 247 NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV 306
EV + H N++ F+G Y+ K+ I E++ G+L I +S W
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-----YPWSQR 110
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK----------- 355
A IA G+ YLH N I+H D+ HN + E+ ++DFGLA+
Sbjct: 111 VSFAKDIASGMAYLHS-MN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167
Query: 356 -QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414
++ KK G ++APE+ + K DV+S+G+++ E +IGR NAD
Sbjct: 168 LRSLKKPDRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCE-IIGRVNAD-- 222
Query: 415 VSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMA------KKMILVSLWCIQTHPPDR 468
P+ + + ++ G+ + +++ C P R
Sbjct: 223 --------PDYLPRTMDF-------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
Query: 469 PSMTKVVEMLEGSIENL--QIPPKPSL-SLPTGYAKQSSPTSS 508
PS K+ LE +L +P P L L G+ + S
Sbjct: 268 PSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGES 310
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-53
Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 40/300 (13%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
++G+G Y +V+ G G VAVKV ++ E+ H NI+ F+
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 267 CYEKKKR----ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH- 321
+ LI ++ NGSL Y+ TL+ +++ ++A GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 322 ----RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA--KQTEKKESFISMLDTRGTAGY 375
I H D+K NI + ++ I+D GLA ++ E I GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 376 IAPEVF-----CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY-FPNAIYKQ 429
+ PEV HF +D+YS+G+++ E+ V EY P
Sbjct: 213 MPPEVLDESLNRNHF-QSYIMADMYSFGLILWEVARR----CVSGGIVEEYQLPYHDLVP 267
Query: 430 IETEYDFQLDGVVTEEE-----KEMAKKMILVSLW-----CIQTHPPDRPSMTKVVEMLE 479
+ Y+ + V ++ + L + C +P R + +V + L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-50
Identities = 60/303 (19%), Positives = 114/303 (37%), Gaps = 46/303 (15%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+ +G+G + +V++G G VAVK+ + ++ E+ H NI+ F+
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 267 CYEKKKRA----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH- 321
+ L+ ++ +GSL Y+ + T+ + ++A+ A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHM 157
Query: 322 ----RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA--KQTEKKESFISMLDTRGTAGY 375
I H D+K NI + ++ I+D GLA + I+ GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 376 IAPEVF-----CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430
+APEV +HF ++D+Y+ G++ E+ + P
Sbjct: 218 MAPEVLDDSINMKHF-ESFKRADIYAMGLVFWEIARR---CSIGGIHEDYQLPYYDLVPS 273
Query: 431 ETEYDFQLDGVVTEEE--------------KEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ + V ++ + MAK M C + R + ++ +
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR----ECWYANGAARLTALRIKK 329
Query: 477 MLE 479
L
Sbjct: 330 TLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 5e-50
Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 38/299 (12%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+ +G+G Y +V++G+ G VAVK+ + + E+ + H NI+ F+
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 267 CYEKKKRA----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH- 321
+ + LI + GSL Y+ TL+ + +I + IA GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHI 123
Query: 322 ----RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA--KQTEKKESFISMLDTRGTAGY 375
I H D+K NI + ++ I+D GLA + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 376 IAPEVFCRHFGGV----SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431
+APEV + D++++G+++ E+ R ++ V F + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 432 TEYDFQLDGVVTEE------EKEMAKKMILVSLW-----CIQTHPPDRPSMTKVVEMLE 479
E + VV + L SL C +P R + ++ + L
Sbjct: 243 FE---DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-40
Identities = 66/274 (24%), Positives = 105/274 (38%), Gaps = 37/274 (13%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVM---KNLKDNGEEFINEVASISRTSHVNIVP 262
F ++G+G + VYKG VA + K K + F E + H NIV
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 263 FLGFCYEKKKRA----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
F K L+ E M +G+L Y+ + ++ + + I +GL+
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQ 143
Query: 319 YLHRGCNIRIVHLDIKPHNIRLD-EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
+LH I+H D+K NI + KI D GLA GT ++A
Sbjct: 144 FLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMA 198
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-DF 436
PE++ DVY++GM + EM + S IY+++ +
Sbjct: 199 PEMYEE---KYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRRVTSGVKPA 249
Query: 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS 470
D V E KE+ + CI+ + +R S
Sbjct: 250 SFDKVAIPEVKEIIEG-------CIRQNKDERYS 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 51/311 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK--NLKDNGEEFINEVASISRTSHVNIVPFLG 265
LG+GG+ V++ D A+K ++ N + E+ + EV ++++ H IV +
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 266 FCYEK---------KKRALIY---EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
EK + +Y + +L ++ E I + I
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHIFLQI 127
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR--- 370
A +E+LH + ++H D+KP NI D K+ DFGL ++ E ++L
Sbjct: 128 AEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 371 -------GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP 423
GT Y++PE + SHK D++S G+++ E++ S++
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELL---------YPFSTQMER 233
Query: 424 NAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483
+ L E M + M + P +RP ++E E
Sbjct: 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDM-------LSPSPMERPEAINIIEN--AVFE 284
Query: 484 NLQIPPKPSLS 494
+L P K L
Sbjct: 285 DLDFPGKTVLR 295
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 63/289 (21%), Positives = 112/289 (38%), Gaps = 50/289 (17%)
Query: 206 SFSDKLGQGGYADVYKGTL-PDGRLVAVKVMK--NLKDNGEEFINEVASISRTSHVNIVP 262
+++G+G + +V+ G L D LVAVK + D +F+ E + + SH NIV
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+G C +K+ ++ E + G ++ L +T+ Q+ A G+EYL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTE-----GARLRVKTLLQMVGDAAAGMEYLES 231
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----A 377
+H D+ N + E KISDFG++++ G + A
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTA 283
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEYFPNAIYKQI 430
PE ++G S +SDV+S+G+++ E N + +
Sbjct: 284 PEAL--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------------REFV 328
Query: 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
E G + + + C P RPS + + + L+
Sbjct: 329 E-------KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 50/293 (17%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
LGQG + V K D R A+K +++ ++ ++EV ++ +H +V +
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 268 YEK----------KKRALIY---EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
E+ KK++ ++ E+ NG+L I + + +++ I
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-----HSENLNQQRDEYWRLFRQIL 126
Query: 315 RGLEYLH-RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR--- 370
L Y+H +G I+H D+KP NI +DE KI DFGLAK + + +
Sbjct: 127 EALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 371 ---------GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY 421
GTA Y+A EV G + K D+YS G++ EM+ S+
Sbjct: 183 SSDNLTSAIGTAMYVATEV-LDGTGHYNEKIDMYSLGIIFFEMIYP---------FSTGM 232
Query: 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474
I K++ + + + + ++ KK+I I P RP +
Sbjct: 233 ERVNILKKLRSV-SIEFPPDFDDNKMKVEKKII---RLLIDHDPNKRPGARTL 281
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 206 SFSDKLGQGGYADVYKGTL--PDGRL---VAVKVMKN--LKDNGEEFINEVASISRTSHV 258
LG G + VYKG ++ VA+K ++ +E ++E ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
++ LG C LI + MP G L Y+ +H K + + + V IA+G+
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMN 131
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-- 376
YL R+VH D+ N+ + KI+DFGLAK +E G +
Sbjct: 132 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPI 183
Query: 377 ---APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
A E +H+SDV+SYG+ + E++ G +++
Sbjct: 184 KWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 209 DKLGQGGYADVYKGTLPD---GRLVAVKVMK-NLKDNGE---EFINEVASISRTSHVNIV 261
DKLG GG + VY D VA+K + ++ E F EV + S+ SH NIV
Sbjct: 17 DKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
+ E L+ E++ +L +YI H L T I G+++ H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAH 128
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GTAGYIAP 378
+RIVH DIKP NI +D + KI DFG+AK S S+ T GT Y +P
Sbjct: 129 D---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSP 181
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
E + +D+YS G++++EM++G
Sbjct: 182 EQ-AKG-EATDECTDIYSIGIVLYEMLVGE 209
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 62/293 (21%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+ +LG G + V G VAVK++K + +EF E ++ + SH +V F G
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C ++ ++ E++ NG L Y+ H + LE + ++ + G+ +L
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSH-----GKGLEPSQLLEMCYDVCEGMAFLES--- 122
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APEV 380
+ +H D+ N +D D C K+SDFG+ + + APEV
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ------YVSSVGTKFPVKWSAPEV 176
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------FPNAI 426
F H+ S KSDV+++G+++ E+ N++V + S + + I
Sbjct: 177 F--HYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTI 234
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
Y QI M C P RP+ +++ +E
Sbjct: 235 Y-QI------------------M--------YSCWHELPEKRPTFQQLLSSIE 260
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 62/282 (21%), Positives = 121/282 (42%), Gaps = 51/282 (18%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF-- 266
+G GG+ V+K DG+ +K +K +N E+ EV ++++ HVNIV + G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVK--YNN-EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 267 -----------CYEKKKRALIY---EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
+ K ++ EF G+L+Q+I E G++ + ++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK-VLALELFEQ 130
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372
I +G++Y+H + ++++ D+KP NI L + KI DFGL + GT
Sbjct: 131 ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---GT 184
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432
Y++PE + D+Y+ G+++ E++ A +S++F + I
Sbjct: 185 LRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTA----FETSKFFTDLRDGIISD 238
Query: 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474
+D + ++ + P DRP+ +++
Sbjct: 239 IFDKKEKTLLQ---------------KLLSKKPEDRPNTSEI 265
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 209 DKLGQGGYADVYKGTLPD---GRLVAVKVMK-NLKDNGE---EFINEVASISRTSHVNIV 261
+ LG GG ++V+ D R VAVKV++ +L + F E + + +H IV
Sbjct: 18 EILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 262 PFLGFCYEKKKRALIY----EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+ + E++ +L ++ + + ++ + L
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQAL 129
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GTAG 374
+ H+ I+H D+KP NI + K+ DFG+A+ +S S+ T GTA
Sbjct: 130 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y++PE R V +SDVYS G +++E++ G
Sbjct: 185 YLSPEQ-ARG-DSVDARSDVYSLGCVLYEVLTGE 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-34
Identities = 69/298 (23%), Positives = 119/298 (39%), Gaps = 62/298 (20%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+F ++G G + V+ G + VA+K ++ + E+FI E + + SH +V G
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C E+ L+ EFM +G L Y+ TL + + + G+ YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE--- 122
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APEV 380
++H D+ N + E+ K+SDFG+ + + T T +PEV
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWASPEV 176
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------FPNAI 426
F F S KSDV+S+G+++ E+ R N++V S+ + +
Sbjct: 177 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 234
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
Y QI M C + P DRP+ ++++ L E+
Sbjct: 235 Y-QI------------------M--------NHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 57/298 (19%), Positives = 108/298 (36%), Gaps = 62/298 (20%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+F +LG G + V G VA+K++K + +EFI E + SH +V G
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C +++ +I E+M NG L Y+ + + L ++ + +EYL
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL-----LEMCKDVCEAMEYLES--- 138
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APEV 380
+ +H D+ N +++ K+SDFGL++ E T PEV
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPEV 192
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------FPNAI 426
+ S KSD++++G+++ E+ N++ + +
Sbjct: 193 L--MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
Y I M C +RP+ ++ + ++
Sbjct: 251 Y-TI------------------M--------YSCWHEKADERPTFKILLSNILDVMDE 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-34
Identities = 76/324 (23%), Positives = 131/324 (40%), Gaps = 74/324 (22%)
Query: 207 FSDKLGQGGYADVYKGTL--PDGR---LVAVKVMKN--LKDNGEEFINEVASISRTSHVN 259
+G G + +VYKG L G+ VA+K +K + +F+ E + + SH N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
I+ G + K +I E+M NG+LD+++ + + + + GIA G++Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKY 162
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI--- 376
L + VH D+ NI ++ + K+SDFGL++ E + G I
Sbjct: 163 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA----TYTTSGGKIPIR 215
Query: 377 --APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY------ 421
APE + + SDV+S+G+++ E++ N +V + + +
Sbjct: 216 WTAPEAI--SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273
Query: 422 -FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480
P+AIY QL M + C Q RP +V +L+
Sbjct: 274 DCPSAIY---------QL----------M--------MQCWQQERARRPKFADIVSILDK 306
Query: 481 SIEN-------LQIPPKPSLSLPT 497
I P+ S+ LP+
Sbjct: 307 LIRAPDSLKTLADFDPRVSIRLPS 330
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 45/209 (21%), Positives = 78/209 (37%), Gaps = 30/209 (14%)
Query: 209 DKLGQGGYADVYKG--TLPDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHVNIVPFL 264
+ GG +Y +GR V +K + + D + E ++ H +IV
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 265 --GFCYEKKKRALIY---EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
++ + Y E++ SL + + L + I L Y
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--------GQKLPVAEAIAYLLEILPALSY 197
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
LH I +V+ D+KP NI L E+ K+ D G + GT G+ APE
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY------GTPGFQAPE 247
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ R G + +D+Y+ G + + +
Sbjct: 248 I-VR--TGPTVATDIYTVGRTLAALTLDL 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 61/286 (21%), Positives = 112/286 (39%), Gaps = 35/286 (12%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVM-KNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
KLG+GG++ V L DG A+K + + + + EE E +H NI+ + +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 268 YEKKKRA----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
++ L+ F G+L I + L + + +GI RGLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQILWLLLGICRGLEAIHA- 152
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-------RGTAGYI 376
H D+KP NI L ++ P + D G Q T R T Y
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 377 APEVF-CRHFGGVSHKSDVYSYGMMIHEMVIGRK--NADVKVSCSSEYFPNAIYKQIETE 433
APE+F + + ++DV+S G +++ M+ G + + +++ ++ +
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-------DSVALAVQNQ 263
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ +++ + P RP + ++ LE
Sbjct: 264 LSIPQSPRHSSA----LWQLL---NSMMTVDPHQRPHIPLLLSQLE 302
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 62/292 (21%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
KLGQG + +V+ GT VA+K +K + E F+ E + + H +V
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
++ ++ E+M GSL ++ + L + +A IA G+ Y+ R +
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---M 299
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APEVF 381
VH D++ NI + E+ K++DFGLA+ E E T APE
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAA 353
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEY-------FPNAIY 427
+G + KSDV+S+G+++ E+ G N +V Y P +++
Sbjct: 354 --LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 411
Query: 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
M C + P +RP+ + LE
Sbjct: 412 DL-------------------M--------CQCWRKEPEERPTFEYLQAFLE 436
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 69/292 (23%), Positives = 110/292 (37%), Gaps = 62/292 (21%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
KLG G + +V+ T VAVK MK + E F+ E + H +V
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
K+ +I EFM GSL ++ E + + IA G+ ++ +
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQ---R 303
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APEVF 381
+H D++ NI + KI+DFGLA+ E E T APE
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE------YTAREGAKFPIKWTAPEAI 357
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------FPNAIY 427
+FG + KSDV+S+G+++ E+V G N +V + Y P +Y
Sbjct: 358 --NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415
Query: 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
I M + C + P +RP+ + +L+
Sbjct: 416 -NI------------------M--------MRCWKNRPEERPTFEYIQSVLD 440
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 65/292 (22%), Positives = 105/292 (35%), Gaps = 46/292 (15%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-- 256
V +++ D LG G + + D R VAVK + L + EV + R S
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--LPECFSFADREVQ-LLRESDE 76
Query: 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
H N++ + +++ + + E +L +Y+ L + G
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV----EQKDFAHLG-LEPITLLQQTTSG 130
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDE-----DFCPKISDFGLAKQTEKKE-SFISMLDTR 370
L +LH ++ IVH D+KPHNI + ISDFGL K+ SF
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 371 GTAGYIAPEVFCRHF-GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC------SSEYFP 423
GT G+IAPE+ ++ D++S G + + ++
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI-----------SEGSHPFGKSLQR 236
Query: 424 NAIYKQIETEYDF-QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474
A D + +E+ +KM I P RPS V
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKM-------IAMDPQKRPSAKHV 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 39/300 (13%)
Query: 207 FSDKLGQGGYADVYKGTLP-----DGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNI 260
F +LG+G + V G +VAVK ++ + +++ +F E+ + H NI
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 261 VPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
V + G CY +R LI E++P GSL Y+ H+ L Q I +G+E
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGME 128
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-- 376
YL R +H D+ NI ++ + KI DFGL K + + F + I
Sbjct: 129 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV--KEPGESPIFW 183
Query: 377 -APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435
APE S SDV+S+G++++E+ + + + N Q+
Sbjct: 184 YAPE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-- 239
Query: 436 FQLDGVVTEEE---------KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486
L ++ E+ M C + RPS + ++ +N+
Sbjct: 240 -HLIELLKNNGRLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 52/293 (17%)
Query: 207 FSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
KLG G Y +VY+G VAVK +K EEF+ E A + H N+V LG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
C + +I EFM G+L Y+ ++ + + +A I+ +EYL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL----RECNRQEVSAVVLLYMATQISSAMEYLEK--- 336
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
+H ++ N + E+ K++DFGL++ + + + + APE +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESL--AY 393
Query: 386 GGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------FPNAIYKQIE 431
S KSDV+++G+++ E+ G + V +Y P +Y+
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE--- 450
Query: 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
+ C Q +P DRPS ++ + E +
Sbjct: 451 ------------------------LMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK--NLKDNGE--EFINEVASISRTSHVNIVPF 263
K+G+G +++VY+ L DG VA+K ++ +L D + I E+ + + +H N++ +
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
E + ++ E G L + I + R + RTV++ V + LE++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPERTVWKYFVQLCSALEHMHSR 155
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
R++H DIKP N+ + K+ D GL + K + GT Y++PE
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH--SLVGTPYYMSPER-IH 209
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRK--NADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441
G + KSD++S G +++EM + D + K + +Y
Sbjct: 210 E-NGYNFKSDIWSLGCLLYEMAALQSPFYGD------KMNLYSLCKKIEQCDYPPLPSDH 262
Query: 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
+EE +++ CI P RP +T V ++
Sbjct: 263 YSEELRQLVN-------MCINPDPEKRPDVTYVYDV 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 71/312 (22%), Positives = 120/312 (38%), Gaps = 44/312 (14%)
Query: 192 PKRFSYSDVRRMTKS---FSDKLGQGGYADVYKGTLP-----DGRLVAVKVMK--NLKDN 241
K + D K LG+G + V G VAVK +K + ++
Sbjct: 7 KKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH 66
Query: 242 GEEFINEVASISRTSHVNIVPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKR 299
+ E+ + H NIV + G C E LI EF+P+GSL +Y+ + K
Sbjct: 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-----KN 121
Query: 300 TLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359
+ + + AV I +G++YL + VH D+ N+ ++ + KI DFGL K E
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 360 KESFISMLDTRGTAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-IGRKNADV 413
+ + T APE C SDV+S+G+ +HE++ ++
Sbjct: 179 DKEYY----TVKDDRDSPVFWYAPE--CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
Query: 414 KVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAK------KMILVSLWCIQTHPPD 467
P + Q+ +E K + ++ + C + P +
Sbjct: 233 MALFLKMIGPT--HGQMTVTRLVNT----LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSN 286
Query: 468 RPSMTKVVEMLE 479
R S ++E E
Sbjct: 287 RTSFQNLIEGFE 298
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVP 262
SD LGQG A+V++G G L A+KV + + + E + + +H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 263 FLGFCYEKKKRALIY---EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
E+ EF P GSL + + ++ G E+ V + + G+ +
Sbjct: 72 LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR---DVVGGMNH 127
Query: 320 LHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGY 375
L IVH +IKP NI D K++DFG A++ E E F+S+ GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEY 181
Query: 376 IAPEVFCRHFGGV------SHKSDVYSYGMMIHEMVIGR 408
+ P+++ R D++S G+ + G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 67/292 (22%), Positives = 113/292 (38%), Gaps = 62/292 (21%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
KLGQG + +V+ GT VA+K +K + E F+ E + + H +V
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
++ ++ E+M GSL ++ + L + +A IA G+ Y+ R +
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---M 382
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APEVF 381
VH D++ NI + E+ K++DFGLA+ E E T APE
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAA 436
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEY-------FPNAIY 427
+G + KSDV+S+G+++ E+ G N +V Y P +++
Sbjct: 437 --LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 494
Query: 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
M C + P +RP+ + LE
Sbjct: 495 DL-------------------M--------CQCWRKEPEERPTFEYLQAFLE 519
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 35/227 (15%)
Query: 206 SFSDKLGQGGYADVYKGTL--PDGRL---VAVKVMKN--LKDNGEEFINEVASISRTSHV 258
LG G + VYKG ++ VA+K ++ +E ++E ++ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
++ LG C LI + MP G L Y+ +H K + + + V IA+G+
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMN 131
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-- 376
YL + R+VH D+ N+ + KI+DFGLAK +E G +
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-----YHAEGGKVPI 183
Query: 377 ---APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
A E +H+SDV+SYG+ + E++ G +++
Sbjct: 184 KWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 62/293 (21%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
++LG G + +V+ G VAVK +K + + F+ E + + H +V
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
++ +I E+M NGSL ++ L + +A IA G+ ++
Sbjct: 76 VV-TQEPIYIITEYMENGSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEE--- 127
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APEV 380
+H D++ NI + + KI+DFGLA+ E E T APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------YTAREGAKFPIKWTAPEA 181
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEYF-------PNAI 426
++G + KSDV+S+G+++ E+V G N +V + Y P +
Sbjct: 182 I--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
Y Q+ M C + P DRP+ + +LE
Sbjct: 240 Y-QL------------------M--------RLCWKERPEDRPTFDYLRSVLE 265
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 76/313 (24%), Positives = 130/313 (41%), Gaps = 45/313 (14%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
LG+GG+A ++ + + A K++ L E+ E++ +H ++V F G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
F + ++ E SL + K E Y I G +YLHR
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARY-YLRQIVLGCQYLHRN-- 160
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFCRH 384
R++H D+K N+ L+ED KI DFGLA + E GT YIAPEV +
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAPEVLSKK 216
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR---KNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441
G S + DV+S G +++ +++G+ + + +K Y +I + ++ +
Sbjct: 217 --GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----------ETYLRI-KKNEYSIPKH 263
Query: 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE---MLEGSIENLQIPPKPSLSLPTG 498
+ + +KM +QT P RP++ +++ G I ++P P
Sbjct: 264 INPVAASLIQKM-------LQTDPTARPTINELLNDEFFTSGYIPA-RLPITCLTIPPRF 315
Query: 499 YAKQSSPTSSFMK 511
SS S K
Sbjct: 316 SIAPSSLDPSNRK 328
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-33
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 210 KLGQGGYADVYKGTL--PDGRL-VAVKVMKN--LKDNGEEFINEVASISRTSHVNIVPFL 264
+LG G + V +G ++ VA+KV+K K + EE + E + + + IV +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G C + + L+ E G L +++ + + V ++ ++ G++YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEE-- 128
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE 379
VH D+ N+ L KISDFGL+K +S+ + +AG APE
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPE 183
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
+F S +SDV+SYG+ + E + K +V
Sbjct: 184 CI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 46/278 (16%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
LG+G +A VY+ + G VA+K++ K + G + NEV + H +I+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRT---VYQIAVGIARGLEYLHR 322
+ + L+ E NG + + + K E ++QI G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQII----TGMLYLHS 130
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVF 381
I+H D+ N+ L + KI+DFGLA Q + T GT YI+PE+
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYTLCGTPNYISPEIA 184
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR---KNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
R +SDV+S G M + ++IGR VK ++ D+++
Sbjct: 185 TRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVK----------NTLNKV-VLADYEM 231
Query: 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
++ E K++ ++ ++ +P DR S++ V++
Sbjct: 232 PSFLSIEAKDLIHQL-------LRRNPADRLSLSSVLD 262
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 80/331 (24%), Positives = 131/331 (39%), Gaps = 65/331 (19%)
Query: 206 SFSDKLGQGGYADVYKGTL--PDGR--LVAVKVMKN--LKDNGEEFINEVASISRTSHVN 259
S +G G + +V G L P + VA+K +K + +F+ E + + + H N
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
I+ G + K ++ E+M NGSLD ++ H+ + + GIA G++Y
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKY 162
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI--- 376
L + VH D+ NI ++ + K+SDFGL + E TRG I
Sbjct: 163 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT--TRGGKIPIRWT 217
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------F 422
+PE + + SDV+SYG+++ E++ N DV + Y
Sbjct: 218 SPEAI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 423 PNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482
P A+Y QL M L C Q +RP ++V +L+ I
Sbjct: 276 PAALY---------QL----------M--------LDCWQKDRNNRPKFEQIVSILDKLI 308
Query: 483 EN---LQIPPKPSLSLPTGYAKQSSPTSSFM 510
N L+I + QS+ +
Sbjct: 309 RNPGSLKIITSAAARPSNLLLDQSNVDITTF 339
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 65/331 (19%), Positives = 119/331 (35%), Gaps = 69/331 (20%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRL-----VAVKVMKN--LKDNGEEFINEVASISRTSHVN 259
LG G + V+KG V +KV+++ + + + + + +I H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
IV LG C L+ +++P GSL ++ H + G + L V IA+G+ Y
Sbjct: 77 IVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
L +VH ++ N+ L +++DFG+A + + + + ++A E
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV--KVS----------CSSE 420
HFG +H+SDV+SYG+ + E++ G + A+V + C
Sbjct: 188 SI--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQIC--- 242
Query: 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480
+Y M++V W RP+ ++
Sbjct: 243 --TIDVY-------------------------MVMVKCW--MIDENIRPTFKELANEFTR 273
Query: 481 SIENLQIPPKPSLSLPTGYAKQSSPTSSFMK 511
+ G A P K
Sbjct: 274 MARDPPRYLVIKRESGPGIAPGPEPHGLTNK 304
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 68/258 (26%), Positives = 100/258 (38%), Gaps = 23/258 (8%)
Query: 157 LNSSCKNCSSCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSD-VRRMTKSFSDKLGQGG 215
L S K SS S + + + V L P + Y + V MT ++G+G
Sbjct: 13 LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ--PRVGRGS 70
Query: 216 YADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274
+ +V++ G AVK ++ L+ E E+ + + S IVP G E
Sbjct: 71 FGEVHRMKDKQTGFQCAVKKVR-LEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVN 126
Query: 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334
+ E + GSL Q I L GLEYLH RI+H D+K
Sbjct: 127 IFMELLEGGSLGQLIKQM------GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVK 177
Query: 335 PHNIRLDEDFCP-KISDFGLAKQTEKKESFISMLDT---RGTAGYIAPEVFCRHFGGVSH 390
N+ L D + DFG A + S+L GT ++APEV
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK--PCDA 235
Query: 391 KSDVYSYGMMIHEMVIGR 408
K D++S M+ M+ G
Sbjct: 236 KVDIWSSCCMMLHMLNGC 253
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 77/309 (24%), Positives = 127/309 (41%), Gaps = 62/309 (20%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGR----LVAVKVMKNL---KDNGEEFINEVASISRTSHV 258
LG+G + V +G L VAVK MK + EEF++E A + SH
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 259 NIVPFLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
N++ LG C E + +I FM G L Y+ G + + +T+ + V I
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
A G+EYL N +H D+ N L +D ++DFGL+K+ + + +G
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGRI 208
Query: 374 GYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEY 421
+ A E + KSDV+++G+ + E+ G +N ++
Sbjct: 209 AKMPVKWIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-------- 258
Query: 422 FPNAIYKQIETEYDFQLDGVVTEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
YD+ L G ++ E+ + M C +T P DRP+ + +
Sbjct: 259 ------------YDYLLHGHRLKQPEDCLDELYEIM----YSCWRTDPLDRPTFSVLRLQ 302
Query: 478 LEGSIENLQ 486
LE +E+L
Sbjct: 303 LEKLLESLP 311
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 38/343 (11%), Positives = 79/343 (23%), Gaps = 48/343 (13%)
Query: 167 CSYHKETRHDQNAEAAFVRNYGSLAPKRF-SYSDVRRMTKSFSDKLGQGGYADVYKGT-L 224
C EA + A S + L G + V+ +
Sbjct: 25 CREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV 84
Query: 225 PDGRLVAVKVM----KNLKDNGEEFINEVASISRTSHVNI-------------------- 260
A+KV +N + E + +R +
Sbjct: 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144
Query: 261 ---VPFLGFCYEKKKRALIYEFMP--NGSLDQYI-YDHESSNGKRTLEWRTVYQIAVGIA 314
L + A MP + L+ + ++ + +
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
R L +VH P N+ + D + D + + S
Sbjct: 205 RLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VPVT 256
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK-NADVKVSCSSEYFPNAIYKQIETE 433
Y E +H + + G+ I+ + V + ++
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
F + + K + + + R + +E
Sbjct: 317 LAFGSCTPLPDFVKTLIGRF-------LNFDRRRRLLPLEAME 352
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 68/302 (22%), Positives = 117/302 (38%), Gaps = 43/302 (14%)
Query: 207 FSDKLGQGGYADVYKGTLP-----DGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNI 260
F +LG+G + V G +VAVK ++ + +++ +F E+ + H NI
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 261 VPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
V + G CY +R LI E++P GSL Y+ H+ L Q I +G+E
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGME 159
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-- 376
YL R +H D+ NI ++ + KI DFGL K + + + G
Sbjct: 160 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPI 212
Query: 377 ---APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433
APE S SDV+S+G++++E+ + + + N Q+
Sbjct: 213 FWYAPE--SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270
Query: 434 YDFQLDGVVTEEE---------KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
L ++ E+ M C + RPS + ++ +
Sbjct: 271 ---HLIELLKNNGRLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQIRDQ 323
Query: 485 LQ 486
+
Sbjct: 324 MA 325
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 53/306 (17%), Positives = 124/306 (40%), Gaps = 46/306 (15%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVM--KNLKDNG-EEFINEVASISRTSH--VNIVPF 263
++G GG + V++ ++ A+K + + + + + NE+A +++ I+
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ + ++ E N L+ ++ K++++ + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKK------KKSIDPWERKSYWKNMLEAVHTIHQ- 145
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
IVH D+KP N + + K+ DFG+A Q + + + GT Y+ PE
Sbjct: 146 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 384 HFG---------GVSHKSDVYSYGMMIHEMVIGR---KNADVKVSCSSEYFPNAIYKQIE 431
+S KSDV+S G +++ M G+ + ++ + ++ I+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------SKLHAIID 254
Query: 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKP 491
++ + + ++ +++ K C++ P R S+ E+L +Q P
Sbjct: 255 PNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIP---ELLAHPYVQIQTHPVN 304
Query: 492 SLSLPT 497
++ T
Sbjct: 305 QMAKGT 310
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 62/299 (20%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRL-VAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFL 264
+ KLG G Y +VY+G L VAVK +K EEF+ E A + H N+V L
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G C + +I EFM G+L Y+ + ++ + + +A I+ +EYL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEK-- 129
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE 379
+H D+ N + E+ K++DFGL++ T APE
Sbjct: 130 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT------YTAHAGAKFPIKWTAPE 182
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------FPNA 425
+ S KSDV+++G+++ E+ G + V +Y P
Sbjct: 183 SL--AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
+Y ++ M C Q +P DRPS ++ + E +
Sbjct: 241 VY-EL------------------M--------RACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 41/275 (14%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
LG+GG+A ++ + + A K++ L E+ E++ +H ++V F G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
F + ++ E SL + K E Y I G +YLHR
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARY-YLRQIVLGCQYLHR--- 133
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFCRH 384
R++H D+K N+ L+ED KI DFGLA + E GT YIAPEV +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGTPNYIAPEVLSKK 190
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR---KNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441
G S + DV+S G +++ +++G+ + + +K Y +I + ++ +
Sbjct: 191 --GHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----------ETYLRI-KKNEYSIPKH 237
Query: 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ + +KM +QT P RP++ +++
Sbjct: 238 INPVAASLIQKM-------LQTDPTARPTINELLN 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 206 SFSDKLGQGGYADVYKGTL--PDGR--LVAVKVMKN--LKDNGEEFINEVASISRTSHVN 259
+ LG+G + +VY+G G VAVK K DN E+F++E + H +
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
IV +G E++ +I E P G L Y+ +++S TL ++ I + + Y
Sbjct: 75 IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAY 128
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI--- 376
L I VH DI NI + C K+ DFGL++ E ++ + + +
Sbjct: 129 LES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIK 179
Query: 377 --APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
+PE +F + SDV+ + + + E++ +N DV
Sbjct: 180 WMSPESI--NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 66/311 (21%), Positives = 120/311 (38%), Gaps = 63/311 (20%)
Query: 206 SFSDKLGQGGYADVYKGTLPDG----RLVAVKVMK---NLKDNGEEFINEVASISRTSHV 258
+ LG+G + V + L VAVK++K + EEF+ E A + H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 259 NIVPFLGFCYEKKKRA------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
++ +G + + +I FM +G L ++ L +T+ + V
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372
IA G+EYL + +H D+ N L ED ++DFGL+++ + + +G
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGC 197
Query: 373 AGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSE 420
A + A E + SDV+++G+ + E++ G +NA++
Sbjct: 198 ASKLPVKWLALESL--ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------- 248
Query: 421 YFPNAIYKQIETEYDFQLDGVVTEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
Y + G ++ +E+ M C P RPS T +
Sbjct: 249 ------YNYLI-------GGNRLKQPPECMEEVYDLM----YQCWSADPKQRPSFTCLRM 291
Query: 477 MLEGSIENLQI 487
LE + +L +
Sbjct: 292 ELENILGHLSV 302
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 66/330 (20%), Positives = 121/330 (36%), Gaps = 58/330 (17%)
Query: 207 FSDKLGQGGYADVYKGTLP-----DGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNI 260
+ +LG+G + V G LVAVK ++ + D +F E+ + I
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 261 VPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
V + G Y +++ L+ E++P+G L ++ H + L+ + + I +G+E
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-----RARLDASRLLLYSSQICKGME 141
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-- 376
YL R VH D+ NI ++ + KI+DFGLAK + + G
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPI 194
Query: 377 ---APEVFCRHFGGVSHKSDVYSYGMMIHEMV-IGRKNADVKVSCSSEYFPNAIYKQIET 432
APE S +SDV+S+G++++E+ K + +
Sbjct: 195 FWYAPE--SLSDNIFSRQSDVWSFGVVLYELFTYCDK-------------SCSPSAEFLR 239
Query: 433 EYDFQLDGVVTEEEKEMAKK---------------MILVSLWCIQTHPPDRPSMTKVVEM 477
+ D E+ ++ ++ W P DRPS + +
Sbjct: 240 MMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQ 297
Query: 478 LEGSIENLQIPPKPSLSLPTGYAKQSSPTS 507
L+ + + + S S
Sbjct: 298 LDMLWSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 49/283 (17%), Positives = 118/283 (41%), Gaps = 43/283 (15%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVM--KNLKDNG-EEFINEVASISRTSH--VNIVPF 263
++G GG + V++ ++ A+K + + + + + NE+A +++ I+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ + ++ E N L+ ++ K++++ + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKK------KKSIDPWERKSYWKNMLEAVHTIHQ- 126
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF-- 381
IVH D+KP N + + K+ DFG+A Q + + + GT Y+ PE
Sbjct: 127 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 382 -------CRHFGGVSHKSDVYSYGMMIHEMVIGR---KNADVKVSCSSEYFPNAIYKQIE 431
+ +S KSDV+S G +++ M G+ + ++S ++ I+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------KLHAIID 235
Query: 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474
++ + + ++ +++ K C++ P R S+ ++
Sbjct: 236 PNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISIPEL 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 206 SFSDKLGQGGYADVYKGTL--PDGR--LVAVKVMKN--LKDNGEEFINEVASISRTSHVN 259
+G+G + DV++G P+ VA+K KN E+F+ E ++ + H +
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
IV +G + +I E G L ++ K +L+ ++ A ++ L Y
Sbjct: 78 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAY 131
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI--- 376
L R VH DI N+ + + C K+ DFGL++ E + + G +
Sbjct: 132 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIK 182
Query: 377 --APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
APE +F + SDV+ +G+ + E++ G KN DV
Sbjct: 183 WMAPESI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 13/202 (6%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVK-VMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCY 268
LG+G Y VY G L + +A+K + + + E+A H NIV +LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 269 EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRI 328
E + E +P GSL + S G +T+ I GL+YLH +I
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 329 VHLDIKPHNIRLD-EDFCPKISDFGLAKQTEKKESFI-SMLDTRGTAGYIAPEVFCRHFG 386
VH DIK N+ ++ KISDFG +K+ + GT Y+APE+ +
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGPR 200
Query: 387 GVSHKSDVYSYGMMIHEMVIGR 408
G +D++S G I EM G+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 66/312 (21%), Positives = 117/312 (37%), Gaps = 64/312 (20%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGR----LVAVKVMKNLKDNGE--EFINEVASI 252
+ F++ +G+G + VY GTL D AVK + + D GE +F+ E +
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 253 SRTSHVNIVPFLGFCYEKKKRAL-IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
SH N++ LG C + L + +M +G L +I + + + +
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGL 135
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
+A+G++YL + + VH D+ N LDE F K++DFGLA+ KE +
Sbjct: 136 QVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV---HNK 189
Query: 372 TAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSS 419
T + A E + KSDV+S+G+++ E++ D+
Sbjct: 190 TGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------ 241
Query: 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAK------KMILVSLWCIQTHPPDRPSMTK 473
+ + + + V L C RPS ++
Sbjct: 242 -------TVYLLQGR-------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 281
Query: 474 VVEMLEGSIENL 485
+V +
Sbjct: 282 LVSRISAIFSTF 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 63/295 (21%), Positives = 118/295 (40%), Gaps = 49/295 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK--NLKDNG-EEFINEVASISRTSHVNIVPFL 264
K+G+G + DGR +K + + EE EVA ++ H NIV +
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
E ++ ++ G L + I + + + V I L+++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHDR- 144
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFCR 383
+I+H DIK NI L +D ++ DFG+A+ GT Y++PE+ C
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR---ACIGTPYYLSPEI-CE 198
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGR--------KNADVKVSCSSEYFPNAIYKQIETEYD 435
+ ++KSD+++ G +++E+ + KN +K+ + + + Y
Sbjct: 199 N-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-------ISGSFPPVSLHYS 250
Query: 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM--LEGSIENLQIP 488
+ L +V+ + +P DRPS+ ++E + IE P
Sbjct: 251 YDLRSLVS---------------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-32
Identities = 66/304 (21%), Positives = 112/304 (36%), Gaps = 49/304 (16%)
Query: 207 FSDKLGQGGYADVYKGTL-----PDGRLVAVKVMK--NLKDNGEEFINEVASISRTSHVN 259
LG+G + V G +VAVK +K + + E+ + H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 260 IVPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
I+ + G C + + L+ E++P GSL Y+ H + + A I G+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGM 147
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI- 376
YLH +H D+ N+ LD D KI DFGLAK + + + G
Sbjct: 148 AYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV----REDGDSP 200
Query: 377 ----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-IGRKNADVKVSCSSEYFPNAIYKQIE 431
APE C + SDV+S+G+ ++E++ + Q+
Sbjct: 201 VFWYAPE--CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMT 256
Query: 432 TEYDFQLDGVVTEEE---------KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482
+L ++ E E+ M C +T RP+ ++ +L+
Sbjct: 257 VL---RLTELLERGERLPRPDKCPAEVYHLM----KNCWETEASFRPTFENLIPILKTVH 309
Query: 483 ENLQ 486
E Q
Sbjct: 310 EKYQ 313
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-32
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 210 KLGQGGYADVYKGTLPDGRL---VAVKVMKN---LKDNGEEFINEVASISRTSHVNIVPF 263
+LG G + V KG ++ VAVK++KN +E + E + + + IV
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+G C E + L+ E G L++Y+ + R ++ + + ++ ++ G++YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE- 135
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----AP 378
VH D+ N+ L KISDFGL+K E++ T G AP
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAP 189
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
E ++ S KSDV+S+G+++ E G K ++V
Sbjct: 190 ECI--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-32
Identities = 58/226 (25%), Positives = 90/226 (39%), Gaps = 31/226 (13%)
Query: 206 SFSDKLGQGGYADVYKGTL--PDGRL--VAVKVMK----NLKDNGEEFINEVASISRTSH 257
+KLG G + V +G P G+ VAVK +K + + ++FI EV ++ H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
N++ G ++ E P GSL + H+ TL + AV +A G+
Sbjct: 81 RNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL-----SRYAVQVAEGM 134
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI- 376
YL R +H D+ N+ L KI DFGL + + + M
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM--QEHRKVPFA 189
Query: 377 --APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
APE SH SD + +G+ + EM IG + +
Sbjct: 190 WCAPESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 233
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 72/303 (23%), Positives = 119/303 (39%), Gaps = 66/303 (21%)
Query: 207 FSDKLGQGGYADVYKGTL--PDGR--LVAVKVMKN--LKDNGEEFINEVASISRTSHVNI 260
+G G +V G L P R VA+K +K + +F++E + + + H NI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
+ G + ++ E+M NGSLD ++ H+ + + G+ G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYL 167
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI---- 376
+ VH D+ N+ +D + K+SDFGL++ E T G I
Sbjct: 168 SD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT----TTGGKIPIRW 220
Query: 377 -APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY------- 421
APE F S SDV+S+G+++ E++ N DV S Y
Sbjct: 221 TAPEAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMG 278
Query: 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481
P+A++ QL M L C RP +++V +L+
Sbjct: 279 CPHALH---------QL----------M--------LDCWHKDRAQRPRFSQIVSVLDAL 311
Query: 482 IEN 484
I +
Sbjct: 312 IRS 314
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVP 262
SD LGQG A+V++G G L A+KV + + + E + + +H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 263 FLGFCYEKKKRALIY---EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
E+ EF P GSL + + ++ G E+ V + + G+ +
Sbjct: 72 LFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR---DVVGGMNH 127
Query: 320 LHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGY 375
L IVH +IKP NI D K++DFG A++ E E F+S+ GT Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEY 181
Query: 376 IAPEVFCRHFGGVSH------KSDVYSYGMMIHEMVIGR 408
+ P+++ R H D++S G+ + G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 67/328 (20%), Positives = 115/328 (35%), Gaps = 52/328 (15%)
Query: 165 SSCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSD-----KLGQGGYADV 219
+ Y + Q +F R S + Y R + +LG G Y +V
Sbjct: 15 TENLYFQSMHQLQPRRVSF-RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEV 73
Query: 220 YKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASISR-TSHVNIVPFLGFCYEKKKRA 274
+K DGRL AVK + ++ + EV S + H V +E+
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGGIL 132
Query: 275 LIY-EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI 333
+ E SL Q+ +L V+ L +LH + +VHLD+
Sbjct: 133 YLQTELC-GPSLQQHCEAW-----GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDV 183
Query: 334 KPHNIRLDEDFCPKISDFGLAKQ---TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSH 390
KP NI L K+ DFGL + E G Y+APE+ + G
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPRYMAPEL-LQ--GSYGT 234
Query: 391 KSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI-ETEYDFQLDGVVTEEEKEM 449
+DV+S G+ I E+ + ++Q+ + + ++ E + +
Sbjct: 235 AADVFSLGLTILEVACNME----------LPHGGEGWQQLRQGYLPPEFTAGLSSELRSV 284
Query: 450 AKKMILVSLWCIQTHPPDRPSMTKVVEM 477
M ++ P R + ++ +
Sbjct: 285 LVMM-------LEPDPKLRATAEALLAL 305
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 32/231 (13%)
Query: 202 RMTKSFSDKLGQGGYADVYKGTLPDGR----LVAVKVMKNL--KDNGEEFINEVASISRT 255
R+ +G+G + VY G D A+K + + E F+ E +
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 256 SHVNIVPFLGFCYEKKKRALI-YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
+H N++ +G + + +M +G L Q+I +R + + + +A
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-----QRNPTVKDLISFGLQVA 134
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
RG+EYL + VH D+ N LDE F K++DFGLA+ +E + +
Sbjct: 135 RGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV---QQHRHA 188
Query: 375 YI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADV 413
+ A E + KSDV+S+G+++ E++ D+
Sbjct: 189 RLPVKWTALESL--QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-31
Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 192 PKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTL--PDGRL-VAVKVMKN--LKDNGEEFI 246
K R +LG G + V +G ++ VA+KV+K K + EE +
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 247 NEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV 306
E + + + IV +G C + + L+ E G L +++ + + V
Sbjct: 385 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNV 438
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366
++ ++ G++YL VH ++ N+ L KISDFGL+K +S+ +
Sbjct: 439 AELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495
Query: 367 LDTRGTAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
+AG APE +F S +SDV+SYG+ + E + K +V
Sbjct: 496 ----RSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 69/313 (22%), Positives = 121/313 (38%), Gaps = 66/313 (21%)
Query: 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGR----LVAVKVMKNLKDNGE--EFINEVASI 252
+ F++ +G+G + VY GTL D AVK + + D GE +F+ E +
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 253 SRTSHVNIVPFLGFCYEKKK-RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
SH N++ LG C + ++ +M +G L +I + + + +
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGL 199
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRG 371
+A+G+++L + + VH D+ N LDE F K++DFGLA+ KE
Sbjct: 200 QVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNK 253
Query: 372 TAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSS 419
T + A E + KSDV+S+G+++ E++ D+ V
Sbjct: 254 TGAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
Query: 420 -------EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMT 472
EY P+ +Y ++ M L C RPS +
Sbjct: 312 GRRLLQPEYCPDPLY---------EV----------M--------LKCWHPKAEMRPSFS 344
Query: 473 KVVEMLEGSIENL 485
++V +
Sbjct: 345 ELVSRISAIFSTF 357
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 59/285 (20%), Positives = 108/285 (37%), Gaps = 46/285 (16%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASISRTSHVNIVPFLG 265
+G G Y K DG+++ K + E ++EV + H NIV +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 266 FCYEKKKRAL--IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-- 321
++ L + E+ G L I + ++ L+ V ++ + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEV 380
++H D+KP N+ LD K+ DFGLA+ S T GT Y++PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT---SFAKTFVGTPYYMSPEQ 187
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGRK--NAD------VKVSCSSEYFPNAIYKQIET 432
+ KSD++S G +++E+ A K+ +++I
Sbjct: 188 -MNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKFRRIPY 238
Query: 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
Y +L+ ++T + RPS+ +++E
Sbjct: 239 RYSDELNEIIT---------------RMLNLKDYHRPSVEEILEN 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+G+G + DV G G VAVK +KN + F+ E + +++ H N+V LG
Sbjct: 24 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLG 81
Query: 266 FCYEKKKRALI-YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
E+K I E+M GSL Y+ S G+ L + + ++ + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEG-- 135
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
VH D+ N+ + ED K+SDFGL K+ + L + T APE
Sbjct: 136 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEAL--R 187
Query: 385 FGGVSHKSDVYSYGMMIHEMV 405
S KSDV+S+G+++ E+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 67/322 (20%), Positives = 123/322 (38%), Gaps = 63/322 (19%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNL--KDNGEEFINEVASISRTSH 257
+ LG G + +VY+G + VAVK + + + + +F+ E IS+ +H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARG 316
NIV +G + R ++ E M G L ++ + + +L + +A IA G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 317 LEYLHRGCNIRIVHLDIKPHNI---RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
+YL +H DI N KI DFG+A+ + + +G
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGC 204
Query: 374 GYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEY 421
+ PE F G + K+D +S+G+++ E+ + N +V
Sbjct: 205 AMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------- 254
Query: 422 FPNAIYKQIETEYDFQLD---GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
+ + + ++D + M C Q P DRP+ ++E +
Sbjct: 255 -----LEFVTSGG--RMDPPKNCPGPVYRIM--------TQCWQHQPEDRPNFAIILERI 299
Query: 479 EGSIENLQIPPKPSLSLPTGYA 500
E ++ P + +LP Y
Sbjct: 300 EYCTQD---PDVINTALPIEYG 318
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 8e-31
Identities = 40/222 (18%), Positives = 78/222 (35%), Gaps = 28/222 (12%)
Query: 207 FSDKLGQGGYADVYKGT------LPDGRLVAVKVMKNLKDNGEEF---INEVASISRTSH 257
LG+G +A VY+ T + + +KV K N EF + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--PANPWEFYIGTQLMERLKPSMQ 126
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+ F + L+ E G+L I ++++ K + + A+ + +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS-FAMRMLYMI 185
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCP-----------KISDFGLAKQTEKKESFISM 366
E +H + I+H DIKP N L F + D G + +
Sbjct: 186 EQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
T+G+ E+ +++ D + ++ M+ G
Sbjct: 243 TAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGT 282
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 52/238 (21%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 192 PKRFSYSDVR---RMTKSFSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNLKDNG 242
P+ FS + V R +LG+G + V+ + LVAVK +K ++
Sbjct: 27 PQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA 86
Query: 243 E-EFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY---------IYDH 292
+F E ++ H +IV F G C E + +++E+M +G L+++ +
Sbjct: 87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 293 ESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352
L + +A +A G+ YL + VH D+ N + + KI DFG
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 353 LAKQTEKKESFISMLDTRGTAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV 405
+++ + + G + PE + + +SDV+S+G+++ E+
Sbjct: 204 MSRDIYSTDYY-----RVGGRTMLPIRWMPPESIL--YRKFTTESDVWSFGVVLWEIF 254
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 48/234 (20%), Positives = 89/234 (38%), Gaps = 40/234 (17%)
Query: 202 RMTKSFS--DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASISRT 255
R T F +K+G G + V+K DG + A+K K + + EV + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 256 S-HVNIVPFLGFCYEKKKRALIY-EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
H ++V + + + LI E+ GSL I ++ + + + + +
Sbjct: 68 GQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMS--YFKEAELKDLLLQV 124
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP-------------------KISDFGLA 354
RGL Y+H ++ +VH+DIKP NI + P KI D G
Sbjct: 125 GRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ + G + ++A EV + K+D+++ + +
Sbjct: 182 TRISSPQVEE------GDSRFLANEV-LQENYTHLPKADIFALALTVVCAAGAE 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 55/304 (18%), Positives = 106/304 (34%), Gaps = 73/304 (24%)
Query: 206 SFSDKLGQGGYADVYKGTL--------PDGRLVAVKVMKNLK-DNGEEFINEVASISRTS 256
F++ LGQG + ++KG V +KV+ + E F + +S+ S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
H ++V G C + L+ EF+ GSLD Y+ + K + ++A +A
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-----KNCINILWKLEVAKQLAAA 125
Query: 317 LEYLHRGCNIRIVHLDIKPHNI--------RLDEDFCPKISDFGLAKQTEKKESFISMLD 368
+ +L ++H ++ NI + K+SD G++ K+
Sbjct: 126 MHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 369 TRGTAGY------IAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVKV 415
+ PE + ++ +D +S+G + E+ +
Sbjct: 176 -----ILQERIPWVPPECI-ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-- 227
Query: 416 SCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475
+ E + QL + E+A + C+ P RPS ++
Sbjct: 228 -----------LQFYEDRH--QLP---APKAAELANLI----NNCMDYEPDHRPSFRAII 267
Query: 476 EMLE 479
L
Sbjct: 268 RDLN 271
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 51/297 (17%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLG 265
LG G V GR VAVK M L D + + E+ ++ + H N++ +
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRYYC 76
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHE-SSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ + E N +L + S + + + IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 325 NIRIVHLDIKPHNI-------------RLDEDFCPKISDFGLAKQ-TEKKESFISMLDTR 370
+++I+H D+KP NI E+ ISDFGL K+ + SF + L+
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 371 -GTAGYIAPEVFCRHFGGVSHKS-----DVYSYGMMIHEMVIG-------RKNADVKVSC 417
GT+G+ APE+ + + D++S G + + ++ + + + +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII- 251
Query: 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474
I+ E D + E ++ +M I P RP+ KV
Sbjct: 252 ------RGIFS--LDEMKCLHDRSLIAEATDLISQM-------IDHDPLKRPTAMKV 293
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 70/288 (24%), Positives = 112/288 (38%), Gaps = 58/288 (20%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+G+G + DV G G VAVK +KN + F+ E + +++ H N+V LG
Sbjct: 197 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 267 CYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
E+K ++ E+M GSL Y+ S G+ L + + ++ + +EYL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 307
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
VH D+ N+ + ED K+SDFGL K+ + + + APE
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEAL--RE 360
Query: 386 GGVSHKSDVYSYGMMIHEMVI-------GRKNADVKVSCSSEY-------FPNAIYKQIE 431
S KSDV+S+G+++ E+ DV Y P A+Y
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY---- 416
Query: 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ M C RP+ ++ E LE
Sbjct: 417 -----DV----------M--------KNCWHLDAATRPTFLQLREQLE 441
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 75/310 (24%), Positives = 122/310 (39%), Gaps = 54/310 (17%)
Query: 184 VRNYGSLAPKRFSYSDVRRMTK--SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMK---- 236
+ ++ P F + LG+G + +V G+ AVKV+
Sbjct: 5 MMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV 64
Query: 237 NLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSN 296
K + E + EV + + H NI+ F +K L+ E G L I + +
Sbjct: 65 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 297 GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGL 353
E +I + G+ Y+H +IVH D+KP N+ L +D +I DFGL
Sbjct: 125 -----E-VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175
Query: 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413
+ E + + GTA YIAPEV + K DV+S G++++ ++ G
Sbjct: 176 STHFEASKKMKDKI---GTAYYIAPEVLHGTYD---EKCDVWSTGVILYILLSG------ 223
Query: 414 KVSCSSEYFP------NAIYKQIET-EYDFQLD--GVVTEEEKEMAKKMILVSLWCIQTH 464
P I K++E +Y F+L V+E K++ +KM+
Sbjct: 224 -------CPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV------- 269
Query: 465 PPDRPSMTKV 474
P R S
Sbjct: 270 PSMRISARDA 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 48/282 (17%), Positives = 111/282 (39%), Gaps = 47/282 (16%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVM--KNLKDNG-EEFINEVASISRTSH--VNIVPF 263
++G GG + V++ ++ A+K + + + + + NE+A +++ I+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVY--QIAVGIARGLEYLH 321
+ + ++ E N L+ ++ R Y + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNML----EAVHTIH 172
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
+ IVH D+KP N + + K+ DFG+A Q + + + G Y+ PE
Sbjct: 173 Q---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 382 CRHFGG---------VSHKSDVYSYGMMIHEMVIGR---KNADVKVSCSSEYFPNAIYKQ 429
+S KSDV+S G +++ M G+ + ++ + ++
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------SKLHAI 280
Query: 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471
I+ ++ + + ++ +++ K C++ P R S+
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLKC-------CLKRDPKQRISI 315
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 48/221 (21%), Positives = 80/221 (36%), Gaps = 49/221 (22%)
Query: 209 DKLGQGGYADVYKGTLPD---GRLVAVKVMK-NLKDNG---EEFINEVASISRTSHVNIV 261
+G+GG DVY+ D R+VA+K+M L + E + R ++V
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 262 PFLGFCYEKKKRALIY-------------EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQ 308
P I+ + L + L
Sbjct: 98 P-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQ------GPLAPPRAVA 138
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
I I L+ H H D+KP NI + D + DFG+A T + ++ L
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLG 193
Query: 369 TR-GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT Y+APE F ++++D+Y+ +++E + G
Sbjct: 194 NTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGS 232
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 80/323 (24%), Positives = 124/323 (38%), Gaps = 53/323 (16%)
Query: 170 HKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTK--SFSDKLGQGGYADVYKGT-LPD 226
H H E + + P F S +++ KLG G Y +V
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 227 GRLVAVKVM---KNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283
A+K++ + + + EVA + H NI+ F +K+ L+ E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL--- 340
L I N E I + G+ YLH IVH D+KP N+ L
Sbjct: 122 ELFDEIIHRMKFN-----E-VDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESK 172
Query: 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMM 400
++D KI DFGL+ E ++ L GTA YIAPEV + + K DV+S G++
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPEVLRKKYD---EKCDVWSIGVI 226
Query: 401 IHEMVIGRKNADVKVSCSSEYFP------NAIYKQIET-EYDFQLD--GVVTEEEKEMAK 451
+ ++ G Y P I +++E +Y F V+E K++ K
Sbjct: 227 LFILLAG-------------YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 452 KMILVSLWCIQTHPPDRPSMTKV 474
+M +Q R S +
Sbjct: 274 QM-------LQFDSQRRISAQQA 289
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-30
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
+KLG+G Y VYK G++VA+K + ++ + +E I E++ + + ++V + G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKYYG-S 92
Query: 268 YEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARGLEYLHRG 323
Y K ++ E+ GS+ D K E +IA +GLEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTE----DEIATILQSTLKGLEYLH-- 142
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPE 379
+R +H DIK NI L+ + K++DFG+A Q K+ + I GT ++APE
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPE 195
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
V G + +D++S G+ EM G
Sbjct: 196 VIQE--IGYNCVADIWSLGITAIEMAEG 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 209 DKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEF---INEVASISRTSHVNIVPFL 264
+LG G V+K + P G ++A K++ +L+ I E+ + + IV F
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G Y + ++ E M GSLDQ + R E + + ++++ + +GL YL
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPE-QILGKVSIAVIKGLTYLRE-- 149
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFCR 383
+I+H D+KP NI ++ K+ DFG++ Q SM ++ GT Y++PE
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQG 204
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
S +SD++S G+ + EM +GR +P + + + G
Sbjct: 205 --THYSVQSDIWSMGLSLVEMAVGR-------------YP---IPPPDAKELELMFGCQV 246
Query: 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLPTG 498
E + + D + E+L+ I +P LP+G
Sbjct: 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD------YIVNEPPPKLPSG 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 67/322 (20%), Positives = 122/322 (37%), Gaps = 63/322 (19%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNLKDNGE--EFINEVASISRTSH 257
+ LG G + +VY+G + VAVK + + + +F+ E IS+ +H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARG 316
NIV +G + R ++ E M G L ++ + + +L + +A IA G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 317 LEYLHRGCNIRIVHLDIKPHNI---RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
+YL +H DI N KI DFG+A+ + + +G
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGC 245
Query: 374 GYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSSEY 421
+ PE F G + K+D +S+G+++ E+ + N +V
Sbjct: 246 AMLPVKWMPPEAFM--EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------- 295
Query: 422 FPNAIYKQIETEYDFQLD---GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478
+ + + ++D + M C Q P DRP+ ++E +
Sbjct: 296 -----LEFVTSGG--RMDPPKNCPGPVYRIM--------TQCWQHQPEDRPNFAIILERI 340
Query: 479 EGSIENLQIPPKPSLSLPTGYA 500
E ++ P + +LP Y
Sbjct: 341 EYCTQD---PDVINTALPIEYG 359
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-30
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF---INEVASISRTS-HVNIVPF 263
+LG+G Y V K +P G+++AVK + N +E + ++ RT V F
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G + + + E M + SLD+ Y G+ E + +IAV I + LE+LH
Sbjct: 72 YGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPE-DILGKIAVSIVKALEHLHS- 127
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ---TEKKESFISMLDTRGTAGYIAPEV 380
+ ++H D+KP N+ ++ K+ DFG++ K+ G Y+APE
Sbjct: 128 -KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA------GCKPYMAPER 180
Query: 381 FCRHFGGV--SHKSDVYSYGMMIHEMVIGR 408
S KSD++S G+ + E+ I R
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 68/309 (22%)
Query: 207 FSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNLKDNGE--EFINEVASISRTSHV 258
S +LGQG + VY+G VA+K + E EF+NE + + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYI----YDHESSNGKRTLEWRTVYQIAVGIA 314
++V LG + + +I E M G L Y+ ++ + Q+A IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
G+ YL+ + VH D+ N + EDF KI DFG+ + + + + +G G
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGGKG 200
Query: 375 YI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADVKVSCSS--- 419
+ +PE G + SDV+S+G+++ E+ G N V
Sbjct: 201 LLPVRWMSPESLK--DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 420 ----EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475
+ P+ +++ ++ W Q +P RPS +++
Sbjct: 259 LDKPDNCPDMLFE-------------------------LMRMCW--QYNPKMRPSFLEII 291
Query: 476 EMLEGSIEN 484
++ +E
Sbjct: 292 SSIKEEMEP 300
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-30
Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 42/281 (14%)
Query: 158 NSSCKNCSSCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTK-------SFSDK 210
+ + K+ + +Y + + +Y+
Sbjct: 338 RALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRC 397
Query: 211 LGQGGYADVYKGTL--PDGR--LVAVKVMKN--LKDNGEEFINEVASISRTSHVNIVPFL 264
+G+G + DV++G P+ VA+K KN E+F+ E ++ + H +IV +
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G + +I E G L ++ K +L+ ++ A ++ L YL
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVR-----KFSLDLASLILYAYQLSTALAYLES-- 509
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE 379
R VH DI N+ + + C K+ DFGL++ E + + G + APE
Sbjct: 510 -KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPE 562
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMV-------IGRKNADV 413
+F + SDV+ +G+ + E++ G KN DV
Sbjct: 563 SI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 601
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
LG+G + +VY ++A+KV+ L+ G + EV S H NI+ G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRT---VYQIAVGIARGLEYLHR 322
+ ++ + LI E+ P G++ Y K E RT + ++A L Y H
Sbjct: 77 YFHDATRVYLILEYAPLGTV----YRELQKLSKFD-EQRTATYITELA----NALSYCHS 127
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVF 381
R++H DIKP N+ L KI+DFG + S GT Y+ PE+
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-----SRRTDLCGTLDYLPPEMI 179
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR-----KNADVKVSCSSEYFPNAIYKQIETEYDF 436
K D++S G++ +E ++G+ YK+I + +F
Sbjct: 180 EGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANT------------YQETYKRI-SRVEF 224
Query: 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
VTE +++ ++ ++ +P RP + +V+E
Sbjct: 225 TFPDFVTEGARDLISRL-------LKHNPSQRPMLREVLE 257
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 76/308 (24%), Positives = 127/308 (41%), Gaps = 54/308 (17%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVM---KNLKDNGEEFINEVASISRTSHVNIV 261
+ LG+G + +V K + AVKV+ + + EV + + H NI+
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
+ ++ E G L I + + E +I + G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS-----E-HDAARIIKQVFSGITYMH 138
Query: 322 RGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
IVH D+KP NI L ++D KI DFGL+ ++ + GTA YIAP
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAP 192
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------NAIYKQIET 432
EV + K DV+S G++++ ++ G P I K++ET
Sbjct: 193 EVLRGTYD---EKCDVWSAGVILYILLSG-------------TPPFYGKNEYDILKRVET 236
Query: 433 -EYDFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE---MLEGSIENLQ 486
+Y F L ++++ K++ +KM + HP R + T+ +E + + S E
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKM-------LTFHPSLRITATQCLEHPWIQKYSSETPT 289
Query: 487 IPPKPSLS 494
I PSL
Sbjct: 290 ISDLPSLE 297
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 70/309 (22%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNL--KDNGEEFINEVASISRTSH 257
F ++LG+ + VYKG L VA+K +K+ EEF +E +R H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH----------ESSNGKRTLEWRTVY 307
N+V LG + + ++I+ + +G L +++ + K LE
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
+ IA G+EYL +VH D+ N+ + + KISD GL ++ + +
Sbjct: 132 HLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY---- 184
Query: 368 DTRGTAGYI-----APE-VFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNADVK 414
+ APE + F S SD++SYG+++ E+ G N DV
Sbjct: 185 -KLLGNSLLPIRWMAPEAIMYGKF---SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV- 239
Query: 415 VSCSSEYFPNAIYKQIETEYDFQLDGVVTEE----EKEMAKKMILVSLWCIQTHPPDRPS 470
+ I + V + M + C P RP
Sbjct: 240 ------------VEMIR-------NRQVLPCPDDCPAWVYALM----IECWNEFPSRRPR 276
Query: 471 MTKVVEMLE 479
+ L
Sbjct: 277 FKDIHSRLR 285
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVM----KNLKDNGEEFINEVASISRTSHVNIVPF 263
++G G + VY + + +VA+K M K + ++ I EV + + H N + +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 264 LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARGLEY 319
G CY ++ A L+ E+ + D K+ L +IA G +GL Y
Sbjct: 120 RG-CYLREHTAWLVMEYCLGSASDLL------EVHKKPL---QEVEIAAVTHGALQGLAY 169
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
LH + ++H D+K NI L E K+ DFG A SF+ GT ++APE
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPE 220
Query: 380 V-FCRHFGGVSHKSDVYSYGMMIHEMVIG 407
V G K DV+S G+ E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNLKDNGE-EFINEVASISRTSHV 258
+LG+G + V+ + LVAVK +K+ +F E ++ H
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH----------ESSNGKRTLEWRTVYQ 308
+IV F G C + +++E+M +G L++++ H + K L +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
IA IA G+ YL VH D+ N + + KI DFG+++ + +
Sbjct: 138 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----- 189
Query: 369 TRGTAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV 405
G + PE + + +SDV+S+G+++ E+
Sbjct: 190 RVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIF 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGF 266
+ +G G Y VYKG + G+L A+KVM D EE E+ + + S H NI + G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG- 88
Query: 267 CYEKKKRA-------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARG 316
+ KK L+ EF GS+ I +++ G E IA I RG
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKE----EWIAYICREILRG 141
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGT 372
L +LH +++H DIK N+ L E+ K+ DFG++ Q ++ +FI GT
Sbjct: 142 LSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GT 192
Query: 373 AGYIAPEVFCRHFGGVS---HKSDVYSYGMMIHEMVIG 407
++APEV + KSD++S G+ EM G
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 77/359 (21%), Positives = 139/359 (38%), Gaps = 75/359 (20%)
Query: 184 VRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDG---RLVAVKVMKNLKD 240
++G P Y + F D +G+G + V K + A+K MK
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 241 NGE--EFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH----- 292
+ +F E+ + + H NI+ LG C + L E+ P+G+L ++
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 293 -----ESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347
+++ TL + + A +ARG++YL + +H D+ NI + E++ K
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAK 182
Query: 348 ISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE-VFCRHFGGVSHKSDVYSYGMMI 401
I+DFGL++ E + T G + A E + + + SDV+SYG+++
Sbjct: 183 IADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVY---TTNSDVWSYGVLL 231
Query: 402 HEMVI-------GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEK------E 448
E+V G A++ Y+++ Y +L EK E
Sbjct: 232 WEIVSLGGTPYCGMTCAEL-------------YEKLPQGY--RL-------EKPLNCDDE 269
Query: 449 MAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLPTGYAKQSSPTS 507
+ M C + P +RPS +++ L +E + +L YA
Sbjct: 270 VYDLM----RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 41/250 (16%)
Query: 186 NYGSLAPKRFSYSD---VRRMTKSFSDKLGQGGYADVYKGTLPDGR------LVAVKVMK 236
NY + P + Y R SF LG G + V + T VAVK++K
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 237 NLKDNGE--EFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH- 292
E ++E+ +S +H+NIV LG C +I E+ G L ++
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 293 -----------ESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341
+ + L+ + + +A+G+ +L +H D+ NI L
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179
Query: 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE-VFCRHFGGVSHKSDVY 395
KI DFGLA+ + ++ + APE +F + + +SDV+
Sbjct: 180 HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVY---TFESDVW 231
Query: 396 SYGMMIHEMV 405
SYG+ + E+
Sbjct: 232 SYGIFLWELF 241
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF---INEVASISRTS-HVNIVPF 263
++G+G Y V K P G+++AVK + + +E + ++ + R+S IV F
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G + + + E M + S D+ Y + S + + +I + + L +L
Sbjct: 87 YGALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILGKITLATVKALNHLKE- 143
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR--GTAGYIAPEVF 381
N++I+H DIKP NI LD K+ DFG++ Q S+ TR G Y+APE
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDAGCRPYMAPERI 197
Query: 382 --CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
G +SDV+S G+ ++E+ GR
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK--NLKDNGEEFINEVASISRTSHVNIVPFLG 265
+ +G G A V P VA+K + + + +E + E+ ++S+ H NIV +
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARGLEYLHR 322
K + L+ + + GS+ I H + G+ IA + GLEYLH+
Sbjct: 81 SFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ---------TEKKESFISMLDTRGTA 373
+H D+K NI L ED +I+DFG++ + +++F+ GT
Sbjct: 140 ---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTP 190
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
++APEV + G K+D++S+G+ E+ G
Sbjct: 191 CWMAPEVMEQV-RGYDFKADIWSFGITAIELATGA 224
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (298), Expect = 1e-28
Identities = 62/267 (23%), Positives = 107/267 (40%), Gaps = 33/267 (12%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVPF 263
++LG GG+ V + G VA+K + N E + E+ + + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 264 LGFCYEKKKRA------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+K A L E+ G L +Y+ E+ G + RT+ I+ L
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD---ISSAL 134
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISDFGLAKQTEKKESFISMLDTR-GTA 373
YLH RI+H D+KP NI L + KI D G AK+ ++ E + GT
Sbjct: 135 RYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTL 187
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433
Y+APE+ + + D +S+G + E + G + P + ++ +
Sbjct: 188 QYLAPELLEQK--KYTVTVDYWSFGTLAFECITGF------RPFLPNWQPVQWHGKVREK 239
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWC 460
+ VV ++ K ++
Sbjct: 240 SNE--HIVVYDDLTGAVKFSSVLPTPN 264
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+LG G + VYK G L A KV++ ++ E++I E+ ++ H IV LG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARGLEYLHRG 323
Y K ++ EF P G++D + R L T QI V + L +LH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIM-----LELDRGL---TEPQIQVVCRQMLEALNFLH-- 134
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPE 379
+ RI+H D+K N+ + + +++DFG++ + +K++SFI GT ++APE
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPE 187
Query: 380 VFCRHF---GGVSHKSDVYSYGMMIHEMVIG 407
V +K+D++S G+ + EM
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 81/318 (25%), Positives = 123/318 (38%), Gaps = 64/318 (20%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKV--------------MKNLKDNGEEFINEVA 250
KLG G Y +V A+KV KN++ EE NE++
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 251 SISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIA 310
+ H NI+ +KK L+ EF G L + I + + E I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD-----E-CDAANIM 152
Query: 311 VGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISML 367
I G+ YLH IVH DIKP NI L + KI DFGL+ K L
Sbjct: 153 KQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209
Query: 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP---- 423
GTA YIAPEV + + K DV+S G++++ ++ G Y P
Sbjct: 210 ---GTAYYIAPEVLKKKYN---EKCDVWSCGVIMYILLCG-------------YPPFGGQ 250
Query: 424 --NAIYKQIET-EYDFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM- 477
I K++E +Y F + +++E KE+ K M+ R + + +
Sbjct: 251 NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYD-------YNKRCTAEEALNSR 303
Query: 478 -LEGSIENLQIPPKPSLS 494
++ N+ + +L
Sbjct: 304 WIKKYANNINKSDQKTLC 321
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFI-NEVASISRTSHVNIVPFLGF 266
K+G+G V GR VAVK+M K E + NEV + H N+V
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARGLEYLHRG 323
++ ++ EF+ G+L + S + E QIA + + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV-----SQVRLN-E----EQIATVCEAVLQALAYLH-- 158
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPE 379
++H DIK +I L D K+SDFG Q K++S + GT ++APE
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPE 211
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
V R + + D++S G+M+ EMV G
Sbjct: 212 VISR--SLYATEVDIWSLGIMVIEMVDG 237
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 68/324 (20%), Positives = 125/324 (38%), Gaps = 48/324 (14%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVM-KNLKDNGEEFINEVASISR-TSHVNIVPFLGF 266
L +GG+A VY+ + GR A+K + N ++ I EV + + + H NIV F
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 267 CYEKKKRA-------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
K+ + L+ + G L +++ ES + L TV +I R +++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES---RGPLSCDTVLKIFYQTCRAVQH 151
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA---------KQTEKKESFISMLDTR 370
+HR I+H D+K N+ L K+ DFG A + ++ + + TR
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 371 -GTAGYIAPEVFCRHFG-GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428
T Y PE+ + + K D+++ G +++ + + F +
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-----------FEDGAKL 259
Query: 429 QI-ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE---- 483
+I +Y + + M +Q +P +R S+ +VV L+
Sbjct: 260 RIVNGKYSIPPHDTQYTVFHSLIRAM-------LQVNPEERLSIAEVVHQLQEIAAARNV 312
Query: 484 NLQIPPKPSLSLPTGYAKQSSPTS 507
N + P L GY +
Sbjct: 313 NPKSPITELLEQNGGYGSATLSRG 336
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMK-NLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
K+GQG VY + G+ VA++ M + E INE+ + + NIV +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-S 85
Query: 268 YEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV---GIARGLEYLHRG 323
Y ++ E++ GSL + + G QIA + LE+LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEG----------QIAAVCRECLQALEFLH-- 133
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPE 379
+ +++H DIK NI L D K++DFG Q K+ + + GT ++APE
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPE 186
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIG 407
V R K D++S G+M EM+ G
Sbjct: 187 VVTR--KAYGPKVDIWSLGIMAIEMIEG 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 58/302 (19%), Positives = 98/302 (32%), Gaps = 70/302 (23%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMK------NLKDNGEEFINEVASISRTSHVN 259
+GQG Y V + A+K+M + E EV + + H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG------- 312
I +++ L+ E G L + + + QI
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 313 ---------------------------IARGLEYLHRGCNIRIVHLDIKPHNIRL--DED 343
I L YLH N I H DIKP N ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 344 FCPKISDFGLAKQTEKKES--FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMI 401
F K+ DFGL+K+ K + + M GT ++APEV K D +S G+++
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 402 HEMVIGRKNADVKVSCSSEYFP------NAIYKQIET-EYDFQLD--GVVTEEEKEMAKK 452
H +++G P Q+ + F+ V++ +++
Sbjct: 267 HLLLMG-------------AVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN 313
Query: 453 MI 454
++
Sbjct: 314 LL 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 57/246 (23%), Positives = 97/246 (39%), Gaps = 37/246 (15%)
Query: 186 NYGSLAPKRFSYSD---VRRMTKSFSDKLGQGGYADVYKGTLPDGR------LVAVKVMK 236
+Y + P + Y++ R F LG G + V + T VAVK++K
Sbjct: 26 SYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85
Query: 237 NLKDNGE--EFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY----- 288
+ E ++E+ +S H NIV LG C +I E+ G L +
Sbjct: 86 STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 289 ---IYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC 345
D + T R + + +A+G+ +L +H D+ N+ L
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202
Query: 346 PKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE-VFCRHFGGVSHKSDVYSYGM 399
KI DFGLA+ ++ + APE +F + + +SDV+SYG+
Sbjct: 203 AKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVY---TVQSDVWSYGI 254
Query: 400 MIHEMV 405
++ E+
Sbjct: 255 LLWEIF 260
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+K+G+G + +V+KG ++VA+K++ + +D E+ E+ +S+ + + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 266 FCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
Y K + +I E++ GS + L+ + I I +GL+YLH
Sbjct: 88 -SYLKDTKLWIIMEYLGGGSALDLLE-------PGPLDETQIATILREILKGLDYLH--- 136
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGYIAPEV 380
+ + +H DIK N+ L E K++DFG+A Q K+ +F+ GT ++APEV
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 190
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIG 407
+ K+D++S G+ E+ G
Sbjct: 191 IKQ--SAYDSKADIWSLGITAIELARG 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 58/265 (21%), Positives = 105/265 (39%), Gaps = 38/265 (14%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVP 262
F KLG G + DV+ G +K + + E+ E+ + H NI+
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+ ++ E G L + I ++ + E V ++ + L Y H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS-E-GYVAELMKQMMNALAYFH- 141
Query: 323 GCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
+ +VH D+KP NI KI DFGLA+ + E + GTA Y+APE
Sbjct: 142 --SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPE 196
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------NAIYKQIET- 432
VF R K D++S G++++ ++ G P + ++
Sbjct: 197 VFKRDVT---FKCDIWSAGVVMYFLLTG-------------CLPFTGTSLEEVQQKATYK 240
Query: 433 EYDFQLD-GVVTEEEKEMAKKMILV 456
E ++ ++ +T + ++ K+M+
Sbjct: 241 EPNYAVECRPLTPQAVDLLKQMLTK 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 62/280 (22%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 211 LGQGGYADVYKG-TLPDGRLVAVKVM--KNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
LG+G + +VY + ++A+KV+ L+ G + E+ S H NI+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRT---VYQIAVGIARGLEYLHR 322
+ +++K+ L+ EF P G L Y +G+ E R+ + ++A L Y H
Sbjct: 82 YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD-EQRSATFMEELA----DALHYCHE 132
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVF 381
+++H DIKP N+ + KI+DFG + T GT Y+ PE+
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRTMCGTLDYLPPEMI 184
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR-----KNADVKVSCSSEYFPNAIYKQIETEYDF 436
K D++ G++ +E ++G + +++I D
Sbjct: 185 EGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPS------------HTETHRRIVNV-DL 229
Query: 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ +++ K++ K+ ++ HPP R + V+E
Sbjct: 230 KFPPFLSDGSKDLISKL-------LRYHPPQRLPLKGVME 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/322 (19%), Positives = 120/322 (37%), Gaps = 64/322 (19%)
Query: 188 GSLAPKRFSYSDVR-----RMTKSFSDK------LGQGGYADVYKGT-LPDGRLVAVKVM 235
K F + D+ K+ D+ LG G +V + VA++++
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 236 K---------NLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286
D E+ + + +H I+ F ++ + ++ E M G L
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF 227
Query: 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DED 343
+ ++ YQ+ ++YLH I+H D+KP N+ L +ED
Sbjct: 228 DKVVGNKRLKEATCK--LYFYQML----LAVQYLHE---NGIIHRDLKPENVLLSSQEED 278
Query: 344 FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF-GGVSHKSDVYSYGMMIH 402
KI+DFG +K + M GT Y+APEV G + D +S G+++
Sbjct: 279 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
Query: 403 EMVIGRKNADVKVSC-----SSEYFPNAIYKQIET-EYDFQLD--GVVTEEEKEMAKKMI 454
+ S ++ QI + +Y+F + V+E+ ++ KK++
Sbjct: 336 ICL-----------SGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 384
Query: 455 LVSLWCIQTHPPDRPSMTKVVE 476
+V P R + + +
Sbjct: 385 VV-------DPKARFTTEEALR 399
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 18/211 (8%)
Query: 209 DKLGQG--GYADVYKGT-LPDGRLVAVKVM---KNLKDNGEEFINEVASISRTSHVNIVP 262
+G+G V P G V V+ + + E+ +H NIVP
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+ + ++ FM GS I H + + I G+ + L+Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHF----MDGMNELAIAYILQGVLKALDYIHH 146
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTR-GTAGYIA 377
+ VH +K +I + D +S +++ +++
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
PEV ++ G KSD+YS G+ E+ G
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 45/221 (20%), Positives = 83/221 (37%), Gaps = 31/221 (14%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMK------------------NLKDNGEEFINEVAS 251
L QG + + D + A+K + ++K ++F NE+
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 252 ISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH---ESSNGKRTLEWRTVYQ 308
I+ + + G + +IYE+M N S+ ++ + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLD 368
I + Y+H NI H D+KP NI +D++ K+SDFG ++ +
Sbjct: 157 IK-SVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYMVD-----KKIK 208
Query: 369 TR-GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT ++ PE F K D++S G+ ++ M
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 68/324 (20%), Positives = 117/324 (36%), Gaps = 76/324 (23%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNLKDNGE--EFINEVASISRTSH 257
+ +G+G + V++ P +VAVK++K +F E A ++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH------------------ESSNGKR 299
NIV LG C K L++E+M G L++++ SS G
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 300 TLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359
L IA +A G+ YL + VH D+ N + E+ KI+DFGL++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 360 KESFISMLDTRGTAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV-------IG 407
+ + I PE + + +SDV++YG+++ E+ G
Sbjct: 227 ADYY-----KADGNDAIPIRWMPPESIF--YNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 408 RKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE----EKEMAKKMILVSLWCIQT 463
+ +V + DG + E+ M C
Sbjct: 280 MAHEEV--------------------IYYVRDGNILACPENCPLELYNLM----RLCWSK 315
Query: 464 HPPDRPSMTKVVEMLEGSIENLQI 487
P DRPS + +L+ E +
Sbjct: 316 LPADRPSFCSIHRILQRMCERAEG 339
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 65/266 (24%), Positives = 109/266 (40%), Gaps = 44/266 (16%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVM---KNLKDNGEEFINEVASISRTSHVNIVP 262
LG+G + +V K + AVKV+ + + EV + + H NI+
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+ ++ E G L I + + + Q+ GI Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGIT----YMH- 138
Query: 323 GCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
IVH D+KP NI L ++D KI DFGL+ ++ + GTA YIAPE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYYIAPE 193
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------NAIYKQIET- 432
V + K DV+S G++++ ++ G P I K++ET
Sbjct: 194 VLRGTYD---EKCDVWSAGVILYILLSG-------------TPPFYGKNEYDILKRVETG 237
Query: 433 EYDFQLD--GVVTEEEKEMAKKMILV 456
+Y F L ++++ K++ +KM+
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTF 263
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 63/337 (18%), Positives = 111/337 (32%), Gaps = 90/337 (26%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKV--MKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+G+GG+ V++ D A+K + N + E+ + EV ++++ H IV +
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNG---------------------------- 297
E E D+ SS
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 298 -------------KRTL-------------EWRTVYQIAVGIARGLEYLHRGCNIRIVHL 331
K L E I + IA +E+LH + ++H
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188
Query: 332 DIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR----------GTAGYIAPEVF 381
D+KP NI D K+ DFGL ++ E ++L GT Y++PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI-ETEYDFQLDG 440
+ SHK D++S G+++ E++ +V I + ++
Sbjct: 249 HGN--NYSHKVDIFSLGLILFELLYSFSTQMERVR---------IITDVRNLKFPLLFTQ 297
Query: 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477
+E M+ + P +RP T ++E
Sbjct: 298 KYPQE-----HMMV---QDMLSPSPTERPEATDIIEN 326
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 66/331 (19%), Positives = 130/331 (39%), Gaps = 77/331 (23%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGR--------LVAVKVMKNLKDNGE--EFINEVASISR- 254
+ LG+G + V VAVK++K+ + + ++E+ +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY----------IYDHESSNGKRTLEWR 304
H NI+ LG C + +I E+ G+L +Y + + + ++
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364
+ +ARG+EYL + + +H D+ N+ + E+ KI+DFGLA+ + +
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 213
Query: 365 SMLDTRGTAGYI-----APE-VFCRHFGGVSHKSDVYSYGMMIHEMVI-------GRKNA 411
+ T G + APE +F R + +H+SDV+S+G+++ E+ G
Sbjct: 214 ----KKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 412 DVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAK------KMILVSLWCIQTHP 465
++ +K ++ + M K ++ ++ C P
Sbjct: 267 EL-------------FKLLKEGH-------------RMDKPANCTNELYMMMRDCWHAVP 300
Query: 466 PDRPSMTKVVEMLEGSIENLQIPPKPSLSLP 496
RP+ ++VE L+ + LS P
Sbjct: 301 SQRPTFKQLVEDLDRILTLTTNEEYLDLSQP 331
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 30/236 (12%), Positives = 62/236 (26%), Gaps = 45/236 (19%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINE--------------------- 248
LGQ + T G V V + I +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 249 -----VASISRTSHVNIVPF--LGFCYEKKKRALIYEFMP-----NGSLDQYIYDHESSN 296
+ + + P + + + H S++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 297 GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356
+L Q+ + + R L LH +VH ++P +I LD+ ++ F
Sbjct: 206 K--SLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 357 TEKKESFISMLDTR-GTAGYIAPEVFCRHFGG---VSHKSDVYSYGMMIHEMVIGR 408
S +S + A + ++ D ++ G+ I+ +
Sbjct: 260 -RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 61/255 (23%), Positives = 98/255 (38%), Gaps = 46/255 (18%)
Query: 186 NYGSLAPKRFSYSD---VRRMTKSFSDKLGQGGYADVYKGTLPDGR------LVAVKVMK 236
Y + + + Y R F LG G + V T VAVK++K
Sbjct: 25 EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 84
Query: 237 NLKDNGE--EFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH- 292
D+ E ++E+ +++ SH NIV LG C LI+E+ G L Y+
Sbjct: 85 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 293 ----------------ESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPH 336
E L + + A +A+G+E+L VH D+
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR 201
Query: 337 NIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI-----APE-VFCRHFGGVSH 390
N+ + KI DFGLA+ ++ + APE +F + +
Sbjct: 202 NVLVTHGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIY---TI 253
Query: 391 KSDVYSYGMMIHEMV 405
KSDV+SYG+++ E+
Sbjct: 254 KSDVWSYGILLWEIF 268
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/226 (23%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 207 FSDKLGQGGYADVYKGTLPDGR--------LVAVKVMKNLKDNGE--EFINEVASISR-T 255
LG+G + V VAVK++K+ + + ++E+ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 256 SHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY----------IYDHESSNGKRTLEWRT 305
H NI+ LG C + +I E+ G+L +Y + + + ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+ +ARG+EYL + + +H D+ N+ + E+ KI+DFGLA+ + +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 259
Query: 366 MLDTRGTAGYI-----APE-VFCRHFGGVSHKSDVYSYGMMIHEMV 405
+ T G + APE +F R + +H+SDV+S+G+++ E+
Sbjct: 260 ---KKTTNGRLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEIF 299
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 40/287 (13%), Positives = 80/287 (27%), Gaps = 58/287 (20%)
Query: 166 SCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGT-L 224
+ S + ++ D + + S R T LGQ + T
Sbjct: 38 TTSEYMQSAADSLVSTSLWNTGQPFRVE--SELGERPRTLVRGTVLGQEDPYAYLEATDQ 95
Query: 225 PDGRLVAVKVMKNLKDNGEE-----------------------------FINEVASISRT 255
G V V + FI +
Sbjct: 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 256 SHVNIVPFLGFC--YEKKKRALIYEFM--PNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
++ R +Y M + + + H S++ L Q+ +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS--LVHHARLQLTL 213
Query: 312 GIARGLEYLH-RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR 370
+ R L LH G +VH ++P +I LD+ ++ F + +
Sbjct: 214 QVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVS------S 263
Query: 371 GTAGYIAPEVFCR---------HFGGVSHKSDVYSYGMMIHEMVIGR 408
+ G+ PE+ R ++ D ++ G++I+ +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 66/289 (22%), Positives = 109/289 (37%), Gaps = 54/289 (18%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF---INEVASISRTS-HVNIVPF 263
++G G V+K G ++AVK M N EE + ++ + ++ IV
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G + E M + E R + ++ V I + L YL
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEKLKKR-----MQGPIPE-RILGKMTVAIVKALYYLKE- 142
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ---TEKKESFISMLDTRGTAGYIAPEV 380
++H D+KP NI LDE K+ DFG++ + + K+ G A Y+APE
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA------GCAAYMAPER 195
Query: 381 FCRHF---GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
++DV+S G+ + E+ G+ FP YK +T+++
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQ-------------FP---YKNCKTDFE-V 238
Query: 438 LDGVVTEEEKEMAKKMI-------LVSLWCIQTHPPDRPSMTKVVEMLE 479
L V+ EE + M V C+ RP ++LE
Sbjct: 239 LTKVLQEEPPLLPGHMGFSGDFQSFVKD-CLTKDHRKRPKYN---KLLE 283
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 206 SFSDKLGQGGYADVYKGTLPD--------GRLVAVKVMKNLKDNGE--EFINEVASISR- 254
LG+G + V VAVK++K+ + + I+E+ +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY----------IYDHESSNGKRTLEWR 304
H NI+ LG C + +I E+ G+L +Y + S N + L +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364
+ A +ARG+EYL + + +H D+ N+ + ED KI+DFGLA+ + +
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY- 247
Query: 365 SMLDTRGTAGYI-----APEVFCRHFGGVSHKSDVYSYGMMIHEMV 405
+ T G + APE +H+SDV+S+G+++ E+
Sbjct: 248 ----KKTTNGRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIF 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 52/268 (19%), Positives = 99/268 (36%), Gaps = 40/268 (14%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFI------NEVASISRTSHVN 259
+ +G+G ++ V + G+ AVK++ K + E + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 260 IVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
IV L +++EFM L I + + E I L Y
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS-E-AVASHYMRQILEALRY 145
Query: 320 LHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
H + I+H D+KPH + L + K+ FG+A Q + GT ++
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFM 200
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP-----NAIYKQI- 430
APEV R DV+ G+++ ++ G P +++ I
Sbjct: 201 APEVVKRE--PYGKPVDVWGCGVILFILLSG-------------CLPFYGTKERLFEGII 245
Query: 431 ETEYDFQLD--GVVTEEEKEMAKKMILV 456
+ +Y ++E K++ ++M+++
Sbjct: 246 KGKYKMNPRQWSHISESAKDLVRRMLML 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 47/265 (17%), Positives = 98/265 (36%), Gaps = 44/265 (16%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVPF 263
+ +G+G + +V A K + ++D + F E+ + H NI+
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-DRFKQEIEIMKSLDHPNIIRL 71
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ L+ E G L + + E +I + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFR-----E-SDAARIMKDVLSAVAYCH-- 123
Query: 324 CNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
+ + H D+KP N D K+ DFGLA + + + + + GT Y++P+V
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 179
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------NAIYKQIET-E 433
+G + D +S G+M++ ++ G Y P + + +I
Sbjct: 180 LEGLYG---PECDEWSAGVMMYVLLCG-------------YPPFSAPTDSEVMLKIREGT 223
Query: 434 YDFQLD--GVVTEEEKEMAKKMILV 456
+ F V+ + + + ++++
Sbjct: 224 FTFPEKDWLNVSPQAESLIRRLLTK 248
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 66/325 (20%), Positives = 125/325 (38%), Gaps = 82/325 (25%)
Query: 207 FSDKLGQGGYADVYKGTLPDGR------LVAVKVMKNLKDNGE--EFINEVASISRTSHV 258
LG+G + V K T + VAVK++K E + ++E + + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQY------------------IYDHESSNGKRT 300
+++ G C + LI E+ GSL + +R
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 301 LEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360
L + A I++G++YL +++VH D+ NI + E KISDFGL++ ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 361 ESFISMLDTRGTAGYI-----APE-VFCRHFGGVSHKSDVYSYGMMIHEMVI-------G 407
+S+ + + G I A E +F + + +SDV+S+G+++ E+V G
Sbjct: 204 DSY-----VKRSQGRIPVKWMAIESLFDHIY---TTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 408 RKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAK------KMILVSLWCI 461
+ + ++T + M + +M + L C
Sbjct: 256 IPPERL-------------FNLLKTGH-------------RMERPDNCSEEMYRLMLQCW 289
Query: 462 QTHPPDRPSMTKVVEMLEGSIENLQ 486
+ P RP + + LE + +
Sbjct: 290 KQEPDKRPVFADISKDLEKMMVKRR 314
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 206 SFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKDNGE--EFINEVASISR-TS 256
LG+G + V + R VAVK++K + E ++E+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 257 HVNIVPFLGFCYEKKK-RALIYEFMPNGSLDQY----------IYDHESSNGKRTLEWRT 305
H+N+V LG C + +I EF G+L Y K L
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+ + +A+G+E+L + + +H D+ NI L E KI DFGLA+ K +
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-- 204
Query: 366 MLDTRGTAGYI-----APE-VFCRHFGGVSHKSDVYSYGMMIHEMV 405
R + APE +F R + + +SDV+S+G+++ E+
Sbjct: 205 ---VRKGDARLPLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIF 244
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 70/317 (22%), Positives = 124/317 (39%), Gaps = 55/317 (17%)
Query: 204 TKSFSDK-------LGQGGYADVYKGT-LPDGRLVAVKVM-KNLKDNGEEFINEVASISR 254
+ F D LG+G +A V L + AVK++ K EV + +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 255 -TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
H N++ + F E+ + L++E M GS+ +I+ N E V Q +
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EASVVVQD---V 120
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFI-----S 365
A L++LH N I H D+KP NI ++ KI DF L +
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 366 MLDTRGTAGYIAPEVFCRHFGGVSH---KSDVYSYGMMIHEMVIG--------RKNADVK 414
+L G+A Y+APEV S + D++S G++++ ++ G +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 415 VSCSSEYFPNAIYKQIET-EYDFQLD--GVVTEEEKEMAKKM-------------ILVSL 458
+ N +++ I+ +Y+F ++ K++ K+ +L
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297
Query: 459 WCIQTHPPDRPSMTKVV 475
W +Q P+ T +V
Sbjct: 298 W-VQGCAPENTLPTPMV 313
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 46/272 (16%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMK---------NLKDNGEEFINEVASISRTS 256
S LG G +V + VA+K++ D E+ + + +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
H I+ F ++ + ++ E M G L + ++ YQ+
Sbjct: 74 HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK--LYFYQML----LA 126
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
++YLH I+H D+KP N+ L +ED KI+DFG +K + M GT
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTP 180
Query: 374 GYIAPEVFCRHF-GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC-----SSEYFPNAIY 427
Y+APEV G + D +S G+++ + S ++
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL-----------SGYPPFSEHRTQVSLK 229
Query: 428 KQIET-EYDFQLD--GVVTEEEKEMAKKMILV 456
QI + +Y+F + V+E+ ++ KK+++V
Sbjct: 230 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 63/275 (22%), Positives = 111/275 (40%), Gaps = 49/275 (17%)
Query: 204 TKSFSDK------LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASIS 253
+ FSD LG+G ++ V + G A K++ K + + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 254 RTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
+ H NIV E+ L+++ + G L + I E + + QI
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQIL--- 115
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTR 370
+ Y H + IVH ++KP N+ L + K++DFGLA + E++
Sbjct: 116 -ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--- 168
Query: 371 GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------N 424
GT GY++PEV + D+++ G++++ +++G Y P +
Sbjct: 169 GTPGYLSPEVLKKDPYS--KPVDIWACGVILYILLVG-------------YPPFWDEDQH 213
Query: 425 AIYKQIET-EYDFQLD--GVVTEEEKEMAKKMILV 456
+Y QI+ YD+ VT E K + M+ V
Sbjct: 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 248
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 60/286 (20%), Positives = 115/286 (40%), Gaps = 56/286 (19%)
Query: 202 RMTKSFSDK------LGQGGYADVYKGT-LPDGRLVAVKVMK----------NLKDNGEE 244
T F + LG+G + V + P + AVK++ +++ E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 245 FINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEW 303
+ EV + + S H NI+ L+++ M G L Y+ + + + K T
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--- 126
Query: 304 RTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363
R + + + + LH + IVH D+KP NI LD+D K++DFG + Q + E
Sbjct: 127 RKIMRA---LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-- 178
Query: 364 ISMLDTRGTAGYIAPEVFCRHFGGVSH----KSDVYSYGMMIHEMVIGRKNADVKVSCSS 419
+ + GT Y+APE+ + D++S G++++ ++ G
Sbjct: 179 -KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG------------ 225
Query: 420 EYFP------NAIYKQIET-EYDFQLD--GVVTEEEKEMAKKMILV 456
P + + I + Y F ++ K++ + ++V
Sbjct: 226 -SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 270
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 62/264 (23%), Positives = 111/264 (42%), Gaps = 42/264 (15%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVM-KNLKDNGEEFINEVASISRTSHVNIVPFL 264
F + LG G +++V+ G+L A+K + K+ NE+A + + H NIV
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
L+ + + G L +D G T E + + + ++YLH
Sbjct: 73 DIYESTTHYYLVMQLVSGGEL----FDRILERGVYT-E-KDASLVIQQVLSAVKYLH--- 123
Query: 325 NIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
IVH D+KP N+ +E+ I+DFGL+K + M GT GY+APEV
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVL 179
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------NAIYKQIET-EY 434
+ S D +S G++ + ++ G Y P + ++++I+ Y
Sbjct: 180 AQK--PYSKAVDCWSIGVITYILLCG-------------YPPFYEETESKLFEKIKEGYY 224
Query: 435 DFQLD--GVVTEEEKEMAKKMILV 456
+F+ ++E K+ ++
Sbjct: 225 EFESPFWDDISESAKDFICHLLEK 248
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 46/284 (16%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFL 264
+ +G G Y+ + AVK++ K + E E+ + R H NI+
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ K ++ E M G L I ++ R + I + +EYLH
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILR------QKFFSEREASAVLFTITKTVEYLH--- 133
Query: 325 NIRIVHLDIKPHNIRL---DEDFCP-KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
+VH D+KP NI + +I DFG AKQ + ++ TA ++APEV
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEV 191
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIG-----RKNADVKVSCSSEYFPNAIYKQIET-EY 434
R G D++S G++++ M+ G D P I +I + ++
Sbjct: 192 LERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDD---------TPEEILARIGSGKF 240
Query: 435 DFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
V++ K++ KM + P R + V+
Sbjct: 241 SLSGGYWNSVSDTAKDLVSKM-------LHVDPHQRLTAALVLR 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 25/240 (10%)
Query: 171 KETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDK--------LGQGGYADVYKG 222
E ++ + + P F + V + + LG G + V+K
Sbjct: 49 TERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108
Query: 223 T-LPDGRLVAVKVM-KNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280
G +A K++ + EE NE++ +++ H N++ K L+ E++
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168
Query: 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340
G L I D E T+ + I G+ ++H + I+HLD+KP NI
Sbjct: 169 DGGELFDRIIDE----SYNLTELDTILFMKQ-ICEGIRHMH---QMYILHLDLKPENILC 220
Query: 341 --DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYG 398
+ KI DFGLA++ + +E GT ++APEV F VS +D++S G
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDF--VSFPTDMWSVG 275
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 16/196 (8%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFL 264
++ LG+G + V++ + K +K + E++ ++ H NI+
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
++ +I+EF+ + + I L R + + L++LH
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEALQFLH--- 119
Query: 325 NIRIVHLDIKPHNIRL--DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
+ I H DI+P NI KI +FG A+Q + ++F + Y APEV
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQ 176
Query: 383 RHFGGVSHKSDVYSYG 398
VS +D++S G
Sbjct: 177 HD--VVSTATDMWSLG 190
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 56/247 (22%), Positives = 94/247 (38%), Gaps = 26/247 (10%)
Query: 165 SSCSYHKETRHDQNAEAAFVRNYGSLAP---KRFSYSDVRRMTKSFSD------KLGQGG 215
S +H ++ + + +Y K++ V S D +LG G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 216 YADVYKGT-LPDGRLVAVKVM-KNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273
+ V++ GR+ K + + NE++ +++ H ++ +K +
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI 333
LI EF+ G L I + + V GL+++H IVHLDI
Sbjct: 124 VLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 334 KPHNIRL--DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHK 391
KP NI + KI DFGLA + E TA + APE+ R V
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE--PVGFY 230
Query: 392 SDVYSYG 398
+D+++ G
Sbjct: 231 TDMWAIG 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 23/247 (9%)
Query: 162 KNCSSCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSD------KLGQGG 215
+ + + ++ NY K++ V D +LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 216 YADVYKGT-LPDGRLVAVKVMKNLKDNGEEFI-NEVASISRTSHVNIVPFLGFCYEKKKR 273
+ V++ T G A K + ++ +E + E+ ++S H +V + +
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM 229
Query: 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI 333
+IYEFM G L + + D + + + + +GL ++H VHLD+
Sbjct: 230 VMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 281
Query: 334 KPHNIRL--DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHK 391
KP NI K+ DFGL + K+S GTA + APEV V +
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA--EGKPVGYY 336
Query: 392 SDVYSYG 398
+D++S G
Sbjct: 337 TDMWSVG 343
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 60/267 (22%), Positives = 110/267 (41%), Gaps = 45/267 (16%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASISRTSHVNIVP 262
++LG+G ++ V + G A K++ K + + E + H NIV
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
E+ L+++ + G L + I E + + QI + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--CIQQIL----ESIAYCH- 145
Query: 323 GCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
+ IVH ++KP N+ L + K++DFGLA + E++ GT GY++PE
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 200
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP-------NAIYKQIET 432
V + S D+++ G++++ +++G +P + +Y QI+
Sbjct: 201 VLKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQHRLYAQIKA 244
Query: 433 -EYDFQLD--GVVTEEEKEMAKKMILV 456
YD+ VT E K + M+ V
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSMLTV 271
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 58/239 (24%), Positives = 107/239 (44%), Gaps = 42/239 (17%)
Query: 184 VRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGE 243
+ + + +Y++ + +G G + V++ L + VA+K K L+D +
Sbjct: 29 ASDGKTGEQREIAYTNCK--------VIGNGSFGVVFQAKLVESDEVAIK--KVLQD--K 76
Query: 244 EFIN-EVASISRTSHVNIVPFLGFCYEKKKRA------LIYEFMPNGSLDQYIYDHESSN 296
F N E+ + H N+V F Y + L+ E++P ++ + + +
Sbjct: 77 RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY--AK 133
Query: 297 GKRTLEWRTV----YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP-KISDF 351
K+T+ + YQ+ R L Y+H +I I H DIKP N+ LD K+ DF
Sbjct: 134 LKQTMPMLLIKLYMYQLL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDF 186
Query: 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
G AK E +S + +R Y APE+ ++ + D++S G ++ E++ G+
Sbjct: 187 GSAKILIAGEPNVSYICSR---YYRAPELIFGATNY---TTNIDIWSTGCVMAELMQGQ 239
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 48/272 (17%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG-------EEFINEVASISRTSH 257
++LG G +A V K G+ A K +K + + EE EV + H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
NI+ K LI E + G L ++ + ES + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT--QFLKQIL----DGV 121
Query: 318 EYLHRGCNIRIVHLDIKPHNI----RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
YLH RI H D+KP NI + + K+ DFG+A + E F ++ GT
Sbjct: 122 HYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTP 175
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------NAIY 427
++APE+ ++ + ++D++S G++ + ++ G P
Sbjct: 176 EFVAPEIV--NYEPLGLEADMWSIGVITYILLSG-------------ASPFLGETKQETL 220
Query: 428 KQIET-EYDFQLD--GVVTEEEKEMAKKMILV 456
I YDF + +E K+ +++++
Sbjct: 221 TNISAVNYDFDEEYFSNTSELAKDFIRRLLVK 252
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 65/318 (20%), Positives = 131/318 (41%), Gaps = 48/318 (15%)
Query: 174 RHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGT-LPDGRLVAV 232
H + + + PK+++ +D +++K LG G V + G+ A+
Sbjct: 3 HHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSK---QVLGLGVNGKVLECFHRRTGQKCAL 59
Query: 233 KVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRA-----LIYEFMPNGSLD 286
K++ + +E V + S +IV L YE +I E M G L
Sbjct: 60 KLLYDSPKARQE----VDHHWQASGGPHIVCILDV-YENMHHGKRCLLIIMECMEGGEL- 113
Query: 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DED 343
+ G + R +I I +++LH + I H D+KP N+ ++D
Sbjct: 114 ---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKD 167
Query: 344 FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHE 403
K++DFG AK+T + + T Y+APEV D++S G++++
Sbjct: 168 AVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYI 221
Query: 404 MVIGRK--NADVKVSCSSEYFPNAIYKQIET-EYDFQLD--GVVTEEEKEMAKKMILVSL 458
++ G ++ + + + ++I +Y F V+E+ K++ + +
Sbjct: 222 LLCGFPPFYSN-----TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLL----- 271
Query: 459 WCIQTHPPDRPSMTKVVE 476
++T P +R ++T+ +
Sbjct: 272 --LKTDPTERLTITQFMN 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMK-------NLKDNGEEFINEVASISRTSH 257
++LG G +A V K G A K +K + EE EV+ + + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
N++ + LI E + G L ++ ES + + + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT--SFIKQIL----DGV 128
Query: 318 EYLHRGCNIRIVHLDIKPHNIRL---DEDFCP-KISDFGLAKQTEKKESFISMLDTRGTA 373
YLH +I H D+KP NI L + K+ DFGLA + E F ++ GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTP 182
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYG 398
++APE+ + ++D++S G
Sbjct: 183 EFVAPEIVNYE--PLGLEADMWSIG 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 59/268 (22%), Positives = 114/268 (42%), Gaps = 44/268 (16%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVM---KNLKDNGEEFINEVASISRTSHVNIV 261
++LG+G ++ V + + G+ A ++ K + ++ E H NIV
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
E+ LI++ + G L + I E + + QI + + H
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH--CIQQIL----EAVLHCH 127
Query: 322 RGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
+ +VH ++KP N+ L + K++DFGLA + E ++ GT GY++P
Sbjct: 128 ---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSP 182
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP-------NAIYKQIE 431
EV + G D+++ G++++ +++G +P + +Y+QI+
Sbjct: 183 EVLRKDPYG--KPVDLWACGVILYILLVG--------------YPPFWDEDQHRLYQQIK 226
Query: 432 T-EYDFQLD--GVVTEEEKEMAKKMILV 456
YDF VT E K++ KM+ +
Sbjct: 227 AGAYDFPSPEWDTVTPEAKDLINKMLTI 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 53/282 (18%), Positives = 116/282 (41%), Gaps = 40/282 (14%)
Query: 208 SDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLG 265
LG+G ++ K + AVK++ K E+ ++ H NIV
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+++ L+ E + G L + I + + + ++ + ++H +
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY--IMRKLV----SAVSHMH---D 124
Query: 326 IRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
+ +VH D+KP N+ +++ KI DFG A+ + T Y APE+
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLN 182
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGR-----KNADVKVSCSSEYFPNAIYKQIET-EYDF 436
++ G D++S G++++ M+ G+ + + + + E I K+I+ ++ F
Sbjct: 183 QN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-----IMKKIKKGDFSF 235
Query: 437 QLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ + V++E K++ + + + P R M+ +
Sbjct: 236 EGEAWKNVSQEAKDLIQGL-------LTVDPNKRLKMSGLRY 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMK-------NLKDNGEEFINEVASISRTSH 257
++LG G +A V K G A K +K EE EV+ + + H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
NI+ + LI E + G L ++ ES + + + Q I G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT--SFIKQ----ILDGV 128
Query: 318 EYLHRGCNIRIVHLDIKPHNI----RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
YLH +I H D+KP NI + K+ DFGLA + E F ++ GT
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GTP 182
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYG 398
++APE+ ++ + ++D++S G
Sbjct: 183 EFVAPEIV--NYEPLGLEADMWSIG 205
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEF-INEVASISRTSHVNIVP 262
LG+GG+ +V+ K T G+L A K + K G + + E +++ IV
Sbjct: 193 LGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 263 FLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + +E K L+ M G + +IY+ + N E R ++ A I GLE+LH
Sbjct: 250 -LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTA-QIVSGLEHLH 306
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEV 380
+ I++ D+KP N+ LD+D +ISD GLA + + ++ GT G++APE+
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPEL 360
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
D ++ G+ ++EM+ R
Sbjct: 361 LLGE--EYDFSVDYFALGVTLYEMIAAR 386
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-23
Identities = 69/240 (28%), Positives = 112/240 (46%), Gaps = 43/240 (17%)
Query: 184 VRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNG 242
G P+ SY+D + +G G + VY+ L G LVA+K K L+D
Sbjct: 43 TPGQGPDRPQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIK--KVLQD-- 90
Query: 243 EEFIN-EVASISRTSHVNIVPFLGFCYEKKKRA------LIYEFMPNGSLDQYIYDHESS 295
+ F N E+ + + H NIV F Y ++ L+ +++P ++ + + +
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 149
Query: 296 NGKRTLEWRTV----YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP-KISD 350
K+TL V YQ+ R L Y+H + I H DIKP N+ LD D K+ D
Sbjct: 150 --KQTLPVIYVKLYMYQLF----RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 200
Query: 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
FG AKQ + E +S + +R Y APE+ + + DV+S G ++ E+++G+
Sbjct: 201 FGSAKQLVRGEPNVSYICSR---YYRAPELIFGATDY---TSSIDVWSAGCVLAELLLGQ 254
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 58/285 (20%), Positives = 113/285 (39%), Gaps = 55/285 (19%)
Query: 202 RMTKSFSDK------LGQGGYADVYKGT-LPDGRLVAVKVMK---------NLKDNGEEF 245
K F K +G+G + V + G AVK+M+ L++ E
Sbjct: 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 246 INEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWR 304
E + + + H +I+ + L+++ M G L Y+ + + + K T R
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET---R 203
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364
++ + + + +LH IVH D+KP NI LD++ ++SDFG + E E
Sbjct: 204 SIMRS---LLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--- 254
Query: 365 SMLDTRGTAGYIAPEVFCRHFGGV----SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420
+ + GT GY+APE+ + D+++ G+++ ++ G
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG------------- 301
Query: 421 YFP------NAIYKQIET-EYDFQLD--GVVTEEEKEMAKKMILV 456
P + + I +Y F + K++ +++ V
Sbjct: 302 SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQV 346
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 36/213 (16%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEF-INE---VASISRTSHVN 259
+G+GG+ +VY T G++ A+K + GE +NE ++ +S
Sbjct: 197 IGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 260 IVPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
IV + + + + I + M G L ++ H E + A I GLE
Sbjct: 254 IVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAA-EIILGLE 306
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIA 377
++H +V+ D+KP NI LDE +ISD GLA KK+ GT GY+A
Sbjct: 307 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-----ASVGTHGYMA 358
Query: 378 PEVFCRHFGGVSHKSDV--YSYGMMIHEMVIGR 408
PEV + GV++ S +S G M+ +++ G
Sbjct: 359 PEVLQK---GVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMK-------NLKDNGEEFINEVASISRTSH 257
++LG G +A V K G A K +K + E+ EV+ + H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
N++ K LI E + G L ++ + ES + + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQIL----NGV 127
Query: 318 EYLHRGCNIRIVHLDIKPHNI----RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
YLH +++I H D+KP NI R KI DFGLA + + F ++ GT
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTP 181
Query: 374 GYIAPEVFCRHFGGVSHKSDVYSYG 398
++APE+ + ++D++S G
Sbjct: 182 EFVAPEIVNYE--PLGLEADMWSIG 204
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 62/204 (30%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
LG+G Y +V VAVK++ K D E E+ +H N+V F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYLHRGCNI 326
E + L E+ G L +D + + + + + G+ YLH I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLHG---I 124
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVF-CRH 384
I H DIKP N+ LDE KISDFGLA +L+ GT Y+APE+ R
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKRRE 183
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
F DV+S G+++ M+ G
Sbjct: 184 FHA--EPVDVWSCGIVLTAMLAGE 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 44/287 (15%)
Query: 205 KSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVP 262
K S LG G V + A+K++++ E V R S +IV
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 119
Query: 263 FLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+ YE ++ E + G L + G + R +I I +
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 318 EYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
+YLH +I I H D+KP N+ + K++DFG AK+T S+ T
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK--NADVKVSCSSEYFPNAIYKQIET 432
Y+APEV D++S G++++ ++ G ++ ++ S + +I
Sbjct: 229 YVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIRM 281
Query: 433 -EYDFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+Y+F V+EE K + + + ++T P R ++T+ +
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNL-------LKTEPTQRMTITEFMN 321
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 74/312 (23%), Positives = 116/312 (37%), Gaps = 38/312 (12%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
LG+G Y +V VAVK++ K D E E+ +H N+V F G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQ--IAVGIARGLEYLHRGC 324
E + L E+ G L +D + + + + +A G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHG-- 123
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVF-C 382
I I H DIKP N+ LDE KISDFGLA +L+ GT Y+APE+
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKR 181
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442
R F DV+S G+++ M+ G D EY E + +
Sbjct: 182 REFHA--EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-----DWKEKKTYLNPWKKI 234
Query: 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE---MLEGSIENLQIPPKPSLSLPTGY 499
+ K+ + +P R ++ + + + + + P S +
Sbjct: 235 DSAPLALLHKI-------LVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESP 287
Query: 500 AKQSSPTSSFMK 511
+ S S +
Sbjct: 288 SGFSKHIQSNLD 299
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 52/298 (17%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLG 265
+LG+G + VY+ + A+KV+K D + E+ + R SH NI+
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNIIKLKE 115
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ +L+ E + G L I + + + + V QI + YLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD--AVKQIL----EAVAYLH---E 166
Query: 326 IRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
IVH D+KP N+ D KI+DFGL+K E + ++ GT GY APE+
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPEILR 223
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC-----SSEYFPNAIYKQIET-EYDF 436
+ D++S G++ + ++ C E ++++I EY F
Sbjct: 224 GC--AYGPEVDMWSVGIITYILL-----------CGFEPFYDERGDQFMFRRILNCEYYF 270
Query: 437 QLD--GVVTEEEKEMAKKMILV----------SL---WCIQTHPPDRPSMTKVVEMLE 479
V+ K++ +K+I++ +L W + + M + L+
Sbjct: 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW-VTGKAANFVHMDTAQKKLQ 327
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-22
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEF-INEVASISRTSHVNIVP 262
LG+GG+ +V + T G++ A K ++ K GE +NE + + + +V
Sbjct: 192 LGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 263 FLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTL-EWRTVYQIAVGIARGLEYL 320
L + YE K L+ M G L +IY G+ E R V+ A I GLE L
Sbjct: 249 -LAYAYETKDALCLVLTLMNGGDLKFHIYHM----GQAGFPEARAVFYAA-EICCGLEDL 302
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
HR RIV+ D+KP NI LD+ +ISD GLA + ++ + GT GY+APEV
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEV 356
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ D ++ G +++EM+ G+
Sbjct: 357 VKNE--RYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 46/197 (23%), Positives = 84/197 (42%), Gaps = 20/197 (10%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVM---KNLKDNGEEFINEVASISRTSHV-NIVPFL 264
+LG+G +A V + G+ A K + + +D E ++E+A + ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ LI E+ G + + E V ++ I G+ YLH
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCL--PELAEMVS-E-NDVIRLIKQILEGVYYLH--- 148
Query: 325 NIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
IVHLD+KP NI L KI DFG++++ ++ GT Y+APE+
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---GTPEYLAPEIL 205
Query: 382 CRHFGGVSHKSDVYSYG 398
++ ++ +D+++ G
Sbjct: 206 --NYDPITTATDMWNIG 220
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 58/207 (28%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE 269
+G G + LVAVK ++ E E+ + H NIV F E
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF----KE 83
Query: 270 ----KKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYLHRGC 324
A+I E+ G L + I + G+ E R +Q + G+ Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQ---QLLSGVSYCHS-- 134
Query: 325 NIRIVHLDIKPHNIRLDEDFCP--KISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVF 381
++I H D+K N LD P KI DFG +K + S + GT YIAPEV
Sbjct: 135 -MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVL 189
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
R +DV+S G+ ++ M++G
Sbjct: 190 LRQ-EYDGKIADVWSCGVTLYVMLVGA 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 24/208 (11%), Positives = 58/208 (27%), Gaps = 53/208 (25%)
Query: 209 DKLGQGGYADVYKGTLPD---GRLVAVKVMK--NLKDNG--EEFINEVASISRTSHVNIV 261
G ++ D R VA+ + + + +E ++ +SR +
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + + ++ E++ GSL + + + +A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA--------DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 322 R-GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
R G + P +R+ D G +
Sbjct: 147 RAG----VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPD-- 178
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ + D+ G ++ +++ R
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNR 199
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 64/315 (20%), Positives = 113/315 (35%), Gaps = 61/315 (19%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISR-----------TSHV 258
LG+GG+ V+ G L D VA+KV+ + G +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGL 317
++ L + ++ L+ E Q ++D+ + G R + + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFG---QVVAAI 152
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCP-KISDFGLAKQTEKKESFISMLDTR-GTAGY 375
++ H +VH DIK NI +D K+ DFG GT Y
Sbjct: 153 QHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-----EPYTDFDGTRVY 204
Query: 376 IAPEVFCRH--FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433
PE RH + V+S G+++++MV G P ++I E
Sbjct: 205 SPPEWISRHQYHA---LPATVWSLGILLYDMVCG-------------DIPFERDQEI-LE 247
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE---MLEGSIENLQIPPK 490
+ V+ + +I C+ P RPS+ +++ M + + +P
Sbjct: 248 AELHFPAHVSPD----CCALI---RRCLAPKPSSRPSLEEILLDPWMQTPAED---VPLN 297
Query: 491 PSLSLPTGYAKQSSP 505
PS P A P
Sbjct: 298 PSKGGPAPLAWSLLP 312
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 62/279 (22%), Positives = 109/279 (39%), Gaps = 49/279 (17%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN---------EVASISRTSHVNI 260
LG G + V+ + V VK +K K + +I E+A +SR H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRT-LEWRTVYQIAVGIARGLEY 319
+ L + L+ E +G LD ++ + + +++ + + Y
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFR---QLVSAVGY 145
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAP 378
L I+H DIK NI + EDF K+ DFG A E+ + + T GT Y AP
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LFYTFCGTIEYCAP 198
Query: 379 EVFC-RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
EV + G + +++S G+ ++ +V P ++ E
Sbjct: 199 EVLMGNPYRG--PELEMWSLGVTLYTLVFE-------------ENPFCELEET-VEAAIH 242
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+V++E + + +Q P R ++ K+V
Sbjct: 243 PPYLVSKELMSLVSGL-------LQPVPERRTTLEKLVT 274
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 33/231 (14%)
Query: 196 SYSDVRRMTKSFSD--KLGQGGYADVYKGTL-PDGRLVAVK-VMKNLKDNGEEFINEVAS 251
+ R+ F GQG + V G G VA+K V+++ + E + +
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQD 72
Query: 252 ISRTSHVNIVPFLGFCYEKKKRA-------LIYEFMPNGSLDQYIYDHESSNGKRTLEWR 304
++ H NIV + Y +R ++ E++P+ +L + ++ +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY--YRRQVAPPPI 129
Query: 305 TV----YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP-KISDFGLAKQTEK 359
+ +Q+ R + LH + + H DIKPHN+ ++E K+ DFG AK+
Sbjct: 130 LIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 360 KESFISMLDTRGTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
E ++ + +R Y APE+ +H+ + D++S G + EM++G
Sbjct: 185 SEPNVAYICSR---YYRAPELIFGNQHY---TTAVDIWSVGCIFAEMMLGE 229
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
+KLG G YA VYKG G VA+K +K D+ E I E++ + H NIV
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKL--DSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ + K L++EFM N L +Y+ N R LE V + +GL + H
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354
+I+H D+KP N+ +++ K+ DFGLA
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 63/283 (22%), Positives = 126/283 (44%), Gaps = 58/283 (20%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFIN-EVASISRTSHVNIVPFLGF 266
+G+G +A V + GR VA+K++ L + + EV + +H NIV
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 267 CYE----KKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYLH 321
+E +K LI E+ G + +D+ ++G+ + E R+ ++ I ++Y H
Sbjct: 80 -FEVIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFR---QIVSAVQYCH 131
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEV 380
+ RIVH D+K N+ LD D KI+DFG + + LD G Y APE+
Sbjct: 132 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPEL 184
Query: 381 FC-RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP------NAIYKQIETE 433
F + + G + DV+S G++++ +V G P + +++
Sbjct: 185 FQGKKYDG--PEVDVWSLGVILYTLVSG-------------SLPFDGQNLKELRERV-LR 228
Query: 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+++ ++ + + + K+ + +P R ++ ++++
Sbjct: 229 GKYRIPFYMSTDCENLLKRF-------LVLNPIKRGTLEQIMK 264
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 34/215 (15%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLK----DNGEEFIN-EVASISRTSHVNIVPFL 264
LG+G Y V + AVK++K K NGE + E+ + R H N++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 265 GFCYE------KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEW--RTVYQIAVGIARG 316
+ K+K ++ E+ G + + D KR + + G
Sbjct: 72 ---VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPE--KRFPVCQAHGYFC---QLIDG 121
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGY 375
LEYLH IVH DIKP N+ L KIS G+A+ + T G+ +
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRTSQGSPAF 177
Query: 376 IAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
PE+ F G K D++S G+ ++ + G
Sbjct: 178 QPPEIANGLDTFSGF--KVDIWSAGVTLYNITTGL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-19
Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDN-GEEFIN--EVASISRTSHVNIVPFL 264
K+G+G Y V+K G++VA+K +D+ + I E+ + + H N+V L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
K++ L++E+ + ++ + + +R + V I + + + H+
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIAPEVF-- 381
+H D+KP NI + + K+ DFG A+ T + + + TR Y +PE+
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---WYRSPELLVG 176
Query: 382 CRHFG-GVSHKSDVYSYGMMIHEMVIGR 408
+G V DV++ G + E++ G
Sbjct: 177 DTQYGPPV----DVWAIGCVFAELLSGV 200
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 8e-19
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEFIN-EVASISRTSHVNIVP 262
LG+G ++ V T R A+K+++ +K+N ++ E +SR H V
Sbjct: 38 LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+ +K + NG L +YI E T + A I LEYLH
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTA-EIVSALEYLH- 147
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-----GTAGYIA 377
I+H D+KP NI L+ED +I+DFG AK + R GTA Y++
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-----QARANSFVGTAQYVS 200
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
PE+ SD+++ G +I+++V G
Sbjct: 201 PELLTEK--SACKSSDLWALGCIIYQLVAGL 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 41/229 (17%)
Query: 199 DVRRMTKSFS--DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF--------IN 247
DV+ K + D LG+G +A VYK ++VA+K +K + E +
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALR 61
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV- 306
E+ + SH NI+ L K +L+++FM L+ I D+ L +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN-----SLVLTPSHIK 115
Query: 307 ---YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKES 362
+GLEYLH+ I+H D+KP+N+ LDE+ K++DFGLAK +
Sbjct: 116 AYMLMTL----QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168
Query: 363 FISMLDTRGTAGYIAPEVF--CRHFG-GVSHKSDVYSYGMMIHEMVIGR 408
+ + TR Y APE+ R +G GV D+++ G ++ E+++
Sbjct: 169 YTHQVVTR---WYRAPELLFGARMYGVGV----DMWAVGCILAELLLRV 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 56/280 (20%), Positives = 103/280 (36%), Gaps = 51/280 (18%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN-------EVASISRTSHV--NI 260
LG GG+ VY G + D VA+K ++ + + + EV + + S +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
+ L + +E+ + Q ++D + G L+ + + +
Sbjct: 111 IRLLDW-FERPDS--FVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHC 165
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCP-KISDFGLAKQTEKKESFISMLDTR-GTAGYIAP 378
H ++H DIK NI +D + K+ DFG + ++ GT Y P
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPP 217
Query: 379 EVFCRH--FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436
E H G + V+S G+++++MV G P ++I
Sbjct: 218 EWIRYHRYHG---RSAAVWSLGILLYDMVCG-------------DIPFEHDEEI-IRGQV 260
Query: 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
V+ E + +I WC+ P DRP+ ++
Sbjct: 261 FFRQRVSSE----CQHLI---RWCLALRPSDRPTFEEIQN 293
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMK----NLKDNGEEFINEVASISRTSHVNIVP 262
+G+G + V T ++ A+K M ++ E+ + H +V
Sbjct: 23 IGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 263 FLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + ++ ++ ++ + + G L H N E I + L+YL
Sbjct: 80 -LWYSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFK-EETVKLFIC-ELVMALDYLQ 132
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
RI+H D+KP NI LDE I+DF +A ++ +M GT Y+APE+F
Sbjct: 133 N---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMF 186
Query: 382 CRHFG-GVSHKSDVYSYGMMIHEMVIGR 408
G G S D +S G+ +E++ GR
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVM---KNLKDNGEEFIN-EVASISRTSHVNIVPFLG 265
LG G + V G G VAVK++ K + I E+ ++ H +I+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 266 FCYE----KKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYL 320
Y+ ++ E++ G L +D+ +G+ +E R ++Q I ++Y
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQ---QILSAVDYC 127
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPE 379
HR +VH D+KP N+ LD KI+DFGL+ E L T G+ Y APE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPE 180
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
V + D++S G++++ ++ G
Sbjct: 181 VISGR-LYAGPEVDIWSCGVILYALLCGT 208
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 41/156 (26%), Positives = 78/156 (50%), Gaps = 22/156 (14%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
+K+G+G Y VYK G +VA+K ++ L E I E++ + +H NIV
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV----YQIAVGIARGLEY 319
L + + K L++EF+ L +++ ++ + + +Q+ +GL +
Sbjct: 68 LDVIHTENKLYLVFEFLHQ-DLKKFM----DASALTGIPLPLIKSYLFQLL----QGLAF 118
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
H R++H D+KP N+ ++ + K++DFGLA+
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 56/312 (17%), Positives = 114/312 (36%), Gaps = 82/312 (26%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVM--------------------KNLKDNGEEFIN 247
D++G+G Y V D A+KV+ + +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 248 EVASISR-------TSHVNIVPFLGFCYE------KKKRALIYEFMPNGSLDQYIYDHES 294
+ + + H N+V E + +++E + G + +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVP----- 129
Query: 295 SNGK-RTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353
+ + R +Q + +G+EYLH +I+H DIKP N+ + ED KI+DFG+
Sbjct: 130 TLKPLSEDQARFYFQ---DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 354 AKQTEKKESFISMLDTR-GTAGYIAPEVFCRHFGGVS-HKSDVYSYGMMIHEMVIGRKNA 411
+ + + ++ L GT ++APE S DV++ G+ ++ V G
Sbjct: 184 SNEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG---- 236
Query: 412 DVKVSCSSEYFP------NAIYKQIET-EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTH 464
P ++ +I++ +F + E+ K++ +M + +
Sbjct: 237 ---------QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRM-------LDKN 280
Query: 465 PPDRPSMTKVVE 476
P R + ++
Sbjct: 281 PESRIVVPEIKL 292
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 14/151 (9%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPFL 264
+K+G+G Y VYK GR+VA+K ++ L E I E++ + H NIV +
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ ++ L++EFM L + + ++ K L+ + + RG+ + H+
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDEN-----KTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
RI+H D+KP N+ ++ D K++DFGLA+
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 14/151 (9%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPFL 264
+K+G+G Y VYK G A+K ++ L+ E I E++ + H NIV
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ KK+ L++E + L + + E LE T + + G+ Y H
Sbjct: 67 DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDR- 119
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
R++H D+KP N+ ++ + KI+DFGLA+
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
+G+G Y V K GR+VA+K D+ + + E+ + + H N+V
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQLRHENLVNL 89
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
L C +KK+ L++EF+ + ++ + L+++ V + I G+ + H
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIAPEVF- 381
I+H DIKP NI + + K+ DFG A+ E + + TR Y APE+
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR---WYRAPELLV 197
Query: 382 -CRHFG-GVSHKSDVYSYGMMIHEMVIGR 408
+G V DV++ G ++ EM +G
Sbjct: 198 GDVKYGKAV----DVWAIGCLVTEMFMGE 222
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN----EVASISRTSHVNIVPFLG 265
LG G + V G G VAVK++ K + + E+ ++ H +I+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 266 FCYE----KKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYL 320
Y+ ++ E++ G L +D+ NG+ E R ++Q I G++Y
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQ---QILSGVDYC 132
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPE 379
HR +VH D+KP N+ LD KI+DFGL+ E L T G+ Y APE
Sbjct: 133 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE----FLRTSCGSPNYAAPE 185
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
V + D++S G++++ ++ G
Sbjct: 186 VISGR-LYAGPEVDIWSSGVILYALLCGT 213
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 2e-17
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
+K+G+G Y V+K +VA+K ++ L D+ E + E+ + H NIV
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ KK L++EF L +Y L+ V + +GL + H
Sbjct: 67 HDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355
++H D+KP N+ ++ + K+++FGLA+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 27/212 (12%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEFINEVASI-SRTSHVNIVP 262
+G+G +++V K T G++ A+K+M LK E + I
Sbjct: 69 IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 263 FLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L F ++ + L+ E+ G L S G+R + +A I ++ +H
Sbjct: 126 -LHFAFQDENYLYLVMEYYVGGDL----LTLLSKFGERIPAEMARFYLA-EIVMAIDSVH 179
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
+ VH DIKP NI LD +++DFG + + S++ GT Y++PE+
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPEIL 235
Query: 382 CRHFGGVSHKS-----DVYSYGMMIHEMVIGR 408
GG S D ++ G+ +EM G+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 50/245 (20%), Positives = 96/245 (39%), Gaps = 63/245 (25%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN-EVASISRTSHVNIVPFLGF 266
LG G + V + + G+ A+K K L+D + N E+ + HVNI+ + +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 267 CYEKKKRA--------------------------------------LIYEFMPNGSLDQY 288
Y +I E++P+ +L +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 289 IYDHESSNGKRTLEW--RTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346
+ S + +YQ+ R + ++H ++ I H DIKP N+ ++
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLF----RAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 347 -KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHE 403
K+ DFG AK+ E ++ + +R Y APE+ + + D++S G + E
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSR---FYRAPELMLGATEY---TPSIDLWSIGCVFGE 234
Query: 404 MVIGR 408
+++G+
Sbjct: 235 LILGK 239
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEV--------ASISRTSHV- 258
KLG G ++ V+ + + VA+K+++ K E +E+ A ++ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 259 --NIVPFLG-FCYEKKKRA---LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
+I+ L F ++ +++E L + + R + V QI+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP------KISDFGLAKQTEKKESFISM 366
+ GL+Y+HR C I +H DIKP N+ ++ P KI+D G A E + +
Sbjct: 140 LLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNS 195
Query: 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ TR Y +PEV +D++S +I E++ G
Sbjct: 196 IQTR---EYRSPEVLLGA--PWGCGADIWSTACLIFELITGD 232
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 209 DKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEF--INEVASISRTSHVNIVPFLG 265
DKLG+G YA VYKG LVA+K ++ + G I EV+ + H NIV
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ +K L++E++ L QY+ + + V + RGL Y HR
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYL-----DDCGNIINMHNVKLFLFQLLRGLAYCHRQ-- 119
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIAPEVF--C 382
+++H D+KP N+ ++E K++DFGLA+ + +++ + + T Y P++
Sbjct: 120 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL---WYRPPDILLGS 175
Query: 383 RHFG-GVSHKSDVYSYGMMIHEMVIGR 408
+ + D++ G + +EM GR
Sbjct: 176 TDYSTQI----DMWGVGCIFYEMATGR 198
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 47/212 (22%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISR--TSHVNIVPFLGF 266
KLG+G Y++V++ + + V VK++K +K ++ E+ I NI+
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREI-KILENLRGGPNIITLADI 99
Query: 267 CY--EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV----YQIAVGIARGLEYL 320
+ AL++E + N Q +TL + Y+I + L+Y
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEIL----KALDYC 146
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCP-KISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
H I+H D+KPHN+ +D + ++ D+GLA+ + + + +R + PE
Sbjct: 147 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR---YFKGPE 200
Query: 380 VF--CRHFGGVSHKSDVYSYGMMIHEMVIGRK 409
+ + + + D++S G M+ M+ ++
Sbjct: 201 LLVDYQMY---DYSLDMWSLGCMLASMIFRKE 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 49/210 (23%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEFINEVASI-SRTSHVNIVP 262
+G+G + +V K T ++ A+K++ +K + F E I + + +V
Sbjct: 77 IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 263 FLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + ++ + ++ E+MP G L + ++ E + A + L+ +H
Sbjct: 134 -LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTA-EVVLALDAIH 185
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEV 380
++ +H D+KP N+ LD+ K++DFG + K+ DT GT YI+PEV
Sbjct: 186 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC--DTAVGTPDYISPEV 240
Query: 381 FCRHFGGVSHKSDV--YSYGMMIHEMVIGR 408
G + + +S G+ ++EM++G
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 51/220 (23%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASI-------SRTS 256
LG+G + V K T GR A+K++K K+ I +EVA +
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILK--KE----VIVAKDEVAHTLTENRVLQNSR 206
Query: 257 HVNIVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
H PF L + ++ R + E+ G L ++ S + E R + A
Sbjct: 207 H----PFLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGA-E 256
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLD 368
I L+YLH N+ V+ D+K N+ LD+D KI+DFGL K+ ++F
Sbjct: 257 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---- 310
Query: 369 TRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT Y+APEV + D + G++++EM+ GR
Sbjct: 311 --GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 346
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 211 LGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN----EVASISRTSHVNIVPFLG 265
LG+G + V T + VA+K + + E++ + H +I+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 266 FCYE----KKKRALIYEFMPNGSLDQYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYL 320
Y+ ++ E+ G L +D+ + E R +Q I +EY
Sbjct: 75 --YDVITTPTDIVMVIEYA-GGEL----FDYIVEKKRMTEDEGRRFFQ---QIICAIEYC 124
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPE 379
HR +IVH D+KP N+ LD++ KI+DFGL+ L T G+ Y APE
Sbjct: 125 HR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN----FLKTSCGSPNYAAPE 177
Query: 380 VFC-RHFGGVSHKSDVYSYGMMIHEMVIGR 408
V + + G + DV+S G++++ M++GR
Sbjct: 178 VINGKLYAG--PEVDVWSCGIVLYVMLVGR 205
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 32/217 (14%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK--NLKDNGEEF----INEVA---SISRTSHV 258
++G G Y VYK G VA+K ++ N G + EVA + H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 259 NIVPFLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313
N+V + C + L++E + L Y+ L T+ +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKDLMRQF 129
Query: 314 ARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTA 373
RGL++LH IVH D+KP NI + K++DFGLA+ + + ++ T
Sbjct: 130 LRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL--- 183
Query: 374 GYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y APEV + V D++S G + EM +
Sbjct: 184 WYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 45/160 (28%), Positives = 68/160 (42%), Gaps = 27/160 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
KLG+G Y +VYK VA+K ++ L+ E I EV+ + H NI+
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDH---ESSNGKRTLEWRTVYQIAVGIARGLEYL 320
+ + LI+E+ N L +Y+ + K L YQ+ G+ +
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFL-----YQLI----NGVNFC 148
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCP-----KISDFGLAK 355
H R +H D+KP N+ L KI DFGLA+
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 36/213 (16%)
Query: 211 LGQGGYADVY---KGTLPD-GRLVAVKVMKN---LKDNGEEFINEVASISRTSHVNIVPF 263
LGQG + V+ K + D +L A+KV+K + E + +H PF
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH----PF 87
Query: 264 ---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
L + ++ + + LI +F+ G L + S T E Y +A L++
Sbjct: 88 IVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY--LAELALALDH 141
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRGTAGY 375
LH ++ I++ D+KP NI LDE+ K++DFGL+K+ +K SF GT Y
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEY 192
Query: 376 IAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+APEV R G + +D +S+G+++ EM+ G
Sbjct: 193 MAPEVVNRR--GHTQSADWWSFGVLMFEMLTGT 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 7e-16
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 211 LGQGGYADVY---KGTLPD-GRLVAVKVMKNLKDNGEEFINEVASI-------SRTSHVN 259
LG+GGY V+ K T + G++ A+KV+K K + A H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNILEEVKH-- 80
Query: 260 IVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315
PF L + ++ + LI E++ G L + +E + +A I+
Sbjct: 81 --PFIVDLIYAFQTGGKLYLILEYLSGGELFMQL-----EREGIFMEDTACFYLA-EISM 132
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRG 371
L +LH I++ D+KP NI L+ K++DFGL K+ +F G
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC------G 183
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
T Y+APE+ R G + D +S G ++++M+ G
Sbjct: 184 TIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGA 218
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 27/211 (12%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEFINEVASI-SRTSHVNIVP 262
+G+G + +V K ++ A+K++ LK E + I
Sbjct: 82 IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 263 FLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + ++ L+ ++ G L S R E + +A + ++ +H
Sbjct: 139 -LHYAFQDDNNLYLVMDYYVGGDL----LTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH 192
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEV 380
+ VH DIKP NI +D + +++DFG + + + S GT YI+PE+
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SVAVGTPDYISPEI 247
Query: 381 FCRHFGGVSH--KS-DVYSYGMMIHEMVIGR 408
GG D +S G+ ++EM+ G
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 43/216 (19%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHV----N 259
+G+G YA V K T R+ A+KV+K K+ + ++ + HV +
Sbjct: 17 IGRGSYAKVLLVRLKKT---DRIYAMKVVK--KE----LVNDDEDIDWVQTEKHVFEQAS 67
Query: 260 IVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315
PF L C++ + R + E++ G L ++ ++ E + A I+
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAE-ISL 121
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GT 372
L YLH I++ D+K N+ LD + K++D+G+ K+ + T GT
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-----TSTFCGT 173
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
YIAPE+ D ++ G+++ EM+ GR
Sbjct: 174 PNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 53/221 (23%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASI--------SRT 255
LG+G + V +K T + A+K +K KD + ++V
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALK--KD----VVLMDDDVECTMVEKRVLSLAW 75
Query: 256 SHVNIVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
H PF + ++ K+ + E++ G L +I + + R + A
Sbjct: 76 EH----PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAA- 125
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKKESFISMLDTR 370
I GL++LH + IV+ D+K NI LD+D KI+DFG+ K+ ++ T
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK-----TN 176
Query: 371 ---GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT YIAPE+ +H D +S+G++++EM+IG+
Sbjct: 177 TFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 211 LGQGGYADVY---KGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRT-----SHVNIV 261
LG G Y V+ K + D G+L A+KV+K K + RT H+
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLK--KATIVQKAKTTEHT-RTERQVLEHIRQS 118
Query: 262 PF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
PF L + ++ + + LI +++ G L + H S + T +Y I L
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIY--VGEIVLAL 172
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-----GT 372
E+LH + I++ DIK NI LD + ++DFGL+K+ F++ R GT
Sbjct: 173 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE------FVADETERAYDFCGT 223
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y+AP++ G D +S G++++E++ G
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 52/220 (23%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASI-------SRTS 256
LG+G + V K T GR A+K+++ K+ I +EVA T
Sbjct: 13 LGKGTFGKVILVREKAT---GRYYAMKILR--KE----VIIAKDEVAHTVTESRVLQNTR 63
Query: 257 HVNIVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVG 312
H PF L + ++ R + E+ G L ++ S + E R + A
Sbjct: 64 H----PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGA-E 113
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLD 368
I LEYLH + +V+ DIK N+ LD+D KI+DFGL K+ ++F
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---- 166
Query: 369 TRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT Y+APEV + D + G++++EM+ GR
Sbjct: 167 --GTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 53/221 (23%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASI--------SRT 255
LG+G + V K T G L AVKV+K KD I ++V
Sbjct: 31 LGKGSFGKVMLARVKET---GDLYAVKVLK--KD----VILQDDDVECTMTEKRILSLAR 81
Query: 256 SHVNIVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
+H PF L C++ R + EF+ G L +I +R E R + A
Sbjct: 82 NH----PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAA- 131
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISML 367
I L +LH I++ D+K N+ LD + K++DFG+ K+ +F
Sbjct: 132 EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC--- 185
Query: 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT YIAPE+ D ++ G++++EM+ G
Sbjct: 186 ---GTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 49/219 (22%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHV----N 259
LG+G + V KGT L AVK++K KD + ++V V
Sbjct: 28 LGKGSFGKVMLSERKGT---DELYAVKILK--KD----VVIQDDDVECTMVEKRVLALPG 78
Query: 260 IVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315
PF L C++ R + E++ G L +I R E V+ A IA
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAA-EIAI 132
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR----- 370
GL +L + I++ D+K N+ LD + KI+DFG+ K+ ++ D
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------NIWDGVTTKTF 181
Query: 371 -GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT YIAPE+ D +++G++++EM+ G+
Sbjct: 182 CGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 211 LGQGGYADV----YKGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHV----N 259
LG+G + V KGT L AVK++K KD + ++V V
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILK--KD----VVIQDDDVECTMVEKRVLALPG 399
Query: 260 IVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315
PF L C++ R + E++ G L +I R E V+ A IA
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAA-EIAI 453
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRG 371
GL +L + I++ D+K N+ LD + KI+DFG+ K+ ++F G
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------G 504
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
T YIAPE+ D +++G++++EM+ G+
Sbjct: 505 TPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 45/217 (20%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASISRTSHV----N 259
+G+G YA V K T R+ A++V+K K+ + ++ + HV +
Sbjct: 60 IGRGSYAKVLLVRLKKT---DRIYAMRVVK--KE----LVNDDEDIDWVQTEKHVFEQAS 110
Query: 260 IVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIAR 315
PF L C++ + R + E++ G L ++ ++ E + A I+
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAE-ISL 164
Query: 316 GLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ----TEKKESFISMLDTRG 371
L YLH I++ D+K N+ LD + K++D+G+ K+ + +F G
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------G 215
Query: 372 TAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
T YIAPE+ D ++ G+++ EM+ GR
Sbjct: 216 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGR 250
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 40/220 (18%)
Query: 209 DKLGQGGYADVYKG--TLPDGRLVAVKVMKNLKDNGEEF----INEVA---SISRTSHVN 259
++G+G Y V+K GR VA+K ++ ++ E I EVA + H N
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 260 IVPFLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV----YQIA 310
+V C + L++E + L Y+ + + T+ +Q+
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTETIKDMMFQLL 130
Query: 311 VGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR 370
RGL++LH R+VH D+KP NI + K++DFGLA+ + + S++ T
Sbjct: 131 ----RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183
Query: 371 GTAGYIAPEVF--CRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y APEV + V D++S G + EM +
Sbjct: 184 ---WYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 57/220 (25%), Positives = 88/220 (40%), Gaps = 51/220 (23%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKNLKDNGEEFI---NEVASI--------SRT 255
+G+G + V K AVKV++ K I E I
Sbjct: 46 IGKGSFGKVLLARHKAE---EVFYAVKVLQ--KK----AILKKKEEKHIMSERNVLLKNV 96
Query: 256 SHVNIVPF---LGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAV 311
H PF L F ++ + + +++ G L ++ + LE R + A
Sbjct: 97 KH----PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAA- 146
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR- 370
IA L YLH ++ IV+ D+KP NI LD ++DFGL K+ + S T
Sbjct: 147 EIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-----TST 198
Query: 371 --GTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
GT Y+APEV + D + G +++EM+ G
Sbjct: 199 FCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGL 236
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 54/246 (21%), Positives = 90/246 (36%), Gaps = 49/246 (19%)
Query: 191 APKRFSYSDVRRMTKSFSDKLGQGGYADVYKG---TLPDGRLVAVKVMKNLKDNGEEF-- 245
V + + K+G+G Y VYK D + A +K ++ G
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYA---LKQIEGTGISMSA 65
Query: 246 INEVASISRTSHVNIVPFLGFCYEKKKRA--LIYEFMPNGSLDQYIYDHESSNGKRT--- 300
E+A + H N++ R L++++ + L I H +S +
Sbjct: 66 CREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQ 124
Query: 301 LEWRTV----YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF----CPKISDFG 352
L V YQ I G+ YLH ++H D+KP NI + + KI+D G
Sbjct: 125 LPRGMVKSLLYQ----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 353 LAKQTEKKESFISMLDTRGTAG-------YIAPEVF--CRHFG-GVSHKSDVYSYGMMIH 402
A+ F S L Y APE+ RH+ + D+++ G +
Sbjct: 178 FAR------LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFA 227
Query: 403 EMVIGR 408
E++
Sbjct: 228 ELLTSE 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEFI-NEVASISRTSHVNIVP 262
LG G + V K + G A+K++ +K E NE + + +V
Sbjct: 49 LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+ ++ E++ G + ++ R E + A I EYLH
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFYAA-QIVLTFEYLH- 158
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GTAGYIAPE 379
++ +++ D+KP N+ +D+ +++DFG AK+ + + T GT +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--------TWTLCGTPEALAPE 208
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ G + D ++ G++I+EM G
Sbjct: 209 IILSK--GYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 211 LGQGGYADVY----KGTLPDGRLVAVKVMKN---LKDNGEEFI-NEVASISRTSHVNIVP 262
LG G + V+ + GR A+KV+K ++ E +E +S +H I+
Sbjct: 14 LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
G + ++ +I +++ G L + +R + A + LEYLH
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAA-EVCLALEYLH- 123
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR---GTAGYIAPE 379
+ I++ D+KP NI LD++ KI+DFG AK T GT YIAPE
Sbjct: 124 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--------TYTLCGTPDYIAPE 173
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
V + D +S+G++I+EM+ G
Sbjct: 174 VVSTK--PYNKSIDWWSFGILIYEMLAGY 200
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 65/287 (22%)
Query: 205 KSFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVP 262
K S LG G V + A+K++++ E V R S +IV
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 75
Query: 263 FLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+ YE ++ E + G L I D G + R +I I +
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQDR----GDQAFTEREASEIMKSIGEAI 130
Query: 318 EYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
+YLH +I I H D+KP N+ + K++DFG
Sbjct: 131 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------- 166
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK--NADVKVSCSSEYFPNAIYKQIET 432
A E + D++S G++++ ++ G ++ ++ S + +I
Sbjct: 167 --AKETTGEKYD---KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIRM 216
Query: 433 -EYDFQLD--GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+Y+F V+EE K + + + ++T P R ++T+ +
Sbjct: 217 GQYEFPNPEWSEVSEEVKMLIRNL-------LKTEPTQRMTITEFMN 256
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 31/163 (19%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEF----INEVASISRTSHVNIVPF 263
K+GQG + +V+K G+ VA+K + +++ E F + E+ + H N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 264 LGFCYEKKKRA--------LIYEFMPNGSLDQYIYDHE----SSNGKRTLEWRTVYQIAV 311
+ C K L+++F +H+ SN + ++
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 312 GIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354
+ GL Y+HR +I+H D+K N+ + D K++DFGLA
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 53/261 (20%), Positives = 88/261 (33%), Gaps = 76/261 (29%)
Query: 210 KLGQGGYADVYKG-TLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFC 267
KLG G ++ V+ + + VA+KV+K+ + E ++E+ + + + P
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 268 YEKKKRALIYEFM---PNGS--------LDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
L+ +F NG+ L ++ + + L V +I + +G
Sbjct: 104 -----VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRL------------------------------------ 340
L+YLH C I +H DIKP NI L
Sbjct: 159 LDYLHTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 341 -------------DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGG 387
E KI+D G A K + T Y + EV G
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGS--G 269
Query: 388 VSHKSDVYSYGMMIHEMVIGR 408
+ +D++S M E+ G
Sbjct: 270 YNTPADIWSTACMAFELATGD 290
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 40/134 (29%), Positives = 57/134 (42%), Gaps = 17/134 (12%)
Query: 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334
++ E M +L Q I L +YQ+ G+++LH I+H D+K
Sbjct: 107 IVMELMDA-NLCQVIQMELDHERMSYL----LYQML----CGIKHLHSA---GIIHRDLK 154
Query: 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDV 394
P NI + D KI DFGLA+ M T Y APEV G D+
Sbjct: 155 PSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDI 209
Query: 395 YSYGMMIHEMVIGR 408
+S G ++ EM+ G
Sbjct: 210 WSVGCIMGEMIKGG 223
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 47/210 (22%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISR------TSHVNIV 261
+G+G + V K + VA+K+++N K + E+ + + +N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L + + +E L +Y+ N + V + A I + L+ LH
Sbjct: 163 HMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCP--KISDFGLA-KQTEKKESFISMLDTRGTAGYIAP 378
+ RI+H D+KP NI L + K+ DFG + + ++ ++I +R Y AP
Sbjct: 218 K---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SR---FYRAP 268
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
EV D++S G ++ E++ G
Sbjct: 269 EVILGA--RYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 24/210 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISR------TSHVNIV 261
+G+G + V K + VA+K++KN K + EV + IV
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
+ L++E L +YD + R + + A + L +L
Sbjct: 120 HLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCP--KISDFGLA-KQTEKKESFISMLDTRGTAGYIAP 378
+ I+H D+KP NI L KI DFG + + ++ +I +R Y +P
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ---SR---FYRSP 227
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
EV D++S G ++ EM G
Sbjct: 228 EVLLGM--PYDLAIDMWSLGCILVEMHTGE 255
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 52/221 (23%), Positives = 79/221 (35%), Gaps = 38/221 (17%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEE---FINEVASISRT---------- 255
+ G Y V G +G VA+K + N +G + R
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLNHF 86
Query: 256 SHVNIVPFLGFCYEKKKRA-----LIYEFMPNGSLDQYIYDHE---SSNGKRTLEWRTVY 307
H NI+ ++ A L+ E M L Q I+D S + +Y
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF----MY 141
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
I GL LH +VH D+ P NI L ++ I DF LA++ +
Sbjct: 142 HIL----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKT 191
Query: 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
Y APE+ F G + D++S G ++ EM +
Sbjct: 192 HYVTHRWYRAPELVM-QFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 28/209 (13%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASISRTSHVNIVPFLG 265
+G G Y V G VA+K + + E+ + H N++ L
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 266 -FCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
F R L+ FM L + + S + L VYQ+ +GL+Y
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYL----VYQML----KGLKY 141
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPE 379
+H +VH D+KP N+ ++ED KI DFGLA+ + M T Y APE
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPE 193
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
V + + D++S G ++ EM+ G+
Sbjct: 194 VILS-WMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 25/208 (12%)
Query: 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340
D + K L + + +A+G+E+L + + +H D+ NI L
Sbjct: 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILL 226
Query: 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGV-SHKSDVYSYGM 399
E KI DFGLA+ K ++ D R ++APE F V + +SDV+S+G+
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI---FDRVYTIQSDVWSFGV 283
Query: 400 MIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE---YDFQLDGVVTEEEKEMAKKMILV 456
++ E+ S P Y ++ + +G +M
Sbjct: 284 LLWEIF------------SLGASP---YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328
Query: 457 SLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
L C P RP+ +++VE L ++
Sbjct: 329 MLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 10/97 (10%)
Query: 206 SFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKDNGE--EFINEVAS-ISRTS 256
LG+G + V + R VAVK++K + E ++E+ I
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 257 HVNIVPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDH 292
H+N+V LG C + +I EF G+L Y+
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 60/273 (21%), Positives = 97/273 (35%), Gaps = 48/273 (17%)
Query: 159 SSCKNCSSCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRR----MTKSFSD--KLG 212
+ + C + + + + + +S +V + K + + +G
Sbjct: 13 TLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSV-EVGDSTFTVLKRYQNLKPIG 71
Query: 213 QGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFIN---------EVASISRTSHVNIVP 262
G V R VA+K + F N E+ + +H NI+
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 263 FLG-FCYEKKKRA-----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
L F +K L+ E M +L Q I L +YQ+ G
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYL----LYQML----CG 176
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
+++LH I+H D+KP NI + D KI DFGLA+ M T Y
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYR 230
Query: 377 APEV-FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
APEV + D++S G ++ EMV +
Sbjct: 231 APEVILGMGY---KENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
VYQ+ +GL Y+H I+H D+KP N+ ++ED KI DFGLA+Q +
Sbjct: 134 VYQML----KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----E 181
Query: 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
M T Y APEV + + D++S G ++ EM+ G+
Sbjct: 182 MTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQI RGL+Y+H I+H D+KP N+ ++ED KI DFGLA+ T
Sbjct: 138 IYQIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----E 185
Query: 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
M T Y APE+ + + D++S G ++ E++ GR
Sbjct: 186 MTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 15/107 (14%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQI RGL+Y+H ++H D+KP N+ L+ KI DFGLA+ +
Sbjct: 134 LYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 366 ML----DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
L TR Y APE+ + G + D++S G ++ EM+ R
Sbjct: 187 FLTEYVATR---WYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 24/179 (13%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVP-FLGFC 267
K+G G + ++ G L VA+K+ K + E + + +P F
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 268 YEKKKRALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
K A++ E + G SL+ + + +L+ TV IA+ + +EY+H +
Sbjct: 75 PCGKYNAMVLELL--GPSLEDL---FDLCDRTFSLK--TVLMIAIQLISRMEYVH---SK 124
Query: 327 RIVHLDIKPHN--IRLDEDFCPK---ISDFGLAKQ-----TEKKESFISMLDTRGTAGY 375
+++ D+KP N I + + I DF LAK+ T+K + GTA Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 29/105 (27%), Positives = 52/105 (49%), Gaps = 10/105 (9%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP-KISDFGLAKQTEKKESFI 364
+YQ+ RGL+Y+H ++H D+KP N+ ++ + KI DFGLA+ + S
Sbjct: 126 MYQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 365 SML-DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
L + T Y +P + + D+++ G + EM+ G+
Sbjct: 179 GHLSEGLVTKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 39/234 (16%), Positives = 76/234 (32%), Gaps = 55/234 (23%)
Query: 160 SCKNCSSCSYHKETRHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFS--------DKL 211
S ++ H + + + + R + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 212 GQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRT----------SHVNI 260
G G Y V + + R+VA+K + F + + R +H ++
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKKILR------VFEDLIDC-KRILREIAILNRLNHDHV 114
Query: 261 VPFLGFCYEKKKRA-----LIYEFMPNGSLDQYIY-------DHESSNGKRTLEWRTVYQ 308
V L K ++ E + + H +TL +Y
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELH-----IKTL----LYN 164
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362
+ G++Y+H I+H D+KP N +++D K+ DFGLA+ + E+
Sbjct: 165 LL----VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 36/170 (21%), Positives = 62/170 (36%), Gaps = 34/170 (20%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMK-------NLKD--------NGEEFINEVASIS 253
K+G GG+ +Y A V+K L ++ I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 254 RTSHVNIVPFLGF----CYEKKKRALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTVYQ 308
+ ++ I F G + R ++ E + G L + NG TV Q
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS----GQNGTFKK--STVLQ 155
Query: 309 IAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI--SDFGLAKQ 356
+ + + LEY+H VH DIK N+ L ++ +D+GL+ +
Sbjct: 156 LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 33/171 (19%), Positives = 66/171 (38%), Gaps = 33/171 (19%)
Query: 210 KLGQGGYADVYKGT---------LPDGRLVAVKV-MKNLKDNGE----------EFINEV 249
+ +Y+ P + ++K+ K+ + E +N+
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 250 ASISRTSHVNIVPFLGF-CYEKKKRALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTVY 307
+ T + I +GF ++ K R L+ + G SL + + K L R+V
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL----DVSPKHVLSERSVL 162
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI--SDFGLAKQ 356
Q+A + LE+LH VH ++ NI +D + ++ + +G A +
Sbjct: 163 QVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 36/179 (20%), Positives = 74/179 (41%), Gaps = 24/179 (13%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVP-FLGFC 267
++G+G + +++GT L + + VA+K + + + +E + + +P F
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 268 YEKKKRALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
E L+ + + G SL+ + K +++ TV A + ++ +H
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDL---LDLCGRKFSVK--TVAMAAKQMLARVQSIH---EK 125
Query: 327 RIVHLDIKPHNIRLDEDFCPK-----ISDFGLAKQ-----TEKKESFISMLDTRGTAGY 375
+V+ DIKP N + + DFG+ K T++ + + GTA Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 7e-09
Identities = 25/187 (13%), Positives = 48/187 (25%), Gaps = 44/187 (23%)
Query: 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---------EEFINEVA---------S 251
K+G+G + +V++ D VA+K++ + EE + E+
Sbjct: 27 KIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 252 ISRTSHVNIVPFLGFC----------------YEKKKRALIYEFMPNGSLDQYIYDHESS 295
+ Y K + +I
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 296 NG-------KRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348
G + T I + L ++R H D+ N+ L + K+
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKL 203
Query: 349 SDFGLAK 355
K
Sbjct: 204 HYTLNGK 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 43/251 (17%), Positives = 87/251 (34%), Gaps = 54/251 (21%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE---FINEVASISRTSHVNIVPFL 264
+G+G Y VY + VA+K + + ++ + + E+ ++R I+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 265 GFCYEKKKRA-----LIYEFMPNGSLDQYIY-------DHESSNGKRTLEWRTVYQIAVG 312
++ E + L + +H +T+ +Y +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEH-----IKTI----LYNLL-- 139
Query: 313 IARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372
G ++H I+H D+KP N L++D K+ DFGLA+ ++ + D
Sbjct: 140 --LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 373 AG--------------------YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412
Y APE+ + D++S G + E++ ++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKSIDIWSTGCIFAELLNMLQSHI 253
Query: 413 VKVSCSSEYFP 423
+ FP
Sbjct: 254 NDPTNRFPLFP 264
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 28/111 (25%), Positives = 52/111 (46%), Gaps = 16/111 (14%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+YQ R ++ LH ++H D+KP N+ ++ + K+ DFGLA+ ++ + S
Sbjct: 118 IYQTL----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 366 MLDTRGTA--GYI------APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+ + ++ APEV S DV+S G ++ E+ + R
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRR 220
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 36/172 (20%), Positives = 63/172 (36%), Gaps = 35/172 (20%)
Query: 210 KLGQGGYADVYKGT------LPDGRLVAVKVMKN----LKD--------NGEEFINEVAS 251
+GQGG+ +Y + VKV + L E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 252 ISRTSHVNIVPFLGF----CYEKKKRALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTV 306
+ ++ + + G K R +I + G L + + + +TV
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN-----AKRFSRKTV 154
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI--SDFGLAKQ 356
Q+++ I LEY+H VH DIK N+ L+ ++ D+GLA +
Sbjct: 155 LQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 44/177 (24%), Positives = 71/177 (40%), Gaps = 22/177 (12%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVP-FLGFC 267
K+G G + D+Y GT + G VA+K+ K + E +P
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECV-KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 268 YEKKKRALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
E ++ E + G SL+ + K +L+ TV +A + +EY+H +
Sbjct: 75 AEGDYNVMVMELL--GPSLEDL---FNFCSRKFSLK--TVLLLADQMISRIEYIH---SK 124
Query: 327 RIVHLDIKPHNI---RLDEDFCPKISDFGLAKQ-----TEKKESFISMLDTRGTAGY 375
+H D+KP N + I DFGLAK+ T + + + GTA Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 22/177 (12%)
Query: 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVP-FLGFC 267
K+G G + ++Y GT + VA+K+ K + + E +P F
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 268 YEKKKRALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
E L+ + + G SL+ + K +L +TV +A + +E++H +
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDL---FNFCSRKLSL--KTVLMLADQMINRVEFVH---SK 122
Query: 327 RIVHLDIKPHNIRLDEDFCPK---ISDFGLAKQ-----TEKKESFISMLDTRGTAGY 375
+H DIKP N + I DFGLAK+ T + + + GTA Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 28/122 (22%), Positives = 52/122 (42%), Gaps = 27/122 (22%)
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
VYQ+ + ++YLH G ++H D+KP NI L+ + K++DFGL++ +
Sbjct: 115 VYQLI----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 366 MLDTRGTAG-------------------YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI 406
+ Y APE+ + D++S G ++ E++
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILC 226
Query: 407 GR 408
G+
Sbjct: 227 GK 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 50/226 (22%), Positives = 83/226 (36%), Gaps = 38/226 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISR-----TSHVNIVP 262
K+G G + V + + + AVKV++N+K E + + ++ NIV
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
+ G LI+E L +Y+ + N + + I + L YL +
Sbjct: 101 YHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR------GTAGYI 376
+ + H D+KP NI LD+ + K KK T G A +
Sbjct: 156 ---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 377 --------------APEVFCRHFG-GVSHKSDVYSYGMMIHEMVIG 407
APEV G SD++S+G ++ E+ G
Sbjct: 213 SDYHGSIINTRQYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 44/227 (19%), Positives = 79/227 (34%), Gaps = 44/227 (19%)
Query: 209 DKLGQGGYADVYKG--TLPDGRLVAVKVMKNLKDNGEEFINEVASISR------TSHVNI 260
LG+G + V + VA+K+++N+ E E+ + + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
V + + +E L + ++ N + V +A + L +L
Sbjct: 85 VLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCP-------------------KISDFGLAKQTEKKE 361
H ++ H D+KP NI +++DFG A T E
Sbjct: 140 HE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHE 194
Query: 362 SFISMLDTRGTAGYIAPEVFCRHFG-GVSHKSDVYSYGMMIHEMVIG 407
+++ TR Y PEV G + DV+S G ++ E G
Sbjct: 195 HHTTIVATR---HYRPPEVI---LELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 56/227 (24%), Positives = 87/227 (38%), Gaps = 44/227 (19%)
Query: 209 DKLGQGGYADVYKG--TLPDGRLVAVKVMKNLKDNGEEFINEVASISR------TSHVNI 260
D LG+G + V + GR VAVK++KN+ E +E+ + S
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
V L + +++E L YD NG + ++A I + + +L
Sbjct: 80 VQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCP-------------------KISDFGLAKQTEKKE 361
H ++ H D+KP NI + K+ DFG A T E
Sbjct: 135 HS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDE 189
Query: 362 SFISMLDTRGTAGYIAPEVFCRHFG-GVSHKSDVYSYGMMIHEMVIG 407
+++ TR Y APEV G S DV+S G ++ E +G
Sbjct: 190 HHSTLVSTR---HYRAPEVI---LALGWSQPCDVWSIGCILIEYYLG 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 3e-06
Identities = 60/476 (12%), Positives = 127/476 (26%), Gaps = 163/476 (34%)
Query: 21 PSLNLNCENDTAT-LVLGEVKYRVLNIDQKEQ----LL--------RIAKQVYFDGFCPQ 67
P+ ++ + L + ++ + + + + LL + F+ C
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN--AFNLSCK- 267
Query: 68 RNFTIDSTLFTYADGYKMLTLISGCPTMSGNSVCYINGLNYANGFMQTGSPDCNFSVTIP 127
L T K +T +S + +I+ +++ T
Sbjct: 268 -------ILLTTRF--KQVTDF-----LSAATTTHISLDHHSMTL------------TPD 301
Query: 128 VAETLLSAAKG-SLAGLKEALETGFELKWKLNSSCKNCSSCSYHKETRHDQNAEAAFVRN 186
++LL L + T + S A +R+
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRR---------LSII-------------AESIRD 339
Query: 187 YGSLAPKRFSY------SDVRRMTKSFSDKLGQGGYADVYK--GTLPDGRLVAVKVMKNL 238
+ + + +S + L Y ++ P + ++ +
Sbjct: 340 G----LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
Query: 239 -----KDNGEEFINEVASIS---------------------------RTSHVNIVPFLGF 266
K + +N++ S H +IV
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD---- 451
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDH------ESSNGKRTLEWRTVYQIAVGIARGLEYL 320
Y K + +P LDQY Y H + +R +R V+
Sbjct: 452 HYNIPKTFDSDDLIPP-YLDQYFYSHIGHHLKNIEHPERMTLFRMVF------------- 497
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCP-KISDFGLAKQTEKKESFISML-DTRGTAGYIAP 378
LD F KI A S ++ L + YI
Sbjct: 498 -------------------LDFRFLEQKIRHDSTAWNA--SGSILNTLQQLKFYKPYICD 536
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD-VKVSCSSEYFPNAIYKQIETE 433
+ + + + + I E +I K D ++++ +E AI+++ +
Sbjct: 537 N--DPKYERLV--NAILDFLPKIEENLICSKYTDLLRIALMAED--EAIFEEAHKQ 586
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.64 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.56 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.47 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.32 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.54 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.44 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.06 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.32 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.49 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=444.57 Aligned_cols=261 Identities=24% Similarity=0.375 Sum_probs=214.1
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
..+.+|.++||+|+||+||+|.+. +++.||||+++... ...++|.+|+.++++++|||||+++|+|.+.+..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 344568899999999999999853 46789999997543 2347899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED 343 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~ 343 (511)
+||||||++|+|.++|...... .....++|..++.|+.|||.||+|||++ +||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 9999999999999999754311 1135699999999999999999999998 99999999999999999
Q ss_pred CceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCc
Q 040808 344 FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYF 422 (511)
Q Consensus 344 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~ 422 (511)
+.+||+|||+|+...............||+.|+|||++.+ +.++.++|||||||+||||+| |+.||... -
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-------~ 252 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-------S 252 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-------C
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCC-------C
Confidence 9999999999987755443333445679999999999965 478999999999999999998 88898633 1
Q ss_pred hHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 423 PNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
...+...+..+.....+.. ....+.+++.+||+.||++||||+||++.|+..
T Consensus 253 ~~~~~~~i~~~~~~~~p~~-------~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 NQDVVEMIRNRQVLPCPDD-------CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCCCCCccc-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3344555555443333332 234577888999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=437.41 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=202.2
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.+.++||+|+||+||+|++++ .||||+++..... .++|.+|+.++++++|||||+++|++.+ +..+||||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 578899999999999999753 5999999754333 3679999999999999999999998865 568999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.++|.... ..++|..++.|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+.......
T Consensus 116 GsL~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 116 SSLYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CBHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999996432 4699999999999999999999998 999999999999999999999999999987754433
Q ss_pred eeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
........||+.|||||++.+. .+.++.++|||||||+||||+||+.||.... ....+...+....... .
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~------~~~~~~~~~~~~~~~p---~ 258 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN------NRDQIIFMVGRGYASP---D 258 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHTTCCCC---C
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC------hHHHHHHHHhcCCCCC---C
Confidence 3334456799999999999643 2468999999999999999999999996321 1233333333332211 1
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
......+....+.+++.+||+.||++||||.||+++|+.+...+
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11111223455778889999999999999999999998765443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-56 Score=441.57 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=205.7
Q ss_pred hhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.+.++||+|+||+||+|.++ +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46689999999999999854 478899999986433 24689999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 279 FMPNGSLDQYIYDHESS---------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
||++|+|.++|+..... .....++|..++.|+.|||.||+|||+. +|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 99999999999765321 1235799999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 428 (511)
|||+|+...............||+.|||||++.+. .++.++|||||||+||||+| |+.||... -...+..
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-------~~~~~~~ 271 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQL-------SNTEAID 271 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSS-------CHHHHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCC-------CHHHHHH
Confidence 99999977554433333456799999999999764 78999999999999999999 89998633 1334455
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.+..+.....+...+ ..+.+++.+||+.||++||||+||+++|+.+.+
T Consensus 272 ~i~~g~~~~~p~~~~-------~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 CITQGRELERPRACP-------PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHTCCCCCCTTCC-------HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCccccc-------HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 555554444443333 346778899999999999999999999998765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=441.44 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=213.5
Q ss_pred HhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC-hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN-GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.+.++||+|+||+||+|.+. +++.||||+++..... .++|.+|+++|++++|||||+++|+|.+.+..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 456789999999999999853 4778999999865432 468999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhccc-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 278 EFMPNGSLDQYIYDHE-------SSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
|||++|+|.++|.... .......++|..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence 9999999999997642 112345799999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||+|+...............||+.|+|||++.+. .++.++|||||||+||||+| |+.||... -...+...
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-------~~~~~~~~ 242 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQL-------SNNEVIEC 242 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTS-------CHHHHHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHH
Confidence 9999877655443333345699999999999764 78999999999999999998 89998643 23445555
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
+..+.....+...+ ..+.+++.+||+.||++||||++|++.|+.+.+.
T Consensus 243 i~~~~~~~~p~~~~-------~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRVLQRPRTCP-------QEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCccch-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 55554444333333 3567788999999999999999999999986543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=422.93 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=198.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||+||+|+++ +|+.||||+++..... .+++.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 567789999999999999954 6999999999764332 367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+||+|.++|.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+++|.+||+|||+|+.....
T Consensus 106 ~gg~L~~~i~~~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 106 EGGDLFKRINAQK----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp TTCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCcHHHHHHHcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999996532 34678999999999999999999998 9999999999999999999999999999877543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+..........
T Consensus 179 ~~~--~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~~~~ 247 (350)
T 4b9d_A 179 VEL--ARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIISGSFPPVSL 247 (350)
T ss_dssp HHH--HHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCCT
T ss_pred ccc--ccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCCCCc
Confidence 221 2234699999999999764 68999999999999999999999996432 233334443333223333
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.++++ +.+++.+||+.||++|||++|+++
T Consensus 248 ~~s~~-------~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYSYD-------LRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSCHH-------HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHH-------HHHHHHHHccCChhHCcCHHHHhc
Confidence 44443 455667788999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=420.35 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=200.3
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecC----eEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK----KRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~ 280 (511)
+.+.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++++|.+.+ ..+||||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 34568999999999999998 5799999999754322223334566667889999999999998653 679999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC-----NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
++|+|.++|+. ..++|..+.+|+.|++.||+|||+++ ..+|+||||||+|||||+++.+||+|||+|+
T Consensus 84 ~~gsL~~~l~~-------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 84 EHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp TTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCcHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999954 35899999999999999999999752 3489999999999999999999999999998
Q ss_pred ccCCCCcee--eecCCCCCCCccchhhccccc----CCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------CC
Q 040808 356 QTEKKESFI--SMLDTRGTAGYIAPEVFCRHF----GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--------EY 421 (511)
Q Consensus 356 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--------~~ 421 (511)
......... ......||+.|+|||++.+.. +.++.++|||||||+||||+||+.|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 775543322 122346999999999986431 2467899999999999999999887753321110 11
Q ss_pred chHHHHHHHhhhhccccCCCCChH--HHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 422 FPNAIYKQIETEYDFQLDGVVTEE--EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+.+.+... .+++.++.. ..+..+.+.+++.+||+.||++||||.||+++|+.+.+
T Consensus 237 ~~~~~~~~~~~~---~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQ---KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTS---CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc---cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 112222222111 111222221 22456678899999999999999999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=428.60 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=217.1
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcCC------CcEEEEEEeccCCCC--hHHHHHHHHHHHccCC-cceeeeeceEeec
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLPD------GRLVAVKVMKNLKDN--GEEFINEVASISRTSH-VNIVPFLGFCYEK 270 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h-~niv~l~~~~~~~ 270 (511)
+.+..+.+.++||+|+||+||+|.+.. ++.||||+++..... .++|.+|+++|.++.| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 444556778999999999999998532 368999999765432 3579999999999965 8999999999764
Q ss_pred -CeEEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 271 -KKRALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 271 -~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
+..++|||||++|+|.++|+..... .....++|..+..|+.|||+||+|||++ +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 5689999999999999999764321 1235689999999999999999999998 9999999999999
Q ss_pred EcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCC
Q 040808 340 LDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCS 418 (511)
Q Consensus 340 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~ 418 (511)
|++++.+||+|||+|+...............||+.|||||++.+. .++.++|||||||+||||+| |+.||....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~--- 292 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVK--- 292 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC---
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCC---
Confidence 999999999999999987666555555566799999999999764 78999999999999999998 899986321
Q ss_pred CCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 419 SEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+.+.+..+..+..+...++ .+.+++.+||+.||++|||++||++.|+.+++
T Consensus 293 ---~~~~~~~~i~~g~~~~~p~~~~~-------~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 293 ---IDEEFCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ---CSHHHHHHHHHTCCCCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCCCCCccCCH-------HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 23445555666555544444433 46678889999999999999999999998765
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=413.65 Aligned_cols=245 Identities=23% Similarity=0.308 Sum_probs=205.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|+.+ +|+.||||++++. ....+.+.+|+++|++++|||||++++++.+.+..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 677899999999999999954 6999999999743 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++||+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+....
T Consensus 114 ~~gG~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 114 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999643 4699999999999999999999998 999999999999999999999999999998765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
..........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...+...+... .+.++
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~-~~~~p 254 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGN-------EGLIFAKIIKL-EYDFP 254 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHT-CCCCC
T ss_pred CCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcC-CCCCC
Confidence 4433334566899999999999764 68899999999999999999999996431 33344444332 23344
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
..++++. .+++.+||+.||++|||++|++
T Consensus 255 ~~~s~~~-------~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 255 EKFFPKA-------RDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp TTCCHHH-------HHHHHHHSCSSGGGSTTSGGGT
T ss_pred cccCHHH-------HHHHHHHccCCHhHCcChHHHc
Confidence 4555544 4455667799999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=417.48 Aligned_cols=260 Identities=22% Similarity=0.216 Sum_probs=204.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.+.++||+|+||+||+|+++ +|+.||||+++.... +.+|+.++++++|||||++++++.+.+..+|||||++||
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 345678999999999999965 699999999986432 247999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccccCCCCc
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQTEKKES 362 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~~ 362 (511)
+|.++|... ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.+| .+||+|||+|+.......
T Consensus 136 ~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 136 SLGQLIKQM------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999643 4699999999999999999999998 999999999999999988 699999999998754332
Q ss_pred e---eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-c-cc
Q 040808 363 F---ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-D-FQ 437 (511)
Q Consensus 363 ~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-~~ 437 (511)
. ......+||+.|||||++.+. .++.++|||||||++|||++|+.||..... .... ..+.... . ..
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~----~~i~~~~~~~~~ 277 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFR---GPLC----LKIASEPPPIRE 277 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCC---SCCH----HHHHHSCCGGGG
T ss_pred ccceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHH----HHHHcCCCCchh
Confidence 1 112234699999999999764 689999999999999999999999964321 1111 1222211 1 11
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~ 493 (511)
++..+++ .+.+++.+||+.||++|||+.|+++.|...+..+..-.+|.+
T Consensus 278 ~~~~~s~-------~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 278 IPPSCAP-------LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp SCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred cCccCCH-------HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 2233343 345566778899999999999999999887766554445543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=415.56 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=202.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|++.++||+|+||+||+|.++ +|+.||||+++... ...+.+.+|+.+|++++|||||++++++.+.+..+||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 566789999999999999965 69999999997543 3456789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+.......
T Consensus 156 g~L~~~l~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 156 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999853 3589999999999999999999998 999999999999999999999999999998755432
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc--CC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL--DG 440 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 440 (511)
. ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... +..+...+.......+ ..
T Consensus 226 ~--~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~~~~~~~~~~ 294 (346)
T 4fih_A 226 R--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDNLPPRLKNLH 294 (346)
T ss_dssp C--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSSCCCCSCGG
T ss_pred c--ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCCCCccc
Confidence 2 2356799999999999654 68999999999999999999999996331 2334444443322211 12
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+++ .+.+++.+||+.||++|||++|+++
T Consensus 295 ~~s~-------~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSP-------SLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCH-------HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCH-------HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2333 3456677788999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=405.75 Aligned_cols=242 Identities=26% Similarity=0.386 Sum_probs=195.9
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEee----cCeEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYE----KKKRALIY 277 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 277 (511)
.|.++||+|+||+||+|.+. +++.||+|++..... ..++|.+|++++++++|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999965 689999999975432 23579999999999999999999999865 35689999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCEEEc-CCCceEEeeccCc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR--IVHLDIKPHNIRLD-EDFCPKISDFGLA 354 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DFGla 354 (511)
|||++|+|.+++... ..+++..+..|+.||+.||+|||++ + |+||||||+||||+ +++.+||+|||+|
T Consensus 109 Ey~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred eCCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 999999999999643 4699999999999999999999997 6 99999999999998 4899999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+...... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||.... ....+.+.+....
T Consensus 180 ~~~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~------~~~~~~~~i~~~~ 246 (290)
T 3fpq_A 180 TLKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGV 246 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTC
T ss_pred EeCCCCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCC------cHHHHHHHHHcCC
Confidence 8654432 234579999999999853 58899999999999999999999995321 1334444444332
Q ss_pred cc-ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DF-QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ..+...++ .+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~-------~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPASFDKVAIP-------EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGGGCCCH-------HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCccCCH-------HHHHHHHHHccCChhHCcCHHHHhc
Confidence 21 12222333 3556778899999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=398.88 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=189.5
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.|.+.++||+|+||+||+|..+ +|+.||||++++.. ...+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3567889999999999999964 69999999997532 234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+ +|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+...
T Consensus 94 y~-~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 94 YA-GNELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp CC-CEEHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred CC-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99 78999999643 4699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... .....||+.|+|||++.+. ...+.++||||+||++|||++|+.||.... ...+.+.+... ...+
T Consensus 164 ~~~~---~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~~~-~~~~ 231 (275)
T 3hyh_A 164 DGNF---LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNISNG-VYTL 231 (275)
T ss_dssp --------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHT-CCCC
T ss_pred CCCc---cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcC-CCCC
Confidence 4432 2345799999999999764 235689999999999999999999996431 23344444433 2333
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+..++++ +.+++.+||+.||++|||++|+++
T Consensus 232 p~~~s~~-------~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFLSPG-------AAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTSCHH-------HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCHH-------HHHHHHHHccCChhHCcCHHHHHc
Confidence 4445544 445666788999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=416.57 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=202.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.++||+|+||+||+|.++ +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+..+||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 566789999999999999965 69999999997543 3346789999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ..+++..+..|+.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 233 G~L~~~i~~-------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 233 GALTDIVTH-------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CcHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999853 3589999999999999999999998 999999999999999999999999999987754432
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc--CC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL--DG 440 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 440 (511)
. ....+||+.|||||++.+. .++.++|||||||++|||++|+.||... -+..++..+.......+ ..
T Consensus 303 ~--~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~-------~~~~~~~~i~~~~~~~~~~~~ 371 (423)
T 4fie_A 303 R--RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNE-------PPLKAMKMIRDNLPPRLKNLH 371 (423)
T ss_dssp C--BCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHSCCCCCSCTT
T ss_pred c--ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCc-------CHHHHHHHHHcCCCCCCcccc
Confidence 1 2355799999999999764 6899999999999999999999999633 13334444444322211 22
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+++ .+.+++.+||+.||++|||++|+++
T Consensus 372 ~~s~-------~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSP-------SLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCH-------HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCH-------HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3343 3455667788999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=395.52 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=188.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecC----------
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKK---------- 271 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---------- 271 (511)
|.+.+.||+|+||+||+|+.+ +|+.||||+++..... .+++.+|+.+|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 456789999999999999965 6999999999754332 357899999999999999999999987544
Q ss_pred --eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 272 --KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 272 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
..++||||+++|+|.+++.... .....++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC---TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC---SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC---CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999996533 123456778899999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCce----------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC
Q 040808 350 DFGLAKQTEKKESF----------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS 419 (511)
Q Consensus 350 DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~ 419 (511)
|||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||++ ||...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~----- 230 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQ----- 230 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSH-----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCc-----
Confidence 99999877543221 112345699999999999764 78999999999999999996 55321
Q ss_pred CCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCC
Q 040808 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKP 491 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p 491 (511)
......+..... ...++...+.......++.+||+.||++|||+.|+++. ..++++..|.++
T Consensus 231 ----~~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h--~~~~~~~~p~~~ 292 (299)
T 4g31_A 231 ----MERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN--AVFEDLDFPGKT 292 (299)
T ss_dssp ----HHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS--GGGCCC------
T ss_pred ----cHHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhCCCCCCCch
Confidence 111111111111 22333344444455678899999999999999999762 334445545443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=400.87 Aligned_cols=243 Identities=25% Similarity=0.319 Sum_probs=191.6
Q ss_pred HhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
|++.++||+|+||+||+|+.. .++.||||++++.. ....++.+|+++|++++|||||++++++.+.+..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 567889999999999999852 47899999997532 22357889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||++||+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+..
T Consensus 106 Ey~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp CCCTTCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EcCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999643 4699999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...+...+... ...
T Consensus 177 ~~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~-~~~ 244 (304)
T 3ubd_A 177 IDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKD-------RKETMTMILKA-KLG 244 (304)
T ss_dssp ----C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC-CCC
T ss_pred cCCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcC-------HHHHHHHHHcC-CCC
Confidence 44332 12345799999999999764 78899999999999999999999996432 23333433332 233
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCH-----HHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM-----TKVV 475 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~-----~evl 475 (511)
.+..++++ +.+++.+||+.||++|||+ +|++
T Consensus 245 ~p~~~s~~-------~~~li~~~L~~dP~~R~ta~~~~~~eil 280 (304)
T 3ubd_A 245 MPQFLSPE-------AQSLLRMLFKRNPANRLGAGPDGVEEIK 280 (304)
T ss_dssp CCTTSCHH-------HHHHHHHHTCSSGGGSTTCSTTTHHHHH
T ss_pred CCCcCCHH-------HHHHHHHHcccCHHHCCCCCcCCHHHHH
Confidence 34445544 4456677889999999984 5665
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=390.06 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=193.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEee------cCeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYE------KKKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 274 (511)
|.+.++||+|+||+||+|.++ +|+.||||++++.... .+.+++|+++|++++|||||++++++.. .+..+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 567789999999999999964 6999999999765433 3568899999999999999999998753 36789
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
||||||+ |+|.+++.. ...+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 136 ivmE~~~-g~L~~~i~~------~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHS------SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEECCS-EEHHHHHTS------SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeCCC-CCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 9999995 789999943 35799999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCc--eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 355 KQTEKKES--FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 355 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
+.+..... .......+||+.|+|||++.+. ..++.++||||+||++|||++|+.||.... ....+..+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~-------~~~~l~~I~~ 277 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKN-------YVHQLQLIMM 277 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-------HHHHHHHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCC-------HHHHHHHHHH
Confidence 87643221 1123456799999999998654 357899999999999999999999996432 1111111111
Q ss_pred hhcc-------------------ccCCCCChHHH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYDF-------------------QLDGVVTEEEK----EMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~~-------------------~~~~~~~~~~~----~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... .++........ .......+++.+||+.||++|||++|+++
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1100 00000000000 11234556778899999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=383.26 Aligned_cols=195 Identities=21% Similarity=0.331 Sum_probs=166.5
Q ss_pred HhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++|.++ +|||||++++++.+.++.++||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 567789999999999999743 46789999987543 456788999999988 599999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-CceEEeeccCccccC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTE 358 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~~~ 358 (511)
+++|+|.+++ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus 102 ~~g~~L~~~~---------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 102 LEHESFLDIL---------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp CCCCCHHHHH---------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CCcccHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 9999999998 2489999999999999999999998 99999999999999876 799999999998654
Q ss_pred CCCce--------------------------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 359 KKESF--------------------------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 359 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
..... ......+||+.|+|||++.+. ..++.++||||+||++|||++|+.||.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 32110 012234699999999999654 357899999999999999999999995
Q ss_pred C
Q 040808 413 V 413 (511)
Q Consensus 413 ~ 413 (511)
.
T Consensus 249 ~ 249 (361)
T 4f9c_A 249 K 249 (361)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=395.83 Aligned_cols=245 Identities=26% Similarity=0.311 Sum_probs=194.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHH---HHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFIN---EVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
|.+.+.||+|+||+||+|+.+ +|+.||||++++. ........+ ++.+++.++|||||++++++.+.+..|||
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 345688999999999999965 6999999999743 222333444 46677778999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||++||+|.++|... ..+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.
T Consensus 271 mEy~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp ECCCCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999643 4699999999999999999999998 999999999999999999999999999988
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
...... ...+||+.|||||++.+. ..++.++|||||||++|||++|+.||...... -...+...+.. ...
T Consensus 342 ~~~~~~----~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~----~~~~i~~~i~~-~~~ 411 (689)
T 3v5w_A 342 FSKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTLT-MAV 411 (689)
T ss_dssp CSSCCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC----CHHHHHHHHHH-CCC
T ss_pred cCCCCC----CCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhhcC-CCC
Confidence 765432 356799999999999642 36789999999999999999999999643211 11222222222 223
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVV 475 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl 475 (511)
..+..++++..+ ++.+||+.||++|++ ++||+
T Consensus 412 ~~p~~~S~~a~d-------LI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 412 ELPDSFSPELRS-------LLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp CCCTTSCHHHHH-------HHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCCccCCHHHHH-------HHHHHccCCHhHCCCCCCCCHHHHh
Confidence 344556665544 455567999999998 57765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=395.14 Aligned_cols=246 Identities=23% Similarity=0.315 Sum_probs=201.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||+|+||+||+|..+ +|+.||+|++..... ..+.+.+|+.+|+.++|||||++++++.+....++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3567889999999999999965 699999999976433 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC--CceEEeeccCccccCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED--FCPKISDFGLAKQTEK 359 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~DFGla~~~~~ 359 (511)
||+|.++|... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 238 gg~L~~~i~~~-----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 238 GGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCBHHHHHTCT-----TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred CCcHHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999432 24699999999999999999999998 99999999999999854 8999999999998866
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-cc--
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-DF-- 436 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~-- 436 (511)
.... ...+||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ....+..+.... .+
T Consensus 310 ~~~~---~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 310 KQSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKSCDWNMDD 377 (573)
T ss_dssp TSEE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCCCCS
T ss_pred CCce---eeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHhCCCCCCc
Confidence 5443 234699999999999764 68999999999999999999999996432 233333333321 11
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+++ ...+++.+||+.||++|||++|+++
T Consensus 378 ~~~~~~s~-------~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISE-------DGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCH-------HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCH-------HHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122333 3456677899999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=363.69 Aligned_cols=271 Identities=32% Similarity=0.535 Sum_probs=215.0
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
.+.+.||+|+||+||+|.+++++.||||++..... ..+++.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 34578999999999999988899999999876543 34689999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 122 L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 122 LKRHLYGSD--LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp TGGGSSSSC--CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred HHHHHhccC--CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999986433 2234699999999999999999999998 99999999999999999999999999998754433222
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-ccccCCC-C
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-DFQLDGV-V 442 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~ 442 (511)
......||+.|+|||++.+. .++.++||||||+++|||++|+.|+.............+......... ....+.. .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 22334589999999998653 688999999999999999999999975543322233333322221111 0011111 1
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.....+....+.+++.+||+.||++|||+++|++.|+..++
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 12234566778899999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=355.89 Aligned_cols=279 Identities=32% Similarity=0.570 Sum_probs=223.0
Q ss_pred CCCCCCHHHHHHHHHhhh--------cccCCcCceEEEEEEcCCCcEEEEEEeccCC-----CChHHHHHHHHHHHccCC
Q 040808 191 APKRFSYSDVRRMTKSFS--------DKLGQGGYADVYKGTLPDGRLVAVKVMKNLK-----DNGEEFINEVASISRTSH 257 (511)
Q Consensus 191 ~~~~~~~~e~~~~~~~~~--------~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h 257 (511)
....|++.++.+++.+|. ++||+|+||+||+|.. +++.||+|++.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 346789999999999886 4599999999999997 67899999987532 224678999999999999
Q ss_pred cceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 040808 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337 (511)
Q Consensus 258 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~N 337 (511)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG---GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 999999999999999999999999999999996533 234699999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC
Q 040808 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC 417 (511)
Q Consensus 338 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~ 417 (511)
|++++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.|+......
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999999987755433333334569999999999854 4788999999999999999999999754321
Q ss_pred CCCCchHHHHHHHhhhh---ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 418 SSEYFPNAIYKQIETEY---DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
.....+ .+.+.... ...+..............+.+++.+||+.||++|||+++|++.|+++.
T Consensus 241 --~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 241 --QLLLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp --SBTTHH-HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred --HHHHHH-HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111221 12111110 001112222233455677888999999999999999999999999754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=366.06 Aligned_cols=286 Identities=36% Similarity=0.642 Sum_probs=223.6
Q ss_pred CCCCCCHHHHHHHHHhh--hcccCCcCceEEEEEEcCCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeece
Q 040808 191 APKRFSYSDVRRMTKSF--SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGF 266 (511)
Q Consensus 191 ~~~~~~~~e~~~~~~~~--~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~ 266 (511)
..+.+++.++...+.+| .+.||+|+||+||+|..++|+.||||++..... ....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34678888887666555 578999999999999988899999999976432 23478999999999999999999999
Q ss_pred EeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCce
Q 040808 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346 (511)
Q Consensus 267 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~ 346 (511)
+.+....++||||+++|+|.+++.... .....+++..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERP--ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCS--TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 999999999999999999999997643 234569999999999999999999999766699999999999999999999
Q ss_pred EEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC--CCCchH
Q 040808 347 KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS--SEYFPN 424 (511)
Q Consensus 347 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~--~~~~~~ 424 (511)
||+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||+...... .....+
T Consensus 174 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp EECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred EeccCccccccCcccccc-cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 999999998775443322 2345699999999998653 67899999999999999999999996322111 112233
Q ss_pred HHHHHHhhhhcc-ccC-CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 425 AIYKQIETEYDF-QLD-GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 425 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
++.......... ... ........+....+.+++.+||+.||++|||+++|+++|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 322211111100 000 011112244567788999999999999999999999999974
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=349.97 Aligned_cols=257 Identities=24% Similarity=0.443 Sum_probs=213.7
Q ss_pred HHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
..+.+.++||+|+||+||+|..+++..||+|+++......+++.+|++++.+++||||+++++++.+....++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 34567789999999999999988888999999988777778899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 88 GCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999996532 4689999999999999999999998 999999999999999999999999999987755443
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.... .......+........+..
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 229 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVVLKVSQGHRLYRPHL 229 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHHHHTTCCCCCCTT
T ss_pred h-cccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccC-------hHHHHHHHHcCCCCCCCCc
Confidence 2 23445678889999999653 67899999999999999999 999986332 2233333333333232322
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
.+ ..+.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 230 ~~-------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 AS-------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred Ch-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 33 3466788899999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=366.48 Aligned_cols=261 Identities=23% Similarity=0.433 Sum_probs=209.6
Q ss_pred HHhhhcccCCcCceEEEEEEc--------CCCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCe
Q 040808 204 TKSFSDKLGQGGYADVYKGTL--------PDGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKK 272 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 272 (511)
.+.+.+.||+|+||+||+|.+ .++..||||+++.... ..+++.+|+.+++++ +||||+++++++.+.+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 456678999999999999974 2356799999976433 235789999999999 89999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC
Q 040808 273 RALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE 342 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~ 342 (511)
.++||||+++|+|.+++...... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 99999999999999999764311 1124689999999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCC
Q 040808 343 DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEY 421 (511)
Q Consensus 343 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~ 421 (511)
++.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.||....
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~------ 310 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 310 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC------
Confidence 999999999999876554433333345678899999998653 68999999999999999999 888886431
Q ss_pred chHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+...+........+...+ ..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 311 -~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 311 -VEELFKLLKEGHRMDKPANCT-------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -GGGHHHHHHTTCCCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHhcCCCCCCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222333343333333333333 346678889999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.35 Aligned_cols=269 Identities=25% Similarity=0.322 Sum_probs=207.8
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecC----eEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK----KRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~ 279 (511)
.|.+.++||+|+||+||+|... ++.||||+++........+.+|+.++.+++||||+++++++.+.. ..++||||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 3456789999999999999975 789999999765555556777999999999999999999998744 47999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC-------NIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~g~L~~~l~~-------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 104 HEKGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp CTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999954 34899999999999999999999851 2289999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhccccc---CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHH----
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF---GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNA---- 425 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~---- 425 (511)
+++...............||+.|+|||++.+.. ..++.++||||||+++|||++|+.||..........+...
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 998776554433334457999999999986521 2456789999999999999999999975433222222111
Q ss_pred -----HHHHHhhhhccccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 426 -----IYKQIETEYDFQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 426 -----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+...+... ........ ........+.+++.+||+.||++|||+.||+++|+.+.+
T Consensus 257 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 257 PSLEDMQEVVVHK---KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp CCHHHHHHHHTTS---CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cchhhhhhhhhcc---cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 11111111 112344568889999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=355.59 Aligned_cols=261 Identities=26% Similarity=0.462 Sum_probs=198.5
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+.+.++||+|+||+||+|.. +|+.||||++...... .+++.+|++++++++||||+++++++.+....++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 456678999999999999987 5788999999765433 357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR--IVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
++|+|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 117 ~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 117 SRGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp TTCBHHHHHHSTT---HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred CCCcHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999996432 123489999999999999999999998 7 9999999999999999999999999998654
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh-hhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE-TEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 437 (511)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... .......+. ......
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~-------~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 191 STFL--SSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLN-------PAQVVAAVGFKCKRLE 259 (309)
T ss_dssp -------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSC-------HHHHHHHHHHSCCCCC
T ss_pred cccc--ccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCCC
Confidence 3321 12345699999999999764 67899999999999999999999986431 222222221 222222
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~ 489 (511)
.+...+ ..+.+++.+||+.||++|||++++++.|+..++....||
T Consensus 260 ~~~~~~-------~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 260 IPRNLN-------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp CCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred CCccCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 333333 346677888999999999999999999999887654443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=347.31 Aligned_cols=255 Identities=24% Similarity=0.462 Sum_probs=212.0
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+.+.++||+|+||+||+|.+.+++.||+|++.......+++.+|++++++++||||+++++++.+....++||||++++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 34567899999999999999888899999999987777789999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 91 CLSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp BHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred cHHHHHHhc-----CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999543 24689999999999999999999998 999999999999999999999999999986644322
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.......+|+.|+|||.+... .++.++||||||+++|+|++ |+.|+... ....+...+........+...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDISTGFRLYKPRLA 232 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTCCCCCCTTS
T ss_pred ccccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCC-------CHHHHHHHHhcCccCCCCCcC
Confidence 122344578899999999653 78899999999999999999 88888643 133344444444333333333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+ ..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 233 ~-------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 S-------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp C-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 3 346677788999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.53 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=209.7
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+.+.++||+|+||+||+|.+++++.||+|+++......+++.+|++++.+++||||+++++++.+....++||||++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 45667899999999999999888889999999987777789999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 105 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 105 CLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp BHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 9999996532 4699999999999999999999998 999999999999999999999999999987644322
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.... .......+........+...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~ 246 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRPHLA 246 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHHHHTTCCCCCCTTC
T ss_pred ccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccC-------hhHHHHHHhcccCCCCCCcC
Confidence 112344578899999999653 68899999999999999998 999986431 23333444443333333233
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+ ..+.+++.+||+.||++|||++++++.|+.+++
T Consensus 247 ~-------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 247 S-------EKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp C-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 3 346678889999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=355.96 Aligned_cols=274 Identities=22% Similarity=0.365 Sum_probs=195.3
Q ss_pred HHhhhcccCCcCceEEEEEEcCC-Cc---EEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeE---
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD-GR---LVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKR--- 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~-~~---~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 273 (511)
.|.+.+.||+|+||+||+|.+.. ++ .||||+++.. ....+++.+|++++++++||||+++++++.+....
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 45677899999999999999654 32 7999999754 22346899999999999999999999999876655
Q ss_pred ---EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 274 ---ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 274 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
++||||+++|+|.+++...........+++..++.|+.|++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 89999999999999997654333334699999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||+++...............+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||.... ...+...
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~-------~~~~~~~ 251 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------NAEIYNY 251 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHH
T ss_pred ccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccC-------hHHHHHH
Confidence 9999876554433333344578899999998654 68899999999999999999 888886432 1222333
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCCCC
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLP 496 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~~~p 496 (511)
+............+ ..+.+++.+||+.||++|||+.++++.|+.++........+.-+.+
T Consensus 252 ~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 252 LIGGNRLKQPPECM-------EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp HHTTCCCCCCTTCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred HhcCCCCCCCCccC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence 33333222233333 3467788899999999999999999999998876655444443333
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.27 Aligned_cols=259 Identities=23% Similarity=0.406 Sum_probs=205.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
+.+.++||+|+||+||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 456789999999999999965 68999999886533 3346799999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 92 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 92 GTLRGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CBHHHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999996532 4689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ee------------eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 363 FI------------SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 363 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
.. ......||+.|+|||++.+. .++.++||||||+++|||++|..|+............. .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~ 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFL 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccc
Confidence 11 01134699999999999663 78899999999999999999999886543322211110 11111
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
.. ..+...++ .+.+++.+||+.||++|||++++++.|+.+...+
T Consensus 241 ~~----~~~~~~~~-------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 241 DR----YCPPNCPP-------SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HH----TCCTTCCT-------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc----cCCCCCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 11222332 3667788899999999999999999999876654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.57 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=213.0
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
...+.+.++||+|+||+||+|.++++..||||+++......++|.+|+.++++++||||+++++++. .+..++||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 3445677899999999999999888899999999877667889999999999999999999999886 567899999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 266 ~g~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 266 KGSLLDFLKSDE----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp TCBHHHHHHSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred CCcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999996432 23688999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. .......+|+.|+|||++.. +.++.++||||||+++|||++ |+.||... ....+...+........+.
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~-------~~~~~~~~i~~~~~~~~~~ 408 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGM-------SNPEVIRALERGYRMPRPE 408 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------CHHHHHHHHHHTCCCCCCT
T ss_pred e-eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCCCCCCCC
Confidence 1 11123457889999999965 478999999999999999999 99998532 1233444444443333332
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
.. ...+.+++.+||+.||++|||+++|+++|+......
T Consensus 409 ~~-------~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 409 NC-------PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TS-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CC-------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 22 345777889999999999999999999999977654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=355.28 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=207.2
Q ss_pred HHHhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
..|.+.+.||+|+||+||+|.+. .+..||||+++.... ..+++.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 34556688999999999999964 345699999986432 235799999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH-----DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EECCTTCBHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eeCCCCCcHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999543 24699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 357 TEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 357 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
....... .......+|+.|+|||++.+. .++.++||||||+++|||++ |+.||... ....+...+....
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~-------~~~~~~~~~~~~~ 271 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNM-------TNRDVISSVEEGY 271 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTS-------CHHHHHHHHHTTC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccC-------CHHHHHHHHHcCC
Confidence 7544322 122334578899999999653 68899999999999999999 99998533 2333444444443
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
....+...+ ..+.+++.+||+.||++|||+++|+++|+.++..
T Consensus 272 ~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 RLPAPMGCP-------HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCcC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 333333333 3466788899999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=366.21 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=206.6
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.+.+.++||+|+||+||+|.++ +++.||||+++.... ..++|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 3456789999999999999976 789999999975432 2246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 195 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 195 QGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999996532 4689999999999999999999998 9999999999999999999999999999875443
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
..........+++.|+|||.+.. +.++.++||||||+++|||++ |+.|+.... ...+...+........+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 337 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLS-------NQQTREFVEKGGRLPCP 337 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-------HHHHHHHHHTTCCCCCC
T ss_pred ceeecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCC
Confidence 22111112235778999999865 368899999999999999998 888885331 23334444444333333
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+ ..+.+++.+||+.||++|||+++|++.|+.+.+
T Consensus 338 ~~~~-------~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 338 ELCP-------DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp TTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 3332 346678889999999999999999999997643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=350.00 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=207.7
Q ss_pred CCCCCHHHHHHHHHh------------hhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCC
Q 040808 192 PKRFSYSDVRRMTKS------------FSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSH 257 (511)
Q Consensus 192 ~~~~~~~e~~~~~~~------------~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h 257 (511)
+..+++.++++++.. ..++||+|+||+||+|... +|+.||||++.... ...+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356788888877653 3458999999999999966 79999999997543 345678999999999999
Q ss_pred cceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 040808 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337 (511)
Q Consensus 258 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~N 337 (511)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 171 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence 9999999999999999999999999999999842 3589999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC
Q 040808 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC 417 (511)
Q Consensus 338 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~ 417 (511)
||++.++.+||+|||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~-- 245 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDS-- 245 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSC--
T ss_pred EEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 99999999999999999876543321 2345699999999999653 68899999999999999999999986431
Q ss_pred CCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.......+......... ........+.+++.+||+.||++|||++++++.
T Consensus 246 -----~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 -----PVQAMKRLRDSPPPKLK-----NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -----HHHHHHHHHHSSCCCCT-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHHHhcCCCCCcC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22223333222111110 011123346677888999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=370.20 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=208.0
Q ss_pred HHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
..+.+.++||+|+||+||+|.++++..||||+++......++|.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 3456778999999999999998888889999998766667899999999999999999999999876 678999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 263 gsL~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 263 GSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CBHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999995432 24589999999999999999999998 999999999999999999999999999987654321
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.......+|+.|+|||.+.. +.++.++||||||+++|||++ |+.|+... ....+...+........+..
T Consensus 336 -~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~-------~~~~~~~~i~~~~~~~~~~~ 405 (452)
T 1fmk_A 336 -TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGYRMPCPPE 405 (452)
T ss_dssp --------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCTT
T ss_pred -ecccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCCCCCCCCC
Confidence 11223457889999999865 478999999999999999999 88888532 23344445544443333333
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
. ...+.+++.+||+.||++|||+++|++.|+.......
T Consensus 406 ~-------~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 406 C-------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp S-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred C-------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 3 3456778889999999999999999999999876554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=376.88 Aligned_cols=262 Identities=26% Similarity=0.457 Sum_probs=216.2
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
++....+.+.++||+|+||+||+|.++. +..||||+++......++|.+|+.++++++||||++++++|.+....++||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3444556678899999999999999764 889999999877777889999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 296 E~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 296 EFMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp ECCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EccCCCCHHHHHHhcC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999996532 34689999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.... ........+|+.|+|||++.. +.++.++||||||+++|||++ |+.|+.... ...+.+.+......
T Consensus 369 ~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~ 438 (495)
T 1opk_A 369 TGDT-YTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRM 438 (495)
T ss_dssp TTCC-EECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-------GGGHHHHHHTTCCC
T ss_pred cCCc-eeecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCC
Confidence 5432 222234457889999999865 368899999999999999999 888885432 22233444444333
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
..+...+ ..+.+++.+||+.||++|||+.+|+++|+...+.
T Consensus 439 ~~~~~~~-------~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 439 ERPEGCP-------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCC-------HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 3333233 4566788899999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=359.89 Aligned_cols=275 Identities=24% Similarity=0.387 Sum_probs=218.1
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcC--------CCcEEEEEEeccCCCC--hHHHHHHHHHHHcc-CCcceeeeeceEe
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLP--------DGRLVAVKVMKNLKDN--GEEFINEVASISRT-SHVNIVPFLGFCY 268 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~ 268 (511)
+....+.+.++||+|+||+||+|.+. .+..||||+++..... .+++.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 33445667889999999999999842 2457999999764332 36789999999999 8999999999999
Q ss_pred ecCeEEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCE
Q 040808 269 EKKKRALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNI 338 (511)
Q Consensus 269 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NI 338 (511)
+.+..++||||+++|+|.+++...... .....+++..++.|+.||+.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 999999999999999999999764311 1234699999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCC
Q 040808 339 RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSC 417 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~ 417 (511)
|+++++.+||+|||+++...............+|+.|+|||++.+ ..++.++||||||+++|||++ |+.|+...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~--- 297 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--- 297 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999987765443333345568899999999965 378999999999999999999 99888533
Q ss_pred CCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 040808 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~ 493 (511)
-...+.+.+............+ ..+.+++.+||+.||++|||+++|++.|+.++........+..
T Consensus 298 ----~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 298 ----PVEELFKLLKEGHRMDKPSNCT-------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp ----CHHHHHHHHHTTCCCCCCSSCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred ----CHHHHHHHHHcCCCCCCCccCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 1334444454444333333333 3466778889999999999999999999998776655544444
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=350.43 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=200.1
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||+|+||.||+|.+ .+|+.||||++...... .+++.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 45678999999999999996 57999999999764332 356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 97 SGGEVFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp TTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 999999999653 3589999999999999999999998 9999999999999999999999999999876544
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. .....||+.|+|||++.+. ...+.++|||||||++|||++|+.||.... ...+...+... ....+.
T Consensus 168 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~-~~~~p~ 235 (328)
T 3fe3_A 168 GK---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELRERVLRG-KYRIPF 235 (328)
T ss_dssp CG---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC-CCCCCT
T ss_pred Cc---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhC-CCCCCC
Confidence 32 2345799999999999764 234589999999999999999999996432 22233333222 222333
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+++ +.+++.+||+.||++|||++|+++
T Consensus 236 ~~s~~-------~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 236 YMSTD-------CENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp TSCHH-------HHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCHH-------HHHHHHHHCCCChhHCcCHHHHhc
Confidence 34443 455667788999999999999976
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=355.68 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=199.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcE----EEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRL----VAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
.|.+.++||+|+||+||+|.+. +++. ||+|.++... ...+++.+|+.++++++||||++++++|.+.. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 4556789999999999999854 4544 5888776432 34578999999999999999999999998765 7899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+||+++|+|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EECCTTCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999996543 4699999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
..............||+.|+|||++.+. .++.++||||||+++|||++ |+.||.... ...+...+.....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~~~~~~ 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILEKGER 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCC
T ss_pred ccCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCC-------HHHHHHHHHcCCC
Confidence 7655443333445678899999999753 78999999999999999999 999986432 1223333333332
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
....... ...+..++.+||+.||++|||+.+|++.|+.....
T Consensus 238 ~~~~~~~-------~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 LPQPPIC-------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCTTB-------CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCccC-------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 2222222 23567788899999999999999999999886653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.68 Aligned_cols=265 Identities=18% Similarity=0.199 Sum_probs=207.8
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.++||+|+||+||+|.. .+|+.||||++.... ..+++.+|+.+++++ +||||+++++++.+....++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 45678999999999999995 578999999987543 345688999999999 8999999999999999999999999 9
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc-----eEEeeccCcccc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC-----PKISDFGLAKQT 357 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DFGla~~~ 357 (511)
++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 89 ~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 89 PSLEDLFDLC-----DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred CCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9999999653 24799999999999999999999998 9999999999999999887 999999999876
Q ss_pred CCCCcee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 358 EKKESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 358 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .. .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~---~~-~~~~~~~i~~ 234 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKA---DT-LKERYQKIGD 234 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---SS-HHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCcccccc---cc-HHHHHHHHHh
Confidence 4433211 12345799999999999764 688999999999999999999999974321 11 1222222222
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~ 489 (511)
..... . ......... .+.+++.+||+.||.+||++++|++.|+...+.+..+.
T Consensus 235 ~~~~~-~--~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 287 (330)
T 2izr_A 235 TKRAT-P--IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF 287 (330)
T ss_dssp HHHHS-C--HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred hhccC-C--HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence 11100 0 000001122 67888899999999999999999999998776654443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=363.02 Aligned_cols=263 Identities=23% Similarity=0.379 Sum_probs=208.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
.+.+.++||+|+||+||+|.+. +++.||||+++.... ...++.+|+.++++++||||+++++++.+....++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 4567789999999999999843 467899999975432 23578899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC---ceEEeec
Q 040808 276 IYEFMPNGSLDQYIYDHESS-NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF---CPKISDF 351 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DF 351 (511)
||||+++|+|.+++...... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 99999999999999764321 2234699999999999999999999998 999999999999999555 5999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHH
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
|+++...............||+.|+|||++.+. .++.++|||||||++|||++ |+.||.... ...+...+
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~-------~~~~~~~i 299 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFV 299 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHH
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH
Confidence 999865332221122234589999999998653 78999999999999999998 888886431 33344444
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
............+ ..+.+++.+||+.||++|||+.+|++.|+...+..
T Consensus 300 ~~~~~~~~~~~~~-------~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 TSGGRMDPPKNCP-------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HcCCCCCCCccCC-------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 4443333333333 34667888999999999999999999998876654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.03 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=195.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+.+.+.||+|+||+||+|.++ ++..||||+++.... ..++|.+|+.++++++||||+++++++.+....++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3456789999999999999864 577899999975432 2357999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 126 e~~~~~sL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 126 EYMENGSLDSFLRKH-----DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp ECCTTCBHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eCCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999643 24689999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCcee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 358 EKKESFI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 358 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
....... ......+|+.|+|||++.+ ..++.++||||||+++|||++ |+.||... ....+...+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-------~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEM-------SNQDVIKAVDEGYR 268 (373)
T ss_dssp ----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-------CHHHHHHHHHTTEE
T ss_pred ccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCCC
Confidence 5433211 1122346788999999965 378999999999999999998 99998533 12333444444333
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
...... ....+.+++.+||+.||++||++++|+++|+.++..
T Consensus 269 ~~~~~~-------~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 LPPPMD-------CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCCCTT-------CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcc-------ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 222222 234577888999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=351.30 Aligned_cols=247 Identities=20% Similarity=0.258 Sum_probs=203.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
|.+.++||+|+||+||+|... +++.||+|+++......+.+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 456789999999999999965 6889999999866555667899999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC--CCceEEeeccCccccCCCC
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE--DFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~~ 361 (511)
+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 87 ~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 87 DIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999432 24689999999999999999999998 9999999999999987 7899999999998876554
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. ....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.... ...+...+..... .
T Consensus 159 ~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~-----~ 221 (321)
T 1tki_A 159 NF---RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEY-----T 221 (321)
T ss_dssp EE---EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCC-----C
T ss_pred cc---ccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHHHcCCC-----C
Confidence 32 234599999999999653 57899999999999999999999996431 2223333322211 1
Q ss_pred CCh-HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTE-EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ........+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11233455778889999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=348.50 Aligned_cols=266 Identities=23% Similarity=0.417 Sum_probs=202.6
Q ss_pred HHHhhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEee--cCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 274 (511)
..+.+.++||+|+||+||+|++ .+++.||||++..... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4456788999999999999983 2588999999975433 23678999999999999999999999864 35689
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 90 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEeCCCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 9999999999999996543 4589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCcee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC-----CCC----CchH
Q 040808 355 KQTEKKESFI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC-----SSE----YFPN 424 (511)
Q Consensus 355 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~-----~~~----~~~~ 424 (511)
+......... ......+|+.|+|||.+.+. .++.++||||||+++|||++|..|+...... ... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 8775443221 12234577889999999654 6899999999999999999999887643110 000 1111
Q ss_pred HHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 425 AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
.+...+........+... ...+.+++.+||+.||++|||+++|+++|+.+.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGC-------PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHTTCCCCCCTTC-------CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhccCcCCCCcCc-------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 222222222222222222 345777888999999999999999999999887665
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.20 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=199.6
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccC-CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNL-KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||+|+||+||+|.+ .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 345678999999999999995 46899999998654 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 101 GGSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp TCBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999953 3589999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc--cccC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD--FQLD 439 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 439 (511)
.. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.... +......+..... ...+
T Consensus 171 ~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~ 239 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNGTPELQNP 239 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHCSCCCSCG
T ss_pred cc--cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCc
Confidence 32 2345699999999999654 68899999999999999999999986331 1111112211111 1111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ....+.+++.+||+.||++|||++|+++
T Consensus 240 ~~-------~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EK-------LSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GG-------SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc-------cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 12 2334667788899999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=346.05 Aligned_cols=260 Identities=27% Similarity=0.362 Sum_probs=201.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.|.+.++||+|+||+||+|.+. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 3567789999999999999954 6899999998653322 3578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 92 YIEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp CCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999543 3689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
..... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.... ......+.+..... ..
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~-~~ 232 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDSVP-NV 232 (294)
T ss_dssp -------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHSSCCC-CH
T ss_pred ccccc-ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhccCC-Cc
Confidence 43221 12234699999999999664 67889999999999999999999996432 11222222221110 00
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhccccCC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-SMTKVVEMLEGSIENL 485 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~~l 485 (511)
. .....++...+..++.+||+.||++|| +++++.+.|+..+..-
T Consensus 233 ~---~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 233 T---TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp H---HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred c---hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0 000112334567788899999999999 9999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.65 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=199.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
|.+.+.||+|+||+||+|..+ +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 567789999999999999965 689999999975432 246789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC----ceEEeecc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF----CPKISDFG 352 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DFG 352 (511)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++ .+||+|||
T Consensus 94 ~e~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 94 LELVSGGELFDFLAQ------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EECCCSCBHHHHHTT------CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEcCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999943 34699999999999999999999998 999999999999998877 79999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.... .......+..
T Consensus 165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~ 232 (361)
T 2yab_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITA 232 (361)
T ss_dssp SCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHT
T ss_pred CceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh
Confidence 9987765432 2345699999999999653 68899999999999999999999996431 2223333322
Q ss_pred hhccccCCCCChH-HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYDFQLDGVVTEE-EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~~~~~~~~~~~-~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. . ..... .......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~-~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VS-Y----DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TC-C----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cC-C----CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 21 1 11111 1122334556778888999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.72 Aligned_cols=252 Identities=24% Similarity=0.257 Sum_probs=197.5
Q ss_pred CCCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCCh---HHHHHHHHHHHcc-CCcceeeeeceE
Q 040808 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG---EEFINEVASISRT-SHVNIVPFLGFC 267 (511)
Q Consensus 193 ~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~niv~l~~~~ 267 (511)
.+....++....+.+.++||+|+||+||+|.+. +|+.||||++....... .++.+|+..+.++ +||||++++++|
T Consensus 47 ~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 47 DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp CTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 334445566667778899999999999999966 79999999987543332 3456666666555 899999999999
Q ss_pred eecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 268 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
.+.+..++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEE
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence 9999999999999 789999986542 4699999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 427 (511)
|+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|||++|+.++... ...
T Consensus 198 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~ 261 (311)
T 3p1a_A 198 LGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGG----------EGW 261 (311)
T ss_dssp ECCCTTCEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHH
T ss_pred EccceeeeecccCCC---CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHH
Confidence 999999987654332 233469999999999864 6789999999999999999998766421 112
Q ss_pred HHHhhhhccccCCCCC-hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 428 KQIETEYDFQLDGVVT-EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+.... .. .........+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~-------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 262 QQLRQGY-------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTTC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhccC-------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2222111 11 111223455777888999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=345.30 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=201.1
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
..|.+.+.||+|+||+||+|..+ +|+.||+|+++.... ..+++.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34677889999999999999965 689999999975432 3567999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC----ceEEee
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF----CPKISD 350 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~D 350 (511)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 91 lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEECCCSCBHHHHHTT------SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEcCCCCCHHHHHHh------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 99999999999999943 34699999999999999999999998 999999999999999887 899999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
||+++....... .....||+.|+|||++... .++.++||||||+++|+|++|+.||.... .......+
T Consensus 162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~ 229 (326)
T 2y0a_A 162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANV 229 (326)
T ss_dssp CTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHH
T ss_pred CCCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHH
Confidence 999987754432 2345699999999998653 68899999999999999999999986331 22222222
Q ss_pred hhhhccccCCCCCh-HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDGVVTE-EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... . .... ........+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~-~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 230 SAVN-Y----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHTC-C----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhcC-C----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2211 1 1111 11122344667788899999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.05 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=197.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 456789999999999999965 789999999865432 23678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 89 GGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp TEEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999998842 34699999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.........||+.|+|||++.+. ...+.++||||||+++|+|++|+.||...... ......+.......
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~---- 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKKTYL---- 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT------SHHHHHHHTTCTTS----
T ss_pred cccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHhcccccC----
Confidence 32233455799999999999653 23477999999999999999999999643211 11111111111110
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.........+.+++.+||+.||++|||++|+++.
T Consensus 229 --~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011223445677888999999999999999764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=343.72 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=197.4
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHc--cCCcceeeeeceEee----cCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISR--TSHVNIVPFLGFCYE----KKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~lv~ 277 (511)
.+.+.++||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++.+ ....++||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 345678999999999999997 6889999998753 34566777777766 789999999998754 34688999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH--------RGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+
T Consensus 86 e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 86 HYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp CCCTTCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred hhccCCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999932 46899999999999999999999 76 99999999999999999999999
Q ss_pred eccCccccCCCCceee--ecCCCCCCCccchhhcccccC----CCCccccchhHHHHHHHHHhC----------CCCCCC
Q 040808 350 DFGLAKQTEKKESFIS--MLDTRGTAGYIAPEVFCRHFG----GVSHKSDVYSYGMMIHEMVIG----------RKNADV 413 (511)
Q Consensus 350 DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~s~~sDvwSlG~il~elltg----------~~p~~~ 413 (511)
|||+++.......... .....||+.|+|||++.+... .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999986654433221 123469999999999865311 345789999999999999999 666643
Q ss_pred ccCCCCCCchHHHHHHHhhhhccccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 414 KVSCSSEYFPNAIYKQIETEYDFQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
...... .+ ........... .....+. ........+.+++.+||+.||++|||+++|+++|+.+
T Consensus 236 ~~~~~~-~~-~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDP-SF-EDMRKVVCVDQ---QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSC-CH-HHHHHHHTTSC---CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCc-ch-hhhhHHHhccC---CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 321111 11 11111111111 0111111 1234566788999999999999999999999999863
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=345.12 Aligned_cols=271 Identities=23% Similarity=0.390 Sum_probs=208.8
Q ss_pred CCHHHHHHHHHhhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceE
Q 040808 195 FSYSDVRRMTKSFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFC 267 (511)
Q Consensus 195 ~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~ 267 (511)
+....+.+..+.+.++||+|+||.||+|.+ .+++.||+|+++... ...+.+.+|+.++++++||||+++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 333344444566788999999999999983 368899999997543 3447899999999999999999999999
Q ss_pred eec--CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc
Q 040808 268 YEK--KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC 345 (511)
Q Consensus 268 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~ 345 (511)
.+. ...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~ 164 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 164 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCC
Confidence 876 66899999999999999995432 4689999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCccccCCCCcee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccC--------
Q 040808 346 PKISDFGLAKQTEKKESFI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVS-------- 416 (511)
Q Consensus 346 ~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~-------- 416 (511)
+||+|||+++......... ......||..|+|||.+.+. .++.++||||||+++|+|++|+.|+.....
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 242 (302)
T 4e5w_A 165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242 (302)
T ss_dssp EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred EEECcccccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC
Confidence 9999999998876554322 22345688899999998654 678899999999999999999987642210
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
.........+...+............+ ..+.+++.+||+.||++|||+++++++|+.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEGKRLPCPPNCP-------DEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCGGGHHHHHHHHHHTTCCCCCCTTCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCHHHHHHHHhccCCCCCCCCCC-------HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000111112222333332222222233 45677888999999999999999999999765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.81 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=203.3
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecC-eEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK-KRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g 283 (511)
+.+.++||+|+||+||+|..+ |+.||||+++... ..++|.+|+.++++++||||+++++++.+.. ..++||||+++|
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 456789999999999999975 6799999998644 5678999999999999999999999987665 799999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++......
T Consensus 273 ~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 273 SLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp BHHHHHHHHC----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 9999997542 23579999999999999999999998 99999999999999999999999999998654322
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
....+|+.|+|||.+.. ..++.++||||||+++|||++ |+.|+.... ...+...+..+.....+...
T Consensus 344 ---~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~~~~~p~~~ 411 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPDGC 411 (450)
T ss_dssp ------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-------TTTHHHHHHTTCCCCCCTTC
T ss_pred ---cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCCcC
Confidence 12357899999999965 378999999999999999998 999986432 11233344444333333333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+ ..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 412 ~-------~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 412 P-------PAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp C-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 3 456678889999999999999999999997643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=350.49 Aligned_cols=263 Identities=23% Similarity=0.399 Sum_probs=208.4
Q ss_pred HHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
.+.+.+.||+|+||.||+|.+. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 3456789999999999999864 348899999986432 23678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 040808 276 IYEFMPNGSLDQYIYDHESSN------------------GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~N 337 (511)
||||+++|+|.+++....... ....+++..++.++.||+.||+|||++ +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 999999999999997642110 125799999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccC
Q 040808 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVS 416 (511)
Q Consensus 338 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~ 416 (511)
||+++++.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++ |+.||....
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~- 281 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA- 281 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCC-
Confidence 99999999999999999876544332223345689999999998653 68899999999999999999 998885331
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
...+...+........+...+ ..+.+++.+||+.||++|||+.+|++.|+.+.+..
T Consensus 282 ------~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 ------HEEVIYYVRDGNILACPENCP-------LELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp ------HHHHHHHHHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ------hHHHHHHHhCCCcCCCCCCCC-------HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 233333343333222222222 35677888999999999999999999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=355.88 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=209.0
Q ss_pred HHHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCCC--hHHHHHHHHHHHcc-CCcceeeeeceEeecC-e
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKDN--GEEFINEVASISRT-SHVNIVPFLGFCYEKK-K 272 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~ 272 (511)
..+.+.++||+|+||.||+|.+ .+++.||||+++..... .+.+.+|++++.++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 3456678999999999999973 24689999999764332 35789999999999 7999999999998755 4
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCC--------------------------------------------------------
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSN-------------------------------------------------------- 296 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------- 296 (511)
.++||||+++|+|.+++.......
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 899999999999999997643100
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCC
Q 040808 297 ----GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGT 372 (511)
Q Consensus 297 ----~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 372 (511)
....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...............||
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 012389999999999999999999998 9999999999999999999999999999877554444444456789
Q ss_pred CCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHH
Q 040808 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAK 451 (511)
Q Consensus 373 ~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (511)
+.|+|||++.+ ..++.++||||||+++|||++ |+.||.... ....+...+........+...++
T Consensus 259 ~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~------- 323 (359)
T 3vhe_A 259 LKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFCRRLKEGTRMRAPDYTTP------- 323 (359)
T ss_dssp GGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC------CSHHHHHHHHHTCCCCCCTTCCH-------
T ss_pred ceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccc------hhHHHHHHHHcCCCCCCCCCCCH-------
Confidence 99999999865 378899999999999999998 999986432 22334444444433333333333
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 452 KMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 452 ~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.+.+++.+||+.||++|||+++|++.|+.+++
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 46677788999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=357.41 Aligned_cols=277 Identities=16% Similarity=0.188 Sum_probs=206.2
Q ss_pred HHhhhcccCCcCceEEEEEEcCC------CcEEEEEEeccCCC------------ChHHHHHHHHHHHccCCcceeeeec
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD------GRLVAVKVMKNLKD------------NGEEFINEVASISRTSHVNIVPFLG 265 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~ 265 (511)
.|.+.++||+|+||+||+|.++. ++.||||++..... ....++.|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 56677899999999999998754 47899999875431 1123455667778888999999999
Q ss_pred eEeec----CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 266 FCYEK----KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 266 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
++... ...++||||+ +++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-----AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 98764 4589999999 99999999653 25699999999999999999999998 999999999999999
Q ss_pred --CCCceEEeeccCccccCCCCceee-----ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 342 --EDFCPKISDFGLAKQTEKKESFIS-----MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 342 --~~~~~kl~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
.++.+||+|||+++.......... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 899999999999987654322111 1233599999999999764 6899999999999999999999999743
Q ss_pred cCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCC
Q 040808 415 VSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLS 494 (511)
Q Consensus 415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~~ 494 (511)
... ..................++.... .......+.+++.+||+.+|++||++++|++.|+..++.+..+....+.
T Consensus 265 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 340 (364)
T 3op5_A 265 LKD--PKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD 340 (364)
T ss_dssp TTC--HHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred ccC--HHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence 210 001111111110000000000000 0112345777888999999999999999999999999888777666554
Q ss_pred C
Q 040808 495 L 495 (511)
Q Consensus 495 ~ 495 (511)
+
T Consensus 341 w 341 (364)
T 3op5_A 341 L 341 (364)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.17 Aligned_cols=255 Identities=24% Similarity=0.452 Sum_probs=210.5
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+.+.+.||+|+||.||+|...+++.||+|+++......+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 34567899999999999999888899999999887767788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 89 ~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 89 CLSDYLRTQR-----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred cHHHHHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 9999996532 4689999999999999999999998 999999999999999999999999999987643221
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.|+.... ...+...+........+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~i~~~~~~~~~~~~ 230 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKPRLA 230 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCCCCTTS
T ss_pred cccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCC-------HHHHHHHHhcCCcCCCCccC
Confidence 112334578899999999653 67899999999999999999 888886331 23333344433322222222
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
+ ..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 231 ~-------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 S-------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp C-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred c-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2 346678888999999999999999999997653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=346.31 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=199.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.+.||+|+||+||++..+ +|+.||+|++++. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 456789999999999999965 6999999999753 34557889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999542 4689999999999999999999998 999999999999999999999999999986433
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+...+... ....+
T Consensus 158 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~-~~~~p 225 (337)
T 1o6l_A 158 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILME-EIRFP 225 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC-CCCCC
T ss_pred CCC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCC-------HHHHHHHHHcC-CCCCC
Confidence 221 12345699999999999654 67899999999999999999999996431 22333333222 22333
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
...+++ +.+++.+||+.||++|| +++++++
T Consensus 226 ~~~s~~-------~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 RTLSPE-------AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHH-------HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCHH-------HHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 344443 45566678899999999 8999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.84 Aligned_cols=259 Identities=24% Similarity=0.409 Sum_probs=210.4
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+.+.+.||+|+||+||+|..++++.||+|+++......+.+.+|++++++++||||+++++++.+ +..++||||++++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCC
Confidence 456778999999999999998888899999998776677899999999999999999999998764 5589999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 93 ~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 93 SLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp BHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CHHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 9999995322 13689999999999999999999998 999999999999999999999999999987754432
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
.......+|+.|+|||.+.+ +.++.++||||||+++|||++ |+.|+.... ...+...+............
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~ 235 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNC 235 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCTTC
T ss_pred ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccC-------HHHHHHHHhcccCCCCcccc
Confidence 22234457889999999864 367899999999999999999 888885321 22333344333322222222
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCC
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~ 487 (511)
+ ..+.+++.+||+.||++|||+++++++|+........
T Consensus 236 ~-------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 236 P-------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp C-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred c-------HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 2 3566788889999999999999999999988766543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.76 Aligned_cols=262 Identities=24% Similarity=0.425 Sum_probs=210.9
Q ss_pred HHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
.|.+.+.||+|+||.||+|.. .+++.||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 455678999999999999985 2457899999975432 23678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 040808 276 IYEFMPNGSLDQYIYDHESSN------------------GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~N 337 (511)
||||+++|+|.+++....... ....+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 999999999999997643210 123589999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccC
Q 040808 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVS 416 (511)
Q Consensus 338 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~ 416 (511)
||+++++.+||+|||+++...............+|+.|+|||.+.+. .++.++||||||+++|||++ |+.|+....
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~- 257 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIP- 257 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 99999999999999999877655544444455688999999998653 67899999999999999999 999886432
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
...+...+............+ ..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 258 ------~~~~~~~~~~~~~~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 ------PERLFNLLKTGHRMERPDNCS-------EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp ------GGGHHHHHHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------HHHHHHHhhcCCcCCCCccCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 222333333333333333333 3466778889999999999999999999987653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=348.65 Aligned_cols=277 Identities=22% Similarity=0.333 Sum_probs=205.6
Q ss_pred HHhhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEe--ecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCY--EKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 275 (511)
.+.+.++||+|+||+||+|.+ .+++.||||++..... ..+.+.+|++++++++||||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 456778999999999999983 3588999999976533 2356899999999999999999999886 4567899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++++|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEECCTTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEeecCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999996532 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCcee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC--------CCCCchHHH
Q 040808 356 QTEKKESFI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC--------SSEYFPNAI 426 (511)
Q Consensus 356 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~--------~~~~~~~~~ 426 (511)
......... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+...... ........+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 775444322 22334588899999998653 6789999999999999999999988533210 000111222
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCCCCC
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSLPT 497 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~~~p~ 497 (511)
...+............ ...+.+++.+||+.||++|||+++|++.|+.+.........+....++
T Consensus 254 ~~~~~~~~~~~~~~~~-------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p 317 (327)
T 3lxl_A 254 LELLEEGQRLPAPPAC-------PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHP 317 (327)
T ss_dssp HHHHHTTCCCCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------------
T ss_pred HHHhhcccCCCCCCcc-------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCc
Confidence 2233333222222222 344667788899999999999999999999987766555444444333
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=344.62 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=195.0
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|.+.+|+.||+|+++..... .+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 4567899999999999999888999999999754322 3678899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 103 -~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 103 -KDLKKVLDEN-----KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp -EEHHHHHHTC-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred -CCHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 5888888542 24689999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY------- 434 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 434 (511)
. ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||...... .....+...+....
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---DQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT---THHHHHHHHHCCCCTTTSGGG
T ss_pred c--cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHHCCCChHHhhhh
Confidence 2 12345689999999998653 36789999999999999999999999643211 11111111110000
Q ss_pred ---------ccccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 ---------DFQLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ---------~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
......... .........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000 000112235667888999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=349.38 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=201.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcE----EEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRL----VAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.+.++||+|+||+||+|.+. +++. ||+|++.... ...+++.+|+.++++++||||+++++++. ....++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 456788999999999999854 4544 7888775432 23357789999999999999999999886 56689999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 94 QYLPLGSLLDHVRQH-----RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp ECCTTCBSHHHHHSS-----GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EeCCCCCHHHHHHHc-----cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999643 24688899999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.............||+.|+|||++.+. .++.++||||||+++|||++ |+.||.... ...+...+......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~~~~~~ 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLR-------LAEVPDLLEKGERL 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------TTHHHHHHHTTCBC
T ss_pred CcccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccC-------HHHHHHHHHcCCCC
Confidence 655433333445688899999999653 78999999999999999999 999986432 22233334333333
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
..+...+. .+..++.+||+.||++|||++++++.|+.....
T Consensus 237 ~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 AQPQICTI-------DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CCCTTBCT-------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCcCcH-------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 33333333 356677889999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.00 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=202.0
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC------CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL------KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
...|.+.+.||+|+||+||+|..+ +|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 345778899999999999999864 6899999998632 124578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc---eEEeec
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC---PKISDF 351 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DF 351 (511)
+||||+++|+|.+++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD--AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEeCCCCCCHHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999988865431 234589999999999999999999998 9999999999999986654 999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|+++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||... ...+...+.
T Consensus 178 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~i~ 245 (351)
T 3c0i_A 178 GVAIQLGESGLV--AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGT--------KERLFEGII 245 (351)
T ss_dssp TTCEECCTTSCB--CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSS--------HHHHHHHHH
T ss_pred cceeEecCCCee--ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCc--------HHHHHHHHH
Confidence 999877554321 2345699999999999654 6789999999999999999999999642 122233332
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... ... ......+...+.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~-~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 246 KGKY-KMN---PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HTCC-CCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCC-CCC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2211 000 1111123345667888899999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=371.96 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=214.4
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+....+.+.++||+|+||+||+|.++++..||||+++......++|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3344556778999999999999998888889999998766667899999999999999999999999876 678999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 343 ~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 343 MSKGSLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CTTEEHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hcCCcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999995432 24589999999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
... .......++..|+|||++.. +.++.++||||||+++|||++ |+.||... ....+...+........
T Consensus 416 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-------~~~~~~~~i~~~~~~~~ 485 (535)
T 2h8h_A 416 NEY-TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGYRMPC 485 (535)
T ss_dssp HHH-HTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-------CHHHHHHHHHTTCCCCC
T ss_pred Cce-ecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCCCCCC
Confidence 221 11223457889999999865 478999999999999999999 88888532 23344445554443333
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
.... ...+.+++.+||+.||++|||+++|+++|+.......
T Consensus 486 ~~~~-------~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 486 PPEC-------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCC-------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 3333 3356778889999999999999999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=348.06 Aligned_cols=270 Identities=22% Similarity=0.407 Sum_probs=212.6
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC--------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeec
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP--------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEK 270 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 270 (511)
...|.+.+.||+|+||+||+|.+. +++.||+|+++.... ..+++.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 345667889999999999999853 467899999976432 235789999999999 899999999999999
Q ss_pred CeEEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE
Q 040808 271 KKRALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll 340 (511)
+..++||||+++|+|.+++...... .....+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999754321 0123589999999999999999999998 99999999999999
Q ss_pred cCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCC
Q 040808 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSS 419 (511)
Q Consensus 341 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~ 419 (511)
+.++.+||+|||+++...............+|+.|+|||++.+. .++.++||||||+++|||++ |+.|+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~----- 263 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 263 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcC-----
Confidence 99999999999999877655444334455688999999998653 67899999999999999999 99888533
Q ss_pred CCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCC
Q 040808 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPK 490 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~ 490 (511)
-...+...+............+ ..+.+++.+||+.||++|||+.++++.|+.++........
T Consensus 264 --~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~ 325 (334)
T 2pvf_A 264 --PVEELFKLLKEGHRMDKPANCT-------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEY 325 (334)
T ss_dssp --CHHHHHHHHHHTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred --CHHHHHHHHhcCCCCCCCccCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcc
Confidence 1233344444433333333333 3466788889999999999999999999998765544333
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.79 Aligned_cols=264 Identities=25% Similarity=0.428 Sum_probs=212.1
Q ss_pred HHHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 273 (511)
..+.+.+.||+|+||+||+|.+ .+++.||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 3456778999999999999984 2467899999986543 246789999999999 899999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 274 ALIYEFMPNGSLDQYIYDHESS------------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 9999999999999999764321 1123589999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCC
Q 040808 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSE 420 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~ 420 (511)
.++.+||+|||+++...............||+.|+|||.+.+. .++.++||||||+++|||++ |+.|+....
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~----- 252 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMP----- 252 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCccc-----
Confidence 9999999999999887665544333445688899999998653 78899999999999999998 998886432
Q ss_pred CchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
........+............+ ..+.+++.+||+.||++|||+++++++|+..+.+
T Consensus 253 -~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 -VDSKFYKMIKEGFRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -SSHHHHHHHHHTCCCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -chhHHHHHhccCCCCCCcccCC-------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1223333333333322222233 3466778889999999999999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.72 Aligned_cols=258 Identities=26% Similarity=0.340 Sum_probs=190.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|..+ +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 456788999999999999965 68999999997543 234788999999999999999999999999999999999997
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
|+|.+++...........+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 69999997654333345699999999999999999999998 99999999999999999999999999998765332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc-----
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF----- 436 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 436 (511)
. ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||.... .......+......
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 163 N--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTN-------DEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp C--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHHHCSCCTTT
T ss_pred c--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCChhH
Confidence 2 12345689999999998653 357899999999999999999999986432 11111111111000
Q ss_pred ------------ccCCCCChHHH---------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 437 ------------QLDGVVTEEEK---------EMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 437 ------------~~~~~~~~~~~---------~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........... .....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000000 12235778888999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=344.38 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=195.6
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecC---------
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKK--------- 271 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------- 271 (511)
.|.+.+.||+|+||.||+|.++ +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 3456789999999999999976 799999999975432 3467999999999999999999999986543
Q ss_pred ------------------------------------------------eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCH
Q 040808 272 ------------------------------------------------KRALIYEFMPNGSLDQYIYDHESSNGKRTLEW 303 (511)
Q Consensus 272 ------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~ 303 (511)
..++||||+++|+|.+++.... .....++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~ 163 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC---SLEDREH 163 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC---SGGGSCH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc---Cccchhh
Confidence 3799999999999999997543 2345677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce----------eeecCCCCCC
Q 040808 304 RTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF----------ISMLDTRGTA 373 (511)
Q Consensus 304 ~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~ 373 (511)
..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999998 9999999999999999999999999999877654221 1123346999
Q ss_pred CccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHH
Q 040808 374 GYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKM 453 (511)
Q Consensus 374 ~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 453 (511)
.|+|||++.+. .++.++||||||+++|||++|..|+.. .......... ...+.........+
T Consensus 241 ~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~~~-------~~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDVRN-------LKFPLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHHHT-------TCCCHHHHHHCHHH
T ss_pred CccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHhhc-------cCCCcccccCChhH
Confidence 99999999654 689999999999999999998765320 0111111111 22334444555667
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 040808 454 ILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 454 ~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+++.+||+.||++|||++|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 78889999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=348.34 Aligned_cols=265 Identities=25% Similarity=0.411 Sum_probs=208.5
Q ss_pred HHHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCC--CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLK--DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 273 (511)
..+.+.+.||+|+||+||+|.+ .+++.||+|+++... ...+.+.+|+.++.++ +||||+++++++.+.+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 3456778999999999999985 245689999997532 3346899999999999 899999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESS-----------------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPH 336 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~ 336 (511)
++||||+++|+|.+++...... .....+++..++.++.||+.||+|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 9999999999999999754321 0113489999999999999999999998 9999999999
Q ss_pred CEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCcc
Q 040808 337 NIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKV 415 (511)
Q Consensus 337 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~ 415 (511)
|||++.++.+||+|||+++...............||+.|+|||.+.+ +.++.++||||||+++|||++ |+.||....
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999987755544333445568899999999865 378899999999999999998 999986432
Q ss_pred CCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 416 SCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
........+........+...+ ..+..++.+||+.||++|||+.+|++.|+..+...
T Consensus 280 ------~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 ------VDANFYKLIQNGFKMDQPFYAT-------EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp ------CSHHHHHHHHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ------cHHHHHHHHhcCCCCCCCCCCC-------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 1223333344333333232233 34667888899999999999999999999877654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=338.53 Aligned_cols=270 Identities=16% Similarity=0.205 Sum_probs=211.2
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.+.||+|+||+||+|.. .+++.||+|++.... ..+.+.+|+.++.++ +|+|++++++++.+....++||||+ +
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 45678999999999999995 578999999987543 345688999999999 7999999999999999999999999 9
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc-----eEEeeccCcccc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC-----PKISDFGLAKQT 357 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~DFGla~~~ 357 (511)
++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 90 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 90 PSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred CCHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99999996532 4699999999999999999999998 9999999999999987776 999999999876
Q ss_pred CCCCce-----eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 358 EKKESF-----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 358 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
...... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~ 235 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAA----TNKQKYERIGE 235 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC----CHHHHHHHHHH
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhcc----ccHHHHHHHHh
Confidence 543321 112345699999999998654 6799999999999999999999999753211 12222222222
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~ 493 (511)
..... ............+.+++.+||+.||++|||+++|++.|+.+++.+.......+
T Consensus 236 ~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 293 (298)
T 1csn_A 236 KKQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 293 (298)
T ss_dssp HHHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred hccCc---cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcc
Confidence 11100 00000112334577788889999999999999999999998887765544433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=343.39 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=197.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecC-----
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKK----- 271 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 271 (511)
.|.+.+.||+|+||+||+|... .++.||+|+++..... .+.+.+|+.++++++||||+++++++.+..
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 4556788999999999999743 3458999999754332 357899999999999999999999997654
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
..++||||+++|+|.+++...........+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeec
Confidence 3599999999999999996544333456799999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHH
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
|+++...............+++.|+|||.+.+ ..++.++||||||+++|+|++ |+.|+.... .......+
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~ 262 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-------NHEMYDYL 262 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------GGGHHHHH
T ss_pred CcceecccccccCcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCC-------HHHHHHHH
Confidence 99987654433222234457889999999965 368899999999999999999 888875332 12222333
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
............ ...+.+++.+||+.||++|||++++++.|+.+++.+
T Consensus 263 ~~~~~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LHGHRLKQPEDC-------LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HTTCCCCCBTTC-------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HcCCCCCCCccc-------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 333222222222 235677888999999999999999999999887655
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=350.57 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=195.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.++||+|+||+||+|+.+ +++.||+|++++.. ...+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 456789999999999999965 58899999998542 2235688999999887 79999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 134 ~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999643 4699999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC--CCCchHHHHHHHhhhhcc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS--SEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 436 (511)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .......+.+.+... ..
T Consensus 205 ~~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-~~ 279 (396)
T 4dc2_A 205 RPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI 279 (396)
T ss_dssp CTTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-CC
T ss_pred cCCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-cc
Confidence 2221 12345799999999999764 68899999999999999999999996432211 112233344443332 23
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
.++..++.. +..++.+||+.||++||++
T Consensus 280 ~~p~~~s~~-------~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPRSLSVK-------AASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCTTSCHH-------HHHHHHHHTCSCTTTSTTC
T ss_pred CCCCcCCHH-------HHHHHHHHhcCCHhHcCCC
Confidence 334444544 4456667889999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=346.45 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=200.5
Q ss_pred HhhhcccCCcCceEEEEEEcCC-----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD-----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
+.+.+.||+|+||+||+|.+.. +..||+|+++.... ...++.+|+.++++++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 3455789999999999998542 24699999975432 2357889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 126 e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 126 EYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp ECCTTEEHHHHHHHT-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eCCCCCcHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999643 24689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 358 EKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 358 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
...... .......+|+.|+|||.+.. ..++.++||||||+++|||++ |+.||... ....+...+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~-------~~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDGFR 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTCC
T ss_pred ccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccC-------CHHHHHHHHHCCCc
Confidence 543221 11123346889999999865 368899999999999999998 99998532 12333444444333
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCC
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIP 488 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p 488 (511)
...... ....+.+++.+||+.||++||++.++++.|+.++......
T Consensus 269 ~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 314 (333)
T 1mqb_A 269 LPTPMD-------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314 (333)
T ss_dssp CCCCTT-------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred CCCccc-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 222222 2345677888999999999999999999999877654433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=348.66 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=200.5
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
...|.+.++||+|+||+||+|..+ +|+.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345677889999999999999865 6899999999764432 356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC---CceEEeeccCc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED---FCPKISDFGLA 354 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla 354 (511)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 108 e~~~gg~L~~~l~~------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 108 DLVTGGELFEDIVA------REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp CCCCSCBHHHHHTT------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999843 34689999999999999999999998 99999999999999765 45999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ...+...+....
T Consensus 179 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~-------~~~~~~~i~~~~ 246 (362)
T 2bdw_A 179 IEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGA 246 (362)
T ss_dssp BCCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTC
T ss_pred eEecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCC
Confidence 87764432 2345699999999999653 68899999999999999999999986431 223333333321
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ..+ ......+...+.+++.+||+.||++|||+.++++
T Consensus 247 ~-~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 247 Y-DYP---SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp C-CCC---TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred C-CCC---cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 111 1111122344667778899999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=340.18 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=207.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecC--eEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKK--KRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|.+. +++.||||+++... ...+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 456789999999999999965 58999999997533 34577889999999999999999999988655 78999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE----cCCCceEEeeccCcc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAK 355 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 355 (511)
+++++|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 91 CPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp CTTCBHHHHHHSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred CCCCCHHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999965431 23499999999999999999999998 99999999999999 888899999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccc------cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRH------FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
........ ....||+.|+|||++... ...++.++||||||+++|||++|+.||...... ......+.+.
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYKI 239 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG--GGCHHHHHHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--chhHHHHHHH
Confidence 77655432 244699999999998521 246889999999999999999999999643211 1112222222
Q ss_pred Hhhhh-------------------ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 430 IETEY-------------------DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 430 ~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
+.... ........ .......+..++.+||+.||++|||++|+++...+..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSL---SRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSS---CHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCccccc---chhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 21110 00111112 2345556778889999999999999999999988654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=346.59 Aligned_cols=265 Identities=26% Similarity=0.426 Sum_probs=195.1
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
|+....+.+.++||+|+||+||+|.... .||+|+++..... .+.+.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 4444556778899999999999998643 5999999765433 35789999999999999999999965 4566899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS-----ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp EEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred EEEecCCCcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecc
Confidence 99999999999999533 35699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
...............||+.|+|||.+... ...++.++||||||+++|+|++|+.||.... ..+.+.+.+....
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~ 242 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------NRDQIIEMVGRGS 242 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC------CHHHHHHHHHHTS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcccc
Confidence 66543322223345699999999998521 2367889999999999999999999996432 1223333332222
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
... ............+.+++.+||+.||++|||+++++++|+.+.+
T Consensus 243 ~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSP---DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCC---CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCc---chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111 1111111233457778889999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=339.75 Aligned_cols=262 Identities=26% Similarity=0.395 Sum_probs=199.5
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+.+.||+|+||+||+|... ++.||+|++... ...+.|.+|+.++++++||||+++++++.+ ..++||||+++|+
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 456788999999999999974 688999998743 345789999999999999999999998874 4789999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc-eEEeeccCccccCCCCce
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC-PKISDFGLAKQTEKKESF 363 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~DFGla~~~~~~~~~ 363 (511)
|.+++.... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.......
T Consensus 86 L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 86 LYNVLHGAE---PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp HHHHHHCSS---SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred HHHHHhccC---CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999996532 1235789999999999999999999933239999999999999998886 7999999997654332
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... . ...+................+
T Consensus 161 ---~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~---~--~~~~~~~~~~~~~~~~~~~~~ 230 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGG---P--AFRIMWAVHNGTRPPLIKNLP 230 (307)
T ss_dssp -------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCS---S--HHHHHHHHHTTCCCCCBTTCC
T ss_pred ---ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCc---c--HHHHHHHHhcCCCCCcccccC
Confidence 234599999999999653 688999999999999999999999863311 1 111122222222222222223
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCC
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPS 492 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~ 492 (511)
..+.+++.+||+.||++|||+++++++|+.+.+.++.+..|.
T Consensus 231 -------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 231 -------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp -------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred -------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 346678888999999999999999999998887776555443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=347.27 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=195.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+.+.+.||+|+||+||+|+.+ +|+.||||++++. ....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 3566789999999999999965 6899999999753 33456788999999988 6999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 104 E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 104 EFVNGGDLMFHIQKS------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999543 4699999999999999999999998 9999999999999999999999999999864
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+... ...
T Consensus 175 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~-~~~ 242 (353)
T 3txo_A 175 ICNGV--TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILND-EVV 242 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC-CCC
T ss_pred ccCCc--cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCC-------HHHHHHHHHcC-CCC
Confidence 33221 12345799999999999764 67899999999999999999999996432 23334444332 222
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM------TKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~------~evl~ 476 (511)
.+...++. +..++.+||+.||++||++ +++++
T Consensus 243 ~p~~~~~~-------~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 YPTWLHED-------ATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCTTSCHH-------HHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCHH-------HHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 33334443 4456667789999999998 67664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.31 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=196.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcE----EEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRL----VAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
|.+.++||+|+||+||+|.+. +++. ||+|.+... ....+++.+|+.++++++||||+++++++.+.. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 456789999999999999854 4554 577776543 334578999999999999999999999998765 78999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp CCCSSCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EecCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999996543 4689999999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.............+|+.|+|||.+.+. .++.++||||||+++|||++ |+.||.... ...+...+......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~-------~~~~~~~~~~~~~~ 238 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILEKGERL 238 (327)
T ss_dssp ------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCCC
T ss_pred cCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCC
Confidence 554433333445578899999999754 78899999999999999999 999986432 22233333333333
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
......+. .+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 239 ~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 PQPPICTI-------DVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCTTBCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCccCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 33333333 466778889999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.63 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=213.8
Q ss_pred HHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 201 RRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 201 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
....+.+.++||+|+||+||+|.++ +++.||+|++.......+++.+|+.++++++||||+++++++.+....++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3445667789999999999999965 488999999987766678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 91 MTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp CTTEEHHHHHHHCC----TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred CCCCcHHHHHHhcc----cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999996532 35689999999999999999999998 999999999999999999999999999987764
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
... .......+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.|+.... ...+...+........
T Consensus 164 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~-------~~~~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 164 DTY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMER 233 (288)
T ss_dssp SSS-EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------GGGHHHHHHTTCCCCC
T ss_pred Ccc-ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhccCCCCC
Confidence 432 223344578899999999653 68899999999999999999 888885432 2223333333333333
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
+...+ ..+.+++.+||+.||++|||+++++++|+.....
T Consensus 234 ~~~~~-------~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 234 PEGCP-------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC-------HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 33333 3466777889999999999999999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=333.72 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=199.0
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC--------hHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN--------GEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
.+.+.+.||+|+||+||+|.+ .+++.||+|++...... .+++.+|+.++++++||||+++++++.+.. +
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 345678999999999999996 47899999998643221 167899999999999999999999987665 6
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCEEEcCCCc-----eE
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR--IVHLDIKPHNIRLDEDFC-----PK 347 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dlkp~NIll~~~~~-----~k 347 (511)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +|
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDK-----AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp EEEECCTTCBHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred EEEEecCCCCHHHHHhcc-----cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 999999999999988543 35799999999999999999999998 7 999999999999988776 99
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 427 (511)
|+|||+++..... .....||+.|+|||++......++.++||||||+++|||++|+.||..... .......
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~ 240 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY----GKIKFIN 240 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC----CHHHHHH
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc----cHHHHHH
Confidence 9999999855432 234569999999999854434678899999999999999999999964321 0111111
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
...............+ ..+.+++.+||+.||++|||++++++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIREEGLRPTIPEDCP-------PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHSCCCCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHhccCCCCCCCcccC-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1112222222222222 3466778889999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=337.28 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=194.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||+||+|.+. +++.||+|+++..... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 456789999999999999965 6899999999754332 367889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~-~l~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 84 DQ-DLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp SE-EHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred CC-CHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 65 666666432 24699999999999999999999998 9999999999999999999999999999876533
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. ......||+.|+|||++.+. ..++.++||||||+++|||++|+.|+..... .......+..........
T Consensus 155 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~------~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 155 VR--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGND------VDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS------HHHHHHHHHHHHCCCCTT
T ss_pred cc--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCC------HHHHHHHHHHHhCCCChh
Confidence 22 12345689999999998654 2478999999999999999999888643211 112222221111000000
Q ss_pred ---------------------CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 ---------------------VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ---------------------~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
............+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000112334567778899999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.97 Aligned_cols=253 Identities=25% Similarity=0.296 Sum_probs=193.5
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|...+|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 456789999999999999988899999999975432 23678899999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 84 -QDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp -EEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred -CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 49999885432 4689999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc----
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ---- 437 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 437 (511)
. ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||..... .+.+ ..+.......
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~-~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 155 R--KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQL-MRIFRILGTPNSKN 224 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-HHHHHHHCCCCTTT
T ss_pred c--ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHHHHCCCChhh
Confidence 1 12234689999999998653 3578999999999999999999999864311 1111 1111100000
Q ss_pred ---------cCCCC--------ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 ---------LDGVV--------TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ---------~~~~~--------~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ..........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000112344667888899999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=342.62 Aligned_cols=283 Identities=23% Similarity=0.293 Sum_probs=207.8
Q ss_pred hhCCCCCCCCCHHHHHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHcc--CCcceeee
Q 040808 186 NYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRT--SHVNIVPF 263 (511)
Q Consensus 186 ~~~~~~~~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l 263 (511)
...+....+....+.....|.+.++||+|+||+||+|... ++.||||++.... ...+..|.+++... +||||+++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~ 96 (337)
T 3mdy_A 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGF 96 (337)
T ss_dssp HHCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred cCCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeE
Confidence 3444444444555555667788899999999999999975 8999999986532 34556666666655 89999999
Q ss_pred eceEeec----CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCC
Q 040808 264 LGFCYEK----KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC-----NIRIVHLDIK 334 (511)
Q Consensus 264 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiH~Dlk 334 (511)
++++.+. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ ..+|+|||||
T Consensus 97 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS-------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp EEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCC
T ss_pred EEEEccCCCCCCceEEEEeccCCCcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccc
Confidence 9999877 789999999999999999953 35899999999999999999999752 2389999999
Q ss_pred CCCEEEcCCCceEEeeccCccccCCCCceee--ecCCCCCCCccchhhcccccCCCCc------cccchhHHHHHHHHHh
Q 040808 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFIS--MLDTRGTAGYIAPEVFCRHFGGVSH------KSDVYSYGMMIHEMVI 406 (511)
Q Consensus 335 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~------~sDvwSlG~il~ellt 406 (511)
|+|||++.++.+||+|||+++.......... .....||+.|+|||++.+. ..+. ++||||||+++|||++
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHh
Confidence 9999999999999999999977654332211 1234699999999998654 2333 4899999999999999
Q ss_pred C----------CCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 040808 407 G----------RKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474 (511)
Q Consensus 407 g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~ev 474 (511)
| +.|+...... ..........+.. . ......+. ...+....+.+++.+||+.||++|||+++|
T Consensus 248 g~~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 248 RCVSGGIVEEYQLPYHDLVPS--DPSYEDMREIVCI-K--KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp TBCBTTBCCCCCCTTTTTSCS--SCCHHHHHHHHTT-S--CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccCcccccccccccHhhhcCC--CCchhhhHHHHhh-h--ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 9 4454322111 1111111111111 1 11111221 123566778899999999999999999999
Q ss_pred HHHhhccccCC
Q 040808 475 VEMLEGSIENL 485 (511)
Q Consensus 475 l~~L~~~~~~l 485 (511)
++.|+.+.+..
T Consensus 323 l~~L~~l~~~~ 333 (337)
T 3mdy_A 323 KKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHhhc
Confidence 99999877654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=343.88 Aligned_cols=257 Identities=22% Similarity=0.368 Sum_probs=199.9
Q ss_pred HHHhhhcccCCcCceEEEEEEcCC-C-------cEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPD-G-------RLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
..+.+.++||+|+||+||+|.... + ..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 345677899999999999998543 3 479999997543 3457899999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc--------
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC-------- 345 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~-------- 345 (511)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999996532 3589999999999999999999998 9999999999999998887
Q ss_pred eEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHH
Q 040808 346 PKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNA 425 (511)
Q Consensus 346 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 425 (511)
+||+|||++....... ...||+.|+|||++.+. ..++.++||||||+++|||++|..|+..... ...
T Consensus 160 ~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~------~~~ 226 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD------ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALD------SQR 226 (289)
T ss_dssp EEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHH
T ss_pred eeeccCcccccccCcc------ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccc------hHH
Confidence 9999999997654332 23488999999999652 3688999999999999999997655532211 111
Q ss_pred HHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 040808 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489 (511)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~ 489 (511)
........ ...+...+ ..+.+++.+||+.||++|||++++++.|+.++.....++
T Consensus 227 ~~~~~~~~--~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 227 KLQFYEDR--HQLPAPKA-------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp HHHHHHTT--CCCCCCSS-------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred HHHHhhcc--CCCCCCCC-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 11212211 12222222 236677788999999999999999999999876544443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.71 Aligned_cols=241 Identities=25% Similarity=0.329 Sum_probs=198.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||++..+ +|+.||+|++++. ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 456789999999999999965 6999999999753 23457788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 88 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999642 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. ....||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ....+..+... ....+
T Consensus 159 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~-~~~~p 223 (318)
T 1fot_A 159 VT-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILNA-ELRFP 223 (318)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHC-CCCCC
T ss_pred cc-----ccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhC-CCCCC
Confidence 32 245699999999999654 68899999999999999999999996431 22233333222 12333
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
...+++ +.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~-------~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 PFFNED-------VKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TTSCHH-------HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHH-------HHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 344443 44566677899999999 8888873
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=356.84 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=199.2
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
..|.+.++||+|+||+||+|... +|+.+|+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 34667889999999999999854 789999999976442 23568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc---CCCceEEeeccCcc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISDFGLAK 355 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~ 355 (511)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++
T Consensus 91 ~~~gg~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 91 LVTGGELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp CCBCCBHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred eCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999643 4689999999999999999999998 999999999999998 56889999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
........ .....||+.|+|||++.+. .++.++||||+|+++|+|++|+.||.... ...+...+.....
T Consensus 162 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~ 230 (444)
T 3soa_A 162 EVEGEQQA--WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDED-------QHRLYQQIKAGAY 230 (444)
T ss_dssp CCCTTCCB--CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCC
T ss_pred EecCCCce--eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhCCC
Confidence 77544321 2345799999999999653 68899999999999999999999985431 2333344433321
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 DFPSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111 01112234556777888999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=333.32 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=189.5
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCC-----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLK-----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++||+|+||+||+|.+. ++.||||+++... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 456789999999999999974 7899999987542 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC--------CCceEEeec
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE--------DFCPKISDF 351 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~--------~~~~kl~DF 351 (511)
+++++|.+++. ...+++..++.++.|++.||+|||++...+|+||||||+|||++. ++.+||+||
T Consensus 88 ~~~~~L~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 88 ARGGPLNRVLS-------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CTTEEHHHHHT-------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred CCCCCHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999983 246899999999999999999999982122999999999999986 778999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|+++....... ....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.... ..........
T Consensus 161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~ 228 (271)
T 3dtc_A 161 GLAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAM 228 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHT
T ss_pred Ccccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHhhhc
Confidence 99986654332 234699999999998653 68899999999999999999999986431 1111122222
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
.......+...+ ..+.+++.+||+.||++|||++|+++.|+.
T Consensus 229 ~~~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NKLALPIPSTCP-------EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SCCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCcccC-------HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 222222222222 346678888999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.76 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=199.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++||+|+||+||+|..+ +++.||+|++++. ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 445688999999999999965 5899999999752 23345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 151 ~~gg~L~~~l~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 151 MPGGDLVNLMSN-------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp CTTEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 999999999853 3589999999999999999999998 999999999999999999999999999987755
Q ss_pred CCceeeecCCCCCCCccchhhccccc--CCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh---
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHF--GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY--- 434 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 434 (511)
... .......||+.|+|||++.+.. +.++.++|||||||++|||++|+.||.... ....+..+....
T Consensus 221 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 221 EGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNHKNSL 292 (410)
T ss_dssp TSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTHHHHC
T ss_pred CCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-------hhhHHHHHHhccccc
Confidence 432 2233567999999999996532 127789999999999999999999996432 233333333221
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPD--RPSMTKVVEM 477 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPs~~evl~~ 477 (511)
.+.....++++.. .++.+||+.+|++ ||+++||++.
T Consensus 293 ~~p~~~~~s~~~~-------~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPDDNDISKEAK-------NLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCTTCCCCHHHH-------HHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCCcccccHHHH-------HHHHHHccChhhhCCCCCHHHHhcC
Confidence 2222234455444 4455677888888 9999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=336.60 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=191.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---------------------------ChHHHHHHHHHHHccC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---------------------------NGEEFINEVASISRTS 256 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~ 256 (511)
|.+.++||+|+||+||+|.+. +++.||||++..... ..+++.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 456789999999999999854 689999999975321 1356889999999999
Q ss_pred CcceeeeeceEee--cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 040808 257 HVNIVPFLGFCYE--KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334 (511)
Q Consensus 257 h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlk 334 (511)
||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||+.||+|||+. +|+|||||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-------LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999986 568999999999999977542 24699999999999999999999998 99999999
Q ss_pred CCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccC-CCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG-GVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 335 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
|+|||++.++.+||+|||+++........ .....||+.|+|||.+.+... ..+.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999877654332 234579999999999865321 146789999999999999999999863
Q ss_pred ccCCCCCCchHHHHHHHhhh-hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 414 KVSCSSEYFPNAIYKQIETE-YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 414 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ...+...+... .........+ ..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~-------~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER-------IMCLHSKIKSQALEFPDQPDIA-------EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS-------HHHHHHHHHHCCCCCCSSSCCC-------HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc-------HHHHHHHHhcccCCCCCccccC-------HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 31 12222222221 1111112223 34667778899999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=335.97 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=209.5
Q ss_pred hhhc-ccCCcCceEEEEEEcC---CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 206 SFSD-KLGQGGYADVYKGTLP---DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 206 ~~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.+.+ .||+|+||+||+|.+. +++.||+|+++.... ..+++.+|++++++++||||+++++++ +.+..++||||
T Consensus 12 ~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 90 (287)
T 1u59_A 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEM 90 (287)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEe
Confidence 3444 8999999999999853 578899999986432 346789999999999999999999998 55679999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 91 AGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp CTTEEHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CCCCCHHHHHHhC-----CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 9999999999532 35699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 360 KESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 360 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
...... .....||+.|+|||++.+. .++.++||||||+++|||++ |+.||.... ...+...+.......
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~i~~~~~~~ 233 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRME 233 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------THHHHHHHHTTCCCC
T ss_pred CcceeeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC-------HHHHHHHHhcCCcCC
Confidence 433221 2234578999999998653 67899999999999999998 999986432 223333444433333
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCC
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKP 491 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p 491 (511)
.+...+ ..+.+++.+||+.||++||++.++++.|+....+...+..+
T Consensus 234 ~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 234 CPPECP-------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp CCTTCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCCCcC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 333333 35667888899999999999999999999988777665443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=344.16 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=180.2
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
++||+|+||+||+|.++ +++.||||++.+. ....+.+|+.++.++. ||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 57999999999999965 6899999999753 3467889999999997 999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC---ceEEeeccCccccCCCCce
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF---CPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~ 363 (511)
+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++........
T Consensus 95 ~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 95 ERIKKK------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999642 4699999999999999999999998 999999999999997765 8999999999876543321
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
.....||+.|+|||++.+. .++.++||||||+++|+|++|+.||..............+...+..... . ...
T Consensus 166 --~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~---~~~ 237 (325)
T 3kn6_A 166 --LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-S---FEG 237 (325)
T ss_dssp --------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-C---CCS
T ss_pred --ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-C---CCc
Confidence 2345689999999999654 6889999999999999999999999754322111222333333333211 1 111
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+....+...+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 222334455677888899999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.47 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=204.3
Q ss_pred hhhcccCCcCceEEEEEEcC-C---CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeE-EEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-D---GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKR-ALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e 278 (511)
...++||+|+||+||+|.+. + +..||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+.. ++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 34578999999999999843 2 23799999986443 236789999999999999999999999876654 99999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+.+|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 104 ~~~~~~L~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 104 YMCHGDLLQFIRSP-----QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp CCTTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred cccCCCHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999642 35689999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 359 KKESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 359 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
..... .......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.|+..... ...+...+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~ 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHID------PFDLTHFLAQGRRL 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------GGGHHHHHHTTCCC
T ss_pred CCcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCC------HHHHHHHhhcCCCC
Confidence 43211 112344688999999999653 688999999999999999997766542211 22223333333323
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCC
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIP 488 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p 488 (511)
......+ ..+.+++.+||+.||++|||+++++++|+.++..+...
T Consensus 248 ~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 248 PQPEYCP-------DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCCccch-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 3233333 34667788899999999999999999999988776443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.46 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=191.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
.|.+.++||+|+||+||++... +++.||||++.......+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 100 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCC
Confidence 3567889999999999999965 789999999987766668899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc--eEEeeccCccccCCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC--PKISDFGLAKQTEKK 360 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~~~~~ 360 (511)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 101 ~~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 101 GELYERICNA------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999542 3589999999999999999999998 9999999999999987765 999999999754332
Q ss_pred CceeeecCCCCCCCccchhhcccccCCC-CccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGV-SHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. .....||+.|+|||++.+. .+ +.++||||||+++|+|++|+.||..... ...+...+.............
T Consensus 172 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--PRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp ------------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC------CCCHHHHHHHHHTTCCCCCTT
T ss_pred CC---CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhcCCCCCCCc
Confidence 22 2234699999999998654 44 4458999999999999999999964321 111222222222211111111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~s-------~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 IRIS-------PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SCCC-------HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCC-------HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1233 345667788999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=342.41 Aligned_cols=259 Identities=19% Similarity=0.266 Sum_probs=208.8
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccC
Q 040808 182 AFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTS 256 (511)
Q Consensus 182 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~ 256 (511)
.+...+........... .|.+.+.||+|+||.||++..+ +|+.||+|++++. ....+.+.+|+.++++++
T Consensus 25 ~~~~~~~~~~~~~~~~~-----~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~ 99 (350)
T 1rdq_E 25 DFLKKWETPSQNTAQLD-----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99 (350)
T ss_dssp HHHHHHHSCCCCCCCGG-----GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC
T ss_pred HHHhhhccccccCCCHH-----HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC
Confidence 45555555444444433 3456789999999999999965 6999999999653 244578899999999999
Q ss_pred CcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 040808 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPH 336 (511)
Q Consensus 257 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~ 336 (511)
||||+++++++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+
T Consensus 100 hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~ 170 (350)
T 1rdq_E 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPE 170 (350)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred CCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccc
Confidence 999999999999999999999999999999999643 3589999999999999999999998 9999999999
Q ss_pred CEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccC
Q 040808 337 NIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVS 416 (511)
Q Consensus 337 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~ 416 (511)
|||++.++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 171 NIll~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~- 242 (350)
T 1rdq_E 171 NLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQ- 242 (350)
T ss_dssp GEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred eEEECCCCCEEEcccccceeccCCc-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCC-
Confidence 9999999999999999998765432 244699999999999764 67899999999999999999999996431
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
...+...+... ....+..++. .+.+++.+||+.||++||+ +++|++
T Consensus 243 ------~~~~~~~i~~~-~~~~p~~~~~-------~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 243 ------PIQIYEKIVSG-KVRFPSHFSS-------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------HHHHHHHHHHC-CCCCCTTCCH-------HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------HHHHHHHHHcC-CCCCCCCCCH-------HHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 23334444332 2223333443 3556677788999999998 888864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.98 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=194.3
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC------CChHHHHHHHHHHHccC---CcceeeeeceEe
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK------DNGEEFINEVASISRTS---HVNIVPFLGFCY 268 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 268 (511)
++....|.+.++||+|+||+||+|.+ .+++.||||+++... .....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34445667789999999999999996 468999999987432 22356778888777765 999999999998
Q ss_pred ecC-----eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC
Q 040808 269 EKK-----KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED 343 (511)
Q Consensus 269 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~ 343 (511)
... ..++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~ 156 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAP----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG 156 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTT
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCC
Confidence 754 5889999995 69999996532 24599999999999999999999998 99999999999999999
Q ss_pred CceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCch
Q 040808 344 FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP 423 (511)
Q Consensus 344 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~ 423 (511)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.... .
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~ 224 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNS-------E 224 (308)
T ss_dssp SCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSS-------H
T ss_pred CCEEEeeCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCC-------H
Confidence 9999999999987654332 2345699999999999653 68999999999999999999999986432 1
Q ss_pred HHHHHHHhhhhccccCC---------------CCC----hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 424 NAIYKQIETEYDFQLDG---------------VVT----EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 424 ~~~~~~~~~~~~~~~~~---------------~~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
......+.......... ... ....+....+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 12222222111100000 000 000122345667888899999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.44 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=201.5
Q ss_pred ccCCcCceEEEEEEcC---CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 210 KLGQGGYADVYKGTLP---DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+||+|+||+||+|.++ ++..||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999753 46679999998643 345789999999999999999999999876 56899999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++... ...+++..+..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.........
T Consensus 422 L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 99999532 35699999999999999999999998 99999999999999999999999999998775433221
Q ss_pred -eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 365 -SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 365 -~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
......+|+.|+|||++.. +.++.++||||||+++|||++ |+.||.... ...+...+..+.....+...
T Consensus 494 ~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-------~~~~~~~i~~~~~~~~p~~~ 564 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRMECPPEC 564 (613)
T ss_dssp --------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------SHHHHHHHHTTCCCCCCTTC
T ss_pred eeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCCCCCCcC
Confidence 1123346789999999965 478999999999999999998 999986432 23344455554433333333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
...+.+++.+||+.||++||++++|+++|+.....+.
T Consensus 565 -------~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 565 -------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp -------CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred -------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 3457778899999999999999999999998766553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=345.06 Aligned_cols=247 Identities=24% Similarity=0.300 Sum_probs=184.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
|.+.++||+|+||+||+|.+. +++.||||+++... ..+.+.+|++++++++||||+++++++.+....++||||+++|
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 456788999999999999966 58899999998643 3467889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCccccCCC
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~~ 360 (511)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 134 ~L~~~l~~------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 134 ELFDRIVE------KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp BHHHHHTT------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999943 34689999999999999999999998 9999999999999975 889999999999876543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ....+...+.........
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~i~~~~~~~~~- 272 (349)
T 2w4o_A 205 VL---MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDER------GDQFMFRRILNCEYYFIS- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTT------CHHHHHHHHHTTCCCCCT-
T ss_pred cc---cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCc------ccHHHHHHHHhCCCccCC-
Confidence 22 2234699999999999653 68899999999999999999999985332 122233333332211111
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+...+....+.+++.+||+.||++|||+.++++
T Consensus 273 ---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 ---PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111123345667888999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=335.67 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=192.7
Q ss_pred HHHhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
..|.+.+.||+|+||+||+|.+.. +..||+|+++.... ..+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 345678899999999999998642 45799999876432 2357899999999999999999999874 4568899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EECCTTEEHHHHHHHT-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EecCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999643 24689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
........ .....+|+.|+|||.+... .++.++||||||+++|||++ |+.||.... ...+...+.....
T Consensus 166 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~-------~~~~~~~i~~~~~ 235 (281)
T 1mp8_A 166 MEDSTYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGER 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCC
T ss_pred cCcccccc-cccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCC-------HHHHHHHHHcCCC
Confidence 65433211 2234578899999998653 68899999999999999996 888886432 1122333333332
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+...+ ..+.+++.+||+.||++|||+.++++.|+.+++
T Consensus 236 ~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 236 LPMPPNCP-------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 33333333 346677888999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.70 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=191.5
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecC----eEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKK----KRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 274 (511)
.|.+.++||+|+||+||+|.+ .+++.||||+++..... ...+.+|+.++.+++||||+++++++.... ..+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 356678999999999999995 57899999999764322 246889999999999999999999987644 349
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 93 lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred EEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999643 3689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 355 KQTEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 355 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
+........ .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~ 235 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVRED 235 (311)
T ss_dssp ------------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCC
Confidence 876543221 122234699999999999654 68899999999999999999999986432 112222222211
Q ss_pred hccccCCCCChH--HHHHHHHHHHHHHhccccCCCCCCCHH-HHHHHhhccccC
Q 040808 434 YDFQLDGVVTEE--EKEMAKKMILVSLWCIQTHPPDRPSMT-KVVEMLEGSIEN 484 (511)
Q Consensus 434 ~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~~p~~RPs~~-evl~~L~~~~~~ 484 (511)
. .... .......+..++.+||+.||++||++. ++.+.|......
T Consensus 236 ~-------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 236 P-------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp C-------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred C-------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 1 1111 112334567788899999999999555 455666655443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.76 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=197.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.++||+|+||+||+|+++ +++.||+|++++. ....+.+.+|+.++..++||||++++++|.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 345689999999999999966 5889999999752 22334588999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 156 ~~gg~L~~~l~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 156 YVGGDLLTLLSKF-----EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CTTCBHHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHHc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 9999999999642 24699999999999999999999998 999999999999999999999999999987655
Q ss_pred CCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh-hhc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET-EYD 435 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 435 (511)
.... ......||+.|+|||++... .+.++.++|||||||++|||++|+.||.... ....+..+.. ...
T Consensus 228 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 228 DGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKER 299 (437)
T ss_dssp TSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTHHHH
T ss_pred CCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-------hhHHHHhhhhcccc
Confidence 4332 22345799999999998621 2467899999999999999999999996431 2223333322 222
Q ss_pred cccCC---CCChHHHHHHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 040808 436 FQLDG---VVTEEEKEMAKKMILVSLWCIQTHPPD--RPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~~p~~--RPs~~evl~ 476 (511)
...+. .++++..+ ++.+||+.+|++ ||+++|+++
T Consensus 300 ~~~p~~~~~~s~~~~d-------Li~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKD-------LIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCCSSCCCSCHHHHH-------HHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccCCcccccCCHHHHH-------HHHHHhcccccccCCCCHHHHhC
Confidence 22222 24554444 445566667777 999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=347.73 Aligned_cols=262 Identities=18% Similarity=0.195 Sum_probs=196.3
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccCCC------------ChHHHHHHHHHHHccCCcceeee
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNLKD------------NGEEFINEVASISRTSHVNIVPF 263 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l 263 (511)
+....|.+.++||+|+||+||+|... ++..+|+|++..... ....+.+|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 33345667889999999999999965 577899999875432 12346788899999999999999
Q ss_pred eceEee----cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEE
Q 040808 264 LGFCYE----KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIR 339 (511)
Q Consensus 264 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIl 339 (511)
++++.+ ....++||||+ +++|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 183 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL 183 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence 999987 77899999999 99999998532 3799999999999999999999998 9999999999999
Q ss_pred EcCCC--ceEEeeccCccccCCCCcee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 340 LDEDF--CPKISDFGLAKQTEKKESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 340 l~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
++.++ .+||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 98887 99999999998765332211 11344699999999998753 68999999999999999999999995
Q ss_pred CccCCCCCCchHHHHHHHhhhhccccCCCCChHHH------HHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 413 VKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEK------EMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.... ....... ....... ..+.... .....+.+++.+||+.||++|||+++|++.|+....
T Consensus 262 ~~~~-----~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 262 QNLK-----DPVAVQT-AKTNLLD----ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp GGTT-----CHHHHHH-HHHHHHH----TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccc-----ccHHHHH-HHHhhcc----cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 3211 0111111 1111110 1111111 233467778889999999999999999999997543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.47 Aligned_cols=248 Identities=22% Similarity=0.341 Sum_probs=200.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||++... +++.||+|++.+. ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 456789999999999999855 5899999999743 34457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~gg~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 97 LLGGDLRYHLQQ------NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CTTEEHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999953 24699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCceeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
... .....||+.|+|||++... ...++.++|||||||++|||++|+.||...... ....+...+... ....
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~~~~~~~~-~~~~ 239 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST----SSKEIVHTFETT-VVTY 239 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS----CHHHHHHHHHHC-CCCC
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc----cHHHHHHHHhhc-ccCC
Confidence 432 2345799999999998642 135788999999999999999999999643211 122222222221 1222
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-MTKVVE 476 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-~~evl~ 476 (511)
+...+. .+..++.+||+.||++||+ +++|++
T Consensus 240 p~~~s~-------~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 PSAWSQ-------EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CTTSCH-------HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCcCCH-------HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 333333 4566777888999999998 676654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=335.36 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=194.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.|.+.++||+|+||+||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 4677899999999999999964 68999999987543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE---cCCCceEEeeccCcccc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQT 357 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 357 (511)
++|+|.+++..... ....+++..++.|+.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 103 ~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 103 EGGELLERIVSAQA--RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp SCCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCcHHHHHHhhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999965321 125699999999999999999999998 99999999999999 55688999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||.... ...+........ ..
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~-~~ 243 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTS-------LEEVQQKATYKE-PN 243 (285)
T ss_dssp ------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCC-CC
T ss_pred CCccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCC-------HHHHHhhhccCC-cc
Confidence 54332 234469999999999853 67899999999999999999999986431 222222221111 00
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...........+.+++.+||+.||++|||+.||++
T Consensus 244 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 244 ----YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111112334667788899999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=345.43 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=196.2
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|.+ .+++.||+|++... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 45678999999999999995 57899999998643 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+ +|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 91 ~-~g~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 91 A-GGELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp C-CEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred C-CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9 78999998543 4689999999999999999999998 999999999999999999999999999987655
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... ....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||+...... . .+.+.. .....+
T Consensus 161 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~-----~~~i~~-~~~~~p 228 (336)
T 3h4j_B 161 GNFL---KTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--L-----FKKVNS-CVYVMP 228 (336)
T ss_dssp SBTT---CCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--C-----BCCCCS-SCCCCC
T ss_pred Cccc---ccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--H-----HHHHHc-CCCCCc
Confidence 4322 345699999999999654 234789999999999999999999996432111 0 000000 011222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...++ .+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~s~-------~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 229 DFLSP-------GAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp TTSCH-------HHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ccCCH-------HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 22333 3556778899999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=346.17 Aligned_cols=272 Identities=25% Similarity=0.354 Sum_probs=197.0
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHH--HccCCcceeeeeceEee-----cCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASI--SRTSHVNIVPFLGFCYE-----KKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~-----~~~~~lv~ 277 (511)
+.+.++||+|+||+||+|+. +++.||||+++... ...+..|.+++ ..++||||+++++.+.. ....++||
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 45678999999999999987 67999999997543 34555555554 45899999999985532 33678999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC------NIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
||+++|+|.+++... ..++..+..|+.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+||
T Consensus 92 e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp CCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred ecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999999542 3588999999999999999999852 228999999999999999999999999
Q ss_pred cCccccCCCCc------eeeecCCCCCCCccchhhcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC
Q 040808 352 GLAKQTEKKES------FISMLDTRGTAGYIAPEVFCRH-----FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420 (511)
Q Consensus 352 Gla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~ 420 (511)
|+++....... ........||+.|+|||++.+. ...++.++||||||+++|||++|+.|+.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987654321 1112244699999999998652 124567899999999999999998777543221111
Q ss_pred --Cch---------HHHHHHHhh-hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCC
Q 040808 421 --YFP---------NAIYKQIET-EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487 (511)
Q Consensus 421 --~~~---------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~ 487 (511)
.+. ......+.. .....++.... ........+.+++.+||+.||++|||++||+++|+.++.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK-ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC-CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccc-cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 110 111111111 11111111111 1123455688899999999999999999999999988766543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=342.18 Aligned_cols=199 Identities=26% Similarity=0.338 Sum_probs=173.8
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC-----CcceeeeeceEeecCeE
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS-----HVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~ 273 (511)
+....|.+.++||+|+||+||+|.+ .+++.||||+++......+.+..|+.++.+++ ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3344566778999999999999996 46899999999865555677888999999997 99999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-----------
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE----------- 342 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~----------- 342 (511)
++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNN----YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred EEEEcCC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchh
Confidence 9999999 999999996533 24589999999999999999999998 9999999999999975
Q ss_pred --------------CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCC
Q 040808 343 --------------DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408 (511)
Q Consensus 343 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~ 408 (511)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCC
Confidence 7899999999998754432 245699999999999764 6899999999999999999999
Q ss_pred CCCCC
Q 040808 409 KNADV 413 (511)
Q Consensus 409 ~p~~~ 413 (511)
.||..
T Consensus 257 ~pf~~ 261 (360)
T 3llt_A 257 LLFRT 261 (360)
T ss_dssp CSCCC
T ss_pred CCCCC
Confidence 99964
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.41 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=192.7
Q ss_pred hcccCCcCceEEEEEEc-CCCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 208 SDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
.+.||+|+||.||+|.. .+|+.||+|+++... ...+++.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 45799999999999985 469999999998643 3346899999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE--cCCCceEEeeccCccccCCCCce
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL--DEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 174 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 174 FDRIIDES-----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp HHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 99886432 4689999999999999999999998 99999999999999 67789999999999877654332
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
....||+.|+|||++.. ..++.++||||||+++|||++|+.||.... .......+.... .... .
T Consensus 246 ---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~-~~~~---~ 309 (373)
T 2x4f_A 246 ---KVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-------DAETLNNILACR-WDLE---D 309 (373)
T ss_dssp ---CCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTC-CCSC---S
T ss_pred ---ccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcc-CCCC---h
Confidence 23469999999999865 368899999999999999999999986432 122222222211 1111 1
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+...+.+++.+||+.||++|||++|+++
T Consensus 310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111123345677888999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=341.54 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=192.2
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCC--cceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTSH--VNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||++...+++.||||++...... .+.+.+|+.++.+++| +||+++++++.+....++|||+
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 4567899999999999999888999999999754433 3578899999999986 9999999999999999999994
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
.+++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 91 -~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 91 -GNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp -CSEEHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred -CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 589999999642 4689999999999999999999998 999999999999997 57899999999987755
Q ss_pred CCceeeecCCCCCCCccchhhccc---------ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCR---------HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
...........||+.|+|||++.+ ..+.++.++||||||+++|||++|+.||..... ....+...+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence 443323334579999999999854 114678899999999999999999999963211 111222222
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
........+...+ ..+.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~-------~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 DPNHEIEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CTTSCCCCCCCSC-------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCcccCCcccCC-------HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2222222222222 245677788999999999999999853
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.57 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=200.5
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeec--CeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEK--KKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 279 (511)
+.+.++||+|+||+||+|.++ ++.||+|+++..... .+++.+|+.++++++||||+++++++.+. ...++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 456789999999999999985 789999999865432 35789999999999999999999999876 788999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR--IVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
+++|+|.+++.... ...+++..++.++.|++.||+|||+. + ++||||||+|||+++++.++|+|||++...
T Consensus 91 ~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 91 MPYGSLYNVLHEGT----NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CTTCBHHHHHHSCS----SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cCCCcHHHHHhhcc----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999996432 23689999999999999999999997 7 999999999999999999999999987654
Q ss_pred CCCCceeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
... ...||+.|+|||.+.+. ....+.++||||||+++|||++|+.||.... ...............
T Consensus 164 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 164 QSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEGLRP 230 (271)
T ss_dssp SCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSCCCC
T ss_pred ccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcCCCC
Confidence 322 34589999999998653 1233448999999999999999999986331 122222222222222
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
..+...+ ..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 231 ~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 TIPPGIS-------PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2333333 346677788999999999999999999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.79 Aligned_cols=203 Identities=20% Similarity=0.229 Sum_probs=173.2
Q ss_pred HHhhhcccCCc--CceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQG--GYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.|.+.++||+| +||+||+|..+ +|+.||||+++..... .+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 35677899999 99999999965 6999999999764332 356788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 106 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 106 SFMAYGSAKDLICTHF----MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp ECCTTCBHHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EccCCCCHHHHHhhhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999996542 24589999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCce-----eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 358 EKKESF-----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 358 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
...... .......||+.|+|||++.+....++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 322111 11122368999999999976434688999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=339.11 Aligned_cols=246 Identities=22% Similarity=0.314 Sum_probs=194.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+.||+|+||.||+|+.+ +++.||+|++++... ..+.+.+|..++.++ +||||+++++++.+....++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 456789999999999999965 589999999986432 234578899999987 89999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999542 3689999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--CCchHHHHHHHhhhhcc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--EYFPNAIYKQIETEYDF 436 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~ 436 (511)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......+.+.+... ..
T Consensus 162 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~ 236 (345)
T 3a8x_A 162 RPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-QI 236 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-CC
T ss_pred CCCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-CC
Confidence 2221 12345799999999999764 678999999999999999999999964321111 11223333333332 22
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
.++...+. .+.+++.+||+.||++||++
T Consensus 237 ~~p~~~s~-------~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RIPRSLSV-------KAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCCTTSCH-------HHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCCH-------HHHHHHHHHhcCCHhHCCCC
Confidence 33333443 34556677889999999996
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=334.14 Aligned_cols=260 Identities=24% Similarity=0.420 Sum_probs=200.2
Q ss_pred HhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEe-ecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCY-EKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 277 (511)
+.+.++||+|+||+||+|.+.+ +..+|+|.++.... ..+++.+|+.++++++||||+++++++. +.+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4567899999999999998542 23689999876433 2367899999999999999999999865 456789999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 107 e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 107 PYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp ECCTTCBHHHHHHCT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred eCCCCCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999542 35689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 358 EKKESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 358 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
...... .......||+.|+|||.+.+. .++.++||||||+++|+|++|..|+..... .......+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~------~~~~~~~~~~~~~ 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRR 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSC------TTTHHHHHHTTCC
T ss_pred cccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCC------HHHHHHHHhcCCC
Confidence 543321 122344678899999999654 688999999999999999995554432211 1111222222222
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCC
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~ 487 (511)
...+...+ ..+.+++.+||+.||++|||+++++++|+.++..+..
T Consensus 251 ~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 LLQPEYCP-------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCccCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 22222223 3466788889999999999999999999998876543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=349.28 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=192.4
Q ss_pred HhhhcccCCcCceEEEEEEcC--C--CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEee-cCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP--D--GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYE-KKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 277 (511)
+.+.++||+|+||+||+|.+. + +..||+|.++.... ..++|.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 456688999999999999853 2 24689999875433 34679999999999999999999998754 56789999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 171 e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp ECCTTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred ECCCCCCHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999543 24688999999999999999999998 9999999999999999999999999999866
Q ss_pred CCCCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 358 EKKESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 358 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
...... .......+|+.|+|||.+.+. .++.++||||||+++|||++ |..|+..... . + +...+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~---~-~~~~~~~~~ 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---F---D-ITVYLLQGR 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---S---C-HHHHHHTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---H---H-HHHHHHcCC
Confidence 433211 112334578899999998653 78899999999999999999 5555543211 1 1 112222222
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
....+...+ ..+.+++.+||+.||++|||++++++.|+.++..+.
T Consensus 314 ~~~~p~~~~-------~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 RLLQPEYCP-------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 222222222 346778889999999999999999999999887654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=345.68 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=199.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||+|+||+||+|..+ +|+.||+|++..... ....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 3567789999999999999865 689999999975432 34578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC--CCceEEeeccCccccCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE--DFCPKISDFGLAKQTEK 359 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~ 359 (511)
+|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 132 gg~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 132 GGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCcHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999998532 24689999999999999999999998 9999999999999974 57899999999988765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
..... ...||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+.... ...+
T Consensus 204 ~~~~~---~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~i~~~~-~~~~ 270 (387)
T 1kob_A 204 DEIVK---VTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVKRCD-WEFD 270 (387)
T ss_dssp TSCEE---EECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHCC-CCCC
T ss_pred Cccee---eeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCC-CCCC
Confidence 44322 33599999999999653 68899999999999999999999996431 122222222211 1111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
... ...+...+.+++.+||+.||++|||+.++++.
T Consensus 271 ~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDA---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SST---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 110 11223446678889999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.60 Aligned_cols=260 Identities=21% Similarity=0.266 Sum_probs=197.1
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC------CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL------KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
..|.+.++||+|+||+||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 34567889999999999999864 6889999998643 2334689999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCC----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 040808 276 IYEFMPNGSLDQYIYDHESSN----------------------------------GKRTLEWRTVYQIAVGIARGLEYLH 321 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~----------------------------------~~~~l~~~~~~~i~~~i~~~l~yLH 321 (511)
||||+++|+|.+++....... ....+++..++.|+.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999985321100 0123467788899999999999999
Q ss_pred hCCCCCcEecCCCCCCEEEcCCC--ceEEeeccCccccCCCCc--eeeecCCCCCCCccchhhcccccCCCCccccchhH
Q 040808 322 RGCNIRIVHLDIKPHNIRLDEDF--CPKISDFGLAKQTEKKES--FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSY 397 (511)
Q Consensus 322 ~~~~~~iiH~Dlkp~NIll~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSl 397 (511)
+. +|+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||.+.+....++.++|||||
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 98 999999999999998776 899999999986543221 11223456999999999996543578899999999
Q ss_pred HHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 398 GMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 398 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
|+++|||++|+.||.... ..+............. .+........+.+++.+||+.||++|||+.++++
T Consensus 263 G~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVN------DADTISQVLNKKLCFE-----NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCTT-----SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCC------hHHHHHHHHhcccccC-----CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 999999999999986432 1222222222211111 1111122345667788899999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=340.23 Aligned_cols=263 Identities=22% Similarity=0.356 Sum_probs=208.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
..|.+.+.||+|+||+||+|.+. +++.||+|++..... ...++.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 34567789999999999999754 367899999975433 2346889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 275 LIYEFMPNGSLDQYIYDHES----SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
+||||+++|+|.+++..... ......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 99999999999999965321 11124578999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||+++...............||+.|+|||++.+. .++.++||||||+++|+|++ |+.|+.... ...+...
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~ 252 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRF 252 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHHHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCC-------HHHHHHH
Confidence 9999876544433333344578999999998653 68899999999999999999 788875321 2233333
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
+............+ ..+.+++.+||+.||++|||+.++++.|+..+..
T Consensus 253 ~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VMEGGLLDKPDNCP-------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHcCCcCCCCCCCC-------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 33332222222222 3466778889999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=347.48 Aligned_cols=274 Identities=19% Similarity=0.221 Sum_probs=209.0
Q ss_pred HHhhhcccCCcCceEEEEEEcCC---------CcEEEEEEeccCCCChHHHHHHHHHHHccCCcceee------------
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD---------GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVP------------ 262 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 262 (511)
.|.+.+.||+|+||+||+|.... ++.||+|++... +.+.+|+.++.+++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 45677899999999999999653 789999998754 46889999999999999988
Q ss_pred ---eeceEee-cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCE
Q 040808 263 ---FLGFCYE-KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNI 338 (511)
Q Consensus 263 ---l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NI 338 (511)
+++++.. ....++||||+ +++|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+||
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5666665 67899999999 999999996542 25799999999999999999999998 999999999999
Q ss_pred EEcCCC--ceEEeeccCccccCCCCceee-----ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 040808 339 RLDEDF--CPKISDFGLAKQTEKKESFIS-----MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411 (511)
Q Consensus 339 ll~~~~--~~kl~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~ 411 (511)
|++.++ .+||+|||+++.......... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCc
Confidence 999998 999999999987654332111 1234699999999999664 6889999999999999999999999
Q ss_pred CCccCCCCCCchHHHHHHHhhhhcc--ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCC
Q 040808 412 DVKVSCSSEYFPNAIYKQIETEYDF--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489 (511)
Q Consensus 412 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~ 489 (511)
..... ....+.......... .+.... .........+.+++.+||+.||++|||+++|+++|+.+++......
T Consensus 269 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 269 TNCLP-----NTEDIMKQKQKFVDKPGPFVGPC-GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp GGGTT-----CHHHHHHHHHHHHHSCCCEECTT-SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred ccCCc-----CHHHHHHHHHhccCChhhhhhhc-cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 64321 112222221111100 000000 0000112446677788999999999999999999999998887776
Q ss_pred CCCCCCCC
Q 040808 490 KPSLSLPT 497 (511)
Q Consensus 490 ~p~~~~p~ 497 (511)
...+.++.
T Consensus 343 ~~~~dw~~ 350 (352)
T 2jii_A 343 YDPIGLPM 350 (352)
T ss_dssp TSCCCCCC
T ss_pred CccccCcC
Confidence 66555543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.58 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=198.3
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+.+.+.||+|+||+||+|..+ +|+.||+|++++. ....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3456789999999999999965 6899999999753 34456788999999877 8999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 98 E~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp ECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred eCCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 999999999999542 3689999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+...+.... ..
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~-~~ 236 (345)
T 1xjd_A 169 MLGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQD-------EEELFHSIRMDN-PF 236 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCC-CC
T ss_pred ccCCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHhCC-CC
Confidence 33222 12345799999999999764 68899999999999999999999996432 233334333321 22
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMT-KVV 475 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~-evl 475 (511)
.+..+++ .+.+++.+||+.||++||++. +++
T Consensus 237 ~p~~~s~-------~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 YPRWLEK-------EAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCTTSCH-------HHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCcccCH-------HHHHHHHHHhcCCHhHcCCChHHHH
Confidence 2333443 345566778899999999997 554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.19 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=203.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 456789999999999999965 7999999999753 23356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 98 VSGGELFDYICK------NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp CSSEEHHHHTTS------SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999943 34699999999999999999999998 999999999999999999999999999987755
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... .....||+.|+|||++.+. ...+.++||||||+++|||++|+.||+... ...+...+.... ...+
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~-~~~p 236 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDH-------VPTLFKKICDGI-FYTP 236 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------SHHHHHHHHTTC-CCCC
T ss_pred ccc---ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhcCC-cCCC
Confidence 432 2345699999999999754 234789999999999999999999996432 122333333321 2222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--Hhhcc
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE--MLEGS 481 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~--~L~~~ 481 (511)
...++ .+.+++.+||+.||++|||++++++ .+...
T Consensus 237 ~~~s~-------~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 QYLNP-------SVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TTCCH-------HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ccCCH-------HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 33333 3556777888999999999999986 45543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=335.68 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=201.5
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
..|.+.+.||+|+||.||+|... +|+.||+|+++.... ..+++.+|+.++++++||||+++++++.+....+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34677899999999999999965 689999999975422 2467999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC----ceEEee
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF----CPKISD 350 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~D 350 (511)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEECCCCSCBHHHHHHT------CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEcCCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999953 24689999999999999999999998 999999999999999888 799999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
||+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.... .......+
T Consensus 163 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i 230 (321)
T 2a2a_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANI 230 (321)
T ss_dssp CTTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHH
T ss_pred CccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHH
Confidence 999987765432 2344699999999998653 67899999999999999999999986431 22222222
Q ss_pred hhhhccccCCCCChH-HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDGVVTEE-EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... ...... .......+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 TSVS-----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HTTC-----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Hhcc-----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2211 011111 1123345677889999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=339.13 Aligned_cols=275 Identities=21% Similarity=0.307 Sum_probs=211.0
Q ss_pred CCCCHHHHHHHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHc--cCCcceeeeeceEeec
Q 040808 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISR--TSHVNIVPFLGFCYEK 270 (511)
Q Consensus 193 ~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 270 (511)
.++...+.....|.+.+.||+|+||+||+|.. +|+.||||+++.. ..+.+.+|++++.. ++||||+++++++...
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 44444566666778889999999999999998 5899999998643 34678889999887 7899999999999876
Q ss_pred C----eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCcEecCCCCCCE
Q 040808 271 K----KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH--------RGCNIRIVHLDIKPHNI 338 (511)
Q Consensus 271 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--------~~~~~~iiH~Dlkp~NI 338 (511)
. ..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+||
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 5 88999999999999999953 35899999999999999999999 66 999999999999
Q ss_pred EEcCCCceEEeeccCccccCCCCcee--eecCCCCCCCccchhhcccccC----CCCccccchhHHHHHHHHHhC-----
Q 040808 339 RLDEDFCPKISDFGLAKQTEKKESFI--SMLDTRGTAGYIAPEVFCRHFG----GVSHKSDVYSYGMMIHEMVIG----- 407 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDvwSlG~il~elltg----- 407 (511)
|++.++.+||+|||+++......... ......||+.|+|||++.+... ..+.++||||||+++|||++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999998765443321 1234469999999999865311 233689999999999999999
Q ss_pred -----CCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 408 -----RKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 408 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
+.||...... ......+.+.+... ......+. ...+....+.+++.+||+.||++|||+.+|++.|+.
T Consensus 259 ~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPS--DPSVEEMRKVVCEQ---KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp BCCCCCCTTTTTSCS--SCCHHHHHHHHTTS---CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccCccccCcC--cccHHHHHHHHHHH---HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 5666432211 11112222222111 11111221 123456678889999999999999999999999998
Q ss_pred cccCC
Q 040808 481 SIENL 485 (511)
Q Consensus 481 ~~~~l 485 (511)
+.+..
T Consensus 334 i~~~~ 338 (342)
T 1b6c_B 334 LSQQE 338 (342)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 76543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.96 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=199.6
Q ss_pred cccCCcCceEEEEEEcC---CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP---DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++||+|+||+||+|.+. .++.||||+++.... ..+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999642 467899999986433 24789999999999999999999999864 558899999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999542 4689999999999999999999998 999999999999999999999999999987754432
Q ss_pred e-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 363 F-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 363 ~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
. .......+|+.|+|||++.. ..++.++||||||+++|||++ |+.||... ....+...+........+.
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-------~~~~~~~~i~~~~~~~~p~ 595 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-------KGSEVTAMLEKGERMGCPA 595 (635)
T ss_dssp ----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCT
T ss_pred ccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCCCCCCCC
Confidence 2 12223457889999999965 378999999999999999998 99998643 2334455555544433333
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
..+ ..+.+++.+||+.||++|||+++|+++|+....+
T Consensus 596 ~~~-------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 596 GCP-------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCC-------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCC-------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 333 4567788899999999999999999999976543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=328.55 Aligned_cols=246 Identities=18% Similarity=0.268 Sum_probs=201.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC-CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL-KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||+|+||+||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 4567789999999999999965 5789999998754 3456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE---cCCCceEEeeccCccccC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~ 358 (511)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 90 GGELFERVVHK------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp SCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999998543 4589999999999999999999998 99999999999999 888999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
..... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+.....
T Consensus 161 ~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~--- 224 (277)
T 3f3z_A 161 PGKMM---RTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPT-------DSEVMLKIREGTF--- 224 (277)
T ss_dssp TTSCB---CCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCC---
T ss_pred Cccch---hccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCC---
Confidence 44322 34469999999999854 57899999999999999999999986432 2223333322211
Q ss_pred CCCCCh-HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 439 DGVVTE-EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 439 ~~~~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... ........+.+++.+||+.||++|||+.++++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 --TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11123455777888899999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=345.20 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=193.3
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccC--CcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTS--HVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||+||++...+++.||||++...... .+.+.+|+.++.+++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 5667899999999999999888999999999754332 367899999999997 5999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+.+++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 137 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 137 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 5689999999643 3688999999999999999999998 999999999999996 57999999999987755
Q ss_pred CCceeeecCCCCCCCccchhhcccc---------cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH---------FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
...........||+.|+|||++.+. ...++.++|||||||++|||++|+.||..... ....+...+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence 4332223455799999999998541 13578899999999999999999999963211 112222222
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
........+...+ ..+.+++.+||+.||++|||+.||++.
T Consensus 282 ~~~~~~~~~~~~~-------~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNHEIEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTSCCCCCCCSC-------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CccccCCCCccch-------HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 2222222222222 345677888999999999999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=339.27 Aligned_cols=244 Identities=21% Similarity=0.299 Sum_probs=197.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+.||+|+||+||+|..+ +|+.||+|++++. ....+.+.+|..++..+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 456789999999999999976 4889999999753 34457788999999988 79999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 102 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 99999999999643 3589999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+...+... ....
T Consensus 173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~-~~~~ 240 (353)
T 2i0e_A 173 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEH-NVAY 240 (353)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC-CCCC
T ss_pred cCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhC-CCCC
Confidence 2221 12345799999999999654 67899999999999999999999996431 23334443332 2223
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
+..++. .+.+++.+||+.||++||+ ++++++
T Consensus 241 p~~~s~-------~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 PKSMSK-------EAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CTTSCH-------HHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCH-------HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 333444 3455667788999999995 466653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.57 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=209.2
Q ss_pred HHHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCCC--hHHHHHHHHHHHcc-CCcceeeeeceEeecC-e
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKDN--GEEFINEVASISRT-SHVNIVPFLGFCYEKK-K 272 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~ 272 (511)
..|.+.+.||+|+||+||+|.+ .+++.||||+++..... .+.+.+|+.++.++ +||||+++++++.+.+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 3456778999999999999973 35689999999864332 35788999999999 6999999999987654 5
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSN----------GKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE 342 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~ 342 (511)
.++||||+++|+|.+++....... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 899999999999999997543100 022388999999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCC
Q 040808 343 DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEY 421 (511)
Q Consensus 343 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~ 421 (511)
++.+||+|||+++...............||+.|+|||++.+. .++.++||||||+++|||++ |+.|+....
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~------ 255 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVK------ 255 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccc------
Confidence 999999999999877655444444455689999999998653 68899999999999999998 998885432
Q ss_pred chHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+...+............+ ..+.+++.+||+.||++|||+.+|++.|+.+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 256 IDEEFCRRLKEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHhccCccCCCCCCCC-------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1233344444443333333333 346677788999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.66 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=204.4
Q ss_pred hhhcccCCcCceEEEEEEcC-----CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-----DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALI 276 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 276 (511)
.+.++||+|+||+||++..+ +++.||||+++.... ..+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 66789999999999988632 578999999986532 23578999999999999999999999987 4678999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 114 ~e~~~~~~L~~~l~~-------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ECCCTTCBHHHHGGG-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EecccCCcHHHHHhh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 999999999999943 3489999999999999999999998 999999999999999999999999999988
Q ss_pred cCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC----CCCch----HHHH
Q 040808 357 TEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS----SEYFP----NAIY 427 (511)
Q Consensus 357 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~----~~~~~----~~~~ 427 (511)
......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.|+....... ..... ..+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 765443221 2334588899999999653 67889999999999999999999986331100 00000 0111
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
+.+........... ....+.+++.+||+.||++|||++++++.|+.+.+.++
T Consensus 262 ~~~~~~~~~~~~~~-------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 262 ELLERGERLPRPDK-------CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHTTCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhcccCCCCCcc-------ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 12222222222222 23457778889999999999999999999998876654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=327.80 Aligned_cols=270 Identities=19% Similarity=0.257 Sum_probs=207.0
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceE-eecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC-YEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~ 282 (511)
|.+.+.||+|+||+||+|.+ .+++.||||++.... ..+++.+|+.++.+++|++++..+..+ .+....++||||+ +
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 45678899999999999995 579999999987543 345789999999999998877666655 5677889999999 9
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE---cCCCceEEeeccCccccCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~~ 359 (511)
++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+ ++++.+||+|||+++....
T Consensus 89 ~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 89 PSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999996432 4699999999999999999999998 99999999999999 4889999999999987654
Q ss_pred CCcee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 360 KESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 360 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
..... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..............+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~ 235 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK---KM 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH---HH
T ss_pred cccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc---cc
Confidence 43211 12345699999999999764 6889999999999999999999999754322221111111111 11
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~ 493 (511)
.... ..........+.+++.+||+.||++|||+++|++.|+........+....+
T Consensus 236 ~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~ 290 (296)
T 3uzp_A 236 STPI----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 290 (296)
T ss_dssp HSCH----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCC
T ss_pred CCch----HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccc
Confidence 1100 000011234577788889999999999999999999998877766544333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=327.40 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=203.2
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEee--------
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE-------- 269 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 269 (511)
......|.+.+.||+|+||.||+|.+. +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 344455677889999999999999965 79999999997543 467789999999999999999998854
Q ss_pred --------cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 270 --------KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 270 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
....++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+|+||||+|||++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 455889999999999999996543 24689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCC
Q 040808 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY 421 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~ 421 (511)
+++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||+++|+|++|..|+..
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~-------- 223 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFE-------- 223 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHH--------
T ss_pred CCCCEEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchh--------
Confidence 999999999999987755432 2244699999999998653 678999999999999999999977631
Q ss_pred chHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCC
Q 040808 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQI 487 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~ 487 (511)
.......+.. ..+....+. .+.+++.+||+.||++|||+.|+++.|+...+..+.
T Consensus 224 -~~~~~~~~~~---~~~~~~~~~-------~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 224 -TSKFFTDLRD---GIISDIFDK-------KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp -HHHHHHHHHT---TCCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred -HHHHHHHhhc---ccccccCCH-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1111222211 112223333 355677889999999999999999999987665443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=351.77 Aligned_cols=248 Identities=19% Similarity=0.240 Sum_probs=197.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.+.||+|+||+||+++.+ +|+.||+|++++. ....+.+.+|..++.+++||||+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 345678999999999999965 6999999999752 22334688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 143 ~~gg~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 143 YVGGDLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CCSCBHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 99999999996432 3689999999999999999999998 999999999999999999999999999987755
Q ss_pred CCceeeecCCCCCCCccchhhcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh-
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH-----FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE- 433 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 433 (511)
.... ......||+.|+|||++... .+.++.++|||||||++|||++|+.||.... ....+..+...
T Consensus 215 ~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~ 286 (412)
T 2vd5_A 215 DGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-------TAETYGKIVHYK 286 (412)
T ss_dssp TSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTHH
T ss_pred CCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcc
Confidence 4332 22345799999999999631 1357899999999999999999999996432 22333333221
Q ss_pred hccccC---CCCChHHHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 040808 434 YDFQLD---GVVTEEEKEMAKKMILVSLWCIQTHPPDR---PSMTKVVE 476 (511)
Q Consensus 434 ~~~~~~---~~~~~~~~~~~~~~~~l~~~Cl~~~p~~R---Ps~~evl~ 476 (511)
.....+ ..++ ..+.+++.+||+ +|++| |+++|+++
T Consensus 287 ~~~~~p~~~~~~s-------~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 EHLSLPLVDEGVP-------EEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHCCCC----CCC-------HHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cCcCCCccccCCC-------HHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111 2233 345566677888 99998 58988874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=351.63 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=189.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.++||+|+||.||+|... +|+.||||+++.. ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 456789999999999999954 6899999999743 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
+++|+|.+++... ..+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++...
T Consensus 230 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 230 ANGGELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CSSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999542 468999999999999999999998 7 99999999999999999999999999998643
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+...+... ....
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~-~~~~ 368 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILME-EIRF 368 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC-CCCC
T ss_pred CCCc--ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHHhC-CCCC
Confidence 3322 12345799999999999653 78999999999999999999999996431 22233332222 2223
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
+...++ .+.+++.+||+.||++|| +++|+++
T Consensus 369 p~~~~~-------~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRTLGP-------EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTTSCH-------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCH-------HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 333443 355667778899999999 9999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=342.53 Aligned_cols=246 Identities=23% Similarity=0.287 Sum_probs=189.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHH-HHccCCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVAS-ISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.+.||+|+||+||+|+.+ +++.||+|++++.. ...+.+.+|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 467789999999999999965 58899999997543 223456777776 577899999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 120 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 120 YINGGELFYHLQRE------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999542 4688999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...+++.+... ....
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~-~~~~ 258 (373)
T 2r5t_A 191 EHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNK-PLQL 258 (373)
T ss_dssp CCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSB-------HHHHHHHHHHS-CCCC
T ss_pred cCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhc-ccCC
Confidence 3221 12345799999999999754 68899999999999999999999996431 23333333332 2233
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEML 478 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L 478 (511)
+..++.. +.+++.+||+.||++||++.+.++.+
T Consensus 259 ~~~~~~~-------~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 259 KPNITNS-------ARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp CSSSCHH-------HHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CCCCCHH-------HHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 3444443 44566677899999999986444433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=336.13 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=188.9
Q ss_pred HHhhhcccCCcCceEEEEEEc----CCCcEEEEEEeccCC-----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL----PDGRLVAVKVMKNLK-----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
.|.+.+.||+|+||+||++.. .+|+.||+|++++.. .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 456778999999999999986 468999999997642 23356788999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 98 LILEYLSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEECCTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEeCCCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999542 3588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... .......+...
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~- 236 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGEN-------RKKTIDKILKC- 236 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHT-
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhC-
Confidence 76533222 12345699999999999653 67899999999999999999999996431 22222333222
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
...++..++. .+.+++.+||+.||++|| ++.++++
T Consensus 237 ~~~~p~~~~~-------~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 KLNLPPYLTQ-------EARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCCCCTTSCH-------HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCCCCH-------HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1222333333 355667788899999999 6778764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=333.13 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=192.8
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
+.||+|+||+||+|... +++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 57999999999999954 68999999997654 3357899999999885 799999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc---eEEeeccCccccCCCCc
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC---PKISDFGLAKQTEKKES 362 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~~~~~~~ 362 (511)
.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.......
T Consensus 99 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKR------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999643 4689999999999999999999998 9999999999999998776 99999999876542211
Q ss_pred -----eeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCC-----c---hHHH
Q 040808 363 -----FISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEY-----F---PNAI 426 (511)
Q Consensus 363 -----~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~-----~---~~~~ 426 (511)
........||+.|+|||++... ...++.++||||||+++|||++|+.||.........+ . ...+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 0112234599999999998541 1247889999999999999999999997543221111 1 1122
Q ss_pred HHHHhhhhccccCCCCCh-HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 427 YKQIETEYDFQLDGVVTE-EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+.+.... . ..+. ........+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~i~~~~-~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 250 FESIQEGK-Y----EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHCC-C----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhccC-c----ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 23332221 1 1111 11223445778888999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=328.72 Aligned_cols=268 Identities=19% Similarity=0.262 Sum_probs=204.7
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceE-eecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC-YEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~ 281 (511)
.|.+.+.||+|+||+||+|.+ .+++.||||++..... .+++.+|+.++.+++|++++..+..+ .+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 456778999999999999995 5789999998765332 34688999999999988877776665 5677889999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE---cCCCceEEeeccCccccC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~ 358 (511)
+++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 88 ~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 88 GPSLEDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CCBHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999999996432 4699999999999999999999998 99999999999999 789999999999998765
Q ss_pred CCCcee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 359 KKESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 359 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
...... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||..............+ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~ 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI---SEKK 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH---HHHH
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh---hccc
Confidence 443211 12245699999999999764 6889999999999999999999999754322221111111 1111
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCC
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPK 490 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~ 490 (511)
..... ..........+.+++.+||+.||++|||+++|++.|+.+......+..
T Consensus 235 ~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 4hgt_A 235 MSTPI----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp HHSCH----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTT
T ss_pred ccchh----hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCcc
Confidence 11100 000011234577788889999999999999999999998877765443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=337.38 Aligned_cols=246 Identities=25% Similarity=0.340 Sum_probs=196.1
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.+...++||+|+||+||+|.. .+|+.||||++...... .+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 355667899999999999995 57899999999754322 2568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 135 ~~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 135 YCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp CCS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred cCC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 996 78888885432 4689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
... ...||+.|+|||++.. ..+.++.++||||||+++|||++|+.|+.... ....+...........
T Consensus 206 ~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 206 PAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESPAL 273 (348)
T ss_dssp SBC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCCCC
T ss_pred CCC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCCCC
Confidence 432 3469999999999853 12467889999999999999999999985331 1222222222211111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.....+ ..+.+++.+||+.||++|||++++++.
T Consensus 274 ~~~~~~-------~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 QSGHWS-------EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCC-------HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 112222 345667788999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.41 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=192.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||+||+|.+. +|+.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 456789999999999999965 5899999998765433 356789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~~l~~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 85 DHTVLHELDRY------QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp SEEHHHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred CCchHHHHHhh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999988743 24689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh-------
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE------- 433 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 433 (511)
... .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||..... .+.. ..+...
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~~~~ 225 (311)
T 4agu_A 156 SDY--YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSD------VDQL-YLIRKTLGDLIPR 225 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-HHHHHHHCSCCHH
T ss_pred ccc--cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHHHhcccccc
Confidence 321 2244689999999998653 3678999999999999999999999864321 1111 111100
Q ss_pred -------------hccccCCCCChH---HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 -------------YDFQLDGVVTEE---EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 -------------~~~~~~~~~~~~---~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
............ .......+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000 0123345778889999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=330.10 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=203.1
Q ss_pred HHhhhc-ccCCcCceEEEEEEc---CCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 204 TKSFSD-KLGQGGYADVYKGTL---PDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 204 ~~~~~~-~LG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
.+.+.+ .||+|+||+||+|.+ .+++.||||+++..... .+++.+|+.++++++||||+++++++ +.+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 344556 899999999999953 24788999999764322 46789999999999999999999998 66778999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EECCTTEEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEeCCCCCHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999642 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 357 TEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 357 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
......... .....+|+.|+|||.+.+. .++.++||||||+++|+|++ |+.||.... ...+...+....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~ 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGE 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCC
Confidence 755443222 2233577899999999653 67889999999999999999 999986431 233344444433
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
....+... ...+.+++.+||+.||++|||+.+|+++|+.......
T Consensus 238 ~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 238 RMGCPAGC-------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCCCCTTC-------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 33322223 3456678888999999999999999999998766543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=346.59 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=207.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecC--eEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKK--KRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~ 279 (511)
|.+.++||+|+||+||+|.+. +|+.||||+++... ...+.+.+|++++++++||||+++++++.+.. ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 456789999999999999965 58999999997543 34578889999999999999999999998755 78999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE----cCCCceEEeeccCcc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAK 355 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 355 (511)
+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 91 ~~~g~L~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 91 CPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CTTEEHHHHTTSGGG---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred CCCCCHHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999965331 23499999999999999999999998 99999999999999 888889999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccc------cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRH------FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
........ ....||+.|+|||++.+. ...++.++||||||+++|||++|+.||....... .....+.+.
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKI 239 (396)
T ss_dssp ECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHH
T ss_pred EccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHH
Confidence 77554432 245699999999998541 1256789999999999999999999996432211 112222222
Q ss_pred Hhhhh-------------------ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 430 IETEY-------------------DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 430 ~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
+.... .......+ ...+...+..++.+||+.||++||+++++++.|+.++..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l---~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSL---SRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSS---CHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCccccc---chHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 22110 00111111 234555677888999999999999999999999887653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=346.40 Aligned_cols=280 Identities=22% Similarity=0.250 Sum_probs=208.1
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC----
Q 040808 182 AFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS---- 256 (511)
Q Consensus 182 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---- 256 (511)
+....|.......+..+++....|.+.++||+|+||+||+|.. .+++.||||+++......+.+.+|+.++++++
T Consensus 16 e~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~ 95 (397)
T 1wak_A 16 EDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP 95 (397)
T ss_dssp ------CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCT
T ss_pred cccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCC
Confidence 4556666666667777777667788889999999999999985 46899999999865555678899999999986
Q ss_pred ----CcceeeeeceEe----ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 040808 257 ----HVNIVPFLGFCY----EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRI 328 (511)
Q Consensus 257 ----h~niv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~i 328 (511)
|+||+++++++. +....++||||+ +++|.+++.... ...+++..++.|+.||+.||+|||+++ +|
T Consensus 96 ~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--gi 168 (397)
T 1wak_A 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RI 168 (397)
T ss_dssp TCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CE
T ss_pred CCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CE
Confidence 788999999987 566899999999 667777775432 246999999999999999999999853 89
Q ss_pred EecCCCCCCEEEcCCC-------------------------------------------------ceEEeeccCccccCC
Q 040808 329 VHLDIKPHNIRLDEDF-------------------------------------------------CPKISDFGLAKQTEK 359 (511)
Q Consensus 329 iH~Dlkp~NIll~~~~-------------------------------------------------~~kl~DFGla~~~~~ 359 (511)
+||||||+|||++.++ .+||+|||+++....
T Consensus 169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~ 248 (397)
T 1wak_A 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248 (397)
T ss_dssp ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB
T ss_pred ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc
Confidence 9999999999999775 799999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc--
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ-- 437 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 437 (511)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... .......+.......
T Consensus 249 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~p~ 320 (397)
T 1wak_A 249 HF-----TEDIQTRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTR-DEDHIALIIELLGKVPR 320 (397)
T ss_dssp CS-----CSCCSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH-HHHHHHHHHHHHCSCCH
T ss_pred cC-----ccCCCCCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCc-hHHHHHHHHHhcCCCCh
Confidence 32 345699999999999764 68899999999999999999999997543221111 111111111100000
Q ss_pred ---------------------cCCCCC-----------hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 ---------------------LDGVVT-----------EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ---------------------~~~~~~-----------~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+..... ....+....+.+++.+||+.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred HHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000 011344567888999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=327.36 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=198.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||+||+|.++ +++.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 456789999999999999865 6899999999754433 356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc---eEEeeccCcccc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC---PKISDFGLAKQT 357 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~DFGla~~~ 357 (511)
++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++...
T Consensus 88 ~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 88 TGGELFEDIVAR------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999988543 4689999999999999999999998 9999999999999986655 999999999877
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
...... ....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.... .......+......
T Consensus 159 ~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~- 225 (284)
T 3kk8_A 159 NDSEAW---HGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYD- 225 (284)
T ss_dssp CSSCBC---CCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCC-
T ss_pred ccCccc---cCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCc-------hhHHHHHHHhcccc-
Confidence 554332 245699999999999653 67899999999999999999999985431 22233333222111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+. +........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPS---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCT---TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCc---hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 110 011112334667788899999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=342.55 Aligned_cols=254 Identities=17% Similarity=0.160 Sum_probs=199.4
Q ss_pred HHhhhcccCCcCceEEEEEE------cCCCcEEEEEEeccCCCChHHHHHHHHHHHccC---CcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGT------LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS---HVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 274 (511)
.|.+.++||+|+||+||+|. ..+++.||||+++.. ...++..|++++.+++ |+||+++++++...+..+
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~ 143 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcE
Confidence 34567889999999999994 346889999999753 4567888999888887 999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-----------C
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-----------D 343 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-----------~ 343 (511)
+||||+++|+|.+++..... .....+++..++.|+.||+.||+|||+. +|+||||||+||||+. +
T Consensus 144 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 144 LVGELYSYGTLLNAINLYKN-TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEECCCCSCBHHHHHHHHHT-STTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEeccCCCcHHHHHHHhhc-ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999975432 1235799999999999999999999998 9999999999999998 8
Q ss_pred CceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCch
Q 040808 344 FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFP 423 (511)
Q Consensus 344 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~ 423 (511)
+.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.|+...... .+.
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~- 294 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--ECK- 294 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--EEE-
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCC--cee-
Confidence 99999999999765433333334556799999999999764 6899999999999999999999998533210 000
Q ss_pred HHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHhhccccC
Q 040808 424 NAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDR-PSMTKVVEMLEGSIEN 484 (511)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~R-Ps~~evl~~L~~~~~~ 484 (511)
....+... .. ...+.+++..|++.+|.+| |+++++.+.|+..+..
T Consensus 295 ----------~~~~~~~~-~~-----~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 ----------PEGLFRRL-PH-----LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ----------ECSCCTTC-SS-----HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------echhcccc-Cc-----HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00000111 10 1223455566779999999 5788899888876653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=337.32 Aligned_cols=264 Identities=23% Similarity=0.402 Sum_probs=204.2
Q ss_pred HHhhhcccCCcCceEEEEEEc-----CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecC--eEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-----PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKK--KRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 275 (511)
.+.+.++||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 356778999999999999983 3688999999976433 3467899999999999999999999887644 6799
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 122 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EECCCTTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999996532 4589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC-----CCC----CchHH
Q 040808 356 QTEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC-----SSE----YFPNA 425 (511)
Q Consensus 356 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~-----~~~----~~~~~ 425 (511)
.......... .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ... .....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 8765443222 1234578889999998653 6789999999999999999999887532100 000 00111
Q ss_pred HHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
+.+.+........... ....+.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDG-------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCCCCCTT-------CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCc-------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1222222222222222 234577788899999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.71 Aligned_cols=262 Identities=24% Similarity=0.424 Sum_probs=207.3
Q ss_pred HHhhhcccCCcCceEEEEEEcCC-C-----cEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD-G-----RLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 274 (511)
.+.+.+.||+|+||+||+|.... + ..||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 45567899999999999998542 3 4799999976432 246789999999999 8999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCce
Q 040808 275 LIYEFMPNGSLDQYIYDHESS--------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~ 346 (511)
+||||+++|+|.+++...... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence 999999999999999653210 0124689999999999999999999998 99999999999999999999
Q ss_pred EEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHH
Q 040808 347 KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNA 425 (511)
Q Consensus 347 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 425 (511)
||+|||+++...............||+.|+|||.+.+. .++.++||||||+++|||++ |+.|+.... ....
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~------~~~~ 275 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGIL------VNSK 275 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC------SSHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccc------hhHH
Confidence 99999999876554433333445678899999998653 68899999999999999998 888885432 1223
Q ss_pred HHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+........+...+ ..+.+++.+||+.||++|||+++|++.|+....
T Consensus 276 ~~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 276 FYKLVKDGYQMAQPAFAP-------KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCC-------HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 333333333222222222 346678889999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=334.61 Aligned_cols=266 Identities=26% Similarity=0.445 Sum_probs=207.6
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcE--EEEEEeccC--CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRL--VAVKVMKNL--KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+.+.+.||+|+||.||+|.+. ++.. +|+|.++.. ....+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 3457789999999999999854 5664 499988753 23346789999999999 8999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 278 EFMPNGSLDQYIYDHES----------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
||+++|+|.+++..... ......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEE
Confidence 99999999999965320 01234789999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAI 426 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 426 (511)
|+|||+++....... .....+|+.|+|||++.+. .++.++||||||+++|||++ |+.||.... ...+
T Consensus 183 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~-------~~~~ 250 (327)
T 1fvr_A 183 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAEL 250 (327)
T ss_dssp ECCTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHH
T ss_pred EcccCcCcccccccc---ccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCc-------HHHH
Confidence 999999875432211 1233578899999998653 67899999999999999998 999986431 2334
Q ss_pred HHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCC
Q 040808 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKP 491 (511)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p 491 (511)
...+............+ ..+.+++.+||+.||++|||++++++.|+.++.........
T Consensus 251 ~~~~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 308 (327)
T 1fvr_A 251 YEKLPQGYRLEKPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308 (327)
T ss_dssp HHHGGGTCCCCCCTTBC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCC
T ss_pred HHHhhcCCCCCCCCCCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcccc
Confidence 44444433333222333 34667788899999999999999999999888766544443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=352.81 Aligned_cols=194 Identities=22% Similarity=0.350 Sum_probs=151.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEee-----cCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYE-----KKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~ 274 (511)
.|.+.++||+|+||+||+|.++ +++.||||++...... .+++.+|+.+|++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 3567789999999999999865 6899999999764333 3578899999999999999999999843 35789
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+ +++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 134 lv~e~~-~~~L~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRT------PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEECCC-SEEHHHHHHS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecc-ccchhhhccc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 999998 6899999853 24699999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCce-------------------------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCC
Q 040808 355 KQTEKKESF-------------------------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408 (511)
Q Consensus 355 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~ 408 (511)
+........ .......||+.|+|||++... ..++.++|||||||++|||++|.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhc
Confidence 876432210 122345689999999987433 36899999999999999999953
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=332.39 Aligned_cols=267 Identities=24% Similarity=0.369 Sum_probs=197.0
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.|.+.++||+|+||.||+|.. .+|+.||+|+++... ...+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 356778999999999999985 478999999997532 123578899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++.... .....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 113 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 113 LADAGDLSRMIKHFK--KQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp CCCSCBHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred cCCCCCHHHHHHHhc--ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999996533 1235689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
..... .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||..... -...+...+........
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~ 258 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPL 258 (310)
T ss_dssp -------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTCSCCC
T ss_pred CCCcc--ccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhcccCCCC
Confidence 43221 1234689999999998653 688999999999999999999999853211 11222222222211111
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPK 490 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~ 490 (511)
. . ......+.+++.+||+.||++|||+++|++.|+.+......|+.
T Consensus 259 ~---~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 259 P---S---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp C---T---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred c---c---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 1 0 11233566788889999999999999999999998776655543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=337.58 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=203.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
..|.+.+.||+|+||+||+|.+. +++.||||++..... ...++.+|+.++++++||||+++++++.+....+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 34567789999999999999842 477899999975432 3457899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEee
Q 040808 275 LIYEFMPNGSLDQYIYDHESS-NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISD 350 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D 350 (511)
+||||+++++|.+++...... .....+++..++.++.||+.||+|||+. +|+||||||+|||++. +..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence 999999999999999765421 1224689999999999999999999998 9999999999999984 45699999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||+++...............||+.|+|||.+.+. .++.++||||||+++|+|++ |+.|+.... ...+...
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~ 257 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEF 257 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHH
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcC-------HHHHHHH
Confidence 9999765433322222334589999999998653 68899999999999999998 888885331 2333334
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
+............+ ..+.+++.+||+.||++|||+.+|++.|+......
T Consensus 258 ~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 258 VTSGGRMDPPKNCP-------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HhcCCCCCCCCCCC-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 43333333233333 34667888899999999999999999999776543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=327.01 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=198.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 274 (511)
..|.+.++||+|+||+||+|... +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45677899999999999999965 689999999875321 3578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC----ceEEee
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF----CPKISD 350 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~D 350 (511)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+||+|
T Consensus 85 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEeecCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence 999999999999999542 4689999999999999999999998 999999999999998877 899999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
||++......... ....||+.|+|||++... .++.++||||||+++|+|++|+.||.... .......+
T Consensus 156 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~ 223 (283)
T 3bhy_A 156 FGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGET-------KQETLTNI 223 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHH
T ss_pred cccceeccCCCcc---cccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcc-------hHHHHHHh
Confidence 9999876544322 234599999999998653 68899999999999999999999986431 12222222
Q ss_pred hhhhccccCCCCCh-HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDGVVTE-EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... ..... ........+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 224 SAVN-----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HTTC-----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Hhcc-----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2211 01111 11223445778889999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=349.73 Aligned_cols=197 Identities=20% Similarity=0.321 Sum_probs=163.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeec-----CeEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEK-----KKRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 275 (511)
|.+.+.||+|+||+||+|.+. +++.||||+++..... .+++.+|+.++++++||||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 456789999999999999965 6889999999764333 35788999999999999999999998765 57999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+. |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 108 v~e~~~-~~L~~~~~~------~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKT------PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEECCS-EEHHHHHHS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCC-cCHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999985 699999953 24699999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCce--------------------eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 356 QTEKKESF--------------------ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 356 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
........ .......||+.|+|||++... ..++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhcccccc
Confidence 76543211 113456799999999987443 468999999999999999998665553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.55 Aligned_cols=248 Identities=23% Similarity=0.258 Sum_probs=187.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeec------CeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 274 (511)
|.+.++||+|+||+||+|.+. +++.||||++..... ..+++.+|+.++++++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 456788999999999999854 689999999975422 246788999999999999999999998654 4679
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 144 lv~E~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEeCCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 99999965 5766662 2489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+. +..+....
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~------~~~-~~~i~~~l 279 (464)
T 3ttj_A 212 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDY------IDQ-WNKVIEQL 279 (464)
T ss_dssp -----CCC---C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHH-HHHHHHHH
T ss_pred eecCCCcc---cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHHhc
Confidence 87654322 2345699999999999764 788999999999999999999999964321 111 11111100
Q ss_pred cc----------------------------------ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DF----------------------------------QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~----------------------------------~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ................+.+++.+||+.||++|||++|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000111122233456788999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=348.73 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=187.4
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---------ChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
.|.+.++||+|+||+||+|..+ +++.||||++..... ....+.+|+.++++++||||+++++++. .+..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 4567789999999999999854 689999999875321 1235789999999999999999999875 5568
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC---CceEEee
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED---FCPKISD 350 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~D 350 (511)
++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|
T Consensus 215 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVG------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EEEEECCTTCBGGGGTSS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 999999999999988843 35699999999999999999999998 99999999999999654 4599999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
||+++....... .....||+.|+|||++.. ....++.++||||||+++|+|++|+.||...... .. +...
T Consensus 286 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~----~~~~ 356 (419)
T 3i6u_A 286 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VS----LKDQ 356 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CC----HHHH
T ss_pred cccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HH----HHHH
Confidence 999987754332 234569999999999853 2246788999999999999999999999643211 11 1122
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+..... ...++........+.+++.+||+.||++|||++|+++
T Consensus 357 i~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKY----NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCC----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCC----CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 222111 0111112233455777888999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=352.79 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=202.2
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccCCc-ceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV-NIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.++||+|+||.||+|.+ .+++.||||++..... .+++.+|++++..++|+ ++..+..++.+.+..++||||+ +
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 45678999999999999995 5699999998875433 34688999999999874 5556666667888999999999 9
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE---cCCCceEEeeccCccccCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~~~ 359 (511)
++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++....
T Consensus 87 ~sL~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 87 PSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999996432 4699999999999999999999998 99999999999999 6889999999999987754
Q ss_pred CCcee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 360 KESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 360 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
..... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~i~~~~ 232 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----KKQKYEKISEKK 232 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----HHHHHHHHHHHH
T ss_pred CccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchh----HHHHHHHHhhcc
Confidence 43211 12245699999999999764 68899999999999999999999996432211 111122221111
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
.. .............+.+++.+||+.+|++||++++|+++|+.++...
T Consensus 233 ~~---~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 233 VA---TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HH---SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cc---ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00 0011111223456778889999999999999999999998875533
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=327.48 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=198.6
Q ss_pred HHhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
.+.+.+.||+|+||+||+|.+.+ +..||+|+++.... ..+++.+|+.++++++||||+++++++.+. ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 34567899999999999998432 34699999976432 346789999999999999999999987654 568999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 92 ELYPYGELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp ECCTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred ecCCCCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999996532 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
...... ......+|+.|+|||.+.+ ..++.++||||||+++|||++ |+.||.... .......+......
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~-------~~~~~~~~~~~~~~ 233 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDVIGVLEKGDRL 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------GGGHHHHHHHTCCC
T ss_pred cccccc-ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCC-------hHHHHHHHhcCCCC
Confidence 543321 1233457889999999865 368899999999999999998 999986332 11222333333323
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
..+...+ ..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 234 ~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 PKPDLCP-------PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCC-------HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 3233333 346677888999999999999999999987643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=333.53 Aligned_cols=255 Identities=20% Similarity=0.274 Sum_probs=194.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 456789999999999999965 6899999999754322 26788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 116 INGVDLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp CCCEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred cCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 9999999999643 3689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc--c
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF--Q 437 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 437 (511)
... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.... ...+...+...... .
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~ 256 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQ-------LSVMGAHINQAIPRPST 256 (309)
T ss_dssp -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCH-------HHHHHHHHHSCCCCGGG
T ss_pred ccc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCch-------HHHHHHHhccCCCCccc
Confidence 321 112244699999999998653 67889999999999999999999986431 12222222221110 1
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhccccCC
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-SMTKVVEMLEGSIENL 485 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~~l 485 (511)
.....+ ..+.+++.+||+.||++|| +++++++.|+..+...
T Consensus 257 ~~~~~~-------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 257 VRPGIP-------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TSTTCC-------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cCCCCC-------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 112222 3466777889999999999 9999999999877654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=336.08 Aligned_cols=240 Identities=25% Similarity=0.305 Sum_probs=196.0
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC---------ChHHHHHHHHHHHccCCcceeeeeceEeecCeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD---------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 273 (511)
.|.+.+.||+|+||+||+|.+ .+++.||||+++.... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 456678999999999999985 4689999999976432 234678899999999999999999999999999
Q ss_pred EEEEEeCCCC-CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 274 ALIYEFMPNG-SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 274 ~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
++||||+.+| +|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 105 ~lv~e~~~~g~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDR------HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEECCTTSCBHHHHHHT------CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeCCCCccHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999777 99999953 24699999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
+++........ ....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||...... .
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~-- 237 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V-- 237 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T--
T ss_pred cceECCCCCce---eccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H--
Confidence 99877654432 234599999999998654 23478999999999999999999998632110 0
Q ss_pred hhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
......+...++ .+.+++.+||+.||++|||++++++.
T Consensus 238 ~~~~~~~~~~~~-------~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 EAAIHPPYLVSK-------ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TTCCCCSSCCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hhccCCCcccCH-------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111222333 35667778999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.65 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=199.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---------hHHHHHHHHHHHcc-CCcceeeeeceEeecCe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---------GEEFINEVASISRT-SHVNIVPFLGFCYEKKK 272 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 272 (511)
.|.+.+.||+|+||.||+|.+. +|+.||||+++..... .+.+.+|+.++.++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 3455689999999999999975 6999999999754321 34678899999999 79999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 99999999999999999642 4689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccc----cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRH----FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
++........ .....||+.|+|||++.+. ...++.++||||||+++|||++|+.||.... ......
T Consensus 246 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-------~~~~~~ 315 (365)
T 2y7j_A 246 FSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-------QILMLR 315 (365)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH
T ss_pred cccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-------HHHHHH
Confidence 9987765433 2345699999999998532 1257889999999999999999999986321 222222
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+..... .. ..+........+.+++.+||+.||++|||++++++
T Consensus 316 ~i~~~~~-~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIMEGQY-QF---SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHTCC-CC---CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCC-CC---CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222211 00 01111122345677888999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.74 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=198.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 4566789999999999999965 68999999987543 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 88 SGGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp TTEEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCcHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999998842 34689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
..........||+.|+|||.+.+. ...+.++||||||+++|||++|+.||...... ......+....... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~-~- 229 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS------CQEYSDWKEKKTYL-N- 229 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT------SHHHHHHHTTCTTS-T-
T ss_pred cchhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHhhhccccc-C-
Confidence 322223345699999999998653 23477899999999999999999999643211 11112222111110 0
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........+.+++.+||+.||++|||++++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01122334667788899999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=336.03 Aligned_cols=261 Identities=20% Similarity=0.285 Sum_probs=201.0
Q ss_pred CCCHHHHHHHHHhhh-cccCCcCceEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHccC-CcceeeeeceE
Q 040808 194 RFSYSDVRRMTKSFS-DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---DNGEEFINEVASISRTS-HVNIVPFLGFC 267 (511)
Q Consensus 194 ~~~~~e~~~~~~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 267 (511)
.|...+.....|.+. ++||+|+||+||+|... +++.||+|+++... ....++.+|+.++.++. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344455555556565 78999999999999865 68999999997543 23468899999999995 69999999999
Q ss_pred eecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CC
Q 040808 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DF 344 (511)
Q Consensus 268 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~ 344 (511)
.+....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++. ++
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE----LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC----C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999988432 235799999999999999999999998 9999999999999988 78
Q ss_pred ceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchH
Q 040808 345 CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPN 424 (511)
Q Consensus 345 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 424 (511)
.+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.... ..
T Consensus 172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~ 239 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGED-------NQ 239 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HH
T ss_pred cEEEeeCccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------ch
Confidence 999999999987754432 2234699999999999653 68899999999999999999999986432 22
Q ss_pred HHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 425 AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.....+..... ... .+........+.+++.+||+.||++|||++++++.
T Consensus 240 ~~~~~i~~~~~-~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 240 ETYLNISQVNV-DYS---EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHTCC-CCC---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHhccc-ccC---chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 22222222111 111 11111223446677888999999999999999763
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=323.92 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=195.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 456789999999999999855 5789999998643 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~~~~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 91 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999543 3589999999999999999999998 999999999999999999999999999865543
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... ....||+.|+|||.+.+. ..+.++||||||+++|+|++|+.||.... .....+.+... ....+
T Consensus 162 ~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~ 227 (279)
T 3fdn_A 162 SRR----TDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRV-EFTFP 227 (279)
T ss_dssp ----------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHT-CCCCC
T ss_pred ccc----cccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCc-------HHHHHHHHHhC-CCCCC
Confidence 322 344699999999998653 67889999999999999999999986331 22333333322 22223
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...++ .+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTE-------GARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCH-------HHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCH-------HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 33333 35567788999999999999999863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.16 Aligned_cols=247 Identities=28% Similarity=0.356 Sum_probs=197.5
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--------------CChHHHHHHHHHHHccCCcceeeeeceEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--------------DNGEEFINEVASISRTSHVNIVPFLGFCY 268 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 268 (511)
.|.+.++||+|+||+||+|..+ +++.||+|+++... ...+++.+|+.++++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3556789999999999999965 58899999997542 23467899999999999999999999999
Q ss_pred ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC---c
Q 040808 269 EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF---C 345 (511)
Q Consensus 269 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---~ 345 (511)
+....++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++ .
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999998543 4699999999999999999999998 999999999999998776 6
Q ss_pred eEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHH
Q 040808 346 PKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNA 425 (511)
Q Consensus 346 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 425 (511)
+||+|||+++....... .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... ...
T Consensus 188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~ 254 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQN-------DQD 254 (504)
T ss_dssp EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHH
T ss_pred EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCC-------HHH
Confidence 99999999987765432 234569999999999853 57899999999999999999999996432 233
Q ss_pred HHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+...+..... ..+ .+....+...+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~i~~~~~-~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVEKGKY-YFD---FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHCCC-CCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCCC-CCC---ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 3344333211 000 0111223345667778889999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.23 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=201.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
+.+.+.||+|+||.||+|..+ +|+.||+|++.+. ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 345578999999999999965 6999999999643 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 266 ~~gg~L~~~l~~~~----~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 266 MNGGDLKFHIYHMG----QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCSCBHHHHHHSSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999996432 34599999999999999999999998 999999999999999999999999999988765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+...+... .....
T Consensus 339 ~~~~---~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~---~~~~~~i~~~i~~~-~~~~p 409 (576)
T 2acx_A 339 GQTI---KGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKK---KIKREEVERLVKEV-PEEYS 409 (576)
T ss_dssp TCCE---ECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSS---CCCHHHHHHHHHHC-CCCCC
T ss_pred Cccc---cccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCccccc---chhHHHHHHHhhcc-cccCC
Confidence 4432 345799999999999653 678999999999999999999999974321 11223333333222 12223
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
..++++ +.+++.+||+.||++|| +++||++
T Consensus 410 ~~~s~~-------~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERFSPQ-------ARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTSCHH-------HHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccCCHH-------HHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 334443 45566677899999999 6788864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=328.48 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=194.6
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeec-CeEEEEEEeCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEK-KKRALIYEFMPN 282 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~ 282 (511)
.+.+.+.||+|+||+||++..+ |+.||+|+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||+++
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 3456789999999999999874 7899999997543 457899999999999999999999987554 478999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 100 GSLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp EEHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCHHHHHHhcc----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999996532 13488999999999999999999998 99999999999999999999999999998654432
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
....+++.|+|||.+.+. .++.++||||||+++|+|++ |+.|+.... ...+...+...........
T Consensus 172 ----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 238 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPDG 238 (278)
T ss_dssp --------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-------GGGHHHHHTTTCCCCCCTT
T ss_pred ----cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcCCCCCCccc
Confidence 133578999999998653 68899999999999999998 998886431 1222333333333333333
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
.+ ..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 239 ~~-------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 239 CP-------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC-------HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 33 34667778899999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=342.50 Aligned_cols=198 Identities=26% Similarity=0.399 Sum_probs=157.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccC-CcceeeeeceEeecC--eEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTS-HVNIVPFLGFCYEKK--KRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 276 (511)
.|.+.++||+|+||+||+|.+. +|+.||||++..... ..+++.+|+.++.++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 4566789999999999999854 689999999865432 2356789999999998 999999999997543 78999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~e~~~-~~L~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EECCS-EEHHHHHHH-------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecccC-cCHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99996 699999853 3588999999999999999999998 999999999999999999999999999986
Q ss_pred cCCCCc-------------------eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 357 TEKKES-------------------FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 357 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
...... ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 543110 1112345799999999998653 3688999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.81 Aligned_cols=245 Identities=21% Similarity=0.303 Sum_probs=195.9
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 277 (511)
..|.+.++||+|+||+||+|... +++.||+|+++.... ...++.+|+..+.++ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 34566789999999999999965 799999999985422 345788999999999 8999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC--------------
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-------------- 343 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-------------- 343 (511)
||+++++|.+++..... ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 91 EYCNGGSLADAISENYR--IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp ECCTTCBHHHHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EecCCCcHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999965421 124689999999999999999999998 99999999999999844
Q ss_pred -----CceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC
Q 040808 344 -----FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS 418 (511)
Q Consensus 344 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~ 418 (511)
..+||+|||++....... ...||+.|+|||++.+. ...+.++||||||+++|+|++|+.++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~---- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNG---- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSS----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcch----
Confidence 479999999998775433 23599999999999654 35668999999999999999998775322
Q ss_pred CCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 419 SEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+.......++...+ ..+.+++.+||+.||++|||+.++++
T Consensus 235 ------~~~~~~~~~~~~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 ------DQWHEIRQGRLPRIPQVLS-------QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------HHHHHHHTTCCCCCSSCCC-------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------hHHHHHHcCCCCCCCcccC-------HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1122233322222333333 34566778899999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.32 Aligned_cols=248 Identities=27% Similarity=0.351 Sum_probs=196.7
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
..|.+.++||+|+||+||+|..+ +++.||+|+++.. ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 34677889999999999999965 6899999999754 2335789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCcc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAK 355 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~ 355 (511)
|+++|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 117 ~~~~g~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 117 CYKGGELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999988543 4689999999999999999999998 9999999999999976 4559999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ...+...+.....
T Consensus 188 ~~~~~~~---~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~ 254 (494)
T 3lij_A 188 VFENQKK---MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQT-------DQEILRKVEKGKY 254 (494)
T ss_dssp ECBTTBC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCC
T ss_pred ECCCCcc---ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCC
Confidence 7765432 234569999999999853 67899999999999999999999996432 2333444433321
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... .+....+...+.+++.+||+.||++|||+.++++
T Consensus 255 ~~~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 TFD----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCC----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 110 1111122334566778888999999999999984
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=323.69 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=196.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC-----CCChHHHHHHHHHHHccCCcceeeeeceEe--ecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL-----KDNGEEFINEVASISRTSHVNIVPFLGFCY--EKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv 276 (511)
|.+.+.||+|+||.||++... +++.||+|+++.. ....+.+.+|+.++++++||||+++++++. +....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 456789999999999999964 6899999999753 233467999999999999999999999984 45688999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||++++ |.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 87 ~e~~~~~-l~~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVP----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EECCSEE-HHHHHHHST----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ehhccCC-HHHHHHhCc----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999766 777775432 35689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
..............||+.|+|||++.+.....+.++||||||+++|||++|+.|+.... .......+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~-~~ 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYKLFENIGKG-SY 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHC-CC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHHHhcC-CC
Confidence 65433222334556999999999986532345789999999999999999999986431 22233333322 12
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
......++ .+.+++.+||+.||++|||++++++.
T Consensus 231 ~~~~~~~~-------~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 AIPGDCGP-------PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCCSSSCH-------HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCccCH-------HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22333333 45567788999999999999999963
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=335.74 Aligned_cols=266 Identities=22% Similarity=0.331 Sum_probs=190.1
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccC-CcceeeeeceEe--------ecCe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTS-HVNIVPFLGFCY--------EKKK 272 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~ 272 (511)
.|.+.++||+|+||+||+|.+. +++.||||++..... ..+.+.+|+.++.++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4567789999999999999954 689999998865432 3467889999999996 999999999984 3456
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCEEEcCCCceEEee
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR--IVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
.++||||+ +|+|.+++.... ....+++..++.|+.||+.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 109 ~~lv~e~~-~g~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 109 FLLLTELC-KGQLVEFLKKME---SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEECC-SEEHHHHHHHHH---TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred EEEEEEec-CCCHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 88999999 589999986532 134699999999999999999999998 7 99999999999999999999999
Q ss_pred ccCccccCCCCcee----------eecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC
Q 040808 351 FGLAKQTEKKESFI----------SMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS 419 (511)
Q Consensus 351 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~ 419 (511)
||+++......... ......||+.|+|||++.. ....++.++||||||+++|||++|+.||.....
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--- 258 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--- 258 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH---
Confidence 99998765432211 1113458999999999832 123678899999999999999999999863321
Q ss_pred CCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCC
Q 040808 420 EYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSL 493 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~ 493 (511)
...+............+. .+.+++.+||+.||++|||++|+++.|+........++++..
T Consensus 259 -------~~~~~~~~~~~~~~~~~~-------~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~ 318 (337)
T 3ll6_A 259 -------LRIVNGKYSIPPHDTQYT-------VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318 (337)
T ss_dssp --------------CCCCTTCCSSG-------GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred -------HHhhcCcccCCcccccch-------HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence 011111111111122222 255677889999999999999999999998877766665544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=336.06 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=189.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|... +++.||+|+++..... ...+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 456789999999999999965 6899999999754322 2245689999999999999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 -~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 84 -KDLKQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp -EEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred -cCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 69999886532 4689999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ......||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.... .......+...........
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 155 K--TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGST-------VEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHHHCCCCTTT
T ss_pred c--ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHHHhCCCChHh
Confidence 2 12234689999999998653 367899999999999999999999996432 1111111111110000000
Q ss_pred C------------------C----hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 V------------------T----EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~------------------~----~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. . .........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 0 000112345667888999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=321.95 Aligned_cols=242 Identities=23% Similarity=0.369 Sum_probs=198.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 456789999999999999965 6889999998643 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 96 APRGELYKELQKH------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999643 3589999999999999999999998 999999999999999999999999999976654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... ....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.... .......+... ....+
T Consensus 167 ~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~-~~~~~ 232 (284)
T 2vgo_A 167 LRR----RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPS-------HTETHRRIVNV-DLKFP 232 (284)
T ss_dssp SCB----CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTT-CCCCC
T ss_pred ccc----ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCC-------HhHHHHHHhcc-ccCCC
Confidence 322 244699999999999653 67899999999999999999999986431 12222222221 22222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...+. .+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~-------~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLSD-------GSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSCH-------HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcCCH-------HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 33333 4556778889999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.84 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=195.3
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.+.||+|+||+||+|..+ +|+.||+|++++.... ..+|++++.++ +||||+++++++.+....++||||++
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 4567789999999999999965 6899999999865433 45688888888 79999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC----CceEEeeccCcccc
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED----FCPKISDFGLAKQT 357 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~~ 357 (511)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++..
T Consensus 100 gg~L~~~i~~------~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 100 GGELLDKILR------QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp SCBHHHHHHT------CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCcHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999953 24689999999999999999999998 99999999999998433 35999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
...... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ......+...+..... .
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~-~ 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGP----DDTPEEILARIGSGKF-S 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSST----TSCHHHHHHHHHHCCC-C
T ss_pred cCCCCc--eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCC----cCCHHHHHHHHccCCc-c
Confidence 544321 2345799999999999654 57889999999999999999999996431 1123344444433321 1
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ...+...+.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGY---WNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTT---TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 0112233556667788999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.69 Aligned_cols=256 Identities=19% Similarity=0.248 Sum_probs=194.7
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEee--------cC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYE--------KK 271 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 271 (511)
.|.+.++||+|+||+||+|.. .+|+.||+|++.... .....+.+|+.++++++||||+++++++.+ .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 356678999999999999996 478999999986433 224578899999999999999999999976 45
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
..++||||++ |+|.+.+... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 98 ~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 98 SIYLVFDFCE-HDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp EEEEEEECCS-EEHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccC-CCHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 6899999996 5887777543 24699999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCc--eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 352 GLAKQTEKKES--FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 352 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
|+++....... ........||+.|+|||++.+. ..++.++||||||+++|||++|+.||.... .......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~ 240 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-------EQHQLAL 240 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHH
Confidence 99987643221 1122345689999999998653 357899999999999999999999986432 1111222
Q ss_pred Hhhhhcccc-------------------CCCCChHHHHH-----HHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 430 IETEYDFQL-------------------DGVVTEEEKEM-----AKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 430 ~~~~~~~~~-------------------~~~~~~~~~~~-----~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+........ ..........+ ...+.+++.+||+.||++|||++|+++
T Consensus 241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 211110000 00000001111 234678889999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.05 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=185.5
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHc-cCCcceeeeeceEee----cCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISR-TSHVNIVPFLGFCYE----KKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 282 (511)
+.||+|+||+||++.++ +|+.||||+++. ...+.+|+.++.+ .+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999865 689999999974 3567789988744 579999999998875 5678999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCccccCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAKQTEK 359 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~ 359 (511)
|+|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 144 g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 144 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CcHHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999996532 24699999999999999999999998 9999999999999997 78999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ... ....+.... ...+
T Consensus 217 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-~~~~i~~~~-~~~~ 287 (400)
T 1nxk_A 217 HNS---LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPG-MKTRIRMGQ-YEFP 287 (400)
T ss_dssp -------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS--CCS-HHHHHHHTC-CCCC
T ss_pred CCc---cccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc--cHH-HHHHHHcCc-ccCC
Confidence 332 234569999999999965 3788999999999999999999999965432111 111 112222111 1111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
. .....+...+.+++.+||+.||++|||++++++.
T Consensus 288 ~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 288 N---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp T---TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0011123446678889999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.40 Aligned_cols=196 Identities=22% Similarity=0.303 Sum_probs=169.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHcc------CCcceeeeeceEeecCeEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRT------SHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lv 276 (511)
.|.+.++||+|+||+||+|.+. +++.||||+++......+++.+|+.++..+ .|+||+++++++......++|
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 4567789999999999999855 589999999987655556788899888887 577999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc--eEEeeccCc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC--PKISDFGLA 354 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla 354 (511)
|||+. ++|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+||||+.++. +||+|||++
T Consensus 178 ~e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNK----FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp ECCCC-CBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EeccC-CCHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99995 79999996533 24589999999999999999999998 9999999999999999887 999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCcc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 7654332 245699999999999764 6899999999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=348.16 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=200.4
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
...|.+.++||+|+||+||+|..+ +++.||||++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 345778899999999999999965 7899999998642 344678999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc---CCCceEEeeccCc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISDFGLA 354 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla 354 (511)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 101 e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EcCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 999999999998543 4689999999999999999999998 999999999999995 5668999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ...+...+....
T Consensus 172 ~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~ 238 (486)
T 3mwu_A 172 TCFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGK 238 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTC
T ss_pred eECCCCCc---cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCC
Confidence 87654432 234569999999999864 57899999999999999999999996431 223333333322
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.. .. .+....+...+.+++.+||+.||++|||+.++++.
T Consensus 239 ~~-~~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 239 YA-FD---LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CC-SC---SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC-CC---CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 00 01111223345677788889999999999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=333.61 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=199.1
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEe----ecCeEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCY----EKKKRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~ 277 (511)
.|.+.++||+|+||.||++.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++. .....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 356678999999999999996 579999999886533 33467899999999999999999999987 344788999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 110 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 110 PFFKRGTLWNEIERLK--DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp ECCTTCBHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EeCCCCcHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999997543 2235799999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCce-------eeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 358 EKKESF-------ISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 358 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
...... .......||+.|+|||.+... ...++.++||||||+++|||++|+.||........ . +...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-S----VALA 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-C----HHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-h----hhHH
Confidence 422110 001123479999999998543 12368899999999999999999999853211100 0 1111
Q ss_pred HhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 430 IETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
+............+ ..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 260 ~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQNQLSIPQSPRHS-------SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHCC--CCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhccCCCCccccCC-------HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11111111112222 34667888899999999999999999999754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.10 Aligned_cols=253 Identities=23% Similarity=0.255 Sum_probs=198.6
Q ss_pred HhhhcccCCcCceEEEEEEc----CCCcEEEEEEeccC-----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL----PDGRLVAVKVMKNL-----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~----~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 274 (511)
|.+.++||+|+||+||+++. .+++.||||+++.. ....+.+.+|++++.++ +||||+++++++.+....+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 46678999999999999986 36899999998753 23446678899999999 6999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 136 lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEeecCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999643 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+......... .....||+.|+|||++.+....++.++||||||+++|||++|+.||...... .....+...+...
T Consensus 207 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~- 281 (355)
T 1vzo_A 207 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKS- 281 (355)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHC-
T ss_pred eecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc---chHHHHHHHHhcc-
Confidence 8764332211 2234699999999999754345788999999999999999999999643211 1122222222221
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHh
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVEML 478 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~~L 478 (511)
....+...+ ..+.+++.+||+.||++|| +++++++..
T Consensus 282 ~~~~~~~~~-------~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 EPPYPQEMS-------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCCCTTSC-------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCCcccC-------HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112222233 3456677889999999999 999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.00 Aligned_cols=248 Identities=27% Similarity=0.368 Sum_probs=201.9
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
...|.+.++||+|+||+||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 445777889999999999999965 7899999999643 33457899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE---cCCCceEEeeccC
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGL 353 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGl 353 (511)
|||+++|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+
T Consensus 105 ~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp ECCCCSCBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999998542 4689999999999999999999998 99999999999999 5678999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++....... .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... ...+...+...
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~ 242 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGAN-------EYDILKKVEKG 242 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC
T ss_pred eEEcccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcC
Confidence 987654432 223469999999999854 57899999999999999999999996432 23333333332
Q ss_pred h-ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 Y-DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ~-~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .+.. +....+...+.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 KYTFEL-----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCS-----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCC-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 2 1111 111122344567778889999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=321.84 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=194.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEee----cCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYE----KKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 276 (511)
+.+.++||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 345678999999999999854 688999999975433 23578899999999999999999998865 3568999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCEEEc-CCCceEEeeccC
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR--IVHLDIKPHNIRLD-EDFCPKISDFGL 353 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DFGl 353 (511)
|||+++++|.+++... ..+++..++.++.||+.||+|||+. + |+||||||+|||++ +++.+||+|||+
T Consensus 108 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEecCCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999543 4689999999999999999999998 7 99999999999998 789999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
+........ ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ....+...+...
T Consensus 179 ~~~~~~~~~----~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~ 245 (290)
T 1t4h_A 179 ATLKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSG 245 (290)
T ss_dssp GGGCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTT
T ss_pred ccccccccc----ccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcC------cHHHHHHHHhcc
Confidence 976544332 23469999999999853 58899999999999999999999986422 122333333322
Q ss_pred hcc-ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 YDF-QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ~~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ..+... ...+.+++.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPASFDKVA-------IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGGGGCC-------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccccCCCC-------CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 111112 234677888999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=326.38 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=200.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 278 (511)
|.+.+.||+|+||+||++... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 456789999999999999965 689999999975432 23578899999999999999999998854 678999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----cEecCCCCCCEEEcCCCceEEeeccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR-----IVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
|+++++|.+++..... ....+++..++.++.|++.||+|||+. + |+||||||+|||+++++.+||+|||+
T Consensus 88 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 88 YCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp CCTTEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred CCCCCCHHHHHHhhcc--cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999975431 234589999999999999999999998 6 99999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++........ .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.|+.... ...+...+...
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~ 231 (279)
T 2w5a_A 163 ARILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKELAGKIREG 231 (279)
T ss_dssp HHHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHT
T ss_pred heeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccC-------HHHHHHHHhhc
Confidence 9876543321 1223589999999998653 67899999999999999999999986431 22333344333
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
....++...+ ..+.+++.+||+.||++|||+++|++.+..
T Consensus 232 ~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 KFRRIPYRYS-------DELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccccCCcccC-------HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 3222222333 346677788999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=327.63 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=197.8
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
..|.+.+.||+|+||+||++... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45667889999999999999965 689999999986533 3457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE---cCCCceEEeeccCcccc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL---DEDFCPKISDFGLAKQT 357 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 357 (511)
++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+++..
T Consensus 89 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 89 SGGELFDRILER------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCccHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999998543 3689999999999999999999998 99999999999999 78899999999999765
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... ....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.... ...+...+..... .
T Consensus 160 ~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~-~ 225 (304)
T 2jam_A 160 QNGIM----STACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEET-------ESKLFEKIKEGYY-E 225 (304)
T ss_dssp CCBTT----HHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHCCC-C
T ss_pred CCCcc----ccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCC-C
Confidence 43321 233589999999999653 68899999999999999999999986431 2233333333221 1
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... .......+.+++.+||+.||++|||++++++
T Consensus 226 ~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FESPF---WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCTTT---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCccc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11110 1112334667778888999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=335.76 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=187.5
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.|.+.++||+|+||+||+|... +++.||||+++..... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 4566789999999999999854 7899999999754322 35678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE-----cCCCceEEeeccCc
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL-----DEDFCPKISDFGLA 354 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll-----~~~~~~kl~DFGla 354 (511)
++ |+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||++
T Consensus 115 ~~-~~L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 115 AE-NDLKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp CS-EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CC-CCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 96 5999999543 3589999999999999999999998 99999999999999 45566999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||..... .+.+.. +....
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~-~~~~~ 254 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSE------IDQLFK-IFEVL 254 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHHH
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH------HHHHHH-HHHHh
Confidence 87643322 12344689999999998653 3578999999999999999999999864321 111111 11111
Q ss_pred ccccC-----------------CCCChHHHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DFQLD-----------------GVVTEEEKE-----MAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~~~~-----------------~~~~~~~~~-----~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ......... ....+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 000000111 2245677888999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=348.43 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=197.1
Q ss_pred hhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 207 FSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+.+.||+|+||+||+|..+ +|+.||+|++++. ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 4467999999999999965 6999999999753 2345678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+++......
T Consensus 269 gg~L~~~l~~~~--~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 269 GGDIRYHIYNVD--EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp TCBHHHHHHTSS--TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCCHHHHHHHhh--cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 999999996543 2235699999999999999999999998 99999999999999999999999999998775443
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+.+.+... ....+..
T Consensus 344 ~~--~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~---~~~~~~~~~~i~~~-~~~~p~~ 415 (543)
T 3c4z_A 344 TK--TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRVLEQ-AVTYPDK 415 (543)
T ss_dssp CC--BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTC---CCCHHHHHHHHHHC-CCCCCTT
T ss_pred cc--cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCcc---chhHHHHHHHHhhc-ccCCCcc
Confidence 21 2234799999999999764 688999999999999999999999974321 11223333333222 1222333
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~ 471 (511)
++.. +.+++.+||+.||++||++
T Consensus 416 ~s~~-------~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 416 FSPA-------SKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp SCHH-------HHHHHHHHSCSSGGGSCCC
T ss_pred cCHH-------HHHHHHHhccCCHhHCCCC
Confidence 4443 4456677889999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.04 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=193.9
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC------ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD------NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
.|.+.+.||+|+||+||+|.+. +|+.||||+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4567789999999999999965 589999999974321 124788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EECCSE-EHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEcCCC-CHHHHHHhc-----CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999965 898888532 24688899999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
...... ......||+.|+|||++.+. ..++.++||||||+++|||++|..|+.... .......+......
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~-------~~~~~~~i~~~~~~ 231 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDS-------DLDQLTRIFETLGT 231 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHHHCC
T ss_pred ccCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHHHcCC
Confidence 654332 12345699999999998653 357889999999999999999998885431 11112222111100
Q ss_pred ccCC------------------CCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 437 QLDG------------------VVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 437 ~~~~------------------~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.... ..+ .........+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000 0001123457778888999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=324.04 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=198.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||++.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 456788999999999999965 58899999987542 2235788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 97 CRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp CTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999988542 4689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... .....||+.|+|||.+.+. ..+.++||||||+++|+|++|+.||.... .......+... ....+
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~ 235 (294)
T 2rku_A 168 DGER--KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKN-EYSIP 235 (294)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTT-CCCCC
T ss_pred Cccc--cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhhc-cCCCc
Confidence 3221 2234699999999998653 67889999999999999999999986432 11222222221 12222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
...+ ..+.+++.+||+.||++|||++++++.
T Consensus 236 ~~~~-------~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHIN-------PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTSC-------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccC-------HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2333 345667788999999999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.24 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=193.9
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC---------CChHHHHHHHHHHHccCCcceeeeeceEeecC
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK---------DNGEEFINEVASISRTSHVNIVPFLGFCYEKK 271 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 271 (511)
...|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 445677899999999999999865 68999999987532 11235789999999999999999999987655
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc---eEE
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC---PKI 348 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl 348 (511)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp -EEEEEECCTTEETHHHHST------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred -eEEEEecCCCCcHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence 8999999999999999843 34689999999999999999999998 9999999999999987654 999
Q ss_pred eeccCccccCCCCceeeecCCCCCCCccchhhccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH
Q 040808 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR-HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 349 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 427 (511)
+|||+++....... .....||+.|+|||++.. ....++.++||||||+++|+|++|+.||...... .. +.
T Consensus 159 ~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~----~~ 229 (322)
T 2ycf_A 159 TDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VS----LK 229 (322)
T ss_dssp CCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SC----HH
T ss_pred ccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HH----HH
Confidence 99999987654322 123359999999999742 1246788999999999999999999999643211 11 11
Q ss_pred HHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+..... . ..+.........+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~-~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 DQITSGKY-N---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHTCC-C---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhCcc-c---cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 22222111 0 011111223456778888999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.12 Aligned_cols=253 Identities=20% Similarity=0.316 Sum_probs=194.7
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEee--cCeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYE--KKKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~ 279 (511)
.|.+.++||+|+||+||+|.. .+++.||||+++. ...+.+.+|+.++.+++ ||||+++++++.+ ....++||||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~ 114 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEec
Confidence 355678999999999999985 5789999999974 33578999999999997 9999999999987 6688999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccccC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQTE 358 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 358 (511)
+++++|.+++ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus 115 ~~~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 115 VNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp CCCCCHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred cCchhHHHHH---------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999988 2488999999999999999999998 999999999999999776 89999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchH--------HHHHHH
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPN--------AIYKQI 430 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~ 430 (511)
..... ....||+.|+|||++.+. ..++.++||||||+++|||++|+.||........ .+.. .....+
T Consensus 183 ~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHH
T ss_pred CCCcc---ccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHH
Confidence 54332 344689999999998653 3688999999999999999999999853321000 0000 000000
Q ss_pred hhhhccccCC-----------------CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDG-----------------VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ....+. ........+...+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKY-NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHT-TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHh-ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000000 000001113455778889999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=323.20 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=200.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 456788999999999999854 6899999999754 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++.. ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 104 GGSALDLLEP-------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp TEEHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCcHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999842 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
. ......||+.|+|||++.+. .++.++||||||+++|+|++|+.|+.... .......+.......+...
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 242 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELH-------PMKVLFLIPKNNPPTLEGN 242 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCCCSS
T ss_pred c--ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcC-------HHHHHHHhhcCCCCCCccc
Confidence 2 12345699999999999653 67889999999999999999999986321 2222233333222222333
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.+ ..+.+++.+||+.||++|||+.++++.
T Consensus 243 ~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 YS-------KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CC-------HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cC-------HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 33 346677888999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=329.59 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=198.5
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||++.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 456788999999999999965 58899999987542 2246788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~~~~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 123 CRRRSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CTTCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999988542 4689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.... .......+... ...++
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~-~~~~~ 261 (335)
T 2owb_A 194 DGER--KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKN-EYSIP 261 (335)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHT-CCCCC
T ss_pred Cccc--ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHhcC-CCCCC
Confidence 3221 2245699999999999653 67889999999999999999999986431 12222222222 12222
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...++ .+.+++.+||+.||++|||++++++
T Consensus 262 ~~~~~-------~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHINP-------VAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTSCH-------HHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCCH-------HHHHHHHHHccCChhHCcCHHHHhc
Confidence 33333 3556778899999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=329.86 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=192.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.+.||+|+||+||+|... +|+.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 456789999999999999965 5899999998765433 245789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 ~~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 107 DHTILDDLELF------PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp SEEHHHHHHHS------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CcchHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999887643 24689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh--------
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET-------- 432 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 432 (511)
... .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||..... .+.+......
T Consensus 178 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 178 GEV--YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD------IDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp --------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCSCCHHH
T ss_pred ccc--cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCChhh
Confidence 221 2245699999999998653 3678899999999999999999999864321 1111111100
Q ss_pred ------h---hccccCC--CCChH---HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 ------E---YDFQLDG--VVTEE---EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ------~---~~~~~~~--~~~~~---~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .....+. ..... .......+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0000000 00000 0123456778889999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.67 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=194.3
Q ss_pred cccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 209 DKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
..||+|+||+||+|.. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 3799999999999995 4689999999976433 3467899999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeeccCccccCCCCceee
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
+++.... ....+++..+..++.|++.||+|||+. +|+|+||||+||+++. ++.+||+|||+++........
T Consensus 108 ~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-- 179 (295)
T 2clq_A 108 ALLRSKW---GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-- 179 (295)
T ss_dssp HHHHHTT---CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred HHHHhhc---cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence 9996532 234577899999999999999999998 9999999999999987 899999999999876543221
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChH
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (511)
.....||+.|+|||++.+....++.++||||||+++|+|++|+.||..... ................++...+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-- 252 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQAAMFKVGMFKVHPEIPESMS-- 252 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HHHHHHHHHHHCCCCCCCTTSC--
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hhHHHHhhccccccccccccCC--
Confidence 224469999999999965433478899999999999999999999853211 1111111111111112222222
Q ss_pred HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 446 ~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+.+++.+||+.||++|||++++++
T Consensus 253 -----~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 253 -----AEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -----HHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 34667788899999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.26 Aligned_cols=245 Identities=25% Similarity=0.408 Sum_probs=178.5
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|.. .+|+.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 45678899999999999996 47999999999643 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 93 CHNGEMNRYLKNR-----VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp CTTEEHHHHHHTC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred CCCCcHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999643 25689999999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... .....||+.|+|||.+.+. ..+.++||||||+++|||++|+.|+...... ... ..+.. .....+
T Consensus 165 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~-~~~~~-~~~~~~ 232 (278)
T 3cok_A 165 PHEK--HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVK------NTL-NKVVL-ADYEMP 232 (278)
T ss_dssp -------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS-SCCCCC
T ss_pred CCCc--ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHH------HHH-HHHhh-cccCCc
Confidence 3221 1234689999999998654 6788999999999999999999998643211 111 11100 111122
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...+ ..+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~-------~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SFLS-------IEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TTSC-------HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccC-------HHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2223 34567788899999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=325.98 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=189.7
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEee-------------
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE------------- 269 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------- 269 (511)
.|.+.+.||+|+||+||+|... +++.||||+++......+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 3566789999999999999964 79999999997655556789999999999999999999998865
Q ss_pred cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 270 KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 270 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred CCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 457889999999999999996432 4678899999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCc------------eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCC
Q 040808 350 DFGLAKQTEKKES------------FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSC 417 (511)
Q Consensus 350 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~ 417 (511)
|||+++....... ........||+.|+|||++.+. +.++.++||||||+++|||++ |+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999987643211 1112344689999999998643 367899999999999999998 332110
Q ss_pred CCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........+... ....+..... .....+.+++.+||+.||++|||++++++
T Consensus 233 ----~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ----ERVNILKKLRSV-SIEFPPDFDD---NKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ----HHHHHHHHHHST-TCCCCTTCCT---TTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----hHHHHHHhcccc-ccccCccccc---cchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111222222221 1111222221 22334667888899999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=348.27 Aligned_cols=243 Identities=16% Similarity=0.155 Sum_probs=183.4
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccC----CCChHHHHHHH---HHHHccCCcceeeee-------ceEee
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNL----KDNGEEFINEV---ASISRTSHVNIVPFL-------GFCYE 269 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~ 269 (511)
|.+.+.||+|+||+||+|.+ .+|+.||||++... ....+.+.+|+ .++++++|||||+++ +++.+
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 34567899999999999996 46999999999743 22346788999 555666899999998 55544
Q ss_pred cC-----------------eEEEEEEeCCCCCHHHHHhcccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEec
Q 040808 270 KK-----------------KRALIYEFMPNGSLDQYIYDHESS-NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHL 331 (511)
Q Consensus 270 ~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~ 331 (511)
.+ ..++||||+ +|+|.+++...... .....+++..++.|+.||+.||+|||++ +|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 43 378999999 78999999754311 1123455788999999999999999998 99999
Q ss_pred CCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccc---------cCCCCccccchhHHHHHH
Q 040808 332 DIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH---------FGGVSHKSDVYSYGMMIH 402 (511)
Q Consensus 332 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDvwSlG~il~ 402 (511)
||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. ...++.++|||||||++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999864331 234567 999999999653 015789999999999999
Q ss_pred HHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 403 EMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 403 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
||++|+.||........ .. .+ .......+ ..+.+++.+||+.||++|||+.++++
T Consensus 305 elltg~~Pf~~~~~~~~---~~----~~-----~~~~~~~~-------~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGG---SE----WI-----FRSCKNIP-------QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CC---SG----GG-----GSSCCCCC-------HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccc---hh----hh-----hhhccCCC-------HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999864321110 00 00 01112233 34666778899999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.13 Aligned_cols=243 Identities=21% Similarity=0.300 Sum_probs=198.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+.+.++||+|+||+||+|..+ +++.||||++++. ....+.+.+|..++..+ +||+|+++++++.+.+..++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 456789999999999999965 6889999999753 34457788999999987 69999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 423 ~~~gg~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 423 YVNGGDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp CCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CcCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 99999999999643 3689999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...++..+... ....
T Consensus 494 ~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~-~~~~ 561 (674)
T 3pfq_A 494 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEH-NVAY 561 (674)
T ss_dssp CTTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHSS-CCCC
T ss_pred cCCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhC-CCCC
Confidence 3222 12345799999999999654 78999999999999999999999996432 23344444332 2233
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCH-----HHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM-----TKVV 475 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~-----~evl 475 (511)
+..++++ +.+++.+||+.||++||++ ++|+
T Consensus 562 p~~~s~~-------~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 562 PKSMSKE-------AVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp CTTSCHH-------HHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred CccCCHH-------HHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 3444444 4455666779999999997 6665
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.23 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=192.6
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3456789999999999999965 7899999998643 2345688999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 92 YVSGGELFDYICKH------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp CCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred ccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999643 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
.... .....||+.|+|||.+.+. ...+.++||||||+++|+|++|+.|+.... ...+.+.+.... ...
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~-~~~ 230 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLFKKIRGGV-FYI 230 (276)
T ss_dssp C----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCC-CCC
T ss_pred CCcc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHhhcCc-ccC
Confidence 4432 1234689999999998653 234689999999999999999999986431 223333333321 122
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
+...+ ..+.+++.+||+.||++|||++++++.
T Consensus 231 ~~~~~-------~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PEYLN-------RSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhcC-------HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22223 345677788999999999999999873
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.16 Aligned_cols=248 Identities=23% Similarity=0.262 Sum_probs=185.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecC------eEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKK------KRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 274 (511)
|.+.+.||+|+||+||+|... +++.||||++...... .+++.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 456788999999999999854 6899999999764332 356889999999999999999999987654 789
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||++ |+|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 107 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEECCS-EEHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred EEEEcCC-CCHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 9999996 57888883 3488999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .+ .+..+....
T Consensus 175 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~-~~~~i~~~~ 242 (371)
T 2xrw_A 175 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDH------ID-QWNKVIEQL 242 (371)
T ss_dssp ------------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HH-HHHHHHC-C
T ss_pred cccccccc---cCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCH------HH-HHHHHHHHh
Confidence 87654322 2245699999999999763 688999999999999999999999964321 01 111110000
Q ss_pred -----------------------cc-----------ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 -----------------------DF-----------QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 -----------------------~~-----------~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ................+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 0001111222334566788999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=328.48 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=195.6
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+.+.+.||+|+||+||+|..++ .+|+|+++... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 4567899999999999999754 49999987542 233567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+++|.+++... ...+++..++.++.||+.||+|||+. +++||||||+|||++ ++.+||+|||+++......
T Consensus 113 ~~~L~~~l~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 113 GRTLYSVVRDA-----KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp SEEHHHHTTSS-----CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred CCcHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 99999999532 24689999999999999999999998 999999999999998 6799999999987653221
Q ss_pred c---eeeecCCCCCCCccchhhcccc-------cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 362 S---FISMLDTRGTAGYIAPEVFCRH-------FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 362 ~---~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
. ........||+.|+|||.+... ...++.++||||||+++|||++|+.||.... ...+...+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~ 256 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------AEAIIWQMG 256 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-------HHHHHHHHH
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHhc
Confidence 1 1112234589999999998642 1357889999999999999999999986431 233333333
Q ss_pred hhhccccC-CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCCCCCC
Q 040808 432 TEYDFQLD-GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLS 494 (511)
Q Consensus 432 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~p~~~ 494 (511)
........ ...+ ..+.+++.+||+.||++|||+++++++|+.+.+.....+.|...
T Consensus 257 ~~~~~~~~~~~~~-------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~ 313 (319)
T 2y4i_B 257 TGMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF 313 (319)
T ss_dssp TTCCCCCCCSSCC-------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------------
T ss_pred cCCCCCCCcCCCC-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccc
Confidence 33222111 1222 34667778899999999999999999999988776555554433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=332.54 Aligned_cols=248 Identities=21% Similarity=0.278 Sum_probs=186.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecC------eEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKK------KRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 274 (511)
|.+.+.||+|+||+||+|.+. +|+.||||++...... .+++.+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 456788999999999999964 6999999999654332 357889999999999999999999987653 469
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 107 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp EEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 999999 8999999853 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+..... .....||+.|+|||++.+. ..++.++||||+||++|||++|+.||..... .+.+ ..+....
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~l-~~i~~~~ 242 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDH------LDQL-KEIMKVT 242 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH-HHHHHhc
Confidence 876543 2345689999999998653 3688999999999999999999999964321 1111 1111100
Q ss_pred cc-----------------------ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DF-----------------------QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~-----------------------~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ................+.+++.+||+.||++|||++++++
T Consensus 243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00 0000000000111234667778899999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.06 Aligned_cols=256 Identities=21% Similarity=0.253 Sum_probs=185.0
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCe-------EEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKK-------RAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~~l 275 (511)
.|.+.++||+|+||+||+|.+. +|+.||||++.........+.+|+..+..++||||+++++++..... .++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 3456788999999999999965 68999999997766666778899999999999999999999975433 789
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCcEecCCCCCCEEEcC-CCceEEeecc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH--RGCNIRIVHLDIKPHNIRLDE-DFCPKISDFG 352 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH--~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DFG 352 (511)
||||+++ +|.+.+.... .....+++..+..++.|++.||+||| +. +|+||||||+|||++. ++.+||+|||
T Consensus 104 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYY--RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEECCSC-BHHHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred Eeecccc-cHHHHHHHHh--hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 9999965 6555553322 22457899999999999999999999 76 9999999999999997 8999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 432 (511)
+++........ ....||+.|+|||++.+. ..++.++||||||+++|||++|+.||.... .......+..
T Consensus 178 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~-------~~~~~~~~~~ 246 (360)
T 3e3p_A 178 SAKKLSPSEPN---VAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-------SAGQLHEIVR 246 (360)
T ss_dssp TCBCCCTTSCC---CSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHH
T ss_pred CceecCCCCCc---ccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-------hHHHHHHHHH
Confidence 99877654432 244689999999998653 357899999999999999999999996432 1111111111
Q ss_pred hhc----------------ccc--CCCC------ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYD----------------FQL--DGVV------TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~----------------~~~--~~~~------~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ... .... ..........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 100 000 0000 0000012456788999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=324.14 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=198.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----------ChHHHHHHHHHHHccC-CcceeeeeceEeecCe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----------NGEEFINEVASISRTS-HVNIVPFLGFCYEKKK 272 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 272 (511)
|.+.+.||+|+||.||+|..+ +|+.||||+++.... ..+.+.+|+.++.++. ||||+++++++.+...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 456788999999999999965 689999999975431 1356789999999996 9999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999642 4689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccc----cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRH----FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
++........ .....||+.|+|||++... ...++.++||||||+++|+|++|+.|+.... ......
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~ 239 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLR 239 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-------HHHHHH
Confidence 9987654432 2344699999999998521 2357889999999999999999999985331 222222
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+.... .... .+........+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~-~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGN-YQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTC-CCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCC-cccC---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 222221 1111 1111223445778888999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.46 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=197.7
Q ss_pred HHHhhhcccCCcCceEEEEEEc-C-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc------eeeeeceEeecCeEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL-P-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN------IVPFLGFCYEKKKRA 274 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~ 274 (511)
..|.+.++||+|+||+||+|.+ + +++.||||+++......+.+.+|+.++..++|++ ++++++++.+.+..+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 3566788999999999999985 3 6889999999866555678889999999987665 999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC------------
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE------------ 342 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~------------ 342 (511)
+||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENG----FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEcCC-CCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 999999 999999996532 24689999999999999999999998 9999999999999987
Q ss_pred -------CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCcc
Q 040808 343 -------DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKV 415 (511)
Q Consensus 343 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~ 415 (511)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6789999999998754432 245699999999999653 68899999999999999999999986432
Q ss_pred CCCCCCchHHHHHHHhhhhccc------------------c-CCCCCh-----------------HHHHHHHHHHHHHHh
Q 040808 416 SCSSEYFPNAIYKQIETEYDFQ------------------L-DGVVTE-----------------EEKEMAKKMILVSLW 459 (511)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~------------------~-~~~~~~-----------------~~~~~~~~~~~l~~~ 459 (511)
. ......+....... . ...... ........+.+++.+
T Consensus 239 ~-------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 311 (339)
T 1z57_A 239 S-------KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK 311 (339)
T ss_dssp H-------HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred h-------HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH
Confidence 1 11111111100000 0 000000 011234567889999
Q ss_pred ccccCCCCCCCHHHHHH
Q 040808 460 CIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 460 Cl~~~p~~RPs~~evl~ 476 (511)
||+.||++|||++|+++
T Consensus 312 ~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 312 MLEYDPAKRITLREALK 328 (339)
T ss_dssp HTCSSTTTSCCHHHHTT
T ss_pred HhCcCcccccCHHHHhc
Confidence 99999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=323.17 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=192.5
Q ss_pred HHhhhcccCCcCceEEEEEEcC--CCc--EEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP--DGR--LVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
.|.+.++||+|+||+||+|.+. +++ .||+|+++... ...+++.+|+.++++++||||+++++++.+.. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 4567789999999999999842 333 68999987532 23467899999999999999999999988765 889
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++
T Consensus 98 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 999999999999996532 4689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 356 QTEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 356 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
.......... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||.... ...+...+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~ 240 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKE 240 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTS
T ss_pred cccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCC-------HHHHHHHHHcc
Confidence 7755433221 2234578899999998653 67899999999999999999 999986331 22222222221
Q ss_pred -hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 434 -YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 434 -~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
........ ....+.+++.+||+.||++|||+.++++.|+...
T Consensus 241 ~~~~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 241 GERLPRPED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCcC-------cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11122222 2345677888899999999999999999999754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=331.34 Aligned_cols=197 Identities=26% Similarity=0.377 Sum_probs=169.8
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
..|.+.++||+|+||+||+|.+. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 34566789999999999999965 689999999976432 236789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++++|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~~~~~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999643 3589999999999999999999983 1799999999999999999999999999975532
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
.. .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cc----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 1234699999999999653 688999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=331.06 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=181.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.|.+.+.||+|+||+||+|... +++.||||++... ....+++.+|+.++.+++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 3456789999999999999954 6899999998653 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 281 PNGSLDQYIYDHES--SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 281 ~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
++++|.+++..... ......+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999964211 11235689999999999999999999998 99999999999999999999999999987665
Q ss_pred CCCcee---eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 359 KKESFI---SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 359 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
...... ......||+.|+|||++.+. ..++.++||||||+++|||++|+.||..... ............
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~- 244 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPP------MKVLMLTLQNDP- 244 (303)
T ss_dssp ---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG------GGHHHHHHTSSC-
T ss_pred cCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCch------hhHHHHHhccCC-
Confidence 432111 11234699999999998642 3578999999999999999999999864321 111111111110
Q ss_pred cccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 FQLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........ .........+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00000000 000112235677888999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.24 Aligned_cols=258 Identities=21% Similarity=0.273 Sum_probs=194.4
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeec-----CeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEK-----KKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 275 (511)
.|.+.++||+|+||+||+|... +++.||||++...... .+.+.+|++++.+++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 3566789999999999999855 6889999999754322 36788999999999999999999998654 47899
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+. |+|.+++.. ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 108 v~e~~~-~~L~~~l~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEECCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEcccC-cCHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 999995 699999853 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh--
Q 040808 356 QTEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET-- 432 (511)
Q Consensus 356 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 432 (511)
.......... .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||...... .....+...+..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPS 252 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSCC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCCC
Confidence 7754332211 2334699999999987543 35789999999999999999999999643210 000111100000
Q ss_pred ---------------hhccccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 ---------------EYDFQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ---------------~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
............ ........+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 00112345677888999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=320.89 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=195.4
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
...|.+.+.||+|+||.||+|... +|+.||+|++.... ..+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 334566789999999999999865 58999999997643 4578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 107 ~~~~L~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 107 GAGSVSDIIRLR-----NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp TTEEHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred CCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999532 24689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.. ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.... .......+.........
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~- 246 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIH-------PMRAIFMIPTNPPPTFR- 246 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCCS-
T ss_pred cc--ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCcccC-
Confidence 22 12344699999999998653 68899999999999999999999986321 11111111111111100
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .......+.+++.+||+.||++|||+.++++
T Consensus 247 -~---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 -K---PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -S---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -C---cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 1112345667888899999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.10 Aligned_cols=263 Identities=20% Similarity=0.261 Sum_probs=180.9
Q ss_pred hcccCCcCceEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEEeCCC
Q 040808 208 SDKLGQGGYADVYKGTLP---DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYEFMPN 282 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 282 (511)
+++||+|+||+||+|..+ +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 458999999999999955 57899999997543 34678899999999999999999999954 678999999995
Q ss_pred CCHHHHHhcccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE----cCCCceEEeeccCcc
Q 040808 283 GSLDQYIYDHES---SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL----DEDFCPKISDFGLAK 355 (511)
Q Consensus 283 gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~DFGla~ 355 (511)
|+|.+++..... ......+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 688888854321 11223599999999999999999999998 99999999999999 778999999999998
Q ss_pred ccCCCCc-eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--CCchHHHHHHHhh
Q 040808 356 QTEKKES-FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS--EYFPNAIYKQIET 432 (511)
Q Consensus 356 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~ 432 (511)
....... ........||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ ..+.......+..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 7654321 1122345699999999998653 3588999999999999999999999964432111 1111111122211
Q ss_pred hhccccCCC------CChH----------------HHH--------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 EYDFQLDGV------VTEE----------------EKE--------MAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 ~~~~~~~~~------~~~~----------------~~~--------~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
......... .... ... ....+.+++.+||+.||++|||++|+++
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111100000 0000 000 0234667889999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=333.04 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=185.8
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC------------hHHHHHHHHHHHccCCcceeeeeceEee---
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN------------GEEFINEVASISRTSHVNIVPFLGFCYE--- 269 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~--- 269 (511)
|.+.+.||+|+||+||+|...+|+.||||++...... .+.+.+|+.++++++||||+++++++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence 4456899999999999999888999999998643221 2678999999999999999999999853
Q ss_pred --cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 270 --KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 270 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
....++||||++ |+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHDQ-----RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHCT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCcceEEEEEccCC-CCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEE
Confidence 346899999996 7888888532 34699999999999999999999998 999999999999999999999
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 427 (511)
|+|||+++....... .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.... ..+ ..
T Consensus 175 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~-~~ 243 (362)
T 3pg1_A 175 ICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGST------FYN-QL 243 (362)
T ss_dssp ECCTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHH-HH
T ss_pred EEecCcccccccccc---cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCC------HHH-HH
Confidence 999999986544332 2234689999999998653 368899999999999999999999996432 111 11
Q ss_pred HHHhhhhc--------------------cccCCCCC----hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 428 KQIETEYD--------------------FQLDGVVT----EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 428 ~~~~~~~~--------------------~~~~~~~~----~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+..... ........ .........+.+++.+||+.||++|||++|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111000 00000000 000111334677889999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=323.65 Aligned_cols=249 Identities=28% Similarity=0.378 Sum_probs=192.6
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEee------cCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYE------KKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~lv 276 (511)
|.+.+.||+|+||.||+|.+ .+|+.||||++.......+++.+|+.++.++ +||||+++++++.. ....++|
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 45678999999999999996 4789999999987766778899999999999 79999999999976 5688999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||++..
T Consensus 106 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTK----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EECCTTEEHHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred EEcCCCCcHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 99999999999996542 25689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
...... ......||+.|+|||++... ...++.++||||||+++|+|++|+.|+.... .......+...
T Consensus 179 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~ 249 (326)
T 2x7f_A 179 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-------PMRALFLIPRN 249 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHS
T ss_pred cCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHhhcC
Confidence 643321 11234699999999998521 2367889999999999999999999985321 11111122221
Q ss_pred hccc-cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 YDFQ-LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ~~~~-~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... .....+ ..+.+++.+||+.||++|||++++++
T Consensus 250 ~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRLKSKKWS-------KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCCSCSCSC-------HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCCccccC-------HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 111222 34667778899999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.91 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=190.4
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeec------------
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEK------------ 270 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------ 270 (511)
.|.+.++||+|+||+||+|.+ .+|+.||||++...... ..+|++++++++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 456778999999999999985 57999999998754332 33799999999999999999998543
Q ss_pred --------------------------CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 040808 271 --------------------------KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324 (511)
Q Consensus 271 --------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~ 324 (511)
...++||||++ |+|.+.+.... .....+++..+..++.||+.||+|||+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 160 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHSL- 160 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence 34889999997 68888876432 1235799999999999999999999998
Q ss_pred CCCcEecCCCCCCEEEc-CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHH
Q 040808 325 NIRIVHLDIKPHNIRLD-EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHE 403 (511)
Q Consensus 325 ~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~e 403 (511)
+|+||||||+|||++ +++.+||+|||+++........ ....||+.|+|||.+.+. ..++.++||||+||++||
T Consensus 161 --gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 161 --GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp --TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHH
T ss_pred --cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHH
Confidence 999999999999998 6899999999999876554432 244689999999998653 357899999999999999
Q ss_pred HHhCCCCCCCccCCCCCCchHHHHHHHhhhh---------------ccccCCCCChHHH-----HHHHHHHHHHHhcccc
Q 040808 404 MVIGRKNADVKVSCSSEYFPNAIYKQIETEY---------------DFQLDGVVTEEEK-----EMAKKMILVSLWCIQT 463 (511)
Q Consensus 404 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~-----~~~~~~~~l~~~Cl~~ 463 (511)
|++|+.||..... .+.+...+.... ....+........ .....+.+++.+||+.
T Consensus 235 ll~g~~pf~~~~~------~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 235 LILGKPLFSGETS------IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHhCCCCCCCCCh------HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999964321 111111111000 0000000000000 1223467788899999
Q ss_pred CCCCCCCHHHHHH
Q 040808 464 HPPDRPSMTKVVE 476 (511)
Q Consensus 464 ~p~~RPs~~evl~ 476 (511)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999983
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.19 Aligned_cols=251 Identities=11% Similarity=0.012 Sum_probs=175.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC----ChHHHHHHHHHHHcc--CCcceeeee-------ceEeec
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD----NGEEFINEVASISRT--SHVNIVPFL-------GFCYEK 270 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~ 270 (511)
|.+.++||+|+||+||+|.+. +|+.||||+++.... ..+.+.+|+.++..+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 456788999999999999955 789999999987543 234667785444444 699988755 333322
Q ss_pred -----------------CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 040808 271 -----------------KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTV------YQIAVGIARGLEYLHRGCNIR 327 (511)
Q Consensus 271 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~yLH~~~~~~ 327 (511)
...++||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||++ +
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 34799999998 89999997643 23455555 77889999999999998 9
Q ss_pred cEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhC
Q 040808 328 IVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIG 407 (511)
Q Consensus 328 iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg 407 (511)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+....++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998764322 13457799999999965223679999999999999999999
Q ss_pred CCCCCCccCCCCCCchHHHHH-HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 408 RKNADVKVSCSSEYFPNAIYK-QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 408 ~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+.||..........+...... .......+..... +...+.+++.+||+.||++|||+.++++
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP-------LPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSC-------CCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchhhhhhhhccccccchhhccC-------CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999975532211110000000 0000000111112 2345667778899999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=324.87 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=193.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC-CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL-KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.+.||+|+||+||+|... +++.||+|++... ....+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 566789999999999999965 5899999998754 34457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++........
T Consensus 101 ~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 101 GAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 99999986432 4689999999999999999999998 999999999999999999999999998764321111
Q ss_pred eeeecCCCCCCCccchhhccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 363 FISMLDTRGTAGYIAPEVFCR---HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
......||+.|+|||++.. ....++.++||||||+++|+|++|+.|+.... .......+........
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~- 242 (302)
T 2j7t_A 173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSDPPTL- 242 (302)
T ss_dssp --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHSCCCCC-
T ss_pred --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-------HHHHHHHHhccCCccc-
Confidence 1123459999999999842 12467889999999999999999999986431 1222222222211100
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. .......+.+++.+||+.||++|||+.++++
T Consensus 243 --~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 --LT--PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --SS--GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --CC--ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 1112334667888899999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.35 Aligned_cols=249 Identities=26% Similarity=0.344 Sum_probs=199.3
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC---CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL---KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
...|.+.++||+|+||+||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 345677889999999999999965 6899999998653 234578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC---CceEEeeccCc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED---FCPKISDFGLA 354 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~DFGla 354 (511)
||+++++|.+++... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.+ +.+||+|||++
T Consensus 101 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 101 ELYTGGELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp CCCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999988543 3689999999999999999999998 99999999999999754 47999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
......... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ...+.+.+....
T Consensus 172 ~~~~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~ 238 (287)
T 2wei_A 172 TCFQQNTKM---KDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGK 238 (287)
T ss_dssp GTBCCCSSC---SCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCC
T ss_pred eeecCCCcc---ccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCC
Confidence 876544321 23348899999999854 57899999999999999999999986431 222333333321
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ..+ .+....+...+.+++.+||+.||++|||++++++
T Consensus 239 ~-~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 Y-AFD---LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C-CCC---SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCC---chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1 100 0111122345667888899999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.09 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=191.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeec-----CeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEK-----KKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 276 (511)
|.+.+.||+|+||+||+|... +|+.||||+++.... ...++.+|+.++++++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 456788999999999999965 689999999975432 235788999999999999999999987654 678999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp ECCCS-EEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EeccC-ccHHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99995 699999853 3589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCcee--------eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 357 TEKKESFI--------SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 357 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
........ ......||+.|+|||++... ..++.++||||||+++|+|++|+.||..... .+.+ .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~-~ 233 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDY------RHQL-L 233 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH-H
T ss_pred cccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHH-H
Confidence 65332111 12234689999999987543 4688999999999999999999999864321 1111 0
Q ss_pred HHhhhh----------------------ccccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 QIETEY----------------------DFQLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 ~~~~~~----------------------~~~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+.... ......... .........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 000000000 000123345678889999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=327.23 Aligned_cols=259 Identities=24% Similarity=0.284 Sum_probs=195.6
Q ss_pred HHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC-----------CcceeeeeceEeec
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS-----------HVNIVPFLGFCYEK 270 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 270 (511)
..|.+.++||+|+||+||+|.+ .+++.||||++.......+.+.+|+.++.++. |+||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 3566788999999999999995 47899999999865555577889999999886 88999999998765
Q ss_pred C----eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-----
Q 040808 271 K----KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD----- 341 (511)
Q Consensus 271 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~----- 341 (511)
+ ..++|||++ +++|.+++.... ...+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhh----ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 4 789999999 999999996543 245899999999999999999999952 899999999999994
Q ss_pred -CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCC
Q 040808 342 -EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420 (511)
Q Consensus 342 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~ 420 (511)
.++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 45589999999998765432 244699999999999764 6789999999999999999999999754321111
Q ss_pred CchHHHHHHHhhhhccc-----------------------c-C-CCCC---------hHHHHHHHHHHHHHHhccccCCC
Q 040808 421 YFPNAIYKQIETEYDFQ-----------------------L-D-GVVT---------EEEKEMAKKMILVSLWCIQTHPP 466 (511)
Q Consensus 421 ~~~~~~~~~~~~~~~~~-----------------------~-~-~~~~---------~~~~~~~~~~~~l~~~Cl~~~p~ 466 (511)
...+. ...+....... . . ...+ .........+.+++.+||+.||+
T Consensus 245 ~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 245 KDDDH-IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp CHHHH-HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred ChHHH-HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 11111 11111100000 0 0 0000 00124556788899999999999
Q ss_pred CCCCHHHHHH
Q 040808 467 DRPSMTKVVE 476 (511)
Q Consensus 467 ~RPs~~evl~ 476 (511)
+|||++||++
T Consensus 324 ~Rpt~~ell~ 333 (373)
T 1q8y_A 324 KRADAGGLVN 333 (373)
T ss_dssp TCBCHHHHHT
T ss_pred ccCCHHHHhh
Confidence 9999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=323.44 Aligned_cols=252 Identities=24% Similarity=0.340 Sum_probs=192.6
Q ss_pred HhhhcccCCcCceEEEEEEc--CCCcEEEEEEeccCCC---ChHHHHHHHHHHHcc---CCcceeeeeceEe-----ecC
Q 040808 205 KSFSDKLGQGGYADVYKGTL--PDGRLVAVKVMKNLKD---NGEEFINEVASISRT---SHVNIVPFLGFCY-----EKK 271 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~~ 271 (511)
|.+.+.||+|+||+||+|.+ .+|+.||+|+++.... ....+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 45678999999999999996 3688999999874322 234677788777766 8999999999987 566
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
..++||||++ |+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred eEEEEEecCC-CCHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 8899999996 69999996543 24589999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||.... .......+.
T Consensus 165 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~ 232 (326)
T 1blx_A 165 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSS-------DVDQLGKIL 232 (326)
T ss_dssp CSCCCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHH
T ss_pred cccccccCCCC---ccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHH
Confidence 99987654332 2345689999999999653 68899999999999999999999986432 111111111
Q ss_pred hhhccc------c-------------CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 TEYDFQ------L-------------DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 ~~~~~~------~-------------~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...... . ..............+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 110000 0 00000001122345667888999999999999999984
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.70 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=182.3
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCCh---HHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
.+.+.++||+|+||+||+|.. .+|+.||+|+++...... +.+.++...++.++||||+++++++.+.+..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 355678999999999999995 478999999997543222 2344555568888999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++ |+|.+++.... .....+++..++.|+.|++.||+|||++ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 88 MD-TSLDKFYKQVI--DKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CS-EEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hc-cchHHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 96 69888875432 1235799999999999999999999984 2899999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhccc--ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCR--HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
... .....||+.|+|||++.. ....++.++||||||+++|+|++|+.|+..... -...+...+.......
T Consensus 163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCCCC
T ss_pred ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCCCc
Confidence 432 123369999999999731 123678899999999999999999999863211 1111222222211111
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ...+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 PADKF-------SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CTTTS-------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccccC-------CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11122 334667888899999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=332.41 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=175.4
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeec------CeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEK------KKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 274 (511)
|.+.+.||+|+||.||+|.+ .+|+.||||++...... .+++.+|+.++++++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 45678899999999999985 46899999999754332 35788999999999999999999998654 5679
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+|+|++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 111 lv~e~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp EEEECC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEeccc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 999999 7899888842 4689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+..... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... .+. ...+....
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~-l~~i~~~~ 246 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQ-LKLILRLV 246 (367)
T ss_dssp ----------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHH-HHHHHHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHHHh
Confidence 876432 2345699999999998653 3678999999999999999999999864321 111 11111100
Q ss_pred cc----ccCCCCChHHH-------------------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DF----QLDGVVTEEEK-------------------EMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~----~~~~~~~~~~~-------------------~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ......+.... .....+.+++.+||+.||++|||++++++
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00 00000000000 11234667888999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.72 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=198.9
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC----h--------------HHHHHHHHHHHccCCcceeeeec
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN----G--------------EEFINEVASISRTSHVNIVPFLG 265 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~--------------~~~~~E~~~l~~l~h~niv~l~~ 265 (511)
.|.+.+.||+|+||.||+|.. +|+.||+|++...... . +.+.+|+.++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345678999999999999998 8999999998743211 1 78999999999999999999999
Q ss_pred eEeecCeEEEEEEeCCCCCHHHHHhccc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCEEEcC
Q 040808 266 FCYEKKKRALIYEFMPNGSLDQYIYDHE--SSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIRLDE 342 (511)
Q Consensus 266 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NIll~~ 342 (511)
++.+.+..++||||+++|+|.+++.... .......+++..++.++.|++.||+|||+ . +|+||||||+|||++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 9999999999999999999999832111 01114679999999999999999999998 7 9999999999999999
Q ss_pred CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCc-cccchhHHHHHHHHHhCCCCCCCccCCCCCC
Q 040808 343 DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSH-KSDVYSYGMMIHEMVIGRKNADVKVSCSSEY 421 (511)
Q Consensus 343 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~sDvwSlG~il~elltg~~p~~~~~~~~~~~ 421 (511)
++.+||+|||++...... ......||+.|+|||.+.+. ..++. ++||||||+++|||++|+.||.....
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 257 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS----- 257 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-----
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-----
Confidence 999999999999876543 22355699999999998653 23445 99999999999999999999964321
Q ss_pred chHHHHHHHhhhhccccCCC--------C----ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 422 FPNAIYKQIETEYDFQLDGV--------V----TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~--------~----~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.......+.... ...+.. . ..........+.+++.+||+.||++|||+.++++
T Consensus 258 -~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 -LVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -SHHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122222222221 111100 0 0000223345677888999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=320.15 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=190.5
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHccC--CcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---GEEFINEVASISRTS--HVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||.||++...+++.||+|++...... .+.+.+|+.++.+++ |+||+++++++.+....++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 4567899999999999999888999999999754332 367899999999997 5999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+.+++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++ +.+||+|||+++....
T Consensus 109 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 109 CGNIDLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp CCSEEHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 5689999999643 4689999999999999999999998 9999999999999975 8999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccc---------cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRH---------FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
...........||+.|+|||.+... ...++.++||||||+++|||++|+.||..... ....+...+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~ 253 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 253 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHH
Confidence 4332222344699999999998541 13578899999999999999999999863311 111122222
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
........+...+ ..+.+++.+||+.||++|||++++++.
T Consensus 254 ~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 254 DPNHEIEFPDIPE-------KDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CTTSCCCCCCCSC-------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccCCcccch-------HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2222222222222 346677788999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=332.73 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=188.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeE------E
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKR------A 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------~ 274 (511)
|.+.++||+|+||+||+|.+. +|+.||||++...... .+++.+|+.++++++||||+++++++...+.. +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 445678999999999999855 6899999999764333 35788999999999999999999999876654 9
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+. ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 124 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp EEEECCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEcccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 9999996 78988772 3489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+...... ....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||.... ..+.+ ..+....
T Consensus 192 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~-~~i~~~~ 258 (371)
T 4exu_A 192 RHADAEM-----TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQL-TQILKVT 258 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHH-HHHHHHH
T ss_pred cccccCc-----CCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------hHHHH-HHHHHHh
Confidence 8664332 345689999999998653 368899999999999999999999996432 11111 1111100
Q ss_pred cc-------------------ccCCCCChH----HHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 435 DF-------------------QLDGVVTEE----EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 435 ~~-------------------~~~~~~~~~----~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
.. .+....... .......+.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000000000 01123456778889999999999999999853
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=353.08 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=201.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
..+.+.+.||+|+||+||+|.+.. +..||+|+++.... ..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence 345677899999999999998642 46799999875432 23678999999999999999999999854 568999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 469 ~E~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 469 MELCTLGELRSFLQVR-----KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EECCTTCBHHHHHHHT-----TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEcCCCCcHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999643 24689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
........ .....+|+.|+|||++... .++.++||||||+++|||++ |+.||.... ...+...+.....
T Consensus 541 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-------~~~~~~~i~~~~~ 610 (656)
T 2j0j_A 541 MEDSTYYK-ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGER 610 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHHTCC
T ss_pred cCCCccee-ccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCCC
Confidence 75443221 2234578899999999653 78999999999999999997 888886331 2333444444433
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+...+ ..+.+++.+||+.||++|||+.+|+++|+.+++
T Consensus 611 ~~~~~~~~-------~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 LPMPPNCP-------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccc-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 33333333 346678888999999999999999999998654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.60 Aligned_cols=254 Identities=20% Similarity=0.254 Sum_probs=188.2
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecC------eEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKK------KRALIY 277 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 277 (511)
+|.+.++||+|+||+||+|.+..+..||+|++...... ..+|++++++++||||+++++++.... ..++||
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 35677899999999999999877677999988654322 236999999999999999999996543 378999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-CCCceEEeeccCccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD-EDFCPKISDFGLAKQ 356 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~DFGla~~ 356 (511)
||++++ +.+.+.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 118 e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 118 EYVPET-VYRASRHYA--KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp ECCSEE-HHHHHHHHH--HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eccCcc-HHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999764 444433211 1235799999999999999999999998 999999999999999 799999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh---
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE--- 433 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 433 (511)
....... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... .+.+...+...
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~l~~i~~~~g~p 261 (394)
T 4e7w_A 192 LIAGEPN---VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESG------IDQLVEIIKVLGTP 261 (394)
T ss_dssp CCTTCCC---CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCC
T ss_pred ccCCCCC---cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCC
Confidence 7544432 245689999999998653 3588999999999999999999999964321 11111111100
Q ss_pred ------------hccccCCCCChHHH-----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 434 ------------YDFQLDGVVTEEEK-----EMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 434 ------------~~~~~~~~~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....+........ .....+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000000000 12345777888999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=330.56 Aligned_cols=198 Identities=23% Similarity=0.287 Sum_probs=167.4
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccC-Cc-----ceeeeeceEeecCeEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTS-HV-----NIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv 276 (511)
.|.+.++||+|+||+||+|.+. +++.||||+++......+++.+|+.++..++ |+ +|+++++++...+..++|
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 4566789999999999999865 6889999999865544567788999988875 44 499999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc--CCCceEEeeccCc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD--EDFCPKISDFGLA 354 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla 354 (511)
|||++ |+|.+++.... ...+++..+..++.|++.||+|||.+ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 135 ~e~~~-~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 135 FEMLS-YNLYDLLRNTN----FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EECCC-CBHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EecCC-CCHHHHHhhcC----cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99995 69999996533 24589999999999999999999952 23899999999999994 5788999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 8775432 245699999999999764 6889999999999999999999999643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=318.35 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=185.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEe--------------
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCY-------------- 268 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-------------- 268 (511)
|.+.+.||+|+||+||+|... +++.||+|++.... ...+++.+|+.++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 456788999999999999966 58999999987543 23467899999999999999999998873
Q ss_pred ecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-CCCceE
Q 040808 269 EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD-EDFCPK 347 (511)
Q Consensus 269 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~k 347 (511)
+....++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+|
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccCceeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 4468899999996 699999832 4589999999999999999999998 999999999999997 577999
Q ss_pred EeeccCccccCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHH
Q 040808 348 ISDFGLAKQTEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI 426 (511)
Q Consensus 348 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 426 (511)
|+|||+++........ .......+|+.|+|||.+.+. ..++.++||||||+++|||++|+.||..... ...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~ 233 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-------LEQ 233 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-------HHH
Confidence 9999999876432211 112234579999999998543 3688999999999999999999999964321 111
Q ss_pred HHHHhhhhcc-------------------cc-CCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 427 YKQIETEYDF-------------------QL-DGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 427 ~~~~~~~~~~-------------------~~-~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...+...... .. ....+ .........+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111111000 00 00000 000123456778899999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=332.12 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=187.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeec------CeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 277 (511)
|.+.+.||+|+||+||+|.+. +|+.||||++..... .+.+|++++++++||||+++++++... ...++||
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 132 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeeh
Confidence 456788999999999999965 699999999875432 234799999999999999999988542 2467999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-CceEEeeccCccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQ 356 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~DFGla~~ 356 (511)
||+++ +|.+.+.... .....+++..+..++.||+.||+|||+. +|+||||||+||||+.+ +.+||+|||+++.
T Consensus 133 e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 133 DYVPE-TVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp ECCCE-EHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred hcccc-cHHHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 99965 6766664322 1235799999999999999999999998 99999999999999955 6789999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh----
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET---- 432 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 432 (511)
....... ....||+.|+|||++.+. ..++.++|||||||++|||++|+.||..... .+.+.+.+..
T Consensus 207 ~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~------~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 207 LVRGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTP 276 (420)
T ss_dssp CCTTCCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCSC
T ss_pred cccCCCc---eeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCC
Confidence 6544332 245689999999998653 3678999999999999999999999864321 1111111110
Q ss_pred -------h----hccccCCCCChHH-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 433 -------E----YDFQLDGVVTEEE-----KEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 433 -------~----~~~~~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ..+.++....... ......+.+++.+||+.||++|||+.|+++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 0000000000000 012245677888899999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=322.66 Aligned_cols=199 Identities=20% Similarity=0.328 Sum_probs=169.7
Q ss_pred HHHHHhhhcccCCcCceEEEEEEcC-CC-cEEEEEEeccCCCChHHHHHHHHHHHccCCcc------eeeeeceEeecCe
Q 040808 201 RRMTKSFSDKLGQGGYADVYKGTLP-DG-RLVAVKVMKNLKDNGEEFINEVASISRTSHVN------IVPFLGFCYEKKK 272 (511)
Q Consensus 201 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 272 (511)
....|.+.++||+|+||+||+|... ++ +.||+|+++......+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3445677889999999999999864 34 78999999865555677889999999998766 8999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEE------------
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL------------ 340 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll------------ 340 (511)
.++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred EEEEEecc-CCChHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 99999999 777777775432 24689999999999999999999998 99999999999999
Q ss_pred -------cCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 040808 341 -------DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADV 413 (511)
Q Consensus 341 -------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~ 413 (511)
+.++.+||+|||+++...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 668899999999998754432 245699999999999653 688999999999999999999999964
Q ss_pred c
Q 040808 414 K 414 (511)
Q Consensus 414 ~ 414 (511)
.
T Consensus 242 ~ 242 (355)
T 2eu9_A 242 H 242 (355)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=334.62 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=183.2
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||+ +|+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~-~gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC-SEEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC-CCCHH
Confidence 4679999999998776668999999998753 245678999999876 8999999999999999999999999 57999
Q ss_pred HHHhcccCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCC-------------CceEEeecc
Q 040808 287 QYIYDHESSNGK-RTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-------------FCPKISDFG 352 (511)
Q Consensus 287 ~~l~~~~~~~~~-~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~-------------~~~kl~DFG 352 (511)
+++......... ....+..++.|+.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999754321111 1123345678999999999999998 99999999999999754 489999999
Q ss_pred CccccCCCCcee--eecCCCCCCCccchhhcccc-----cCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchH
Q 040808 353 LAKQTEKKESFI--SMLDTRGTAGYIAPEVFCRH-----FGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPN 424 (511)
Q Consensus 353 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 424 (511)
+++......... ......||+.|+|||++.+. ...++.++|||||||++|||++ |+.||..... ..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~ 247 (434)
T 2rio_A 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS------RE 247 (434)
T ss_dssp TCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT------HH
T ss_pred cceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh------hH
Confidence 998876543221 12245699999999998641 2467899999999999999998 8988853211 11
Q ss_pred HHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 425 AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...+...... ..............+.+++.+||+.||++|||+.+|++
T Consensus 248 --~~i~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHTCCCC--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcCCCCc--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111111111 11111112345567788999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=320.74 Aligned_cols=243 Identities=24% Similarity=0.360 Sum_probs=188.4
Q ss_pred HHHHHHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-------ChHHHHHHHHHHHcc----CCcceeeeece
Q 040808 199 DVRRMTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-------NGEEFINEVASISRT----SHVNIVPFLGF 266 (511)
Q Consensus 199 e~~~~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~~~ 266 (511)
+.....|.+.++||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++.++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34455677889999999999999985 4689999999975432 223456799999998 89999999999
Q ss_pred EeecCeEEEEEEe-CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-CCC
Q 040808 267 CYEKKKRALIYEF-MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD-EDF 344 (511)
Q Consensus 267 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~-~~~ 344 (511)
+.+.+..++|||+ +++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++ +++
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 9999999999999 7899999999642 3589999999999999999999998 999999999999999 899
Q ss_pred ceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchH
Q 040808 345 CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPN 424 (511)
Q Consensus 345 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~ 424 (511)
.+||+|||+++....... ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||... .
T Consensus 178 ~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~---------~ 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERD---------Q 243 (312)
T ss_dssp EEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------H
T ss_pred eEEEEEcchhhhcccCcc----cccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCCh---------H
Confidence 999999999987755432 345699999999998653 23356899999999999999999998532 1
Q ss_pred HHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 425 AIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. +.. .........+ ..+.+++.+||+.||++|||++|+++
T Consensus 244 ~----~~~-~~~~~~~~~~-------~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 E----ILE-AELHFPAHVS-------PDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H----HHH-TCCCCCTTSC-------HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred H----Hhh-hccCCcccCC-------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111 1122222333 34567778899999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=326.54 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=187.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCe------EE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKK------RA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 274 (511)
|.+.+.||+|+||+||+|.+. +|+.||||++...... .+++.+|+.++++++||||+++++++.+... .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 455678999999999999964 6899999999764332 3578899999999999999999999987653 49
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||++ ++|.+++. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 106 lv~e~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp EEEECCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEecccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 9999996 68877762 3589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+...... ....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||..... .+. ...+....
T Consensus 174 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~-~~~i~~~~ 240 (353)
T 3coi_A 174 RHADAEM-----TGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQ-LTQILKVT 240 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH------HHH-HHHHHHHH
T ss_pred cCCCCCc-----cccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH-HHHHHHHh
Confidence 8654332 244689999999998653 3678999999999999999999999864321 111 11111100
Q ss_pred c-----------------------cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 D-----------------------FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~-----------------------~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. .................+.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000011111122345677888899999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=322.55 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=168.3
Q ss_pred Hhhh-cccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEee----cCeEEEEEE
Q 040808 205 KSFS-DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE----KKKRALIYE 278 (511)
Q Consensus 205 ~~~~-~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e 278 (511)
|.+. +.||+|+||+||+|.++ +|+.||||++..... ...+....+..+.||||+++++++.. ....++|||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 4453 46999999999999965 699999999975322 22222334566789999999999876 456899999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCcc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAK 355 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~ 355 (511)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 107 ~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 107 CMEGGELFSRIQERG----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp CCTTEEHHHHHHTC-----CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred ccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999996532 24699999999999999999999998 9999999999999976 4569999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
...... .....||+.|+|||++.. ..++.++||||||+++|+|++|+.||....... ........+....
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~- 249 (336)
T 3fhr_A 180 ETTQNA----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA---ISPGMKRRIRLGQ- 249 (336)
T ss_dssp EC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred eccccc----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchh---hhhhHHHhhhccc-
Confidence 665332 124468999999999854 367889999999999999999999986432111 1011111111110
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH--Hhhc
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE--MLEG 480 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~--~L~~ 480 (511)
.... .+........+.+++.+||+.||++|||++++++ .+.+
T Consensus 250 ~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 YGFP---NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -CCC---TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccC---chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0001 0001122334667778899999999999999997 4444
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=322.49 Aligned_cols=239 Identities=23% Similarity=0.329 Sum_probs=194.3
Q ss_pred HHHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-------ChHHHHHHHHHHHccC--CcceeeeeceEeecCe
Q 040808 203 MTKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-------NGEEFINEVASISRTS--HVNIVPFLGFCYEKKK 272 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 272 (511)
..|.+.+.||+|+||+||+|.. .+++.||||+++.... ..+.+.+|+.++++++ |+||+++++++.+.+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 3456778999999999999985 4689999999975432 2256778999999997 5999999999999999
Q ss_pred EEEEEEeCCC-CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc-CCCceEEee
Q 040808 273 RALIYEFMPN-GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD-EDFCPKISD 350 (511)
Q Consensus 273 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~D 350 (511)
.++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++ +++.+||+|
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEEEcCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999976 8999999642 4689999999999999999999998 999999999999999 789999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
||+++....... ....||+.|+|||++.+. ...+.++||||||+++|||++|+.||.... . +
T Consensus 194 fg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~----~ 255 (320)
T 3a99_A 194 FGSGALLKDTVY----TDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------E----I 255 (320)
T ss_dssp CTTCEECCSSCB----CCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H----H
T ss_pred Cccccccccccc----cCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChh---------h----h
Confidence 999987754322 345699999999998653 234788999999999999999999985321 1 1
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
... ........+ ..+.+++.+||+.||++|||+++|++
T Consensus 256 ~~~-~~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IRG-QVFFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHC-CCCCSSCCC-------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcc-cccccccCC-------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 112223333 34667788899999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=322.19 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=172.8
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC--hHHHHHHHH-HHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN--GEEFINEVA-SISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.+.+.||+|+||.||+|..+ +|+.||||+++..... ..++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 45678999999999999965 6899999999764322 245666666 6777899999999999999999999999996
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
|+|.+++..... .....+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 105 -~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 105 -TSFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp -EEHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred -CChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 588888753221 1235789999999999999999999984 389999999999999999999999999998765433
Q ss_pred ceeeecCCCCCCCccchhhccc--ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCR--HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
. .....||+.|+|||++.. ....++.++||||||+++|+|++|+.||...... .+. ...+.......+.
T Consensus 181 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~-~~~~~~~~~~~~~ 251 (327)
T 3aln_A 181 A---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQ-LTQVVKGDPPQLS 251 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCCC
T ss_pred c---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHH-HHHHhcCCCCCCC
Confidence 2 123369999999999832 1235788999999999999999999998642110 000 0001111101111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ........+.+++.+||+.||++|||+.++++
T Consensus 252 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NS---EEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC---SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Cc---ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 10 00112345777888999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.09 Aligned_cols=249 Identities=21% Similarity=0.296 Sum_probs=175.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCCh---HHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||+||+|.+. +|+.||||++....... +.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 345678999999999999965 68999999997653322 23444556788889999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR-GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++.+..+.... ...+++..+..++.|++.||+|||+ . +|+|+||||+|||++.++.+||+|||++.....
T Consensus 107 -~~~~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 107 -GTCAEKLKKRM-----QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp -SEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred -CCcHHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 66666555332 2468999999999999999999998 4 899999999999999999999999999976654
Q ss_pred CCceeeecCCCCCCCccchhhccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCR---HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
... .....||+.|+|||++.. ....++.++||||||+++|||++|+.||.... ........+......
T Consensus 178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~ 248 (318)
T 2dyl_A 178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK------TDFEVLTKVLQEEPP 248 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHHSCCC
T ss_pred Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC------ccHHHHHHHhccCCC
Confidence 332 123469999999999853 12367889999999999999999999986421 112222222222211
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+.. ......+.+++.+||+.||++|||++++++
T Consensus 249 ~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 LLPGH-----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCSS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc-----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11110 012234667788899999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.73 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=180.6
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
+.+.+.||+|+||+||.....+|+.||||++.... .+.+.+|+++++++ +|||||++++++.+....++||||++ |
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 45567899999999766555678999999986532 23466899999999 79999999999999999999999995 6
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-----CCceEEeeccCccccC
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-----DFCPKISDFGLAKQTE 358 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DFGla~~~~ 358 (511)
+|.+++.... ..+.+..+..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++...
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 103 TLQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EHHHHHHSSS-----CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CHHHHHHhcC-----CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 9999996533 2344445678999999999999998 9999999999999953 3368899999998775
Q ss_pred CCCc-eeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 359 KKES-FISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 359 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
.... ........||+.|+|||++.+. ....+.++|||||||++|||++ |+.|+.... .... ..+.....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-------~~~~-~~~~~~~~ 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-------QRQA-NILLGACS 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-------THHH-HHHTTCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-------HHHH-HHHhccCC
Confidence 4321 1223345699999999998642 2356789999999999999999 888874321 1111 11111111
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
. ...... ......+.+++.+||+.||++|||+++|+
T Consensus 247 ~--~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 247 L--DCLHPE--KHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp C--TTSCTT--CHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred c--cccCcc--ccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 1 111111 12223456788999999999999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=343.91 Aligned_cols=238 Identities=21% Similarity=0.281 Sum_probs=190.6
Q ss_pred HHHhhhcccCCcCceEEEEEEcC--CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCe-----E
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP--DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKK-----R 273 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 273 (511)
..|.+.++||+|+||+||+|.+. +|+.||||++..... ..+.+.+|+.++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 34667889999999999999965 689999999875432 23578899999999999999999999987655 7
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||+++++|.+++. ..+++..++.|+.||+.||+|||++ +|+||||||+|||++++ .+||+|||+
T Consensus 160 ~lv~E~~~g~~L~~~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEECCCCEECC------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 99999999999988762 2689999999999999999999998 99999999999999986 899999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhh
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE 433 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 433 (511)
++..... ....||++|+|||++.+ ..+.++||||||+++|+|++|..|+....... .+
T Consensus 228 a~~~~~~------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---~~---------- 285 (681)
T 2pzi_A 228 VSRINSF------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---LP---------- 285 (681)
T ss_dssp CEETTCC------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---CC----------
T ss_pred chhcccC------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc---cc----------
Confidence 9876543 23469999999999865 34889999999999999999988775321100 00
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhccc
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-SMTKVVEMLEGSI 482 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~ 482 (511)
...........+..++.+||+.||++|| +++++.+.|.+.+
T Consensus 286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0011122334577888999999999999 5777777777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=307.54 Aligned_cols=232 Identities=11% Similarity=0.070 Sum_probs=178.9
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
.-.|.+.+.||+|+||.||+|.+. +++.||||++...... .+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 345677889999999999999965 5899999999865433 26789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++++|.+++.. ......+..|+.|++.||+|||++ +|+||||||+|||+++++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~--------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT--------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EECCCEEEHHHHHTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEecCCCCHHHHHhc--------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 999999999999832 134556888999999999999998 99999999999999999999997443
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
|++ .++.++||||||+++|||++|+.||............. +.+....
T Consensus 175 ------------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~-- 222 (286)
T 3uqc_A 175 ------------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQP-- 222 (286)
T ss_dssp ------------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSCB--
T ss_pred ------------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccCC--
Confidence 333 35789999999999999999999997543211000000 0000000
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
. ........+...+.+++.+||+.||++| |+.|++++|+.....
T Consensus 223 ~---~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 I---EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp C---CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred C---ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0 0000001223446678888999999999 999999999986644
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.48 Aligned_cols=240 Identities=17% Similarity=0.138 Sum_probs=173.9
Q ss_pred hhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC----CChHHHHHHHHHHHccCC-ccee---------------eee-
Q 040808 207 FSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK----DNGEEFINEVASISRTSH-VNIV---------------PFL- 264 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h-~niv---------------~l~- 264 (511)
..+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+.++..++| +|.. .+.
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 456899999999999994 479999999988332 234689999999999987 2211 111
Q ss_pred -----ceEee-----cCeEEEEEEeCCCCCHHHHHhcccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCC
Q 040808 265 -----GFCYE-----KKKRALIYEFMPNGSLDQYIYDHES-SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDI 333 (511)
Q Consensus 265 -----~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dl 333 (511)
.++.. ....+++|+++ +++|.+++..... ......+++..++.|+.||+.||+|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 11111 12456777766 7899999853210 12235688999999999999999999998 9999999
Q ss_pred CCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhccc--------ccCCCCccccchhHHHHHHHHH
Q 040808 334 KPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR--------HFGGVSHKSDVYSYGMMIHEMV 405 (511)
Q Consensus 334 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~s~~sDvwSlG~il~ell 405 (511)
||+||||+.++.+||+|||+++..... .....| +.|+|||++.. ....++.++|||||||++|||+
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999875433 234567 99999999832 1125778999999999999999
Q ss_pred hCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 040808 406 IGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 406 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
+|+.||........ .. .+ +.....++ ..+.+++.+||+.||++|||+.+++
T Consensus 312 tg~~Pf~~~~~~~~---~~----~~-----~~~~~~~~-------~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGG---SE----WI-----FRSCKNIP-------QPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSC---SG----GG-----GSSCCCCC-------HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhh---HH----HH-----HhhcccCC-------HHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999964321110 00 00 11111223 4467778889999999999966553
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=336.02 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=190.9
Q ss_pred HHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEee------cCeE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYE------KKKR 273 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 273 (511)
..|.+.++||+|+||+||+|.+. +|+.||||+++.... ..+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 34677889999999999999964 689999999875422 24678999999999999999999998765 6778
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCc---eEEee
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFC---PKISD 350 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~D 350 (511)
++||||+++|+|.+++.... ....+++..++.|+.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~---~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS---CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEeCCCCCHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 99999999999999996543 224688899999999999999999998 9999999999999997664 99999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCC--CCCchHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCS--SEYFPNAIYK 428 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~ 428 (511)
||+++........ ....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ..........
T Consensus 168 FG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 168 LGYAKELDQGELC---TEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCCCBTTSCCCC---CCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccccccc---ccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9999877554322 34569999999999865 378999999999999999999999986431000 0000000000
Q ss_pred H------Hhhhhcc----ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHH
Q 040808 429 Q------IETEYDF----QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTK 473 (511)
Q Consensus 429 ~------~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~e 473 (511)
. ......+ ..+.... ......+.+++.+||+.||++|||+.+
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~---~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLS---GILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCC---GGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhc---hhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0 0000000 0011111 224556778889999999999999977
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.77 Aligned_cols=223 Identities=21% Similarity=0.283 Sum_probs=172.8
Q ss_pred cccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHH-HccCCcceeeeeceEee----cCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASI-SRTSHVNIVPFLGFCYE----KKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 282 (511)
+.||+|+||.||++.. .+++.||+|+++. ...+.+|+.++ +..+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 6799999999999986 4689999999974 35677899888 56689999999999877 6788999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCccccCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLAKQTEK 359 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla~~~~~ 359 (511)
|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~~L~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 172 (299)
T 3m2w_A 100 GELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172 (299)
T ss_dssp CBHHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT
T ss_pred CcHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccccccc
Confidence 99999997532 24699999999999999999999998 9999999999999998 78999999999864321
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
..++.++||||||+++|||++|+.||....... ............ .
T Consensus 173 --------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------~~~~~~~~~~~~-~ 218 (299)
T 3m2w_A 173 --------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------ISPGMKTRIRMG-Q 218 (299)
T ss_dssp --------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCCSSCTT-C
T ss_pred --------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-------hhHHHHHHHhhc-c
Confidence 145678999999999999999999986432110 000000000000 0
Q ss_pred CCCC-hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVT-EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~-~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...+ .........+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111 111223455777888999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=306.56 Aligned_cols=241 Identities=15% Similarity=0.113 Sum_probs=182.2
Q ss_pred HHHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC---------ChHHHHHHHHHHHccC----------------
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD---------NGEEFINEVASISRTS---------------- 256 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~---------------- 256 (511)
...|.+.++||+|+||+||+|+. +|+.||||+++.... ..+.+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34567889999999999999998 679999999975421 2378899999999886
Q ss_pred ----------CcceeeeeceEee-------------cCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHH
Q 040808 257 ----------HVNIVPFLGFCYE-------------KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGI 313 (511)
Q Consensus 257 ----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i 313 (511)
||||+++++++.+ ....++||||+++|++.+.+.. ..+++..+..|+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHH
Confidence 4555555555544 6889999999999977666621 458999999999999
Q ss_pred HHHHHHHH-hCCCCCcEecCCCCCCEEEcCCC--------------------ceEEeeccCccccCCCCceeeecCCCCC
Q 040808 314 ARGLEYLH-RGCNIRIVHLDIKPHNIRLDEDF--------------------CPKISDFGLAKQTEKKESFISMLDTRGT 372 (511)
Q Consensus 314 ~~~l~yLH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt 372 (511)
+.||+||| +. +|+||||||+||||+.++ .+||+|||+|+..... ...||
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt 240 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC 240 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence 99999999 87 999999999999999887 8999999999876543 23599
Q ss_pred CCccchhhcccccCCCCccccchhHHHH-HHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHH
Q 040808 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMM-IHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAK 451 (511)
Q Consensus 373 ~~y~aPE~~~~~~~~~s~~sDvwSlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (511)
+.|+|||++.+. .+.++||||+|++ .+++++|..|+... .....+...+....... ..........+..
T Consensus 241 ~~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 241 DVSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK-TKCNTPAMKQIKR 310 (336)
T ss_dssp CCTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS-SCCCSHHHHHHHH
T ss_pred ecccChhhhcCC---CccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC-cccchhhhhhcCH
Confidence 999999999754 3889999998777 77788888876310 00011111221111111 1122334556777
Q ss_pred HHHHHHHhccccCCCCCCCHHHHH
Q 040808 452 KMILVSLWCIQTHPPDRPSMTKVV 475 (511)
Q Consensus 452 ~~~~l~~~Cl~~~p~~RPs~~evl 475 (511)
.+.+++.+||+.| |++|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8889999999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-32 Score=287.84 Aligned_cols=184 Identities=17% Similarity=0.128 Sum_probs=129.0
Q ss_pred ccCCcCceEEEEEE-cCCCcEEEEEEeccCC-----------CChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEE
Q 040808 210 KLGQGGYADVYKGT-LPDGRLVAVKVMKNLK-----------DNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 276 (511)
.++.|++|.+..++ .--|+.+|+|++.+.. .+.++|.+|+++|+++ +|+||+++++++++.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777776654 2357889999997532 1235799999999999 699999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||++|++|.++|... ..++.. +|+.||+.||+|+|++ |||||||||+||||+++|.+||+|||+|+.
T Consensus 321 MEyv~G~~L~d~i~~~------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EECCCSEEHHHHHHTT------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EecCCCCcHHHHHHhC------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCee
Confidence 9999999999999543 345543 5899999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCC
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN 410 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p 410 (511)
...... ......||++|+|||++.+ ....++|+||+|+++++|.++..+
T Consensus 389 ~~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CCCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence 754432 1234569999999999965 467789999999998887666433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-28 Score=255.97 Aligned_cols=184 Identities=18% Similarity=0.173 Sum_probs=144.6
Q ss_pred hcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC---------hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 208 SDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN---------GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.+.||+|+||+||+|.. .++.+++|........ .+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 46899999999999954 5688999986532211 2457899999999999999976666667778899999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999832 457999999999999998 9999999999999998 99999999999876
Q ss_pred CCCcee-----eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 040808 359 KKESFI-----SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411 (511)
Q Consensus 359 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~ 411 (511)
...... ......||+.|+|||++......++..+|+||..+-..+.+.++.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 533211 11234699999999999764346788899999999998888777654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-24 Score=208.60 Aligned_cols=141 Identities=16% Similarity=0.092 Sum_probs=115.4
Q ss_pred hhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC-------------------ChHHHHHHHHHHHccCCcceeeeeceE
Q 040808 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD-------------------NGEEFINEVASISRTSHVNIVPFLGFC 267 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~~ 267 (511)
+.+.||+|+||.||+|.+.+|+.||+|+++.... ....+.+|+.++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4588999999999999987799999999964321 1346889999999999 5 7777765
Q ss_pred eecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceE
Q 040808 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPK 347 (511)
Q Consensus 268 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~k 347 (511)
.. +..++||||+++|+|.+ +.. .....++.|++.||+|||+. +|+||||||+|||++ ++.+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEE
T ss_pred ec-cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEE
Confidence 44 55699999999999987 411 12446999999999999998 999999999999999 99999
Q ss_pred EeeccCccccCCCCceeeecCCCCCCCccchhhccc
Q 040808 348 ISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383 (511)
Q Consensus 348 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 383 (511)
|+|||+++. +..+.|||++.+
T Consensus 233 l~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp ECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEECCCCeE---------------CCCCCHHHHHHH
Confidence 999999863 345789999853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=9.1e-21 Score=182.74 Aligned_cols=133 Identities=20% Similarity=0.211 Sum_probs=103.6
Q ss_pred hhcccCCcCceEEEEEEc-CCCcE--EEEEEeccCCCC-------------------------hHHHHHHHHHHHccCCc
Q 040808 207 FSDKLGQGGYADVYKGTL-PDGRL--VAVKVMKNLKDN-------------------------GEEFINEVASISRTSHV 258 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~ 258 (511)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+.++.++.|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999997 67888 999997543111 12578899999999888
Q ss_pred ce--eeeeceEeecCeEEEEEEeCCC-C----CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcEe
Q 040808 259 NI--VPFLGFCYEKKKRALIYEFMPN-G----SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH-RGCNIRIVH 330 (511)
Q Consensus 259 ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH-~~~~~~iiH 330 (511)
++ ..+++. ...+|||||+.+ | +|.++... .++..+..++.|++.||+||| +. +|+|
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 64 333321 356899999942 4 77776522 223456789999999999999 77 9999
Q ss_pred cCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 331 LDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 331 ~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=3.1e-18 Score=172.21 Aligned_cols=136 Identities=13% Similarity=0.131 Sum_probs=96.2
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCC---------------ChHHHH--------HHHHHHHccCCccee
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD---------------NGEEFI--------NEVASISRTSHVNIV 261 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~~--------~E~~~l~~l~h~niv 261 (511)
|.+.++||.|+||.||+|...+|+.||||+++.... .....+ +|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456789999999999999998999999999763210 111222 355555555443332
Q ss_pred eeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 262 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
... .+. ....+|||||++|++|.++.. . .....++.|++.+|.|||+. +||||||||.|||++
T Consensus 177 vp~-p~~-~~~~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 177 VPE-PIA-QSRHTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CCC-EEE-EETTEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCe-eee-ccCceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 111 111 122379999999988865431 1 12356789999999999998 999999999999998
Q ss_pred CCC----------ceEEeeccCcccc
Q 040808 342 EDF----------CPKISDFGLAKQT 357 (511)
Q Consensus 342 ~~~----------~~kl~DFGla~~~ 357 (511)
+++ .+.|+||+.+-..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3899999987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.3e-12 Score=123.76 Aligned_cols=137 Identities=14% Similarity=0.034 Sum_probs=107.5
Q ss_pred hhcccCCcCceEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLK-DNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+...++.|+.+.||+.... ++.+++|+..... .....+.+|+++++.+. +..+.++++++.+.+..++|||+++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 4566888889999999854 6889999987522 23356889999999885 6678889999888889999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC---------------------------------------- 324 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~---------------------------------------- 324 (511)
|.+.+.. ......++.+++++|+.||+..
T Consensus 97 l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 97 CSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp HHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred hhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9876410 1123467889999999999810
Q ss_pred ----------------CCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 325 ----------------NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 325 ----------------~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-11 Score=118.46 Aligned_cols=130 Identities=18% Similarity=0.108 Sum_probs=98.3
Q ss_pred ccC-CcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc--eeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 210 KLG-QGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN--IVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 210 ~LG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
.++ .|..+.||+....+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++..+.+..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 354 55669999998777888999997653 3356788999999887555 456888887778899999999998883
Q ss_pred HHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 040808 287 QYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC------------------------------------------ 324 (511)
Q Consensus 287 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------ 324 (511)
.. ... ...++.++++.|+.||+..
T Consensus 104 --~~---------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 104 --SS---------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp --TS---------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred --cC---------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 21 111 2256777888888888742
Q ss_pred -------------CCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 325 -------------NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 325 -------------~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
...++|+|++|.|||+++++.+.|+|||.+.
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887777799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=116.94 Aligned_cols=141 Identities=15% Similarity=0.161 Sum_probs=105.9
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEec--cCC--CChHHHHHHHHHHHccC--CcceeeeeceEeec---CeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMK--NLK--DNGEEFINEVASISRTS--HVNIVPFLGFCYEK---KKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 279 (511)
+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 568999999999998754 678888776 322 22356788999999987 45578888888766 458899999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC----------------------------------- 324 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~----------------------------------- 324 (511)
++|..+.+.. ...++......++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~--------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 123 VSGRVLWDQS--------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCBCCCCTT--------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred cCCeecCCCc--------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9987774311 134678888899999999999999721
Q ss_pred --------------------CCCcEecCCCCCCEEEcCCCc--eEEeeccCccccC
Q 040808 325 --------------------NIRIVHLDIKPHNIRLDEDFC--PKISDFGLAKQTE 358 (511)
Q Consensus 325 --------------------~~~iiH~Dlkp~NIll~~~~~--~kl~DFGla~~~~ 358 (511)
...++|+|+++.|||++.++. +.|+||+.+....
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 247999999999999997753 6899999987543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=3.2e-10 Score=111.35 Aligned_cols=187 Identities=20% Similarity=0.206 Sum_probs=119.7
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccC-Ccc--eeeeeceEeecC---eEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVN--IVPFLGFCYEKK---KRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~ 282 (511)
+.++.|....||+.. +.+++|+.... .....+.+|++++..+. +.. +.+++....... ..++|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 358889999999753 45889986532 23467889999998884 332 334443332322 35789999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC-------------------------------------- 324 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------- 324 (511)
.+|.+... ..++......++.+++..++.||+..
T Consensus 101 ~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 101 VPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred eECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 88865331 24666777788888888888888611
Q ss_pred -----------------CCCcEecCCCCCCEEEcC--CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcc---
Q 040808 325 -----------------NIRIVHLDIKPHNIRLDE--DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC--- 382 (511)
Q Consensus 325 -----------------~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--- 382 (511)
...++|+|++|.||++++ +..+.|+||+.+............. ....-..|+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~---~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLM---EDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTC---CTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHH---hhccccCHHHHHHHH
Confidence 135899999999999998 5668899999987643321111000 000002222211
Q ss_pred cccCC---------CCccccchhHHHHHHHHHhCCCCC
Q 040808 383 RHFGG---------VSHKSDVYSYGMMIHEMVIGRKNA 411 (511)
Q Consensus 383 ~~~~~---------~s~~sDvwSlG~il~elltg~~p~ 411 (511)
..++. .....+.|++|.++|.+.+|..++
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11111 112358999999999999998553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=6.3e-07 Score=87.85 Aligned_cols=136 Identities=17% Similarity=0.132 Sum_probs=91.8
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCc---ceeeeeceEe-ecCeEEEEEEeCCCCC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV---NIVPFLGFCY-EKKKRALIYEFMPNGS 284 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gs 284 (511)
+.++.|....||+. |+.+++|+-.. ......+.+|+++|..+.+. .+.+++.+.. ..+..++|||+++|.+
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 35778888899987 46688888532 22346788999999999753 2445555553 3456789999999988
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG----------------------------------------- 323 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~----------------------------------------- 323 (511)
|.+... ..++......++.++++.|+.||+.
T Consensus 100 l~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 100 LGEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CHHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred Cchhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 865321 1233444445555555555555542
Q ss_pred ----------------CCCCcEecCCCCCCEEEcC---CCc-eEEeeccCcccc
Q 040808 324 ----------------CNIRIVHLDIKPHNIRLDE---DFC-PKISDFGLAKQT 357 (511)
Q Consensus 324 ----------------~~~~iiH~Dlkp~NIll~~---~~~-~kl~DFGla~~~ 357 (511)
....++|+|++|.|||+++ ++. +.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 455 489999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1e-06 Score=84.34 Aligned_cols=134 Identities=16% Similarity=0.100 Sum_probs=94.2
Q ss_pred cCCcCc-eEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCCCCHHH
Q 040808 211 LGQGGY-ADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQ 287 (511)
Q Consensus 211 LG~G~~-g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 287 (511)
+..|.. +.||+.... +++.+.+|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 333433 479988755 4678999986532 3456788999998875 3346678888888899999999999988876
Q ss_pred HHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 040808 288 YIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC------------------------------------------- 324 (511)
Q Consensus 288 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~------------------------------------------- 324 (511)
...... .....+..+++..|+-||+..
T Consensus 110 ~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 110 VLEEYP----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHCG----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccCCH----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 652211 122345556666666666310
Q ss_pred ------------CCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 325 ------------NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 325 ------------~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
...++|+|+++.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.1e-06 Score=87.80 Aligned_cols=78 Identities=6% Similarity=-0.038 Sum_probs=54.4
Q ss_pred ccc-CCcCceEEEEEEcC-------CCcEEEEEEeccCC---C-ChHHHHHHHHHHHccCC---cceeeeeceEeec---
Q 040808 209 DKL-GQGGYADVYKGTLP-------DGRLVAVKVMKNLK---D-NGEEFINEVASISRTSH---VNIVPFLGFCYEK--- 270 (511)
Q Consensus 209 ~~L-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~--- 270 (511)
+.| +.|....+|+.... +++.+++|+-.... . ....+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999988754 26778999865432 1 12467788888887753 3466777776554
Q ss_pred CeEEEEEEeCCCCCHH
Q 040808 271 KKRALIYEFMPNGSLD 286 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~ 286 (511)
+..++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.9e-05 Score=77.95 Aligned_cols=142 Identities=13% Similarity=0.113 Sum_probs=80.6
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCc--ceeeeec------eEeecCeEEEEEEeCC
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV--NIVPFLG------FCYEKKKRALIYEFMP 281 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~e~~~ 281 (511)
.|+.|..+.||+....+| .+++|+.... .++...|+.++..+... .+.+++. +....+..+++|+|++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 466677899999987655 4899988752 23444555555554321 2333332 1234677899999999
Q ss_pred CCCHH--------------HHHhcccC-C--C-C----CCCCCHHHH-------------------------------HH
Q 040808 282 NGSLD--------------QYIYDHES-S--N-G----KRTLEWRTV-------------------------------YQ 308 (511)
Q Consensus 282 ~gsL~--------------~~l~~~~~-~--~-~----~~~l~~~~~-------------------------------~~ 308 (511)
|.++. ..++.... . . . ...-.|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86532 11111110 0 0 0 011233211 11
Q ss_pred HHHHHHHHHHHHHh----------CCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 309 IAVGIARGLEYLHR----------GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 309 i~~~i~~~l~yLH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
+...+..++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11234446667763 023589999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.3e-05 Score=81.34 Aligned_cols=73 Identities=11% Similarity=0.083 Sum_probs=49.1
Q ss_pred cccCCcCceEEEEEEcC-CCcEEEEEEeccCC--------CChHHHHHHHHHHHccCC--cc-eeeeeceEeecCeEEEE
Q 040808 209 DKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--------DNGEEFINEVASISRTSH--VN-IVPFLGFCYEKKKRALI 276 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~lv 276 (511)
+.||.|..+.||++... +++.++||...... ...+++..|++++..+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46999999999999864 46889999764321 123567889999887742 33 3355543 34456899
Q ss_pred EEeCCCC
Q 040808 277 YEFMPNG 283 (511)
Q Consensus 277 ~e~~~~g 283 (511)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.89 E-value=6.3e-05 Score=73.60 Aligned_cols=140 Identities=14% Similarity=0.161 Sum_probs=91.2
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccC---CcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTS---HVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
+.|+.|....+|+... +++.+++|+.... ....+..|++.|+.+. ...+.+++++....+..++|||++++..+
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4689999999999986 4677889987643 3567888999888875 35677888888777889999999998754
Q ss_pred H--------H---HHhcccCCC----------------CCCCCCHHHHH---HHH----------------HHHHHH-HH
Q 040808 286 D--------Q---YIYDHESSN----------------GKRTLEWRTVY---QIA----------------VGIARG-LE 318 (511)
Q Consensus 286 ~--------~---~l~~~~~~~----------------~~~~l~~~~~~---~i~----------------~~i~~~-l~ 318 (511)
. . .|+...... ....-+|.... ++. ..++.. .+
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 1 122211100 00112454332 111 111111 22
Q ss_pred HHHh-CCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 319 YLHR-GCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 319 yLH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 2245899999999999999887 8898974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00014 Score=70.20 Aligned_cols=72 Identities=18% Similarity=0.272 Sum_probs=51.9
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCc---ceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHV---NIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+|.|..+.||+..+.+|+.|.+|+-..... ....|..|++.|+.+... -+.+++++ + ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 46899999999999999999999998764332 234678899998887532 23344432 2 2378999997654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00017 Score=73.60 Aligned_cols=81 Identities=10% Similarity=0.023 Sum_probs=47.1
Q ss_pred CCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccC-CCCccccchhHHHHHHHH
Q 040808 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG-GVSHKSDVYSYGMMIHEM 404 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~sDvwSlG~il~el 404 (511)
..++|+|++|.|||+++++ ++|+||+.+......-....... .-...|++|+......+ ......++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 99999998876542211110000 00123555554421100 111234455777777777
Q ss_pred HhCC
Q 040808 405 VIGR 408 (511)
Q Consensus 405 ltg~ 408 (511)
..++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00054 Score=67.17 Aligned_cols=145 Identities=14% Similarity=0.117 Sum_probs=83.6
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc--eeeeece-----EeecCeEEEEEEeCCC
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN--IVPFLGF-----CYEKKKRALIYEFMPN 282 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~e~~~~ 282 (511)
.|+ |....||+....+|+.+++|+........+.+..|+.++..+.... +.+++.. ....+..+++|++++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 466 7788999988777778999998744334567777888887775322 3444442 1234567889999987
Q ss_pred CCHH-----H------H---HhcccC---CCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC---
Q 040808 283 GSLD-----Q------Y---IYDHES---SNGKRTLEWRTV----YQI---------------AVGIARGLEYLHRG--- 323 (511)
Q Consensus 283 gsL~-----~------~---l~~~~~---~~~~~~l~~~~~----~~i---------------~~~i~~~l~yLH~~--- 323 (511)
.++. . . ++.... .......++... ..+ ...+...++.+.+.
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 5431 1 1 111100 000112222211 000 11111223333221
Q ss_pred -CCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 324 -CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 324 -~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 234789999999999999 4 8999999887543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00013 Score=70.80 Aligned_cols=141 Identities=10% Similarity=0.057 Sum_probs=75.1
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-eeeeceEeecCeEEEEEEeC-CCCCHH
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-VPFLGFCYEKKKRALIYEFM-PNGSLD 286 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL~ 286 (511)
+.|+.|....+|+. +.+++|+-...........+|+.++..+...++ .+++++ +.+..++++||+ ++.+|.
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence 56888999999998 458888876532222223467777776653333 344443 333457899999 654442
Q ss_pred HH------------------HhcccCCCCCCCCC-HHHHHHHHH--------------HHHHHHH----HHHh-CCCCCc
Q 040808 287 QY------------------IYDHESSNGKRTLE-WRTVYQIAV--------------GIARGLE----YLHR-GCNIRI 328 (511)
Q Consensus 287 ~~------------------l~~~~~~~~~~~l~-~~~~~~i~~--------------~i~~~l~----yLH~-~~~~~i 328 (511)
.. ++.... ....... +..+..+.. .+...+. .|.. .....+
T Consensus 97 ~~~~~~~~~~~~~~~~~La~lH~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 97 PEKFKTRPGSPARAGEAFRKLHGSGA-VFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp HHHHHHSTTHHHHHHHHHHHHHTSCC-CCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred HhhHhhhHHHHHHHHHHHHHHhCCCC-CCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 10 111110 0000011 111111110 0111111 1111 123468
Q ss_pred EecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 329 VHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 329 iH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
+|+|+.+.||+ ..++.+.|+||..+....
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 99999999999 556678999999876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00025 Score=71.30 Aligned_cols=144 Identities=16% Similarity=0.197 Sum_probs=84.1
Q ss_pred cccCCcCceEEEEEEcC--------CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-eeeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLP--------DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-VPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 279 (511)
+.|..|-...+|+.... +++.+.+|+-.........+.+|..+++.+...++ .++++.+.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45777888899998864 25789999865433345677789999888763333 455655543 299999
Q ss_pred CCCCCHHH--------------HH---hcccCCCCCCCC-CHHHHHHHHHHHHH-------------------HHHHHH-
Q 040808 280 MPNGSLDQ--------------YI---YDHESSNGKRTL-EWRTVYQIAVGIAR-------------------GLEYLH- 321 (511)
Q Consensus 280 ~~~gsL~~--------------~l---~~~~~~~~~~~l-~~~~~~~i~~~i~~-------------------~l~yLH- 321 (511)
++|.+|.. .| +.......+... -|.++.++..++.. .++.|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98755431 11 111111111111 24555555544322 233332
Q ss_pred ---h-CCCCCcEecCCCCCCEEEcCC----CceEEeeccCccc
Q 040808 322 ---R-GCNIRIVHLDIKPHNIRLDED----FCPKISDFGLAKQ 356 (511)
Q Consensus 322 ---~-~~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~ 356 (511)
. .....++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123579999999999999876 7899999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00032 Score=68.66 Aligned_cols=145 Identities=12% Similarity=0.090 Sum_probs=80.4
Q ss_pred cccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcc--eeeeece------EeecCeEEEEEEeC
Q 040808 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVN--IVPFLGF------CYEKKKRALIYEFM 280 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~~ 280 (511)
+.|+.|....+|+....+| .+++|+.... ...+++..|+.++..+...+ +.+++.. ....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3577788899999987665 5789988752 12345566777777664322 2333321 12345678999999
Q ss_pred CCCCHHH--------------HHhccc-CCCCC-----CCCCHHHHHH------------HHHHHHHHHHHHHhC----C
Q 040808 281 PNGSLDQ--------------YIYDHE-SSNGK-----RTLEWRTVYQ------------IAVGIARGLEYLHRG----C 324 (511)
Q Consensus 281 ~~gsL~~--------------~l~~~~-~~~~~-----~~l~~~~~~~------------i~~~i~~~l~yLH~~----~ 324 (511)
+|..+.. .++... ..... ....|...+. +...+...++.+++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8864311 111110 00000 0012322111 011244556666532 1
Q ss_pred CCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 325 ~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
..+++|+|+++.|||++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3479999999999999987666899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00081 Score=66.15 Aligned_cols=146 Identities=12% Similarity=0.066 Sum_probs=74.3
Q ss_pred ccCCcCceE-EEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCC--cceeeeeceEeecCeEEEEEEeCCCCCHH
Q 040808 210 KLGQGGYAD-VYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSH--VNIVPFLGFCYEKKKRALIYEFMPNGSLD 286 (511)
Q Consensus 210 ~LG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 286 (511)
.|+.|+... +|+....+|+.+++|...... .+++..|+.++..+.. -.+.+++.+..+.+ +++||++.+.++.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 465554444 667765446778787654432 1233455666655542 23445665433333 7899999777776
Q ss_pred HHHhccc-------------------CCC-CCCCCCHHHHH-------H-------------HHHHHHHHHHHHH---hC
Q 040808 287 QYIYDHE-------------------SSN-GKRTLEWRTVY-------Q-------------IAVGIARGLEYLH---RG 323 (511)
Q Consensus 287 ~~l~~~~-------------------~~~-~~~~l~~~~~~-------~-------------i~~~i~~~l~yLH---~~ 323 (511)
+++.... ... ....++..... . ....+...++.+. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 5443211 000 00112111100 0 0011222233331 11
Q ss_pred CCCCcEecCCCCCCEEEcCC----CceEEeeccCccccCC
Q 040808 324 CNIRIVHLDIKPHNIRLDED----FCPKISDFGLAKQTEK 359 (511)
Q Consensus 324 ~~~~iiH~Dlkp~NIll~~~----~~~kl~DFGla~~~~~ 359 (511)
....++|+|+.+.|||++.+ +.+.|+||+.+.....
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 23489999999999999874 6889999998875543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00063 Score=69.65 Aligned_cols=71 Identities=14% Similarity=0.235 Sum_probs=49.7
Q ss_pred cccCCcCceEEEEEEcCC--------CcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-eeeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLPD--------GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-VPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 279 (511)
+.|+.|....||+....+ ++.+.+|+.... ...+.+.+|+.++..+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 468888889999998653 578999988432 222677789999888864444 456665432 289999
Q ss_pred CCCCC
Q 040808 280 MPNGS 284 (511)
Q Consensus 280 ~~~gs 284 (511)
++|.+
T Consensus 154 l~G~~ 158 (429)
T 1nw1_A 154 IPSRP 158 (429)
T ss_dssp CCEEE
T ss_pred eCCcc
Confidence 98643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00048 Score=71.05 Aligned_cols=73 Identities=16% Similarity=-0.003 Sum_probs=47.5
Q ss_pred cccCCcCceEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-eeeeceEeecCeEEEEEEeCCCCCH
Q 040808 209 DKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-VPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
+.|+.|-...+|+....+ ++.+++|+........-+..+|..++..+...++ .++++.+. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 458888889999998765 5788899875432222123578888888876555 45666653 2 259999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00041 Score=69.43 Aligned_cols=72 Identities=15% Similarity=0.143 Sum_probs=43.1
Q ss_pred cccCCcCceEEEEEEcCC---------CcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-eeeeceEeecCeEEEEEE
Q 040808 209 DKLGQGGYADVYKGTLPD---------GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-VPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 278 (511)
+.|+.|....+|+....+ ++.+++|+.........+...|.+++..+...++ .++++.. . ..+|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457888889999988654 2688999876432222223568887777754343 3555433 2 268999
Q ss_pred eCCCCC
Q 040808 279 FMPNGS 284 (511)
Q Consensus 279 ~~~~gs 284 (511)
|++|.+
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0054 Score=60.53 Aligned_cols=32 Identities=19% Similarity=0.206 Sum_probs=28.3
Q ss_pred CCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998888999999877654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.026 Score=51.36 Aligned_cols=102 Identities=13% Similarity=0.063 Sum_probs=66.0
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
..+|.+.|.... .++.++++|.++.|.+.+|.-+-.+. .-..+=+.|..|+|..+|.|-..+ ..+.
T Consensus 32 ~vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------ 97 (229)
T 2yle_A 32 ALSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------ 97 (229)
T ss_dssp EEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred cccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------
Confidence 347999997654 68999999999999999987762210 111233446899999999887764 1110
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~ 408 (511)
.....+.|||... ...+.+.=|||||+++|.-+-=.
T Consensus 98 --------~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------------CCSS---SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred --------ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcC
Confidence 1222456888763 25678889999999999988433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.03 Score=56.85 Aligned_cols=143 Identities=12% Similarity=0.157 Sum_probs=84.2
Q ss_pred cccCCcCceEEEEEEcCC--------CcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-eeeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLPD--------GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-VPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 279 (511)
+.|..|-...+|+....+ ++.+++|+-.......-+..+|..+++.+...++ .++++.+ .+ .+||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEEE
Confidence 457778889999988653 5789999865432222234578888877753333 3444432 22 689999
Q ss_pred CCCCCHHH--------------HH---hcccC-----CC--CCCCCCHHHHHHHHHHH-------------------HHH
Q 040808 280 MPNGSLDQ--------------YI---YDHES-----SN--GKRTLEWRTVYQIAVGI-------------------ARG 316 (511)
Q Consensus 280 ~~~gsL~~--------------~l---~~~~~-----~~--~~~~l~~~~~~~i~~~i-------------------~~~ 316 (511)
++|.+|.. .+ +.... .. ...+..|..+.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99865321 01 11110 00 11222354444443322 223
Q ss_pred HHHHHh---------------------CCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 317 LEYLHR---------------------GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 317 l~yLH~---------------------~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+++|.+ .....++|+|+.+.||+ ++++.+.|+||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11346899999999999 8888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.94 E-value=0.27 Score=49.33 Aligned_cols=30 Identities=27% Similarity=0.243 Sum_probs=25.2
Q ss_pred CcEecCCCCCCEEE------cCCCceEEeeccCccc
Q 040808 327 RIVHLDIKPHNIRL------DEDFCPKISDFGLAKQ 356 (511)
Q Consensus 327 ~iiH~Dlkp~NIll------~~~~~~kl~DFGla~~ 356 (511)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.06 E-value=0.69 Score=41.98 Aligned_cols=83 Identities=11% Similarity=0.067 Sum_probs=60.4
Q ss_pred CCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCcEecCCC
Q 040808 256 SHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE-YLHRGCNIRIVHLDIK 334 (511)
Q Consensus 256 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~-yLH~~~~~~iiH~Dlk 334 (511)
.||.+ -..+-.+.+...+.|+.-+++.=...+ +.++...+++++.+|+.... +++ .-+|.-|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEe
Confidence 57777 333446677778888876444333334 35777888998888887666 454 45899999
Q ss_pred CCCEEEcCCCceEEeeccCc
Q 040808 335 PHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 335 p~NIll~~~~~~kl~DFGla 354 (511)
|+||++|.++.+++.-.|+-
T Consensus 112 P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGGEEECTTCCEEESCCEET
T ss_pred CceEEEeCCCcEEEEEcCCc
Confidence 99999999999999877763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.32 E-value=0.47 Score=42.95 Aligned_cols=117 Identities=11% Similarity=0.102 Sum_probs=77.1
Q ss_pred cCCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCC
Q 040808 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIK 334 (511)
Q Consensus 255 l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlk 334 (511)
..||+.+.. .+-.+.+...+.|+.-+++.=...+ +.++...+++++.+|+...++++. =+|.-|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~ 106 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLA 106 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCS
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEe
Confidence 357888765 3555666666666654422111112 467888999999999998866664 4899999
Q ss_pred CCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 040808 335 PHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412 (511)
Q Consensus 335 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~ 412 (511)
|+||++|.++.|++.--|+...+... =+.+|-+ .-.+=+++..+++++..|+
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~f------------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNVVDPL--------------PVSEAEF------------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTTBSCC--------------CCCHHHH------------HHHHHHHHHHHHCTTCCHH
T ss_pred cceEEEcCCCCEEEEEccCccCCCCC--------------CCCHHHH------------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999999877653222110 0122222 2345678888898887663
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.49 E-value=0.075 Score=54.62 Aligned_cols=59 Identities=7% Similarity=0.013 Sum_probs=17.8
Q ss_pred hhcccCCcCceEEEEEEcCC-CcEEEE------EEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEe
Q 040808 207 FSDKLGQGGYADVYKGTLPD-GRLVAV------KVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCY 268 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 268 (511)
+.++|| ||.||+|.+.. ...||+ |..+... .....|.+|..++..++|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 446776 99999999754 467888 6665422 22346888999999999999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 511 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (550), Expect = 3e-67
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 27/288 (9%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPF 263
++G G + VYKG VAVK++ + F NEV + +T HVNI+ F
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+G+ + A++ ++ SL +++ E+ E + IA A+G++YLH
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHAK 123
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF-C 382
I+H D+K +NI L ED KI DFGLA + G+ ++APEV
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442
+ S +SDVY++G++++E++ G+ + + I + Y V
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLSKV 234
Query: 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPK 490
+ K+++ C++ +RP +++ +E +L PK
Sbjct: 235 RSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARSL---PK 276
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-62
Identities = 64/278 (23%), Positives = 120/278 (43%), Gaps = 24/278 (8%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
F ++G G + V+ G + VA+K ++ + E+FI E + + SH +V G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
C E+ L++EFM +G L Y+ T+ + + + G+ YL C
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQRGLF-----AAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
++H D+ N + E+ K+SDFG+ + + S T+ + +PEVF F
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVKWASPEVF--SFS 177
Query: 387 GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446
S KSDV+S+G+++ E+ K + + + I T + + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK------IPYENRSNSEVVEDISTGFRLYKPRLASTHV 231
Query: 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
++ C + P DRP+ ++++ L E+
Sbjct: 232 YQIM-------NHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 9e-62
Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 24/273 (8%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
++LG G + +V+ G VAVK +K + + F+ E + + H +V
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
++ +I E+M NGSL ++ L + +A IA G+ ++
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFLKTP----SGIKLTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
+H D++ NI + + KI+DFGLA+ E E + + + APE ++G
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAI--NYG 185
Query: 387 GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446
+ KSDV+S+G+++ E+V + + + +E Y EE
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPY------PGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
++ + C + P DRP+ + +LE
Sbjct: 240 YQLMR-------LCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-61
Identities = 65/289 (22%), Positives = 120/289 (41%), Gaps = 24/289 (8%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
KLGQG + +V+ GT VA+K +K + E F+ E + + H +V
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
++ ++ E+M GSL ++ + L + +A IA G+ Y+ +
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDFLKGE----TGKYLRLPQLVDMAAQIASGMAYVE---RM 132
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
VH D++ NI + E+ K++DFGLA+ E E + + + + APE G
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALY--G 189
Query: 387 GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446
+ KSDV+S+G+++ E+ + + Q+E Y E
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLDQVERGYRMPCPPECPESL 243
Query: 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKPSLSL 495
++ + C + P +RP+ + LE + + +P +L
Sbjct: 244 HDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-61
Identities = 55/273 (20%), Positives = 111/273 (40%), Gaps = 24/273 (8%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
F +LG G + V G VA+K++K + +EFI E + SH +V G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
C +++ +I E+M NG L Y+ + + + + + ++ + +EYL
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREM-----RHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
+H D+ N +++ K+SDFGL++ E S + ++ + PEV
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY--S 176
Query: 387 GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEE 446
S KSD++++G+++ E+ K + + + I + +E+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK------MPYERFTNSETAEHIAQGLRLYRPHLASEKV 230
Query: 447 KEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ C +RP+ ++ +
Sbjct: 231 YTIM-------YSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (497), Expect = 3e-59
Identities = 72/303 (23%), Positives = 132/303 (43%), Gaps = 26/303 (8%)
Query: 189 SLAPKRFSYSD--VRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEF 245
++ P +Y + R + KLG G Y +VY+G VAVK +K EEF
Sbjct: 1 AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60
Query: 246 INEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRT 305
+ E A + H N+V LG C + +I EFM G+L Y+ + ++ +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC----NRQEVSAVV 116
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+ +A I+ +EYL + +H D+ N + E+ K++DFGL++ +++ +
Sbjct: 117 LLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTA 172
Query: 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNA 425
+ + APE S KSDV+++G+++ E+ + + +
Sbjct: 173 HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQ 224
Query: 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485
+Y+ +E +Y + E+ E+ C Q +P DRPS ++ + E +
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELM-------RACWQWNPSDRPSFAEIHQAFETMFQES 277
Query: 486 QIP 488
I
Sbjct: 278 SIS 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-59
Identities = 56/293 (19%), Positives = 115/293 (39%), Gaps = 30/293 (10%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCY 268
+ +G+G + +V++G G VAVK+ + ++ E+ H NI+ F+
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 269 EK----KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ + L+ ++ +GSL Y+ + T+ + ++A+ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 325 -----NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR--GTAGYIA 377
I H D+K NI + ++ I+D GLA + + I + GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 378 PEVFCRHF----GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYF-------PNAI 426
PEV ++D+Y+ G++ E+ + Y+
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+++ E + + + E + M + C + R + ++ + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-58
Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 30/274 (10%)
Query: 207 FSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
+G+G + DV G G VAVK +KN + F+ E + +++ H N+V LG
Sbjct: 11 LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 267 CYEKKKR-ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
E+K ++ E+M GSL Y+ G+ L + + ++ + +EYL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSR----GRSVLGGDCLLKFSLDVCEAMEYLEG--- 121
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
VH D+ N+ + ED K+SDFGL K+ + + + APE
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE-- 174
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445
S KSDV+S+G+++ E+ + ++ + ++E Y
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYKMDAPDGCPPA 228
Query: 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
E+ K C RPS ++ E LE
Sbjct: 229 VYEVMKN-------CWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-58
Identities = 71/323 (21%), Positives = 125/323 (38%), Gaps = 41/323 (12%)
Query: 185 RNYGSLAPKRFSYSD---VRRMTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVM 235
NY + P + Y R SF LG G + V + T VAVK++
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 236 KNLKDNG--EEFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH 292
K E ++E+ +S +H+NIV LG C +I E+ G L ++
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 293 ESS------------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRL 340
S + + L+ + + +A+G+ +L + +H D+ NI L
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178
Query: 341 DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMM 400
KI DFGLA+ + +++ + R ++APE + +SDV+SYG+
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIF 236
Query: 401 IHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWC 460
+ E+ + + YK I+ + E ++ K C
Sbjct: 237 LWELFSLGSS-----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT-------C 284
Query: 461 IQTHPPDRPSMTKVVEMLEGSIE 483
P RP+ ++V+++E I
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 9e-58
Identities = 63/303 (20%), Positives = 119/303 (39%), Gaps = 44/303 (14%)
Query: 207 FSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDNG--EEFINEVASISRTSHV 258
+ +G+G + V++ P +VAVK++K +F E A ++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHE------------------SSNGKRT 300
NIV LG C K L++E+M G L++++ SS G
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 301 LEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360
L IA +A G+ YL + VH D+ N + E+ KI+DFGL++
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420
+ + + + ++ PE + + +SDV++YG+++ E+ ++
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA---- 247
Query: 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480
+ + DG + + ++ + C P DRPS + +L+
Sbjct: 248 --HEEVIYYV-------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 481 SIE 483
E
Sbjct: 299 MCE 301
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 1e-57
Identities = 68/281 (24%), Positives = 110/281 (39%), Gaps = 36/281 (12%)
Query: 204 TKSFSD--KLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE----FINEVASISRTS 256
K FSD ++G G + VY + + +VA+K M E I EV + +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
H N + + G + L+ E+ + D K+ L+ + + G +G
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH------KKPLQEVEIAAVTHGALQG 127
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
L YLH ++H D+K NI L E K+ DFG A SF+ GT ++
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWM 178
Query: 377 APEVF-CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435
APEV G K DV+S G+ E+ + + +A+Y + E
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNESP 232
Query: 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
G +E + C+Q P DRP+ +++
Sbjct: 233 ALQSGHWSEYFRNFVDS-------CLQKIPQDRPTSEVLLK 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 2e-57
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 43/310 (13%)
Query: 195 FSYSDVRRMTKSFSD-----------KLGQGGYADVYKGTLP----DGRLVAVKVMKNLK 239
F++ D + F+ +G G + +V G L VA+K +K+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 240 DNG--EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNG 297
+F++E + + + H N++ G + +I EFM NGSLD ++ ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 298 KRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357
+ + GIA G++YL VH D+ NI ++ + K+SDFGL++
Sbjct: 126 ----TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 358 EKKES---FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414
E S + S L + + APE + SDV+SYG+++ E++ +
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGE----- 231
Query: 415 VSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKV 474
+ + IE +Y ++ L C Q RP ++
Sbjct: 232 -RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM-------LDCWQKDRNHRPKFGQI 283
Query: 475 VEMLEGSIEN 484
V L+ I N
Sbjct: 284 VNTLDKMIRN 293
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-57
Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 30/288 (10%)
Query: 210 KLGQGGYADVYKGTL---PDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHVNIVPFL 264
+LG G + V +G VA+KV+K + EE + E + + + IV +
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
G C + + L+ E G L +++ + + V ++ ++ G++YL
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLE--- 126
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAPEVFCR 383
VH D+ N+ L KISDFGL+K +S+ + + + APE
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-- 184
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
+F S +SDV+SYG+ + E + + + + IE +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKP------YKKMKGPEVMAFIEQGKRMECPPECP 238
Query: 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPKP 491
E + C DRP V + + +L +
Sbjct: 239 PELYALMSD-------CWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 6e-56
Identities = 62/264 (23%), Positives = 112/264 (42%), Gaps = 28/264 (10%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHVNIVP 262
+LG G V+K + P G ++A K++ + I E+ + + IV
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 263 FLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
F G Y + ++ E M GSLDQ + + + + ++++ + +GL YL
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE 122
Query: 323 GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFC 382
+I+H D+KP NI ++ K+ DFG++ Q + GT Y++PE
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERL- 175
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442
S +SD++S G+ + EM +GR P K++E + Q++G
Sbjct: 176 -QGTHYSVQSDIWSMGLSLVEMAVGRYP-----------IPPPDAKELELMFGCQVEGDA 223
Query: 443 TEEEKEMAKKMILVSLWCIQTHPP 466
E +S + + + PP
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPP 247
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 7e-56
Identities = 56/276 (20%), Positives = 110/276 (39%), Gaps = 28/276 (10%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK---NLKDNGEEFINEVASISRTSHVNIVPFL 264
+G G Y K DG+++ K + + + ++EV + H NIV +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 265 GFCYEKKKRAL--IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHR 322
++ L + E+ G L I + + ++ L+ V ++ + L+ HR
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 323 --GCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
++H D+KP N+ LD K+ DFGLA+ SF T Y++PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMSPEQ 185
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440
R + KSD++S G +++E+ + + + +I ++
Sbjct: 186 MNR--MSYNEKSDIWSLGCLLYELCALM-------PPFTAFSQKELAGKIREGKFRRIPY 236
Query: 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
++E E+ + + RPS+ +++E
Sbjct: 237 RYSDELNEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-55
Identities = 60/277 (21%), Positives = 108/277 (38%), Gaps = 32/277 (11%)
Query: 210 KLGQGGYADVYKGTLPD---GRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPF 263
+LG G + V KG + VAVK++KN ++ +E + E + + + IV
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+G C E + L+ E G L++Y+ + R ++ + + ++ ++ G++YL
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLE-- 124
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT-RGTAGYIAPEVFC 382
VH D+ N+ L KISDFGL+K E++ + + APE
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 383 RHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442
S KSDV+S+G+++ E + + + +E
Sbjct: 184 Y--YKFSSKSDVWSFGVLMWEAFSYGQKP------YRGMKGSEVTAMLEKGERMGCPAGC 235
Query: 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
E ++ C +RP V L
Sbjct: 236 PREMYDLMNL-------CWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-55
Identities = 71/299 (23%), Positives = 111/299 (37%), Gaps = 43/299 (14%)
Query: 207 FSDKLGQGGYADVYKGTLPD------GRLVAVKVMKNLKDNGE--EFINEVASISR-TSH 257
F LG G + V T VAVK++K D+ E ++E+ +++ SH
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH-----------------ESSNGKRT 300
NIV LG C LI+E+ G L Y+ E
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 301 LEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360
L + + A +A+G+E+L VH D+ N+ + KI DFGLA+
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSE 420
+++ + R ++APE G + KSDV+SYG+++ E+ N
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY-----PGI 270
Query: 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
YK I+ + TEE + + C RPS + L
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQS-------CWAFDSRKRPSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-54
Identities = 61/289 (21%), Positives = 114/289 (39%), Gaps = 40/289 (13%)
Query: 193 KRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNG----EEFIN 247
++++ D LG+G + +VY ++A+KV+ + +
Sbjct: 1 RQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 248 EVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVY 307
EV S H NI+ G+ ++ + LI E+ P G++ + + + +
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL------SKFDEQRTA 109
Query: 308 QIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISML 367
+A L Y H R++H DIKP N+ L KI+DFG +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RT 162
Query: 368 DTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY 427
GT Y+ PE+ K D++S G++ +E ++G+ Y
Sbjct: 163 TLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGK-------PPFEANTYQETY 213
Query: 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
K+I +F VTE +++ + ++ +P RP + +V+E
Sbjct: 214 KRISRV-EFTFPDFVTEGARDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-54
Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 32/287 (11%)
Query: 202 RMTKSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKDNGE--EFINEVASISRT 255
+ F++ +G+G + VY GTL D AVK + + D GE +F+ E +
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 256 SHVNIVPFLGFCYEKKKRA-LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
SH N++ LG C + ++ +M +G L +I + + + + +A
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVA 140
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDT--RGT 372
+G+ + + VH D+ N LDE F K++DFGLA+ KE T +
Sbjct: 141 KGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 373 AGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432
++A E + KSDV+S+G+++ E++ V+ I +
Sbjct: 198 VKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQ 249
Query: 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ E+ L C RPS +++V +
Sbjct: 250 GRRLLQPEYCPDPLYEVM-------LKCWHPKAEMRPSFSELVSRIS 289
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 3e-54
Identities = 69/322 (21%), Positives = 139/322 (43%), Gaps = 45/322 (13%)
Query: 192 PKRF---SYSDVRRMTKSFSDKLGQGGYADVYKGTLPDG---RLVAVKVMKNL--KDNGE 243
P + ++D++ F D +G+G + V K + A+K MK KD+
Sbjct: 1 PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 244 EFINEVASISR-TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHE--------- 293
+F E+ + + H NI+ LG C + L E+ P+G+L ++
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 294 -SSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352
+++ TL + + A +ARG++YL + +H D+ NI + E++ KI+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172
Query: 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNAD 412
L++ +E ++ R ++A E + SDV+SYG+++ E+V
Sbjct: 173 LSRG---QEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPY 227
Query: 413 VKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMT 472
++ +Y+++ Y + +E ++ ++ C + P +RPS
Sbjct: 228 CGMT------CAELYEKLPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFA 274
Query: 473 KVVEMLEGSIENLQIPPKPSLS 494
+++ L +E + +L
Sbjct: 275 QILVSLNRMLEERKTYVNTTLY 296
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-53
Identities = 66/280 (23%), Positives = 110/280 (39%), Gaps = 37/280 (13%)
Query: 207 FSDKLGQGGYADVYKGTLPD-GRLVAVKVMKN---LKDNGEEFINEVASISRTSHVNIVP 262
F ++G+G + VYKG + VA +++ K + F E + H NIV
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 263 FLGFCYE----KKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
F KK L+ E M +G+L Y+ + ++ + + I +GL+
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQ 126
Query: 319 YLHRGCNIRIVHLDIKPHNIRL-DEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
+LH I+H D+K NI + KI D GLA + GT ++A
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMA 181
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI-ETEYDF 436
PE++ DVY++GM + EM S IY+++
Sbjct: 182 PEMYE---EKYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPA 232
Query: 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
D V E KE+ + CI+ + +R S+ ++
Sbjct: 233 SFDKVAIPEVKEIIEG-------CIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-52
Identities = 60/275 (21%), Positives = 110/275 (40%), Gaps = 31/275 (11%)
Query: 209 DKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNG-EEFINEVASISRTSHVNIVPFLGF 266
+LG G + VYK + L A KV+ + E+++ E+ ++ H NIV L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
Y + ++ EF G++D + + +R L + + L YLH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLEL-----ERPLTESQIQVVCKQTLDALNYLHDN--- 129
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF---CR 383
+I+H D+K NI D K++DFG++ + + GT ++APEV
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEVVMCETS 187
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE--YDFQLDGV 441
+K+DV+S G+ + EM E P + +I
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHH-------ELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ K+ KK C++ + R + +++++
Sbjct: 241 WSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-52
Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 31/287 (10%)
Query: 206 SFSDKLGQGGYADVYKGTLPDG-----RLVAVKVMKNLKDNGE--EFINEVASISRTSHV 258
+ +G G + +VYKG L VA+K +K + +F+ E + + SH
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
NI+ G + K +I E+M NG+LD+++ + + + GIA G++
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLREK-----DGEFSVLQLVGMLRGIAAGMK 124
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ-TEKKESFISMLDTRGTAGYIA 377
YL VH D+ NI ++ + K+SDFGL++ + E+ + + + A
Sbjct: 125 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
PE + + SDV+S+G+++ E++ + E + + K I
Sbjct: 182 PEAI--SYRKFTSASDVWSFGIVMWEVMTYGE------RPYWELSNHEVMKAIN------ 227
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484
DG + + + + C Q RP +V +L+ I
Sbjct: 228 -DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 5e-52
Identities = 67/271 (24%), Positives = 99/271 (36%), Gaps = 25/271 (9%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVM--KNLKDNGEEFINEVASISRTSHVNIVPFLG 265
LG+G Y +V VAVK++ K D E E+ +H N+V F G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
E + L E+ G L I + + + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
I I H DIKP N+ LDE KISDFGLA + GT Y+APE+ R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR- 180
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEE 445
+ DV+S G+++ M+ G D EY E + +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKTYLNPWKKIDSA 235
Query: 446 EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ K + +P R ++ + +
Sbjct: 236 PLALLHK-------ILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 8e-52
Identities = 68/312 (21%), Positives = 128/312 (41%), Gaps = 38/312 (12%)
Query: 192 PKRFSYSDV--------RRMTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKN 237
P+ FS +DV R + S +LGQG + VY+G VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 238 LKDNGE--EFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH--- 292
E EF+NE + + + ++V LG + + +I E M G L Y+
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 293 -ESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351
++ + Q+A IA G+ YL + VH D+ N + EDF KI DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNA 411
G+ + + + + +++PE G + SDV+S+G+++ E+ +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQP 235
Query: 412 DVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSM 471
+S + + + ++G + ++ + + C Q +P RPS
Sbjct: 236 YQGLS------NEQVLRFV-------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 472 TKVVEMLEGSIE 483
+++ ++ +E
Sbjct: 283 LEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-50
Identities = 67/294 (22%), Positives = 122/294 (41%), Gaps = 39/294 (13%)
Query: 207 FSDKLGQGGYADVYKGTLP--------DGRLVAVKVMKN--LKDNGEEFINEVASISR-T 255
LG+G + V VAVK++K+ + + + I+E+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 256 SHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDH----------ESSNGKRTLEWRT 305
H NI+ LG C + +I E+ G+L +Y+ S N + L +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 306 VYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365
+ A +ARG+EYL + + +H D+ N+ + ED KI+DFGLA+ + +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNA 425
+ R ++APE +H+SDV+S+G+++ E+ + V
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEE 245
Query: 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
++K ++ + T E M + C P RP+ ++VE L+
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLD 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-50
Identities = 62/279 (22%), Positives = 111/279 (39%), Gaps = 30/279 (10%)
Query: 209 DKLGQGGYADVYKGTLP----DGRLVAVKVMK----NLKDNGEEFINEVASISRTSHVNI 260
+KLG G + V +G VAVK +K + + ++FI EV ++ H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
+ G + ++ E P GSL + H + T+ + AV +A G+ YL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKH-----QGHFLLGTLSRYAVQVAEGMGYL 127
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
+ R +H D+ N+ L KI DFGL + + + M + R
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440
+ SH SD + +G+ + EM + + ++ + I +I+ E G
Sbjct: 185 SLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKE------G 231
Query: 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
++ + + V + C P DRP+ + + L
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-50
Identities = 70/316 (22%), Positives = 124/316 (39%), Gaps = 37/316 (11%)
Query: 206 SFSDKLGQGGYADVYKGT-LPDGRLVAVKV-MKNLKDNG-----EEFINEVASISRTSHV 258
LG G + VYKG +P+G V + V +K L++ +E ++E ++ +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
++ LG C + LI + MP G L Y+ +H K + + + V IA+G+
Sbjct: 72 HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMN 125
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
YL + R+VH D+ N+ + KI+DFGLAK +E + ++A
Sbjct: 126 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
E +H+SDV+SYG+ + E++ + I +E
Sbjct: 183 ESILH--RIYTHQSDVWSYGVTVWELMTFGSKP------YDGIPASEISSILEKGERLPQ 234
Query: 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN----LQIPPKPSLS 494
+ T + + K C RP +++ + L I +
Sbjct: 235 PPICTIDVYMIMVK-------CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 495 LPTGYAKQSSPTSSFM 510
LP+ S+ + M
Sbjct: 288 LPS--PTDSNFYRALM 301
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 4e-50
Identities = 62/283 (21%), Positives = 112/283 (39%), Gaps = 31/283 (10%)
Query: 207 FSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKDNG--EEFINEVASISRTSHVNI 260
+G+G + DV++G VA+K KN + E+F+ E ++ + H +I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
V +G E +I E G L ++ K +L+ ++ A ++ L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYL 124
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
R VH DI N+ + + C K+ DFGL++ E + + + ++APE
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPES 180
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440
+F + SDV+ +G+ + E+++ V N + +IE +
Sbjct: 181 I--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------NNDVIGRIENGERLPMPP 232
Query: 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483
+ K C P RP T++ L +E
Sbjct: 233 NCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-49
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 37/297 (12%)
Query: 207 FSDKLGQGGYADVYKGT------LPDGRLVAVKVMKNLKDNGE--EFINEVASISRTSH- 257
LG+G + V + R VAVK++K + E ++E+ + H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 258 VNIVPFLGFCYEKKKR-ALIYEFMPNGSLDQYIYDH----------ESSNGKRTLEWRTV 306
+N+V LG C + +I EF G+L Y+ K L +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 307 YQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISM 366
+ +A+G+E+L + + +H D+ NI L E KI DFGLA+ K ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 367 LDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAI 426
D R ++APE + +SDV+S+G+++ E+ +
Sbjct: 194 GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEF 246
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483
++++ + T E + L C P RP+ +++VE L ++
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTM-------LDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-48
Identities = 63/272 (23%), Positives = 110/272 (40%), Gaps = 32/272 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE-FINEVASISRTSHVNIVPFLGF 266
+K+GQG VY + G+ VA++ M + +E INE+ + + NIV +L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
+ ++ E++ GSL + + + + + LE+LH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAAVCRECLQALEFLHS---N 135
Query: 327 RIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFG 386
+++H DIK NI L D K++DFG Q ++S S GT ++APEV R
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTR--K 191
Query: 387 GVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETE--YDFQLDGVVTE 444
K D++S G+M EM+ G P I T + Q ++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYL-------NENPLRALYLIATNGTPELQNPEKLSA 244
Query: 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
++ + C+ R S ++++
Sbjct: 245 IFRDFLNR-------CLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (415), Expect = 9e-47
Identities = 61/272 (22%), Positives = 110/272 (40%), Gaps = 28/272 (10%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG-EEFINEVASISRTSHVNIVPFLGF 266
++LG G + V++ T G A K + ++ E E+ ++S H +V
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
+ + +IYEFM G L + + D + + + +GL ++H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 327 RIVHLDIKPHNIRLDEDFCP--KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
VHLD+KP NI K+ DFGL + K+S T GTA + APEV
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVA--E 198
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE 444
V + +D++S G++ + ++ G S + + +++ D+ +D
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGL-------SPFGGENDDETLRNVKSC-DWNMDDSAFS 250
Query: 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
E K I + P R ++ + +E
Sbjct: 251 GISEDGKDFI---RKLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-45
Identities = 59/278 (21%), Positives = 103/278 (37%), Gaps = 31/278 (11%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE----FINEVASISRTSHVNIV 261
F LG+G ++ V L R A+K+++ E E +SR H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
+ +K + NG L +YI + + I LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLH 125
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
I+H D+KP NI L+ED +I+DFG AK + GTA Y++PE+
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441
SD+++ G +I+++V G I+++I + ++
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGL-------PPFRAGNEYLIFQKI-IKLEYDFPEK 232
Query: 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479
+ +++ +K + R ++
Sbjct: 233 FFPKARDLVEK-------LLVLDATKRLGCEEMEGYGP 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 156 bits (396), Expect = 6e-44
Identities = 67/292 (22%), Positives = 115/292 (39%), Gaps = 34/292 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVM-KNLKDNGEEFINEVASISRTSHVNIVPFLGF 266
++LG G + V++ GR+ K + + NE++ +++ H ++
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNI 326
+K + LI EF+ G L I + V GL+++H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHE---H 146
Query: 327 RIVHLDIKPHNIRLDEDFCP--KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
IVHLDIKP NI + KI DFGLA + E + T TA + APE+ R
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR- 202
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV--V 442
V +D+++ G++ + ++ G + E + +++F D V
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSP------FAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM--LEGSIENLQIPPKPS 492
+ E K+ K +Q P R ++ +E L+G NL S
Sbjct: 256 SPEAKDFIKN-------LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (392), Expect = 7e-44
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 31/276 (11%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE--FINEVASISRTSHVNIVPF 263
F D LG G +++V +LVA+K + G+E NE+A + + H NIV
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
LI + + G L I + K R ++ + ++YLH
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVE------KGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
+ LDED ISDFGL+K + + GT GY+APEV +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPGYVAPEVLAQ 183
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI---ETEYDFQLDG 440
S D +S G++ + ++ G + +++QI E E+D
Sbjct: 184 --KPYSKAVDCWSIGVIAYILLCGYPPFY-------DENDAKLFEQILKAEYEFDSPYWD 234
Query: 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+++ K+ + ++ P R + + ++
Sbjct: 235 DISDSAKDFIRH-------LMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-43
Identities = 56/310 (18%), Positives = 113/310 (36%), Gaps = 33/310 (10%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
+ LG+G + V++ + K +K + E++ ++ H NI+
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327
++ +I+EF+ + + I L R + + L++LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTS-----AFELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 328 IVHLDIKPHNIRLDEDFCP--KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
I H DI+P NI KI +FG A+Q + ++F + Y APEV
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQH-- 177
Query: 386 GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV--VT 443
VS +D++S G +++ ++ G +E I + EY F + ++
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFL------AETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM--LEGSIENLQIPPKPSLSLPTGYAK 501
E + + + R + ++ ++ L+ IE + +L Y
Sbjct: 232 IEAMDFVDR-------LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
Query: 502 QSSPTSSFMK 511
+ +
Sbjct: 285 LIKKDLNMVV 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 5e-43
Identities = 51/290 (17%), Positives = 98/290 (33%), Gaps = 27/290 (9%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
K+G G + D+Y GT + G VA+K+ +K + E +P + +C
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327
+ ++ + SL+ R +TV +A + +EY+H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHS---KN 123
Query: 328 IVHLDIKPHNI---RLDEDFCPKISDFGLAK-----QTEKKESFISMLDTRGTAGYIAPE 379
+H D+KP N + I DFGLAK +T + + + GTA Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 380 VFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439
S + D+ S G ++ +G ++ E + ++
Sbjct: 184 THLG--IEQSRRDDLESLGYVLMYFNLGS-------LPWQGLKAATKRQKYERISEKKMS 234
Query: 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489
+ K + +C D+P + + ++
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 8e-43
Identities = 44/292 (15%), Positives = 102/292 (34%), Gaps = 29/292 (9%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
++G+G + +++GT L + + VA+K D + +E + + +P + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 268 YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR 327
++ ++ + SL+ + R +TV A + ++ +H
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLC-----GRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 328 IVHLDIKPHNIRLDEDFCP-----KISDFGLAKQ-----TEKKESFISMLDTRGTAGYIA 377
+V+ DIKP N + + DFG+ K T++ + + GTA Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
S + D+ + G + + G + +++ I ++ ++ +
Sbjct: 182 INTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPP 489
L EE + P + + +E L
Sbjct: 240 LCAGFPEEFYKYMHY-------ARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (381), Expect = 1e-42
Identities = 59/284 (20%), Positives = 117/284 (41%), Gaps = 39/284 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK----------NLKDNGEEFINEVASISRTS- 256
+ LG+G + V + P + AVK++ +++ E + EV + + S
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
H NI+ L+++ M G L Y+ + K TL + +I +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE------KVTLSEKETRKIMRALLEV 122
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
+ LH+ + IVH D+KP NI LD+D K++DFG + Q + E + + GT Y+
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 176
Query: 377 APEVF----CRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET 432
APE+ + G + D++S G++++ ++ G + + I
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-------HRKQMLMLRMI-M 228
Query: 433 EYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
++Q ++ + K ++ + P R + + +
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLV---SRFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 3e-41
Identities = 66/276 (23%), Positives = 108/276 (39%), Gaps = 34/276 (12%)
Query: 206 SFSDKLGQGGYADVYKGTLPD-GRLVAVKVMK----NLKDNGEEFINEVASISRTS---H 257
S +G+GG+ +VY D G++ A+K + +K +NE +S S
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 258 VNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
IV + K + I + M G L ++ H + + A I GL
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS------EADMRFYAAEIILGL 120
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
E++H +V+ D+KP NI LDE +ISD GLA KK+ S+ GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
PEV + +D +S G M+ +++ G + I + T +
Sbjct: 174 PEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFR----QHKTKDKHEIDRMTLT-MAVE 227
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTK 473
L + E + + + +Q R
Sbjct: 228 LPDSFSPELRSLLEG-------LLQRDVNRRLGCLG 256
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 9e-41
Identities = 77/348 (22%), Positives = 131/348 (37%), Gaps = 55/348 (15%)
Query: 192 PKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLPD-GRLVAVKVMKNLKDNGEEFINEVA 250
P+ SY+D + +G G + VY+ L D G LVA+K + K E+
Sbjct: 17 PQEVSYTDTK--------VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65
Query: 251 SISRTSHVNIVPFLGFCYEKKKR------ALIYEFMPNGSLDQYIYDHESSNGKRTLEWR 304
+ + H NIV F Y ++ L+ +++P + S K+TL
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY---SRAKQTLPVI 122
Query: 305 TVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKKESF 363
V + R L Y+H I H DIKP N+ LD D K+ DFG AKQ + E
Sbjct: 123 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR-------------KN 410
+S + +R Y APE+ + DV+S G ++ E+++G+ +
Sbjct: 180 VSYICSR---YYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 411 ADVKVSCSSEYFPNAIYKQIETEYD----FQLDGVVTEEEKEMAKKMILVSLWCIQTHPP 466
V + + E E ++ V A + ++ P
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC---SRLLEYTPT 292
Query: 467 DRPSMTKVV------EMLEGSIENLQIPPKPSLSLPTGYAKQSSPTSS 508
R + + E+ + +++ P+L T S+P +
Sbjct: 293 ARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLA 340
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 145 bits (366), Expect = 1e-40
Identities = 54/282 (19%), Positives = 111/282 (39%), Gaps = 33/282 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEE----FINEVASISRTSHVNIVPF 263
+ LG GG ++V+ L R VAVKV++ F E + + +H IV
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 264 LGFCYEKKKRA----LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEY 319
+ ++ E++ +L ++ + + ++ + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNF 126
Query: 320 LHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAP 378
H+ I+H D+KP NI + K+ DFG+A+ + ++ GTA Y++P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
E V +SDVYS G +++E++ G + + + Y+ + +
Sbjct: 184 EQARG--DSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVREDPIPPS 235
Query: 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-SMTKVVEMLE 479
+ ++ + V L + +P +R + ++ L
Sbjct: 236 -----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 65/300 (21%), Positives = 112/300 (37%), Gaps = 34/300 (11%)
Query: 208 SDKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLG 265
S LG G V + A+K++++ + EV R S +IV +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVD 72
Query: 266 FCY----EKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
+K ++ E + G L I D G + R +I I ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDR----GDQAFTEREASEIMKSIGEAIQYLH 128
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCP---KISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
I I H D+KP N+ K++DFG AK+T S + T Y+AP
Sbjct: 129 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---YYVAP 182
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
EV D++S G++++ ++ G + + + E+
Sbjct: 183 EVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM--LEGSIENLQIPPKPSLSLP 496
V+EE K + + ++T P R ++T+ + + S + Q P S L
Sbjct: 241 WSEVSEEVKMLIRN-------LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 207 FSDKLGQGGYADVYKGT-LPDGRLVAVKVMKN----LKDNGEEFINEVASISRT-SHVNI 260
LG+G + V+ + A+K +K + D+ E + E +S H +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
K+ + E++ G L +I + A I GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFL 119
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H IV+ D+K NI LD+D KI+DFG+ K+ ++ + GT YIAPE+
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEI 174
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+H D +S+G++++EM+IG+
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-39
Identities = 63/308 (20%), Positives = 117/308 (37%), Gaps = 35/308 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG------EEFINEVASISRTSHVNIV 261
D LG+G +A VYK ++VA+K +K + + E+ + SH NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 262 PFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLH 321
L K +L+++FM + L + + +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIK------DNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVF 381
+ I+H D+KP+N+ LDE+ K++DFGLAK + T Y APE+
Sbjct: 118 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG--SPNRAYTHQVVTRWYRAPELL 172
Query: 382 CRHFGGVSHKSDVYSYGMMIHEMVIGR-------------KNADVKVSCSSEYFPNAIYK 428
D+++ G ++ E+++ + + + + E +P+
Sbjct: 173 FGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIP 488
+ + ++ + +P R + T + L+ + +
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT---QALKMKYFSNRPG 288
Query: 489 PKPSLSLP 496
P P LP
Sbjct: 289 PTPGCQLP 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 6e-39
Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 11/204 (5%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG--EEFINEVASISRTSHVNIVPFLG 265
+G+G Y V + VA+K + + + + E+ + R H NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ ++ + +Y + L + I RGL+Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSA-- 128
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTR-GTAGYIAPEVFCRH 384
++H D+KP N+ L+ KI DFGLA+ + L T Y APE+
Sbjct: 129 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
G + D++S G ++ EM+ R
Sbjct: 188 KGY-TKSIDIWSVGCILAEMLSNR 210
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-37
Identities = 66/291 (22%), Positives = 112/291 (38%), Gaps = 34/291 (11%)
Query: 209 DKLGQGGYADVYKGT--LPDGRLVAVKVMKNLKDNG---EEFINEVA---SISRTSHVNI 260
++G+G Y V+K GR VA+K ++ I EVA + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
V C + + +DQ + + + + T+ + + RGL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEV 380
H +VH D+KP NI + K++DFGLA+ + + S+ T Y APEV
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEV 186
Query: 381 FCRHFGGVSHKSDVYSYGMMIHEMVIGR-------------KNADVKVSCSSEYFPN--A 425
+ + D++S G + EM + K DV E +P A
Sbjct: 187 LLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 426 IYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ +Q Q + E+ K ++ L C+ +P R S +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLL---LKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (344), Expect = 2e-37
Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 35/288 (12%)
Query: 209 DKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFLG 265
+K+G+G Y VYK G A+K ++ K++ I E++ + H NIV
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 266 FCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCN 325
+ KK+ L++E + + LE T + + G+ Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVC------EGGLESVTAKSFLLQLLNGIAYCHD--- 118
Query: 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHF 385
R++H D+KP N+ ++ + KI+DFGLA+ T Y AP+V
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS- 175
Query: 386 GGVSHKSDVYSYGMMIHEMVIGR-------------KNADVKVSCSSEYFPNAI----YK 428
S D++S G + EMV G + + + +S+ +PN Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
T Y+ + E ++ ++ P R + + +E
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLL---SKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-36
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 37/280 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG-------EEFINEVASISRTSHVNI 260
++LG G +A V K G A K +K + E+ EV+ + H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 261 VPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYL 320
+ K LI E + G L ++ + K +L + I G+ YL
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAE------KESLTEEEATEFLKQILNGVYYL 129
Query: 321 HRGCNIRIVHLDIKPHNIRLDEDFCP----KISDFGLAKQTEKKESFISMLDTRGTAGYI 376
H I H D+KP NI L + P KI DFGLA + + F ++ GT ++
Sbjct: 130 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI---FGTPEFV 183
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436
APE+ ++ + ++D++S G++ + ++ G + + Y+F
Sbjct: 184 APEIV--NYEPLGLEADMWSIGVITYILLSGASP------FLGDTKQETLANVSAVNYEF 235
Query: 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
+ + +AK I + P R ++ ++
Sbjct: 236 EDE--YFSNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-36
Identities = 55/279 (19%), Positives = 95/279 (34%), Gaps = 45/279 (16%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLK-------DNGEEFINEVASISRTS--HV 258
LG GG+ VY G + D VA+K ++ + NG EV + + S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
++ L + LI E + L+ + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVR 124
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDED-FCPKISDFGLAKQTEKKESFISMLDTRGTAGYIA 377
+ N ++H DIK NI +D + K+ DFG + D GT Y
Sbjct: 125 HC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSP 177
Query: 378 PEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437
PE R+ + V+S G+++++MV G P ++I
Sbjct: 178 PEWI-RYHRYHGRSAAVWSLGILLYDMVCGD-------------IPFEHDEEI-IRGQVF 222
Query: 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
V+ E + + + C+ P DRP+ ++
Sbjct: 223 FRQRVSSECQHLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (336), Expect = 8e-36
Identities = 61/267 (22%), Positives = 102/267 (38%), Gaps = 36/267 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG----EEFINEVASISRTSHVNIVPF 263
LG G + V+ +GR A+KV+K E +E +S +H I+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
G + ++ +I +++ G L + + A + LEYLH
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP------NPVAKFYAAEVCLALEYLHSK 123
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
I++ D+KP NI LD++ KI+DFG AK GT YIAPEV
Sbjct: 124 D---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVST 175
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
+ D +S+G++I+EM+ G + Y++I + +
Sbjct: 176 --KPYNKSIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKI-LNAELRFPPFFN 225
Query: 444 EEEKEMAKKMILVSLWCIQTHPPDRPS 470
E+ K++ + I R
Sbjct: 226 EDVKDLLSR-------LITRDLSQRLG 245
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-35
Identities = 58/289 (20%), Positives = 105/289 (36%), Gaps = 35/289 (12%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMK---NLKDNGEEFINEVASISRTSHVNIVPFL 264
+K+G+G Y VYK G +VA+K ++ + I E++ + +H NIV L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ + K L++EF+ + + + +GL + H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASA-----LTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
++H D+KP N+ ++ + K++DFGLA+ + T Y APE+
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGC 177
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR-------------KNADVKVSCSSEYFPNAI----Y 427
S D++S G + EMV R + + +P Y
Sbjct: 178 -KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 428 KQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
K ++ Q V E + ++ + P R S +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLL---SQMLHYDPNKRISAKAALA 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 1e-33
Identities = 58/268 (21%), Positives = 98/268 (36%), Gaps = 33/268 (12%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKN----LKDNGEEFINEVASISRTSHVNIVPF 263
LG+G + V GR A+K+++ KD + E + T H +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 264 LGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRG 323
+ + E+ G L ++ R I LEYLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS- 123
Query: 324 CNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
+V+ DIK N+ LD+D KI+DFGL K+ + +M GT Y+APEV
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLED 179
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443
D + G++++EM+ GR + +++ I E + + ++
Sbjct: 180 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHERLFELILME-EIRFPRTLS 229
Query: 444 EEEKEMAKKMILVSLWCIQTHPPDRPSM 471
E K + ++ P R
Sbjct: 230 PEAKSLLAG-------LLKKDPKQRLGG 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 4e-33
Identities = 53/299 (17%), Positives = 103/299 (34%), Gaps = 41/299 (13%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFL 264
K+GQG + +V+K G+ VA+K + + + E+ + H N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 265 GFCYEKKKRA--------LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARG 316
C K L+++F + N + ++ + G
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQMLLNG 129
Query: 317 LEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ--TEKKESFISMLDTRGTAG 374
L Y+HR +I+H D+K N+ + D K++DFGLA+ K + T
Sbjct: 130 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 375 YIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR-------------KNADVKVSCSSEY 421
Y PE+ D++ G ++ EM + + S + E
Sbjct: 187 YRPPELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSL----WCIQTHPPDRPSMTKVVE 476
+PN ++ + + +++ A +L + P R +
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-32
Identities = 53/290 (18%), Positives = 107/290 (36%), Gaps = 37/290 (12%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFL 264
+K+G+G Y V+K +VA+K ++ D+ + E+ + H NIV
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ KK L++EF + + L+ V + +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCH--- 118
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
+ ++H D+KP N+ ++ + K+++FGLA+ S T Y P+V
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVVTLWYRPPDVLFGA 176
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR--------------KNADVKVSCSSEYFPNAI---- 426
S D++S G + E+ + + + + E +P+
Sbjct: 177 -KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 427 YKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476
YK V + + ++ ++ +P R S + ++
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLL---QNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-31
Identities = 55/288 (19%), Positives = 105/288 (36%), Gaps = 31/288 (10%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFL 264
+G G Y V G VA+K + + + E+ + H N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ +F + K L + + + +GL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
I H D+KP N+ ++ED KI DFGLA+Q + + M T Y APEV
Sbjct: 142 II---HRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNW 193
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR--------KNADVKVSCSSEYFPNAIYKQIETEYDF 436
+ D++S G ++ EM+ G+ + ++ + P ++++++
Sbjct: 194 -MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 437 Q-LDGVVTEEEKEMAKKMILVS-------LWCIQTHPPDRPSMTKVVE 476
+ G+ E+K+ A + S + R + + +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (304), Expect = 2e-31
Identities = 44/205 (21%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGF 266
KLG+G Y++V++ + + V VK++K ++ E+ + NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 267 CYEKKKR--ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ R AL++E + N Q +TL + I + L+Y H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 325 NIRIVHLDIKPHNIRLDEDFCP-KISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCR 383
I+H D+KPHN+ +D + ++ D+GLA+ + + + + + PE+
Sbjct: 150 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELLVD 203
Query: 384 HFGGVSHKSDVYSYGMMIHEMVIGR 408
+ + D++S G M+ M+ +
Sbjct: 204 Y-QMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 121 bits (304), Expect = 4e-31
Identities = 45/240 (18%), Positives = 90/240 (37%), Gaps = 26/240 (10%)
Query: 174 RHDQNAEAAFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGT-LPDGRLVAV 232
A+ F++ + + + R+ LG G + V G A+
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRI-----KTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 233 KVMKNLKDNG----EEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY 288
K++ K E +NE + + +V + ++ E++ G + +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 289 IYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKI 348
+ A I EYLH + +++ D+KP N+ +D+ ++
Sbjct: 132 LRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 349 SDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+DFG AK+ + + GT +APE+ G + D ++ G++I+EM G
Sbjct: 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-31
Identities = 62/312 (19%), Positives = 113/312 (36%), Gaps = 44/312 (14%)
Query: 209 DKLGQGGYADVYKGTL----PDGRLVAVKVMK-----NLKDNGEEFINEVASISRTSHV- 258
LG G Y V+ G+L A+KV+K E E +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 259 NIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
+V + K LI +++ G L ++ V I LE
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
+LH+ + I++ DIK NI LD + ++DFGL+K+ E+ + D GT Y+AP
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMAP 199
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438
++ G D +S G++++E++ G V + I ++I + +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD---GEKNSQAEISRRI-LKSEPPY 255
Query: 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTK--VVEMLE---------GSIENLQI 487
++ K++ ++ + P R E+ E + ++
Sbjct: 256 PQEMSALAKDLIQR-------LLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 308
Query: 488 PP--KPSLSLPT 497
P KP +
Sbjct: 309 PAPFKPVIRDEL 320
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 7e-29
Identities = 44/212 (20%), Positives = 83/212 (39%), Gaps = 16/212 (7%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFC 267
KLG G ++ V+ + + VA+K+++ K E +E+ + R + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 268 ----------YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGL 317
+ K ++ M L + + R + V QI+ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 318 EYLHRGCNIRIVHLDIKPHNIRLD-EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYI 376
+Y+HR C I+H DIKP N+ ++ D + +A ++ T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 377 APEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
+PEV +D++S +I E++ G
Sbjct: 197 SPEVLLG--APWGCGADIWSTACLIFELITGD 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-27
Identities = 49/210 (23%), Positives = 75/210 (35%), Gaps = 27/210 (12%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFL 264
+G G V R VA+K + N + E+ + +H NI+ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 265 GFC------YEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLE 318
E + L+ E M + + + + + G++
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---------HERMSYLLYQMLCGIK 133
Query: 319 YLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAP 378
+LH I H D+KP NI + D KI DFGLA+ M T Y AP
Sbjct: 134 HLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 187
Query: 379 EVFCRHFGGVSHKSDVYSYGMMIHEMVIGR 408
EV G D++S G ++ EMV +
Sbjct: 188 EVILGM--GYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-26
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 15/204 (7%)
Query: 209 DKLGQGGYADVYKGT-LPDGRLVAVKVMKNLKDNG---EEFINEVASISRTSHVNIVPFL 264
+G G Y V G VAVK + + + E+ + H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 265 GFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC 324
+ + L ++ K L V + I RGL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSAD 141
Query: 325 NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRH 384
I H D+KP N+ ++ED KI DFGLA+ T+ + + T Y APE+
Sbjct: 142 II---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLNW 193
Query: 385 FGGVSHKSDVYSYGMMIHEMVIGR 408
+ D++S G ++ E++ GR
Sbjct: 194 -MHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 1e-22
Identities = 30/210 (14%), Positives = 60/210 (28%), Gaps = 33/210 (15%)
Query: 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN-----------GEEFINEVASISR 254
+ +G+G + V+ VK K + F +R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 255 TSHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIA 314
+ G K +Y + N L + I E + ++ I
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKE----LYRVRVENPDEVLDMIL 113
Query: 315 RGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAG 374
+ + IVH D+ +N+ L + I DF + + ++ +L+
Sbjct: 114 EEVAKFYHRG---IVHGDLSQYNV-LVSEEGIWIIDFPQSVEVGEEGWR-EILER----- 163
Query: 375 YIAPEVFCRHFGGV-SHKSDVYSYGMMIHE 403
+F + D+ S I +
Sbjct: 164 --DVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.17 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-54 Score=413.94 Aligned_cols=255 Identities=24% Similarity=0.436 Sum_probs=203.1
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGS 284 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 284 (511)
+.+.++||+|+||+||+|.+++++.||||+++......++|.+|++++++++|||||+++|+|.+.+..++||||+++|+
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 35678999999999999999888999999998877777899999999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCcee
Q 040808 285 LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFI 364 (511)
Q Consensus 285 L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 364 (511)
|.+++... ...+++..++.|+.|||.||+|||+. +|+||||||+|||+|+++.+||+|||+++.........
T Consensus 87 L~~~l~~~-----~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 87 LSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp HHHHHHTT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred HHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99998643 25689999999999999999999998 99999999999999999999999999998775543322
Q ss_pred eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCCh
Q 040808 365 SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE 444 (511)
Q Consensus 365 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (511)
.....||+.|+|||++.+. .++.++|||||||++|||+|++.|+.... -...+...+........+...+
T Consensus 159 -~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~------~~~~~~~~i~~~~~~~~p~~~~- 228 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTGFRLYKPRLAS- 228 (263)
T ss_dssp -------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSC------CHHHHHHHHHHTCCCCCCTTSC-
T ss_pred -ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCC------CHHHHHHHHHhcCCCCCccccC-
Confidence 2345699999999999764 78999999999999999999655543221 1333444555544433333333
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 445 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
..+.+++.+||+.||++||||+||++.|+++.+
T Consensus 229 ------~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 229 ------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 346778899999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=413.97 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=212.3
Q ss_pred HHHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
..+.+.++||+|+||+||+|.+++++.||||+++......++|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 3456788999999999999999888999999998877778899999999999999999999998865 457899999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.... ...+++..++.|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+.......
T Consensus 92 g~L~~~~~~~~----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 92 GSLVDFLKTPS----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CBHHHHTTSHH----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CcHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999885432 24699999999999999999999998 999999999999999999999999999998765433
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
. ......||+.|+|||++... .++.++|||||||++|||+||+.|+.... ....+...+........+...
T Consensus 165 ~-~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~------~~~~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 165 T-AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHTTCCCCCCTTC
T ss_pred c-cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhcCCCCCcccC
Confidence 2 23455799999999999653 68899999999999999999766654221 233445555555444433333
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
+ ..+.+++.+||+.||++||||++|+++|+...
T Consensus 236 ~-------~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 236 P-------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp C-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h-------HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 3 34667888999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=414.59 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=201.5
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
+.+.++||+|+||+||+|+.++ .||||+++... ...++|.+|+.++++++|||||++++++.+ ...++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 4567899999999999998653 59999997543 234689999999999999999999998765 46799999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.... ..+++..+..|+.||++||+|||++ +|+||||||+||||++++.+||+|||+|+......
T Consensus 87 ~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 87 GSSLYHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEHHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 999999996432 4699999999999999999999998 99999999999999999999999999998776544
Q ss_pred ceeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
.........||+.|+|||++... .+.++.++|||||||++|||+||+.||.... ....+...+..........
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~------~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------NRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHHTSCCCCGG
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC------hHHHHHHHHhcCCCCCcch
Confidence 33334456799999999998643 2357899999999999999999999986432 1223333333332111101
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
.. ..+....+.+++.+||+.||++||||++|++.|+.+.+++
T Consensus 233 ~~---~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 233 KV---RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GS---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hc---cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11 1123345777889999999999999999999999877654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-53 Score=411.07 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=218.6
Q ss_pred HHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 200 VRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 200 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
+....+.+.++||+|+||+||+|.++ +|+.||||+++......++|.+|+++|++++|||||+++++|.+.+..++|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 33445567889999999999999965 58899999998877778899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+...
T Consensus 94 ~~~~g~l~~~l~~~~----~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 94 FMTYGNLLDYLRECN----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp CCTTCBHHHHHHHSC----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred cccCcchHHHhhhcc----ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999996532 35799999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.|+.... -...+.+.+........
T Consensus 167 ~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~------~~~~~~~~i~~~~~~~~ 237 (287)
T d1opja_ 167 GDTYT-AHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEKDYRMER 237 (287)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHTTCCCCC
T ss_pred CCCce-eeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcc------hHHHHHHHHhcCCCCCC
Confidence 54432 23345689999999998664 78999999999999999999887764322 13344455555444443
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
+...+ ..+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 238 ~~~~~-------~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 PEGCP-------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred Cccch-------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 33333 3466788899999999999999999999987653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-52 Score=412.76 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=196.0
Q ss_pred hhcccCCcCceEEEEEEcC-CC---cEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 207 FSDKLGQGGYADVYKGTLP-DG---RLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 207 ~~~~LG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
+.++||+|+||+||+|.++ ++ ..||||.+..... ..++|.+|+++|++++|||||+++|+|.+.+..++||||+
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 4568999999999999865 23 3689998875433 3357999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++... ...++|..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 110 ~~g~L~~~~~~~-----~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 110 ENGSLDSFLRQN-----DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp TTEEHHHHHHTT-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCcceeeeccc-----cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 999999988543 24699999999999999999999998 9999999999999999999999999999877544
Q ss_pred Ccee---eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 361 ESFI---SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 361 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.... ......||+.|+|||.+.+ +.++.++|||||||++|||+| |+.||... ....+...+......
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-------~~~~~~~~i~~~~~~ 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDM-------TNQDVINAIEQDYRL 252 (299)
T ss_dssp --------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTCCC
T ss_pred CCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCC-------CHHHHHHHHHcCCCC
Confidence 3321 1223458999999999865 478999999999999999998 88888533 133444555554443
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
..+... ...+.+++.+||+.||++||||+||++.|+.++++
T Consensus 253 ~~~~~~-------~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 PPPMDC-------PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp CCCTTC-------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCccc-------hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 333333 34567788999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-52 Score=397.79 Aligned_cols=250 Identities=22% Similarity=0.397 Sum_probs=213.5
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
.|.++||+|+||+||+|++++++.||||++++.....++|.+|+.++++++|||||+++|+|.+.+..++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 46789999999999999998889999999998777788999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceee
Q 040808 286 DQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFIS 365 (511)
Q Consensus 286 ~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 365 (511)
..++.... ..+++..+.+|+.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~ 157 (258)
T d1k2pa_ 87 LNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-S 157 (258)
T ss_dssp HHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-C
T ss_pred HHhhhccc-----cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce-e
Confidence 99985433 5789999999999999999999998 9999999999999999999999999999876554332 2
Q ss_pred ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCCh
Q 040808 366 MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTE 444 (511)
Q Consensus 366 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (511)
.....||+.|+|||.+... .++.++||||||+++|||+| |+.||... -...+...+........+...+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-------~~~~~~~~i~~~~~~~~p~~~~- 227 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERF-------TNSETAEHIAQGLRLYRPHLAS- 227 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTS-------CHHHHHHHHHTTCCCCCCTTCC-
T ss_pred ecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCC-------CHHHHHHHHHhCCCCCCccccc-
Confidence 3345699999999999764 78999999999999999998 78888533 2344555555554444333333
Q ss_pred HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhc
Q 040808 445 EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEG 480 (511)
Q Consensus 445 ~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~ 480 (511)
..+.+++.+||+.||++|||++++++.|.+
T Consensus 228 ------~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 228 ------EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ------HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 356678889999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=406.05 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=209.0
Q ss_pred HHhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
.+++.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++|||||+++|+|.+ +..++||||+++|
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 467889999999999999999888899999998877777899999999999999999999999865 4578999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|..++.... ...++|..++.|+.||+.||+|||+. +|+||||||+|||||+++.+||+|||+++.......
T Consensus 97 ~l~~~~~~~~----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~- 168 (285)
T d1fmka3 97 SLLDFLKGET----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 168 (285)
T ss_dssp BHHHHHSHHH----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred chhhhhhhcc----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence 9999986532 24699999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVT 443 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (511)
.......||+.|+|||++.. +.++.++||||||+++|||++|+.|+.... ....+...+........+...+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~------~~~~~~~~i~~~~~~~~~~~~~ 240 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVERGYRMPCPPECP 240 (285)
T ss_dssp -------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHTTCCCCCCTTSC
T ss_pred eeeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCC------CHHHHHHHHHhcCCCCCCcccC
Confidence 22334569999999999965 478999999999999999999877664322 2333444455444444444433
Q ss_pred hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 444 EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 444 ~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
..+.+++.+||+.||++||||++|+++|+......+
T Consensus 241 -------~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 241 -------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp -------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -------HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 346678889999999999999999999999876653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-52 Score=401.45 Aligned_cols=249 Identities=25% Similarity=0.306 Sum_probs=197.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|.++ +|+.||||+++... ...+++.+|++++++++|||||++++++.+.+..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 456789999999999999965 69999999997543 234578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 87 gg~L~~~l~~------~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 87 GGELFDRIEP------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TEEGGGGSBT------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999842 34799999999999999999999998 99999999999999999999999999999875544
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc-cccCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD-FQLDG 440 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 440 (511)
.........||+.|+|||++.+. ...+.++|||||||++|||++|+.||..... .......+..... .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~~~~~~~~~~~~~~ 230 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNPWK 230 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSST------TSHHHHHHHTTCTTSTTGG
T ss_pred ccccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCCCCccc
Confidence 33334456799999999999654 2346789999999999999999999964321 1111112211111 11112
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.++ ..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~s-------~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 231 KID-------SAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GSC-------HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC-------HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 233 33456677899999999999999853
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=394.02 Aligned_cols=242 Identities=25% Similarity=0.400 Sum_probs=202.6
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|.++ +++.||+|++.+. ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 567889999999999999965 6899999998642 33456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~~g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 88 APLGTVYRELQKL------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred cCCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999643 4699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+.+... ...++
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~-~~~~p 224 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRV-EFTFP 224 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTT-CCCCC
T ss_pred Ccc----cccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcC-CCCCC
Confidence 432 345699999999999764 67899999999999999999999996431 33344444332 22333
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...++ .+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~s~-------~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 DFVTE-------GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCH-------HHHHHHHHHccCCHhHCcCHHHHHc
Confidence 34444 3455667888999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=396.84 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=206.3
Q ss_pred hhc-ccCCcCceEEEEEEcC---CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 207 FSD-KLGQGGYADVYKGTLP---DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 207 ~~~-~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
+.+ +||+|+||+||+|.++ ++..||||+++.... ..++|.+|+++|++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 5999999999999754 355799999975432 34689999999999999999999999865 4689999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 91 ~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 91 GGGPLHKFLVGK-----REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp TTEEHHHHHTTC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred CCCcHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 999999998432 35799999999999999999999998 9999999999999999999999999999987654
Q ss_pred Cceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 361 ESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 361 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
..... .....||+.|+|||++... .++.++|||||||++|||+| |+.||.... ...+...+..+.....
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-------~~~~~~~i~~~~~~~~ 233 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRMEC 233 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------THHHHHHHHTTCCCCC
T ss_pred ccccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCC
Confidence 43322 2234689999999999653 78999999999999999998 899986331 2234455555544444
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
+...+ ..+.+++.+||+.||++||||.+|++.|+....++
T Consensus 234 p~~~~-------~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 234 PPECP-------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CTTCC-------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCcCC-------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 44443 34667889999999999999999999998655433
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=394.41 Aligned_cols=247 Identities=25% Similarity=0.404 Sum_probs=199.2
Q ss_pred cccCCcCceEEEEEEcC---CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 209 DKLGQGGYADVYKGTLP---DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
++||+|+||+||+|.++ .++.||||+++....+ .++|.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 36999999999999854 3568999999754322 3679999999999999999999999865 457899999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 92 g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999999643 4699999999999999999999998 999999999999999999999999999998765443
Q ss_pred eee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCC
Q 040808 363 FIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDG 440 (511)
Q Consensus 363 ~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (511)
... .....||+.|+|||.+... .++.++|||||||++|||++ |+.||... -...+...+..+.....+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~-------~~~~~~~~i~~~~~~~~p~ 233 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGM-------KGSEVTAMLEKGERMGCPA 233 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCT
T ss_pred ccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCC-------CHHHHHHHHHcCCCCCCCc
Confidence 322 2345699999999999653 68899999999999999998 89998632 1334455555554444443
Q ss_pred CCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 441 VVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 441 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
..+ ..+.+++.+||+.||++|||+++|+++|+..
T Consensus 234 ~~~-------~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 234 GCP-------REMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCC-------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccC-------HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 333 3466788899999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=396.76 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=200.5
Q ss_pred hhhcccCCcCceEEEEEEcCC-C----cEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLPD-G----RLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.+.+.||+|+||+||+|.+++ + ..||||+++..... ..+|.+|++++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 456789999999999998653 2 47999999754332 3578999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+.+|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 90 ~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 90 YMENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp CCTTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred ecccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999886433 5799999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... .......||+.|+|||++.+ +.++.++|||||||++|||++|+.|+.... ....+.+.+..+....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~------~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMKAINDGFRLP 233 (283)
T ss_dssp ------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTTCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccC------CHHHHHHHHhccCCCC
Confidence 43321 22234568999999999965 478999999999999999999776654321 2344555555554443
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
.+.. ....+.+++.+||+.||++||||+||+++|+.+++
T Consensus 234 ~~~~-------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 TPMD-------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCTT-------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred Cchh-------hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 3332 23457788899999999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=395.91 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=191.4
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEee--cCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYE--KKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 278 (511)
|.+.+.||+|+||+||+|+.+ +|+.||+|+++..... .+.+.+|++++++++|||||++++++.+ ....++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 456789999999999999854 6999999999765432 3568899999999999999999999865 456899999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC--NIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|+++|+|.+++.... .....+++..++.++.||+.||+|||++. ..+|+||||||+||||++++.+||+|||+|+.
T Consensus 86 y~~~g~L~~~i~~~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 86 YCEGGDLASVITKGT--KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp CCTTEEHHHHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred cCCCCcHHHHHHhcc--ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999996532 12357999999999999999999999862 12499999999999999999999999999998
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||... -...+...+......
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~-------~~~~~~~~i~~~~~~ 232 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAF-------SQKELAGKIREGKFR 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHTCCC
T ss_pred cccCCCc--cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCC-------CHHHHHHHHHcCCCC
Confidence 7554322 2345799999999999654 6899999999999999999999998633 133444455444333
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.++...++ .+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~s~-------~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 RIPYRYSD-------ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcccCH-------HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 33334444 3556677899999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=392.65 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=199.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.++||+|+||+||+|.++ +|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 566789999999999999954 69999999987543 3457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.. ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 102 g~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 102 GSLTDVVTE-------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CBHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CcHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999998743 3589999999999999999999998 999999999999999999999999999987754432
Q ss_pred eeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-ccccCCC
Q 040808 363 FISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-DFQLDGV 441 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 441 (511)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+.+........ ....+..
T Consensus 172 ~--~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp C--BCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCSCCCSSGGG
T ss_pred c--ccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCC------HHHHHHHHHhCCCCCCCCccc
Confidence 1 2345699999999999764 67899999999999999999999995321 1222222222211 1122223
Q ss_pred CChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+++ .+.+++.+||+.||++|||++|+++
T Consensus 242 ~s~-------~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSA-------IFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCH-------HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCH-------HHHHHHHHHccCChhHCcCHHHHhc
Confidence 333 3556677888999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=405.73 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=207.0
Q ss_pred HHhhhcccCCcCceEEEEEEcCC-C-----cEEEEEEeccC--CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD-G-----RLVAVKVMKNL--KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 274 (511)
.+.+.++||+|+||+||+|++.. + ..||+|++... ......+.+|+.++.++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 45678899999999999998542 2 36999998653 23346899999999998 8999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCC
Q 040808 275 LIYEFMPNGSLDQYIYDHESS-----------------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHN 337 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~N 337 (511)
+||||+++|+|.++|...... .....+++..++.|+.||+.||+|||++ +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 999999999999999764321 1124689999999999999999999998 99999999999
Q ss_pred EEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccC
Q 040808 338 IRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVS 416 (511)
Q Consensus 338 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~ 416 (511)
||++.++.+||+|||+|+...............||+.|+|||++.+. .++.++|||||||++|||++ |+.||....
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~- 271 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIP- 271 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCC-
Confidence 99999999999999999887665554444456689999999999653 78999999999999999998 898885321
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhh
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLE 479 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~ 479 (511)
....+.+.+.....+..+...++ .+.+++.+||+.||++|||++||++.|.
T Consensus 272 -----~~~~~~~~~~~~~~~~~p~~~~~-------~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 -----VDANFYKLIQNGFKMDQPFYATE-------EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -----CSHHHHHHHHTTCCCCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHHHhcCCCCCCCCcCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 12334444445444444444443 4667888899999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=391.37 Aligned_cols=242 Identities=26% Similarity=0.389 Sum_probs=195.5
Q ss_pred hhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEee----cCeEEEEE
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYE----KKKRALIY 277 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 277 (511)
.|.++||+|+||+||+|.+. +++.||+|++..... ..+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 46678999999999999965 688999999875432 23578999999999999999999999865 34679999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--cEecCCCCCCEEEc-CCCceEEeeccCc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIR--IVHLDIKPHNIRLD-EDFCPKISDFGLA 354 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~DFGla 354 (511)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ + |+||||||+||||+ +++.+||+|||+|
T Consensus 92 E~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp ECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred eCCCCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 999999999999643 4689999999999999999999997 6 99999999999996 5899999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.... -...+.+.+....
T Consensus 163 ~~~~~~~~----~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~~i~~~~ 229 (270)
T d1t4ha_ 163 TLKRASFA----KAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGV 229 (270)
T ss_dssp GGCCTTSB----EESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTC
T ss_pred eeccCCcc----CCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcc------cHHHHHHHHHcCC
Confidence 87544332 24569999999999854 58899999999999999999999985321 2333444444332
Q ss_pred cc-ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DF-QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~-~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ..+...++ .+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~-------~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 230 KPASFDKVAIP-------EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCGGGGGCCCH-------HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcccCccCCH-------HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 21 12222232 3556778899999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=395.79 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=199.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 282 (511)
|++.++||+|+||+||+|.++ +|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 556789999999999999964 68999999997543 3457899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCc
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKES 362 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 362 (511)
|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 94 g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 94 GAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999985432 4699999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeecCCCCCCCccchhhcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc--c
Q 040808 363 FISMLDTRGTAGYIAPEVFCRH---FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF--Q 437 (511)
Q Consensus 363 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 437 (511)
......||+.|+|||++... ...++.++|||||||++|||++|+.||.... +..+...+...... .
T Consensus 166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 166 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-------PMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp --HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------GGGHHHHHHHSCCCCCS
T ss_pred --cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCC
Confidence 12345799999999998432 2357889999999999999999999986432 11222223222111 1
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+...+ ..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~s-------~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWS-------SNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSC-------HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCC-------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112223 34556778899999999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=394.96 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=200.9
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|..+ +|+.||||++++. ....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 567889999999999999964 6999999999742 33457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 90 ~~gg~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 90 AKNGELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCCHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999998543 4699999999999999999999998 999999999999999999999999999998765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||... -+..+...+... ...++
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~~~~~~~i~~~-~~~~p 230 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAG-------NEYLIFQKIIKL-EYDFP 230 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHTT-CCCCC
T ss_pred CCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCc-------CHHHHHHHHHcC-CCCCC
Confidence 4433333456799999999999764 6889999999999999999999999643 133444444332 22333
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..+++ .+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~s~-------~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 EKFFP-------KARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TTCCH-------HHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ccCCH-------HHHHHHHHHccCCHhHCcCHHHHcC
Confidence 34444 3556778899999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-50 Score=395.18 Aligned_cols=259 Identities=23% Similarity=0.385 Sum_probs=208.8
Q ss_pred HhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
+.+.++||+|+||+||+|+.+ +++.||||+++..... .++|.+|++++++++||||++++++|.+....++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 456789999999999999853 4578999999754332 35799999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccC------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCE
Q 040808 277 YEFMPNGSLDQYIYDHES------------------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNI 338 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NI 338 (511)
|||+++|+|.+++..... ......+++..++.|+.|++.||+|||+. +|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 999999999999975321 11234589999999999999999999998 999999999999
Q ss_pred EEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCC-CCCCccCC
Q 040808 339 RLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK-NADVKVSC 417 (511)
Q Consensus 339 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~-p~~~~~~~ 417 (511)
|||.++.+||+|||+|+...............||+.|+|||.+.+. .++.++|||||||++|||++|.. |+...
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~--- 246 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGM--- 246 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTS---
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCC---
Confidence 9999999999999999877655444444456789999999999764 78999999999999999999975 44322
Q ss_pred CCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccc
Q 040808 418 SSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSI 482 (511)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 482 (511)
-...+...+........+...+ ..+.+++.+||+.+|++||||.||+++|+++.
T Consensus 247 ----~~~e~~~~v~~~~~~~~p~~~~-------~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 ----AHEEVIYYVRDGNILACPENCP-------LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----CHHHHHHHHHTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----CHHHHHHHHHcCCCCCCCccch-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2334444555544333333333 35778899999999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-50 Score=393.77 Aligned_cols=245 Identities=25% Similarity=0.325 Sum_probs=198.2
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
.|...++||+|+||+||+|.. .+|+.||||+++..... .+++.+|+.++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 356678999999999999985 47899999999765432 2468899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|..++.. ...+++..++.|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp CCSEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 9999999877643 24699999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRH-FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
.. ....||+.|+|||++.+. .+.++.++|||||||++|||++|+.||.... ..+.+.+.........
T Consensus 167 ~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~------~~~~~~~i~~~~~~~~ 234 (309)
T d1u5ra_ 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESPAL 234 (309)
T ss_dssp SB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCCCC
T ss_pred CC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCCCC
Confidence 43 235699999999998642 2468899999999999999999999985321 1222222222222112
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.....++ .+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~s~-------~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 QSGHWSE-------YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCTTSCH-------HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCH-------HHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2222333 4556777899999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-50 Score=394.17 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=185.2
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC--CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK--DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.|.+.+.||+|+||+||+|.++ +|+.||||++.+.. ...+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3677889999999999999965 68999999997543 23356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc---CCCceEEeeccCcccc
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISDFGLAKQT 357 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~ 357 (511)
++|+|.++|.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||+|+..
T Consensus 90 ~gg~L~~~l~~------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 90 SGGELFDRIVE------KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CSCBHHHHHHT------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred CCCcHHHhhhc------ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999953 24699999999999999999999998 999999999999994 5789999999999876
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ 437 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (511)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+..... .
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~-~ 227 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDEN-------DAKLFEQILKAEY-E 227 (307)
T ss_dssp ---------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHTTCC-C
T ss_pred cCCCe---eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHhccCC-C
Confidence 54432 2345699999999999764 68999999999999999999999996331 2233333332221 1
Q ss_pred cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
..... ...+...+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPY---WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTT---TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCcc---ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11111 1112234566778889999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=398.47 Aligned_cols=197 Identities=26% Similarity=0.384 Sum_probs=171.6
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.|.+.++||+|+||+||+|.+. +|+.||+|+++.... ..+++.+|+.+|++++|||||+++++|.+.++.++||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 3556789999999999999964 689999999975432 2467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
++|+|.+++... ..+++..+..++.|++.||+|||++ .+|+||||||+||||++++.+||+|||+|+.....
T Consensus 87 ~gg~L~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 87 DGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp TTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999643 3689999999999999999999963 18999999999999999999999999999876433
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
.. ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 159 ~~----~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 MA----NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp TC-------CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred cc----ccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 21 245799999999999764 7899999999999999999999999643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=392.99 Aligned_cols=282 Identities=25% Similarity=0.437 Sum_probs=222.5
Q ss_pred hhCCCCCCCCCHH---HHHHHHHhhhcccCCcCceEEEEEEc------CCCcEEEEEEeccCCC--ChHHHHHHHHHHHc
Q 040808 186 NYGSLAPKRFSYS---DVRRMTKSFSDKLGQGGYADVYKGTL------PDGRLVAVKVMKNLKD--NGEEFINEVASISR 254 (511)
Q Consensus 186 ~~~~~~~~~~~~~---e~~~~~~~~~~~LG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~ 254 (511)
+|....|+.+++. |+.+..+.+.++||+|+||.||+|++ .+++.||||+++.... ...+|.+|+.++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~ 82 (311)
T d1t46a_ 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82 (311)
T ss_dssp TTCCCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHH
T ss_pred CceeeCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHh
Confidence 4555566665542 34455667889999999999999974 2467899999976443 23578999999999
Q ss_pred c-CCcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 040808 255 T-SHVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESS------------NGKRTLEWRTVYQIAVGIARGLEYLH 321 (511)
Q Consensus 255 l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~yLH 321 (511)
+ +|||||+++++|.+....++||||+++|+|.+++...... .....+++..+..++.||+.||+|||
T Consensus 83 l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH 162 (311)
T d1t46a_ 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162 (311)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9 6999999999999999999999999999999999764321 12346899999999999999999999
Q ss_pred hCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHH
Q 040808 322 RGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMI 401 (511)
Q Consensus 322 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il 401 (511)
++ +++||||||+|||++.++.+|++|||+++...............||+.|+|||++.. +.++.++||||||+++
T Consensus 163 ~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 163 SK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFL 237 (311)
T ss_dssp HT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHH
T ss_pred hC---CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHH
Confidence 98 999999999999999999999999999998876655555556679999999999965 4789999999999999
Q ss_pred HHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 402 HEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 402 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
|||+|++.|+..... ....+.+.+........+...+ ..+.+++.+||+.||++||||++|+++|++.
T Consensus 238 ~ellt~g~p~~~~~~-----~~~~~~~~i~~~~~~~~~~~~~-------~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 238 WELFSLGSSPYPGMP-----VDSKFYKMIKEGFRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHTTTCCSSTTCC-----SSHHHHHHHHHTCCCCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCC-----HHHHHHHHHhcCCCCCCccccc-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 999996555432211 1233344444444333332222 3477788999999999999999999999976
Q ss_pred ccC
Q 040808 482 IEN 484 (511)
Q Consensus 482 ~~~ 484 (511)
+.+
T Consensus 306 i~~ 308 (311)
T d1t46a_ 306 ISE 308 (311)
T ss_dssp HHH
T ss_pred hcc
Confidence 543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=390.49 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=200.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCc----EEEEEEeccC--CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGR----LVAVKVMKNL--KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 277 (511)
|++.++||+|+||+||+|.+. +|+ .||+|.++.. ....++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 466789999999999999854 444 5888888643 33457899999999999999999999999875 567888
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
|++.+|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+..
T Consensus 90 e~~~~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 90 QLMPFGCLLDYVREH-----KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp ECCTTCBHHHHHHHT-----SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EeccCCccccccccc-----ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 999999999988653 35799999999999999999999998 9999999999999999999999999999987
Q ss_pred CCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 358 EKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 358 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
.............||+.|+|||++.+ +.++.++|||||||++|||+| |+.|++... ...+...+..+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-------~~~~~~~i~~~~~~ 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILEKGERL 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------GGGHHHHHHHTCCC
T ss_pred ccccccccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCC
Confidence 65554433444569999999999966 478999999999999999998 677775331 22344445444444
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
..+...+ ..+.+++.+||+.||++|||+.||++.|+...+
T Consensus 233 ~~p~~~~-------~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 PQPPICT-------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCTTBC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccC-------HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 3333333 346678889999999999999999999887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=382.60 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=195.9
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEee-cCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYE-KKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g 283 (511)
+.+.++||+|+||.||+|.++ |+.||||++++. ...++|.+|++++++++|||||+++|+|.+ .+..++||||+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 356789999999999999984 678999999764 345789999999999999999999999865 45689999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCCce
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKESF 363 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 363 (511)
+|.++|.... ...++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~~----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 87 SLVDYLRSRG----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp EHHHHHHHHH----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CHHHHHHhcC----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999996532 24589999999999999999999998 99999999999999999999999999998764432
Q ss_pred eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhccccCCCC
Q 040808 364 ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGVV 442 (511)
Q Consensus 364 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (511)
....+|+.|+|||++.+ +.++.++||||||+++|||+| |+.|+... ....+...+..+.....+...
T Consensus 158 ---~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~-------~~~~~~~~i~~~~~~~~~~~~ 225 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPRVEKGYKMDAPDGC 225 (262)
T ss_dssp -------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-------CGGGHHHHHTTTCCCCCCTTC
T ss_pred ---ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHcCCCCCCCccC
Confidence 23458999999999975 378999999999999999998 56666432 122334445554444444433
Q ss_pred ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 443 TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 443 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
+ ..+.+++.+||+.||++||||.+|+++|+.+
T Consensus 226 ~-------~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 226 P-------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp C-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-------HHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 3 3456778899999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=392.03 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=200.6
Q ss_pred HHHHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeec-C
Q 040808 202 RMTKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEK-K 271 (511)
Q Consensus 202 ~~~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 271 (511)
+..+.+.++||+|+||+||+|.+. +++.||||+++.... ..+++.+|+.++.++ +|+|||.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345677899999999999999843 346899999975432 235788888888777 688999999988654 4
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD 341 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~ 341 (511)
..++||||+++|+|.+++...... .....+++..++.++.||++||+|||++ +|+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 689999999999999999754311 1234689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCC-CCCCccCCCCC
Q 040808 342 EDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRK-NADVKVSCSSE 420 (511)
Q Consensus 342 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~-p~~~~~~~~~~ 420 (511)
+++.+||+|||+|+...............||+.|+|||++.+ +.++.++|||||||++|||++|.. |+....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~----- 241 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----- 241 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCC-----
Confidence 999999999999987765554444445679999999999976 378999999999999999999765 553221
Q ss_pred CchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 421 YFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+...+..+.....+...++ .+.+++.+||+.||++|||++||++.|+.+++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~-------~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 242 -IDEEFCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -CSHHHHHHHHHTCCCCCCTTCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHhcCCCCCCCccCCH-------HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 23344455555544444433333 46678889999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.7e-49 Score=393.56 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=201.6
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||+|+||+||+|..+ +|+.||||++..... ..+.+.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4677889999999999999964 699999999975433 24678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc--CCCceEEeeccCccccCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD--EDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~ 359 (511)
+|+|.+++... ...+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++....
T Consensus 107 gg~L~~~l~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 107 GGELFEKVADE-----HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp SCBHHHHHTCT-----TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999432 34699999999999999999999998 999999999999995 468899999999998765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+..... ..+
T Consensus 179 ~~~~---~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~-~~~ 245 (350)
T d1koaa2 179 KQSV---KVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKSCDW-NMD 245 (350)
T ss_dssp TSCE---EEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCC-CSC
T ss_pred cccc---ceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCC-CCC
Confidence 5443 234699999999999764 67899999999999999999999996331 2333333332211 111
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
. .....+...+.+++.+||+.||++|||++|+++.
T Consensus 246 ~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 D---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp C---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1111122345567778899999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=383.37 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=201.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCC-------CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLK-------DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
.|.+.++||+|+||+||+|.++ +|+.||||++++.. ...+.+.+|+.+|++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4677889999999999999964 69999999996432 124679999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC----ceEEeec
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF----CPKISDF 351 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~DF 351 (511)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 91 v~E~~~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEECCCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEcCCCccccchhccc------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999643 4699999999999999999999998 999999999999998776 5999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... .......+.
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~ 229 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVS 229 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHH
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCC-------HHHHHHHHH
Confidence 99988765443 2345699999999999753 68999999999999999999999996431 223333333
Q ss_pred hhhccccCCCCCh-HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 TEYDFQLDGVVTE-EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... .... ........+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~-----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 AVNY-----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTCC-----CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcCC-----CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2211 1111 11223345667888999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=386.42 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=203.9
Q ss_pred HhhhcccCCcCceEEEEEEcCC--C--cEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEee-cCeEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPD--G--RLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYE-KKKRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 277 (511)
.+|.++||+|+||+||+|.+.+ + ..||||++++... ..++|.+|++++++++|||||+++|++.+ ....++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3567789999999999998643 2 3689999975332 33679999999999999999999999876 45889999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++..
T Consensus 109 E~~~~g~l~~~~~~~-----~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-----THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp ECCTTCBHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEeecCchhhhhccc-----cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 999999999998643 35678899999999999999999998 9999999999999999999999999999877
Q ss_pred CCCCcee--eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 358 EKKESFI--SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 358 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
....... ......||+.|+|||.+.. +.++.++||||||+++|||++|+.|+..... ...+...+..+..
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~------~~~~~~~i~~g~~ 252 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRR 252 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCC
T ss_pred cccccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC------HHHHHHHHHcCCC
Confidence 5443221 1223468999999999865 4789999999999999999998888753321 1112223333333
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccC
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIEN 484 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 484 (511)
...+... ...+.+++.+||+.||++||||+||++.|+.++..
T Consensus 253 ~~~p~~~-------~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 LLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcccC-------cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 3332222 23567888999999999999999999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-48 Score=391.24 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=201.7
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|++.++||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.+.+..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 366788999999999999995 4799999999976432 23568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc--CCCceEEeeccCccccCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD--EDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~ 359 (511)
+|+|.+++... ...+++..+..|+.||+.||+|||++ +|+||||||+||||+ +++.+||+|||+|+....
T Consensus 110 gg~L~~~~~~~-----~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 110 GGELFDRIAAE-----DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCBHHHHTTCT-----TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CChHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999887432 34699999999999999999999998 999999999999998 678999999999998866
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh-ccc-
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY-DFQ- 437 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~- 437 (511)
.... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+.... .+.
T Consensus 182 ~~~~---~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~ 249 (352)
T d1koba_ 182 DEIV---KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVKRCDWEFDE 249 (352)
T ss_dssp TSCE---EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHCCCCCCS
T ss_pred CCce---eeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCc
Confidence 5432 234699999999999764 68999999999999999999999996431 222333333321 111
Q ss_pred -cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 -LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 -~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
....++ ..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~s-------~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 250 DAFSSVS-------PEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp STTTTSC-------HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCC-------HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112233 34556778899999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=384.09 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=196.1
Q ss_pred HHHhhhcccCCcCceEEEEEEcCC----CcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 203 MTKSFSDKLGQGGYADVYKGTLPD----GRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 203 ~~~~~~~~LG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
..+.+.+.||+|+||+||+|.+.. +..||||.++..... .+.|.+|+.++++++|||||++++++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 346678899999999999998642 356899998754333 3579999999999999999999999864 578999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.+++... ...+++..++.++.||++||+|||+. +|+||||||+||++++++.+||+|||+|+.
T Consensus 86 ~E~~~~g~l~~~~~~~-----~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR-----KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EECCTTEEHHHHHHHT-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEeccCCcHHhhhhcc-----CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999988543 25789999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
........ .....||+.|+|||++.. +.++.++|||||||++|||++ |+.|+.... ...+...+.....
T Consensus 158 ~~~~~~~~-~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-------~~~~~~~i~~~~~ 227 (273)
T d1mp8a_ 158 MEDSTYYK-ASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGER 227 (273)
T ss_dssp --------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCC
T ss_pred ccCCccee-ccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCC
Confidence 65443322 234568999999999965 378999999999999999998 788875432 2334445555544
Q ss_pred cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 436 FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
...+...+ ..+.+++.+||+.||++|||++||++.|+.+++
T Consensus 228 ~~~~~~~~-------~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 LPMPPNCP-------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCC-------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 44444444 346677888999999999999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=384.35 Aligned_cols=244 Identities=25% Similarity=0.340 Sum_probs=202.3
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|.+.+.||+|+||+||+|+.+ +|+.||||++++. ....+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 457789999999999999964 7999999999753 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+....
T Consensus 87 ~~gg~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 87 ANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cCCCchhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999643 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...+.+.+... ....+
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~-------~~~~~~~i~~~-~~~~p 225 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILME-EIRFP 225 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHC-CCCCC
T ss_pred CCc--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcC-------HHHHHHHHhcC-CCCCC
Confidence 332 12345799999999999764 68999999999999999999999996432 23334443332 23444
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
..++++.. +++.+||+.||++||+ ++|+++
T Consensus 226 ~~~s~~~~-------dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 RTLSPEAK-------SLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TTSCHHHH-------HHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ccCCHHHH-------HHHHhhccCCchhhcccccccHHHHHc
Confidence 55665544 4556678999999995 777765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=385.32 Aligned_cols=259 Identities=26% Similarity=0.447 Sum_probs=206.6
Q ss_pred hhhcccCCcCceEEEEEEcC-CCc--EEEEEEeccC--CCChHHHHHHHHHHHcc-CCcceeeeeceEeecCeEEEEEEe
Q 040808 206 SFSDKLGQGGYADVYKGTLP-DGR--LVAVKVMKNL--KDNGEEFINEVASISRT-SHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
++.++||+|+||+||+|.++ +|. .||||.++.. ....++|.+|+++|+++ +|||||+++|+|.+.+..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 46789999999999999865 444 4788887643 33456899999999998 699999999999999999999999
Q ss_pred CCCCCHHHHHhcccC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEe
Q 040808 280 MPNGSLDQYIYDHES----------SNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKIS 349 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~ 349 (511)
+++|+|.++|..... ......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 999999999965421 12346799999999999999999999998 99999999999999999999999
Q ss_pred eccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCC-CCCccCCCCCCchHHHHH
Q 040808 350 DFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKN-ADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 350 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~ 428 (511)
|||+++....... .....||+.|+|||.+.. +.++.++|||||||++|||++|..| +... -...+..
T Consensus 170 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~-------~~~~~~~ 237 (309)
T d1fvra_ 170 DFGLSRGQEVYVK---KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAELYE 237 (309)
T ss_dssp CTTCEESSCEECC---C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHH
T ss_pred ccccccccccccc---ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCC-------CHHHHHH
Confidence 9999986543322 223469999999999965 4789999999999999999998754 4322 2444555
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCC
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQ 486 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~ 486 (511)
.+..+.....+...+ ..+.+++.+||+.||++||||+||++.|+.+++..+
T Consensus 238 ~i~~~~~~~~~~~~~-------~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLPQGYRLEKPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGGGTCCCCCCTTBC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHhcCCCCCCccCC-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 555554444333333 346677889999999999999999999999876544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=385.61 Aligned_cols=266 Identities=21% Similarity=0.317 Sum_probs=199.3
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHH--HHHHHHccCCcceeeeeceEeecC----eEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFIN--EVASISRTSHVNIVPFLGFCYEKK----KRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 278 (511)
+.+.++||+|+||+||+|++ +|+.||||+++... .+++.. |+..+.+++|||||+++++|.+.+ ..++|||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 34568899999999999997 57899999997543 344444 445556789999999999997654 6789999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC-----NIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-----~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
|+++|+|.++|+. ..++|..+++++.|++.||+|||+.+ ..+|+||||||+||||++++.+||+|||+
T Consensus 82 y~~~g~L~~~l~~-------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 82 YHEHGSLFDYLNR-------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp CCTTCBHHHHHHH-------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cccCCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999954 35899999999999999999999731 24999999999999999999999999999
Q ss_pred ccccCCCCceee--ecCCCCCCCccchhhccccc----CCCCccccchhHHHHHHHHHhCCCCCCCccCCCC--------
Q 040808 354 AKQTEKKESFIS--MLDTRGTAGYIAPEVFCRHF----GGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSS-------- 419 (511)
Q Consensus 354 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~-------- 419 (511)
++.......... .....||+.|+|||++.... ..++.++|||||||+||||+||..|+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 987755433222 23457999999999986431 1357799999999999999999887753322111
Q ss_pred CCchHHHHHHHhhhhccccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 420 EYFPNAIYKQIETEYDFQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
......+.+..... ...+.++. ...+....+.+++.+||+.||++|||+.||+++|+.+.+
T Consensus 235 ~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQ---KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTS---CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcc---ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11112222221111 11112222 123456678899999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=383.99 Aligned_cols=261 Identities=25% Similarity=0.423 Sum_probs=209.3
Q ss_pred HHhhhcccCCcCceEEEEEEcCC--------CcEEEEEEeccCCC--ChHHHHHHHHHHHcc-CCcceeeeeceEeecCe
Q 040808 204 TKSFSDKLGQGGYADVYKGTLPD--------GRLVAVKVMKNLKD--NGEEFINEVASISRT-SHVNIVPFLGFCYEKKK 272 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 272 (511)
.+.+.++||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||+++++|.+...
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 45678899999999999998432 24799999976543 336788999999888 79999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC
Q 040808 273 RALIYEFMPNGSLDQYIYDHESS----------NGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE 342 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~ 342 (511)
.++||||+++|+|.++|...... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 99999999999999999754311 1235689999999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCC
Q 040808 343 DFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEY 421 (511)
Q Consensus 343 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~ 421 (511)
++.+||+|||+++...............||+.|+|||.+.+ +.++.++||||||+++|||++ |+.|+...
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~------- 241 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------- 241 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-------
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCC-------
Confidence 99999999999998766554444455679999999999965 478999999999999999998 67776432
Q ss_pred chHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 422 FPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
....+.+.+..+.....+...++ .+.+++.+||+.||++|||+.||+++|++++.
T Consensus 242 ~~~~~~~~i~~~~~~~~p~~~~~-------~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 PVEELFKLLKEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCSSCCH-------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchH-------HHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 23455566666555554444443 46678899999999999999999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=385.78 Aligned_cols=261 Identities=22% Similarity=0.349 Sum_probs=211.3
Q ss_pred HHhhhcccCCcCceEEEEEEcC------CCcEEEEEEeccCCCC--hHHHHHHHHHHHccCCcceeeeeceEeecCeEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP------DGRLVAVKVMKNLKDN--GEEFINEVASISRTSHVNIVPFLGFCYEKKKRAL 275 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 275 (511)
.+.+.++||+|+||+||+|.++ +++.||||+++..... ...|.+|+.++++++|||||+++++|......++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 4457789999999999999853 3578999999764332 2468999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhccc----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 276 IYEFMPNGSLDQYIYDHE----SSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~----~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
||||+++|+|.+++.... .......+++..+..++.|+++||.|||++ +|+||||||+|||+|+++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 999999999999986532 112234679999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCC-CCCCCccCCCCCCchHHHHHHH
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGR-KNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
|+++...............||+.|+|||.+.+. .++.++||||||+++|||+||+ .|+... -...+...+
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~~i 248 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLRFV 248 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHHHH
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH
Confidence 999877655544444455689999999999764 7889999999999999999986 444321 233344444
Q ss_pred hhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcccc
Q 040808 431 ETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIE 483 (511)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 483 (511)
........+...+ ..+.+++.+||+.+|++||||++|+++|++.++
T Consensus 249 ~~~~~~~~p~~~~-------~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDKPDNCP-------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCCcccch-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 4444333333333 357788899999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-48 Score=380.12 Aligned_cols=241 Identities=25% Similarity=0.329 Sum_probs=200.8
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEe
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 279 (511)
|++.++||+|+||+||+|+++ +|+.||||++++. ....+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 457789999999999999964 6999999999742 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 359 (511)
++||+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+....
T Consensus 86 ~~gg~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 86 IEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCSCBHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred cCCcccccccccc------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999988543 4688899999999999999999998 999999999999999999999999999998765
Q ss_pred CCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccC
Q 040808 360 KESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLD 439 (511)
Q Consensus 360 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (511)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ...+...+... ....+
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~-~~~~p 221 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSN-------TMKTYEKILNA-ELRFP 221 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHC-CCCCC
T ss_pred cc-----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcC-------HHHHHHHHHcC-CCCCC
Confidence 43 345799999999999764 67899999999999999999999996431 23334443332 22333
Q ss_pred CCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 440 GVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 440 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
..++++ +.+++.+||+.||++|+ |++++++
T Consensus 222 ~~~s~~-------~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 PFFNED-------VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp TTSCHH-------HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHH-------HHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 445544 44556677899999996 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=381.07 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=202.7
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMPNG 283 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 283 (511)
|.+.++||+|+||+||+|.++ +|+.||||+++....+...+.+|+++|++++|||||++++++.+.+..++||||+++|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 567789999999999999965 6899999999876655567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC--CCceEEeeccCccccCCCC
Q 040808 284 SLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE--DFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 284 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~~ 361 (511)
+|.++|... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++. .+.+||+|||+++......
T Consensus 87 ~L~~~i~~~-----~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 87 DIFERINTS-----AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSS-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999532 24699999999999999999999998 9999999999999985 4589999999998876544
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccccCCC
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQLDGV 441 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (511)
... ...||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.... ...+...+..... .
T Consensus 159 ~~~---~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~-------~~~~~~~i~~~~~-----~ 221 (321)
T d1tkia_ 159 NFR---LLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEY-----T 221 (321)
T ss_dssp EEE---EEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCC-----C
T ss_pred ccc---ccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCC-----C
Confidence 322 34589999999998654 67899999999999999999999996432 3334444433211 1
Q ss_pred CChH-HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 442 VTEE-EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 442 ~~~~-~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+.. ...+...+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 1123344667788899999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=376.47 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=192.3
Q ss_pred HhhhcccCCcCceEEEEEEcC--CC--cEEEEEEeccCC----CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP--DG--RLVAVKVMKNLK----DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
+++.++||+|+||+||+|+++ ++ ..||||++++.. ...++|.+|+.++++++|||||+++|+|.+. ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence 456789999999999999843 23 368999987532 2236899999999999999999999999764 67899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.+++..+. ..+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 89 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999886543 4699999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCceee-ecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHh-CCCCCCCccCCCCCCchHHHHHHH-hhh
Q 040808 357 TEKKESFIS-MLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVI-GRKNADVKVSCSSEYFPNAIYKQI-ETE 433 (511)
Q Consensus 357 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~-~~~ 433 (511)
......... .....||..|+|||++.+. .++.++||||||+++|||++ |+.||.... ...+...+ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-------~~~~~~~i~~~~ 231 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEG 231 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcC-------HHHHHHHHHhCC
Confidence 755443222 2234588899999999764 78899999999999999998 898885321 22222333 232
Q ss_pred hccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhcc
Q 040808 434 YDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGS 481 (511)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 481 (511)
..+......+ ..+.+++.+||+.||++||||+||++.|++.
T Consensus 232 ~~~~~~~~~~-------~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ERLPRPEDCP-------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCTTCC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccccc-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222222333 3466788999999999999999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.6e-48 Score=373.76 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=200.5
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC----------hHHHHHHHHHHHccC-CcceeeeeceEeecCe
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN----------GEEFINEVASISRTS-HVNIVPFLGFCYEKKK 272 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 272 (511)
|.+.++||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.++++++ |||||++++++.+.+.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 45678999999999999995 47999999999754321 135889999999997 9999999999999999
Q ss_pred EEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeecc
Q 040808 273 RALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFG 352 (511)
Q Consensus 273 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFG 352 (511)
.++||||+++|+|.++|... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999643 4699999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCCCceeeecCCCCCCCccchhhcccc----cCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHH
Q 040808 353 LAKQTEKKESFISMLDTRGTAGYIAPEVFCRH----FGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYK 428 (511)
Q Consensus 353 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 428 (511)
+++....... .....||+.|+|||++.+. ...++.++||||+||++|||++|+.||.... +..+.+
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-------~~~~~~ 225 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLR 225 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-------HHHHHH
Confidence 9998765432 2345699999999998542 1246789999999999999999999996432 233333
Q ss_pred HHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 429 QIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.+..... .... +....+...+.+++.+||+.||++|||++||++
T Consensus 226 ~i~~~~~-~~~~---~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNY-QFGS---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCC-CCCT---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCC-CCCC---cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3333221 1111 111123334667778899999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-47 Score=378.58 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=209.3
Q ss_pred HHHHhhCCCCCCCCCHHHHHHHHHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHHccC
Q 040808 182 AFVRNYGSLAPKRFSYSDVRRMTKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASISRTS 256 (511)
Q Consensus 182 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~ 256 (511)
.+..+..........+. .|.+.++||+|+||+||+|.++ +|+.||||++++. ....+.+.+|+.+|++++
T Consensus 25 ~~~~~~~~~~~~~~~ld-----~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~ 99 (350)
T d1rdqe_ 25 DFLKKWETPSQNTAQLD-----QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99 (350)
T ss_dssp HHHHHHHSCCCCCCCGG-----GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC
T ss_pred HHHhhccccccCCCCcc-----CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC
Confidence 44445544444444432 3567789999999999999964 6999999998642 344578999999999999
Q ss_pred CcceeeeeceEeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCC
Q 040808 257 HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPH 336 (511)
Q Consensus 257 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~ 336 (511)
|||||++++++.+....++||||+.+|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+
T Consensus 100 hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~ 170 (350)
T d1rdqe_ 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPE 170 (350)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred CCcEeecccccccccccccccccccccchhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHH
Confidence 999999999999999999999999999999999543 3689999999999999999999998 9999999999
Q ss_pred CEEEcCCCceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccC
Q 040808 337 NIRLDEDFCPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVS 416 (511)
Q Consensus 337 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~ 416 (511)
||||+.++.+||+|||+|+...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 171 NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~-- 241 (350)
T d1rdqe_ 171 NLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFAD-- 241 (350)
T ss_dssp GEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred HcccCCCCCEEeeeceeeeeccccc-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCc--
Confidence 9999999999999999999875432 245699999999999764 6789999999999999999999999643
Q ss_pred CCCCCchHHHHHHHhhhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 040808 417 CSSEYFPNAIYKQIETEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-----SMTKVVE 476 (511)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~evl~ 476 (511)
-+..+...+.... ...+..++++ +.+++.+||+.||++|+ |++++++
T Consensus 242 -----~~~~~~~~i~~~~-~~~p~~~s~~-------~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 -----QPIQIYEKIVSGK-VRFPSHFSSD-------LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----SHHHHHHHHHHCC-CCCCTTCCHH-------HHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CHHHHHHHHhcCC-CCCCccCCHH-------HHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1333444443332 2333344443 45566678899999994 8999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=376.35 Aligned_cols=250 Identities=23% Similarity=0.257 Sum_probs=190.8
Q ss_pred hcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC------hHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 208 SDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN------GEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 208 ~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
.++||+|+||+||+|.++ +|+.||||+++..... .+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 367999999999999965 6999999999753221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
+++++..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~~~~~~~~------~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 83 ETDLEVIIKD------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp SEEHHHHHTT------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred cchHHhhhhh------cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC
Confidence 8887766552 235688899999999999999999998 9999999999999999999999999999876544
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc----
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF---- 436 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 436 (511)
... .....||+.|+|||++... ..++.++|||||||++|||++|+.||.... .......+.+....
T Consensus 154 ~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~-------~~~~l~~i~~~~~~~~~~ 223 (299)
T d1ua2a_ 154 NRA--YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDS-------DLDQLTRIFETLGTPTEE 223 (299)
T ss_dssp CCC--CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHHHCCCCTT
T ss_pred ccc--ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCC-------HHHHHHHHHHhcCCCChh
Confidence 321 2345699999999998643 357899999999999999999999986432 11122222111000
Q ss_pred --------------ccCCCCChH--HHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 437 --------------QLDGVVTEE--EKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 437 --------------~~~~~~~~~--~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
......+.. .......+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000 0012234667788889999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-47 Score=369.21 Aligned_cols=254 Identities=21% Similarity=0.274 Sum_probs=195.3
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC----hHHHHHHHHHHHccCCcceeeeeceEeecC----eEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN----GEEFINEVASISRTSHVNIVPFLGFCYEKK----KRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 275 (511)
|.+.+.||+|+||+||+|.+ .+|+.||||+++..... .++|.+|++++++++|||||++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 56778999999999999995 47999999999754322 246899999999999999999999987643 4789
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
||||+++|+|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.++|+|||.++
T Consensus 89 vmE~~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEECCCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEECCCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 99999999999988543 4699999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCce-eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 356 QTEKKESF-ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 356 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... ..+...+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCC
Confidence 65433221 223345799999999999653 68899999999999999999999996331 1222333333221
Q ss_pred cc--ccCCCCChHHHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhhccc
Q 040808 435 DF--QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRP-SMTKVVEMLEGSI 482 (511)
Q Consensus 435 ~~--~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~ 482 (511)
.. .....++ ..+.+++.+||+.||++|| |++++++.|..+.
T Consensus 232 ~~~~~~~~~~s-------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPSARHEGLS-------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGGGTSSSCC-------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCchhccCCC-------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11 1112233 3456677789999999999 8999999988643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=380.32 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=193.4
Q ss_pred Hhhh-cccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHcc-CCcceeeeeceEee----cCeEEEEE
Q 040808 205 KSFS-DKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRT-SHVNIVPFLGFCYE----KKKRALIY 277 (511)
Q Consensus 205 ~~~~-~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~ 277 (511)
|.+. +.||+|+||+||+|++ .+++.||||++++ .+.+.+|++++.++ +|||||++++++.+ ....++||
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 3444 4599999999999985 4699999999975 35677899987655 79999999999875 46789999
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC---CCceEEeeccCc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE---DFCPKISDFGLA 354 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~DFGla 354 (511)
|||+||+|.++|.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+|
T Consensus 89 Ey~~gg~L~~~i~~~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRG----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp ECCCSEEHHHHHHSCS----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ECCCCCcHHHHHHhcC----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999996432 35699999999999999999999998 9999999999999975 567999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... .....+...+...
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~---~~~~~~~~~i~~~- 232 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKTRIRMG- 232 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC-
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHH---HHHHHHHHHHhcC-
Confidence 87765543 2345799999999999764 6889999999999999999999999643211 1111111111111
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.... .......+...+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSSC---CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC---CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011 11222344456777888999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.2e-47 Score=380.16 Aligned_cols=246 Identities=26% Similarity=0.309 Sum_probs=194.1
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHH---HHHHHHccCCcceeeeeceEeecCeEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFIN---EVASISRTSHVNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv 276 (511)
|.+.+.||+|+||+||+|+.. +|+.||||++.+. ......+.+ |+.+++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456789999999999999965 6999999998642 122233444 46777778899999999999999999999
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
|||+++|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp ECCCCSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999643 4688999999999999999999998 999999999999999999999999999997
Q ss_pred cCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcc
Q 040808 357 TEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDF 436 (511)
Q Consensus 357 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (511)
...... ....||+.|+|||++... ..++.++|||||||++|||++|+.||...... ....+..... ....
T Consensus 157 ~~~~~~----~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~~~~~~-~~~~ 226 (364)
T d1omwa3 157 FSKKKP----HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMTL-TMAV 226 (364)
T ss_dssp CSSSCC----CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS----CHHHHHHHSS-SCCC
T ss_pred cCCCcc----cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcc-cCCC
Confidence 765432 345799999999998643 35789999999999999999999999643211 1112222111 1112
Q ss_pred ccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 437 QLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
..+..++++ +.+++.+||+.||++||| ++|+++
T Consensus 227 ~~~~~~s~~-------~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDSFSPE-------LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSSSCHH-------HHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCHH-------HHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 223344443 455667788999999999 578864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=375.41 Aligned_cols=243 Identities=23% Similarity=0.331 Sum_probs=200.0
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccC----CCChHHHHHHHHHHH-ccCCcceeeeeceEeecCeEEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNL----KDNGEEFINEVASIS-RTSHVNIVPFLGFCYEKKKRALIYE 278 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e 278 (511)
|.+.++||+|+||+||+|+++ +|+.||||++++. ....+.+..|..++. .++|||||++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 567889999999999999965 6999999999743 344567788888776 6899999999999999999999999
Q ss_pred eCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccC
Q 040808 279 FMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTE 358 (511)
Q Consensus 279 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 358 (511)
|+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 y~~~g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 84 YLNGGDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp CCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ecCCCcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999643 4689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhcccc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQL 438 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (511)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||... -+..+...+... ....
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~-~~~~ 222 (320)
T d1xjda_ 155 LGDAK--TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQ-------DEEELFHSIRMD-NPFY 222 (320)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHC-CCCC
T ss_pred ccccc--ccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCC-------CHHHHHHHHHcC-CCCC
Confidence 43322 2345799999999999764 7889999999999999999999999643 234444444433 2333
Q ss_pred CCCCChHHHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 040808 439 DGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMT-KVV 475 (511)
Q Consensus 439 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~-evl 475 (511)
+..+++. +.+++.+||+.||++|||+. +++
T Consensus 223 p~~~s~~-------~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 PRWLEKE-------AKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CTTSCHH-------HHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CccCCHH-------HHHHHHHhcccCCCCCcCHHHHHH
Confidence 3344443 45666778899999999995 675
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=365.12 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=194.0
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|.+.++||+|+||+||+|.+ .+|+.||||+++... ...+++.+|++++++++|||||++++++.+....++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 45568999999999999995 579999999996533 23568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
.+ ++.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~-~~~~~~~~~----~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 84 HQ-DLKKFMDAS----ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp SE-EHHHHHHHT----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred CC-chhhhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 55 555555332 235699999999999999999999998 9999999999999999999999999999877543
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc-----
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD----- 435 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 435 (511)
.. ......||+.|+|||.+... ...+.++||||+||++|+|++|+.||..... .+.+.+.......
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSE------IDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTT
T ss_pred cc--cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCH------HHHHHHHHHhcCCCchhh
Confidence 32 12345699999999998654 4568899999999999999999999964321 1111111110000
Q ss_pred ---------c--ccCCCCChHH----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 436 ---------F--QLDGVVTEEE----KEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 436 ---------~--~~~~~~~~~~----~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
. .......... ......+.+++.+||+.||++|||++|+++-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 0000000000 1122345667788999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=364.59 Aligned_cols=238 Identities=24% Similarity=0.340 Sum_probs=192.6
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC-------ChHHHHHHHHHHHccC--CcceeeeeceEeecCeE
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD-------NGEEFINEVASISRTS--HVNIVPFLGFCYEKKKR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~ 273 (511)
.|.+.+.||+|+||+||+|.. .+|+.||||++++... ...++.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 356778999999999999995 4799999999875321 1234678999999997 89999999999999999
Q ss_pred EEEEEeCCC-CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-CCceEEeec
Q 040808 274 ALIYEFMPN-GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-DFCPKISDF 351 (511)
Q Consensus 274 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~DF 351 (511)
++||||+.+ +++.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEeccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 999999975 6888888542 4699999999999999999999998 9999999999999985 579999999
Q ss_pred cCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 352 GLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 352 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
|+|+...... .....||+.|+|||++.+. ...+.++||||+||++|||++|+.||... + .+.
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~----~i~ 217 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHD---------E----EII 217 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------H----HHH
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCc---------h----HHh
Confidence 9998765432 2345799999999999654 24567899999999999999999998632 1 111
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
.. ....+..++++ +.+++.+||+.||++|||++|+++
T Consensus 218 ~~-~~~~~~~~s~~-------~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 218 RG-QVFFRQRVSSE-------CQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HC-CCCCSSCCCHH-------HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hc-ccCCCCCCCHH-------HHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 12333445544 455667788999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.8e-46 Score=366.63 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=193.3
Q ss_pred HhhhcccCCcCceEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeCC
Q 040808 205 KSFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
|.+.++||+|+||+||+|.+++|+.||||+++... ...+++.+|+.+|++++|||||++++++.+.+..+++||++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 45678999999999999999899999999997543 234789999999999999999999999999999999999997
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCCC
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKKE 361 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 361 (511)
++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~~~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 84 QDLKKLLDV------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEHHHHHHT------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred hhhHHHHHh------hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 776666652 235799999999999999999999998 99999999999999999999999999998765432
Q ss_pred ceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc------
Q 040808 362 SFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD------ 435 (511)
Q Consensus 362 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 435 (511)
. ......|++.|+|||.+.+. ..++.++|||||||++|||++|+.||..... .+. ...+.....
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~------~~~-~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQ-LMRIFRILGTPNSKN 224 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH-HHHHHHHHCCCCTTT
T ss_pred c--ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCH------HHH-HHHHHHhhCCCChhh
Confidence 2 12344689999999999654 4678999999999999999999999964311 111 111110000
Q ss_pred ---------c----ccCCCC--ChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 ---------F----QLDGVV--TEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ---------~----~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ...... ..........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 0000112234567778899999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=360.63 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=188.0
Q ss_pred HHhhhcccCCcCceEEEEEEc-CC-CcEEEEEEeccCC---CChHHHHHHHHHHHcc---CCcceeeeeceEee-----c
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PD-GRLVAVKVMKNLK---DNGEEFINEVASISRT---SHVNIVPFLGFCYE-----K 270 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 270 (511)
.|.+.++||+|+||+||+|.+ ++ ++.||||+++... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 356678999999999999986 34 6789999986432 2234566777777665 79999999999853 3
Q ss_pred CeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEee
Q 040808 271 KKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISD 350 (511)
Q Consensus 271 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D 350 (511)
...+++|||+.++++...... ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKV-----PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHS-----CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ceEEEEEEeccCCchhhhhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 478899999988777554432 235789999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHH
Q 040808 351 FGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQI 430 (511)
Q Consensus 351 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 430 (511)
||+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... .......+
T Consensus 160 fg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~-------~~~~~~~i 227 (305)
T d1blxa_ 160 FGLARIYSFQMA---LTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSS-------DVDQLGKI 227 (305)
T ss_dssp CCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHH
T ss_pred hhhhhhhccccc---CCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCC-------HHHHHHHH
Confidence 999987654432 2345799999999999764 78999999999999999999999996432 11111211
Q ss_pred hhhhcc------c-------------cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 431 ETEYDF------Q-------------LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 431 ~~~~~~------~-------------~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...... . ...............+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111000 0 000000000011223456778889999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=353.72 Aligned_cols=256 Identities=19% Similarity=0.235 Sum_probs=189.1
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCC---CChHHHHHHHHHHHccCCcceeeeeceEee--------cC
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLK---DNGEEFINEVASISRTSHVNIVPFLGFCYE--------KK 271 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 271 (511)
+|.+.++||+|+||+||+|++ ++|+.||||++.... ....++.+|+++|++++||||+++++++.. ..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 345678999999999999996 479999999986432 234678999999999999999999998854 34
Q ss_pred eEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeec
Q 040808 272 KRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDF 351 (511)
Q Consensus 272 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DF 351 (511)
..++||||++++.+..+. .....++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 91 ~~~iv~e~~~~~~~~~~~------~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp CEEEEEECCCEEHHHHHT------CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccCCCccchhh------hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 678999999877766544 2235788999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCCCce--eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHH
Q 040808 352 GLAKQTEKKESF--ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQ 429 (511)
Q Consensus 352 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 429 (511)
|+++........ .......||+.|+|||++.+. ..++.++||||+||++|||++|+.||.... .......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~-------~~~~~~~ 233 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-------EQHQLAL 233 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCC-------HHHHHHH
Confidence 999876543221 112234699999999998654 367899999999999999999999986321 1111111
Q ss_pred Hhhhhcc------------------ccCCCCChHHHH------HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 430 IETEYDF------------------QLDGVVTEEEKE------MAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 430 ~~~~~~~------------------~~~~~~~~~~~~------~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
+...... ...........+ ....+.+++.+||+.||++|||++|+++
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111100 000000000111 1223456889999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=360.67 Aligned_cols=194 Identities=25% Similarity=0.369 Sum_probs=161.8
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEeecC------eE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYEKK------KR 273 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 273 (511)
+|.+.++||+|+||+||+|.++ +|+.||||+++..... .+.+.+|+++|++++|||||+++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 3556789999999999999964 6999999999754333 357889999999999999999999997654 57
Q ss_pred EEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccC
Q 040808 274 ALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGL 353 (511)
Q Consensus 274 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGl 353 (511)
++||||+ +.+|..++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 99 ~lv~e~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 9999999 6788877742 3599999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 354 AKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 354 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
|+...... ....||+.|+|||++.+. ...+.++||||+||++|||++|+.||...
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 98775543 355799999999998654 36789999999999999999999998643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-43 Score=346.77 Aligned_cols=268 Identities=16% Similarity=0.207 Sum_probs=206.4
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCC-cceeeeeceEeecCeEEEEEEeCC
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSH-VNIVPFLGFCYEKKKRALIYEFMP 281 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~ 281 (511)
.|.+.++||+|+||+||+|++. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++.+....++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 3567889999999999999954 68999999986543 33567889999999875 89999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcC-----CCceEEeeccCccc
Q 040808 282 NGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDE-----DFCPKISDFGLAKQ 356 (511)
Q Consensus 282 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~DFGla~~ 356 (511)
+++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 84 GPSLEDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred CCCHHHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 789999885432 4689999999999999999999998 9999999999999964 57899999999987
Q ss_pred cCCCCce-----eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh
Q 040808 357 TEKKESF-----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE 431 (511)
Q Consensus 357 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 431 (511)
....... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~----~~~~~~~i~ 229 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT----NKQKYERIG 229 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC----HHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchh----HHHHHHHHH
Confidence 6533211 122345799999999999764 68999999999999999999999996432211 112222222
Q ss_pred hhhccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCCCCCCC
Q 040808 432 TEYDFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENLQIPPK 490 (511)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l~~p~~ 490 (511)
....... ..+....+...+.+++..|++.+|++||+++.+.+.|+..++.......
T Consensus 230 ~~~~~~~---~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 230 EKKQSTP---LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp HHHHHSC---HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred hccCCCC---hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCC
Confidence 2111100 0000112234567777889999999999999999999887766655433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=356.25 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=189.1
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC--ChHHHHHHHHHHHccCCcceeeeeceEeecC----eEEEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD--NGEEFINEVASISRTSHVNIVPFLGFCYEKK----KRALIY 277 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 277 (511)
|++.++||+|+||+||+|.+ .+|+.||||+++.... ..+++++|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 55678999999999999985 4799999999975433 2357899999999999999999999986543 234445
Q ss_pred EeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcccc
Q 040808 278 EFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQT 357 (511)
Q Consensus 278 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~ 357 (511)
+++.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++..
T Consensus 90 ~~~~~g~L~~~l~~-------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 90 THLMGADLYKLLKT-------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EECCCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCchhhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56679999999953 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcee-eecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhh----
Q 040808 358 EKKESFI-SMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIET---- 432 (511)
Q Consensus 358 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 432 (511)
....... ......||+.|+|||++... ..++.++||||+||++|||++|+.||..... .+........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~------~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHY------LDQLNHILGILGSP 232 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCSC
T ss_pred cCCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCH------HHHHHHHhhhccCC
Confidence 5443221 12345699999999998554 3678899999999999999999999864321 0110000000
Q ss_pred ----------------hhccccCCCCCh--HHHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 040808 433 ----------------EYDFQLDGVVTE--EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEM 477 (511)
Q Consensus 433 ----------------~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~ 477 (511)
..........+. ....+..++.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 000112346678888999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-43 Score=345.46 Aligned_cols=262 Identities=19% Similarity=0.240 Sum_probs=194.9
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceee-eeceEeecCeEEEEEEeCCC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVP-FLGFCYEKKKRALIYEFMPN 282 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~ 282 (511)
|.+.++||+|+||+||+|.+ .+|+.||||++..... .+++..|++++++++|+|++. +.++..+.+..++||||+ +
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 56788999999999999985 4689999999876433 356889999999998776555 455557788899999999 6
Q ss_pred CCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEc---CCCceEEeeccCccccCC
Q 040808 283 GSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLD---EDFCPKISDFGLAKQTEK 359 (511)
Q Consensus 283 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~DFGla~~~~~ 359 (511)
++|.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+....
T Consensus 87 ~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 87 PSLEDLFNFC-----SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CBHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred Cchhhhhhhc-----cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 6777766433 25799999999999999999999998 999999999999985 355799999999997754
Q ss_pred CCce-----eeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 360 KESF-----ISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 360 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
.... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~---~~~~~~~~~~ 233 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ---KYERISEKKM 233 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------HHHHHHHHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHH---HHHHhhcccC
Confidence 3321 112345699999999999764 68999999999999999999999996443211111 1111111100
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhhccccCC
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVEMLEGSIENL 485 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~l 485 (511)
... .......+...+.+++.+||+.+|++||+++++.+.|+......
T Consensus 234 ~~~----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 STP----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HSC----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCC----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000 00001122345667788899999999999999999998765443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=348.29 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=196.2
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCC---ChHHHHHHHHHHHccCCcceeeeeceEeecCeEEEEEEeC
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKD---NGEEFINEVASISRTSHVNIVPFLGFCYEKKKRALIYEFM 280 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 280 (511)
|++.++||+|+||+||+|++ .+|+.||||+++.... ..+++.+|+.++++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 55678999999999999995 4789999999975432 2468899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCccccCCC
Q 040808 281 PNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAKQTEKK 360 (511)
Q Consensus 281 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 360 (511)
.+++|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 84 ~~~~l~~~~~~------~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 84 DQDLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp SEEHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ccccccccccc------ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999887743 24688999999999999999999998 9999999999999999999999999999887654
Q ss_pred CceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhccc---
Q 040808 361 ESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYDFQ--- 437 (511)
Q Consensus 361 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 437 (511)
... .....+++.|+|||.+... ..++.++||||+||++|||++|+.|+..... ..+. ...+.......
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-----~~~~-~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 155 VRC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQ-LKRIFRLLGTPTEE 225 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHH-HHHHHHHHCCCCTT
T ss_pred Ccc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCC-----HHHH-HHHHHhhcCCCChh
Confidence 332 2234578899999998654 3578999999999999999999999753221 1111 11111110000
Q ss_pred ------------------cCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 438 ------------------LDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 438 ------------------~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
...........+...+.+++.+||+.||++|||++||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000001112234556777888999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=355.17 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=187.3
Q ss_pred HHhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHccCCcceeeeeceEeec------CeEEEE
Q 040808 204 TKSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIVPFLGFCYEK------KKRALI 276 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lv 276 (511)
+|+..++||+|+||+||+|++. +|+.||||++++.... +.+|+++|++++||||++++++|... .+.++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 3455678999999999999965 6999999999765433 34799999999999999999998542 357899
Q ss_pred EEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCcc
Q 040808 277 YEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAK 355 (511)
Q Consensus 277 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~ 355 (511)
|||++++.+....... .....+++..+..|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 98 ~Ey~~~~~~~~l~~~~---~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EECCSEEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EeccCCccHHHHHhhh---hccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999766443333211 1235799999999999999999999998 999999999999999775 89999999998
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHh----
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIE---- 431 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 431 (511)
........ ....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||..... .+.+.+.+.
T Consensus 172 ~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~------~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 172 QLVRGEPN---VSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGT 241 (350)
T ss_dssp ECCTTSCC---CSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH------HHHHHHHHHHHCC
T ss_pred hccCCccc---ccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCH------HHHHHHHHHHhCC
Confidence 77654432 345699999999998654 3688999999999999999999999964321 111111100
Q ss_pred -----------hhhccccCCCCCh-----HHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 432 -----------TEYDFQLDGVVTE-----EEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 432 -----------~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
............. ........+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 00011233556777889999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=351.98 Aligned_cols=251 Identities=23% Similarity=0.255 Sum_probs=197.0
Q ss_pred HhhhcccCCcCceEEEEEEcC----CCcEEEEEEeccC-----CCChHHHHHHHHHHHccCC-cceeeeeceEeecCeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP----DGRLVAVKVMKNL-----KDNGEEFINEVASISRTSH-VNIVPFLGFCYEKKKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~----~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 274 (511)
|.+.++||+|+||+||+|... +|+.||||++++. ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 677899999999999999742 4789999998643 2234678899999999976 89999999999999999
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
++|||+.+|+|.+++... ..++...+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 106 ~v~e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEECCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999653 3577889999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhh
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEY 434 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 434 (511)
+......... .....|++.|+|||.+......++.++|||||||+||||++|+.||..... ......+.+.... .
T Consensus 177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~---~~~~~~i~~~~~~-~ 251 (322)
T d1vzoa_ 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE---KNSQAEISRRILK-S 251 (322)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS---CCCHHHHHHHHHH-C
T ss_pred hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhccc-C
Confidence 8765443322 234569999999999976545678899999999999999999999964421 1222222222211 1
Q ss_pred ccccCCCCChHHHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 040808 435 DFQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPS-----MTKVVE 476 (511)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~evl~ 476 (511)
....+...++ .+.+++.+||+.||++||| ++|+++
T Consensus 252 ~~~~~~~~s~-------~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 EPPYPQEMSA-------LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCCCTTSCH-------HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCcccCCH-------HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1222233343 4555667788999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=346.01 Aligned_cols=252 Identities=24% Similarity=0.233 Sum_probs=183.2
Q ss_pred HhhhcccCCcCceEEEEEEcC-CCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEee------cCeEE
Q 040808 205 KSFSDKLGQGGYADVYKGTLP-DGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYE------KKKRA 274 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~ 274 (511)
|++.++||+|+||+||+|.+. +|+.||||+++..... ..++.+|+.++++++|||||+++++|.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 456689999999999999965 6999999999865433 2468899999999999999999999853 46889
Q ss_pred EEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCc
Q 040808 275 LIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLA 354 (511)
Q Consensus 275 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla 354 (511)
+||||+.++ +.+.+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||++
T Consensus 99 iv~Ey~~~~-l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 99 LVMELMDAN-LCQVIQ--------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEECCSEE-HHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEeccchH-HHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 999999655 444442 3589999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHH-------
Q 040808 355 KQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIY------- 427 (511)
Q Consensus 355 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~------- 427 (511)
+....... .....||+.|+|||++.+. .++.++||||+||+++||++|+.||..... ......+.
T Consensus 167 ~~~~~~~~---~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 167 RTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPC 238 (355)
T ss_dssp -----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred hccccccc---cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCC
Confidence 87655433 2344699999999999764 788999999999999999999999853310 00000000
Q ss_pred ------------HHHhhhhc-----------cccCCCCChHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 428 ------------KQIETEYD-----------FQLDGVVTEEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 428 ------------~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
........ .................+.+++.+||+.||++|||++||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 00011112223345566788999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-43 Score=349.65 Aligned_cols=193 Identities=22% Similarity=0.364 Sum_probs=166.3
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC-CcceeeeeceEee--cCeEEEEEEe
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS-HVNIVPFLGFCYE--KKKRALIYEF 279 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~ 279 (511)
.|.+.++||+|+||+||+|++ .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 466788999999999999996 47999999999753 3578899999999996 9999999999874 4568999999
Q ss_pred CCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC-ceEEeeccCccccC
Q 040808 280 MPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF-CPKISDFGLAKQTE 358 (511)
Q Consensus 280 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 358 (511)
+.+++|..+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 114 ~~~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 114 VNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp CCSCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred cCCCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999987654 4689999999999999999999998 999999999999998654 69999999998776
Q ss_pred CCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCc
Q 040808 359 KKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVK 414 (511)
Q Consensus 359 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~ 414 (511)
.... .....||+.|+|||.+.+. ..++.++||||+||++|||++|+.||...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 5443 2345699999999998654 35789999999999999999999998643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=344.13 Aligned_cols=249 Identities=21% Similarity=0.242 Sum_probs=186.8
Q ss_pred HhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCC---hHHHHHHHHHHHccCCcceeeeeceEee-----cCeEEE
Q 040808 205 KSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDN---GEEFINEVASISRTSHVNIVPFLGFCYE-----KKKRAL 275 (511)
Q Consensus 205 ~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~l 275 (511)
|.+.++||+|+||+||+|++ .+|+.||||++++.... .+++.+|+.+|++++|||||++++++.. ....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 55678999999999999995 57999999999865433 3568899999999999999999998863 334566
Q ss_pred EEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 276 IYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 276 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
+++++.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 100 i~~~~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEECCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 7778889999999832 3599999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCchHHHHHHHhhhhc
Q 040808 356 QTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYFPNAIYKQIETEYD 435 (511)
Q Consensus 356 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (511)
...... ....||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||..... ......+.....
T Consensus 170 ~~~~~~-----~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-------~~~~~~i~~~~~ 236 (348)
T d2gfsa1 170 HTDDEM-----TGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-------IDQLKLILRLVG 236 (348)
T ss_dssp CCTGGG-----SSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHHHC
T ss_pred ccCccc-----ccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcC
Confidence 664432 345689999999997654 3578899999999999999999999864321 111111110000
Q ss_pred c---------------------ccCCCCC--hHHHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 040808 436 F---------------------QLDGVVT--EEEKEMAKKMILVSLWCIQTHPPDRPSMTKVVE 476 (511)
Q Consensus 436 ~---------------------~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~evl~ 476 (511)
. ....... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0000000 000011233556778899999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-38 Score=318.68 Aligned_cols=278 Identities=23% Similarity=0.264 Sum_probs=195.1
Q ss_pred HHhhhcccCCcCceEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHccC-----------CcceeeeeceEee--
Q 040808 204 TKSFSDKLGQGGYADVYKGTL-PDGRLVAVKVMKNLKDNGEEFINEVASISRTS-----------HVNIVPFLGFCYE-- 269 (511)
Q Consensus 204 ~~~~~~~LG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~-- 269 (511)
+|.+.++||+|+||+||+|+. .+|+.||||++++.....+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 467889999999999999996 47999999999876555577889999998875 4789999988754
Q ss_pred cCeEEEEEEeCCCCC-HHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCC----
Q 040808 270 KKKRALIYEFMPNGS-LDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDF---- 344 (511)
Q Consensus 270 ~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~---- 344 (511)
....+++++++..+. ....... .....+++..+..++.||+.||+|||+. .+|+||||||+||||+.++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKK----YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHH----TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred ccceeeeeeeccccccccccccc----ccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccc
Confidence 356667777765543 3333322 2246788999999999999999999983 2899999999999998665
Q ss_pred --ceEEeeccCccccCCCCceeeecCCCCCCCccchhhcccccCCCCccccchhHHHHHHHHHhCCCCCCCccCCCCCCc
Q 040808 345 --CPKISDFGLAKQTEKKESFISMLDTRGTAGYIAPEVFCRHFGGVSHKSDVYSYGMMIHEMVIGRKNADVKVSCSSEYF 422 (511)
Q Consensus 345 --~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDvwSlG~il~elltg~~p~~~~~~~~~~~~ 422 (511)
.++++|||.+....... ....||+.|+|||++... .++.++||||+||++++|++|+.||...........
T Consensus 168 ~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp EEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cceeeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 39999999998665432 245699999999998653 678999999999999999999999864432211111
Q ss_pred hHHHHHHHhhh---------------hcc-------ccCC-CCC----------hHHHHHHHHHHHHHHhccccCCCCCC
Q 040808 423 PNAIYKQIETE---------------YDF-------QLDG-VVT----------EEEKEMAKKMILVSLWCIQTHPPDRP 469 (511)
Q Consensus 423 ~~~~~~~~~~~---------------~~~-------~~~~-~~~----------~~~~~~~~~~~~l~~~Cl~~~p~~RP 469 (511)
.+.+...+... ..+ .... ... .........+.+++.+||+.||++||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 11111110000 000 0000 000 01133456778899999999999999
Q ss_pred CHHHHHHH--hhcc--ccCCCCCCCCCCC
Q 040808 470 SMTKVVEM--LEGS--IENLQIPPKPSLS 494 (511)
Q Consensus 470 s~~evl~~--L~~~--~~~l~~p~~p~~~ 494 (511)
|++|+++- +++. .++.+.|+++...
T Consensus 321 ta~e~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 321 DAGGLVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp CHHHHHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred CHHHHhcCcccCCCCCcccCCCCCcccCC
Confidence 99999863 4422 3445566666554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.6e-25 Score=202.42 Aligned_cols=161 Identities=16% Similarity=0.122 Sum_probs=118.0
Q ss_pred hhhcccCCcCceEEEEEEcCCCcEEEEEEeccCCCC-------------------hHHHHHHHHHHHccCCcceeeeece
Q 040808 206 SFSDKLGQGGYADVYKGTLPDGRLVAVKVMKNLKDN-------------------GEEFINEVASISRTSHVNIVPFLGF 266 (511)
Q Consensus 206 ~~~~~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~E~~~l~~l~h~niv~l~~~ 266 (511)
.++++||+|+||+||+|.+.+|+.||||+++..... ...+.+|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 357899999999999999888999999987532110 1234568889999999999887754
Q ss_pred EeecCeEEEEEEeCCCCCHHHHHhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcEecCCCCCCEEEcCCCce
Q 040808 267 CYEKKKRALIYEFMPNGSLDQYIYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGCNIRIVHLDIKPHNIRLDEDFCP 346 (511)
Q Consensus 267 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~~~~iiH~Dlkp~NIll~~~~~~ 346 (511)
. ..+++|||+++..+.+ ++......++.|++.+|+|||+. +|+||||||+|||+++++ +
T Consensus 83 ~----~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~ 141 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-I 141 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-E
T ss_pred c----CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-E
Confidence 3 2379999998755422 33344567999999999999998 999999999999999765 8
Q ss_pred EEeeccCccccCCCCceeeecCCCCCCCccc------hhhcccccCCCCccccchhHHHH
Q 040808 347 KISDFGLAKQTEKKESFISMLDTRGTAGYIA------PEVFCRHFGGVSHKSDVYSYGMM 400 (511)
Q Consensus 347 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~~sDvwSlG~i 400 (511)
+|+|||+|........ ..|.. .+.+.+ .++.++|+||..--
T Consensus 142 ~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~ 188 (191)
T d1zara2 142 WIIDFPQSVEVGEEGW----------REILERDVRNIITYFSR---TYRTEKDINSAIDR 188 (191)
T ss_dssp EECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHH---HHCCCCCHHHHHHH
T ss_pred EEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcC---CCCCcccHHHHHHH
Confidence 9999999976543221 01111 123322 46788999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=5.4e-07 Score=83.58 Aligned_cols=133 Identities=15% Similarity=0.062 Sum_probs=89.5
Q ss_pred cCCcCceEEEEEEcCCCcEEEEEEeccC-CCChHHHHHHHHHHHccC-CcceeeeeceEeecCeEEEEEEeCCCCCHHHH
Q 040808 211 LGQGGYADVYKGTLPDGRLVAVKVMKNL-KDNGEEFINEVASISRTS-HVNIVPFLGFCYEKKKRALIYEFMPNGSLDQY 288 (511)
Q Consensus 211 LG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 288 (511)
.+.++.+.||+... +++.+.+|+.... ......+.+|+..+..++ +--+.+++.+..+++..++||++++|.++.+.
T Consensus 22 ~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 22 TEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 33345578998875 4556778877543 233446778888887765 43456777777888899999999999888654
Q ss_pred HhcccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 040808 289 IYDHESSNGKRTLEWRTVYQIAVGIARGLEYLHRGC-------------------------------------------- 324 (511)
Q Consensus 289 l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~yLH~~~-------------------------------------------- 324 (511)
.... . ....++.++++.++.||+..
T Consensus 101 ~~~~--------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T d1j7la_ 101 YEDE--------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp TTTC--------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHH
T ss_pred cccc--------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHH
Confidence 4210 1 12223445555555555311
Q ss_pred ------------CCCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 325 ------------NIRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 325 ------------~~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 170 ~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987777799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=4e-06 Score=77.03 Aligned_cols=73 Identities=19% Similarity=0.145 Sum_probs=52.7
Q ss_pred cCCcC-ceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCc--ceeeeeceEeecCeEEEEEEeCCCCCH
Q 040808 211 LGQGG-YADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHV--NIVPFLGFCYEKKKRALIYEFMPNGSL 285 (511)
Q Consensus 211 LG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL 285 (511)
+..|. .+.||+...+++..+.+|...... ...+..|+..++.+... .+.+++.+..+.+..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34443 478999998888889999865432 33566788777766533 356677777888889999999987655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=0.00011 Score=71.91 Aligned_cols=74 Identities=12% Similarity=0.109 Sum_probs=48.0
Q ss_pred cccCCcCceEEEEEEcCC-CcEEEEEEecc----C----CCChHHHHHHHHHHHccC-C--cceeeeeceEeecCeEEEE
Q 040808 209 DKLGQGGYADVYKGTLPD-GRLVAVKVMKN----L----KDNGEEFINEVASISRTS-H--VNIVPFLGFCYEKKKRALI 276 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~-~~~vavK~~~~----~----~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 276 (511)
+.||.|....||+....+ ++.++||.-.. . ....++...|++.|..+. + ..+.+++. .+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 469999999999998654 67899996432 1 112345667888887663 2 23455554 355566899
Q ss_pred EEeCCCCC
Q 040808 277 YEFMPNGS 284 (511)
Q Consensus 277 ~e~~~~gs 284 (511)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.00046 Score=65.46 Aligned_cols=139 Identities=12% Similarity=0.103 Sum_probs=81.1
Q ss_pred ceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcce--eeee-----ceEeecCeEEEEEEeCCCCCHH--
Q 040808 216 YADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI--VPFL-----GFCYEKKKRALIYEFMPNGSLD-- 286 (511)
Q Consensus 216 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~gsL~-- 286 (511)
--.||+....+|+.+++|+.+......+++..|...+..+...++ +..+ ......+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 358999999999999999987665566778889888877753322 1111 1234566788999998763221
Q ss_pred ---HH------H---hcc---cCCCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-HhCCCCCc
Q 040808 287 ---QY------I---YDH---ESSNGKRTLEWR----------------------TVYQIAVGIARGLEYL-HRGCNIRI 328 (511)
Q Consensus 287 ---~~------l---~~~---~~~~~~~~l~~~----------------------~~~~i~~~i~~~l~yL-H~~~~~~i 328 (511)
.+ + +.. .........++. .....+.++...+.-+ ......++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 10 0 100 000111122221 1122223333322222 12224579
Q ss_pred EecCCCCCCEEEcCCCceEEeeccCccc
Q 040808 329 VHLDIKPHNIRLDEDFCPKISDFGLAKQ 356 (511)
Q Consensus 329 iH~Dlkp~NIll~~~~~~kl~DFGla~~ 356 (511)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.98 E-value=0.00059 Score=66.60 Aligned_cols=72 Identities=15% Similarity=0.251 Sum_probs=50.0
Q ss_pred cccCCcCceEEEEEEcCC--------CcEEEEEEeccCCCChHHHHHHHHHHHccCCccee-eeeceEeecCeEEEEEEe
Q 040808 209 DKLGQGGYADVYKGTLPD--------GRLVAVKVMKNLKDNGEEFINEVASISRTSHVNIV-PFLGFCYEKKKRALIYEF 279 (511)
Q Consensus 209 ~~LG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 279 (511)
+.|+.|-.-.+|+....+ .+.|.+++... ........+|..+++.+.-.+++ ++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 568889999999998653 35677777663 33344566899888888644554 66766643 689999
Q ss_pred CCCCCH
Q 040808 280 MPNGSL 285 (511)
Q Consensus 280 ~~~gsL 285 (511)
++|.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.17 E-value=0.01 Score=55.35 Aligned_cols=144 Identities=11% Similarity=0.054 Sum_probs=72.3
Q ss_pred ccCCcCceEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHccCCcce-----eeee-c--eEeecCeEEEEEEeCC
Q 040808 210 KLGQGGYADVYKGTLPDGRLVAVKVMKNLKDNGEEFINEVASISRTSHVNI-----VPFL-G--FCYEKKKRALIYEFMP 281 (511)
Q Consensus 210 ~LG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~-~--~~~~~~~~~lv~e~~~ 281 (511)
.|..|---+.|+....+|+ +++|+.... ...++...|++++..+...++ +... | +..-......++.+..
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 3566777889999876665 899988643 223344456666666543221 1111 1 1223456667777776
Q ss_pred CCCHHH--------------HHhcc-cCCC--CCCCCCH------------------HHHHHHHHHHHHHHHHHHh-CCC
Q 040808 282 NGSLDQ--------------YIYDH-ESSN--GKRTLEW------------------RTVYQIAVGIARGLEYLHR-GCN 325 (511)
Q Consensus 282 ~gsL~~--------------~l~~~-~~~~--~~~~l~~------------------~~~~~i~~~i~~~l~yLH~-~~~ 325 (511)
+..... .++.. .... ....... ......+..+...+.-.+. .-.
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 532210 00000 0000 0000000 0111122222222232222 224
Q ss_pred CCcEecCCCCCCEEEcCCCceEEeeccCcc
Q 040808 326 IRIVHLDIKPHNIRLDEDFCPKISDFGLAK 355 (511)
Q Consensus 326 ~~iiH~Dlkp~NIll~~~~~~kl~DFGla~ 355 (511)
.++||+|+.++||+++++...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 589999999999999998777899999863
|